<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>Apixaban Accord - EN annexes</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 1 6 1 0 1 1 1 1 1;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimHei;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:MingLiU;
	panose-1:2 1 6 9 0 1 1 1 1 1;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;}
@font-face
	{font-family:Mangal;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Latha;
	panose-1:2 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;}
@font-face
	{font-family:Vrinda;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Raavi;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Shruti;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tunga;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:DengXian;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Palatino Linotype";
	panose-1:2 4 5 2 5 5 5 3 3 4;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI Symbol";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:BISansCond;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial Black";
	panose-1:2 11 10 4 2 1 2 2 2 4;}
@font-face
	{font-family:"Bahnschrift Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Bahnschrift;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Light SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight SemiConde";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold SemiConden";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Light Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Candara;
	panose-1:2 14 5 2 3 3 3 2 2 4;}
@font-face
	{font-family:"Candara Light";
	panose-1:2 14 5 2 3 3 3 2 2 4;}
@font-face
	{font-family:"Comic Sans MS";
	panose-1:3 15 7 2 3 3 2 2 2 4;}
@font-face
	{font-family:Consolas;
	panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
	{font-family:Constantia;
	panose-1:2 3 6 2 5 3 6 3 3 3;}
@font-face
	{font-family:Corbel;
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"Corbel Light";
	panose-1:2 11 3 3 2 2 4 2 2 4;}
@font-face
	{font-family:Ebrima;
	panose-1:2 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Franklin Gothic Medium";
	panose-1:2 11 6 3 2 1 2 2 2 4;}
@font-face
	{font-family:Gabriola;
	panose-1:4 4 6 5 5 16 2 2 13 2;}
@font-face
	{font-family:Gadugi;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Georgia;
	panose-1:2 4 5 2 5 4 5 2 3 3;}
@font-face
	{font-family:Impact;
	panose-1:2 11 8 6 3 9 2 5 2 4;}
@font-face
	{font-family:"Ink Free";
	panose-1:3 8 4 2 0 5 0 0 0 0;}
@font-face
	{font-family:"Javanese Text";
	panose-1:2 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Leelawadee UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Leelawadee UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Lucida Console";
	panose-1:2 11 6 9 4 5 4 2 2 4;}
@font-face
	{font-family:"Lucida Sans Unicode";
	panose-1:2 11 6 2 3 5 4 2 2 4;}
@font-face
	{font-family:"Malgun Gothic";
	panose-1:2 11 5 3 2 0 0 2 0 4;}
@font-face
	{font-family:"\@Malgun Gothic";}
@font-face
	{font-family:"Malgun Gothic Semilight";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Malgun Gothic Semilight";}
@font-face
	{font-family:"Microsoft Himalaya";
	panose-1:1 1 1 0 1 1 1 1 1 1;}
@font-face
	{font-family:"Microsoft JhengHei";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei";}
@font-face
	{font-family:"Microsoft JhengHei UI";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei UI";}
@font-face
	{font-family:"Microsoft JhengHei Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei Light";}
@font-face
	{font-family:"Microsoft JhengHei UI Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei UI Light";}
@font-face
	{font-family:"Microsoft New Tai Lue";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft PhagsPa";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft Sans Serif";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Microsoft Tai Le";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft YaHei";
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"\@Microsoft YaHei";}
@font-face
	{font-family:"Microsoft YaHei UI";
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"\@Microsoft YaHei UI";}
@font-face
	{font-family:"Microsoft YaHei Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Microsoft YaHei Light";}
@font-face
	{font-family:"Microsoft YaHei UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Microsoft YaHei UI Light";}
@font-face
	{font-family:"Microsoft Yi Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:MingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MingLiU-ExtB";}
@font-face
	{font-family:PMingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@PMingLiU-ExtB";}
@font-face
	{font-family:MingLiU_HKSCS-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MingLiU_HKSCS-ExtB";}
@font-face
	{font-family:"Mongolian Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:"MS UI Gothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;}
@font-face
	{font-family:"\@MS UI Gothic";}
@font-face
	{font-family:"MS PGothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;}
@font-face
	{font-family:"\@MS PGothic";}
@font-face
	{font-family:"MV Boli";
	panose-1:2 0 5 0 3 2 0 9 0 0;}
@font-face
	{font-family:"Myanmar Text";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Nirmala UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Nirmala UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;}
@font-face
	{font-family:"Segoe Print";
	panose-1:2 0 6 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Segoe Script";
	panose-1:3 11 5 4 2 0 0 0 0 3;}
@font-face
	{font-family:"Segoe UI Black";
	panose-1:2 11 10 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Historic";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Semibold";
	panose-1:2 11 7 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:NSimSun;
	panose-1:2 1 6 9 3 1 1 1 1 1;}
@font-face
	{font-family:"\@NSimSun";}
@font-face
	{font-family:SimSun-ExtB;
	panose-1:2 1 6 9 6 1 1 1 1 1;}
@font-face
	{font-family:"\@SimSun-ExtB";}
@font-face
	{font-family:"Sitka Small";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Text";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Subheading";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Heading";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Display";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Banner";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Trebuchet MS";
	panose-1:2 11 6 3 2 2 2 2 2 4;}
@font-face
	{font-family:Webdings;
	panose-1:5 3 1 2 1 5 9 6 7 3;}
@font-face
	{font-family:"\@Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Yu Gothic UI";
	panose-1:2 11 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI";}
@font-face
	{font-family:"Yu Gothic UI Semibold";
	panose-1:2 11 7 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semibold";}
@font-face
	{font-family:"Yu Gothic Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic Light";}
@font-face
	{font-family:"Yu Gothic UI Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Light";}
@font-face
	{font-family:"Yu Gothic Medium";
	panose-1:2 11 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic Medium";}
@font-face
	{font-family:"Yu Gothic UI Semilight";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semilight";}
@font-face
	{font-family:"HoloLens MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;}
@font-face
	{font-family:"Agency FB";
	panose-1:2 11 5 3 2 2 2 2 2 4;}
@font-face
	{font-family:Algerian;
	panose-1:4 2 7 5 4 10 2 6 7 2;}
@font-face
	{font-family:"Book Antiqua";
	panose-1:2 4 6 2 5 3 5 3 3 4;}
@font-face
	{font-family:"Arial Narrow";
	panose-1:2 11 6 6 2 2 2 3 2 4;}
@font-face
	{font-family:"Arial Rounded MT Bold";
	panose-1:2 15 7 4 3 5 4 3 2 4;}
@font-face
	{font-family:"Baskerville Old Face";
	panose-1:2 2 6 2 8 5 5 2 3 3;}
@font-face
	{font-family:"Bauhaus 93";
	panose-1:4 3 9 5 2 11 2 2 12 2;}
@font-face
	{font-family:"Bell MT";
	panose-1:2 2 5 3 6 3 5 2 3 3;}
@font-face
	{font-family:"Bernard MT Condensed";
	panose-1:2 5 8 6 6 9 5 2 4 4;}
@font-face
	{font-family:"Bodoni MT";
	panose-1:2 7 6 3 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Black";
	panose-1:2 7 10 3 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Condensed";
	panose-1:2 7 6 6 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Poster Compressed";
	panose-1:2 7 7 6 8 6 1 5 2 4;}
@font-face
	{font-family:"Bookman Old Style";
	panose-1:2 5 6 4 5 5 5 2 2 4;}
@font-face
	{font-family:"Bradley Hand ITC";
	panose-1:3 7 4 2 5 3 2 3 2 3;}
@font-face
	{font-family:"Britannic Bold";
	panose-1:2 11 9 3 6 7 3 2 2 4;}
@font-face
	{font-family:"Berlin Sans FB";
	panose-1:2 14 6 2 2 5 2 2 3 6;}
@font-face
	{font-family:"Berlin Sans FB Demi";
	panose-1:2 14 8 2 2 5 2 2 3 6;}
@font-face
	{font-family:Broadway;
	panose-1:4 4 9 5 8 11 2 2 5 2;}
@font-face
	{font-family:"Brush Script MT";
	panose-1:3 6 8 2 4 4 6 7 3 4;}
@font-face
	{font-family:"Bookshelf Symbol 7";
	panose-1:5 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Californian FB";
	panose-1:2 7 4 3 6 8 11 3 2 4;}
@font-face
	{font-family:"Calisto MT";
	panose-1:2 4 6 3 5 5 5 3 3 4;}
@font-face
	{font-family:Castellar;
	panose-1:2 10 4 2 6 4 6 1 3 1;}
@font-face
	{font-family:"Century Schoolbook";
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:Centaur;
	panose-1:2 3 5 4 5 2 5 2 3 4;}
@font-face
	{font-family:Chiller;
	panose-1:4 2 4 4 3 16 7 2 6 2;}
@font-face
	{font-family:"Colonna MT";
	panose-1:4 2 8 5 6 2 2 3 2 3;}
@font-face
	{font-family:"Cooper Black";
	panose-1:2 8 9 4 4 3 11 2 4 4;}
@font-face
	{font-family:"Copperplate Gothic Bold";
	panose-1:2 14 7 5 2 2 6 2 4 4;}
@font-face
	{font-family:"Copperplate Gothic Light";
	panose-1:2 14 5 7 2 2 6 2 4 4;}
@font-face
	{font-family:"Curlz MT";
	panose-1:4 4 4 4 5 7 2 2 2 2;}
@font-face
	{font-family:Dubai;
	panose-1:2 11 5 3 3 4 3 3 2 4;}
@font-face
	{font-family:"Dubai Light";
	panose-1:2 11 3 3 3 4 3 3 2 4;}
@font-face
	{font-family:"Dubai Medium";
	panose-1:2 11 6 3 3 4 3 3 2 4;}
@font-face
	{font-family:Elephant;
	panose-1:2 2 9 4 9 5 5 2 3 3;}
@font-face
	{font-family:"Engravers MT";
	panose-1:2 9 7 7 8 5 5 2 3 4;}
@font-face
	{font-family:"Eras Bold ITC";
	panose-1:2 11 9 7 3 5 4 2 2 4;}
@font-face
	{font-family:"Eras Demi ITC";
	panose-1:2 11 8 5 3 5 4 2 8 4;}
@font-face
	{font-family:"Eras Light ITC";
	panose-1:2 11 4 2 3 5 4 2 8 4;}
@font-face
	{font-family:"Eras Medium ITC";
	panose-1:2 11 6 2 3 5 4 2 8 4;}
@font-face
	{font-family:"Felix Titling";
	panose-1:4 6 5 5 6 2 2 2 10 4;}
@font-face
	{font-family:Forte;
	panose-1:3 6 9 2 4 5 2 7 2 3;}
@font-face
	{font-family:"Franklin Gothic Book";
	panose-1:2 11 5 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Demi";
	panose-1:2 11 7 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Demi Cond";
	panose-1:2 11 7 6 3 4 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Heavy";
	panose-1:2 11 9 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Medium Cond";
	panose-1:2 11 6 6 3 4 2 2 2 4;}
@font-face
	{font-family:"Freestyle Script";
	panose-1:3 8 4 2 3 2 5 11 4 4;}
@font-face
	{font-family:"French Script MT";
	panose-1:3 2 4 2 4 6 7 4 6 5;}
@font-face
	{font-family:"Footlight MT Light";
	panose-1:2 4 6 2 6 3 10 2 3 4;}
@font-face
	{font-family:Garamond;
	panose-1:2 2 4 4 3 3 1 1 8 3;}
@font-face
	{font-family:Gigi;
	panose-1:4 4 5 4 6 16 7 2 13 2;}
@font-face
	{font-family:"Gill Sans MT";
	panose-1:2 11 5 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans MT Condensed";
	panose-1:2 11 5 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans Ultra Bold Condensed";
	panose-1:2 11 10 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans Ultra Bold";
	panose-1:2 11 10 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Gloucester MT Extra Condensed";
	panose-1:2 3 8 8 2 6 1 1 1 1;}
@font-face
	{font-family:"Gill Sans MT Ext Condensed Bold";
	panose-1:2 11 9 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Century Gothic";
	panose-1:2 11 5 2 2 2 2 2 2 4;}
@font-face
	{font-family:"Goudy Old Style";
	panose-1:2 2 5 2 5 3 5 2 3 3;}
@font-face
	{font-family:"Goudy Stout";
	panose-1:2 2 9 4 7 3 11 2 4 1;}
@font-face
	{font-family:"Harlow Solid Italic";
	panose-1:4 3 6 4 2 15 2 2 13 2;}
@font-face
	{font-family:Harrington;
	panose-1:4 4 5 5 5 10 2 2 7 2;}
@font-face
	{font-family:Haettenschweiler;
	panose-1:2 11 7 6 4 9 2 6 2 4;}
@font-face
	{font-family:"High Tower Text";
	panose-1:2 4 5 2 5 5 6 3 3 3;}
@font-face
	{font-family:"Imprint MT Shadow";
	panose-1:4 2 6 5 6 3 3 3 2 2;}
@font-face
	{font-family:"Informal Roman";
	panose-1:3 6 4 2 3 4 6 11 2 4;}
@font-face
	{font-family:"Blackadder ITC";
	panose-1:4 2 5 5 5 16 7 2 13 2;}
@font-face
	{font-family:"Edwardian Script ITC";
	panose-1:3 3 3 2 4 7 7 13 8 4;}
@font-face
	{font-family:"Kristen ITC";
	panose-1:3 5 5 2 4 2 2 3 2 2;}
@font-face
	{font-family:Jokerman;
	panose-1:4 9 6 5 6 13 6 2 7 2;}
@font-face
	{font-family:"Juice ITC";
	panose-1:4 4 4 3 4 10 2 2 2 2;}
@font-face
	{font-family:"Kunstler Script";
	panose-1:3 3 4 2 2 6 7 13 13 6;}
@font-face
	{font-family:"Wide Latin";
	panose-1:2 10 10 7 5 5 5 2 4 4;}
@font-face
	{font-family:"Lucida Bright";
	panose-1:2 4 6 2 5 5 5 2 3 4;}
@font-face
	{font-family:"Lucida Calligraphy";
	panose-1:3 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Lucida Fax";
	panose-1:2 6 6 2 5 5 5 2 2 4;}
@font-face
	{font-family:"Lucida Handwriting";
	panose-1:3 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Lucida Sans";
	panose-1:2 11 6 2 3 5 4 2 2 4;}
@font-face
	{font-family:"Lucida Sans Typewriter";
	panose-1:2 11 5 9 3 5 4 3 2 4;}
@font-face
	{font-family:Magneto;
	panose-1:4 3 8 5 5 8 2 2 13 2;}
@font-face
	{font-family:"Maiandra GD";
	panose-1:2 14 5 2 3 3 8 2 2 4;}
@font-face
	{font-family:"Matura MT Script Capitals";
	panose-1:3 2 8 2 6 6 2 7 2 2;}
@font-face
	{font-family:Mistral;
	panose-1:3 9 7 2 3 4 7 2 4 3;}
@font-face
	{font-family:"Modern No\. 20";
	panose-1:2 7 7 4 7 5 5 2 3 3;}
@font-face
	{font-family:"Monotype Corsiva";
	panose-1:3 1 1 1 1 2 1 1 1 1;}
@font-face
	{font-family:"Niagara Engraved";
	panose-1:4 2 5 2 7 7 3 3 2 2;}
@font-face
	{font-family:"Niagara Solid";
	panose-1:4 2 5 2 7 7 2 2 2 2;}
@font-face
	{font-family:"OCR A Extended";
	panose-1:2 1 5 9 2 1 2 1 3 3;}
@font-face
	{font-family:"Old English Text MT";
	panose-1:3 4 9 2 4 5 8 3 8 6;}
@font-face
	{font-family:Onyx;
	panose-1:4 5 6 2 8 7 2 2 2 3;}
@font-face
	{font-family:"MS Outlook";
	panose-1:5 1 1 0 1 0 0 0 0 0;}
@font-face
	{font-family:"Palace Script MT";
	panose-1:3 3 3 2 2 6 7 12 11 5;}
@font-face
	{font-family:Papyrus;
	panose-1:3 7 5 2 6 5 2 3 2 5;}
@font-face
	{font-family:Parchment;
	panose-1:3 4 6 2 4 7 8 4 8 4;}
@font-face
	{font-family:Perpetua;
	panose-1:2 2 5 2 6 4 1 2 3 3;}
@font-face
	{font-family:"Perpetua Titling MT";
	panose-1:2 2 5 2 6 5 5 2 8 4;}
@font-face
	{font-family:Playbill;
	panose-1:4 5 6 3 10 6 2 2 2 2;}
@font-face
	{font-family:"Poor Richard";
	panose-1:2 8 5 2 5 5 5 2 7 2;}
@font-face
	{font-family:Pristina;
	panose-1:3 6 4 2 4 4 6 8 2 4;}
@font-face
	{font-family:"Rage Italic";
	panose-1:3 7 5 2 4 5 7 7 3 4;}
@font-face
	{font-family:Ravie;
	panose-1:4 4 8 5 5 8 9 2 6 2;}
@font-face
	{font-family:"MS Reference Sans Serif";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"MS Reference Specialty";
	panose-1:5 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Rockwell Condensed";
	panose-1:2 6 6 3 5 4 5 2 1 4;}
@font-face
	{font-family:Rockwell;
	panose-1:2 6 6 3 2 2 5 2 4 3;}
@font-face
	{font-family:"Rockwell Extra Bold";
	panose-1:2 6 9 3 4 5 5 2 4 3;}
@font-face
	{font-family:"Script MT Bold";
	panose-1:3 4 6 2 4 6 7 8 9 4;}
@font-face
	{font-family:"Showcard Gothic";
	panose-1:4 2 9 4 2 1 2 2 6 4;}
@font-face
	{font-family:"Snap ITC";
	panose-1:4 4 10 7 6 10 2 2 2 2;}
@font-face
	{font-family:Stencil;
	panose-1:4 4 9 5 13 8 2 2 4 4;}
@font-face
	{font-family:"Tw Cen MT";
	panose-1:2 11 6 2 2 1 4 2 6 3;}
@font-face
	{font-family:"Tw Cen MT Condensed";
	panose-1:2 11 6 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Tw Cen MT Condensed Extra Bold";
	panose-1:2 11 8 3 2 2 2 2 2 4;}
@font-face
	{font-family:"Tempus Sans ITC";
	panose-1:4 2 4 4 3 13 7 2 2 2;}
@font-face
	{font-family:"Viner Hand ITC";
	panose-1:3 7 5 2 3 5 2 2 2 3;}
@font-face
	{font-family:Vivaldi;
	panose-1:3 2 6 2 5 5 6 9 8 4;}
@font-face
	{font-family:"Vladimir Script";
	panose-1:3 5 4 2 4 4 7 7 3 5;}
@font-face
	{font-family:"Wingdings 2";
	panose-1:5 2 1 2 1 5 7 7 7 7;}
@font-face
	{font-family:"Wingdings 3";
	panose-1:5 4 1 2 1 8 7 7 7 7;}
@font-face
	{font-family:AngsanaUPC;}
@font-face
	{font-family:CordiaUPC;}
@font-face
	{font-family:Abadi;}
@font-face
	{font-family:"Abadi Extra Light";}
@font-face
	{font-family:Aharoni;}
@font-face
	{font-family:Aldhabi;}
@font-face
	{font-family:Aparajita;}
@font-face
	{font-family:"Arabic Typesetting";}
@font-face
	{font-family:"Arial Nova";}
@font-face
	{font-family:"Arial Nova Cond";}
@font-face
	{font-family:"Arial Nova Cond Light";}
@font-face
	{font-family:"Arial Nova Light";}
@font-face
	{font-family:"Avenir Next LT Pro";}
@font-face
	{font-family:"Avenir Next LT Pro Light";}
@font-face
	{font-family:BatangChe;}
@font-face
	{font-family:Bembo;}
@font-face
	{font-family:Biome;}
@font-face
	{font-family:"Biome Light";}
@font-face
	{font-family:"Browallia New";}
@font-face
	{font-family:BrowalliaUPC;}
@font-face
	{font-family:Cavolini;}
@font-face
	{font-family:Dante;}
@font-face
	{font-family:DaunPenh;}
@font-face
	{font-family:David;}
@font-face
	{font-family:Daytona;}
@font-face
	{font-family:"Daytona Condensed";}
@font-face
	{font-family:"Daytona Condensed Light";}
@font-face
	{font-family:"Daytona Light";}
@font-face
	{font-family:"DengXian Light";}
@font-face
	{font-family:DilleniaUPC;}
@font-face
	{font-family:DokChampa;}
@font-face
	{font-family:DotumChe;}
@font-face
	{font-family:"Elephant Pro";}
@font-face
	{font-family:EucrosiaUPC;}
@font-face
	{font-family:Euphemia;}
@font-face
	{font-family:FangSong;}
@font-face
	{font-family:FrankRuehl;}
@font-face
	{font-family:FreesiaUPC;}
@font-face
	{font-family:"Georgia Pro";}
@font-face
	{font-family:"Georgia Pro Black";}
@font-face
	{font-family:"Georgia Pro Cond";}
@font-face
	{font-family:"Georgia Pro Cond Black";}
@font-face
	{font-family:"Georgia Pro Cond Light";}
@font-face
	{font-family:"Georgia Pro Cond Semibold";}
@font-face
	{font-family:"Georgia Pro Light";}
@font-face
	{font-family:"Georgia Pro Semibold";}
@font-face
	{font-family:"Gill Sans Nova";}
@font-face
	{font-family:"Gill Sans Nova Cond";}
@font-face
	{font-family:"Gill Sans Nova Cond Lt";}
@font-face
	{font-family:"Gill Sans Nova Cond Ultra Bold";}
@font-face
	{font-family:"Gill Sans Nova Cond XBd";}
@font-face
	{font-family:"Gill Sans Nova Light";}
@font-face
	{font-family:"Gill Sans Nova Ultra Bold";}
@font-face
	{font-family:Gisha;}
@font-face
	{font-family:Grotesque;}
@font-face
	{font-family:"Grotesque Light";}
@font-face
	{font-family:GulimChe;}
@font-face
	{font-family:Gungsuh;}
@font-face
	{font-family:GungsuhChe;}
@font-face
	{font-family:"Hadassah Friedlaender";}
@font-face
	{font-family:HGGothicE;}
@font-face
	{font-family:HGMaruGothicMPRO;}
@font-face
	{font-family:HGMinchoE;}
@font-face
	{font-family:HGPGothicE;}
@font-face
	{font-family:HGPMinchoE;}
@font-face
	{font-family:HGPSoeiKakugothicUB;}
@font-face
	{font-family:HGSGothicE;}
@font-face
	{font-family:HGSMinchoE;}
@font-face
	{font-family:HGSoeiKakugothicUB;}
@font-face
	{font-family:HGSSoeiKakugothicUB;}
@font-face
	{font-family:IrisUPC;}
@font-face
	{font-family:"Iskoola Pota";}
@font-face
	{font-family:JasmineUPC;}
@font-face
	{font-family:KaiTi;}
@font-face
	{font-family:Kalinga;}
@font-face
	{font-family:Kartika;}
@font-face
	{font-family:"Khmer UI";}
@font-face
	{font-family:Kigelia;}
@font-face
	{font-family:"Kigelia Arabic";}
@font-face
	{font-family:"Kigelia Arabic Light";}
@font-face
	{font-family:"Kigelia Light";}
@font-face
	{font-family:KodchiangUPC;}
@font-face
	{font-family:Kokila;}
@font-face
	{font-family:"Lao UI";}
@font-face
	{font-family:Leelawadee;}
@font-face
	{font-family:"Levenim MT";}
@font-face
	{font-family:LilyUPC;}
@font-face
	{font-family:"Mangal Pro";}
@font-face
	{font-family:Meiryo;}
@font-face
	{font-family:"Meiryo UI";}
@font-face
	{font-family:"Microsoft GothicNeo";}
@font-face
	{font-family:"Microsoft GothicNeo Light";}
@font-face
	{font-family:"Microsoft Uighur";}
@font-face
	{font-family:MingLiU_HKSCS;}
@font-face
	{font-family:Miriam;}
@font-face
	{font-family:"Miriam Fixed";}
@font-face
	{font-family:"Modern Love";}
@font-face
	{font-family:"Modern Love Caps";}
@font-face
	{font-family:"Modern Love Grunge";}
@font-face
	{font-family:MoolBoran;}
@font-face
	{font-family:"MS PMincho";}
@font-face
	{font-family:"MT Extra";}
@font-face
	{font-family:Narkisim;}
@font-face
	{font-family:"Neue Haas Grotesk Text Pro";}
@font-face
	{font-family:"News Gothic MT";}
@font-face
	{font-family:Nyala;}
@font-face
	{font-family:OCRB;}
@font-face
	{font-family:"Plantagenet Cherokee";}
@font-face
	{font-family:Posterama;}
@font-face
	{font-family:"Quire Sans";}
@font-face
	{font-family:"Quire Sans Light";}
@font-face
	{font-family:"Quire Sans Pro Light";}
@font-face
	{font-family:"Rockwell Light";}
@font-face
	{font-family:"Rockwell Nova";}
@font-face
	{font-family:"Rockwell Nova Cond";}
@font-face
	{font-family:"Rockwell Nova Cond Light";}
@font-face
	{font-family:"Rockwell Nova Extra Bold";}
@font-face
	{font-family:"Rockwell Nova Light";}
@font-face
	{font-family:Rod;}
@font-face
	{font-family:"Sabon Next LT";}
@font-face
	{font-family:"Sagona Book";}
@font-face
	{font-family:"Sagona ExtraLight";}
@font-face
	{font-family:"Sakkal Majalla";}
@font-face
	{font-family:"Sanskrit Text";}
@font-face
	{font-family:Selawik;}
@font-face
	{font-family:"Selawik Light";}
@font-face
	{font-family:"Selawik Semibold";}
@font-face
	{font-family:"Shonar Bangla";}
@font-face
	{font-family:"Simplified Arabic";}
@font-face
	{font-family:"Simplified Arabic Fixed";}
@font-face
	{font-family:"Sitka Banner Semibold";}
@font-face
	{font-family:"Sitka Display Semibold";}
@font-face
	{font-family:"Sitka Heading Semibold";}
@font-face
	{font-family:"Sitka Small Semibold";}
@font-face
	{font-family:"Sitka Subheading Semibold";}
@font-face
	{font-family:"Sitka Text Semibold";}
@font-face
	{font-family:"Source Sans Pro";}
@font-face
	{font-family:"Source Sans Pro Black";}
@font-face
	{font-family:"Source Sans Pro ExtraLight";}
@font-face
	{font-family:"Source Sans Pro Light";}
@font-face
	{font-family:"Source Sans Pro SemiBold";}
@font-face
	{font-family:"Speak Pro";}
@font-face
	{font-family:"Speak Pro Light";}
@font-face
	{font-family:STCaiyun;}
@font-face
	{font-family:STFangsong;}
@font-face
	{font-family:STHupo;}
@font-face
	{font-family:STKaiti;}
@font-face
	{font-family:STXihei;}
@font-face
	{font-family:STXingkai;}
@font-face
	{font-family:STXinwei;}
@font-face
	{font-family:STZhongsong;}
@font-face
	{font-family:"TH SarabunPSK";}
@font-face
	{font-family:"The Hand";}
@font-face
	{font-family:"The Hand Black";}
@font-face
	{font-family:"The Hand Extrablack";}
@font-face
	{font-family:"The Hand Light";}
@font-face
	{font-family:"The Serif Hand";}
@font-face
	{font-family:"The Serif Hand Black";}
@font-face
	{font-family:"The Serif Hand Extrablack";}
@font-face
	{font-family:"The Serif Hand Light";}
@font-face
	{font-family:"Tisa Offc Serif Pro";}
@font-face
	{font-family:"Tisa Offc Serif Pro Thin";}
@font-face
	{font-family:"Trade Gothic Next";}
@font-face
	{font-family:"Trade Gothic Next Cond";}
@font-face
	{font-family:"Trade Gothic Next Cond Hv";}
@font-face
	{font-family:"Trade Gothic Next Heavy";}
@font-face
	{font-family:"Trade Gothic Next Light";}
@font-face
	{font-family:"Traditional Arabic";}
@font-face
	{font-family:"UD Digi Kyokasho N-B";}
@font-face
	{font-family:"UD Digi Kyokasho N-R";}
@font-face
	{font-family:"UD Digi Kyokasho NK-B";}
@font-face
	{font-family:"UD Digi Kyokasho NK-R";}
@font-face
	{font-family:"UD Digi Kyokasho NP-B";}
@font-face
	{font-family:"UD Digi Kyokasho NP-R";}
@font-face
	{font-family:Univers;}
@font-face
	{font-family:"Univers Condensed";}
@font-face
	{font-family:"Univers Condensed Light";}
@font-face
	{font-family:"Univers Light";}
@font-face
	{font-family:"Urdu Typesetting";}
@font-face
	{font-family:Utsaah;}
@font-face
	{font-family:Vani;}
@font-face
	{font-family:"Verdana Pro";}
@font-face
	{font-family:"Verdana Pro Black";}
@font-face
	{font-family:"Verdana Pro Cond";}
@font-face
	{font-family:"Verdana Pro Cond Black";}
@font-face
	{font-family:"Verdana Pro Cond Light";}
@font-face
	{font-family:"Verdana Pro Cond SemiBold";}
@font-face
	{font-family:"Verdana Pro Light";}
@font-face
	{font-family:"Verdana Pro SemiBold";}
@font-face
	{font-family:Vijaya;}
@font-face
	{font-family:"Walbaum Display";}
@font-face
	{font-family:"Walbaum Display Heavy";}
@font-face
	{font-family:"Walbaum Display Light";}
@font-face
	{font-family:"Walbaum Display SemiBold";}
@font-face
	{font-family:"Walbaum Heading";}
@font-face
	{font-family:"Walbaum Text";}
@font-face
	{font-family:"Yu Mincho";}
@font-face
	{font-family:"Yu Mincho Demibold";}
@font-face
	{font-family:"Yu Mincho Light";}
@font-face
	{font-family:"TimesNewRoman\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:TimesNewRoman;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:TimesNewRomanPSMT;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Times New Roman Bold";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:PraxisCom-Regular;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial Bold";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:EUAlbertina;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"\@TimesNewRoman\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Arial\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:"\@Batang";
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:"\@BatangChe";}
@font-face
	{font-family:"\@Gungsuh";}
@font-face
	{font-family:"\@GungsuhChe";}
@font-face
	{font-family:"\@DengXian Light";}
@font-face
	{font-family:"\@Gulim";
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:"\@GulimChe";}
@font-face
	{font-family:"\@Dotum";
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:"\@DotumChe";}
@font-face
	{font-family:"\@Meiryo";}
@font-face
	{font-family:"\@Meiryo UI";}
@font-face
	{font-family:"\@MingLiU";
	panose-1:2 1 6 9 0 1 1 1 1 1;}
@font-face
	{font-family:"\@PMingLiU";
	panose-1:2 1 6 1 0 1 1 1 1 1;}
@font-face
	{font-family:"\@MingLiU_HKSCS";}
@font-face
	{font-family:"\@MS PMincho";}
@font-face
	{font-family:"\@STXingkai";}
@font-face
	{font-family:"\@STZhongsong";}
@font-face
	{font-family:"\@Yu Mincho";}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:5.9pt;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0in;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0in;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.MsoCommentReference
	{font-family:"Times New Roman",serif;}
span.MsoLineNumber
	{font-family:"Times New Roman",serif;}
span.MsoPageNumber
	{font-family:"Times New Roman",serif;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-link:"Body Text Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:5.9pt;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
a:link, span.MsoHyperlink
	{font-family:"Times New Roman",serif;
	color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:#954F72;
	text-decoration:underline;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	text-autospace:none;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin:0in;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	font-weight:bold;}
span.BodyTextChar
	{mso-style-name:"Body Text Char";
	mso-style-link:"Body Text";
	font-family:"Times New Roman",serif;}
p.TableParagraph, li.TableParagraph, div.TableParagraph
	{mso-style-name:"Table Paragraph";
	margin:0in;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;
	font-family:"Times New Roman",serif;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;
	font-family:"Times New Roman",serif;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;}
p.MemoHeaderStyle, li.MemoHeaderStyle, div.MemoHeaderStyle
	{mso-style-name:MemoHeaderStyle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.9pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	font-variant:small-caps;
	font-weight:bold;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";
	font-family:"Times New Roman",serif;}
p.EMEAEnBodyText, li.EMEAEnBodyText, div.EMEAEnBodyText
	{mso-style-name:"EMEA En Body Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-link:"Body text \(Agency\)";
	font-family:"Verdana",sans-serif;}
p.DraftingNotesAgency, li.DraftingNotesAgency, div.DraftingNotesAgency
	{mso-style-name:"Drafting Notes \(Agency\)";
	mso-style-link:"Drafting Notes \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:11.0pt;
	font-family:"Courier New";
	color:#339966;
	font-style:italic;}
span.DraftingNotesAgencyChar
	{mso-style-name:"Drafting Notes \(Agency\) Char";
	mso-style-link:"Drafting Notes \(Agency\)";
	font-family:"Courier New";
	color:#339966;
	font-style:italic;}
p.NormalAgency, li.NormalAgency, div.NormalAgency
	{mso-style-name:"Normal \(Agency\)";
	mso-style-link:"Normal \(Agency\) Char";
	margin:0in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
p.TableheadingrowsAgency, li.TableheadingrowsAgency, div.TableheadingrowsAgency
	{mso-style-name:"Table heading rows \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.TabletextrowsAgency, li.TabletextrowsAgency, div.TabletextrowsAgency
	{mso-style-name:"Table text rows \(Agency\)";
	margin:0in;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.NormalAgencyChar
	{mso-style-name:"Normal \(Agency\) Char";
	mso-style-link:"Normal \(Agency\)";
	font-family:"Verdana",sans-serif;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	margin:0in;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
span.msoIns
	{mso-style-name:"";
	text-decoration:underline;
	color:teal;}
span.msoDel
	{mso-style-name:"";
	text-decoration:line-through;
	color:red;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
 /* Page Definitions */
 @page WordSection1
	{size:595.25pt 842.0pt;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:595.25pt 842.0pt;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:595.25pt 842.0pt;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection3
	{page:WordSection3;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink="#954F72" style='word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 align=center style='margin-left:0in;text-align:center;punctuation-wrap:
simple'><a name="SUMMARY OF PRODUCT CHARACTERISTICS"></a><span lang=EN-GB
style='letter-spacing:-.05pt'>ANNE</span><span lang=EN-GB>X<span
style='letter-spacing:-.4pt'>&nbsp;</span>I</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;punctuation-wrap:simple'><b><span
lang=EN-GB style='font-size:11.0pt'>S<span style='letter-spacing:-.05pt'>U</span>MM<span
style='letter-spacing:-.05pt'>A</span>RY<span style='letter-spacing:-.85pt'>&nbsp;</span><span
style='letter-spacing:-.05pt'>O</span>F<span style='letter-spacing:-.8pt'>&nbsp;</span>P<span
style='letter-spacing:-.05pt'>R</span>O<span style='letter-spacing:-.05pt'>D</span>U<span
style='letter-spacing:-.05pt'>C</span>T<span style='letter-spacing:-.8pt'>&nbsp;</span><span
style='letter-spacing:-.05pt'>C</span>H<span style='letter-spacing:-.05pt'>A</span>RA<span
style='letter-spacing:-.05pt'>C</span>TER<span style='letter-spacing:-.05pt'>I</span>STICS</span></b></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center;punctuation-wrap:simple'><span
lang=EN-GB style='font-size:11.0pt'>                                                                           </span></p>

</div>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection2>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>NAME<span style='letter-spacing:-.45pt'> </span>OF<span
style='letter-spacing:-.5pt'> </span>THE<span style='letter-spacing:-.45pt'> </span>M<span
style='letter-spacing:.05pt'>E</span>DICINAL<span style='letter-spacing:-.5pt'>
</span>PRODUCT</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>2<span
style='letter-spacing:-.05pt'>.</span>5<span style='letter-spacing:-.35pt'>&nbsp;</span>mg<span
style='letter-spacing:-.35pt'> </span>fil<span style='letter-spacing:-.1pt'>m</span>-coated<span
style='letter-spacing:-.35pt'> </span>tablets</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>QU</span><span
lang=EN-GB>A<span style='letter-spacing:-.05pt'>LI</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>A</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>IV</span>E<span
style='letter-spacing:-.9pt'> </span>A<span style='letter-spacing:-.05pt'>N</span>D<span
style='letter-spacing:-.9pt'> </span><span style='letter-spacing:-.05pt'>QUAN</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>IT</span>A<span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>IV</span>E<span
style='letter-spacing:-.9pt'> </span>C<span style='letter-spacing:-.05pt'>OM</span><span
style='letter-spacing:.05pt'>P</span><span style='letter-spacing:-.05pt'>OSI</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>ION</span></span></h1>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Each film-coated tablet contains 2.5&nbsp;mg apixaban. </span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Excipients<span style='letter-spacing:-.45pt'> </span>with<span
style='letter-spacing:-.45pt'> </span>k<span style='letter-spacing:-.05pt'>n</span>own<span
style='letter-spacing:-.4pt'> </span>effect</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Each<span style='letter-spacing:-.3pt'> </span>2.5<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>fi<span style='letter-spacing:.05pt'>l</span><span
style='letter-spacing:-.1pt'>m</span>-coated<span style='letter-spacing:-.25pt'>
</span>t<span style='letter-spacing:.05pt'>a</span>blet<span style='letter-spacing:
-.3pt'> </span>contains<span style='letter-spacing:-.25pt'> </span>51.97<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>lac<span style='letter-spacing:.05pt'>t</span>ose<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>sect<span
style='letter-spacing:.05pt'>i</span>on<span style='letter-spacing:-.25pt'>&nbsp;</span>4.4).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>full<span style='letter-spacing:-.25pt'> </span>list<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.2pt'> </span>excipients,<span
style='letter-spacing:-.25pt'> </span>see<span style='letter-spacing:-.2pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>6.1.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>PHAR</span><span
lang=EN-GB style='letter-spacing:.05pt'>M</span><span lang=EN-GB
style='letter-spacing:-.05pt'>A</span><span lang=EN-GB>C<span style='letter-spacing:
-.05pt'>EUT</span>I<span style='letter-spacing:-.05pt'>CA</span>L<span
style='letter-spacing:-1.45pt'> </span><span style='letter-spacing:.05pt'>F</span><span
style='letter-spacing:-.05pt'>ORM</span></span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Fil<span style='letter-spacing:-.1pt'>m</span>-coated<span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>a</span>blet<span style='letter-spacing:-.55pt'> </span>(tablet)</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Yellow, round shaped, approximate 6.00 mm in diameter, biconvex,
film&#8209;coated tablet debossed with “IU1” on one side and plain on the other
side.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>CLI</span><span
lang=EN-GB>N<span style='letter-spacing:-.05pt'>I</span>C<span
style='letter-spacing:-.05pt'>A</span>L<span style='letter-spacing:-1.3pt'> </span><span
style='letter-spacing:-.05pt'>PART</span>I<span style='letter-spacing:-.05pt'>CU</span><span
style='letter-spacing:.05pt'>L</span><span style='letter-spacing:-.05pt'>ARS</span></span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><b><span lang=EN-GB style='font-size:11.0pt'>4.1<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='font-size:11.0pt'>Therapeutic<span
style='letter-spacing:-1.05pt'> </span>indications</span></b></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Prevention<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>venous<span style='letter-spacing:-.35pt'>
</span>th<span style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:
-.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>boembolic<span
style='letter-spacing:-.3pt'> </span>events<span style='letter-spacing:-.35pt'>
</span>(VTE)<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>adult<span style='letter-spacing:-.4pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>who<span style='letter-spacing:-.35pt'> </span>have<span
style='letter-spacing:-.35pt'> </span>underg<span style='letter-spacing:-.05pt'>o</span>ne<span
style='letter-spacing:-.3pt'> </span>elective<span style='letter-spacing:-.35pt'>
</span>hip or<span style='letter-spacing:-.4pt'> </span>knee<span
style='letter-spacing:-.4pt'> </span>replac<span style='letter-spacing:.05pt'>e</span>ment<span
style='letter-spacing:-.4pt'> </span>surger<span style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Prevention<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>stroke<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.35pt'> </span><span style='letter-spacing:
-.1pt'>s</span>yste<span style='letter-spacing:-.1pt'>m</span>ic<span
style='letter-spacing:-.3pt'> </span>e<span style='letter-spacing:-.1pt'>m</span>bolism<span
style='letter-spacing:-.4pt'> </span>in<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>a</span>dult<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>non-valvular<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.05pt'>t</span>rial<span
style='letter-spacing:-.35pt'> </span>fibrillation (NVAF),<span
style='letter-spacing:-.25pt'> </span>wi<span style='letter-spacing:.05pt'>t</span>h<span
style='letter-spacing:-.25pt'> </span>one<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>ore<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>factors,<span
style='letter-spacing:-.25pt'> </span>such<span style='letter-spacing:-.25pt'> </span>as<span
style='letter-spacing:-.25pt'> </span>pri<span style='letter-spacing:-.05pt'>o</span>r<span
style='letter-spacing:-.25pt'> </span>stroke<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>transient<span
style='letter-spacing:-.25pt'> </span>ischa<span style='letter-spacing:.05pt'>e</span>mic<span
style='letter-spacing:-.25pt'> </span>attack<span style='letter-spacing:-.25pt'>
</span>(T<span style='letter-spacing:.05pt'>I</span><span style='letter-spacing:
-.05pt'>A</span>);<span style='letter-spacing:-.25pt'> </span>age &#8805;<span
style='letter-spacing:-.35pt'>&nbsp;</span>75<span style='letter-spacing:-.35pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears;<span style='letter-spacing:-.35pt'> </span>hypertension;<span
style='letter-spacing:-.35pt'> </span>diabetes<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>e</span>ll<span style='letter-spacing:.05pt'>i</span>tus;<span
style='letter-spacing:-.3pt'> </span>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptomatic<span style='letter-spacing:-.3pt'>
</span>heart<span style='letter-spacing:-.3pt'> </span>fai<span
style='letter-spacing:.05pt'>l</span>ure<span style='letter-spacing:-.3pt'> </span>(NYHA<span
style='letter-spacing:-.3pt'> </span>Class<span style='letter-spacing:-.25pt'> </span>&#8805;<span
style='letter-spacing:-.35pt'>&nbsp;</span>II).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Treatment<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>deep<span style='letter-spacing:-.35pt'> </span>vein<span
style='letter-spacing:-.3pt'> </span>th<span style='letter-spacing:-.1pt'>r</span>o<span
style='letter-spacing:-.1pt'>m</span>bosis<span style='letter-spacing:-.3pt'> </span>(DVT)<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>pu<span
style='letter-spacing:-.05pt'>l</span><span style='letter-spacing:-.1pt'>m</span>onary<span
style='letter-spacing:-.25pt'> </span>e<span style='letter-spacing:-.1pt'>m</span>bolism<span
style='letter-spacing:-.4pt'> </span>(PE),<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>prevention<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>r</span>ecurrent DVT<span style='letter-spacing:
-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>adults<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.4<span style='letter-spacing:-.3pt'>
</span>f<span style='letter-spacing:-.15pt'>o</span>r<span style='letter-spacing:
-.3pt'> </span>ha<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>od<span style='letter-spacing:.05pt'>y</span>n<span
style='letter-spacing:-.1pt'>a</span>mically<span style='letter-spacing:-.15pt'>
</span>unstable<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.3pt'> </span>patients).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.2<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Posology<span style='letter-spacing:-.5pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.05pt'>me</span>thod<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.45pt'> </span>ad<span style='letter-spacing:-.05pt'>m</span>inistration</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Posology</span></u></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Prevention<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>VTE<span style='letter-spacing:-.35pt'> </span>(VTEp):<span
style='letter-spacing:-.35pt'> </span>elective<span style='letter-spacing:-.35pt'>
</span>hip<span style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:
-.35pt'> </span>knee<span style='letter-spacing:-.3pt'> </span>replacement<span
style='letter-spacing:-.35pt'> </span>surgery</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mmended<span style='letter-spacing:-.25pt'>
</span>dose<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.2pt'>
</span>is<span style='letter-spacing:-.25pt'> </span>2<span style='letter-spacing:
-.05pt'>.</span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>tak<span
style='letter-spacing:-.05pt'>e</span>n<span style='letter-spacing:-.25pt'> </span>orally<span
style='letter-spacing:-.15pt'> </span>twice<span style='letter-spacing:-.2pt'> </span>daily.<span
style='letter-spacing:-.25pt'> </span>The<span style='letter-spacing:-.25pt'> </span>initial<span
style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>should<span
style='letter-spacing:-.25pt'> </span>be taken<span style='letter-spacing:-.25pt'>
</span>12<span style='letter-spacing:-.2pt'>&nbsp;</span>to<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>2</span>4<span
style='letter-spacing:-.2pt'>&nbsp;</span>h<span style='letter-spacing:-.05pt'>o</span>urs<span
style='letter-spacing:-.25pt'> </span>after<span style='letter-spacing:-.2pt'> </span>surger<span
style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Ph<span style='letter-spacing:.05pt'>y</span><span style='letter-spacing:
-.05pt'>s</span>icians<span style='letter-spacing:-.3pt'> </span>may<span
style='letter-spacing:-.2pt'> </span>cons<span style='letter-spacing:-.05pt'>i</span>der<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.3pt'> </span>potential<span
style='letter-spacing:-.3pt'> </span>benefits<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.4pt'> </span>earlier<span
style='letter-spacing:-.3pt'> </span>anticoagulation<span style='letter-spacing:
-.3pt'> </span>for<span style='letter-spacing:-.35pt'> </span>V<span
style='letter-spacing:-.05pt'>T</span>E<span style='letter-spacing:-.3pt'> </span>prop<span
style='letter-spacing:-.05pt'>h</span>ylaxis<span style='letter-spacing:-.4pt'>
</span>as<span style='letter-spacing:-.3pt'> </span>well as<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>risks<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>post-surgical<span
style='letter-spacing:-.25pt'> </span>bleeding<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.25pt'> </span>deciding<span
style='letter-spacing:-.25pt'> </span>on<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>th</span>e<span style='letter-spacing:-.25pt'> </span>t<span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>e<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:.05pt'>d</span>ministration<span style='letter-spacing:
-.25pt'> </span>within<span style='letter-spacing:-.25pt'> </span>this<span
style='letter-spacing:-.25pt'> </span>ti<span style='letter-spacing:-.1pt'>m</span>e
window.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>In<span style='letter-spacing:-.4pt'> </span>patients<span
style='letter-spacing:-.4pt'> </span>undergoing<span style='letter-spacing:
-.45pt'> </span>hip<span style='letter-spacing:-.45pt'> </span>replacement<span
style='letter-spacing:-.4pt'> </span>surgery</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mmended<span style='letter-spacing:-.25pt'>
</span>durat<span style='letter-spacing:-.05pt'>i</span>on<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.25pt'> </span>32<span
style='letter-spacing:-.25pt'>&nbsp;</span>to<span style='letter-spacing:-.3pt'>&nbsp;</span>38<span
style='letter-spacing:-.25pt'>&nbsp;</span>d<span style='letter-spacing:-.1pt'>a</span><span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>In<span style='letter-spacing:-.45pt'> </span>patients<span
style='letter-spacing:-.4pt'> </span>undergoing<span style='letter-spacing:
-.4pt'> </span>kn<span style='letter-spacing:-.1pt'>e</span>e<span
style='letter-spacing:-.45pt'> </span>replace<span style='letter-spacing:.05pt'>m</span>ent<span
style='letter-spacing:-.4pt'> </span>surgery</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mmended<span style='letter-spacing:-.25pt'>
</span>durat<span style='letter-spacing:-.05pt'>i</span>on<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.25pt'> </span>10<span
style='letter-spacing:-.25pt'>&nbsp;</span>to<span style='letter-spacing:-.3pt'>&nbsp;</span>14<span
style='letter-spacing:-.25pt'>&nbsp;</span>d<span style='letter-spacing:-.1pt'>a</span><span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Prevention<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>stroke<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.4pt'> </span>systemic<span
style='letter-spacing:-.3pt'> </span>embolism<span style='letter-spacing:-.4pt'>
</span>in<span style='letter-spacing:-.35pt'> </span>patien<span
style='letter-spacing:-.1pt'>t</span>s<span style='letter-spacing:-.45pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>non-va<span style='letter-spacing:-.05pt'>lv</span>ular<span
style='letter-spacing:-.4pt'> </span>atrial<span style='letter-spacing:-.35pt'>
</span>f<span style='letter-spacing:-.05pt'>i</span>brillation<span
style='letter-spacing:-.35pt'> </span>(NVAF)</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:
-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>taken<span style='letter-spacing:-.25pt'>
</span>ora<span style='letter-spacing:.05pt'>l</span>ly<span style='letter-spacing:
-.25pt'> </span>twice<span style='letter-spacing:-.25pt'> </span>daily.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Dose<span style='letter-spacing:-.65pt'> </span>reduct<span
style='letter-spacing:.05pt'>i</span>on</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.2pt'> </span>2.5<span style='letter-spacing:
-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>taken<span style='letter-spacing:-.2pt'> </span>orally<span
style='letter-spacing:-.15pt'> </span>twice<span style='letter-spacing:-.25pt'>
</span>daily<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.2pt'> </span>NVAF<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.2pt'> </span>at
least<span style='letter-spacing:-.25pt'> </span>two<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>following<span style='letter-spacing:
-.25pt'> </span>charact<span style='letter-spacing:.05pt'>e</span>risti<span
style='letter-spacing:.05pt'>c</span>s:<span style='letter-spacing:-.25pt'> </span>age<span
style='letter-spacing:-.3pt'> </span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>80<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>e</span>ars,<span style='letter-spacing:-.2pt'> </span>bo<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.15pt'> </span>weight<span
style='letter-spacing:-.3pt'> </span>&#8804;<span style='letter-spacing:-.25pt'>&nbsp;</span>60<span
style='letter-spacing:-.3pt'>&nbsp;</span>kg,<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>ser<span style='letter-spacing:
.05pt'>u</span>m<span style='letter-spacing:-.3pt'> </span>c<span
style='letter-spacing:.05pt'>r</span>eat<span style='letter-spacing:.05pt'>i</span>nine
&#8805;<span style='letter-spacing:-.4pt'>&nbsp;</span>1.5<span
style='letter-spacing:-.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g/dL<span
style='letter-spacing:-.3pt'> </span>(133<span style='letter-spacing:-.35pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>icr<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>o</span>le/L).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Therapy<span style='letter-spacing:-.35pt'> </span>s<span
style='letter-spacing:-.05pt'>h</span>o<span style='letter-spacing:-.05pt'>u</span>ld<span
style='letter-spacing:-.4pt'> </span>be<span style='letter-spacing:-.4pt'> </span>conti<span
style='letter-spacing:-.05pt'>nue</span>d<span style='letter-spacing:-.45pt'> </span>long-ter<span
style='letter-spacing:-.1pt'>m</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Treatment<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>DVT,<span style='letter-spacing:-.3pt'> </span>treatment<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>PE<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.4pt'> </span>prevention<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>recurrent<span
style='letter-spacing:-.3pt'> </span>D<span style='letter-spacing:.05pt'>V</span>T<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.35pt'> </span>(VTEt)</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>for<span style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:
-.25pt'> </span>trea<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.15pt'> </span>of<span style='letter-spacing:-.2pt'> </span>acute<span
style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span><span style='letter-spacing:.05pt'>n</span>t<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>PE<span
style='letter-spacing:-.2pt'> </span>is<span style='letter-spacing:-.25pt'> </span>10<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g
taken<span style='letter-spacing:-.25pt'> </span>oral<span style='letter-spacing:
-.05pt'>l</span>y<span style='letter-spacing:-.1pt'> </span><span
style='letter-spacing:-.05pt'>tw</span>ice<span style='letter-spacing:-.2pt'> </span>daily<span
style='letter-spacing:-.15pt'> </span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>first<span style='letter-spacing:-.2pt'> </span>7<span
style='letter-spacing:-.2pt'>&nbsp;</span>d<span style='letter-spacing:-.1pt'>a</span><span
style='letter-spacing:.05pt'>y</span>s<span style='letter-spacing:-.25pt'> </span>f<span
style='letter-spacing:-.05pt'>o</span>llowed<span style='letter-spacing:-.3pt'>
</span>by<span style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:
-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>taken<span style='letter-spacing:-.2pt'> </span>orally<span
style='letter-spacing:-.2pt'> </span>twice<span style='letter-spacing:-.25pt'> </span>dail<span
style='letter-spacing:.05pt'>y</span>.<span style='letter-spacing:-.2pt'> </span>As<span
style='letter-spacing:-.2pt'> </span>per<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>a</span>vailable medical<span style='letter-spacing:
-.3pt'> </span>guidelines,<span style='letter-spacing:-.25pt'> </span>short<span
style='letter-spacing:-.25pt'> </span>duration<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>tr<span style='letter-spacing:
-.1pt'>e</span><span style='letter-spacing:-.05pt'>a</span><span
style='letter-spacing:.05pt'>t</span><span style='letter-spacing:-.1pt'>m</span>ent<span
style='letter-spacing:-.25pt'> </span>(at<span style='letter-spacing:-.35pt'> </span>least<span
style='letter-spacing:-.3pt'> </span>3<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>onths)<span style='letter-spacing:-.25pt'>
</span>should<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>based<span style='letter-spacing:-.25pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>transient<span style='letter-spacing:
-.3pt'> </span>risk factors<span style='letter-spacing:-.45pt'> </span>(e.g.,<span
style='letter-spacing:-.45pt'> </span>recent<span style='letter-spacing:-.45pt'>
</span>surgery,<span style='letter-spacing:-.45pt'> </span>trauma,<span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.05pt'>m</span><span style='letter-spacing:-.1pt'>m</span>obilisation<span
style='letter-spacing:.05pt'>)</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.2pt'>
</span>f<span style='letter-spacing:.05pt'>o</span>r<span style='letter-spacing:
-.25pt'> </span><span style='letter-spacing:-.05pt'>t</span>he<span
style='letter-spacing:-.25pt'> </span>prevention<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.2pt'> </span>recurrent<span
style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>is<span
style='letter-spacing:-.2pt'> </span>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>taken<span
style='letter-spacing:-.25pt'> </span>oral<span style='letter-spacing:-.05pt'>l</span>y
twice<span style='letter-spacing:-.25pt'> </span>dail<span style='letter-spacing:
.05pt'>y</span>.<span style='letter-spacing:-.3pt'> </span>When<span
style='letter-spacing:-.25pt'> </span>prevention<span style='letter-spacing:
-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>recurrent<span
style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>a</span>nd<span style='letter-spacing:-.2pt'> </span>PE<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.25pt'> </span>indicated,<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>2.5<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.25pt'>
</span>daily<span style='letter-spacing:-.1pt'> </span>dose should<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.25pt'> </span>ini<span
style='letter-spacing:-.05pt'>t</span>iated<span style='letter-spacing:-.25pt'>
</span>followi<span style='letter-spacing:-.05pt'>n</span>g<span
style='letter-spacing:-.25pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>pletion<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>6<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>onths<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>o</span>f<span
style='letter-spacing:-.25pt'> </span>treatment<span style='letter-spacing:
-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.25pt'>
</span>or with<span style='letter-spacing:-.3pt'> </span>another<span
style='letter-spacing:-.3pt'> </span>anticoagulant,<span style='letter-spacing:
-.25pt'> </span>as<span style='letter-spacing:-.3pt'> </span>indicated<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>Table<span
style='letter-spacing:-.25pt'> </span>1<span style='letter-spacing:-.3pt'> </span>below<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>also<span
style='letter-spacing:-.3pt'> </span>section<span style='letter-spacing:-.25pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.35pt'> </span>1:</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:21.2pt'>
  <td width=221 valign=top style='width:2.3in;border:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:21.2pt'>
  <p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=240 valign=top style='width:2.5in;border:solid black 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:21.2pt'>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>Dosing<span style='letter-spacing:-.75pt'> </span>schedule</span></p>
  </td>
  <td width=158 valign=top style='width:118.7pt;border:solid black 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:21.2pt'>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>Maxi<span style='letter-spacing:-.1pt'>m</span><span
  style='letter-spacing:.05pt'>u</span>m<span style='letter-spacing:-.55pt'> </span>daily<span
  style='letter-spacing:-.45pt'> </span>dose</span></p>
  </td>
 </tr>
 <tr style='height:21.1pt'>
  <td width=221 rowspan=2 valign=top style='width:2.3in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:21.1pt'>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>Treatment<span style='letter-spacing:-.25pt'> </span>of<span
  style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.25pt'>
  </span>or<span style='letter-spacing:-.25pt'> </span>PE</span></p>
  </td>
  <td width=240 valign=top style='width:2.5in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:21.1pt'>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>10<span style='letter-spacing:-.2pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.15pt'> </span>twice<span
  style='letter-spacing:-.15pt'> </span>daily<span style='letter-spacing:-.2pt'>
  </span>for<span style='letter-spacing:-.15pt'> </span>the<span
  style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>f</span>irst<span
  style='letter-spacing:-.15pt'> </span>7<span style='letter-spacing:-.2pt'>&nbsp;</span>d<span
  style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:.05pt'>y</span>s</span></p>
  </td>
  <td width=158 valign=top style='width:118.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:21.1pt'>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>20<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g</span></p>
  </td>
 </tr>
 <tr style='height:22.1pt'>
  <td width=240 valign=top style='width:2.5in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:22.1pt'>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>followed<span style='letter-spacing:-.25pt'> </span><span
  style='letter-spacing:-.05pt'>b</span>y<span style='letter-spacing:-.25pt'> </span>5<span
  style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
  style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.25pt'>
  </span>daily</span></p>
  </td>
  <td width=158 valign=top style='width:118.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:22.1pt'>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g</span></p>
  </td>
 </tr>
 <tr style='height:51.1pt'>
  <td width=221 valign=top style='width:2.3in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:51.1pt'>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>Prevention<span style='letter-spacing:-.4pt'> </span>of<span
  style='letter-spacing:-.4pt'> </span>recurrent<span style='letter-spacing:
  -.4pt'> </span>DVT</span></p>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>and/or<span style='letter-spacing:-.4pt'> </span>PE<span
  style='letter-spacing:-.35pt'> </span>fo<span style='letter-spacing:-.05pt'>l</span>lowing<span
  style='letter-spacing:-.35pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>pletion<span
  style='letter-spacing:-.35pt'> </span>of 6<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>onths<span style='letter-spacing:-.2pt'>
  </span>of<span style='letter-spacing:-.25pt'> </span>treatment<span
  style='letter-spacing:-.2pt'> </span>for<span style='letter-spacing:-.25pt'> </span>DVT<span
  style='letter-spacing:-.2pt'> </span>or PE</span></p>
  </td>
  <td width=240 valign=top style='width:2.5in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:51.1pt'>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
  style='letter-spacing:-.2pt'> </span>daily</span></p>
  </td>
  <td width=158 valign=top style='width:118.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:51.1pt'>
  <p class=TableParagraph style='punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>5</span><span lang=EN-GB>&nbsp;</span><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>m</span><span
  lang=EN-GB style='font-size:11.0pt'>g</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>duration<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.3pt'> </span>th<span style='letter-spacing:-.1pt'>e</span>rapy<span
style='letter-spacing:-.25pt'> </span>should<span style='letter-spacing:-.3pt'>
</span>be<span style='letter-spacing:-.3pt'> </span>individualised<span
style='letter-spacing:-.3pt'> </span>after<span style='letter-spacing:-.3pt'> </span>ca<span
style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:.05pt'>f</span>ul<span
style='letter-spacing:-.3pt'> </span>assess<span style='letter-spacing:-.05pt'>m</span>ent<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>treatment benefit<span style='letter-spacing:
-.3pt'> </span>against<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>bleeding<span style='letter-spacing:-.25pt'>
</span>(see<span style='letter-spacing:-.25pt'> </span>section<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.4).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Missed<span style='letter-spacing:-.55pt'> </span>dose</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>If<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>is<span
style='letter-spacing:-.2pt'> </span>missed,<span style='letter-spacing:-.25pt'>
</span>the<span style='letter-spacing:-.25pt'> </span>patient<span
style='letter-spacing:-.2pt'> </span>should<span style='letter-spacing:-.3pt'> </span>take<span
style='letter-spacing:-.25pt'> </span>Apixaban Accord<span style='letter-spacing:
-.25pt'> </span>immediately<span style='letter-spacing:-.15pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>then<span style='letter-spacing:-.25pt'> </span>cont<span
style='letter-spacing:-.05pt'>in</span>ue<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.25pt'>
</span>dai<span style='letter-spacing:-.05pt'>l</span>y intake<span
style='letter-spacing:-.35pt'> </span>as<span style='letter-spacing:-.35pt'> </span>before.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Switching</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Switching<span style='letter-spacing:-.3pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.25pt'> </span>fr<span style='letter-spacing:.05pt'>o</span>m<span
style='letter-spacing:-.35pt'> </span>parenteral<span style='letter-spacing:
-.25pt'> </span>anticoagulants<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>Apixaban Accord<span style='letter-spacing:
-.25pt'> </span>(and<span style='letter-spacing:-.35pt'> </span>vice<span
style='letter-spacing:-.25pt'> </span>versa)<span style='letter-spacing:-.3pt'>
</span>can<span style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:
-.3pt'> </span>d<span style='letter-spacing:-.05pt'>o</span>ne<span
style='letter-spacing:-.25pt'> </span>at<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>next scheduled<span style='letter-spacing:
-.35pt'> </span>dose<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.35pt'> </span>section<span style='letter-spacing:-.3pt'>&nbsp;</span>4.5).<span
style='letter-spacing:-.3pt'> </span>These<span style='letter-spacing:-.35pt'> </span>med<span
style='letter-spacing:-.05pt'>i</span>cinal<span style='letter-spacing:-.3pt'> </span>products<span
style='letter-spacing:-.35pt'> </span>should<span style='letter-spacing:-.35pt'>
</span>not<span style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:
-.35pt'> </span>ad<span style='letter-spacing:-.1pt'>m</span>inistered si<span
style='letter-spacing:-.1pt'>m</span>ultaneously.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Switching<span style='letter-spacing:-.35pt'> </span>fr<span
style='letter-spacing:-.05pt'>o</span>m<span style='letter-spacing:-.35pt'> </span>vitamin<span
style='letter-spacing:-.3pt'> </span>K<span style='letter-spacing:-.35pt'> </span>anta<span
style='letter-spacing:-.05pt'>g</span>onist<span style='letter-spacing:-.3pt'> </span>(<span
style='letter-spacing:-.05pt'>V</span>KA)<span style='letter-spacing:-.3pt'> </span>therapy<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>When<span style='letter-spacing:-.35pt'> </span>conve<span
style='letter-spacing:-.1pt'>r</span>ting<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>f</span>rom<span
style='letter-spacing:-.35pt'> </span>vitamin<span style='letter-spacing:-.3pt'>
</span>K<span style='letter-spacing:-.35pt'> </span>antagonist<span
style='letter-spacing:-.3pt'> </span>(VKA)<span style='letter-spacing:-.3pt'> </span>thera<span
style='letter-spacing:.05pt'>p</span>y<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>Apixaban Accord,<span style='letter-spacing:
-.35pt'> </span>warfarin<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>other VKA<span style='letter-spacing:-.35pt'>
</span>therapy<span style='letter-spacing:-.25pt'> </span>should<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.3pt'> </span>di<span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:-.05pt'>c</span>ontinued<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>star<span style='letter-spacing:
-.05pt'>te</span>d<span style='letter-spacing:-.35pt'> </span>when<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span>international<span
style='letter-spacing:-.3pt'> </span>normalised<span style='letter-spacing:
-.35pt'> </span>rat<span style='letter-spacing:.05pt'>i</span>o<span
style='letter-spacing:-.3pt'> </span>(INR) is<span style='letter-spacing:-.15pt'>
</span>&lt;<span style='letter-spacing:-.1pt'>&nbsp;</span>2.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Switching<span style='letter-spacing:-.35pt'> </span>fr<span
style='letter-spacing:-.05pt'>o</span>m<span style='letter-spacing:-.35pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:
-.4pt'> </span>VKA<span style='letter-spacing:-.3pt'> </span>therapy</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>When<span style='letter-spacing:-.35pt'> </span>conve<span
style='letter-spacing:-.1pt'>r</span>ting<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>f</span>rom<span
style='letter-spacing:-.4pt'> </span>Apixaban Accord<span style='letter-spacing:
-.3pt'> </span>to<span style='letter-spacing:-.35pt'> </span>VKA<span
style='letter-spacing:-.3pt'> </span>thera<span style='letter-spacing:-.05pt'>p</span><span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban Accord<span
style='letter-spacing:-.35pt'> </span>should<span style='letter-spacing:-.3pt'>
</span>be<span style='letter-spacing:-.35pt'> </span><span style='letter-spacing:
-.1pt'>c</span>ontinued for<span style='letter-spacing:-.25pt'> </span>at<span
style='letter-spacing:-.25pt'> </span>least<span style='letter-spacing:-.25pt'>
</span>2<span style='letter-spacing:-.25pt'>&nbsp;</span>da<span
style='letter-spacing:.05pt'>y</span>s<span style='letter-spacing:-.25pt'> </span>after<span
style='letter-spacing:-.25pt'> </span>beginning<span style='letter-spacing:
-.25pt'> </span>VKA<span style='letter-spacing:-.25pt'> </span>therapy.<span
style='letter-spacing:-.25pt'> </span>A<span style='letter-spacing:-.05pt'>f</span>ter<span
style='letter-spacing:-.2pt'> </span>2<span style='letter-spacing:-.25pt'>&nbsp;</span>d<span
style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>coa<span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:
-.25pt'> </span>VKA therap<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.35pt'> </span>an<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>I</span><span style='letter-spacing:-.05pt'>N</span>R<span
style='letter-spacing:-.25pt'> </span>should<span style='letter-spacing:-.3pt'>
</span>be<span style='letter-spacing:-.35pt'> </span>obtained<span
style='letter-spacing:-.25pt'> </span>pr<span style='letter-spacing:-.05pt'>io</span>r<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>next<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:-.05pt'>c</span>heduled<span
style='letter-spacing:-.3pt'> </span>do<span style='letter-spacing:-.1pt'>s</span>e<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>Apixaban
Accord.<span style='letter-spacing:-.35pt'> </span>Coa<span style='letter-spacing:
.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.25pt'> </span>of Apixaban Accord<span style='letter-spacing:
-.25pt'> </span>and<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>V</span>KA<span style='letter-spacing:-.25pt'> </span>therapy<span
style='letter-spacing:-.1pt'> </span>should<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>con<span style='letter-spacing:-.05pt'>t</span>inued<span
style='letter-spacing:-.2pt'> </span>until<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>INR<span style='letter-spacing:-.2pt'> </span>is<span
style='letter-spacing:-.2pt'> </span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>2.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Renal<span style='letter-spacing:-.8pt'> </span>impai<span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>m</span>ent</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ild<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.35pt'> </span>renal<span style='letter-spacing:-.35pt'>
</span><span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:
-.15pt'>m</span><span style='letter-spacing:.05pt'>p</span><span
style='letter-spacing:-.05pt'>a</span>irment,<span style='letter-spacing:-.35pt'>
</span>the<span style='letter-spacing:-.3pt'> </span>following<span
style='letter-spacing:-.4pt'> </span>rec<span style='letter-spacing:.05pt'>o</span>mmendations<span
style='letter-spacing:-.35pt'> </span>app<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span>:</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>pre<span style='letter-spacing:-.05pt'>v</span>ention<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>V<span
style='letter-spacing:-.05pt'>T</span>E<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>elective<span style='letter-spacing:-.25pt'>
</span>hip<span style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:
-.25pt'> </span>knee<span style='letter-spacing:-.25pt'> </span>replacement<span
style='letter-spacing:-.25pt'> </span>surgery<span style='letter-spacing:-.15pt'>
</span>(VTEp),<span style='letter-spacing:-.25pt'> </span>for<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>treatment<span
style='letter-spacing:-.25pt'> </span>of DVT,<span style='letter-spacing:-.25pt'>
</span>treatment<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:-.3pt'> </span>prevention<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>recurr<span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.25pt'> </span>DVT<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>PE<span
style='letter-spacing:-.25pt'> </span>(VTEt),<span style='letter-spacing:-.25pt'>
</span>no<span style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:
-.25pt'> </span>adjustment<span style='letter-spacing:-.25pt'> </span>is necessary<span
style='letter-spacing:-.3pt'> </span>(see<span style='letter-spacing:-.35pt'> </span>section<span
style='letter-spacing:-.4pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>for<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>prevention<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>stroke<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>stemic<span
style='letter-spacing:-.25pt'> </span>e<span style='letter-spacing:-.15pt'>m</span>boli<span
style='letter-spacing:.05pt'>s</span>m<span style='letter-spacing:-.4pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>NVAF<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>serum<span
style='letter-spacing:-.4pt'> </span>c<span style='letter-spacing:.05pt'>r</span>e<span
style='letter-spacing:-.05pt'>a</span>tinine &#8805;<span style='letter-spacing:
-.3pt'>&nbsp;</span>1.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g/dL<span style='letter-spacing:-.2pt'> </span>(133<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>icr<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>o</span>le/L)<span style='letter-spacing:-.2pt'> </span>associa<span
style='letter-spacing:.05pt'>t</span>ed<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.2pt'> </span>age<span style='letter-spacing:-.25pt'> </span>&#8805;<span
style='letter-spacing:-.25pt'>&nbsp;</span>80<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears<span style='letter-spacing:-.2pt'> </span>or<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>b</span>o<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.15pt'> </span>weight<span
style='letter-spacing:-.2pt'> </span>&#8804;<span style='letter-spacing:-.3pt'>&nbsp;</span>60<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>k</span>g,<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.2pt'> </span>dose
reduction<span style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:
-.25pt'> </span>necessary<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>described<span style='letter-spacing:-.25pt'>
</span>above.<span style='letter-spacing:-.25pt'> </span>In<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span>ab<span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:-.05pt'>e</span>nce<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>other<span
style='letter-spacing:-.25pt'> </span>criteria<span style='letter-spacing:-.3pt'>
</span>for<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>reduction<span style='letter-spacing:
-.3pt'> </span>(age, body<span style='letter-spacing:-.3pt'> </span>weight),<span
style='letter-spacing:-.3pt'> </span>no<span style='letter-spacing:-.3pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>adjus<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.05pt'>i</span>s<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>ne</span><span
style='letter-spacing:.05pt'>c</span><span style='letter-spacing:-.05pt'>essar</span>y<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.05pt'>(se</span>e<span
style='letter-spacing:-.3pt'> </span>se<span style='letter-spacing:-.05pt'>ctio</span>n<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>5.2).</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>severe<span
style='letter-spacing:-.35pt'> </span>renal<span style='letter-spacing:-.3pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pairment<span style='letter-spacing:-.3pt'>
</span>(creatinine<span style='letter-spacing:-.35pt'> </span>c<span
style='letter-spacing:.05pt'>l</span>earan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.4pt'> </span>15-29<span style='letter-spacing:-.35pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.05pt'>m</span>in)<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>following rec<span style='letter-spacing:
.05pt'>o</span>mmendations<span style='letter-spacing:-.35pt'> </span>app<span
style='letter-spacing:-.05pt'>l</span>y<span style='letter-spacing:-.25pt'> </span>(s<span
style='letter-spacing:-.1pt'>e</span>e<span style='letter-spacing:-.4pt'> </span>sections<span
style='letter-spacing:-.35pt'>&nbsp;</span>4.4<span style='letter-spacing:-.35pt'>&nbsp;</span>and<span
style='letter-spacing:-.35pt'>&nbsp;</span>5.2<span style='letter-spacing:-.1pt'>)</span>:</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>for the prevention of VTE in elective hip or
knee replacement surgery (VTEp), for the treatment of DVT, treatment of PE and
prevention of recurrent DVT and PE (VTEt) apixaban is to be used with caution;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>for the prevention of stroke and systemic
embolism in patients with NVAF, patients should receive the lower dose of
apixaban 2.5&nbsp;mg twice daily.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>creatinine<span
style='letter-spacing:-.25pt'> </span>clearan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.3pt'> </span>&lt;&nbsp;<span style='letter-spacing:
.05pt'>1</span>5&nbsp;<span style='letter-spacing:-.1pt'>m</span>L<span
style='letter-spacing:.05pt'>/</span><span style='letter-spacing:-.05pt'>m</span>in,<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span>u<span style='letter-spacing:-.05pt'>n</span>dergoing<span
style='letter-spacing:-.3pt'> </span>dia<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is,<span
style='letter-spacing:-.25pt'> </span>there<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.3pt'> </span>no clinical<span
style='letter-spacing:-.35pt'> </span>experience<span style='letter-spacing:
-.3pt'> </span>therefo<span style='letter-spacing:.05pt'>r</span>e<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>is<span style='letter-spacing:-.35pt'> </span>not<span style='letter-spacing:
-.3pt'> </span>recomm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>sections<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.4<span style='letter-spacing:-.3pt'>&nbsp;</span>and<span
style='letter-spacing:-.4pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Hepatic<span style='letter-spacing:-.9pt'> </span>impairment</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>is<span
style='letter-spacing:-.35pt'> </span>contraindicated<span style='letter-spacing:
-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>hepatic<span
style='letter-spacing:-.35pt'> </span>disease<span style='letter-spacing:-.3pt'>
</span>associa<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>coagulopathy<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.35pt'> </span>clinically
relevant<span style='letter-spacing:-.35pt'> </span>ble<span style='letter-spacing:
.05pt'>e</span>ding<span style='letter-spacing:-.3pt'> </span>risk<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.3).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>It<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>not<span style='letter-spacing:-.25pt'> </span>recommended<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>severe<span
style='letter-spacing:-.3pt'> </span>h<span style='letter-spacing:-.15pt'>e</span>pat<span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>pai<span
style='letter-spacing:.05pt'>r</span>ment<span style='letter-spacing:-.25pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>sections<span style='letter-spacing:-.3pt'>&nbsp;</span>4.4<span
style='letter-spacing:-.25pt'>&nbsp;</span>and<span style='letter-spacing:-.25pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>It<span style='letter-spacing:-.25pt'> </span>should<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>u</span>sed<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>caution<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ild<span style='letter-spacing:-.35pt'> </span>or<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.25pt'> </span>he<span style='letter-spacing:.05pt'>p</span><span
style='letter-spacing:-.05pt'>a</span>tic<span style='letter-spacing:-.25pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pairment<span style='letter-spacing:-.25pt'>
</span>(Child<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:
-.05pt'>P</span>u<span style='letter-spacing:-.05pt'>g</span>h<span
style='letter-spacing:-.25pt'> </span>A<span style='letter-spacing:-.25pt'> </span>or
B).<span style='letter-spacing:-.3pt'> </span>No<span style='letter-spacing:
-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>adjustment<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.25pt'> </span>required<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>pa<span
style='letter-spacing:-.05pt'>t</span>ients<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>w</span>ith<span style='letter-spacing:
-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:.05pt'>l</span>d<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.25pt'> </span>hepatic<span style='letter-spacing:-.3pt'>
</span>i<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
.05pt'>p</span>air<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.25pt'> </span>(see
sections<span style='letter-spacing:-.3pt'>&nbsp;</span>4.4&nbsp;and<span
style='letter-spacing:-.3pt'>&nbsp;</span>5<span style='letter-spacing:-.05pt'>.</span>2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Patients<span style='letter-spacing:-.55pt'> </span>with<span
style='letter-spacing:-.5pt'> </span>elevated<span style='letter-spacing:-.5pt'>
</span>liver<span style='letter-spacing:-.5pt'> </span>enz<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.1pt'>m</span>es<span
style='letter-spacing:-.5pt'> </span>a<span style='letter-spacing:.05pt'>l</span>anine<span
style='letter-spacing:-.5pt'> </span>a<span style='letter-spacing:-.1pt'>m</span>inotransferase<span
style='letter-spacing:-.5pt'> </span>(A<span style='letter-spacing:.05pt'>L</span>T)/aspartate<span
style='letter-spacing:-.45pt'> </span>aminotransferase (AST)<span
style='letter-spacing:-.25pt'> </span>&gt;&nbsp;2<span style='letter-spacing:
-.25pt'>&nbsp;</span>x<span style='letter-spacing:-.2pt'>&nbsp;</span>ULN<span
style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.2pt'> </span>total<span
style='letter-spacing:-.25pt'> </span>bilirub<span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.25pt'> </span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>1<span
style='letter-spacing:-.05pt'>.</span>5<span style='letter-spacing:-.2pt'>&nbsp;</span>x<span
style='letter-spacing:-.25pt'>&nbsp;</span>ULN<span style='letter-spacing:-.2pt'>
</span>were<span style='letter-spacing:-.25pt'> </span>excluded<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.3pt'> </span>clinical<span
style='letter-spacing:-.2pt'> </span>trials.<span style='letter-spacing:-.25pt'>
</span>Therefore<span style='letter-spacing:-.2pt'> </span>Apixaban Accord should<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.25pt'> </span>used<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>caution<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>this<span
style='letter-spacing:-.25pt'> </span>population<span style='letter-spacing:
-.25pt'> </span>(see<span style='letter-spacing:-.35pt'> </span>sections<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.4<span style='letter-spacing:-.25pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.2).<span style='letter-spacing:
-.25pt'> </span>Pr<span style='letter-spacing:-.05pt'>i</span>or<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>initiating<span
style='letter-spacing:-.25pt'> </span>Apixaban Accord, liver<span
style='letter-spacing:-.35pt'> </span>function<span style='letter-spacing:-.4pt'>
</span>testing<span style='letter-spacing:-.35pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.35pt'> </span>be<span
style='letter-spacing:-.35pt'> </span>performed.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Body<span style='letter-spacing:-.55pt'> </span>weight</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>VTEp<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>VTEt<span style='letter-spacing:-.25pt'> </span>-<span
style='letter-spacing:-.25pt'> </span>No<span style='letter-spacing:-.25pt'> </span>do<span
style='letter-spacing:-.1pt'>s</span>e<span style='letter-spacing:-.25pt'> </span>adjus<span
style='letter-spacing:.05pt'>t</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.25pt'> </span>required<span
style='letter-spacing:-.2pt'> </span>(see<span style='letter-spacing:-.2pt'> </span>sections<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.4<span style='letter-spacing:-.25pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>NVAF<span style='letter-spacing:-.3pt'> </span>-<span
style='letter-spacing:-.25pt'> </span>No<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>adjus<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span>ent<span style='letter-spacing:-.25pt'> </span>required,<span
style='letter-spacing:-.25pt'> </span>unless<span style='letter-spacing:-.25pt'>
</span>criteria<span style='letter-spacing:-.2pt'> </span>for<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>reduction<span
style='letter-spacing:-.3pt'> </span>are<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>t<span
style='letter-spacing:-.2pt'> </span>(see<span style='letter-spacing:-.25pt'> </span><i>Dose<span
style='letter-spacing:-.25pt'> </span>re<span style='letter-spacing:.05pt'>d</span>uction<span
style='letter-spacing:-.25pt'> </span></i><span style='letter-spacing:-.05pt'>at
</span>the<span style='letter-spacing:-.3pt'> </span>beginn<span
style='letter-spacing:-.05pt'>i</span>ng<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>section<span style='letter-spacing:-.3pt'>&nbsp;</span>4<span
style='letter-spacing:-.05pt'>.</span>2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Gender</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>No<span style='letter-spacing:-.35pt'> </span>dose<span
style='letter-spacing:-.3pt'> </span>adjus<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>required<span style='letter-spacing:-.3pt'>
</span>(see<span style='letter-spacing:-.35pt'> </span>section<span
style='letter-spacing:-.3pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Elderly</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>VTEp<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>VTEt<span style='letter-spacing:-.25pt'> </span>–<span
style='letter-spacing:-.25pt'> </span>No<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>adjus<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.25pt'> </span>required<span style='letter-spacing:-.25pt'>
</span>(see<span style='letter-spacing:-.2pt'> </span>sections<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.4<span style='letter-spacing:-.2pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>NVAF<span style='letter-spacing:-.3pt'> </span>–<span
style='letter-spacing:-.25pt'> </span>No<span style='letter-spacing:-.3pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>adjustment<span style='letter-spacing:
-.25pt'> </span>required,<span style='letter-spacing:-.3pt'> </span>unless<span
style='letter-spacing:-.3pt'> </span>criteria<span style='letter-spacing:-.2pt'>
</span>for<span style='letter-spacing:-.3pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>reduction<span style='letter-spacing:
-.25pt'> </span>are<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>t<span
style='letter-spacing:-.2pt'> </span>(see<span style='letter-spacing:-.3pt'> </span><i>Dose<span
style='letter-spacing:-.25pt'> </span>re<span style='letter-spacing:.05pt'>d</span>uction</i>
at<span style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:
-.25pt'> </span>beginn<span style='letter-spacing:-.05pt'>i</span>ng<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>section<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Patients undergoing catheter ablation (NVAF)</span></u></i></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>Patients can continue apixaban use while undergoing
catheter ablation (see sections 4.3, 4.4 and 4.5).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Patients<span style='letter-spacing:-.8pt'> </span>und<span
style='letter-spacing:-.1pt'>e</span>rgoing<span style='letter-spacing:-.75pt'>
</span>card<span style='letter-spacing:-.05pt'>io</span>version</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.35pt'> </span>can<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.3pt'> </span>initiated<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>continued<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.35pt'> </span>NVAF<span
style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span>who<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.25pt'> </span>require<span style='letter-spacing:-.3pt'>
</span>cardioversion.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For patients not previously treated with anticoagulants, exclusion
of left atrial thrombus using an image guided approach (e.g. transesophageal
echocardiography (TEE) or computed tomographic scan (CT)) prior to
cardioversion should be considered, in accordance with established medical
guidelines.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For patients initiating treatment with apixaban, 5 mg should be
given twice daily for at least 2.5 days (5 single doses) before cardioversion
to ensure adequate anticoagulation (see section 5.1). The dosing regimen should
be reduced to 2.5 mg apixaban given twice daily for at least 2.5 days (5 single
doses) if the patient meets the criteria for dose reduction (see above sections
<i>Dose reduction</i> and <i>Renal impairment</i>).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>If<span style='letter-spacing:-.25pt'> </span>cardioversion<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.25pt'> </span>required<span
style='letter-spacing:-.3pt'> </span>before<span style='letter-spacing:-.25pt'>
</span>5<span style='letter-spacing:-.2pt'>&nbsp;</span>do<span
style='letter-spacing:-.1pt'>s</span>es<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>can<span style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:
-.25pt'> </span>ad<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>nistered,<span style='letter-spacing:-.2pt'>
</span>a<span style='letter-spacing:-.25pt'> </span>10<span style='letter-spacing:
-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>loading<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>d</span>ose should<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.2pt'> </span>gi<span
style='letter-spacing:-.05pt'>ve</span>n,<span style='letter-spacing:-.2pt'> </span>followed<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>b</span>y<span
style='letter-spacing:-.1pt'> </span>5&nbsp;<span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>twice<span style='letter-spacing:-.2pt'> </span>dail<span
style='letter-spacing:.05pt'>y</span>.<span style='letter-spacing:-.3pt'> </span>The<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>d</span>osing<span
style='letter-spacing:-.2pt'> </span>regi<span style='letter-spacing:-.1pt'>m</span>en<span
style='letter-spacing:-.25pt'> </span>shou<span style='letter-spacing:-.1pt'>l</span>d<span
style='letter-spacing:-.2pt'> </span>be<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>e</span>duced<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>5<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g loading<span style='letter-spacing:-.3pt'>
</span>dose<span style='letter-spacing:-.25pt'> </span>followed<span
style='letter-spacing:-.2pt'> </span>by<span style='letter-spacing:-.25pt'> </span>2.5<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.05pt'>a</span>ily<span
style='letter-spacing:-.15pt'> </span>if<span style='letter-spacing:-.3pt'> </span>t<span
style='letter-spacing:.05pt'>h</span>e<span style='letter-spacing:-.2pt'> </span>patient<span
style='letter-spacing:-.25pt'> </span>meets<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>criteria<span style='letter-spacing:-.25pt'>
</span>for<span style='letter-spacing:-.2pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>reduction<span style='letter-spacing:
-.2pt'> </span>(see above<span style='letter-spacing:-.35pt'> </span>sections<span
style='letter-spacing:-.3pt'> </span><i>Dose<span style='letter-spacing:-.3pt'>
</span>reduc<span style='letter-spacing:.05pt'>t</span>ion<span
style='letter-spacing:-.35pt'> </span></i>and<span style='letter-spacing:-.3pt'>
</span><i><span style='letter-spacing:-.05pt'>Rena</span>l<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>impairment</span>)</i>.<span
style='letter-spacing:-.35pt'> </span>The<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>l</span>oading<span
style='letter-spacing:-.35pt'> </span>dose<span style='letter-spacing:-.35pt'> </span>should
be<span style='letter-spacing:-.25pt'> </span>given<span style='letter-spacing:
-.25pt'> </span>at<span style='letter-spacing:-.25pt'> </span>l<span
style='letter-spacing:-.1pt'>e</span>ast<span style='letter-spacing:-.25pt'> </span>2&nbsp;hours<span
style='letter-spacing:-.25pt'> </span>b<span style='letter-spacing:-.1pt'>e</span>fore<span
style='letter-spacing:-.25pt'> </span>cardioversion<span style='letter-spacing:
-.25pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For all patients undergoing cardioversion, confirmation<span
style='letter-spacing:-.3pt'> </span>should<span style='letter-spacing:-.35pt'>
</span>be<span style='letter-spacing:-.3pt'> </span>sought<span
style='letter-spacing:-.35pt'> </span>prior<span style='letter-spacing:-.25pt'>
</span>to<span style='letter-spacing:-.35pt'> </span>cardioversion<span
style='letter-spacing:-.3pt'> </span>that<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>patient<span style='letter-spacing:-.3pt'>
</span>has<span style='letter-spacing:-.25pt'> </span>taken<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>as<span style='letter-spacing:-.3pt'> </span>p<span style='letter-spacing:
-.1pt'>r</span>escribed. Decisions<span style='letter-spacing:-.4pt'> </span>on<span
style='letter-spacing:-.4pt'> </span>initiation<span style='letter-spacing:
-.35pt'> </span>and<span style='letter-spacing:-.45pt'> </span>duration<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.4pt'> </span>t<span
style='letter-spacing:-.1pt'>r</span>eatment<span style='letter-spacing:-.45pt'>
</span>shou<span style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:
-.35pt'> </span>take<span style='letter-spacing:-.4pt'> </span>established<span
style='letter-spacing:-.4pt'> </span>guideline<span style='letter-spacing:-.35pt'>
</span>rec<span style='letter-spacing:.05pt'>o</span>mmen<span
style='letter-spacing:.05pt'>d</span>ations for<span style='letter-spacing:
-.45pt'> </span>anticoagu<span style='letter-spacing:-.05pt'>l</span>ant<span
style='letter-spacing:-.4pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.4pt'> </span>patients<span style='letter-spacing:-.45pt'>
</span>u<span style='letter-spacing:-.05pt'>n</span>dergoing<span
style='letter-spacing:-.45pt'> </span>cardioversion<span style='letter-spacing:
-.4pt'> </span>in<span style='letter-spacing:-.05pt'>t</span>o<span
style='letter-spacing:-.45pt'> </span>account.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Patients with NVAF and acute coronary syndrome (ACS)
and/or percutaneous coronary intervention</span></u></i></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>(PCI)</span></u></i></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>There is limited experience of treatment with apixaban
at the recommended dose for NVAF patients when used in combination with
antiplatelet agents in patients with ACS and/or undergoing PCI after haemostasis
is achieved (see sections 4.4, 5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Paediatric<span style='letter-spacing:-1.0pt'> </span>p<span
style='letter-spacing:-.05pt'>o</span>pulat<span style='letter-spacing:-.05pt'>i</span>on</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>safety<span
style='letter-spacing:-.15pt'> </span>and<span style='letter-spacing:-.25pt'> </span>efficacy<span
style='letter-spacing:-.15pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:
-.25pt'> </span>children<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>adolescents<span style='letter-spacing:
-.25pt'> </span>bel<span style='letter-spacing:.05pt'>o</span>w<span
style='letter-spacing:-.25pt'> </span>age<span style='letter-spacing:-.3pt'> </span>18<span
style='letter-spacing:-.25pt'> </span>have<span style='letter-spacing:-.25pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>been<span style='letter-spacing:-.25pt'> </span>established.
No<span style='letter-spacing:-.3pt'> </span>data<span style='letter-spacing:
-.3pt'> </span>are<span style='letter-spacing:-.3pt'> </span>available.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Method<span style='letter-spacing:-.6pt'> </span>of<span
style='letter-spacing:-.55pt'> </span>a<span style='letter-spacing:-.05pt'>d</span>ministration</span></u></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Oral<span style='letter-spacing:-.35pt'> </span>use</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.3pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>swallowed<span style='letter-spacing:
-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>water,<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>wit<span style='letter-spacing:-.05pt'>h</span>out<span
style='letter-spacing:-.25pt'> </span>f<span style='letter-spacing:-.05pt'>o</span>od.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>who<span style='letter-spacing:-.25pt'> </span>are<span
style='letter-spacing:-.25pt'> </span>unable<span style='letter-spacing:-.25pt'>
</span>to<span style='letter-spacing:-.25pt'> </span>swallow<span
style='letter-spacing:-.25pt'> </span>whole<span style='letter-spacing:-.25pt'>
</span>tablets,<span style='letter-spacing:-.2pt'> </span>Apixaban Accord<span
style='letter-spacing:-.25pt'> </span>table<span style='letter-spacing:-.05pt'>t</span>s<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>y<span style='letter-spacing:-.15pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>crushed<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>sus<span
style='letter-spacing:-.05pt'>p</span>ended<span style='letter-spacing:-.25pt'>
</span>in water,<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>5%<span style='letter-spacing:-.25pt'> </span>glucose<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>water<span
style='letter-spacing:-.2pt'> </span>(G5W),<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>apple<span
style='letter-spacing:-.3pt'> </span>juice<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>ixed<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>apple<span
style='letter-spacing:-.25pt'> </span>puree<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.2pt'> </span>immediately a<span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistered<span
style='letter-spacing:-.3pt'> </span>orally<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.3pt'> </span>section&nbsp;5.2).<span style='letter-spacing:
-.35pt'> </span>Alternativel<span style='letter-spacing:.1pt'>y</span>,<span
style='letter-spacing:-.3pt'> </span>Apixaban Accord<span style='letter-spacing:
-.3pt'> </span>tablets<span style='letter-spacing:-.3pt'> </span>may<span
style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:-.3pt'> </span>crushed<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>suspended<span
style='letter-spacing:-.35pt'> </span>in 60<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>wa<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>e</span>r<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> G</span>5W<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>immediate<span style='letter-spacing:
.05pt'>l</span>y<span style='letter-spacing:-.25pt'> </span>delivered<span
style='letter-spacing:-.3pt'> </span>through<span style='letter-spacing:-.25pt'>
</span>a<span style='letter-spacing:-.3pt'> </span>nasogastric<span
style='letter-spacing:-.25pt'> </span>tube<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>section<span style='letter-spacing:-.25pt'>&nbsp;</span>5.2).
Crushed<span style='letter-spacing:-.25pt'> </span>Apixaban Accord<span
style='letter-spacing:-.2pt'> </span>tablets<span style='letter-spacing:-.25pt'>
</span>are<span style='letter-spacing:-.2pt'> </span>stable<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>water,<span
style='letter-spacing:-.2pt'> G</span>5W,<span style='letter-spacing:-.25pt'> </span>apple<span
style='letter-spacing:-.2pt'> </span>juice,<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.2pt'> </span>apple<span
style='letter-spacing:-.2pt'> </span>puree<span style='letter-spacing:-.25pt'> </span>f<span
style='letter-spacing:-.05pt'>o</span>r<span style='letter-spacing:-.2pt'> </span>up<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>4<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>h</span>ou<span
style='letter-spacing:-.1pt'>r</span>s.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.3<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Contraindications</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>H<span style='letter-spacing:.05pt'>y</span>persensitivity<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>active<span style='letter-spacing:-.25pt'>
</span>substance<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>any<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>excipients<span style='letter-spacing:
-.25pt'> </span>listed<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.2pt'> </span>section<span style='letter-spacing:-.25pt'>&nbsp;</span>6.1.</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Active<span style='letter-spacing:-.55pt'> </span>clinically<span
style='letter-spacing:-.55pt'> </span>significant<span style='letter-spacing:
-.55pt'> </span>bleeding.</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Hepatic<span style='letter-spacing:-.4pt'> </span>disease<span
style='letter-spacing:-.35pt'> </span>associated<span style='letter-spacing:
-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>coagulopathy<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.35pt'> </span>clinically<span
style='letter-spacing:-.25pt'> </span>relev<span style='letter-spacing:-.1pt'>a</span>nt<span
style='letter-spacing:-.35pt'> </span>bleeding<span style='letter-spacing:-.35pt'>
</span>risk<span style='letter-spacing:-.35pt'> </span>(see section<span
style='letter-spacing:-.55pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Lesion<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>condition<span style='letter-spacing:
-.3pt'> </span>if<span style='letter-spacing:-.25pt'> </span>considered<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.25pt'> </span>significant<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.35pt'> </span>factor<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor<span
style='letter-spacing:-.3pt'> </span>bleeding.<span style='letter-spacing:-.25pt'>
</span>This<span style='letter-spacing:-.35pt'> </span>may<span
style='letter-spacing:-.15pt'> </span>include current<span style='letter-spacing:
-.35pt'> </span>or<span style='letter-spacing:-.3pt'> </span>recent<span
style='letter-spacing:-.3pt'> </span>gastrointestinal<span style='letter-spacing:
-.3pt'> </span>ulcerat<span style='letter-spacing:.05pt'>i</span>on,<span
style='letter-spacing:-.35pt'> </span>presence<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>malignant<span
style='letter-spacing:-.3pt'> </span>neopla<span style='letter-spacing:.05pt'>s</span><span
style='letter-spacing:-.1pt'>m</span>s<span style='letter-spacing:-.35pt'> </span>at<span
style='letter-spacing:-.3pt'> </span>high<span style='letter-spacing:-.3pt'> </span>risk<span
style='letter-spacing:-.35pt'> </span>of bleeding,<span style='letter-spacing:
-.3pt'> </span>recent<span style='letter-spacing:-.3pt'> </span>brain<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>s</span>pinal<span style='letter-spacing:-.3pt'> </span>injury,<span
style='letter-spacing:-.3pt'> </span>recent<span style='letter-spacing:-.4pt'> </span>brain,<span
style='letter-spacing:-.3pt'> </span>spinal<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>ophtha<span style='letter-spacing:.05pt'>l</span><span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.25pt'> </span>surge<span
style='letter-spacing:.05pt'>r</span>y,<span style='letter-spacing:-.3pt'> </span>recent
intracranial<span style='letter-spacing:-.5pt'> </span>hae<span
style='letter-spacing:-.1pt'>m</span>orrhage,<span style='letter-spacing:-.45pt'>
</span>known<span style='letter-spacing:-.5pt'> </span>or<span
style='letter-spacing:-.5pt'> </span>suspec<span style='letter-spacing:-.15pt'>t</span>ed<span
style='letter-spacing:-.5pt'> </span>oesophageal<span style='letter-spacing:
-.5pt'> </span>varices,<span style='letter-spacing:-.5pt'> </span>arteriovenous
malfo<span style='letter-spacing:.05pt'>r</span>mations,<span style='letter-spacing:
-.45pt'> </span>vascular<span style='letter-spacing:-.4pt'> </span>a<span
style='letter-spacing:.05pt'>n</span>eur<span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.1pt'>m</span>s<span style='letter-spacing:-.4pt'> </span>or<span
style='letter-spacing:-.4pt'> </span>major<span style='letter-spacing:-.4pt'> </span>intraspinal<span
style='letter-spacing:-.45pt'> </span>or<span style='letter-spacing:-.4pt'> </span>intracer<span
style='letter-spacing:.05pt'>e</span>bral<span style='letter-spacing:-.4pt'> </span>vascular
abnor<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>a</span>lities.</span></p>

<p class=MsoBodyText style='margin-left:27.0pt;text-indent:-27.0pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;letter-spacing:-.25pt'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Conco<span style='letter-spacing:-.1pt'>m</span>itant<span
style='letter-spacing:-.35pt'> </span>treatment<span style='letter-spacing:
-.4pt'> </span>with<span style='letter-spacing:-.4pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>y<span style='letter-spacing:-.3pt'> </span>o<span
style='letter-spacing:-.05pt'>t</span>her<span style='letter-spacing:-.35pt'> </span>anticoagu<span
style='letter-spacing:-.15pt'>l</span>ant<span style='letter-spacing:-.45pt'> </span>agent<span
style='letter-spacing:-.4pt'> </span>e.g.,<span style='letter-spacing:-.35pt'> </span>u<span
style='letter-spacing:-.05pt'>n</span>fractionated<span style='letter-spacing:
-.4pt'> </span>heparin<span style='letter-spacing:-.4pt'> </span>(UFH), low<span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.1pt'>m</span>olecular<span
style='letter-spacing:-.4pt'> </span>weight<span style='letter-spacing:-.45pt'>
</span>heparins<span style='letter-spacing:-.4pt'> </span>(enoxaparin,<span
style='letter-spacing:-.45pt'> </span>dalteparin,<span style='letter-spacing:
-.4pt'> </span>etc.),<span style='letter-spacing:-.45pt'> </span>heparin<span
style='letter-spacing:-.4pt'> </span>derivatives (fondaparin<span
style='letter-spacing:-.05pt'>u</span>x,<span style='letter-spacing:-.45pt'> </span>etc.),<span
style='letter-spacing:-.45pt'> </span>oral<span style='letter-spacing:-.4pt'> </span>anticoagulants<span
style='letter-spacing:-.5pt'> </span>(warf<span style='letter-spacing:-.1pt'>a</span>rin,<span
style='letter-spacing:-.45pt'> </span>rivaroxaban,<span style='letter-spacing:
-.4pt'> </span>dabigatran,<span style='letter-spacing:-.45pt'> </span>etc.)<span
style='letter-spacing:-.45pt'> </span>except<span style='letter-spacing:-.4pt'>
</span>under specific<span style='letter-spacing:-.35pt'> </span>ci<span
style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.05pt'>c</span>umstan<span
style='letter-spacing:.05pt'>c</span>es<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>s<span style='letter-spacing:-.05pt'>w</span>itching<span
style='letter-spacing:-.3pt'> </span>anticoagulant<span style='letter-spacing:
-.3pt'> </span>th<span style='letter-spacing:-.1pt'>e</span>rapy<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>sec<span
style='letter-spacing:.05pt'>t</span>ion<span style='letter-spacing:-.3pt'>&nbsp;</span>4.2)<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>w</span>hen<span style='letter-spacing:-.3pt'> </span>UFH<span
style='letter-spacing:-.3pt'> </span>is given<span style='letter-spacing:-.3pt'>
</span>at<span style='letter-spacing:-.25pt'> </span>dos<span style='letter-spacing:
-.1pt'>e</span>s<span style='letter-spacing:-.3pt'> </span>necessary<span
style='letter-spacing:-.15pt'> </span>to<span style='letter-spacing:-.25pt'> </span>maintain<span
style='letter-spacing:-.25pt'> </span>an<span style='letter-spacing:-.25pt'> </span>op<span
style='letter-spacing:-.15pt'>e</span>n<span style='letter-spacing:-.25pt'> </span>central<span
style='letter-spacing:-.3pt'> </span>venous<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>ar<span style='letter-spacing:
-.05pt'>te</span>rial<span style='letter-spacing:-.25pt'> </span>catheter<span
style='letter-spacing:-.25pt'> or when UFH is given during catheter ablation
for atrial fibrillation </span>(see section<span style='letter-spacing:-.55pt'>&nbsp;4.4
and </span>4.5).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.4<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Special<span style='letter-spacing:-.4pt'> </span>warnings<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>precautions<span
style='letter-spacing:-.35pt'> </span>for<span style='letter-spacing:-.35pt'> </span>use</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Hae<span style='letter-spacing:-.1pt'>m</span>orr<span
style='letter-spacing:.05pt'>h</span>age<span style='letter-spacing:-.8pt'> </span>risk</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>As<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>other<span style='letter-spacing:-.3pt'> </span>anticoagula<span
style='letter-spacing:-.05pt'>n</span>ts,<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>taking<span style='letter-spacing:-.25pt'>
</span>Apixaban Accord<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:-.05pt'>r</span>e<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>careful<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>o</span>bserved<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.3pt'> </span>signs<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>b</span>leeding. It<span style='letter-spacing:
-.3pt'> </span>is<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.35pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>u<span style='letter-spacing:-.1pt'>s</span>ed<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.3pt'> </span>caution<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>con<span
style='letter-spacing:-.05pt'>d</span>itions<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>increased<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>ha<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>orrhage.<span style='letter-spacing:-.2pt'>
</span>Apixaban Accord a<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.35pt'> </span>shou<span style='letter-spacing:-.05pt'>l</span>d<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.35pt'> </span>discontinued<span
style='letter-spacing:-.3pt'> </span>if<span style='letter-spacing:-.35pt'> </span>severe<span
style='letter-spacing:-.35pt'> </span>h<span style='letter-spacing:-.15pt'>a</span>emorrhage<span
style='letter-spacing:-.3pt'> </span>occurs<span style='letter-spacing:-.35pt'>
</span>(see<span style='letter-spacing:-.3pt'> </span>sections&nbsp;4.8<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'>&nbsp;</span>4.9<span
style='letter-spacing:-.1pt'>)</span>.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Although<span style='letter-spacing:-.4pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>does<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>n</span>ot<span style='letter-spacing:-.3pt'> </span>require<span
style='letter-spacing:-.4pt'> </span>ro<span style='letter-spacing:-.05pt'>u</span>tine<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>onitoring<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>e<span
style='letter-spacing:-.05pt'>x</span>posu<span style='letter-spacing:-.1pt'>r</span>e,<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:-.3pt'> </span>calibrated
quantitative<span style='letter-spacing:-.35pt'> </span>anti-Factor<span
style='letter-spacing:-.3pt'> </span>Xa<span style='letter-spacing:-.3pt'> </span>assay<span
style='letter-spacing:-.25pt'> </span>may<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.45pt'> </span>useful<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>exceptional<span
style='letter-spacing:-.3pt'> </span>situations<span style='letter-spacing:
-.35pt'> </span>where<span style='letter-spacing:-.3pt'> </span>knowledge<span
style='letter-spacing:-.3pt'> </span>of apixaban<span style='letter-spacing:
-.35pt'> </span>exposure<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.2pt'> </span>h<span style='letter-spacing:-.1pt'>e</span>lp<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.35pt'> </span>inform<span
style='letter-spacing:-.4pt'> </span>clinical<span style='letter-spacing:-.3pt'>
</span>decisions,<span style='letter-spacing:-.3pt'> </span>e.g.,<span
style='letter-spacing:-.35pt'> </span>overdose<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>em<span style='letter-spacing:
.05pt'>e</span>rgency<span style='letter-spacing:-.2pt'> </span>surgery<span
style='letter-spacing:-.3pt'> </span>(see section<span style='letter-spacing:
-.55pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>An agent to reverse the anti-factor Xa activity of apixaban is
available.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Interaction<span style='letter-spacing:-.5pt'> </span>with<span
style='letter-spacing:-.45pt'> </span>other<span style='letter-spacing:-.45pt'>
</span><span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>e</span>dicin<span style='letter-spacing:-.1pt'>a</span>l<span
style='letter-spacing:-.5pt'> </span>produc<span style='letter-spacing:-.05pt'>t</span>s<span
style='letter-spacing:-.45pt'> </span>affecting<span style='letter-spacing:
-.45pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>ostasis</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Due<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>an<span style='letter-spacing:-.3pt'> </span>increased<span
style='letter-spacing:-.3pt'> </span>bleed<span style='letter-spacing:.05pt'>i</span>ng<span
style='letter-spacing:-.3pt'> </span>risk,<span style='letter-spacing:-.3pt'> </span>con<span
style='letter-spacing:-.1pt'>c</span>o<span style='letter-spacing:-.1pt'>m</span>itant<span
style='letter-spacing:-.3pt'> </span>tr<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.05pt'>a</span><span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>any<span style='letter-spacing:-.3pt'> </span>other<span
style='letter-spacing:-.3pt'> </span>anticoagulants<span style='letter-spacing:
-.3pt'> </span>is contraindicated<span style='letter-spacing:-.5pt'> </span>(see<span
style='letter-spacing:-.45pt'> </span>section<span style='letter-spacing:-.45pt'>&nbsp;</span>4.3).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>conco<span
style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:.05pt'>t</span>ant<span
style='letter-spacing:-.25pt'> </span>use<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>Apixaban Accord<span style='letter-spacing:
-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>antiplatelet<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.05pt'>g</span>ents<span
style='letter-spacing:-.25pt'> </span>increa<span style='letter-spacing:.05pt'>s</span>es<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>risk<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>sec<span
style='letter-spacing:.05pt'>t</span>ion<span style='letter-spacing:-.25pt'>&nbsp;</span>4.5).
</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Care<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>taken<span style='letter-spacing:-.3pt'> </span>if<span
style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>are<span style='letter-spacing:-.3pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>ed<span style='letter-spacing:-.3pt'> </span>con<span
style='letter-spacing:-.1pt'>c</span>o<span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:.05pt'>t</span>antly<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>select<span style='letter-spacing:.05pt'>i</span>ve<span
style='letter-spacing:-.3pt'> </span>serotonin<span style='letter-spacing:-.25pt'>
</span>reuptake<span style='letter-spacing:-.3pt'> </span>inhibitors</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>(SSRIs)<span style='letter-spacing:-.5pt'> </span>or<span
style='letter-spacing:-.45pt'> </span>serotonin<span style='letter-spacing:
-.5pt'> </span>nore<span style='letter-spacing:-.05pt'>p</span>inephrine<span
style='letter-spacing:-.5pt'> </span>re<span style='letter-spacing:-.05pt'>u</span>ptake<span
style='letter-spacing:-.45pt'> </span>inhibi<span style='letter-spacing:-.05pt'>to</span>rs<span
style='letter-spacing:-.45pt'> </span>(SNRIs),<span style='letter-spacing:-.5pt'>
</span><span style='letter-spacing:.05pt'>o</span>r<span style='letter-spacing:
-.45pt'> </span>non-steroid<span style='letter-spacing:-.1pt'>a</span>l<span
style='letter-spacing:-.45pt'> </span>anti-inflammatory drugs<span
style='letter-spacing:-.5pt'> </span>(NSAIDs),<span style='letter-spacing:-.5pt'>
</span>including<span style='letter-spacing:-.5pt'> </span>acet<span
style='letter-spacing:.05pt'>y</span>lsalicylic<span style='letter-spacing:
-.5pt'> </span>acid.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Following<span style='letter-spacing:-.45pt'> </span>surger<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.4pt'> </span>other<span
style='letter-spacing:-.4pt'> </span>platelet<span style='letter-spacing:-.45pt'>
</span>aggregation<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.1pt'>i</span>nh<span style='letter-spacing:-.05pt'>i</span>bit<span
style='letter-spacing:-.05pt'>o</span>rs<span style='letter-spacing:-.4pt'> </span>are<span
style='letter-spacing:-.4pt'> </span>not<span style='letter-spacing:-.4pt'> </span>recommended<span
style='letter-spacing:-.4pt'> </span>conco<span style='letter-spacing:-.1pt'>m</span>itantly<span
style='letter-spacing:-.35pt'> </span>with Apixaban Accord<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.35pt'> </span>section<span
style='letter-spacing:-.35pt'>&nbsp;</span>4.5).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>atrial<span
style='letter-spacing:-.3pt'> </span>fibri<span style='letter-spacing:-.05pt'>l</span>lation<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>conditions<span
style='letter-spacing:-.35pt'> </span>that<span style='letter-spacing:-.35pt'> </span>warrant<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>ono<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.25pt'> </span>dual<span
style='letter-spacing:-.3pt'> </span>ant<span style='letter-spacing:-.05pt'>i</span>p<span
style='letter-spacing:-.05pt'>l</span>atelet<span style='letter-spacing:-.25pt'>
</span>therapy,<span style='letter-spacing:-.3pt'> </span>a careful<span
style='letter-spacing:-.3pt'> </span>assessment<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>p</span>otential<span
style='letter-spacing:-.3pt'> </span>benefits<span style='letter-spacing:-.3pt'>
</span>a<span style='letter-spacing:-.05pt'>g</span>ainst<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>potential<span
style='letter-spacing:-.3pt'> </span>ris<span style='letter-spacing:-.05pt'>k</span>s<span
style='letter-spacing:-.3pt'> </span>should<span style='letter-spacing:-.25pt'>
</span>be<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>de<span
style='letter-spacing:-.3pt'> </span>before c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>bining<span style='letter-spacing:-.4pt'> </span>this<span
style='letter-spacing:-.35pt'> </span>therapy<span style='letter-spacing:-.3pt'>
</span>wi<span style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:
-.35pt'> </span>Apixaban Accord.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>clinical<span style='letter-spacing:-.25pt'>
</span>trial<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>atrial<span
style='letter-spacing:-.25pt'> </span>fib<span style='letter-spacing:-.1pt'>r</span>illation,<span
style='letter-spacing:-.25pt'> </span>conco<span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:.05pt'>t</span>ant<span style='letter-spacing:-.25pt'> </span>use<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> acetylsalicylic
acid (</span>ASA)<span style='letter-spacing:-.25pt'> </span>increased<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>j<span
style='letter-spacing:.05pt'>o</span>r bleeding<span style='letter-spacing:
-.25pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.1pt'>f</span>rom<span style='letter-spacing:
-.3pt'> </span>1.8%<span style='letter-spacing:-.25pt'>&nbsp;</span>per<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>y</span>ear<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.25pt'> </span>3.4%<span
style='letter-spacing:-.3pt'>&nbsp;</span>per<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:.05pt'>y</span>ear<span style='letter-spacing:
-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>i</span>ncreased<span style='letter-spacing:-.25pt'>
</span>the<span style='letter-spacing:-.2pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>on
warfarin<span style='letter-spacing:-.25pt'> </span>fr<span style='letter-spacing:
.05pt'>o</span>m<span style='letter-spacing:-.2pt'> </span>2.7%<span
style='letter-spacing:-.25pt'>&nbsp;</span>per<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:.05pt'>y</span>ear<span style='letter-spacing:
-.25pt'> </span>to<span style='letter-spacing:-.2pt'> </span>4<span
style='letter-spacing:-.05pt'>.</span>6%<span style='letter-spacing:-.25pt'>&nbsp;</span>per<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:.05pt'>y</span>ear.<span
style='letter-spacing:-.2pt'> </span>In<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>t</span>his<span style='letter-spacing:-.3pt'> </span>clinical<span
style='letter-spacing:-.25pt'> </span>trial,<span style='letter-spacing:-.2pt'>
</span>there<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>l<span style='letter-spacing:.05pt'>i</span>m<span
style='letter-spacing:.05pt'>i</span>ted<span style='letter-spacing:-.25pt'> </span>(2.1%)<span
style='letter-spacing:-.2pt'> </span>use<span style='letter-spacing:-.2pt'> </span>of
conco<span style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:
.05pt'>t</span>ant<span style='letter-spacing:-.55pt'> </span>dual<span
style='letter-spacing:-.55pt'> </span>antiplatelet<span style='letter-spacing:
-.5pt'> </span>therap<span style='letter-spacing:.05pt'>y (see section 5.1)</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>A clinical trial enrolled patients with atrial
fibrillation with ACS and/or undergoing PCI and a planned treatment period with
a P2Y12 inhibitor, with or without ASA, and oral anticoagulant (either apixaban
or VKA) for 6 months. Concomitant use of ASA increased the risk of ISTH
(International Society on Thrombosis and Hemostasis) major or CRNM (Clinically
Relevant Non-Major) bleeding in apixaban&#8209;treated subjects from 16.4% per
year to 33.1% per year (see section 5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>clinical<span style='letter-spacing:-.3pt'>
</span>trial<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>high-ri<span style='letter-spacing:-.1pt'>s</span>k<span
style='letter-spacing:-.3pt'> </span>post<span style='letter-spacing:-.25pt'>&#8209;</span>acute<span
style='letter-spacing:-.3pt'> </span>corona<span style='letter-spacing:-.1pt'>r</span>y<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>s</span><span
style='letter-spacing:.05pt'>y</span>nd<span style='letter-spacing:-.1pt'>r</span>ome<span
style='letter-spacing:-.3pt'> </span>patients without atrial fibrillation,<span
style='letter-spacing:-.3pt'> </span>characterised<span style='letter-spacing:
-.25pt'> </span>by<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ultiple<span style='letter-spacing:-.3pt'>
</span>cardiac and<span style='letter-spacing:-.35pt'> </span>non-card<span
style='letter-spacing:-.05pt'>i</span>ac<span style='letter-spacing:-.3pt'> </span>c<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>orbidities,<span
style='letter-spacing:-.3pt'> </span>who<span style='letter-spacing:-.3pt'> </span>rece<span
style='letter-spacing:.05pt'>i</span>ved<span style='letter-spacing:-.3pt'> </span>ASA<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>binat<span
style='letter-spacing:.05pt'>i</span>on<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>ASA<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>clopidogrel,<span style='letter-spacing:
-.3pt'> </span>a significant<span style='letter-spacing:-.35pt'> </span>increa<span
style='letter-spacing:.05pt'>s</span>e<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>risk<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>ISTH<span style='letter-spacing:-.3pt'> </span>(Internation<span
style='letter-spacing:-.05pt'>a</span>l<span style='letter-spacing:-.35pt'> </span>Soc<span
style='letter-spacing:-.05pt'>i</span>ety<span style='letter-spacing:-.35pt'> </span>on<span
style='letter-spacing:-.3pt'> </span>Th<span style='letter-spacing:-.1pt'>r</span>ombosis<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>Hae<span
style='letter-spacing:-.1pt'>m</span>ostasis)<span style='letter-spacing:-.3pt'>
</span>major bleeding<span style='letter-spacing:-.3pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>reported<span style='letter-spacing:-.3pt'>
</span>for<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>(5.13%<span style='letter-spacing:-.3pt'>&nbsp;</span>per<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>y</span>ear)<span
style='letter-spacing:-.3pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>pa<span
style='letter-spacing:.05pt'>r</span>ed<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>placebo<span style='letter-spacing:-.25pt'>
</span>(2.04%&nbsp;per<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:.05pt'>y</span>ear).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Use<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>thrombol<span style='letter-spacing:.05pt'>y</span>tic<span
style='letter-spacing:-.3pt'> </span>agents<span style='letter-spacing:-.4pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>treatment<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>acute<span
style='letter-spacing:-.25pt'> </span>isch<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.25pt'> </span>stroke</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.25pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>very<span style='letter-spacing:-.25pt'> </span>li<span
style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.25pt'> </span>experience<span style='letter-spacing:
-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>use<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>thro<span style='letter-spacing:-.1pt'>m</span>bo<span
style='letter-spacing:-.05pt'>l</span><span style='letter-spacing:.05pt'>y</span>tic<span
style='letter-spacing:-.25pt'> </span>agents<span style='letter-spacing:-.25pt'>
</span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>acute
isch<span style='letter-spacing:.05pt'>e</span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.5pt'> </span>stroke<span style='letter-spacing:-.4pt'> </span>in<span
style='letter-spacing:-.4pt'> </span>patients<span style='letter-spacing:-.5pt'>
</span>a<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:
-.1pt'>m</span>inistered<span style='letter-spacing:-.35pt'> </span>apixaban (see
section 4.5).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Patients<span style='letter-spacing:-.4pt'> </span>with<span
style='letter-spacing:-.4pt'> </span>prosthetic<span style='letter-spacing:
-.4pt'> </span>heart<span style='letter-spacing:-.4pt'> </span>valves</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Safety<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.2pt'> </span>efficacy<span style='letter-spacing:-.2pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>Apixaban<span
style='letter-spacing:-.2pt'> Accord </span>have<span style='letter-spacing:
-.25pt'> </span>not<span style='letter-spacing:-.3pt'> </span>been<span
style='letter-spacing:-.25pt'> </span>studied<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>prosthetic<span
style='letter-spacing:-.25pt'> </span>heart<span style='letter-spacing:-.25pt'>
</span>valves,<span style='letter-spacing:-.2pt'> </span>w<span
style='letter-spacing:.05pt'>i</span>th<span style='letter-spacing:-.25pt'> </span>or
without<span style='letter-spacing:-.3pt'> </span>atrial<span style='letter-spacing:
-.3pt'> </span>fibrillation.<span style='letter-spacing:-.3pt'> </span>Therefore,<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>use<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:
-.25pt'> </span>not<span style='letter-spacing:-.3pt'> </span>recommended<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>this<span
style='letter-spacing:-.3pt'> </span>setting.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Patients with antiphospholipid syndrome</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Direct acting oral anticoagulants (DOACs) including apixaban are not
recommended for patients with a history of thrombosis who are diagnosed with
antiphospholipid syndrome. In particular for patients that are triple positive
(for lupus anticoagulant, anticardiolipin antibodies, and anti-beta 2&#8209;glycoprotein
I antibodies), treatment with DOACs could be associated with increased rates of
recurrent thrombotic events compared with vitamin K antagonist therapy.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Surge<span style='letter-spacing:-.1pt'>r</span>y<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nvasive<span style='letter-spacing:-.45pt'>
</span>procedures</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.3pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>discont<span style='letter-spacing:-.05pt'>i</span>nued<span
style='letter-spacing:-.25pt'> </span>at<span style='letter-spacing:-.25pt'> </span>least<span
style='letter-spacing:-.25pt'> </span>48<span style='letter-spacing:-.25pt'>&nbsp;</span>hours<span
style='letter-spacing:-.25pt'> </span>prior<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>elective<span style='letter-spacing:-.25pt'>
</span>surge<span style='letter-spacing:-.1pt'>r</span>y<span style='letter-spacing:
-.15pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nvasive<span style='letter-spacing:-.25pt'>
</span>procedures<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>a <span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>high<span
style='letter-spacing:-.3pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>bl<span style='letter-spacing:-.1pt'>e</span><span
style='letter-spacing:-.05pt'>e</span>ding.<span style='letter-spacing:-.3pt'> </span>This<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>in</span>cludes<span
style='letter-spacing:-.3pt'> </span>interventions<span style='letter-spacing:
-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>which<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>prob<span
style='letter-spacing:-.1pt'>a</span>bili<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.35pt'> </span>clin<span
style='letter-spacing:-.05pt'>i</span>cally significant<span style='letter-spacing:
-.3pt'> </span>b<span style='letter-spacing:-.05pt'>l</span>eeding<span
style='letter-spacing:-.3pt'> </span>cannot<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>excluded<span style='letter-spacing:-.3pt'>
</span>or<span style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:
-.25pt'> </span>which<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:-.25pt'> </span>risk<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>bl<span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:-.05pt'>e</span>ding<span
style='letter-spacing:-.3pt'> </span>wou<span style='letter-spacing:-.05pt'>l</span>d<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.3pt'> </span>unacceptable.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.3pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>discont<span style='letter-spacing:-.05pt'>i</span>nued<span
style='letter-spacing:-.25pt'> </span>at<span style='letter-spacing:-.25pt'> </span>least<span
style='letter-spacing:-.25pt'> </span>24<span style='letter-spacing:-.25pt'>&nbsp;</span>hours<span
style='letter-spacing:-.25pt'> </span>prior<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>elective<span style='letter-spacing:-.25pt'>
</span>surge<span style='letter-spacing:-.1pt'>r</span>y<span style='letter-spacing:
-.15pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nvasive<span style='letter-spacing:-.25pt'>
</span>procedures<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>a low<span style='letter-spacing:-.25pt'>
</span>risk<span style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:
-.25pt'> </span>bleeding.<span style='letter-spacing:-.25pt'> </span>This<span
style='letter-spacing:-.25pt'> </span>includes<span style='letter-spacing:-.25pt'>
</span>interventions<span style='letter-spacing:-.25pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>which<span style='letter-spacing:-.25pt'> </span>any<span
style='letter-spacing:-.25pt'> </span>b<span style='letter-spacing:-.05pt'>l</span>eeding<span
style='letter-spacing:-.25pt'> </span>that<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>o</span>ccurs<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.25pt'> </span>expected<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>be
min<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>l,<span style='letter-spacing:-.35pt'> </span>non-critical<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.35pt'> </span>its<span
style='letter-spacing:-.3pt'> </span>location<span style='letter-spacing:-.35pt'>
</span>or<span style='letter-spacing:-.3pt'> </span>easily<span
style='letter-spacing:-.25pt'> </span>controll<span style='letter-spacing:-.1pt'>e</span>d.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;text-align:justify;punctuation-wrap:
simple'><span lang=EN-GB>If<span style='letter-spacing:-.3pt'> </span>surgery<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nvasive<span style='letter-spacing:-.3pt'>
</span>procedures<span style='letter-spacing:-.25pt'> </span>cannot<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.25pt'> </span>dela<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>e</span>d,<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>a</span>ppropriate<span
style='letter-spacing:-.25pt'> </span>caution<span style='letter-spacing:-.3pt'>
</span>s<span style='letter-spacing:-.05pt'>h</span>ould<span style='letter-spacing:
-.35pt'> </span>be<span style='letter-spacing:-.3pt'> </span>exercised,<span
style='letter-spacing:-.25pt'> </span>taking into<span style='letter-spacing:
-.25pt'> </span>consideration<span style='letter-spacing:-.25pt'> </span>an<span
style='letter-spacing:-.25pt'> </span>increased<span style='letter-spacing:
-.25pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>bleeding.<span style='letter-spacing:-.25pt'>
</span>T<span style='letter-spacing:-.1pt'>h</span>is<span style='letter-spacing:
-.3pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>bleeding<span style='letter-spacing:-.2pt'>
</span>should<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>weighed<span style='letter-spacing:-.25pt'>
</span>against<span style='letter-spacing:-.2pt'> </span>the urgen<span
style='letter-spacing:-.1pt'>c</span>y<span style='letter-spacing:-.45pt'> </span>of<span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>in</span>tervention.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.3pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>restarted<span style='letter-spacing:
-.3pt'> </span>after<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>invasive<span style='letter-spacing:-.3pt'>
</span>procedure<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>surgical<span style='letter-spacing:-.3pt'>
</span>intervention<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>a</span>s<span style='letter-spacing:-.3pt'> </span>soon<span
style='letter-spacing:-.3pt'> </span>as<span style='letter-spacing:-.3pt'> </span>possible
provided<span style='letter-spacing:-.4pt'> </span>the<span style='letter-spacing:
-.4pt'> </span>clinical<span style='letter-spacing:-.35pt'> </span>situation<span
style='letter-spacing:-.35pt'> </span>allows<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.4pt'> </span>adequate<span
style='letter-spacing:-.4pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>ostasis<span
style='letter-spacing:-.35pt'> </span>has<span style='letter-spacing:-.35pt'> </span>been<span
style='letter-spacing:-.35pt'> </span>established<span style='letter-spacing:
-.4pt'> </span>(for<span style='letter-spacing:-.35pt'> </span>cardioversion see<span
style='letter-spacing:-.35pt'> </span>section&nbsp;4.2).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For patients undergoing catheter ablation for atrial fibrillation,
Apixaban Accord treatment does not need to be interrupted (see sections 4.2,
4.3 and 4.5).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Te<span style='letter-spacing:-.1pt'>m</span>porary<span
style='letter-spacing:-1.15pt'> </span>d<span style='letter-spacing:-.05pt'>i</span>scontinuation</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Discontinui<span style='letter-spacing:-.05pt'>n</span>g<span
style='letter-spacing:-.45pt'> </span>anticoagul<span style='letter-spacing:
-.1pt'>a</span>nts,<span style='letter-spacing:-.4pt'> </span>includ<span
style='letter-spacing:-.05pt'>i</span>ng<span style='letter-spacing:-.4pt'> </span>Apixaban
Accord,<span style='letter-spacing:-.4pt'> </span>for<span style='letter-spacing:
-.4pt'> </span><span style='letter-spacing:-.1pt'>a</span><span
style='letter-spacing:-.05pt'>c</span>tive<span style='letter-spacing:-.4pt'> </span>bleeding,<span
style='letter-spacing:-.4pt'> </span>elective<span style='letter-spacing:-.45pt'>
</span>surger<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.4pt'> </span>or<span style='letter-spacing:-.4pt'> </span>i<span
style='letter-spacing:-.05pt'>n</span>vasive procedures<span style='letter-spacing:
-.3pt'> </span>places<span style='letter-spacing:-.25pt'> </span>pat<span
style='letter-spacing:.05pt'>i</span>ents<span style='letter-spacing:-.3pt'> </span>at<span
style='letter-spacing:-.25pt'> </span>an<span style='letter-spacing:-.3pt'> </span>increased<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>th</span>ro<span
style='letter-spacing:-.1pt'>m</span>bos<span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.05pt'>s</span>.<span style='letter-spacing:-.3pt'> </span>Lapses<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>therapy<span
style='letter-spacing:-.25pt'> </span>should<span style='letter-spacing:-.3pt'>
</span>be<span style='letter-spacing:-.3pt'> </span>avoided<span
style='letter-spacing:-.25pt'> </span>and if<span style='letter-spacing:-.35pt'>
</span>anticoagulation<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>Apixaban Accord<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>ust<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.3pt'> </span>te<span
style='letter-spacing:-.1pt'>m</span>pora<span style='letter-spacing:-.05pt'>r</span>ily<span
style='letter-spacing:-.2pt'> </span>discontinued<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.3pt'> </span>any<span style='letter-spacing:-.35pt'> </span>reason,<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>t</span>herapy<span
style='letter-spacing:-.2pt'> </span>s<span style='letter-spacing:-.05pt'>h</span>ou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.3pt'> </span>be
restarted<span style='letter-spacing:-.3pt'> </span>as<span style='letter-spacing:
-.3pt'> </span>soon<span style='letter-spacing:-.3pt'> </span>as<span
style='letter-spacing:-.3pt'> </span>possi<span style='letter-spacing:-.05pt'>b</span>le.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Spinal/epidural<span style='letter-spacing:-.6pt'> </span>anaesth<span
style='letter-spacing:.05pt'>e</span>sia<span style='letter-spacing:-.55pt'> </span>or<span
style='letter-spacing:-.55pt'> </span>puncture</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>When<span style='letter-spacing:-.5pt'> </span>neuraxial<span
style='letter-spacing:-.45pt'> </span>anaesthes<span style='letter-spacing:
.05pt'>i</span>a<span style='letter-spacing:-.45pt'> </span>(spinal/epidural<span
style='letter-spacing:-.45pt'> </span>anaesth<span style='letter-spacing:.05pt'>e</span>s<span
style='letter-spacing:-.05pt'>i</span>a)<span style='letter-spacing:-.45pt'> </span>or<span
style='letter-spacing:-.45pt'> </span>spinal/epidural<span style='letter-spacing:
-.45pt'> </span>puncture<span style='letter-spacing:-.45pt'> </span>is<span
style='letter-spacing:-.45pt'> </span>e<span style='letter-spacing:-.1pt'>m</span>plo<span
style='letter-spacing:.05pt'>y</span>ed, patients<span style='letter-spacing:
-.35pt'> </span>treated<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>antith<span style='letter-spacing:-.05pt'>r</span>o<span
style='letter-spacing:-.1pt'>m</span>botic<span style='letter-spacing:-.35pt'> </span>age<span
style='letter-spacing:.05pt'>n</span>ts<span style='letter-spacing:-.35pt'> </span>for<span
style='letter-spacing:-.35pt'> </span>preven<span style='letter-spacing:-.05pt'>t</span>ion<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>t</span>hro<span style='letter-spacing:-.1pt'>m</span>boe<span
style='letter-spacing:-.1pt'>m</span>bolic<span style='letter-spacing:-.35pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span>plications<span style='letter-spacing:
-.35pt'> </span>are<span style='letter-spacing:-.35pt'> </span>at<span
style='letter-spacing:-.35pt'> </span>risk of<span style='letter-spacing:-.3pt'>
</span>develop<span style='letter-spacing:-.05pt'>i</span>ng<span
style='letter-spacing:-.35pt'> </span>an<span style='letter-spacing:-.3pt'> </span>epidural<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>o</span>r<span
style='letter-spacing:-.25pt'> </span>spinal<span style='letter-spacing:-.3pt'>
</span>haemat<span style='letter-spacing:.05pt'>o</span><span style='letter-spacing:
-.1pt'>m</span>a<span style='letter-spacing:-.3pt'> </span>w<span
style='letter-spacing:-.05pt'>h</span>ich<span style='letter-spacing:-.25pt'> </span>can<span
style='letter-spacing:-.3pt'> </span>result<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>long-term<span style='letter-spacing:-.35pt'>
</span>or<span style='letter-spacing:-.3pt'> </span>per<span style='letter-spacing:
-.1pt'>m</span>anent<span style='letter-spacing:-.3pt'> </span>paral<span
style='letter-spacing:.05pt'>y</span>sis. The<span style='letter-spacing:-.3pt'>
</span>risk<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>these<span style='letter-spacing:-.25pt'>
</span>events<span style='letter-spacing:-.2pt'> </span>may<span
style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:-.25pt'> </span>i<span
style='letter-spacing:-.05pt'>n</span>creased<span style='letter-spacing:-.25pt'>
</span>by<span style='letter-spacing:-.15pt'> </span>the<span style='letter-spacing:
-.25pt'> </span>post-operative<span style='letter-spacing:-.3pt'> </span>use<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>indwelling<span
style='letter-spacing:-.25pt'> </span>epidural<span style='letter-spacing:-.25pt'>
</span>catheters<span style='letter-spacing:-.25pt'> </span>or the<span
style='letter-spacing:-.4pt'> </span>conco<span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:.05pt'>t</span>ant<span style='letter-spacing:-.35pt'> </span>use<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>medicinal<span
style='letter-spacing:-.35pt'> </span>products<span style='letter-spacing:-.4pt'>
</span>affecting<span style='letter-spacing:-.35pt'> </span>ha<span
style='letter-spacing:.05pt'>e</span><span style='letter-spacing:-.1pt'>m</span>ostasis.<span
style='letter-spacing:-.35pt'> </span>Indwelling<span style='letter-spacing:
-.35pt'> </span>epidural<span style='letter-spacing:-.4pt'> </span>or<span
style='letter-spacing:-.35pt'> </span>intr<span style='letter-spacing:-.1pt'>a</span>thecal
catheters<span style='letter-spacing:-.15pt'> </span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>u</span>st<span
style='letter-spacing:-.2pt'> </span>be<span style='letter-spacing:-.2pt'> </span>re<span
style='letter-spacing:-.1pt'>m</span>oved<span style='letter-spacing:-.2pt'> </span>at<span
style='letter-spacing:-.2pt'> </span>least<span style='letter-spacing:-.2pt'> </span>5<span
style='letter-spacing:-.2pt'>&nbsp;</span>hours<span style='letter-spacing:
-.2pt'> </span>prior<span style='letter-spacing:-.2pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.2pt'> </span>first<span
style='letter-spacing:-.15pt'> </span>dose<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>Apixaban Accord.<span style='letter-spacing:
-.2pt'> </span>The<span style='letter-spacing:-.2pt'> </span>risk<span
style='letter-spacing:-.2pt'> </span>may<span style='letter-spacing:-.1pt'> </span>also<span
style='letter-spacing:-.25pt'> </span>be increased<span style='letter-spacing:
-.3pt'> </span>by<span style='letter-spacing:-.2pt'> </span>tra<span
style='letter-spacing:.05pt'>u</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>tic<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>r</span><span
style='letter-spacing:-.05pt'>e</span>peated<span style='letter-spacing:-.3pt'>
</span>epidural<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>spi<span style='letter-spacing:-.1pt'>n</span>al<span
style='letter-spacing:-.25pt'> </span>puncture.<span style='letter-spacing:
-.3pt'> </span>Patients<span style='letter-spacing:-.3pt'> </span>are<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>frequently<span style='letter-spacing:
-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>onitored for<span
style='letter-spacing:-.3pt'> </span>signs<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptoms<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>neurological<span style='letter-spacing:
-.25pt'> </span>i<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>p</span><span style='letter-spacing:-.05pt'>a</span>i<span
style='letter-spacing:.05pt'>r</span>ment<span style='letter-spacing:-.25pt'> </span>(e.g.,<span
style='letter-spacing:-.3pt'> </span>nu<span style='letter-spacing:-.1pt'>m</span>bness<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.3pt'> </span>weakness<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>legs,<span style='letter-spacing:-.3pt'> </span>bowel<span
style='letter-spacing:-.25pt'> </span>or bladder<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.05pt'>d</span><span
style='letter-spacing:.05pt'>y</span>sf<span style='letter-spacing:-.05pt'>u</span>nction).<span
style='letter-spacing:-.35pt'> </span>If<span style='letter-spacing:-.35pt'> </span>n<span
style='letter-spacing:-.1pt'>e</span>urological<span style='letter-spacing:
-.35pt'> </span>c<span style='letter-spacing:-.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>pr<span style='letter-spacing:.05pt'>o</span>mise<span
style='letter-spacing:-.4pt'> </span>is<span style='letter-spacing:-.3pt'> </span>noted,<span
style='letter-spacing:-.35pt'> </span>u<span style='letter-spacing:-.1pt'>r</span>gent<span
style='letter-spacing:-.35pt'> </span>diagnosis<span style='letter-spacing:
-.35pt'> </span>and<span style='letter-spacing:-.4pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.35pt'> </span>is necessar<span style='letter-spacing:
.05pt'>y</span>.<span style='letter-spacing:-.35pt'> </span>Pr<span
style='letter-spacing:-.05pt'>i</span>or<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>neuraxi<span style='letter-spacing:-.1pt'>a</span>l<span
style='letter-spacing:-.3pt'> </span>intervention<span style='letter-spacing:
-.35pt'> </span>the<span style='letter-spacing:-.3pt'> </span>ph<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>ician<span
style='letter-spacing:-.3pt'> </span>should<span style='letter-spacing:-.35pt'>
</span>consider<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>poten<span style='letter-spacing:-.05pt'>t</span>ial<span
style='letter-spacing:-.3pt'> </span>benefit<span style='letter-spacing:-.3pt'>
</span>versus<span style='letter-spacing:-.35pt'> </span>the risk<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>antic<span
style='letter-spacing:-.05pt'>oa</span>gulated<span style='letter-spacing:-.3pt'>
</span>patients<span style='letter-spacing:-.35pt'> </span>or<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.4pt'> </span>to<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.35pt'> </span>anti<span style='letter-spacing:-.1pt'>c</span>oagulated<span
style='letter-spacing:-.35pt'> </span>for<span style='letter-spacing:-.35pt'> </span>thro<span
style='letter-spacing:-.1pt'>m</span>bopro<span style='letter-spacing:-.05pt'>ph</span><span
style='letter-spacing:.05pt'>y</span>laxis.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.3pt'> </span>clinical<span
style='letter-spacing:-.25pt'> </span>experience<span style='letter-spacing:
-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>use<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>ind<span
style='letter-spacing:-.1pt'>w</span>elling<span style='letter-spacing:-.25pt'>
</span>intrath<span style='letter-spacing:-.1pt'>e</span>cal<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.25pt'> </span>epidural
catheters.<span style='letter-spacing:-.25pt'> </span>In<span style='letter-spacing:
-.25pt'> </span>case<span style='letter-spacing:-.2pt'> </span>there<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.2pt'> </span>such<span
style='letter-spacing:-.2pt'> </span>need<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.2pt'> </span>based<span style='letter-spacing:-.25pt'> </span>on<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>general<span
style='letter-spacing:-.25pt'> </span>PK<span style='letter-spacing:-.2pt'> </span>c<span
style='letter-spacing:.05pt'>h</span>aract<span style='letter-spacing:.05pt'>e</span>ristics<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:.05pt'>o</span>f<span
style='letter-spacing:-.25pt'> </span>apixaban,<span style='letter-spacing:
-.2pt'> </span>a<span style='letter-spacing:-.3pt'> </span>time interval<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>2<span
style='letter-spacing:-.05pt'>0</span>-30<span style='letter-spacing:-.25pt'>&nbsp;</span>h<span
style='letter-spacing:-.05pt'>o</span>urs<span style='letter-spacing:-.25pt'> </span>(i.e.,<span
style='letter-spacing:-.25pt'> </span>2<span style='letter-spacing:-.25pt'>&nbsp;</span>x<span
style='letter-spacing:-.3pt'>&nbsp;</span>half-life)<span style='letter-spacing:
-.25pt'> </span>between<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>last<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:-.05pt'>a</span>theter<span
style='letter-spacing:-.25pt'> </span>withdrawal should<span style='letter-spacing:
-.25pt'> </span>elapse,<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>at<span style='letter-spacing:-.25pt'> </span>least<span
style='letter-spacing:-.25pt'> </span>one<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.2pt'> </span>should<span style='letter-spacing:-.25pt'>
</span>be<span style='letter-spacing:-.25pt'> </span>o<span style='letter-spacing:
-.25pt'>m</span>itted<span style='letter-spacing:-.25pt'> </span>before<span
style='letter-spacing:-.25pt'> </span>catheter<span style='letter-spacing:-.25pt'>
</span>withdrawal.<span style='letter-spacing:-.25pt'> </span>The<span
style='letter-spacing:-.2pt'> </span>next<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>of apixaban<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>y<span style='letter-spacing:-.15pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>given<span style='letter-spacing:-.25pt'>
</span>at<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.05pt'>l</span>east<span style='letter-spacing:-.25pt'> </span>5<span
style='letter-spacing:-.25pt'>&nbsp;</span>hours<span style='letter-spacing:
-.25pt'> </span>after<span style='letter-spacing:-.3pt'> </span>cathet<span
style='letter-spacing:-.15pt'>e</span>r<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:-.1pt'>m</span>oval.<span
style='letter-spacing:-.25pt'> </span>As<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>all<span style='letter-spacing:-.25pt'> </span>new<span
style='letter-spacing:-.25pt'> </span>anticoagulant<span style='letter-spacing:
-.25pt'> </span>medicinal products,<span style='letter-spacing:-.35pt'> </span>ex<span
style='letter-spacing:-.05pt'>pe</span>rience<span style='letter-spacing:-.35pt'>
</span>with<span style='letter-spacing:-.35pt'> </span>neuraxial<span
style='letter-spacing:-.35pt'> </span>bl<span style='letter-spacing:-.05pt'>oc</span>kade<span
style='letter-spacing:-.35pt'> </span>is<span style='letter-spacing:-.35pt'> </span>l<span
style='letter-spacing:-.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>ited<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>extreme<span
style='letter-spacing:-.35pt'> </span>caution<span style='letter-spacing:-.35pt'>
</span>is<span style='letter-spacing:-.35pt'> </span>therefore<span
style='letter-spacing:-.35pt'> </span>rec<span style='letter-spacing:.05pt'>o</span>mmended
when<span style='letter-spacing:-.3pt'> </span>using<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.1pt'>a</span>pixaban<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>presence<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>neuraxial<span
style='letter-spacing:-.3pt'> </span>blockade.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Hae<span style='letter-spacing:-.1pt'>m</span>od<span
style='letter-spacing:.05pt'>y</span>namically<span style='letter-spacing:-.35pt'>
</span>unstable<span style='letter-spacing:-.4pt'> </span>PE<span
style='letter-spacing:-.4pt'> </span>patients<span style='letter-spacing:-.4pt'>
</span>or<span style='letter-spacing:-.4pt'> </span>patien<span
style='letter-spacing:-.1pt'>t</span>s<span style='letter-spacing:-.4pt'> </span>who<span
style='letter-spacing:-.4pt'> </span>require<span style='letter-spacing:-.4pt'>
</span><span style='letter-spacing:-.05pt'>t</span>hro<span style='letter-spacing:
-.1pt'>m</span>bol<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>s</span>is<span style='letter-spacing:-.45pt'> </span>or<span
style='letter-spacing:-.45pt'> </span>pul<span style='letter-spacing:-.1pt'>m</span>onary</span></u><span
lang=EN-GB> </span><u><span lang=EN-GB style='letter-spacing:.05pt'>e</span><span
lang=EN-GB style='letter-spacing:-.1pt'>m</span><span lang=EN-GB>bol<span
style='letter-spacing:-.05pt'>ec</span>t<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>y</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>is<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.35pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mmend<span style='letter-spacing:.05pt'>e</span>d<span
style='letter-spacing:-.3pt'> </span>as<span style='letter-spacing:-.3pt'> </span>an<span
style='letter-spacing:-.3pt'> </span>alternative<span style='letter-spacing:
-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>u<span
style='letter-spacing:-.05pt'>n</span>fr<span style='letter-spacing:-.1pt'>a</span>ctionated<span
style='letter-spacing:-.3pt'> </span>he<span style='letter-spacing:-.05pt'>pa</span>rin<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>patien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>pul<span style='letter-spacing:-.1pt'>m</span>onary
e<span style='letter-spacing:-.1pt'>m</span>bolism<span style='letter-spacing:
-.5pt'> </span>w<span style='letter-spacing:.05pt'>h</span>o<span
style='letter-spacing:-.35pt'> </span>are<span style='letter-spacing:-.35pt'> </span>hae<span
style='letter-spacing:-.1pt'>m</span>odyna<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>cally<span style='letter-spacing:-.3pt'> </span>unstable<span
style='letter-spacing:-.4pt'> </span>or<span style='letter-spacing:-.35pt'> </span>may<span
style='letter-spacing:-.35pt'> </span>receive<span style='letter-spacing:-.4pt'>
</span>thro<span style='letter-spacing:-.1pt'>m</span>bol<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is<span
style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:-.4pt'> </span>pul<span
style='letter-spacing:-.1pt'>m</span>onary e<span style='letter-spacing:-.1pt'>m</span>bolect<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>y<span
style='letter-spacing:-.2pt'> </span>since<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>sa<span style='letter-spacing:.05pt'>f</span>ety<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.3pt'> </span>efficacy<span
style='letter-spacing:-.15pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apixab<span
style='letter-spacing:-.1pt'>a</span>n<span style='letter-spacing:-.25pt'> </span>have<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.25pt'> </span>been<span
style='letter-spacing:-.3pt'> </span>establish<span style='letter-spacing:.05pt'>e</span>d<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>these<span
style='letter-spacing:-.3pt'> </span>clinical situations.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Patients<span style='letter-spacing:-.4pt'> </span>with<span
style='letter-spacing:-.4pt'> </span>active<span style='letter-spacing:-.4pt'> </span>cancer</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Efficacy<span style='letter-spacing:.25pt'> </span>and<span
style='letter-spacing:.2pt'> </span>safety<span style='letter-spacing:.3pt'> </span>of<span
style='letter-spacing:.2pt'> </span>apixaban<span style='letter-spacing:.25pt'>
</span>in<span style='letter-spacing:.2pt'> </span>the<span style='letter-spacing:
.2pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:.25pt'> </span>of<span style='letter-spacing:.15pt'> </span>D<span
style='letter-spacing:-.05pt'>V</span>T,<span style='letter-spacing:.2pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>me<span style='letter-spacing:.05pt'>n</span>t<span
style='letter-spacing:.25pt'> </span>of<span style='letter-spacing:.2pt'> </span>PE<span
style='letter-spacing:.2pt'> </span>and<span style='letter-spacing:.2pt'> </span>prevention<span
style='letter-spacing:.25pt'> </span>of<span style='letter-spacing:.2pt'> </span>recurrent
DVT<span style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:
-.25pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>(VTEt)<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>ac<span
style='letter-spacing:.05pt'>t</span>ive<span style='letter-spacing:-.25pt'> </span>cancer<span
style='letter-spacing:-.3pt'> </span>have<span style='letter-spacing:-.25pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>been<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:-.05pt'>s</span>tablished.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Patients<span style='letter-spacing:-.5pt'> </span>with<span
style='letter-spacing:-.45pt'> </span>renal<span style='letter-spacing:-.45pt'>
</span><span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:
-.1pt'>m</span>pairment</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>L<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:
-.1pt'>m</span>ited<span style='letter-spacing:-.35pt'> </span>clinical<span
style='letter-spacing:-.3pt'> </span>data<span style='letter-spacing:-.35pt'> </span>indicate<span
style='letter-spacing:-.3pt'> </span>that<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>plasma<span style='letter-spacing:-.45pt'>
</span>concentrations<span style='letter-spacing:-.35pt'> </span>are<span
style='letter-spacing:-.3pt'> </span>incre<span style='letter-spacing:.05pt'>a</span>sed<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.3pt'> </span>severe
renal<span style='letter-spacing:-.35pt'> </span><span style='letter-spacing:
.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>pairment<span
style='letter-spacing:-.3pt'> </span>(creatinine<span style='letter-spacing:
-.3pt'> </span>clearan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.3pt'> </span>15-29<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>n)<span
style='letter-spacing:-.3pt'> </span>which<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.25pt'> </span>lead<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>an<span style='letter-spacing:-.35pt'> </span>increa<span
style='letter-spacing:.05pt'>s</span>ed<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.3pt'> </span>risk. For<span style='letter-spacing:-.3pt'>
</span>the<span style='letter-spacing:-.25pt'> </span>prev<span
style='letter-spacing:-.1pt'>e</span>ntion<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>VTE<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>elective<span style='letter-spacing:-.25pt'>
</span>hip<span style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:
-.25pt'> </span><span style='letter-spacing:-.05pt'>k</span>nee<span
style='letter-spacing:-.25pt'> </span>replac<span style='letter-spacing:.05pt'>e</span>ment<span
style='letter-spacing:-.25pt'> </span>surgery<span style='letter-spacing:-.15pt'>
</span>(VTEp),<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>trea<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>DVT,
treatment<span style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:
-.25pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.2pt'> </span>prev<span style='letter-spacing:-.1pt'>e</span>ntion<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>recurrent<span
style='letter-spacing:-.2pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>PE<span style='letter-spacing:-.2pt'> </span>(VTEt),<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:
-.25pt'> </span>be<span style='letter-spacing:-.25pt'> </span>used<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>caution
in<span style='letter-spacing:-.35pt'> </span>patients<span style='letter-spacing:
-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>severe<span
style='letter-spacing:-.3pt'> </span>ren<span style='letter-spacing:.05pt'>a</span>l<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.1pt'>m</span>pai<span
style='letter-spacing:.05pt'>r</span>ment<span style='letter-spacing:-.25pt'> </span>(creatinine<span
style='letter-spacing:-.35pt'> </span>c<span style='letter-spacing:.05pt'>l</span>earan<span
style='letter-spacing:.05pt'>c</span>e<span style='letter-spacing:-.35pt'> </span>15-29<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>L<span
style='letter-spacing:.05pt'>/</span><span style='letter-spacing:-.05pt'>m</span>in)<span
style='letter-spacing:-.3pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>sections<span
style='letter-spacing:-.3pt'> </span>4.2<span style='letter-spacing:-.3pt'> </span>and
5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>prev<span style='letter-spacing:-.1pt'>e</span>ntion<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.25pt'> </span>stroke<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>s<span
style='letter-spacing:.05pt'>y</span>ste<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.35pt'> </span>e<span
style='letter-spacing:-.1pt'>m</span>boli<span style='letter-spacing:.05pt'>s</span>m<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:.05pt'>i</span>n<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>NVAF,<span
style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>severe<span
style='letter-spacing:-.25pt'> </span>renal i<span style='letter-spacing:-.1pt'>m</span>pairment<span
style='letter-spacing:-.35pt'> </span>(creatinine<span style='letter-spacing:
-.35pt'> </span>clearance<span style='letter-spacing:-.3pt'> </span>15-29<span
style='letter-spacing:-.35pt'>&nbsp;</span>mL/<span style='letter-spacing:-.25pt'>m</span>in),<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>ser<span
style='letter-spacing:.05pt'>u</span>m<span style='letter-spacing:-.4pt'> </span>creatinine<span
style='letter-spacing:-.4pt'> </span>&#8805;<span style='letter-spacing:-.35pt'>&nbsp;</span>1.5<span
style='letter-spacing:-.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g/dL
(133<span style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:
-.1pt'>m</span>icr<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.05pt'>m</span>ole/L)<span style='letter-spacing:-.25pt'>
</span>associated<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>age<span style='letter-spacing:-.3pt'> </span>&#8805;<span
style='letter-spacing:-.25pt'>&nbsp;</span>80<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears<span style='letter-spacing:-.2pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>bo<span style='letter-spacing:-.05pt'>d</span>y<span
style='letter-spacing:-.2pt'> </span>weight<span style='letter-spacing:-.35pt'>
</span>&#8804;<span style='letter-spacing:-.25pt'>&nbsp;</span>60<span
style='letter-spacing:-.25pt'>&nbsp;</span>kg<span style='letter-spacing:-.25pt'>
</span>should<span style='letter-spacing:-.2pt'> </span>receive<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>lower
dose<span style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:
-.25pt'> </span>apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.25pt'> </span>2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.1pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>section<span style='letter-spacing:-.25pt'>
</span>4.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>creatinine<span
style='letter-spacing:-.25pt'> </span>clearan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.3pt'> </span>&lt;<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>1</span>5&nbsp;<span style='letter-spacing:-.1pt'>m</span>L<span
style='letter-spacing:.05pt'>/</span><span style='letter-spacing:-.05pt'>m</span>in,<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span>u<span style='letter-spacing:-.05pt'>n</span>dergoing<span
style='letter-spacing:-.3pt'> </span>dia<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is,<span
style='letter-spacing:-.25pt'> </span>there<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.3pt'> </span>no clinical<span
style='letter-spacing:-.35pt'> </span>experience<span style='letter-spacing:
-.3pt'> </span>therefo<span style='letter-spacing:.05pt'>r</span>e<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>is<span style='letter-spacing:-.35pt'> </span>not<span style='letter-spacing:
-.3pt'> </span>recomm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>sections<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.2<span style='letter-spacing:-.3pt'>&nbsp;</span>and&nbsp;5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Elderly<span style='letter-spacing:-.7pt'> </span>patients</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Increasing<span style='letter-spacing:-.35pt'> </span>age<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>y<span style='letter-spacing:-.2pt'> </span>increa<span
style='letter-spacing:.05pt'>s</span>e<span style='letter-spacing:-.35pt'> </span>ha<span
style='letter-spacing:.05pt'>e</span><span style='letter-spacing:-.1pt'>m</span>orrha<span
style='letter-spacing:.05pt'>g</span>ic<span style='letter-spacing:-.3pt'> </span>risk<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.35pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Also,<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>coad<span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:
-.25pt'> </span>ASA<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>el<span style='letter-spacing:-.05pt'>de</span>rly<span
style='letter-spacing:-.2pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.1pt'>s</span>hould<span style='letter-spacing:
-.3pt'> </span>be<span style='letter-spacing:-.3pt'> </span>used<span
style='letter-spacing:-.35pt'> </span>cautious<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.2pt'> </span>b<span style='letter-spacing:-.1pt'>e</span>cause
of<span style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.3pt'>
</span>potential<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.3pt'> </span>hi<span style='letter-spacing:-.05pt'>g</span>her<span
style='letter-spacing:-.3pt'> </span>bleeding<span style='letter-spacing:-.3pt'>
</span>risk.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Bo<span style='letter-spacing:-.05pt'>d</span>y<span
style='letter-spacing:-.5pt'> </span>weight</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Low<span style='letter-spacing:-.3pt'> </span>body<span
style='letter-spacing:-.25pt'> </span>weight<span style='letter-spacing:-.25pt'>
</span>(&lt;<span style='letter-spacing:-.25pt'>&nbsp;</span>60<span
style='letter-spacing:-.25pt'>&nbsp;</span>kg)<span style='letter-spacing:-.25pt'>
</span>may<span style='letter-spacing:-.2pt'> </span>increase<span
style='letter-spacing:-.25pt'> </span>ha<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>orrhagic<span style='letter-spacing:-.25pt'>
</span>risk<span style='letter-spacing:-.25pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>s<span style='letter-spacing:-.05pt'>e</span>ction<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Patients<span style='letter-spacing:-.5pt'> </span>with<span
style='letter-spacing:-.5pt'> </span>hepatic<span style='letter-spacing:-.5pt'>
</span>i<span style='letter-spacing:-.1pt'>m</span>pair<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>is<span
style='letter-spacing:-.35pt'> </span>contraindicated<span style='letter-spacing:
-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>hepatic<span
style='letter-spacing:-.35pt'> </span>disease<span style='letter-spacing:-.35pt'>
</span>associa<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>coagulopathy<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.35pt'> </span>clinically
relevant<span style='letter-spacing:-.35pt'> </span>ble<span style='letter-spacing:
.05pt'>e</span>ding<span style='letter-spacing:-.3pt'> </span>risk<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.3).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>It<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.25pt'> </span>recommended<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>se<span
style='letter-spacing:-.05pt'>v</span>ere<span style='letter-spacing:-.3pt'> </span>hepat<span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>pai<span
style='letter-spacing:.05pt'>r</span>ment<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>section<span style='letter-spacing:-.3pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>It<span style='letter-spacing:-.25pt'> </span>should<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>u</span>sed<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>caution<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ild<span style='letter-spacing:-.35pt'> </span>or<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.25pt'> </span>he<span style='letter-spacing:.05pt'>p</span><span
style='letter-spacing:-.05pt'>a</span>tic<span style='letter-spacing:-.25pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pairment<span style='letter-spacing:-.25pt'>
</span>(Child<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:
-.05pt'>P</span>u<span style='letter-spacing:-.05pt'>g</span>h<span
style='letter-spacing:-.25pt'> </span>A<span style='letter-spacing:-.25pt'> </span>or
B)<span style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:
-.25pt'> </span>secti<span style='letter-spacing:.05pt'>o</span>ns<span
style='letter-spacing:-.2pt'>&nbsp;</span>4.2<span style='letter-spacing:-.25pt'>&nbsp;</span>and<span
style='letter-spacing:-.2pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Patients<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.2pt'> </span>elevated<span style='letter-spacing:-.25pt'>
</span>liver<span style='letter-spacing:-.2pt'> </span>enz<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.1pt'>m</span>es<span
style='letter-spacing:-.2pt'> </span>A<span style='letter-spacing:.05pt'>L</span>T/AST<span
style='letter-spacing:-.25pt'> </span>&gt;<span style='letter-spacing:-.2pt'>&nbsp;</span>2<span
style='letter-spacing:-.25pt'>&nbsp;</span>x<span style='letter-spacing:-.25pt'>&nbsp;</span>ULN<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.25pt'> </span>total<span
style='letter-spacing:-.2pt'> </span>bilirub<span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.3pt'> </span>&#8805;<span style='letter-spacing:-.25pt'>&nbsp;</span>1<span
style='letter-spacing:-.05pt'>.</span>5<span style='letter-spacing:-.25pt'>&nbsp;</span>x<span
style='letter-spacing:-.2pt'>&nbsp;</span>ULN<span style='letter-spacing:-.25pt'>
</span>were excluded<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>c</span>linical<span
style='letter-spacing:-.3pt'> </span>trials.<span style='letter-spacing:-.3pt'>
</span>Therefore<span style='letter-spacing:-.25pt'> </span>Apixaban Accord<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>s</span>hou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>used<span style='letter-spacing:-.25pt'> </span>cautiously<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>t</span>his<span style='letter-spacing:-.3pt'> </span>population<span
style='letter-spacing:-.25pt'> </span>(see section<span style='letter-spacing:
-.3pt'>&nbsp;</span>5.2).<span style='letter-spacing:-.35pt'> </span>Prior<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>initiating<span
style='letter-spacing:-.3pt'> </span>Apixaban Accord,<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:-.1pt'>i</span>ver<span style='letter-spacing:-.35pt'> </span>function<span
style='letter-spacing:-.3pt'> </span>testing<span style='letter-spacing:-.3pt'>
</span>shou<span style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:
-.3pt'> </span>be<span style='letter-spacing:-.3pt'> </span>performed.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Interaction<span style='letter-spacing:-.4pt'> </span>with<span
style='letter-spacing:-.4pt'> </span>inh<span style='letter-spacing:-.05pt'>i</span>bitors<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.4pt'> </span>bo<span
style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:.05pt'>y</span>to<span
style='letter-spacing:-.1pt'>c</span>hro<span style='letter-spacing:-.1pt'>m</span>e<span
style='letter-spacing:-.45pt'> </span>P450<span style='letter-spacing:-.4pt'>&nbsp;</span>3A4<span
style='letter-spacing:-.35pt'>&nbsp;</span>(CYP3A4)<span style='letter-spacing:
-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>P-g<span
style='letter-spacing:-.05pt'>l</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>c</span>oprotein<span style='letter-spacing:-.35pt'>
</span>(P<span style='letter-spacing:-.1pt'>-</span><span style='letter-spacing:
-.05pt'>g</span>p)</span></u><span lang=EN-GB> </span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>use<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:
-.3pt'> </span>not<span style='letter-spacing:-.3pt'> </span>r<span
style='letter-spacing:-.1pt'>e</span>c<span style='letter-spacing:.05pt'>o</span>mmended<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>patien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.3pt'> </span>receiving<span
style='letter-spacing:-.3pt'> </span>concomitant<span style='letter-spacing:
-.3pt'> </span>s<span style='letter-spacing:.05pt'>y</span>stemic<span
style='letter-spacing:-.3pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:-.25pt'> </span>with strong<span style='letter-spacing:
-.35pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>hibi<span
style='letter-spacing:-.05pt'>t</span>ors<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>bo<span style='letter-spacing:-.05pt'>t</span>h<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>C</span><span
style='letter-spacing:-.05pt'>Y</span>P3A4<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.05pt'>P</span>-gp,<span
style='letter-spacing:-.35pt'> </span>such<span style='letter-spacing:-.35pt'> </span>as<span
style='letter-spacing:-.35pt'> </span>azole-anti<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>c</span>otics<span style='letter-spacing:-.3pt'> </span>(e.g.,<span
style='letter-spacing:-.35pt'> </span>ketoconazole, itraconazole,<span
style='letter-spacing:-.4pt'> </span>voriconazole<span style='letter-spacing:
-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>posaconazole)<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>H<span
style='letter-spacing:-.1pt'>I</span>V<span style='letter-spacing:-.4pt'> </span>protease<span
style='letter-spacing:-.4pt'> </span>inhibitors<span style='letter-spacing:
-.4pt'> </span>(e.g.,<span style='letter-spacing:-.45pt'> </span>ritonavir).<span
style='letter-spacing:-.4pt'> </span>These medicinal<span style='letter-spacing:
-.3pt'> </span>products<span style='letter-spacing:-.25pt'> </span>may<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.1pt'>c</span>rease<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>exposure<span style='letter-spacing:-.3pt'> </span>by<span
style='letter-spacing:-.2pt'> </span>2-fold<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>section<span style='letter-spacing:-.3pt'>&nbsp;</span>4.5),<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.25pt'> </span>greater<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the
presence<span style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:
-.35pt'> </span>additional<span style='letter-spacing:-.35pt'> </span>factors<span
style='letter-spacing:-.35pt'> </span>that<span style='letter-spacing:-.35pt'> </span>increase<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>exposure<span style='letter-spacing:-.35pt'> </span>(e.g.,<span
style='letter-spacing:-.35pt'> </span>severe<span style='letter-spacing:-.35pt'>
</span>renal<span style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:
-.1pt'>m</span>pai<span style='letter-spacing:.05pt'>r</span>ment).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Interaction<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.05pt'>d</span>ucers<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>both<span
style='letter-spacing:-.3pt'> </span>CYP3<span style='letter-spacing:-.1pt'>A</span>4<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>P-<span
style='letter-spacing:-.05pt'>g</span>p</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>conco<span
style='letter-spacing:-.1pt'>m</span>itant<span style='letter-spacing:-.3pt'> </span>use<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:
-.3pt'> </span>str<span style='letter-spacing:-.05pt'>o</span>ng<span
style='letter-spacing:-.3pt'> </span>CYP3A4<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.35pt'> </span>P-gp<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.05pt'>d</span>ucers<span style='letter-spacing:-.3pt'> </span>(e.g.,<span
style='letter-spacing:-.3pt'> </span>rifa<span style='letter-spacing:-.1pt'>m</span>picin,<span
style='letter-spacing:-.35pt'> </span>phe<span style='letter-spacing:-.05pt'>n</span><span
style='letter-spacing:.05pt'>y</span>toi<span style='letter-spacing:-.05pt'>n</span>,
carbamazepine,<span style='letter-spacing:-.3pt'> </span>phenobarb<span
style='letter-spacing:-.05pt'>i</span>tal<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>St.<span style='letter-spacing:-.3pt'> </span>Jo<span
style='letter-spacing:-.05pt'>hn</span><span style='letter-spacing:.05pt'>’</span>s<span
style='letter-spacing:-.3pt'> </span>Wort)<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.3pt'> </span>lead<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.3pt'> </span>~5<span
style='letter-spacing:-.05pt'>0</span>%<span style='letter-spacing:-.35pt'> </span>reduction<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>e<span style='letter-spacing:-.05pt'>x</span>posure.
In<span style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.25pt'>
</span>clinical<span style='letter-spacing:-.25pt'> </span>study<span
style='letter-spacing:-.15pt'> </span>in<span style='letter-spacing:-.25pt'> </span>atrial<span
style='letter-spacing:-.25pt'> </span>fibrillation<span style='letter-spacing:
-.25pt'> </span>p<span style='letter-spacing:-.1pt'>a</span>tients,<span
style='letter-spacing:-.25pt'> </span>d<span style='letter-spacing:-.15pt'>i</span><span
style='letter-spacing:-.1pt'>m</span>in<span style='letter-spacing:.05pt'>i</span>shed<span
style='letter-spacing:-.25pt'> </span>efficacy<span style='letter-spacing:-.15pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:
-.25pt'> </span>higher<span style='letter-spacing:-.25pt'> </span>risk<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>were observed<span style='letter-spacing:
-.35pt'> </span>with<span style='letter-spacing:-.3pt'> </span>coad<span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apix<span
style='letter-spacing:-.1pt'>a</span>ban<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>str<span style='letter-spacing:-.05pt'>o</span>ng<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>ducers<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>both<span
style='letter-spacing:-.3pt'> </span>CYP<span style='letter-spacing:-.05pt'>3</span>A4<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>P-gp<span
style='letter-spacing:-.4pt'> </span>c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>pared with<span style='letter-spacing:
-.4pt'> </span>using<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>alone.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>receiving<span style='letter-spacing:-.3pt'>
</span>concomitant<span style='letter-spacing:-.35pt'> </span>s<span
style='letter-spacing:.05pt'>y</span>stemic<span style='letter-spacing:-.3pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>ment<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>strong<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.05pt'>i</span>nducers<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>both<span
style='letter-spacing:-.35pt'> </span>CYP3A4<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>P-gp the<span
style='letter-spacing:-.4pt'> </span>following<span style='letter-spacing:-.4pt'>
</span>rec<span style='letter-spacing:.05pt'>o</span>mmend<span
style='letter-spacing:.05pt'>a</span>tions<span style='letter-spacing:-.35pt'> </span>apply<span
style='letter-spacing:-.4pt'> </span>(see<span style='letter-spacing:-.4pt'> </span>section<span
style='letter-spacing:-.35pt'>&nbsp;</span>4.5):</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='punctuation-wrap:simple'><span lang=EN-GB>- for<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>pre<span
style='letter-spacing:-.05pt'>v</span>ention<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>V<span style='letter-spacing:
-.05pt'>T</span>E<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>elective<span style='letter-spacing:-.25pt'>
</span>hip<span style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:
-.25pt'> </span>knee<span style='letter-spacing:-.25pt'> </span>replac<span
style='letter-spacing:.05pt'>e</span>ment<span style='letter-spacing:-.25pt'> </span>surger<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>prevention<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>stroke
and<span style='letter-spacing:-.3pt'> </span>s<span style='letter-spacing:
.05pt'>y</span>ste<span style='letter-spacing:-.1pt'>m</span>ic<span
style='letter-spacing:-.2pt'> </span>e<span style='letter-spacing:-.1pt'>m</span>boli<span
style='letter-spacing:.05pt'>s</span>m<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>NVAF<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>for<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>prevention<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>recurrent<span
style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>PE, apixaban<span style='letter-spacing:
-.35pt'> </span>should<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>used<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>w</span>ith<span style='letter-spacing:-.3pt'> </span>caution;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='punctuation-wrap:simple'><span lang=EN-GB>- for<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>treatment<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>DVT<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.2pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span><span
style='letter-spacing:.05pt'>n</span>t<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>PE,<span style='letter-spacing:-.25pt'> </span>apix<span
style='letter-spacing:-.1pt'>a</span>ban<span style='letter-spacing:-.2pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>n</span>ot<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>used<span style='letter-spacing:-.2pt'> </span>si<span
style='letter-spacing:-.05pt'>n</span>ce<span style='letter-spacing:-.25pt'> </span>efficacy<span
style='letter-spacing:-.1pt'> </span>may<span style='letter-spacing:-.15pt'> </span>be
<span style='letter-spacing:-.05pt'>c</span><span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>p<span style='letter-spacing:-.05pt'>r</span><span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:-.05pt'>se</span><span style='letter-spacing:.05pt'>d</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Hip<span style='letter-spacing:-.45pt'> </span>fracture<span
style='letter-spacing:-.45pt'> </span>surgery</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.3pt'> </span>has<span
style='letter-spacing:-.25pt'> </span>not<span style='letter-spacing:-.3pt'> </span>been<span
style='letter-spacing:-.25pt'> </span>st<span style='letter-spacing:-.05pt'>ud</span>ied<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>clinical<span
style='letter-spacing:-.3pt'> </span>trials<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>underg<span style='letter-spacing:-.05pt'>o</span>i<span
style='letter-spacing:-.05pt'>n</span>g<span style='letter-spacing:-.25pt'> </span>hip<span
style='letter-spacing:-.3pt'> </span>fracture<span style='letter-spacing:-.35pt'>
</span>surgery<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>e<span style='letter-spacing:-.05pt'>v</span>aluate
effic<span style='letter-spacing:.05pt'>a</span>cy<span style='letter-spacing:
-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:-.05pt'>a</span>fety<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>these<span
style='letter-spacing:-.3pt'> </span>patients.<span style='letter-spacing:-.25pt'>
</span>There<span style='letter-spacing:-.05pt'>f</span>ore,<span
style='letter-spacing:-.25pt'> </span>it<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>not<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mmend<span style='letter-spacing:.05pt'>e</span>d<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>these<span
style='letter-spacing:-.25pt'> </span>patients.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Laborato<span style='letter-spacing:-.05pt'>r</span>y<span
style='letter-spacing:-.9pt'> </span><span style='letter-spacing:-.05pt'>pa</span>rameters</span></u></p>

<p class=MsoBodyText style='margin-left:0in;text-align:justify;punctuation-wrap:
simple'><span lang=EN-GB>Clotting<span style='letter-spacing:-.3pt'> </span>tests<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>[</span><span
style='letter-spacing:-.05pt'>e</span>.g.,<span style='letter-spacing:-.25pt'> </span>prothr<span
style='letter-spacing:-.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.3pt'> </span>time<span style='letter-spacing:-.3pt'> </span>(PT),<span
style='letter-spacing:-.25pt'> </span>INR,<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>a</span>nd<span style='letter-spacing:-.3pt'> </span>activated<span
style='letter-spacing:-.25pt'> </span>partial<span style='letter-spacing:-.3pt'>
</span>thro<span style='letter-spacing:-.15pt'>m</span>boplastin<span
style='letter-spacing:-.3pt'> </span>ti<span style='letter-spacing:-.1pt'>m</span>e<span
style='letter-spacing:-.3pt'> </span>(aPTT)]<span style='letter-spacing:-.45pt'>
</span>are affec<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.25pt'> </span>as<span style='letter-spacing:-.25pt'> </span>e<span
style='letter-spacing:.05pt'>x</span>pected<span style='letter-spacing:-.25pt'>
</span>by<span style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:
-.3pt'> </span>mechanism<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>action<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>apixaban.<span
style='letter-spacing:-.2pt'> </span>Changes<span style='letter-spacing:-.25pt'>
</span>observ<span style='letter-spacing:-.05pt'>e</span>d<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>these<span
style='letter-spacing:-.25pt'> </span>clotting<span style='letter-spacing:-.25pt'>
</span>tests at<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>expected<span style='letter-spacing:-.25pt'>
</span>therapeutic<span style='letter-spacing:-.2pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>are<span style='letter-spacing:-.25pt'> </span>sma<span
style='letter-spacing:.05pt'>l</span>l<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>sub<span style='letter-spacing:-.05pt'>j</span>ect<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>high<span style='letter-spacing:-.25pt'> </span>degree<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>variability<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>secti<span
style='letter-spacing:.05pt'>o</span>n<span style='letter-spacing:-.2pt'> </span>5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Infor<span style='letter-spacing:-.1pt'>m</span>ation<span
style='letter-spacing:-.65pt'> </span>about<span style='letter-spacing:-.65pt'>
</span>excipie<span style='letter-spacing:-.05pt'>n</span>ts</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>contains<span
style='letter-spacing:-.35pt'> </span>lactose.<span style='letter-spacing:-.3pt'>
</span>Patients<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>rare<span style='letter-spacing:-.35pt'> </span>her<span
style='letter-spacing:-.1pt'>e</span>ditary<span style='letter-spacing:-.25pt'>
</span>problems<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>galactose<span style='letter-spacing:
-.35pt'> </span>intolerance,<span style='letter-spacing:-.3pt'> </span>total lactase<span
style='letter-spacing:-.4pt'> </span>deficiency<span style='letter-spacing:
-.3pt'> </span>or<span style='letter-spacing:-.45pt'> </span>gluc<span
style='letter-spacing:-.05pt'>o</span>se-galactose<span style='letter-spacing:
-.3pt'> </span>malab<span style='letter-spacing:-.1pt'>s</span>orption<span
style='letter-spacing:-.4pt'> </span>shou<span style='letter-spacing:-.05pt'>l</span>d<span
style='letter-spacing:-.4pt'> </span>not<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.05pt'>ta</span>ke<span style='letter-spacing:-.4pt'> </span>this<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>dicinal product.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>This medicinal product contains less than 1 mmol sodium (23 mg) per
tablet, that is to say essentially ‘sodium-free’</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.5<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Interaction<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>other<span style='letter-spacing:-.35pt'>
</span>medicinal<span style='letter-spacing:-.35pt'> </span>products<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>other<span
style='letter-spacing:-.35pt'> </span>forms<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>interaction</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Inhibitors<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.4pt'> </span>CYP3A4<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.35pt'> </span>P-gp</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>ap<span
style='letter-spacing:-.05pt'>i</span>xa<span style='letter-spacing:-.05pt'>b</span>an<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>ketoconazole<span
style='letter-spacing:-.25pt'> </span>(400<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>once<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.3pt'> </span>da<span
style='letter-spacing:.05pt'>y</span>),<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>strong<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>in</span>hibitor<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.25pt'> </span>b<span
style='letter-spacing:-.05pt'>ot</span>h CYP3A4<span style='letter-spacing:
-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>P-gp,<span
style='letter-spacing:-.2pt'> </span>led<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.35pt'> </span>2-fold<span
style='letter-spacing:-.2pt'> </span>increase<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:
-.1pt'>m</span>ean<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:.05pt'>p</span>ixaban<span style='letter-spacing:-.25pt'>
</span>AUC<span style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:
-.25pt'> </span>a<span style='letter-spacing:-.2pt'> </span>1<span
style='letter-spacing:-.05pt'>.6-fol</span>d<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>increas</span>e<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.05pt'>mean </span>apixaban<span
style='letter-spacing:-.5pt'> </span>C<sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>use<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:
-.3pt'> </span>not<span style='letter-spacing:-.3pt'> </span>r<span
style='letter-spacing:-.1pt'>e</span>c<span style='letter-spacing:.05pt'>o</span>mmended<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>patien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.3pt'> </span>receiving<span
style='letter-spacing:-.3pt'> </span>concomitant<span style='letter-spacing:
-.3pt'> </span>s<span style='letter-spacing:.05pt'>y</span>stemic<span
style='letter-spacing:-.3pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:-.25pt'> </span>with strong<span style='letter-spacing:
-.35pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>hibi<span
style='letter-spacing:-.05pt'>t</span>ors<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>bo<span style='letter-spacing:-.05pt'>t</span>h<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>C</span><span
style='letter-spacing:-.05pt'>Y</span>P3A4<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.05pt'>P</span>-gp,<span
style='letter-spacing:-.35pt'> </span>such<span style='letter-spacing:-.35pt'> </span>as<span
style='letter-spacing:-.35pt'> </span>azole-anti<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>c</span>otics<span style='letter-spacing:-.3pt'> </span>(e.g.,<span
style='letter-spacing:-.35pt'> </span>ketoconazole, itraconazole,<span
style='letter-spacing:-.4pt'> </span>voriconazole<span style='letter-spacing:
-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>posaconazole)<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.45pt'> </span>HIV<span
style='letter-spacing:-.4pt'> </span>protease<span style='letter-spacing:-.4pt'>
</span>inhibitors<span style='letter-spacing:-.4pt'> </span>(e.g.,<span
style='letter-spacing:-.4pt'> </span>ritonavir)<span style='letter-spacing:
-.4pt'> </span>(see section<span style='letter-spacing:-.55pt'>&nbsp;</span>4.4).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Active<span style='letter-spacing:-.3pt'> </span>substances<span
style='letter-spacing:-.3pt'> </span>which<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:-.3pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>consid<span style='letter-spacing:-.1pt'>e</span>red<span
style='letter-spacing:-.3pt'> </span>strong<span style='letter-spacing:-.3pt'> </span>inhibitors<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>bo<span
style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:-.25pt'> </span>CYP3A4<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>P-gp,<span
style='letter-spacing:-.3pt'> </span>(eg., amiodarone, clarithro<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>c</span>in,<span style='letter-spacing:-.45pt'> </span>diltiaze<span
style='letter-spacing:-.1pt'>m</span>,<span style='letter-spacing:-.45pt'> fluconazole,
</span>naproxen,<span style='letter-spacing:-.45pt'> </span>quinidine, verapa<span
style='letter-spacing:-.1pt'>m</span>il)<span style='letter-spacing:-.45pt'> </span>are<span
style='letter-spacing:-.4pt'> </span>expected<span style='letter-spacing:-.45pt'>
</span>to<span style='letter-spacing:-.45pt'> </span>increase apixaban<span
style='letter-spacing:-.3pt'> </span>plasma<span style='letter-spacing:-.3pt'> </span>concentr<span
style='letter-spacing:.05pt'>a</span>tion<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.3pt'> </span>lesser<span
style='letter-spacing:-.3pt'> </span>extent.<span style='letter-spacing:-.3pt'>
</span>No<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.3pt'> </span>adjus<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>apixab<span style='letter-spacing:-.1pt'>a</span>n<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.3pt'> </span>required<span
style='letter-spacing:-.35pt'> </span>when coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistered<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>agents<span
style='letter-spacing:-.25pt'> </span>that<span style='letter-spacing:-.3pt'> </span>are<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.25pt'> </span>strong<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.1pt'>n</span>hibi<span
style='letter-spacing:-.05pt'>t</span>ors<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>bo<span style='letter-spacing:-.05pt'>t</span>h<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>C</span><span
style='letter-spacing:-.05pt'>Y</span>P3A4<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>P</span>-gp.<span
style='letter-spacing:-.25pt'> </span>For<span style='letter-spacing:-.3pt'> </span>ex<span
style='letter-spacing:-.1pt'>am</span>ple, diltiazem<span style='letter-spacing:
-.35pt'> </span>(360<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>once<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.15pt'> </span>da<span
style='letter-spacing:.05pt'>y</span>),<span style='letter-spacing:2.25pt'> </span>consid<span
style='letter-spacing:-.1pt'>e</span>red<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>m</span>oder<span
style='letter-spacing:-.05pt'>a</span>te<span style='letter-spacing:-.25pt'> </span>CYP3A4<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>weak<span style='letter-spacing:-.2pt'> </span>P-gp<span
style='letter-spacing:-.2pt'> </span>inh<span style='letter-spacing:-.05pt'>i</span>bitor,<span
style='letter-spacing:-.25pt'> </span>l<span style='letter-spacing:-.1pt'>e</span>d<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.2pt'> </span>a
1.4-fold<span style='letter-spacing:-.3pt'> </span>increase<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ean<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>AUC<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>1.3-fold<span
style='letter-spacing:-.3pt'> </span>increase<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.25pt'> </span>C<sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub>.<span style='letter-spacing:
-.25pt'> </span>Naproxen<span style='letter-spacing:-.25pt'> </span>(500<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g,<span
style='letter-spacing:-.25pt'> </span>single dose)<span style='letter-spacing:
-.25pt'> </span>an<span style='letter-spacing:-.2pt'> </span>inhibitor<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>P-gp<span
style='letter-spacing:-.25pt'> </span>but<span style='letter-spacing:-.2pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>an<span style='letter-spacing:-.2pt'> </span>inhibitor<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.3pt'> </span>CYP3A4,<span
style='letter-spacing:-.2pt'> </span>led<span style='letter-spacing:-.2pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>1.5-fold<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span>1.6-fold<span
style='letter-spacing:-.25pt'> </span>increase<span style='letter-spacing:-.2pt'>
</span>in mean<span style='letter-spacing:-.3pt'> </span>apixab<span
style='letter-spacing:.05pt'>a</span>n<span style='letter-spacing:-.25pt'> </span>AUC<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>C<sub><span style='position:relative;top:1.0pt'>m</span></sub></span><sub><span
style='position:relative;top:1.0pt'>ax</span></sub>,<span style='letter-spacing:
-.3pt'> </span>respectivel<span style='letter-spacing:.1pt'>y</span>.<span
style='letter-spacing:-.25pt'> </span>Clarithr<span style='letter-spacing:-.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>y</span>cin<span
style='letter-spacing:-.25pt'> </span>(500<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g,<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.05pt'>a</span><span
style='letter-spacing:.05pt'>y</span>),<span style='letter-spacing:-.25pt'> </span>an<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>nh<span
style='letter-spacing:-.05pt'>i</span>bi<span style='letter-spacing:-.05pt'>t</span>or<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>P-gp<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>strong<span style='letter-spacing:-.25pt'>
</span>inhibitor<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>CYP3A4,<span style='letter-spacing:-.25pt'>
</span>led<span style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:
-.2pt'> </span>a<span style='letter-spacing:-.25pt'> </span>1.<span
style='letter-spacing:-.05pt'>6</span>-fold<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>1.3-fold<span style='letter-spacing:-.25pt'>
</span>increase<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>mean<span style='letter-spacing:-.25pt'> </span>apixab<span
style='letter-spacing:.05pt'>a</span>n<span style='letter-spacing:-.2pt'> </span>AUC
and<span style='letter-spacing:-.4pt'> </span>C<sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub><span style='position:relative;top:1.0pt;letter-spacing:
.6pt'> </span>respectivel<span style='letter-spacing:.1pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Inducers<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>CYP3A4<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.05pt'>P</span>-gp</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistr<span style='letter-spacing:.05pt'>a</span>tion<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>rif<span
style='letter-spacing:.05pt'>a</span>mpicin,<span style='letter-spacing:-.25pt'>
</span>a<span style='letter-spacing:-.3pt'> </span>str<span style='letter-spacing:
-.05pt'>on</span>g<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.05pt'>d</span>ucer<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>b</span>oth<span
style='letter-spacing:-.25pt'> </span>CYP3A4<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>P-gp,<span
style='letter-spacing:-.3pt'> </span>led<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>an approxi<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>te<span
style='letter-spacing:-.3pt'> </span>54%<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>42%<span style='letter-spacing:-.3pt'> </span>decr<span
style='letter-spacing:.05pt'>e</span>ase<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.2pt'> </span>mean<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>AUC<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>C</span><sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub>,<span style='letter-spacing:
-.3pt'> </span>respect<span style='letter-spacing:.05pt'>i</span>vely.<span
style='letter-spacing:-.3pt'> </span>The<span style='letter-spacing:-.3pt'> </span>conc<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>itant
use<span style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:
-.3pt'> </span>apixa<span style='letter-spacing:-.05pt'>b</span>an<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.3pt'> </span>other<span
style='letter-spacing:-.4pt'> </span>strong<span style='letter-spacing:-.3pt'> </span>CYP<span
style='letter-spacing:-.05pt'>3</span>A4<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>P-gp<span style='letter-spacing:-.35pt'> </span>inducers<span
style='letter-spacing:-.35pt'> </span>(e.g.,<span style='letter-spacing:-.3pt'>
</span>phe<span style='letter-spacing:-.05pt'>n</span><span style='letter-spacing:
.05pt'>y</span><span style='letter-spacing:-.05pt'>t</span>oin,<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>c</span><span
style='letter-spacing:-.05pt'>a</span>rba<span style='letter-spacing:-.1pt'>m</span>azepine,
phenobarbital<span style='letter-spacing:-.35pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>St.<span style='letter-spacing:-.3pt'> </span>Jo<span
style='letter-spacing:-.05pt'>hn</span><span style='letter-spacing:.05pt'>’</span>s<span
style='letter-spacing:-.3pt'> </span>Wort)<span style='letter-spacing:-.3pt'> </span>may<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.05pt'>l</span>so<span
style='letter-spacing:-.3pt'> </span>lead<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>reduced<span style='letter-spacing:-.3pt'>
</span>apixaban<span style='letter-spacing:-.25pt'> </span>plasma<span
style='letter-spacing:-.3pt'> </span>concentrations.<span style='letter-spacing:
-.3pt'> </span>No<span style='letter-spacing:-.3pt'> </span>dose adjust<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.35pt'> </span>for<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>is<span style='letter-spacing:-.35pt'> </span>required<span
style='letter-spacing:-.35pt'> </span>dur<span style='letter-spacing:-.05pt'>i</span>ng<span
style='letter-spacing:-.35pt'> </span>con<span style='letter-spacing:-.1pt'>c</span>o<span
style='letter-spacing:-.1pt'>m</span>itant<span style='letter-spacing:-.35pt'> </span>thera<span
style='letter-spacing:-.05pt'>p</span>y<span style='letter-spacing:-.25pt'> </span>wi<span
style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:-.35pt'> </span>such<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>dicinal<span style='letter-spacing:-.35pt'>
</span>pro<span style='letter-spacing:-.05pt'>d</span>ucts, however<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>pa</span>tients<span style='letter-spacing:-.35pt'>
</span>receiving<span style='letter-spacing:-.35pt'> </span>conco<span
style='letter-spacing:-.1pt'>m</span>itant<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>ste<span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.4pt'> </span>treatment<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>strong<span
style='letter-spacing:-.35pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>ducers<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>both<span
style='letter-spacing:-.3pt'> </span>C<span style='letter-spacing:-.1pt'>Y</span>P3A4
and<span style='letter-spacing:-.25pt'> </span>P-gp<span style='letter-spacing:
-.2pt'> </span>ap<span style='letter-spacing:-.05pt'>ix</span>aban<span
style='letter-spacing:-.25pt'> </span>should<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>b</span>e<span style='letter-spacing:
-.3pt'> </span>used<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>caution<span style='letter-spacing:-.2pt'>
</span>for<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.2pt'> </span>prevention<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>o</span>f<span
style='letter-spacing:-.25pt'> </span>VTE<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>elective<span style='letter-spacing:-.2pt'>
</span>hip<span style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:
-.2pt'> </span>k<span style='letter-spacing:-.05pt'>n</span>ee replac<span
style='letter-spacing:.05pt'>e</span>ment<span style='letter-spacing:-.3pt'> </span>surger<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>prevention<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.25pt'> </span>stroke<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.35pt'> </span>s<span
style='letter-spacing:.05pt'>y</span>ste<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.3pt'> </span>e<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>b</span>olism<span
style='letter-spacing:-.4pt'> </span>in<span style='letter-spacing:-.3pt'> </span>pati<span
style='letter-spacing:.05pt'>e</span>nts<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>NVAF<span style='letter-spacing:-.25pt'> </span>and
for<span style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:
-.25pt'> </span>prevention<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>recurrent<span style='letter-spacing:
-.25pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>PE.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.25pt'> </span>recomme<span
style='letter-spacing:.05pt'>n</span>ded<span style='letter-spacing:-.3pt'> </span>f<span
style='letter-spacing:-.05pt'>o</span>r<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>DVT<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.4pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>rece<span style='letter-spacing:.05pt'>i</span>ving<span
style='letter-spacing:-.3pt'> </span>conco<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>tant s<span style='letter-spacing:.05pt'>y</span>ste<span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.3pt'> </span>treatment<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.3pt'> </span>strong<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>nducers<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>bo<span
style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:-.3pt'> </span>CYP3A4<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>P-gp<span
style='letter-spacing:-.3pt'> </span>since<span style='letter-spacing:-.3pt'> </span>efficacy<span
style='letter-spacing:-.15pt'> </span>may<span style='letter-spacing:-.2pt'> </span>be
<span style='letter-spacing:-.05pt'>c</span><span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>p<span style='letter-spacing:-.05pt'>r</span><span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:-.05pt'>se</span>d<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>(se</span>e<span style='letter-spacing:-.45pt'> </span>s<span
style='letter-spacing:-.05pt'>ectio</span>n<span style='letter-spacing:-.4pt'>&nbsp;</span><span
style='letter-spacing:-.05pt'>4.4).</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Anticoagulants,<span style='letter-spacing:-.55pt'> </span>platelet<span
style='letter-spacing:-.55pt'> </span>aggregation<span style='letter-spacing:
-.6pt'> </span>inh<span style='letter-spacing:-.05pt'>i</span>bitors,<span
style='letter-spacing:-.55pt'> </span>SSRIs/SNRIs<span style='letter-spacing:
-.55pt'> </span>and<span style='letter-spacing:-.55pt'> </span>NSAIDs</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Due<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>an<span style='letter-spacing:-.3pt'> </span>increased<span
style='letter-spacing:-.3pt'> </span>bleed<span style='letter-spacing:.05pt'>i</span>ng<span
style='letter-spacing:-.3pt'> </span>risk,<span style='letter-spacing:-.3pt'> </span>con<span
style='letter-spacing:-.1pt'>c</span>o<span style='letter-spacing:-.1pt'>m</span>itant<span
style='letter-spacing:-.3pt'> </span>tr<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.05pt'>a</span><span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>any<span style='letter-spacing:-.3pt'> </span>other<span
style='letter-spacing:-.3pt'> </span>anticoagulants<span style='letter-spacing:
-.3pt'> </span>is contraindicated<span style='letter-spacing:-.5pt'> except under
specific circumstances of switching anticoagulant therapy, when UFH is given at
doses necessary to maintain an open central venous or arterial catheter or when
UFH is given during catheter ablation for atrial fibrillation </span>(see<span
style='letter-spacing:-.45pt'> </span>section<span style='letter-spacing:-.45pt'>&nbsp;</span>4.3).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>After<span style='letter-spacing:-.3pt'> </span>c<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>bi<span
style='letter-spacing:.05pt'>n</span>ed<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inist<span style='letter-spacing:.05pt'>r</span>ation<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>enox<span
style='letter-spacing:-.1pt'>a</span>parin<span style='letter-spacing:-.3pt'> </span>(40<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>single<span style='letter-spacing:-.25pt'>
</span>dose)<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>(5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>single<span
style='letter-spacing:-.3pt'> </span>dose), an<span style='letter-spacing:-.3pt'>
</span>additive<span style='letter-spacing:-.3pt'> </span>effect<span
style='letter-spacing:-.3pt'> </span>on<span style='letter-spacing:-.3pt'> </span>anti-Factor<span
style='letter-spacing:-.3pt'> </span>Xa<span style='letter-spacing:-.3pt'> </span>activi<span
style='letter-spacing:-.05pt'>t</span>y<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>observed.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Phar<span style='letter-spacing:-.1pt'>m</span>acokinetic<span
style='letter-spacing:-.45pt'> </span>or<span style='letter-spacing:-.4pt'> </span>pharmacodyna<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.4pt'> </span>interactions<span style='letter-spacing:
-.4pt'> </span>were<span style='letter-spacing:-.4pt'> </span>not<span
style='letter-spacing:-.4pt'> </span>evident<span style='letter-spacing:-.4pt'>
</span>when<span style='letter-spacing:-.4pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban<span style='letter-spacing:-.4pt'> </span>was
coa<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistered<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>ASA<span
style='letter-spacing:-.25pt'> </span>325<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>once<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>da<span
style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.3pt'> </span>coad<span
style='letter-spacing:-.1pt'>m</span>iniste<span style='letter-spacing:.05pt'>r</span>ed<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>clopidogrel<span
style='letter-spacing:-.3pt'> </span>(75<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>o<span
style='letter-spacing:-.05pt'>n</span>ce<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>da<span style='letter-spacing:.05pt'>y</span>)<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>combination<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.25pt'> </span>clopid<span
style='letter-spacing:-.05pt'>o</span>grel 75<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.2pt'> </span>ASA<span style='letter-spacing:-.2pt'> </span>162<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>once<span style='letter-spacing:-.2pt'> </span>dail<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.2pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.2pt'> </span>prasugrel<span
style='letter-spacing:-.2pt'> </span>(60<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>foll<span
style='letter-spacing:-.05pt'>o</span>wed<span style='letter-spacing:-.2pt'> </span>by<span
style='letter-spacing:-.2pt'> </span>10<span style='letter-spacing:-.15pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>once<span
style='letter-spacing:-.2pt'> </span>dai<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span>)<span style='letter-spacing:-.25pt'> </span>in
Phase<span style='letter-spacing:-.25pt'> </span>I<span style='letter-spacing:
-.25pt'> </span>studies<span style='letter-spacing:-.25pt'> </span>did<span
style='letter-spacing:-.25pt'> </span>not<span style='letter-spacing:-.25pt'> </span>show<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.25pt'> </span>relevant<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:.05pt'>i</span>ncrea<span
style='letter-spacing:.05pt'>s</span>e<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>t<span style='letter-spacing:-.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>p<span style='letter-spacing:.05pt'>l</span><span
style='letter-spacing:-.05pt'>a</span>te<span style='letter-spacing:-.2pt'> </span>bleed<span
style='letter-spacing:.05pt'>i</span>ng<span style='letter-spacing:-.25pt'> </span>ti<span
style='letter-spacing:-.1pt'>m</span>e,<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>further<span style='letter-spacing:-.25pt'>
</span>inhibition<span style='letter-spacing:-.25pt'> </span>of platelet<span
style='letter-spacing:-.4pt'> </span>aggregation,<span style='letter-spacing:
-.4pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>pared<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.4pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:.05pt'>n</span>istration<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.5pt'> </span>the<span
style='letter-spacing:-.4pt'> </span>antiplatelet<span style='letter-spacing:
-.35pt'> </span>agents<span style='letter-spacing:-.4pt'> </span>without<span
style='letter-spacing:-.4pt'> </span>apixaban.<span style='letter-spacing:-.35pt'>
</span>Increa<span style='letter-spacing:.05pt'>s</span>es in<span
style='letter-spacing:-.25pt'> </span>clotting<span style='letter-spacing:-.25pt'>
</span>tests<span style='letter-spacing:-.25pt'> </span>(PT,<span
style='letter-spacing:-.25pt'> </span>INR,<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>aPTT)<span style='letter-spacing:-.25pt'>
</span>were<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.1pt'>c</span>onsistent<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>effects<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>alone.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Naproxen<span style='letter-spacing:-.25pt'> </span>(500<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g),<span
style='letter-spacing:-.25pt'> </span>an<span style='letter-spacing:-.25pt'> </span>inhibitor<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>P-gp,<span
style='letter-spacing:-.2pt'> </span>led<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:-.25pt'> </span>1.5-fold<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>1.6-fold<span
style='letter-spacing:-.3pt'> </span>increase<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.1pt'>m</span>ean<span style='letter-spacing:-.25pt'> </span>apixaban AUC<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>C<sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt;letter-spacing:.05pt'>a</span><span
style='position:relative;top:1.0pt'>x</span></sub>,<span style='letter-spacing:
-.3pt'> </span>respectively.<span style='letter-spacing:-.3pt'> </span>Corresponding<span
style='letter-spacing:-.3pt'> </span>increases<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>cl<span style='letter-spacing:
-.05pt'>o</span>tting<span style='letter-spacing:-.35pt'> </span>tests<span
style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:-.3pt'> </span>observed<span
style='letter-spacing:-.35pt'> </span>for<span style='letter-spacing:-.3pt'> </span>apixaban.<span
style='letter-spacing:-.3pt'> </span>No changes<span style='letter-spacing:
-.35pt'> </span>were<span style='letter-spacing:-.3pt'> </span>observed<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:-.3pt'> </span>effect<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>naproxen<span
style='letter-spacing:-.3pt'> </span>on<span style='letter-spacing:-.45pt'> </span>arachidonic<span
style='letter-spacing:-.3pt'> </span>acid-induced<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>p</span>latelet<span
style='letter-spacing:-.35pt'> </span>aggregation<span style='letter-spacing:
-.3pt'> </span>and no<span style='letter-spacing:-.35pt'> </span>clinical<span
style='letter-spacing:-.05pt'>l</span>y<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>e</span>levant<span
style='letter-spacing:-.35pt'> </span>prol<span style='letter-spacing:-.05pt'>o</span>ngation<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>bl<span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:-.05pt'>e</span>ding<span
style='letter-spacing:-.3pt'> </span>ti<span style='letter-spacing:-.25pt'>m</span>e<span
style='letter-spacing:-.35pt'> </span>was<span style='letter-spacing:-.35pt'> </span>observed<span
style='letter-spacing:-.35pt'> </span>after<span style='letter-spacing:-.35pt'>
</span>conc<span style='letter-spacing:.05pt'>o</span><span style='letter-spacing:
-.1pt'>m</span>itant<span style='letter-spacing:-.35pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of apixaban<span style='letter-spacing:-.5pt'> </span>and<span
style='letter-spacing:-.55pt'> </span>naproxen.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Despite<span style='letter-spacing:-.35pt'> </span>these<span
style='letter-spacing:-.35pt'> </span>findi<span style='letter-spacing:-.05pt'>n</span>gs,<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.1pt'>r</span>e<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>y<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.35pt'> </span>ind<span style='letter-spacing:-.05pt'>i</span>viduals<span
style='letter-spacing:-.4pt'> </span>with<span style='letter-spacing:-.4pt'> </span>a<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>ore<span
style='letter-spacing:-.35pt'> </span>pron<span style='letter-spacing:-.05pt'>o</span>unced<span
style='letter-spacing:-.3pt'> </span>pharmacodyna<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.35pt'> </span>response when<span style='letter-spacing:
-.35pt'> </span>antiplatelet<span style='letter-spacing:-.3pt'> </span>agents<span
style='letter-spacing:-.35pt'> </span>are<span style='letter-spacing:-.35pt'> </span>coa<span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistered<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban.<span style='letter-spacing:-.35pt'>
</span>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>should<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.35pt'> </span>used<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>cauti<span
style='letter-spacing:-.05pt'>o</span>n<span style='letter-spacing:-.35pt'> </span>when
coa<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>iniste<span
style='letter-spacing:.05pt'>r</span>ed<span style='letter-spacing:-.45pt'> </span>with<span
style='letter-spacing:-.4pt'> </span>SSRIs/SNRIs,<span style='letter-spacing:
-.4pt'> </span>NSAIDs, ASA and/or P2Y12 inhibitors<span style='letter-spacing:
-.4pt'> </span>because<span style='letter-spacing:-.45pt'> </span>th<span
style='letter-spacing:.05pt'>e</span>se<span style='letter-spacing:-.35pt'> </span>medicinal
products<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.05pt'>t</span>yp<span style='letter-spacing:-.05pt'>i</span>cally<span
style='letter-spacing:-.2pt'> </span>increase<span style='letter-spacing:-.3pt'>
</span>the<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.35pt'> </span>risk<span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:.05pt'>(</span>see<span style='letter-spacing:-.35pt'> </span>section<span
style='letter-spacing:-.4pt'>&nbsp;</span>4.4).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There is limited experience of co-administration <span
style='letter-spacing:-.4pt'> </span>with other platelet aggregation inhibitors
(such as GPIIb/IIIa receptor antagonists, dipyridamole, dextran or
sulfinpyrazone) or thrombolytic agents. As such agents increase the bleeding risk,
co-administration of these medicinal products with Apixaban Accord is not
recommended (see section 4.4).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Other<span style='letter-spacing:-.65pt'> </span>concomitant<span
style='letter-spacing:-.6pt'> </span>therapies</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>No<span style='letter-spacing:-.45pt'> </span>clinically<span
style='letter-spacing:-.4pt'> </span>significant<span style='letter-spacing:
-.45pt'> </span>p<span style='letter-spacing:-.05pt'>h</span>ar<span
style='letter-spacing:-.1pt'>m</span>acokinetic<span style='letter-spacing:
-.45pt'> </span>or<span style='letter-spacing:-.45pt'> </span>ph<span
style='letter-spacing:-.15pt'>a</span>r<span style='letter-spacing:-.1pt'>m</span>aco<span
style='letter-spacing:-.05pt'>d</span><span style='letter-spacing:.05pt'>y</span>na<span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.45pt'> </span>interactions<span
style='letter-spacing:-.45pt'> </span>were<span style='letter-spacing:-.45pt'> </span>observed<span
style='letter-spacing:-.45pt'> </span>when apixaban<span style='letter-spacing:
-.35pt'> </span>was<span style='letter-spacing:-.3pt'> </span>coad<span
style='letter-spacing:-.1pt'>m</span>inis<span style='letter-spacing:.05pt'>t</span>e<span
style='letter-spacing:.05pt'>r</span>ed<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>atenolol<span style='letter-spacing:-.35pt'>
</span>or<span style='letter-spacing:-.3pt'> </span>f<span style='letter-spacing:
-.05pt'>a</span><span style='letter-spacing:-.1pt'>m</span>otidine.<span
style='letter-spacing:-.35pt'> </span>Coad<span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:.05pt'>n</span>istration<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>10<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.35pt'> </span>with
atenolol<span style='letter-spacing:-.3pt'> </span>1<span style='letter-spacing:
-.05pt'>0</span>0<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>did<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.25pt'> </span>h<span
style='letter-spacing:-.1pt'>a</span>ve<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>clinically<span style='letter-spacing:
-.25pt'> </span>rel<span style='letter-spacing:-.1pt'>e</span>vant<span
style='letter-spacing:-.3pt'> </span>effect<span style='letter-spacing:-.25pt'>
</span>on<span style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:
-.3pt'> </span>ph<span style='letter-spacing:-.1pt'>a</span>r<span
style='letter-spacing:-.1pt'>m</span>acokinetics<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban. Following<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:-.05pt'>d</span>ministration<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>two<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>edicinal<span style='letter-spacing:-.3pt'>
</span>pro<span style='letter-spacing:-.05pt'>duc</span>ts<span
style='letter-spacing:-.3pt'> </span>together,<span style='letter-spacing:-.35pt'>
</span>mean<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>AUC<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.15pt'>C</span><sub><span
style='position:relative;top:1.0pt;letter-spacing:-.1pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub><span style='position:relative;
top:1.0pt;letter-spacing:.7pt'> </span><span style='letter-spacing:-.05pt'>were
</span>15%<span style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:
-.25pt'> </span>18%<span style='letter-spacing:-.3pt'> </span>lower<span
style='letter-spacing:-.25pt'> </span>than<span style='letter-spacing:-.3pt'> </span>when<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistered<span style='letter-spacing:-.3pt'>
</span>alon<span style='letter-spacing:-.05pt'>e</span>.<span style='letter-spacing:
-.25pt'> </span>The<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inist<span style='letter-spacing:.05pt'>r</span>ation<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>with
fa<span style='letter-spacing:-.1pt'>m</span>otidine<span style='letter-spacing:
-.25pt'> </span>40<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>had<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.2pt'> </span>effect<span
style='letter-spacing:-.25pt'> </span>on<span style='letter-spacing:-.2pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>AUC<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>C</span><sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Effect<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>on<span style='letter-spacing:-.35pt'> </span>o<span style='letter-spacing:
-.05pt'>t</span>her<span style='letter-spacing:-.35pt'> </span>medicinal<span
style='letter-spacing:-.35pt'> </span>products</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><i><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>vitro<span
style='letter-spacing:-.3pt'> </span></span></i><span lang=EN-GB>apixaban<span
style='letter-spacing:-.3pt'> </span>studies<span style='letter-spacing:-.3pt'>
</span>showed<span style='letter-spacing:-.3pt'> </span>no<span
style='letter-spacing:-.25pt'> </span>inhibitory<span style='letter-spacing:
-.2pt'> </span>effect<span style='letter-spacing:-.3pt'> </span>on<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>activity<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>CYP1A2,<span
style='letter-spacing:-.25pt'> </span>CYP2A6,<span style='letter-spacing:-.3pt'>
</span>CYP2B6, CYP2C8,<span style='letter-spacing:-.3pt'> </span>CYP2C9,<span
style='letter-spacing:-.25pt'> </span>CYP2D6<span style='letter-spacing:-.3pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>CYP3A4<span
style='letter-spacing:-.25pt'> </span>(IC50<span style='letter-spacing:-.3pt'> </span>&gt;<span
style='letter-spacing:-.25pt'>&nbsp;</span>45<span style='letter-spacing:-.25pt'>&nbsp;</span>µM)<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>weak<span
style='letter-spacing:-.3pt'> </span>inhibitory<span style='letter-spacing:
-.25pt'> </span>effect<span style='letter-spacing:-.25pt'> </span>on<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>activity
of<span style='letter-spacing:-.3pt'> </span>CYP2C19<span style='letter-spacing:
-.3pt'> </span>(IC50<span style='letter-spacing:-.3pt'>&nbsp;</span>&gt;&nbsp;20<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>µ</span>M)<span
style='letter-spacing:-.3pt'> </span>at<span style='letter-spacing:-.25pt'> </span>concentrations<span
style='letter-spacing:-.25pt'> </span>that<span style='letter-spacing:-.35pt'> </span>are<span
style='letter-spacing:-.25pt'> </span>significantly<span style='letter-spacing:
-.25pt'> </span>greater<span style='letter-spacing:-.3pt'> </span>than<span
style='letter-spacing:-.25pt'> </span>peak<span style='letter-spacing:-.3pt'> </span>plas<span
style='letter-spacing:-.1pt'>m</span>a concentrations<span style='letter-spacing:
-.35pt'> </span>observed<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.35pt'> </span>patients.<span style='letter-spacing:
-.35pt'> </span>Apixaban<span style='letter-spacing:-.4pt'> </span>did<span
style='letter-spacing:-.4pt'> </span>not<span style='letter-spacing:-.4pt'> </span>induce<span
style='letter-spacing:-.3pt'> </span>CYP1A2,<span style='letter-spacing:-.35pt'>
</span>CYP2B6,<span style='letter-spacing:-.35pt'> </span>CYP3A4/5<span
style='letter-spacing:-.35pt'> </span>at<span style='letter-spacing:-.35pt'> </span>a
concentration<span style='letter-spacing:-.3pt'> </span>up<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>20<span
style='letter-spacing:-.25pt'>&nbsp;</span>µM.<span style='letter-spacing:-.3pt'>
</span>Therefore,<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.35pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>expected<span style='letter-spacing:-.3pt'>
</span>to<span style='letter-spacing:-.3pt'> </span>alter<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span><span
style='letter-spacing:.05pt'>t</span>abolic<span style='letter-spacing:-.3pt'> </span>clearan<span
style='letter-spacing:.05pt'>c</span>e<span style='letter-spacing:-.3pt'> </span>of
coa<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>iniste<span
style='letter-spacing:.05pt'>r</span>ed<span style='letter-spacing:-.35pt'> </span>medicinal<span
style='letter-spacing:-.25pt'> </span>products<span style='letter-spacing:-.3pt'>
</span>that<span style='letter-spacing:-.35pt'> </span>are<span
style='letter-spacing:-.3pt'> </span>met<span style='letter-spacing:-.05pt'>a</span>bolised<span
style='letter-spacing:-.3pt'> </span>by<span style='letter-spacing:-.2pt'> </span>these<span
style='letter-spacing:-.35pt'> </span>enz<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>es.<span style='letter-spacing:-.3pt'> </span>Apixaban<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.3pt'> </span>not<span
style='letter-spacing:-.35pt'> </span>a significant<span style='letter-spacing:
-.4pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>hibitor<span
style='letter-spacing:-.45pt'> </span>of<span style='letter-spacing:-.4pt'> </span>P-<span
style='letter-spacing:-.05pt'>g</span>p.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>studies<span
style='letter-spacing:-.3pt'> </span>conducted<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.25pt'> </span>he<span style='letter-spacing:
-.1pt'>a</span>lthy<span style='letter-spacing:-.2pt'> </span>subjects,<span
style='letter-spacing:-.35pt'> </span>as<span style='letter-spacing:-.3pt'> </span>described<span
style='letter-spacing:-.2pt'> </span>below,<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>did<span style='letter-spacing:-.35pt'> </span>not<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>eaningfully<span
style='letter-spacing:-.2pt'> </span>alter<span style='letter-spacing:-.25pt'> </span>the
pharmacokinetics<span style='letter-spacing:-.45pt'> </span>of<span
style='letter-spacing:-.45pt'> </span>digo<span style='letter-spacing:-.05pt'>x</span>in,<span
style='letter-spacing:-.4pt'> </span>napr<span style='letter-spacing:-.05pt'>o</span>xen,<span
style='letter-spacing:-.5pt'> </span>or<span style='letter-spacing:-.4pt'> </span>atenolol.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Digoxin</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>ap<span
style='letter-spacing:-.05pt'>i</span>xa<span style='letter-spacing:-.05pt'>b</span>an<span
style='letter-spacing:-.25pt'> </span>(20<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>o<span
style='letter-spacing:-.05pt'>n</span>ce<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>da<span style='letter-spacing:.05pt'>y</span>)<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.3pt'> </span>digox<span
style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:-.25pt'> </span>(0<span
style='letter-spacing:-.05pt'>.</span>25<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>once<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>da<span
style='letter-spacing:.05pt'>y</span>),<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>P-gp<span style='letter-spacing:-.25pt'> </span>s<span
style='letter-spacing:-.05pt'>ubs</span>trate, did<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>n</span>ot<span
style='letter-spacing:-.25pt'> </span>affect<span style='letter-spacing:-.3pt'>
</span>digox<span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.25pt'> </span>AUC<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>C</span><sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub>.<span style='letter-spacing:
-.25pt'> </span>Therefore,<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>does<span style='letter-spacing:-.3pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>inhibit<span style='letter-spacing:-.25pt'>
</span>P-gp<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.1pt'>m</span>ediated<span style='letter-spacing:-.25pt'> </span>substrate transport.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Naproxen</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>single<span
style='letter-spacing:-.3pt'> </span>doses<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>(10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g)<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>naproxen<span style='letter-spacing:-.3pt'>
</span>(500<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g),<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>commonly<span style='letter-spacing:-.3pt'>
</span>used NSAID,<span style='letter-spacing:-.25pt'> </span>did<span
style='letter-spacing:-.2pt'> </span>not<span style='letter-spacing:-.2pt'> </span>have<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.05pt'>n</span>y<span
style='letter-spacing:-.25pt'> </span>effect<span style='letter-spacing:-.2pt'>
</span>on<span style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:
-.25pt'> </span>naproxen<span style='letter-spacing:-.2pt'> </span>AUC<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>C</span><sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Atenolol</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>si<span style='letter-spacing:-.05pt'>n</span>g<span
style='letter-spacing:-.05pt'>l</span>e<span style='letter-spacing:-.3pt'> </span>dose<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban<span style='letter-spacing:-.3pt'> </span>(10<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g)<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>atenolol<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>(</span>100<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g),<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.25pt'> </span>common<span
style='letter-spacing:-.3pt'> </span>beta-blocker, did<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.05pt'>n</span>ot<span
style='letter-spacing:-.3pt'> </span>alter<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>pharmac<span style='letter-spacing:.05pt'>o</span>kinetics<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>atenolol.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Activated<span style='letter-spacing:-.85pt'> </span>ch<span
style='letter-spacing:.05pt'>a</span>rcoal</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>A<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:
-.1pt'>m</span>inistration<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>activated<span style='letter-spacing:
-.4pt'> </span>charcoal<span style='letter-spacing:-.35pt'> </span>r<span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:.05pt'>d</span>uces<span
style='letter-spacing:-.4pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>exposure<span style='letter-spacing:-.4pt'> </span>(see<span
style='letter-spacing:-.35pt'> </span>section&nbsp;4.9).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.6<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Fertility,<span style='letter-spacing:-.55pt'> </span>pregnancy<span
style='letter-spacing:-.5pt'> </span>and<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>l</span>actation</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Pregnancy</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.25pt'> </span>are<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.25pt'> </span>data<span
style='letter-spacing:-.2pt'> </span>fr<span style='letter-spacing:.05pt'>o</span>m<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.2pt'> </span>use<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>pr<span
style='letter-spacing:-.05pt'>e</span>gna<span style='letter-spacing:-.05pt'>n</span>t<span
style='letter-spacing:-.25pt'> </span>women.<span style='letter-spacing:-.25pt'>
</span>Animal<span style='letter-spacing:-.2pt'> </span>studies<span
style='letter-spacing:-.25pt'> </span>do<span style='letter-spacing:-.25pt'> </span>not<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>i</span>ndicate<span
style='letter-spacing:-.25pt'> </span>direct or<span style='letter-spacing:
-.35pt'> </span>indirect<span style='letter-spacing:-.3pt'> </span>h<span
style='letter-spacing:-.1pt'>a</span>r<span style='letter-spacing:-.1pt'>m</span>ful<span
style='letter-spacing:-.35pt'> </span>effects<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>respect<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.3pt'> </span>rep<span
style='letter-spacing:-.1pt'>r</span>oducti<span style='letter-spacing:-.05pt'>v</span>e<span
style='letter-spacing:-.3pt'> </span>toxici<span style='letter-spacing:-.05pt'>t</span><span
style='letter-spacing:.05pt'>y</span>.<span style='letter-spacing:-.35pt'> </span>A<span
style='letter-spacing:-.05pt'>p</span>ixaban<span style='letter-spacing:-.3pt'>
</span>is<span style='letter-spacing:-.35pt'> </span>not<span style='letter-spacing:
-.35pt'> </span>rec<span style='letter-spacing:.05pt'>o</span>mmended<span
style='letter-spacing:-.3pt'> </span>dur<span style='letter-spacing:-.05pt'>i</span>ng
pregnan<span style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:
.05pt'>y</span>.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Breast-<span style='letter-spacing:.05pt'>f</span>eeding</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>It<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>unknown<span style='letter-spacing:-.25pt'>
</span>whether<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.25pt'> </span>its<span
style='letter-spacing:-.25pt'> </span>metabolites<span style='letter-spacing:
-.25pt'> </span>are<span style='letter-spacing:-.2pt'> </span>excreted<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>human<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>ilk.<span
style='letter-spacing:-.25pt'> </span>Available<span style='letter-spacing:
-.25pt'> </span>data<span style='letter-spacing:-.25pt'> </span>in an<span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>als<span
style='letter-spacing:-.25pt'> </span>have<span style='letter-spacing:-.2pt'> </span>shown<span
style='letter-spacing:-.2pt'> </span>excretion<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ilk.<span style='letter-spacing:-.2pt'> </span>In<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>r</span><span
style='letter-spacing:-.05pt'>a</span>t<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ilk,<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>high<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ilk<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>ma<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>e</span>rnal<span style='letter-spacing:-.2pt'> </span>plas<span
style='letter-spacing:-.1pt'>m</span>a<span style='letter-spacing:-.2pt'> </span>ratio
(<span style='letter-spacing:.05pt'>C</span><sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub><span style='position:relative;top:1.0pt;letter-spacing:
.75pt'> </span>about<span style='letter-spacing:-.2pt'> </span>8,<span
style='letter-spacing:-.25pt'> </span>AUC<span style='letter-spacing:-.2pt'> </span>about<span
style='letter-spacing:-.2pt'> </span>30)<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>fou<span style='letter-spacing:-.05pt'>n</span>d,<span
style='letter-spacing:-.2pt'> </span>possib<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>d</span>ue<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.2pt'> </span>active<span
style='letter-spacing:-.2pt'> </span>transport<span style='letter-spacing:-.2pt'>
</span>into<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ilk.<span style='letter-spacing:-.2pt'> </span>A<span
style='letter-spacing:-.2pt'> </span>risk<span style='letter-spacing:-.2pt'> </span>to
newborns<span style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:
-.4pt'> </span>infants<span style='letter-spacing:-.35pt'> </span>cannot<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.35pt'> </span>exclud<span
style='letter-spacing:-.1pt'>e</span>d.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>A<span style='letter-spacing:-.35pt'> </span>decision<span
style='letter-spacing:-.25pt'> </span>must<span style='letter-spacing:-.35pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>made<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>either<span style='letter-spacing:-.3pt'>
</span>discontinue<span style='letter-spacing:-.3pt'> </span>b<span
style='letter-spacing:-.1pt'>r</span>east-feeding<span style='letter-spacing:
-.35pt'> </span>or<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>discontinue/abstain<span
style='letter-spacing:-.35pt'> </span>from<span style='letter-spacing:-.4pt'> </span>apixaban
therap<span style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Fertility</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Studies<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>animals<span style='letter-spacing:-.25pt'>
</span>dosed<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:.05pt'>p</span>ixaban<span
style='letter-spacing:-.3pt'> </span>have<span style='letter-spacing:-.25pt'> </span>shown<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.25pt'> </span>effect<span
style='letter-spacing:-.3pt'> </span>on<span style='letter-spacing:-.25pt'> </span>fertility<span
style='letter-spacing:-.15pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.3).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.7<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Effects<span style='letter-spacing:-.3pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.05pt'>b</span>ility<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>drive<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>use<span
style='letter-spacing:-.25pt'> </span>machines</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.25pt'> </span>has<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>negl<span style='letter-spacing:-.05pt'>i</span>gib<span
style='letter-spacing:-.05pt'>l</span>e<span style='letter-spacing:-.25pt'> </span>influence<span
style='letter-spacing:-.25pt'> </span>on<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>abili<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>t</span>o<span
style='letter-spacing:-.25pt'> </span>drive<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>use<span style='letter-spacing:
-.15pt'> </span>machines.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.8<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Undesirabl</span><span
lang=EN-GB>e<span style='letter-spacing:-.85pt'> </span><span style='letter-spacing:
-.05pt'>effec</span><span style='letter-spacing:.05pt'>t</span>s</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Summary<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.3pt'> </span>safety<span
style='letter-spacing:-.25pt'> </span>profile</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>safety<span
style='letter-spacing:-.15pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>has<span style='letter-spacing:-.25pt'> </span>been<span
style='letter-spacing:-.2pt'> </span>investigated<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>7<span
style='letter-spacing:-.25pt'> </span>Pha<span style='letter-spacing:-.1pt'>s</span>e<span
style='letter-spacing:-.25pt'> </span>III<span style='letter-spacing:-.25pt'> </span>clinical<span
style='letter-spacing:-.25pt'> </span>studies<span style='letter-spacing:-.25pt'>
</span>including<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ore<span style='letter-spacing:-.25pt'> </span>than
21,<span style='letter-spacing:-.05pt'>0</span>00<span style='letter-spacing:
-.3pt'>&nbsp;</span>patie<span style='letter-spacing:-.05pt'>n</span>ts:<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>ore<span
style='letter-spacing:-.25pt'> </span>than<span style='letter-spacing:-.3pt'> </span>5,0<span
style='letter-spacing:-.05pt'>0</span>0<span style='letter-spacing:-.25pt'>&nbsp;</span>patien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>VTEp<span style='letter-spacing:-.4pt'> </span>studies,<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>ore<span
style='letter-spacing:-.25pt'> </span>than<span style='letter-spacing:-.3pt'> </span>11,000<span
style='letter-spacing:-.25pt'>&nbsp;</span>patients<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>NVAF<span
style='letter-spacing:-.3pt'> </span>studies and<span style='letter-spacing:
-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>ore<span
style='letter-spacing:-.25pt'> </span>than<span style='letter-spacing:-.25pt'> </span>4,<span
style='letter-spacing:-.05pt'>0</span>00<span style='letter-spacing:-.3pt'>&nbsp;</span>patients<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>V<span style='letter-spacing:-.05pt'>T</span>E<span
style='letter-spacing:-.25pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.3pt'> </span>(VTEt)<span
style='letter-spacing:-.2pt'> </span>studies,<span style='letter-spacing:-.25pt'>
</span>for<span style='letter-spacing:-.25pt'> </span>an<span style='letter-spacing:
-.25pt'> </span>average<span style='letter-spacing:-.25pt'> </span>total<span
style='letter-spacing:-.25pt'> </span>expo<span style='letter-spacing:-.1pt'>s</span>ure<span
style='letter-spacing:-.25pt'> </span>of 20<span style='letter-spacing:-.25pt'>&nbsp;</span>d<span
style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>s</span>,<span style='letter-spacing:-.25pt'> </span>1.7<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:.05pt'>y</span>ears<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>221<span
style='letter-spacing:-.25pt'>&nbsp;</span>da<span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.3pt'> </span>respectively<span style='letter-spacing:
-.25pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>C<span style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:
-.1pt'>m</span>on<span style='letter-spacing:-.35pt'> </span>adverse<span
style='letter-spacing:-.35pt'> </span>reactions<span style='letter-spacing:
-.35pt'> </span>were<span style='letter-spacing:-.35pt'> </span>haemorrhage,<span
style='letter-spacing:-.35pt'> </span>contu<span style='letter-spacing:-.1pt'>s</span>ion,<span
style='letter-spacing:-.35pt'> </span>epistaxis,<span style='letter-spacing:
-.3pt'> </span>and<span style='letter-spacing:-.35pt'> </span>haematoma<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.35pt'> </span>Tab<span
style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:-.35pt'> </span>2<span
style='letter-spacing:-.35pt'> </span>for adverse<span style='letter-spacing:
-.4pt'> </span>reaction<span style='letter-spacing:-.35pt'> </span>prof<span
style='letter-spacing:-.05pt'>i</span>le<span style='letter-spacing:-.4pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>frequencies<span style='letter-spacing:
-.4pt'> </span><span style='letter-spacing:-.05pt'>b</span>y<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>dicatio<span
style='letter-spacing:-.05pt'>n</span>).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>VTEp<span style='letter-spacing:-.3pt'> </span>studies,<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>to<span
style='letter-spacing:-.05pt'>ta</span>l,<span style='letter-spacing:-.25pt'> </span>11%<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>tre<span style='letter-spacing:.05pt'>a</span>ted<span style='letter-spacing:
-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.15pt'>
</span>experienced adverse<span style='letter-spacing:-.35pt'> </span>reactions.<span
style='letter-spacing:-.3pt'> </span>The<span style='letter-spacing:-.3pt'> </span>ove<span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>a</span>ll<span
style='letter-spacing:-.3pt'> </span>incidence<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>adverse<span
style='letter-spacing:-.25pt'> </span>reactions<span style='letter-spacing:
-.3pt'> </span>related<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>bleeding<span style='letter-spacing:-.35pt'>
</span>with<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>was 10%<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:
-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'> </span>vs<span
style='letter-spacing:-.3pt'> </span>enoxaparin<span style='letter-spacing:
-.3pt'> </span>studies.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>NVAF<span style='letter-spacing:-.3pt'> </span>studies,<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.25pt'> </span>incidence<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>adve<span
style='letter-spacing:-.05pt'>r</span>se<span style='letter-spacing:-.2pt'> </span>reactions<span
style='letter-spacing:-.3pt'> </span>rel<span style='letter-spacing:.05pt'>a</span>ted<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>was 24.3%<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>vs<span style='letter-spacing:-.3pt'> </span>warfarin<span
style='letter-spacing:-.25pt'> </span>study<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.2pt'> </span>9.6%<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>vs<span style='letter-spacing:-.25pt'> </span>acet<span
style='letter-spacing:.05pt'>y</span>lsalic<span style='letter-spacing:.05pt'>y</span>lic<span
style='letter-spacing:-.25pt'> </span>acid<span style='letter-spacing:-.2pt'> </span>study.<span
style='letter-spacing:-.25pt'> </span>In<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he apixaban<span style='letter-spacing:
-.35pt'> </span>vs<span style='letter-spacing:-.35pt'> </span>warfarin<span
style='letter-spacing:-.3pt'> </span>study<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>incide<span style='letter-spacing:-.05pt'>n</span>ce<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>ISTH<span
style='letter-spacing:-.25pt'> </span>m<span style='letter-spacing:-.15pt'>a</span>jor<span
style='letter-spacing:-.35pt'> </span>gastroin<span style='letter-spacing:-.05pt'>t</span>estinal<span
style='letter-spacing:-.3pt'> </span>bleeds<span style='letter-spacing:-.3pt'> </span>(includi<span
style='letter-spacing:-.05pt'>n</span>g<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>u</span>pper<span style='letter-spacing:-.35pt'> </span>GI,
lower<span style='letter-spacing:-.3pt'> </span>GI,<span style='letter-spacing:
-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>rectal<span
style='letter-spacing:-.25pt'> </span>bleed<span style='letter-spacing:.05pt'>i</span>ng)<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.3pt'> </span>0.76%/<span
style='letter-spacing:.05pt'>y</span>ear.<span style='letter-spacing:-.3pt'> </span>The<span
style='letter-spacing:-.35pt'> </span>incidence<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>ISTH<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>jor intraocular<span style='letter-spacing:
-.45pt'> </span>b<span style='letter-spacing:-.05pt'>l</span>eeding<span
style='letter-spacing:-.45pt'> </span>with<span style='letter-spacing:-.45pt'> </span>apixaban<span
style='letter-spacing:-.45pt'> </span>was<span style='letter-spacing:-.4pt'> </span>0.18%/<span
style='letter-spacing:.05pt'>y</span>ear.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>VTEt<span style='letter-spacing:-.2pt'> </span>studies,<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>overall<span
style='letter-spacing:-.25pt'> </span>incidence<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>adve<span
style='letter-spacing:-.05pt'>r</span>se<span style='letter-spacing:-.25pt'> </span>reactions<span
style='letter-spacing:-.2pt'> </span>rela<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>e</span>d<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>bleeding<span style='letter-spacing:-.2pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>was 15.6%<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>vs<span style='letter-spacing:-.25pt'> </span>enoxaparin/warfarin<span
style='letter-spacing:-.25pt'> </span>stu<span style='letter-spacing:-.1pt'>d</span>y<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>a</span>nd<span
style='letter-spacing:-.25pt'> </span>13.3%<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>vs<span style='letter-spacing:-.25pt'> </span>placebo<span
style='letter-spacing:-.25pt'> </span>study<span style='letter-spacing:-.15pt'>
</span>(see section<span style='letter-spacing:-.55pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Tabulated<span style='letter-spacing:-.4pt'> </span>list<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>adverse<span
style='letter-spacing:-.4pt'> </span>reactions</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>2<span
style='letter-spacing:-.25pt'> </span>shows<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>adverse<span style='letter-spacing:-.25pt'>
</span>reactions<span style='letter-spacing:-.25pt'> </span>ra<span
style='letter-spacing:.05pt'>n</span>ked<span style='letter-spacing:-.3pt'> </span>under<span
style='letter-spacing:-.3pt'> </span>headings<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.05pt'>t</span>em<span style='letter-spacing:-.35pt'> </span>organ<span
style='letter-spacing:-.3pt'> </span>class<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>frequency<span style='letter-spacing:-.15pt'>
</span>us<span style='letter-spacing:-.05pt'>i</span>ng the<span
style='letter-spacing:-.3pt'> </span>following<span style='letter-spacing:-.3pt'>
</span>conventi<span style='letter-spacing:-.05pt'>o</span>n:<span
style='letter-spacing:-.35pt'> </span>very<span style='letter-spacing:-.15pt'> </span>com<span
style='letter-spacing:-.1pt'>m</span>on<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>(</span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>1/10);<span
style='letter-spacing:-.3pt'> </span>c<span style='letter-spacing:-.05pt'>o</span>mmon<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>(</span>&#8805;<span
style='letter-spacing:-.35pt'>&nbsp;</span>1/100<span style='letter-spacing:
-.25pt'>&nbsp;</span>to<span style='letter-spacing:-.3pt'>&nbsp;</span>&lt;<span
style='letter-spacing:-.3pt'>&nbsp;</span>1/10);<span style='letter-spacing:
-.3pt'> </span>uncom<span style='letter-spacing:-.1pt'>m</span>on<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>(</span>&#8805;<span
style='letter-spacing:-.3pt'>&nbsp;</span>1/1,000&nbsp;to<span
style='letter-spacing:-.25pt'>&nbsp;</span>&lt;&nbsp;1/1<span style='letter-spacing:
-.05pt'>0</span>0);<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>a</span>re<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>(</span>&#8805;<span
style='letter-spacing:-.25pt'>&nbsp;</span>1/10,000&nbsp;to<span
style='letter-spacing:-.2pt'>&nbsp;</span>&lt;<span style='letter-spacing:-.3pt'>&nbsp;</span>1/1,<span
style='letter-spacing:-.05pt'>0</span>00);<span style='letter-spacing:-.2pt'> </span>ve<span
style='letter-spacing:-.1pt'>r</span>y<span style='letter-spacing:-.15pt'> </span>rare<span
style='letter-spacing:-.25pt'> </span>(&lt;<span style='letter-spacing:-.2pt'>&nbsp;</span>1/10,<span
style='letter-spacing:-.05pt'>0</span>00);<span style='letter-spacing:-.3pt'> </span>not<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>k</span>nown<span
style='letter-spacing:-.25pt'> </span>(<span style='letter-spacing:-.1pt'>c</span>annot<span
style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:-.2pt'> </span>estimated
from<span style='letter-spacing:-.4pt'> </span>the<span style='letter-spacing:
-.3pt'> </span>ava<span style='letter-spacing:.05pt'>i</span>lable<span
style='letter-spacing:-.3pt'> </span>data)<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>VTEp,<span style='letter-spacing:-.3pt'> </span>NVAF,<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>VTEt<span
style='letter-spacing:-.3pt'> </span>respectively.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.35pt'> </span>2</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=623
 style='margin-left:5.5pt;border-collapse:collapse'>
 <thead>
  <tr style='height:11.35pt'>
   <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
   padding:0in 0in 0in 0in;height:11.35pt'>
   <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><b><span
   lang=EN-GB style='font-size:11.0pt'>System<span style='letter-spacing:-.4pt'>
   o</span>rgan<span style='letter-spacing:-.45pt'> </span>class</span></b></p>
   </td>
   <td width=125 style='width:93.9pt;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:11.35pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Prevention<span
   style='letter-spacing:-.65pt'> </span>of VTE<span style='letter-spacing:
   -.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>adult patients<span
   style='letter-spacing:-.6pt'> </span>who have<span style='letter-spacing:
   -.75pt'> </span>undergone elective<span style='letter-spacing:-.35pt'> </span>hip<span
   style='letter-spacing:-.3pt'> </span>or knee<span style='letter-spacing:
   -.8pt'> </span>repla<span style='letter-spacing:.05pt'>c</span>e<span
   style='letter-spacing:-.05pt'>m</span>ent surgery<span style='letter-spacing:
   -.75pt'> </span>(V<span style='letter-spacing:.05pt'>T</span><span
   style='letter-spacing:-.05pt'>E</span>p)</span></b></p>
   </td>
   <td width=122 style='width:91.8pt;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:11.35pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Prevention<span
   style='letter-spacing:-.65pt'> </span>of stroke<span style='letter-spacing:
   -.5pt'> </span>and <span style='letter-spacing:-.05pt'>system</span><span
   style='letter-spacing:.05pt'>i</span>c embolism<span style='letter-spacing:
   -.55pt'> </span>in adult<span style='letter-spacing:-.65pt'> </span>patien<span
   style='letter-spacing:-.1pt'>t</span>s with<span style='letter-spacing:-.4pt'>
   </span>NVAF,<span style='letter-spacing:-.3pt'> </span>with one<span
   style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.25pt'>
   </span>more<span style='letter-spacing:-.15pt'> </span>risk factors<span
   style='letter-spacing:-.75pt'> </span>(NV<span style='letter-spacing:-.05pt'>A</span>F)</span></b></p>
   </td>
   <td width=138 style='width:103.65pt;border:solid black 1.0pt;border-left:
   none;padding:0in 0in 0in 0in;height:11.35pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Treatment<span
   style='letter-spacing:-.45pt'> </span>of<span style='letter-spacing:-.4pt'> </span>DVT
   and<span style='letter-spacing:-.3pt'> </span>PE,<span style='letter-spacing:
   -.25pt'> </span>and prevention<span style='letter-spacing:-.6pt'> </span>of recu<span
   style='letter-spacing:.05pt'>r</span>rent<span style='letter-spacing:-.45pt'>
   </span>D<span style='letter-spacing:-.05pt'>V</span>T<span style='letter-spacing:
   -.45pt'> </span>and PE<span style='letter-spacing:-.5pt'> </span>(VTEt)</span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Blood<span style='letter-spacing:-.45pt'>
  </span>and<span style='letter-spacing:-.45pt'> </span>lymphatic<span
  style='letter-spacing:-.4pt'> </span>system<span style='letter-spacing:-.4pt'>
  </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Anae<span style='letter-spacing:-.1pt'>m</span><span
  style='letter-spacing:.05pt'>i</span>a</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Thro<span style='letter-spacing:-.1pt'>m</span>boc<span
  style='letter-spacing:.05pt'>y</span>t<span style='letter-spacing:-.05pt'>o</span>penia</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Immune<span style='letter-spacing:-.55pt'>
  </span>sys<span style='letter-spacing:.05pt'>t</span>em<span
  style='letter-spacing:-.6pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:.05pt'>y</span>persensitivity,<span
  style='letter-spacing:-.55pt'> </span>allergic<span style='letter-spacing:
  -.5pt'> </span>oede<span style='letter-spacing:-.1pt'>m</span>a<span
  style='letter-spacing:-.5pt'> </span>and a<span style='letter-spacing:-.05pt'>naph</span><span
  style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>laxis</span></span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Pruritus</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on*</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Nervous<span style='letter-spacing:-.55pt'>
  </span>syst<span style='letter-spacing:.05pt'>e</span>m<span
  style='letter-spacing:-.6pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Brain<span style='letter-spacing:-.85pt'>
  </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhag<span
  style='letter-spacing:-.1pt'>e</span><sup>†</sup></span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Eye<span style='letter-spacing:-.6pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>E<span style='letter-spacing:.05pt'>y</span>e<span
  style='letter-spacing:-.6pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage<span
  style='letter-spacing:-.6pt'> </span>(includ<span style='letter-spacing:-.05pt'>i</span>ng
  conjunctival<span style='letter-spacing:-1.25pt'> </span>hae<span
  style='letter-spacing:-.1pt'>m</span>orrhage)</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Vascular<span style='letter-spacing:-.85pt'>
  </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.1pt'>m</span>orr<span
  style='letter-spacing:.05pt'>h</span>age,<span style='letter-spacing:-1.15pt'>
  </span>hae<span style='letter-spacing:-.1pt'>m</span>at<span
  style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.05pt'>m</span>a</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:.05pt'>y</span><span
  style='letter-spacing:-.05pt'>p</span>otension<span style='letter-spacing:
  -.8pt'> </span>(including<span style='letter-spacing:-.8pt'> </span>p<span
  style='letter-spacing:-.1pt'>r</span>ocedural <span style='letter-spacing:
  -.05pt'>h</span><span style='letter-spacing:.05pt'>y</span><span
  style='letter-spacing:-.05pt'>potension)</span></span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Intra-abdo<span style='letter-spacing:
  -.1pt'>m</span>inal<span style='letter-spacing:-1.3pt'> </span>hae<span
  style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Respiratory,<span style='letter-spacing:
  -.55pt'> </span>thoracic<span style='letter-spacing:-.5pt'> </span>and<span
  style='letter-spacing:-.55pt'> </span>mediastinal<span style='letter-spacing:
  -.5pt'> </span><span style='letter-spacing:-.05pt'>d</span>isorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Epistaxis</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.1pt'>m</span>opt<span
  style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Respiratory<span style='letter-spacing:
  -.6pt'> </span>t<span style='letter-spacing:-.1pt'>r</span>act<span
  style='letter-spacing:-.6pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orr<span
  style='letter-spacing:.05pt'>h</span>age</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Gastrointestinal<span style='letter-spacing:
  -1.15pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Nausea</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Gastrointest<span style='letter-spacing:
  .05pt'>i</span>nal<span style='letter-spacing:-1.3pt'> </span>ha<span
  style='letter-spacing:.05pt'>e</span><span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.1pt'>m</span>orrhoidal<span
  style='letter-spacing:-1.25pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Mouth<span style='letter-spacing:-.95pt'>
  </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.05pt'>m</span>atoche<span
  style='letter-spacing:.05pt'>z</span>ia</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Rectal<span style='letter-spacing:-.65pt'>
  </span>ha<span style='letter-spacing:.05pt'>e</span><span style='letter-spacing:
  -.05pt'>m</span><span style='letter-spacing:.05pt'>o</span>rrhage,<span
  style='letter-spacing:-.6pt'> </span>gingival bleeding</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Retroperitoneal<span style='letter-spacing:
  -1.3pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Hepatobilia<span style='letter-spacing:
  -.1pt'>r</span>y<span style='letter-spacing:-1.1pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Liver<span style='letter-spacing:-.4pt'> </span>functi<span
  style='letter-spacing:-.05pt'>o</span>n<span style='letter-spacing:-.4pt'> </span>test<span
  style='letter-spacing:-.4pt'> </span>abnormal,<span style='letter-spacing:
  -.4pt'> </span>asparate a<span style='letter-spacing:-.1pt'>m</span>inotransfe<span
  style='letter-spacing:.05pt'>r</span>ase<span style='letter-spacing:-.75pt'> </span>incr<span
  style='letter-spacing:.05pt'>e</span>ased,<span style='letter-spacing:-.65pt'>
  </span>blood alkaline<span style='letter-spacing:-.55pt'> </span>pho<span
  style='letter-spacing:-.1pt'>s</span>phatase<span style='letter-spacing:-.55pt'>
  </span>increased,<span style='letter-spacing:-.5pt'> </span>blood bilirubin<span
  style='letter-spacing:-.8pt'> </span>increased</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Gamma-glut<span style='letter-spacing:
  .05pt'>a</span><span style='letter-spacing:-.1pt'>m</span><span
  style='letter-spacing:.05pt'>y</span>ltransfer<span style='letter-spacing:
  .05pt'>a</span>se <span style='letter-spacing:-.05pt'>increased</span></span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.1pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Alanine<span style='letter-spacing:-.8pt'>
  </span>a<span style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:
  .05pt'>n</span>otransfera<span style='letter-spacing:.05pt'>s</span>e<span
  style='letter-spacing:-.75pt'> </span>increa<span style='letter-spacing:.05pt'>s</span>ed</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Skin<span style='letter-spacing:-.45pt'> </span>a<span
  style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:-.4pt'> </span>sub<span
  style='letter-spacing:-.1pt'>c</span>utaneous<span style='letter-spacing:
  -.4pt'> </span>tis<span style='letter-spacing:-.1pt'>s</span>ue<span
  style='letter-spacing:-.4pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Skin<span style='letter-spacing:-.4pt'> </span>rash</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Alopecia</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Uncommon</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Uncommon</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Musculoske<span style='letter-spacing:
  .05pt'>l</span>etal<span style='letter-spacing:-.55pt'> </span>and<span
  style='letter-spacing:-.5pt'> </span>conn<span style='letter-spacing:-.1pt'>e</span>ctive<span
  style='letter-spacing:-.5pt'> </span>tissue<span style='letter-spacing:-.5pt'>
  </span>d<span style='letter-spacing:.05pt'>i</span>sorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Muscle<span style='letter-spacing:-.9pt'>
  </span>ha<span style='letter-spacing:.05pt'>e</span>morrhage</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Renal<span style='letter-spacing:-.4pt'> </span>and<span
  style='letter-spacing:-.4pt'> </span>urinary<span style='letter-spacing:-.4pt'>
  </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Haematuria</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Reproductive<span style='letter-spacing:
  -.45pt'> </span>system<span style='letter-spacing:-.45pt'> </span>and<span
  style='letter-spacing:-.45pt'> </span>b<span style='letter-spacing:-.1pt'>r</span>east<span
  style='letter-spacing:-.4pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Abnor<span style='letter-spacing:-.1pt'>m</span><span
  style='letter-spacing:-.05pt'>a</span>l<span style='letter-spacing:-.7pt'> </span>vaginal<span
  style='letter-spacing:-.7pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage,
  urogenital<span style='letter-spacing:-1.05pt'> </span>h<span
  style='letter-spacing:-.1pt'>a</span>e<span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>General<span style='letter-spacing:-.45pt'>
  </span>disorders<span style='letter-spacing:-.45pt'> </span>and<span
  style='letter-spacing:-.45pt'> </span>administration<span style='letter-spacing:
  -.45pt'> </span>site<span style='letter-spacing:-.4pt'> </span>conditions</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Application<span style='letter-spacing:
  -.55pt'> </span>site<span style='letter-spacing:-.55pt'> </span>bleeding</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Investigations</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Occult<span style='letter-spacing:-.45pt'>
  </span>blood<span style='letter-spacing:-.5pt'> </span>positive</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=623 colspan=4 valign=top style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Injury,<span style='letter-spacing:-.55pt'>
  </span>pois<span style='letter-spacing:-.05pt'>o</span>ning<span
  style='letter-spacing:-.5pt'> </span>and<span style='letter-spacing:-.55pt'> </span>pr<span
  style='letter-spacing:-.05pt'>o</span>cedural<span style='letter-spacing:
  -.55pt'> </span>complications</span></i></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Contusion</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>C<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Post<span style='letter-spacing:-.65pt'> </span>procedu<span
  style='letter-spacing:-.1pt'>r</span>al<span style='letter-spacing:-.6pt'> </span>hae<span
  style='letter-spacing:-.1pt'>m</span>orrhage (including<span
  style='letter-spacing:-.6pt'> </span>p<span style='letter-spacing:-.05pt'>o</span>st<span
  style='letter-spacing:-.6pt'> </span>procedural hae<span style='letter-spacing:
  -.1pt'>m</span>at<span style='letter-spacing:.05pt'>o</span><span
  style='letter-spacing:-.05pt'>m</span>a,<span style='letter-spacing:-.7pt'> </span>wound<span
  style='letter-spacing:-.7pt'> </span>haemorrhage, vessel<span
  style='letter-spacing:-.4pt'> </span>puncture<span style='letter-spacing:
  -.35pt'> </span>site<span style='letter-spacing:-.4pt'> </span>haema<span
  style='letter-spacing:.05pt'>t</span>oma<span style='letter-spacing:-.35pt'> </span>and
  catheter<span style='letter-spacing:-.5pt'> </span>site<span
  style='letter-spacing:-.5pt'> </span><span style='letter-spacing:.05pt'>h</span><span
  style='letter-spacing:-.05pt'>a</span>e<span style='letter-spacing:-.1pt'>m</span>orrhage),<span
  style='letter-spacing:-.4pt'> </span>wound secretion,<span style='letter-spacing:
  -.5pt'> </span>incision<span style='letter-spacing:-.5pt'> </span>site<span
  style='letter-spacing:-.5pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage
  (including<span style='letter-spacing:-.6pt'> </span>in<span
  style='letter-spacing:-.1pt'>c</span>ision<span style='letter-spacing:-.5pt'>
  </span>site<span style='letter-spacing:-.5pt'> </span>haemat<span
  style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.05pt'>m</span>a),
  operative<span style='letter-spacing:-1.0pt'> </span>hae<span
  style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=237 valign=top style='width:177.95pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Tra<span style='letter-spacing:.05pt'>u</span><span
  style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tic<span
  style='letter-spacing:-1.05pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=125 style='width:93.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span style='letter-spacing:
  -.5pt'> </span>known</span></p>
  </td>
  <td width=122 style='width:91.8pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=138 style='width:103.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span style='letter-spacing:
  .05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>*<span style='letter-spacing:-.2pt'> </span>The<span
style='letter-spacing:-.1pt'>r</span>e<span style='letter-spacing:-.15pt'> </span>we<span
style='letter-spacing:-.1pt'>r</span>e<span style='letter-spacing:-.1pt'> </span>no<span
style='letter-spacing:-.25pt'> </span>occurre<span style='letter-spacing:-.1pt'>n</span>ces<span
style='letter-spacing:-.15pt'> </span>of<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>g</span>eneralized<span style='letter-spacing:
-.15pt'> </span>p<span style='letter-spacing:-.1pt'>r</span>u<span
style='letter-spacing:-.1pt'>r</span>itus<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.15pt'> </span>CV185057<span style='letter-spacing:-.2pt'>
</span>(long<span style='letter-spacing:-.15pt'> </span>term<span
style='letter-spacing:-.15pt'> </span>prevention<span style='letter-spacing:
-.15pt'> </span>of<span style='letter-spacing:-.2pt'> </span>VTE)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><sup><span lang=EN-GB
style='font-size:10.0pt'>†</span></sup><span lang=EN-GB style='font-size:10.0pt'>
The<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>t</span>erm<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>“B</span>ra<span
style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:-.2pt'> </span>hae<span
style='letter-spacing:-.05pt'>m</span>orrha<span style='letter-spacing:-.1pt'>g</span>e”<span
style='letter-spacing:-.35pt'> </span>enco<span style='letter-spacing:-.05pt'>m</span>pa<span
style='letter-spacing:-.05pt'>ss</span>es<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>l</span>l<span style='letter-spacing:-.25pt'> </span>intr<span
style='letter-spacing:-.05pt'>a</span>cran<span style='letter-spacing:-.05pt'>i</span>al<span
style='letter-spacing:-.4pt'> </span>or<span style='letter-spacing:-.25pt'> </span>i<span
style='letter-spacing:-.1pt'>n</span>traspinal<span style='letter-spacing:-.25pt'>
</span>haemorrhages<span style='letter-spacing:-.2pt'> </span>(<span
style='letter-spacing:-.1pt'>i</span>e.,<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>h</span>aemorrhagic<span style='letter-spacing:
-.25pt'> </span>stro<span style='letter-spacing:-.1pt'>k</span>e<span
style='letter-spacing:-.3pt'> </span>or putamen,<span style='letter-spacing:
-.4pt'> </span>ce<span style='letter-spacing:-.1pt'>r</span>ebella<span
style='letter-spacing:-.05pt'>r</span>,<span style='letter-spacing:-.4pt'> </span>i<span
style='letter-spacing:-.1pt'>n</span>tra<span style='letter-spacing:-.1pt'>v</span>entricular,<span
style='letter-spacing:-.4pt'> </span>or<span style='letter-spacing:-.4pt'> </span>subdural<span
style='letter-spacing:-.4pt'> </span>haemorrha<span style='letter-spacing:-.1pt'>g</span>es).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>use<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.2pt'> </span>Apixaban
Accord<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.1pt'> </span>be<span style='letter-spacing:-.2pt'> </span>associa<span
style='letter-spacing:.05pt'>t</span>ed<span style='letter-spacing:-.25pt'> </span>w<span
style='letter-spacing:.05pt'>i</span>th<span style='letter-spacing:-.2pt'> </span>an<span
style='letter-spacing:-.2pt'> </span>increas<span style='letter-spacing:.05pt'>e</span>d<span
style='letter-spacing:-.2pt'> </span>risk<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>occult<span style='letter-spacing:-.2pt'> </span>or<span
style='letter-spacing:-.2pt'> </span>overt<span style='letter-spacing:-.25pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>from<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>y<span style='letter-spacing:-.1pt'> </span>tissue
or<span style='letter-spacing:-.3pt'> </span>organ,<span style='letter-spacing:
-.25pt'> </span>wh<span style='letter-spacing:-.05pt'>ic</span>h<span
style='letter-spacing:-.25pt'> </span>may<span style='letter-spacing:-.15pt'> </span>result<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>posthaemorrhagic<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.05pt'>n</span>aemia.<span
style='letter-spacing:-.25pt'> </span>The<span style='letter-spacing:-.25pt'> </span>signs,<span
style='letter-spacing:-.25pt'> </span>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptoms,<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>severity<span
style='letter-spacing:-.25pt'> </span>will<span style='letter-spacing:-.3pt'> </span>vary
according<span style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:
-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>location<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>degree<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.3pt'> </span>extent<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>bleeding<span style='letter-spacing:-.25pt'>
</span>(see<span style='letter-spacing:-.25pt'> </span>sections<span
style='letter-spacing:-.2pt'>&nbsp;</span>4.4<span style='letter-spacing:-.25pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Reporting<span style='letter-spacing:-.5pt'> </span>of<span
style='letter-spacing:-.45pt'> </span>suspected<span style='letter-spacing:
-.45pt'> </span>adverse<span style='letter-spacing:-.5pt'> </span>reactions</span></u></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Reporting<span style='letter-spacing:-.35pt'> </span>su<span
style='letter-spacing:-.1pt'>s</span>pected<span style='letter-spacing:-.35pt'>
</span>adverse<span style='letter-spacing:-.3pt'> </span>reactions<span
style='letter-spacing:-.35pt'> </span>after<span style='letter-spacing:-.35pt'>
</span>author<span style='letter-spacing:-.05pt'>i</span>sation<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span><span
style='letter-spacing:.05pt'>d</span>icinal<span style='letter-spacing:-.35pt'>
</span>product<span style='letter-spacing:-.4pt'> </span>is<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.1pt'>m</span>portant.<span
style='letter-spacing:-.35pt'> </span>It allows<span style='letter-spacing:
-.35pt'> </span>continued<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>m</span>onitoring<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.35pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.35pt'> </span>benefit/ri<span
style='letter-spacing:-.1pt'>s</span>k<span style='letter-spacing:-.35pt'> </span>balance<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span><span style='letter-spacing:.05pt'>d</span>icinal<span
style='letter-spacing:-.35pt'> </span>produc<span style='letter-spacing:-.05pt'>t</span>.<span
style='letter-spacing:-.35pt'> </span>Healthcare professionals<span
style='letter-spacing:-.35pt'> </span>are<span style='letter-spacing:-.3pt'> </span>asked<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>report<span
style='letter-spacing:-.3pt'> </span>any<span style='letter-spacing:-.2pt'> </span>su<span
style='letter-spacing:-.1pt'>s</span>pected<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>a</span>dverse<span style='letter-spacing:-.3pt'>
</span>reactions<span style='letter-spacing:-.35pt'> </span>via<span
style='letter-spacing:-.3pt'> </span><span style='background:silver'>the<span
style='letter-spacing:-.3pt'> </span>national<span style='letter-spacing:-.35pt'>
</span>reporting<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>s</span>tem listed<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span><span
style='color:blue'>Ap<span style='letter-spacing:-.05pt'>pe</span>ndix<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>V</span></span><span
style='color:black'>.</span></span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.9<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Overdose</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Overdo<span style='letter-spacing:-.1pt'>s</span>e<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>may<span style='letter-spacing:-.15pt'> </span>result<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>higher<span style='letter-spacing:-.25pt'>
</span>risk<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>bleeding.<span style='letter-spacing:-.3pt'>
</span>In<span style='letter-spacing:-.2pt'> </span>the event<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>hae<span
style='letter-spacing:-.1pt'>m</span>orrhagic<span style='letter-spacing:-.25pt'>
</span>co<span style='letter-spacing:-.1pt'>m</span>pli<span style='letter-spacing:
.05pt'>c</span>ations,<span style='letter-spacing:-.35pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>ment<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ust<span style='letter-spacing:-.35pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>disconti<span style='letter-spacing:-.05pt'>n</span>ued<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>s</span>ource<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>bleeding
investigated.<span style='letter-spacing:-.35pt'> </span>The<span
style='letter-spacing:-.35pt'> </span>initiation<span style='letter-spacing:
-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>appropriate<span
style='letter-spacing:-.35pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment,<span
style='letter-spacing:-.35pt'> </span>e.g.,<span style='letter-spacing:-.35pt'>
</span>surgical<span style='letter-spacing:-.3pt'> </span>hae<span
style='letter-spacing:-.1pt'>m</span>os<span style='letter-spacing:.05pt'>t</span>asis<span
style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>transfusion<span style='letter-spacing:
-.35pt'> </span>of fresh<span style='letter-spacing:-.35pt'> </span>frozen<span
style='letter-spacing:-.35pt'> </span>plasma<span style='letter-spacing:-.35pt'>
or the administration of a reversal agent for factor Xa inhibitors </span>should<span
style='letter-spacing:-.4pt'> </span>be<span style='letter-spacing:-.35pt'> </span>considered.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>controlled<span
style='letter-spacing:-.3pt'> </span>clinical<span style='letter-spacing:-.3pt'>
</span>trials,<span style='letter-spacing:-.2pt'> </span>orall<span
style='letter-spacing:.05pt'>y</span>-ad<span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:.05pt'>n</span>istered<span style='letter-spacing:-.3pt'>
</span>a<span style='letter-spacing:-.1pt'>p</span>ixaban<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>healthy<span
style='letter-spacing:-.25pt'> </span>subjects<span style='letter-spacing:-.3pt'>
</span>at<span style='letter-spacing:-.25pt'> </span>doses<span
style='letter-spacing:-.3pt'> </span>up<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>50<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>daily
for<span style='letter-spacing:-.2pt'> </span>3<span style='letter-spacing:
-.15pt'>&nbsp;</span>to<span style='letter-spacing:-.2pt'>&nbsp;</span>7<span
style='letter-spacing:-.15pt'>&nbsp;</span>d<span style='letter-spacing:-.1pt'>a</span>ys<span
style='letter-spacing:-.15pt'> </span>(25<span style='letter-spacing:-.15pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.15pt'> </span>twice<span
style='letter-spacing:-.15pt'> </span>daily<span style='letter-spacing:-.05pt'>
</span><span style='letter-spacing:-.1pt'>(</span>bid)<span style='letter-spacing:
-.15pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.15pt'> </span>7<span style='letter-spacing:-.15pt'>&nbsp;</span>d<span
style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>5</span>0<span style='letter-spacing:-.15pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.15pt'> </span>once<span
style='letter-spacing:-.15pt'> </span>daily<span style='letter-spacing:-.2pt'> </span>(od)<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.15pt'> </span>3<span style='letter-spacing:-.2pt'>&nbsp;</span>da<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>)<span
style='letter-spacing:-.15pt'> </span>had<span style='letter-spacing:-.2pt'> </span>no
clinically<span style='letter-spacing:-.4pt'> </span>relevant<span
style='letter-spacing:-.5pt'> </span>adverse<span style='letter-spacing:-.45pt'>
</span>events.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>healthy<span
style='letter-spacing:-.1pt'> </span>subjects,<span style='letter-spacing:-.25pt'>
</span>a<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:
-.1pt'>m</span>i<span style='letter-spacing:.05pt'>n</span>istration<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.2pt'> </span>activated<span
style='letter-spacing:-.25pt'> </span>cha<span style='letter-spacing:-.1pt'>r</span>coal<span
style='letter-spacing:-.2pt'> </span>2<span style='letter-spacing:-.2pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>6<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.05pt'>h</span>ours<span style='letter-spacing:-.2pt'> </span>after<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.05pt'>g</span>estion<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>20<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>dose
of<span style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:
-.2pt'> </span>reduced<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ean<span style='letter-spacing:-.2pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban<span style='letter-spacing:-.2pt'> </span>AUC<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>b</span>y<span
style='letter-spacing:-.1pt'> </span>50%<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:-.25pt'> </span>27<span
style='letter-spacing:-.05pt'>%</span>,<span style='letter-spacing:-.2pt'> </span>respectivel<span
style='letter-spacing:.1pt'>y</span>,<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>ha</span>d<span style='letter-spacing:-.25pt'> </span>no<span
style='letter-spacing:-.2pt'> </span>i<span style='letter-spacing:-.1pt'>m</span>pact<span
style='letter-spacing:-.15pt'> </span>on<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.15pt'>C<sub><span style='position:relative;top:1.0pt'>m</span></sub></span><sub><span
style='position:relative;top:1.0pt'>ax</span></sub>. Mean<span
style='letter-spacing:-.3pt'> </span>half-life<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>decreased<span style='letter-spacing:
-.3pt'> </span>from<span style='letter-spacing:-.4pt'> </span>13.4<span
style='letter-spacing:-.35pt'>&nbsp;</span>hou<span style='letter-spacing:-.1pt'>r</span>s<span
style='letter-spacing:-.3pt'> </span>when<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>nistered<span style='letter-spacing:-.3pt'>
</span>alone<span style='letter-spacing:-.3pt'> </span>to 5.3<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>h</span>ours<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>4.9<span
style='letter-spacing:-.35pt'>&nbsp;</span>hours,<span style='letter-spacing:
-.25pt'> </span>r<span style='letter-spacing:-.1pt'>e</span>spectivel<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>w</span>hen<span style='letter-spacing:-.25pt'> </span>activated<span
style='letter-spacing:-.3pt'> </span>charcoal<span style='letter-spacing:-.25pt'>
</span>was<span style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:
.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistered<span
style='letter-spacing:-.2pt'> </span>2<span style='letter-spacing:-.25pt'>&nbsp;</span>and<span
style='letter-spacing:-.3pt'>&nbsp;</span>6<span style='letter-spacing:-.3pt'>&nbsp;</span>hours<span
style='letter-spacing:-.35pt'> </span>after apixaban.<span style='letter-spacing:
-.35pt'> </span>Thus,<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inist<span style='letter-spacing:.05pt'>r</span><span
style='letter-spacing:-.05pt'>a</span>tion<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>activated<span style='letter-spacing:-.3pt'>
</span>charcoal<span style='letter-spacing:-.35pt'> </span>may<span
style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:-.3pt'> </span>usef<span
style='letter-spacing:-.05pt'>u</span>l<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>nage<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>apixaban
overdose<span style='letter-spacing:-.5pt'> </span>or<span style='letter-spacing:
-.45pt'> </span>accidental<span style='letter-spacing:-.45pt'> </span>ingestion.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For situations when reversal of anticoagulation is needed due to
life-threatening or uncontrolled bleeding, a reversal agent for factor Xa
inhibitors is available (see section 4.4).<span style='letter-spacing:-.35pt'> A</span><span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>p<span
style='letter-spacing:-.1pt'>r</span>o<span style='letter-spacing:-.05pt'>t</span>hro<span
style='letter-spacing:-.1pt'>m</span>bin c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>plex<span style='letter-spacing:-.35pt'> </span>concentrates<span
style='letter-spacing:-.35pt'> </span>(PC<span style='letter-spacing:.05pt'>C</span>s)<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.35pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>binant<span
style='letter-spacing:-.3pt'> </span>factor<span style='letter-spacing:-.35pt'>
</span>VIIa<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:-.35pt'> </span>considered.<span
style='letter-spacing:-.3pt'> </span>Reversal<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>Apixaban Accord pharmacod<span
style='letter-spacing:.05pt'>y</span>na<span style='letter-spacing:-.1pt'>m</span>ic<span
style='letter-spacing:-.35pt'> </span>effec<span style='letter-spacing:.05pt'>t</span>s,<span
style='letter-spacing:-.35pt'> </span>as<span style='letter-spacing:-.35pt'> </span>de<span
style='letter-spacing:-.1pt'>m</span>onstra<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.35pt'> </span>by<span style='letter-spacing:-.25pt'> </span>ch<span
style='letter-spacing:-.05pt'>a</span>ng<span style='letter-spacing:-.1pt'>e</span>s<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>thro<span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.3pt'> </span>generation<span style='letter-spacing:
-.35pt'> </span>assa<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.35pt'> </span>was<span style='letter-spacing:-.35pt'> </span>evident
at<span style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:
-.2pt'> </span>end<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>i</span>nfusion<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>r</span>eached<span style='letter-spacing:-.2pt'> </span>basel<span
style='letter-spacing:.05pt'>i</span>ne<span style='letter-spacing:-.2pt'> </span>values<span
style='letter-spacing:-.25pt'> </span>within<span style='letter-spacing:-.2pt'>
</span>4<span style='letter-spacing:-.25pt'> </span>hours<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.1pt'>f</span>ter<span
style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:-.2pt'> </span>start<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>4-factor<span style='letter-spacing:-.2pt'>
</span>PCC 30<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>inute<span style='letter-spacing:-.25pt'> </span>infusion<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>healt<span
style='letter-spacing:-.05pt'>h</span>y<span style='letter-spacing:-.2pt'> </span>subjects.<span
style='letter-spacing:-.3pt'> </span>However,<span style='letter-spacing:-.25pt'>
</span>t<span style='letter-spacing:-.05pt'>h</span>ere<span style='letter-spacing:
-.25pt'> </span>is<span style='letter-spacing:-.25pt'> </span>no<span
style='letter-spacing:-.25pt'> </span>clinical<span style='letter-spacing:-.25pt'>
</span>experience<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>use<span
style='letter-spacing:-.25pt'> </span>of 4&#8209;factor<span style='letter-spacing:
-.3pt'> </span>PCC<span style='letter-spacing:-.25pt'> medicinal </span>products<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>r<span
style='letter-spacing:-.1pt'>e</span>verse<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>indiv<span
style='letter-spacing:-.05pt'>i</span>du<span style='letter-spacing:-.15pt'>a</span>ls<span
style='letter-spacing:-.25pt'> </span>who<span style='letter-spacing:-.3pt'> </span>have<span
style='letter-spacing:-.25pt'> </span>received<span style='letter-spacing:-.25pt'>
</span>Apixaban Accord.<span style='letter-spacing:-.3pt'> </span>Currently<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>t</span>here<span
style='letter-spacing:-.25pt'> </span>is no<span style='letter-spacing:-.3pt'> </span>experience<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>use<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>rec<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>binant<span style='letter-spacing:-.25pt'>
</span>factor<span style='letter-spacing:-.3pt'> </span>VIIa<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>individuals<span
style='letter-spacing:-.3pt'> </span>receiving<span style='letter-spacing:-.25pt'>
</span>apixaban.<span style='letter-spacing:-.25pt'> </span>Re-dosing<span
style='letter-spacing:-.3pt'> </span>of rec<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>binant<span style='letter-spacing:-.35pt'>
</span>factor<span style='letter-spacing:-.35pt'> </span>VIIa<span
style='letter-spacing:-.3pt'> </span>c<span style='letter-spacing:.05pt'>o</span>uld<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.3pt'> </span>considered<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>a</span>nd<span
style='letter-spacing:-.35pt'> </span>titrated<span style='letter-spacing:-.3pt'>
</span>depending<span style='letter-spacing:-.35pt'> </span>on<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.15pt'>m</span>provement<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>bleeding.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Depending<span style='letter-spacing:-.3pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>local<span style='letter-spacing:-.3pt'> </span>availabili<span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.3pt'> </span>con<span
style='letter-spacing:-.1pt'>s</span>ultation<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:
-.35pt'> </span>coagulation<span style='letter-spacing:-.25pt'> </span>expert<span
style='letter-spacing:-.3pt'> </span>should<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>considered<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>case<span
style='letter-spacing:-.25pt'> </span>of major<span style='letter-spacing:-.75pt'>
</span>bleedings.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Hae<span style='letter-spacing:-.1pt'>m</span>odial<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is<span
style='letter-spacing:-.35pt'> </span>decre<span style='letter-spacing:.05pt'>a</span>sed<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>AUC<span style='letter-spacing:-.35pt'> </span>by<span style='letter-spacing:
-.25pt'> </span>14%<span style='letter-spacing:-.4pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>subjects<span style='letter-spacing:-.35pt'>
</span>with<span style='letter-spacing:-.35pt'> </span>end-stage<span
style='letter-spacing:-.3pt'> </span>renal<span style='letter-spacing:-.35pt'> </span>disease<span
style='letter-spacing:-.35pt'> </span>(ES<span style='letter-spacing:.05pt'>R</span>D),
when<span style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:
-.25pt'> </span>single<span style='letter-spacing:-.3pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apix<span
style='letter-spacing:-.1pt'>a</span>ban<span style='letter-spacing:-.3pt'> </span>5<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.2pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inis<span style='letter-spacing:.05pt'>t</span>ered<span
style='letter-spacing:-.25pt'> </span>oral<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span>.<span style='letter-spacing:-.25pt'> </span>Therefore,<span
style='letter-spacing:-.25pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>odial<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.25pt'> </span>unl<span
style='letter-spacing:-.05pt'>ik</span>ely<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>t</span>o be<span style='letter-spacing:-.35pt'> </span>an<span
style='letter-spacing:-.3pt'> </span>effective<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.1pt'>m</span>eans<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>managing<span
style='letter-spacing:-.35pt'> </span>apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.3pt'> </span>overdose.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>PHAR</span><span
lang=EN-GB>M<span style='letter-spacing:-.05pt'>A</span>C<span
style='letter-spacing:-.05pt'>OLOG</span>I<span style='letter-spacing:-.05pt'>CA</span>L
<span style='letter-spacing:-.05pt'>PROPE</span>R<span style='letter-spacing:
-.05pt'>T</span>I<span style='letter-spacing:-.05pt'>ES</span></span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><b><span lang=EN-GB style='font-size:11.0pt'>5.1<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='font-size:11.0pt'>Phar<span
style='letter-spacing:-.05pt'>m</span>acodyna<span style='letter-spacing:-.05pt'>m</span>ic<span
style='letter-spacing:-1.4pt'> </span>properties</span></b></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Phar<span style='letter-spacing:-.1pt'>m</span>acotherapeutic<span
style='letter-spacing:-.45pt'> </span>group:<span style='letter-spacing:-.4pt'>
</span>Antithro<span style='letter-spacing:-.1pt'>m</span>botic<span
style='letter-spacing:-.45pt'> </span>agents,<span style='letter-spacing:-.4pt'>
</span>d<span style='letter-spacing:-.05pt'>i</span>rect<span style='letter-spacing:
-.4pt'> </span>factor<span style='letter-spacing:-.45pt'> </span>Xa<span
style='letter-spacing:-.4pt'> </span>inhibi<span style='letter-spacing:-.05pt'>t</span>ors,<span
style='letter-spacing:-.4pt'> </span>ATC<span style='letter-spacing:-.45pt'> </span>code:<span
style='letter-spacing:-.4pt'> </span>B01AF02 </span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Mechani<span style='letter-spacing:.05pt'>s</span>m<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:.05pt'>o</span>f<span
style='letter-spacing:-.45pt'> </span>action</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.25pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>potent,<span
style='letter-spacing:-.3pt'> </span>oral,<span style='letter-spacing:-.3pt'> </span>reversible,<span
style='letter-spacing:-.25pt'> </span>direct<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>h<span style='letter-spacing:
-.05pt'>i</span>ghly<span style='letter-spacing:-.25pt'> </span>selective<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:.05pt'>c</span>tive<span
style='letter-spacing:-.25pt'> </span>site<span style='letter-spacing:-.25pt'> </span>inhibitor<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>factor<span
style='letter-spacing:-.3pt'> </span>Xa.<span style='letter-spacing:-.25pt'> </span>It
does<span style='letter-spacing:-.35pt'> </span>not<span style='letter-spacing:
-.35pt'> </span>require<span style='letter-spacing:-.35pt'> </span>antithrombin<span
style='letter-spacing:-.3pt'> </span>III<span style='letter-spacing:-.35pt'> </span>for<span
style='letter-spacing:-.35pt'> </span>an<span style='letter-spacing:-.05pt'>t</span>ithro<span
style='letter-spacing:-.1pt'>m</span>botic<span style='letter-spacing:-.3pt'> </span>activi<span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>.<span
style='letter-spacing:-.35pt'> </span>Apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.35pt'> </span>inh<span style='letter-spacing:-.05pt'>i</span>bits<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>f</span>ree<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.35pt'> </span>clot-bound
factor<span style='letter-spacing:-.35pt'> </span>Xa,<span style='letter-spacing:
-.3pt'> </span>a<span style='letter-spacing:.05pt'>n</span>d<span
style='letter-spacing:-.3pt'> </span>prothro<span style='letter-spacing:-.1pt'>m</span>binase<span
style='letter-spacing:-.3pt'> </span>activit<span style='letter-spacing:.1pt'>y</span>.<span
style='letter-spacing:-.35pt'> </span>Apixaban<span style='letter-spacing:-.3pt'>
</span>has<span style='letter-spacing:-.3pt'> </span>no<span style='letter-spacing:
-.3pt'> </span>direct<span style='letter-spacing:-.3pt'> </span>effects<span
style='letter-spacing:-.35pt'> </span>on<span style='letter-spacing:-.3pt'> </span>platelet<span
style='letter-spacing:-.3pt'> </span>aggregation,<span style='letter-spacing:
-.35pt'> </span>but indirectly<span style='letter-spacing:-.35pt'> </span>inhibits<span
style='letter-spacing:-.35pt'> </span>platelet<span style='letter-spacing:-.35pt'>
</span>aggregation<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nduced<span style='letter-spacing:-.45pt'>
</span>by<span style='letter-spacing:-.35pt'> </span>th<span style='letter-spacing:
-.1pt'>r</span>o<span style='letter-spacing:-.1pt'>m</span>bin.<span
style='letter-spacing:-.35pt'> </span>By<span style='letter-spacing:-.25pt'> </span>inhibiting<span
style='letter-spacing:-.35pt'> </span>factor<span style='letter-spacing:-.35pt'>
</span>Xa,<span style='letter-spacing:-.35pt'> </span>apixaban prevents<span
style='letter-spacing:-.4pt'> </span>thr<span style='letter-spacing:-.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>bin<span style='letter-spacing:-.35pt'> </span>generation<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>thrombus<span
style='letter-spacing:-.35pt'> </span>develop<span style='letter-spacing:-.1pt'>m</span>ent.<span
style='letter-spacing:-.4pt'> </span>Preclinical<span style='letter-spacing:
-.35pt'> </span>studies<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.4pt'> </span>an<span style='letter-spacing:
.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>al <span
style='letter-spacing:-.1pt'>m</span>ode<span style='letter-spacing:.05pt'>l</span>s<span
style='letter-spacing:-.4pt'> </span>have<span style='letter-spacing:-.35pt'> </span>de<span
style='letter-spacing:-.1pt'>m</span>onstrated<span style='letter-spacing:-.25pt'>
</span>antithro<span style='letter-spacing:-.1pt'>m</span>botic<span
style='letter-spacing:-.35pt'> </span>efficacy<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:
-.35pt'> </span>prevention<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>arterial<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.35pt'> </span>venous<span
style='letter-spacing:-.35pt'> </span>th<span style='letter-spacing:-.1pt'>r</span>o<span
style='letter-spacing:-.1pt'>m</span>bosis at<span style='letter-spacing:-.4pt'>
</span>doses<span style='letter-spacing:-.35pt'> </span>that<span
style='letter-spacing:-.4pt'> </span>preserved<span style='letter-spacing:-.35pt'>
</span>ha<span style='letter-spacing:.05pt'>e</span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.05pt'>s</span>tas<span style='letter-spacing:.05pt'>i</span>s.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB style='letter-spacing:-.05pt'>Pha</span><span lang=EN-GB
style='letter-spacing:.05pt'>r</span><span lang=EN-GB style='letter-spacing:
-.1pt'>m</span><span lang=EN-GB style='letter-spacing:-.05pt'>acod</span><span
lang=EN-GB style='letter-spacing:.05pt'>y</span><span lang=EN-GB
style='letter-spacing:-.05pt'>n</span><span lang=EN-GB>a<span style='letter-spacing:
-.1pt'>m</span>ic<span style='letter-spacing:-1.15pt'> </span>e<span
style='letter-spacing:-.05pt'>ffec</span><span style='letter-spacing:.05pt'>t</span>s</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>pharma<span
style='letter-spacing:.05pt'>c</span>od<span style='letter-spacing:.05pt'>y</span>na<span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.3pt'> </span>ef<span
style='letter-spacing:.05pt'>f</span>ects<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>are<span style='letter-spacing:-.35pt'> </span>refl<span
style='letter-spacing:.05pt'>e</span><span style='letter-spacing:-.05pt'>c</span>tive<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span>echanism<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.3pt'> </span>action<span
style='letter-spacing:-.35pt'> </span>(FXa<span style='letter-spacing:-.3pt'> </span>inh<span
style='letter-spacing:-.05pt'>i</span>bition). As<span style='letter-spacing:
-.3pt'> </span>a<span style='letter-spacing:-.25pt'> </span>result<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>FXa<span
style='letter-spacing:-.25pt'> </span>inhibit<span style='letter-spacing:-.05pt'>i</span>on,<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>prolo<span style='letter-spacing:-.05pt'>n</span>gs<span
style='letter-spacing:-.25pt'> </span>clot<span style='letter-spacing:-.05pt'>t</span>ing<span
style='letter-spacing:-.25pt'> </span>tests<span style='letter-spacing:-.25pt'>
</span>such<span style='letter-spacing:-.3pt'> </span>as<span style='letter-spacing:
-.25pt'> </span>prothro<span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.25pt'> </span>ti<span style='letter-spacing:-.1pt'>m</span>e<span
style='letter-spacing:-.25pt'> </span>(PT),<span style='letter-spacing:-.2pt'> </span>INR<span
style='letter-spacing:-.25pt'> </span>and activated<span style='letter-spacing:
-.35pt'> </span>partial<span style='letter-spacing:-.3pt'> </span>thro<span
style='letter-spacing:-.1pt'>m</span>boplastin<span style='letter-spacing:-.3pt'>
</span>t<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:
-.1pt'>m</span>e<span style='letter-spacing:-.4pt'> </span>(a<span
style='letter-spacing:.05pt'>P</span>TT).<span style='letter-spacing:-.3pt'> </span>Chan<span
style='letter-spacing:-.1pt'>g</span>es<span style='letter-spacing:-.3pt'> </span>observed<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>t</span>hese<span style='letter-spacing:-.3pt'> </span>clotting<span
style='letter-spacing:-.35pt'> </span>tests<span style='letter-spacing:-.3pt'> </span>at<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span>e<span
style='letter-spacing:.05pt'>x</span>pected therapeutic<span style='letter-spacing:
-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>are<span
style='letter-spacing:-.25pt'> </span>small<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>subject<span style='letter-spacing:-.25pt'>
</span>to<span style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:
-.25pt'> </span>high<span style='letter-spacing:-.3pt'> </span>d<span
style='letter-spacing:-.1pt'>e</span>gree<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>variability.<span style='letter-spacing:
-.2pt'> </span>Th<span style='letter-spacing:-.1pt'>e</span>y<span
style='letter-spacing:-.2pt'> </span>are<span style='letter-spacing:-.2pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>recomme<span style='letter-spacing:.05pt'>n</span>ded<span
style='letter-spacing:-.25pt'> </span>to assess<span style='letter-spacing:
-.35pt'> </span>the<span style='letter-spacing:-.35pt'> </span>pha<span
style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.1pt'>m</span>acodynamic<span
style='letter-spacing:-.35pt'> </span>ef<span style='letter-spacing:.05pt'>f</span>ects<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apixaban.<span
style='letter-spacing:-.35pt'> </span>In<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>thro<span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.3pt'> </span>generation<span style='letter-spacing:
-.35pt'> </span>assa<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>reduced endogenous<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>t</span>hro<span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.35pt'> </span>potential,<span style='letter-spacing:
-.35pt'> </span>a<span style='letter-spacing:-.35pt'> </span>meas<span
style='letter-spacing:.05pt'>u</span>re<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.4pt'> </span>thro<span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.35pt'> </span>generation<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.35pt'> </span>hu<span style='letter-spacing:-.1pt'>m</span>an<span
style='letter-spacing:-.35pt'> </span>plasma.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.3pt'> </span>also<span
style='letter-spacing:-.3pt'> </span>de<span style='letter-spacing:-.1pt'>m</span>onstra<span
style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:-.3pt'> </span>anti-FXa<span
style='letter-spacing:-.3pt'> </span>activi<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.2pt'> </span>as<span style='letter-spacing:-.3pt'> </span>evident<span
style='letter-spacing:-.25pt'> </span>by<span style='letter-spacing:-.2pt'> </span>reduction<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>Factor<span
style='letter-spacing:-.3pt'> </span>Xa<span style='letter-spacing:-.3pt'> </span>enz<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.1pt'>m</span>e<span
style='letter-spacing:-.2pt'> </span>activi<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.2pt'> </span>in <span style='letter-spacing:-.1pt'>m</span>ultiple<span
style='letter-spacing:-.3pt'> </span>c<span style='letter-spacing:.05pt'>o</span>mmerc<span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.05pt'>a</span>l<span
style='letter-spacing:-.3pt'> </span>anti-FXa<span style='letter-spacing:-.3pt'>
</span>kits,<span style='letter-spacing:-.3pt'> </span>however<span
style='letter-spacing:-.3pt'> </span>results<span style='letter-spacing:-.25pt'>
</span>diff<span style='letter-spacing:-.1pt'>e</span>r<span style='letter-spacing:
-.3pt'> </span>across<span style='letter-spacing:-.25pt'> </span>kits.<span
style='letter-spacing:-.3pt'> </span>Data<span style='letter-spacing:-.3pt'> </span>from<span
style='letter-spacing:-.3pt'> </span>clinical<span style='letter-spacing:-.3pt'>
</span>trials<span style='letter-spacing:-.3pt'> </span>are<span
style='letter-spacing:-.3pt'> </span>only available<span style='letter-spacing:
-.35pt'> </span>for<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>Rotachro<span style='letter-spacing:-.1pt'>m
</span>H<span style='letter-spacing:-.05pt'>e</span>parin<span
style='letter-spacing:-.3pt'> </span>chro<span style='letter-spacing:-.1pt'>m</span>ogenic<span
style='letter-spacing:-.35pt'> </span>assa<span style='letter-spacing:.05pt'>y</span>.<span
style='letter-spacing:-.35pt'> </span>Anti-FXa<span style='letter-spacing:-.3pt'>
</span>activity<span style='letter-spacing:-.25pt'> </span>exhibits<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:-.3pt'> </span>clo<span
style='letter-spacing:-.1pt'>s</span>e<span style='letter-spacing:-.35pt'> </span>direct
linear<span style='letter-spacing:-.35pt'> </span>relationship<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>plasma<span style='letter-spacing:-.25pt'>
</span>concent<span style='letter-spacing:-.1pt'>r</span>ation,<span
style='letter-spacing:-.35pt'> </span>reaching<span style='letter-spacing:-.3pt'>
</span>max<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>u</span>m<span
style='letter-spacing:-.4pt'> </span>values<span style='letter-spacing:-.35pt'>
</span>at<span style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:
-.35pt'> </span>t<span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.1pt'>m</span>e<span style='letter-spacing:-.3pt'> </span>of
apixaban<span style='letter-spacing:-.45pt'> </span>peak<span style='letter-spacing:
-.4pt'> </span>plasma<span style='letter-spacing:-.4pt'> </span>concentrations.<span
style='letter-spacing:-.4pt'> </span>The<span style='letter-spacing:-.45pt'> </span>relat<span
style='letter-spacing:-.1pt'>i</span>onship<span style='letter-spacing:-.4pt'> </span>between<span
style='letter-spacing:-.4pt'> </span>apixaban<span style='letter-spacing:-.4pt'>
</span>plasma<span style='letter-spacing:-.4pt'> </span>concentration<span
style='letter-spacing:-.45pt'> </span>and anti-FXa<span style='letter-spacing:
-.3pt'> </span>act<span style='letter-spacing:.05pt'>i</span>vity<span
style='letter-spacing:-.2pt'> </span>is<span style='letter-spacing:-.25pt'> </span>approx<span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>tely<span style='letter-spacing:-.2pt'> </span>linear<span
style='letter-spacing:-.3pt'> </span>over<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>wide<span style='letter-spacing:-.3pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>range<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>apixaban.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>3<span
style='letter-spacing:-.25pt'> </span>below<span style='letter-spacing:-.25pt'>
</span>shows<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>predicted<span style='letter-spacing:
-.25pt'> </span>ste<span style='letter-spacing:.05pt'>a</span>dy<span
style='letter-spacing:-.2pt'> </span>state<span style='letter-spacing:-.25pt'> </span>exposure<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>anti-Factor<span
style='letter-spacing:-.3pt'> </span>Xa<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>c</span>tivity<span style='letter-spacing:-.15pt'>
</span>for<span style='letter-spacing:-.3pt'> </span>each indication.<span
style='letter-spacing:-.3pt'> </span>In<span style='letter-spacing:-.4pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>taking<span style='letter-spacing:-.25pt'>
</span>apixaban<span style='letter-spacing:-.3pt'> </span>f<span
style='letter-spacing:-.05pt'>o</span>r<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>prevent<span style='letter-spacing:-.05pt'>i</span>on<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>VTE<span
style='letter-spacing:-.3pt'> </span>f<span style='letter-spacing:-.05pt'>o</span>llowing<span
style='letter-spacing:-.3pt'> </span>h<span style='letter-spacing:-.05pt'>i</span>p<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>o</span>r<span
style='letter-spacing:-.3pt'> </span>knee<span style='letter-spacing:-.3pt'> </span>replace<span
style='letter-spacing:-.1pt'>m</span>ent surger<span style='letter-spacing:
.05pt'>y</span>,<span style='letter-spacing:-.4pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>results<span style='letter-spacing:-.3pt'>
</span>de<span style='letter-spacing:-.1pt'>m</span>onstrate<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.3pt'> </span>l<span
style='letter-spacing:.05pt'>e</span>ss<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:.05pt'>t</span>han<span style='letter-spacing:-.3pt'> </span>1.6<span
style='letter-spacing:-.05pt'>-</span><span style='letter-spacing:-.1pt'>f</span>old<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>f</span>luctuation<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>peak-to-trou<span
style='letter-spacing:-.05pt'>g</span>h<span style='letter-spacing:-.35pt'> </span>levels.<span
style='letter-spacing:-.3pt'> </span>In non-valvular<span style='letter-spacing:
-.35pt'> </span>atrial<span style='letter-spacing:-.35pt'> </span>fibrillation<span
style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:-.35pt'>
</span>taking<span style='letter-spacing:-.3pt'> </span>ap<span
style='letter-spacing:-.05pt'>i</span>xa<span style='letter-spacing:-.05pt'>b</span>an<span
style='letter-spacing:-.35pt'> </span>for<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>prevention<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>stroke<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>stemic
e<span style='letter-spacing:-.1pt'>m</span>bolis<span style='letter-spacing:
-.1pt'>m</span>,<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>results<span style='letter-spacing:-.3pt'>
</span>demonstrate<span style='letter-spacing:-.35pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>less<span style='letter-spacing:-.35pt'> </span>than<span
style='letter-spacing:-.3pt'> </span>1.7-f<span style='letter-spacing:-.05pt'>ol</span>d<span
style='letter-spacing:-.3pt'> </span>fluctuation<span style='letter-spacing:
-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>peak-to-tr<span
style='letter-spacing:-.05pt'>o</span>ugh<span style='letter-spacing:-.3pt'> </span>levels.<span
style='letter-spacing:-.3pt'> </span>In<span style='letter-spacing:-.4pt'> </span>patients
taking<span style='letter-spacing:-.25pt'> </span>apixa<span style='letter-spacing:
-.05pt'>b</span>an<span style='letter-spacing:-.25pt'> </span>for<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>DVT<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span>PE<span
style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.3pt'> </span>prevention<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>recurrent<span
style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.2pt'> </span>PE,<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>results de<span style='letter-spacing:
-.1pt'>m</span>onstrate<span style='letter-spacing:-.35pt'> </span>a<span
style='letter-spacing:-.4pt'> </span>less<span style='letter-spacing:-.35pt'> </span>than<span
style='letter-spacing:-.35pt'> </span>2.2<span style='letter-spacing:-.1pt'>-</span>fold<span
style='letter-spacing:-.35pt'> </span>fluctuat<span style='letter-spacing:-.05pt'>i</span>on<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>peak-to-trough<span
style='letter-spacing:-.4pt'> </span>levels.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:17.0pt'>
  <td width=638 colspan=5 style='width:6.65in;border:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><b><span
  lang=EN-GB style='font-size:11.0pt'>Table<span style='letter-spacing:-.45pt'>
  </span>3:<span style='letter-spacing:-.4pt'> </span>Predicted<span
  style='letter-spacing:-.4pt'> a</span>pixaban<span style='letter-spacing:
  -.4pt'> s</span>teady-<span style='letter-spacing:-.1pt'>s</span>tate<span
  style='letter-spacing:-.4pt'> e</span>xposure<span style='letter-spacing:
  -.4pt'> </span>and<span style='letter-spacing:-.4pt'> a</span>nti-Xa<span
  style='letter-spacing:-.4pt'> a</span>ctivity</span></b></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix.</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:.05pt'>C</span></b><b><sub><span
  lang=EN-GB style='font-size:11.0pt;position:relative;top:1.0pt;letter-spacing:
  -.1pt'>m</span></sub></b><b><sub><span lang=EN-GB style='font-size:11.0pt;
  position:relative;top:1.0pt'>ax</span></sub></b><b><span lang=EN-GB
  style='font-size:11.0pt;position:relative;top:1.0pt;letter-spacing:.5pt'> </span></b><b><span
  lang=EN-GB style='font-size:11.0pt'>(ng/mL)</span></b></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix.</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:.05pt'>C</span></b><b><sub><span
  lang=EN-GB style='font-size:11.0pt;position:relative;top:1.0pt;letter-spacing:
  -.1pt'>m</span></sub></b><b><sub><span lang=EN-GB style='font-size:11.0pt;
  position:relative;top:1.0pt'>in</span></sub></b><b><span lang=EN-GB
  style='font-size:11.0pt;position:relative;top:1.0pt;letter-spacing:.5pt'> </span></b><b><span
  lang=EN-GB style='font-size:11.0pt'>(ng/mL)</span></b></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix.<span
  style='letter-spacing:-.65pt'> a</span>nti-Xa activity<span style='letter-spacing:
  -.6pt'> m</span>ax (IU/mL)</span></b></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix.<span
  style='letter-spacing:-.65pt'> a</span>nti-Xa activity<span style='letter-spacing:
  -.6pt'> m</span>in (IU/mL)</span></b></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=511 colspan=4 style='width:383.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Median<span
  style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.1pt'>[</span>5th,<span
  style='letter-spacing:-.4pt'> </span>95th<span style='letter-spacing:-.4pt'> </span>Percenti<span
  style='letter-spacing:-.05pt'>l</span>e]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=638 colspan=5 style='width:6.65in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Prevention<span style='letter-spacing:
  -.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>VTE:<span
  style='letter-spacing:-.3pt'> </span>elective<span style='letter-spacing:
  -.3pt'> </span>hip<span style='letter-spacing:-.35pt'> </span>or<span
  style='letter-spacing:-.3pt'> </span>knee<span style='letter-spacing:-.3pt'> </span>replacement<span
  style='letter-spacing:-.35pt'> </span>surgery</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
  style='letter-spacing:-.2pt'> </span>daily</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>77<span style='letter-spacing:
  -.25pt'> </span><span style='letter-spacing:-.1pt'>[</span>41,<span
  style='letter-spacing:-.25pt'> </span>1<span style='letter-spacing:-.05pt'>4</span>6]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>51<span style='letter-spacing:
  -.25pt'> </span><span style='letter-spacing:-.1pt'>[</span>23,<span
  style='letter-spacing:-.25pt'> </span>1<span style='letter-spacing:-.05pt'>0</span>9]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.3<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>0.67,<span
  style='letter-spacing:-.35pt'> </span>2.<span style='letter-spacing:-.05pt'>4</span>]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.84<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>[</span>0.3<span
  style='letter-spacing:-.05pt'>7</span>,<span style='letter-spacing:-.3pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span><span style='letter-spacing:.05pt'>8</span>]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=638 colspan=5 style='width:6.65in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><i><span lang=EN-GB style='font-size:11.0pt'>Prevention<span
  style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>stroke<span
  style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.4pt'> </span>systemic<span
  style='letter-spacing:-.3pt'> </span>embolism:<span style='letter-spacing:
  -.35pt'> </span>NVAF</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>2.5<span style='letter-spacing:-.3pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice
  daily*</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>123<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>69,<span
  style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>2</span>21]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>79<span style='letter-spacing:
  -.25pt'> </span><span style='letter-spacing:-.1pt'>[</span>34,<span
  style='letter-spacing:-.25pt'> </span>1<span style='letter-spacing:-.05pt'>6</span>2]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.8<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>1.0,<span
  style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>3</span>.3]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.2<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>0.51,<span
  style='letter-spacing:-.35pt'> </span>2.<span style='letter-spacing:-.05pt'>4</span>]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>twice<span
  style='letter-spacing:-.25pt'> </span>daily</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>171<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>91,<span
  style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>3</span>21]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>103<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>41,<span
  style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>2</span>30]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2.6<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>1.4,<span
  style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>4</span>.8]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.5<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>0.61,<span
  style='letter-spacing:-.35pt'> </span>3.<span style='letter-spacing:-.05pt'>4</span>]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=638 colspan=5 style='width:6.65in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Treatment<span style='letter-spacing:
  -.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>DVT,<span
  style='letter-spacing:-.25pt'> </span>treatment<span style='letter-spacing:
  -.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>PE<span
  style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.4pt'> </span>prevention<span
  style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>recurrent<span
  style='letter-spacing:-.25pt'> </span>D<span style='letter-spacing:.05pt'>V</span>T<span
  style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>PE<span
  style='letter-spacing:-.3pt'> </span>(VTEt)</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
  style='letter-spacing:-.2pt'> </span>daily</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>67<span style='letter-spacing:
  -.25pt'> </span><span style='letter-spacing:-.1pt'>[</span>30,<span
  style='letter-spacing:-.25pt'> </span>1<span style='letter-spacing:-.05pt'>5</span>3]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>32<span style='letter-spacing:
  -.25pt'> </span><span style='letter-spacing:-.1pt'>[</span>11,<span
  style='letter-spacing:-.2pt'> </span>90]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.0<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>0.46,<span
  style='letter-spacing:-.35pt'> </span>2.<span style='letter-spacing:-.05pt'>5</span>]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.49<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>[</span>0.1<span
  style='letter-spacing:-.05pt'>7</span>,<span style='letter-spacing:-.3pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span><span style='letter-spacing:.05pt'>4</span>]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>twice<span
  style='letter-spacing:-.25pt'> </span>daily</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>132<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>59,<span
  style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>3</span>02]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>63<span style='letter-spacing:
  -.25pt'> </span><span style='letter-spacing:-.1pt'>[</span>22,<span
  style='letter-spacing:-.25pt'> </span>1<span style='letter-spacing:-.05pt'>7</span>7]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2.1<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>0.91,<span
  style='letter-spacing:-.35pt'> </span>5.<span style='letter-spacing:-.05pt'>2</span>]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.0<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>0.33,<span
  style='letter-spacing:-.35pt'> </span>2.<span style='letter-spacing:-.05pt'>9</span>]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
  style='letter-spacing:-.2pt'> </span>daily</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>251<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>111,<span
  style='letter-spacing:-.35pt'> </span>5<span style='letter-spacing:-.05pt'>7</span><span
  style='letter-spacing:.05pt'>2</span>]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>120<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>41,<span
  style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>3</span>35]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>4.2<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>1.8,<span
  style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>1</span>0.<span
  style='letter-spacing:-.05pt'>8</span>]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.9<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>[</span>0.64,<span
  style='letter-spacing:-.35pt'> </span>5.<span style='letter-spacing:-.05pt'>8</span>]</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>*<span style='letter-spacing:-.2pt'> </span>Dose<span
style='letter-spacing:-.15pt'> </span>adjusted<span style='letter-spacing:-.2pt'>
</span>population<span style='letter-spacing:-.2pt'> </span>based<span
style='letter-spacing:-.2pt'> </span>on<span style='letter-spacing:-.15pt'> </span>2<span
style='letter-spacing:-.2pt'>&nbsp;</span>of<span style='letter-spacing:-.15pt'>&nbsp;</span>3<span
style='letter-spacing:-.2pt'>&nbsp;</span>dose<span style='letter-spacing:-.2pt'>
</span><span style='letter-spacing:-.1pt'>r</span>eduction<span
style='letter-spacing:-.15pt'> </span>c<span style='letter-spacing:-.1pt'>r</span>iteria<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.15pt'> </span>t<span
style='letter-spacing:-.1pt'>h</span>e<span style='letter-spacing:-.15pt'> </span>ARISTOTLE<span
style='letter-spacing:-.15pt'> </span>stu<span style='letter-spacing:-.1pt'>d</span><span
style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Although<span style='letter-spacing:-.4pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>does<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>n</span>ot<span style='letter-spacing:-.3pt'> </span>require<span
style='letter-spacing:-.4pt'> </span>ro<span style='letter-spacing:-.05pt'>u</span>tine<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>onitoring<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>e<span
style='letter-spacing:-.05pt'>x</span>posu<span style='letter-spacing:-.1pt'>r</span>e,<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:-.3pt'> </span>calibrated
quantitative<span style='letter-spacing:-.35pt'> </span>anti-Factor<span
style='letter-spacing:-.3pt'> </span>Xa<span style='letter-spacing:-.3pt'> </span>assay<span
style='letter-spacing:-.25pt'> </span>may<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.45pt'> </span>useful<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>exceptional<span
style='letter-spacing:-.3pt'> </span>situations<span style='letter-spacing:
-.35pt'> </span>where<span style='letter-spacing:-.3pt'> </span>knowledge<span
style='letter-spacing:-.3pt'> </span>of apixaban<span style='letter-spacing:
-.35pt'> </span>exposure<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.2pt'> </span>h<span style='letter-spacing:-.1pt'>e</span>lp<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.35pt'> </span>inform<span
style='letter-spacing:-.4pt'> </span>clinical<span style='letter-spacing:-.35pt'>
</span>decisions,<span style='letter-spacing:-.3pt'> </span>e.g.,<span
style='letter-spacing:-.4pt'> </span>overdose<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.35pt'> </span>em<span style='letter-spacing:
.05pt'>e</span>rgency<span style='letter-spacing:-.25pt'> </span>surgery.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Clinical<span style='letter-spacing:-.4pt'> </span>effi<span
style='letter-spacing:.05pt'>c</span>acy<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.4pt'> </span>safety</span></u></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Prevention<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>VTE<span style='letter-spacing:-.35pt'> </span>(VTEp):<span
style='letter-spacing:-.35pt'> </span>elective<span style='letter-spacing:-.35pt'>
</span>hip<span style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:
-.35pt'> </span>knee<span style='letter-spacing:-.3pt'> </span>replacement<span
style='letter-spacing:-.35pt'> </span>surgery</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>clinical<span style='letter-spacing:-.3pt'>
</span>program<span style='letter-spacing:-.35pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>des<span style='letter-spacing:.05pt'>i</span>gned<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.35pt'> </span>de<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.1pt'>o</span>nstrate<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>ef<span
style='letter-spacing:.05pt'>f</span>icacy<span style='letter-spacing:-.15pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>safety<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.3pt'> </span>the
prevention<span style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:
-.25pt'> </span>VTE<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>br<span
style='letter-spacing:-.05pt'>oa</span>d<span style='letter-spacing:-.25pt'> </span>range<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>adult<span
style='letter-spacing:-.25pt'> </span>p<span style='letter-spacing:-.1pt'>a</span>tients<span
style='letter-spacing:-.3pt'> </span>undergo<span style='letter-spacing:-.05pt'>i</span>ng<span
style='letter-spacing:-.25pt'> </span>e<span style='letter-spacing:-.05pt'>l</span>ective<span
style='letter-spacing:-.25pt'> </span>hip<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>knee<span style='letter-spacing:-.25pt'> </span>replacement.<span
style='letter-spacing:-.25pt'> </span>A total<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.4pt'> </span>8<span style='letter-spacing:
-.05pt'>,</span>464<span style='letter-spacing:-.35pt'>&nbsp;</span>patients<span
style='letter-spacing:-.35pt'> </span>were<span style='letter-spacing:-.35pt'> </span>rando<span
style='letter-spacing:-.1pt'>m</span>ised<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.35pt'> </span>two<span style='letter-spacing:-.35pt'> </span>pivotal,<span
style='letter-spacing:-.4pt'> </span>double-blind,<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span>ulti-national<span
style='letter-spacing:-.35pt'> </span>studies,<span style='letter-spacing:-.35pt'>
</span>co<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
.05pt'>p</span>aring apixaban<span style='letter-spacing:-.3pt'> </span>2.5<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>given<span style='letter-spacing:-.25pt'>
</span>orally<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.25pt'>
</span>(<span style='letter-spacing:-.05pt'>4</span>,2<span style='letter-spacing:
-.05pt'>3</span>6<span style='letter-spacing:-.25pt'>&nbsp;</span>patie<span
style='letter-spacing:-.05pt'>n</span>ts)<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>enoxa<span style='letter-spacing:-.05pt'>pa</span>rin<span
style='letter-spacing:-.25pt'> </span>40<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>o<span
style='letter-spacing:-.05pt'>n</span>ce<span style='letter-spacing:-.25pt'> </span>daily
(4,228<span style='letter-spacing:-.3pt'>&nbsp;</span>patien<span
style='letter-spacing:-.05pt'>t</span>s).<span style='letter-spacing:-.25pt'> </span>Included<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.25pt'> </span>this<span style='letter-spacing:-.2pt'> </span>total<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>w</span><span
style='letter-spacing:-.05pt'>e</span>re<span style='letter-spacing:-.2pt'> </span>1,262<span
style='letter-spacing:-.35pt'>&nbsp;</span>pat<span style='letter-spacing:-.05pt'>i</span>ents<span
style='letter-spacing:-.2pt'> </span>(618<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>t</span>he<span
style='letter-spacing:-.2pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>g</span>roup)<span style='letter-spacing:
-.2pt'> </span>of<span style='letter-spacing:-.3pt'> </span>age<span
style='letter-spacing:-.2pt'> </span>75<span style='letter-spacing:-.25pt'> </span>or
older,<span style='letter-spacing:-.25pt'> </span>1<span style='letter-spacing:
-.05pt'>,</span>004<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.05pt'>pa</span>tients<span style='letter-spacing:-.25pt'>
</span>(499<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.05pt'>i</span>n<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>apixab<span style='letter-spacing:-.1pt'>a</span>n<span
style='letter-spacing:-.25pt'> </span>gro<span style='letter-spacing:-.05pt'>u</span>p)<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>low<span
style='letter-spacing:-.25pt'> </span>bo<span style='letter-spacing:-.05pt'>d</span>y<span
style='letter-spacing:-.25pt'> </span>weight<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>(</span>&#8804;<span
style='letter-spacing:-.25pt'>&nbsp;</span>60<span style='letter-spacing:-.3pt'>&nbsp;</span>kg<span
style='letter-spacing:-.1pt'>)</span>,<span style='letter-spacing:-.25pt'> </span>1,<span
style='letter-spacing:-.05pt'>4</span>95<span style='letter-spacing:-.25pt'>&nbsp;</span>patie<span
style='letter-spacing:-.05pt'>n</span>ts (743<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:
-.2pt'> </span>the<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>p</span>ixaban<span style='letter-spacing:-.2pt'>
</span>gro<span style='letter-spacing:-.05pt'>u</span>p)<span style='letter-spacing:
-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>BMI<span
style='letter-spacing:-.2pt'> </span>&#8805;<span style='letter-spacing:-.25pt'>&nbsp;</span>33<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>k</span>g/<span
style='letter-spacing:-.1pt'>m<sup>2</sup></span>,<span style='letter-spacing:
-.2pt'> </span>and<span style='letter-spacing:-.2pt'> </span>415<span
style='letter-spacing:-.3pt'>&nbsp;</span>patients<span style='letter-spacing:
-.2pt'> </span>(203<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.05pt'>p</span>ixaban<span
style='letter-spacing:-.2pt'> </span>gro<span style='letter-spacing:-.05pt'>u</span>p)<span
style='letter-spacing:-.3pt'> </span>with <span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.6pt'> </span>re<span style='letter-spacing:.05pt'>n</span><span
style='letter-spacing:-.05pt'>a</span>l<span style='letter-spacing:-.6pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pairment.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>ADVANCE-3<span
style='letter-spacing:-.35pt'> </span>study<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>in</span>cluded<span style='letter-spacing:-.35pt'>
</span>5,407<span style='letter-spacing:-.4pt'>&nbsp;</span>patients<span
style='letter-spacing:-.35pt'> </span>und<span style='letter-spacing:-.15pt'>e</span>rgoing<span
style='letter-spacing:-.35pt'> </span>elective<span style='letter-spacing:-.35pt'>
</span>hip<span style='letter-spacing:-.3pt'> </span>replacement,<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>the
ADVANCE<span style='letter-spacing:.05pt'>-</span>2<span style='letter-spacing:
-.45pt'> </span>study<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>i</span>ncluded<span style='letter-spacing:-.4pt'>
</span>3,057<span style='letter-spacing:-.4pt'>&nbsp;</span>pa<span
style='letter-spacing:-.05pt'>t</span>ients<span style='letter-spacing:-.45pt'>
</span>under<span style='letter-spacing:-.05pt'>g</span>oing<span
style='letter-spacing:-.4pt'> </span>elective<span style='letter-spacing:-.4pt'>
</span>knee<span style='letter-spacing:-.45pt'> </span>replacement.<span
style='letter-spacing:-.4pt'> </span>Subjects<span style='letter-spacing:-.4pt'>
</span>received either<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>given<span
style='letter-spacing:-.25pt'> </span>orally<span style='letter-spacing:-.2pt'>
</span>twice<span style='letter-spacing:-.25pt'> </span>daily<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>(</span>po<span
style='letter-spacing:-.3pt'> </span>b<span style='letter-spacing:-.05pt'>i</span>d)<span
style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.25pt'> </span>en<span
style='letter-spacing:-.05pt'>o</span>xaparin<span style='letter-spacing:-.25pt'>
</span>40<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>administered
subcutaneously<span style='letter-spacing:-.25pt'> </span>once<span
style='letter-spacing:-.25pt'> </span>dai<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.25pt'> </span>(sc<span style='letter-spacing:-.25pt'> </span>od).<span
style='letter-spacing:-.25pt'> </span>The<span style='letter-spacing:-.25pt'> </span>first<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>was<span style='letter-spacing:-.2pt'> </span>given<span
style='letter-spacing:-.25pt'> </span>12<span style='letter-spacing:-.25pt'>&nbsp;</span>to<span
style='letter-spacing:-.35pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>2</span>4<span
style='letter-spacing:-.25pt'>&nbsp;</span>h<span style='letter-spacing:-.05pt'>o</span>urs<span
style='letter-spacing:-.25pt'> </span>post<span style='letter-spacing:-.1pt'>-</span>surger<span
style='letter-spacing:.05pt'>y</span>, whereas<span style='letter-spacing:-.3pt'>
</span>enoxaparin<span style='letter-spacing:-.25pt'> </span>was<span
style='letter-spacing:-.25pt'> </span>started<span style='letter-spacing:-.3pt'>
</span>9<span style='letter-spacing:-.25pt'>&nbsp;</span>to<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>1</span>5<span
style='letter-spacing:-.3pt'>&nbsp;</span>hours<span style='letter-spacing:
-.3pt'> </span>prior<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>surgery.<span style='letter-spacing:-.25pt'>
</span>Bo<span style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:
-.3pt'> </span>apixaban<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:-.25pt'> </span>enoxaparin<span
style='letter-spacing:-.3pt'> </span>were given<span style='letter-spacing:
-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>32<span
style='letter-spacing:-.1pt'>-</span>38<span style='letter-spacing:-.25pt'>&nbsp;</span>d<span
style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>ADVANCE-3<span style='letter-spacing:
-.25pt'> </span>study<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.25pt'> </span>10-14<span style='letter-spacing:-.25pt'>&nbsp;</span>d<span
style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>ADVANCE-2<span style='letter-spacing:
-.25pt'> </span>study.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Based<span style='letter-spacing:-.35pt'> </span>on<span
style='letter-spacing:-.3pt'> </span>patient<span style='letter-spacing:-.35pt'>
</span>medical<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:.05pt'>h</span>istory<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.3pt'> </span>studied<span
style='letter-spacing:-.35pt'> </span>popul<span style='letter-spacing:-.1pt'>a</span>tion<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>ADVANCE-3<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>ADVANCE<span
style='letter-spacing:.05pt'>-</span>2 (8,464<span style='letter-spacing:-.35pt'>&nbsp;</span>patien<span
style='letter-spacing:-.05pt'>t</span>s),<span style='letter-spacing:-.3pt'> </span>46%<span
style='letter-spacing:-.35pt'> </span>had<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>h</span>ypertension,<span style='letter-spacing:
-.35pt'> </span>10%<span style='letter-spacing:-.35pt'> </span>had<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.05pt'>h</span>y<span
style='letter-spacing:-.05pt'>pe</span>rlipide<span style='letter-spacing:-.1pt'>m</span>ia,<span
style='letter-spacing:-.3pt'> </span>9%<span style='letter-spacing:-.35pt'> </span>had<span
style='letter-spacing:-.3pt'> </span>diabetes,<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>8%<span style='letter-spacing:
-.35pt'> </span>had <span style='letter-spacing:-.05pt'>coronar</span>y<span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.05pt'>arter</span>y<span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.05pt'>disease.</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.35pt'> </span>de<span
style='letter-spacing:-.1pt'>m</span>onstrated<span style='letter-spacing:-.3pt'>
</span>a<span style='letter-spacing:-.25pt'> </span>statistically<span
style='letter-spacing:-.2pt'> </span>superior<span style='letter-spacing:-.35pt'>
</span>r<span style='letter-spacing:-.05pt'>e</span>du<span style='letter-spacing:
-.1pt'>c</span>tion<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.3pt'> </span>pr<span
style='letter-spacing:-.05pt'>im</span>ary<span style='letter-spacing:-.2pt'> </span>endp<span
style='letter-spacing:-.05pt'>o</span>i<span style='letter-spacing:-.05pt'>n</span>t,<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:-.3pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span>posite<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>all VTE/all<span style='letter-spacing:
-.3pt'> </span>cause<span style='letter-spacing:-.25pt'> </span>death,<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>Major<span style='letter-spacing:-.3pt'> </span>VTE<span
style='letter-spacing:-.25pt'> </span>endpoi<span style='letter-spacing:-.05pt'>nt</span>,<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.3pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span>posite<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>pr<span style='letter-spacing:
-.05pt'>o</span>xi<span style='letter-spacing:-.1pt'>m</span>al<span
style='letter-spacing:-.2pt'> </span>DVT,<span style='letter-spacing:-.25pt'> </span>non-fatal<span
style='letter-spacing:-.25pt'> </span>PE,<span style='letter-spacing:-.25pt'> </span>and
VTE-related<span style='letter-spacing:-.3pt'> </span>death,<span
style='letter-spacing:-.3pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>pared<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>enoxaparin<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.4pt'> </span>bo<span
style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:-.3pt'> </span>e<span
style='letter-spacing:-.05pt'>l</span>ective<span style='letter-spacing:-.3pt'>
</span>hip<span style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:
-.35pt'> </span>knee<span style='letter-spacing:-.3pt'> </span>replacement<span
style='letter-spacing:-.3pt'> </span>surgery<span style='letter-spacing:-.3pt'>
</span>(see Table<span style='letter-spacing:-.4pt'> </span>4).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>4:<span
style='letter-spacing:-.3pt'> </span>Efficacy<span style='letter-spacing:-.2pt'>
r</span>esults<span style='letter-spacing:-.25pt'> </span>from<span
style='letter-spacing:-.4pt'> p</span>ivotal<span style='letter-spacing:-.25pt'>
p</span>hase<span style='letter-spacing:-.3pt'> </span>III<span
style='letter-spacing:-.25pt'> s</span>tudies</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.9pt;border-collapse:collapse'>
 <tr style='height:11.35pt'>
  <td width=144 style='width:1.5in;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><b><span
  lang=EN-GB style='font-size:11.0pt'>Study</span></b></p>
  </td>
  <td width=252 colspan=3 style='width:189.0pt;border:solid black 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>ADVANCE<span
  style='letter-spacing:.05pt'>-</span>3<span style='letter-spacing:-.9pt'> </span>(hip)</span></b></p>
  </td>
  <td width=240 colspan=4 style='width:2.5in;border:solid black 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>ADVANCE<span
  style='letter-spacing:.05pt'>-</span>2<span style='letter-spacing:-.95pt'> </span>(knee)</span></b></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=144 style='width:1.5in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stu<span style='letter-spacing:-.05pt'>d</span>y<span
  style='letter-spacing:-.6pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span>ent
  </span></p>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>Dose</span></p>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Duration<span style='letter-spacing:-.45pt'>
  </span>of<span style='letter-spacing:-.45pt'> </span>t<span style='letter-spacing:
  -.1pt'>r</span>eatment</span></p>
  </td>
  <td width=96 style='width:1.0in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Apixaban<br>
  2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:
  -.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>po <br>
  twice<span style='letter-spacing:-.5pt'> </span>daily <br>
  35<span style='letter-spacing:-.1pt'>&nbsp;</span>±<span style='letter-spacing:
  -.15pt'>&nbsp;</span>3&nbsp;d</span></p>
  </td>
  <td width=90 style='width:67.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Enoxaparin</span><span
  lang=EN-GB style='font-size:11.0pt'> <br>
  </span><span lang=EN-GB style='font-size:11.0pt'>40<span style='letter-spacing:
  -.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
  style='letter-spacing:-.15pt'> </span>sc<br>
  once<span style='letter-spacing:-.45pt'> </span>dai<span style='letter-spacing:
  -.05pt'>l</span>y<br>
  35<span style='letter-spacing:-.1pt'>&nbsp;</span>±<span style='letter-spacing:
  -.15pt'>&nbsp;</span>3<span style='letter-spacing:-.1pt'>&nbsp;</span>d</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>p-value</span></p>
  </td>
  <td width=84 style='width:63.0pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Apixaban<br>
  2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:
  -.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>po twice<span
  style='letter-spacing:-.5pt'> </span>daily <br>
  12<span style='letter-spacing:-.2pt'>&nbsp;</span>±<span style='letter-spacing:
  -.15pt'>&nbsp;</span>2<span style='letter-spacing:-.2pt'>&nbsp;</span>d</span></p>
  </td>
  <td width=86 colspan=2 style='width:64.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Enoxaparin</span><span
  lang=EN-GB style='font-size:11.0pt'> <br>
  </span><span lang=EN-GB style='font-size:11.0pt'>40<span style='letter-spacing:
  -.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
  style='letter-spacing:-.15pt'> </span>sc<br>
  once<span style='letter-spacing:-.45pt'> </span>dai<span style='letter-spacing:
  -.05pt'>l</span>y<br>
  12<span style='letter-spacing:-.2pt'>&nbsp;</span>±<span style='letter-spacing:
  -.2pt'>&nbsp;</span>2<span style='letter-spacing:-.2pt'>&nbsp;</span>d</span></p>
  </td>
  <td width=70 style='width:52.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>p-value</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=636 colspan=8 style='width:477.0pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Total<span style='letter-spacing:-.6pt'> </span>VTE/all-cause<span
  style='letter-spacing:-.55pt'> </span>death</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=144 style='width:1.5in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:13.25pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>N<span style='letter-spacing:.05pt'>u</span><span
  style='letter-spacing:-.1pt'>m</span>ber<span style='letter-spacing:-.5pt'> </span>of
  events/subje<span style='letter-spacing:.05pt'>c</span>ts Event<span
  style='letter-spacing:-.5pt'> r</span>ate</span></p>
  </td>
  <td width=96 style='width:1.0in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>27/1<span style='letter-spacing:
  -.05pt'>,</span>949</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.39%</span></p>
  </td>
  <td width=90 style='width:67.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>74/1<span style='letter-spacing:
  -.05pt'>,</span>917</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>3.86%</span></p>
  </td>
  <td width=66 rowspan=2 style='width:49.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>&lt;<span style='letter-spacing:
  -.2pt'>&nbsp;</span>0.0001</span></p>
  </td>
  <td width=87 colspan=2 style='width:65.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>147/<span style='letter-spacing:
  -.05pt'>9</span>76</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>15.<span style='letter-spacing:
  -.05pt'>0</span>6%</span></p>
  </td>
  <td width=83 style='width:62.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>243/<span style='letter-spacing:
  -.05pt'>9</span>97</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>24.<span style='letter-spacing:
  -.05pt'>3</span>7%</span></p>
  </td>
  <td width=70 rowspan=2 style='width:52.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>&lt;0.0001</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=144 style='width:1.5in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:13.25pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>Relativ</span><span
  lang=EN-GB style='font-size:11.0pt'>e<span style='letter-spacing:-.6pt'> r</span><span
  style='letter-spacing:-.05pt'>isk</span></span></p>
  <p class=TableParagraph style='margin-left:13.25pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>95%<span style='letter-spacing:-.2pt'>&nbsp;</span>CI</span></p>
  </td>
  <td width=96 style='width:1.0in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.36</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.22,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>5</span>4)</span></p>
  </td>
  <td width=90 style='width:67.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=87 colspan=2 style='width:65.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.62</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.51,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>7</span>4)</span></p>
  </td>
  <td width=83 style='width:62.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=636 colspan=8 style='width:477.0pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.5pt'> </span>VTE</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=144 style='width:1.5in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:13.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>N<span style='letter-spacing:.05pt'>u</span><span
  style='letter-spacing:-.1pt'>m</span>ber<span style='letter-spacing:-.5pt'> </span>of
  events/subje<span style='letter-spacing:.05pt'>c</span>ts Event<span
  style='letter-spacing:-.5pt'> r</span>ate</span></p>
  </td>
  <td width=96 style='width:1.0in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>10/2<span style='letter-spacing:
  -.05pt'>,</span>199</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.45%</span></p>
  </td>
  <td width=90 style='width:67.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>25/2<span style='letter-spacing:
  -.05pt'>,</span>195</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.14%</span></p>
  </td>
  <td width=66 rowspan=2 style='width:49.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>1</span>07</span></p>
  </td>
  <td width=87 colspan=2 style='width:65.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>13/1<span style='letter-spacing:
  -.05pt'>,</span>195</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.09%</span></p>
  </td>
  <td width=83 style='width:62.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>26/1<span style='letter-spacing:
  -.05pt'>,</span>199</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2.17%</span></p>
  </td>
  <td width=70 rowspan=2 style='width:52.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>3</span>73</span></p>
  </td>
 </tr>
 <tr style='height:11.35pt'>
  <td width=144 style='width:1.5in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:11.35pt'>
  <p class=TableParagraph style='margin-left:13.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>Relativ</span><span
  lang=EN-GB style='font-size:11.0pt'>e<span style='letter-spacing:-.6pt'> r</span><span
  style='letter-spacing:-.05pt'>isk</span></span></p>
  <p class=TableParagraph style='margin-left:13.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>95%<span style='letter-spacing:-.2pt'>&nbsp;</span>CI</span></p>
  </td>
  <td width=96 style='width:1.0in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.40</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.15,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>8</span>0)</span></p>
  </td>
  <td width=90 style='width:67.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=87 colspan=2 style='width:65.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.50</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.26,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>9</span>7)</span></p>
  </td>
  <td width=83 style='width:62.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:11.35pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr height=0>
  <td width=144 style='border:none'></td>
  <td width=96 style='border:none'></td>
  <td width=90 style='border:none'></td>
  <td width=66 style='border:none'></td>
  <td width=84 style='border:none'></td>
  <td width=3 style='border:none'></td>
  <td width=83 style='border:none'></td>
  <td width=70 style='border:none'></td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>safety<span
style='letter-spacing:-.2pt'> </span>e<span style='letter-spacing:-.05pt'>n</span>dpoints<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ajor<span style='letter-spacing:-.3pt'> </span>bleeding,<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.05pt'>t</span>he<span
style='letter-spacing:-.3pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>posite<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>major<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>clinically<span
style='letter-spacing:-.2pt'> </span>relevant<span style='letter-spacing:-.3pt'>
</span>n<span style='letter-spacing:-.05pt'>o</span>n-<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor (CRNM)<span
style='letter-spacing:-.3pt'> </span>bleeding,<span style='letter-spacing:-.3pt'>
</span>a<span style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:
-.25pt'> </span>all<span style='letter-spacing:-.35pt'> </span>bleeding<span
style='letter-spacing:-.3pt'> </span>sh<span style='letter-spacing:-.05pt'>ow</span>ed<span
style='letter-spacing:-.25pt'> </span>si<span style='letter-spacing:-.1pt'>m</span>ilar<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:.05pt'>r</span><span
style='letter-spacing:-.05pt'>a</span>tes<span style='letter-spacing:-.25pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>pati<span style='letter-spacing:.05pt'>e</span>nts<span
style='letter-spacing:-.3pt'> </span>treated<span style='letter-spacing:-.25pt'>
</span>w<span style='letter-spacing:.05pt'>i</span>th<span style='letter-spacing:
-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'> </span>2.5<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g
c<span style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>pared<span
style='letter-spacing:-.3pt'> </span>wi<span style='letter-spacing:.05pt'>t</span>h<span
style='letter-spacing:-.25pt'> </span>enoxaparin<span style='letter-spacing:
-.35pt'> </span>40<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>(see<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>T</span><span
style='letter-spacing:-.05pt'>a</span>ble<span style='letter-spacing:-.25pt'> </span>5).<span
style='letter-spacing:-.25pt'> </span>All<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>bleeding<span style='letter-spacing:-.3pt'>
</span>criteria<span style='letter-spacing:-.25pt'> </span>included<span
style='letter-spacing:-.25pt'> </span>surgical<span style='letter-spacing:-.3pt'>
</span>site bleeding.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>5:<span
style='letter-spacing:-.3pt'> </span>Bleeding<span style='letter-spacing:-.3pt'>
r</span>esults<span style='letter-spacing:-.3pt'> </span>from<span
style='letter-spacing:-.4pt'> p</span>ivotal<span style='letter-spacing:-.25pt'>
p</span>hase<span style='letter-spacing:-.3pt'> </span>III<span
style='letter-spacing:-.3pt'> s</span>tudies*</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.9pt;border-collapse:collapse'>
 <thead>
  <tr style='height:13.15pt'>
   <td width=115 style='width:1.2in;border:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:13.15pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=234 colspan=2 style='width:175.85pt;border:solid black 1.0pt;
   border-left:none;padding:0in 0in 0in 0in;height:13.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>AD</span></b><b><span
   lang=EN-GB style='font-size:11.0pt'>V<span style='letter-spacing:-.05pt'>AN</span>C<span
   style='letter-spacing:-.05pt'>E</span><span style='letter-spacing:.05pt'>-</span>3</span></b></p>
   </td>
   <td width=255 colspan=2 style='width:191.35pt;border:solid black 1.0pt;
   border-left:none;padding:0in 0in 0in 0in;height:13.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>AD</span></b><b><span
   lang=EN-GB style='font-size:11.0pt'>V<span style='letter-spacing:-.05pt'>AN</span>C<span
   style='letter-spacing:-.05pt'>E</span><span style='letter-spacing:.05pt'>-</span>2</span></b></p>
   </td>
  </tr>
  <tr style='height:51.1pt'>
   <td width=115 style='width:1.2in;border:solid black 1.0pt;border-top:none;
   padding:0in 0in 0in 0in;height:51.1pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=121 style='width:90.75pt;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:51.1pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><span lang=EN-GB style='font-size:11.0pt'>Apixaban<br>
   2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:
   -.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>po<span
   style='letter-spacing:-.2pt'> </span>tw<span style='letter-spacing:-.05pt'>i</span>ce
   daily<br>
   35<span style='letter-spacing:-.2pt'>&nbsp;</span>±<span style='letter-spacing:
   -.2pt'>&nbsp;</span>3<span style='letter-spacing:-.2pt'>&nbsp;</span>d</span></p>
   </td>
   <td width=113 style='width:85.1pt;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:51.1pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><span lang=EN-GB style='font-size:11.0pt'>Enoxaparin<br>
   40<span style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:
   -.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>sc<span
   style='letter-spacing:-.15pt'> </span>once daily<br>
   35<span style='letter-spacing:-.2pt'>&nbsp;</span>±<span style='letter-spacing:
   -.2pt'>&nbsp;</span>3<span style='letter-spacing:-.2pt'>&nbsp;</span>d</span></p>
   </td>
   <td width=113 style='width:85.0pt;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:51.1pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><span lang=EN-GB style='font-size:11.0pt'>Apixaban<br>
   2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:
   -.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>po<span
   style='letter-spacing:-.2pt'> </span>tw<span style='letter-spacing:-.05pt'>i</span>ce
   daily<br>
   12<span style='letter-spacing:-.2pt'>&nbsp;</span>±<span style='letter-spacing:
   -.2pt'>&nbsp;</span>2<span style='letter-spacing:-.2pt'>&nbsp;</span>d</span></p>
   </td>
   <td width=142 style='width:106.35pt;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:51.1pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><span lang=EN-GB style='font-size:11.0pt'>Enoxaparin<br>
   40<span style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:
   -.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>sc<span
   style='letter-spacing:-.2pt'> </span>once<span style='letter-spacing:-.2pt'>
   </span>daily <br>
   12<span style='letter-spacing:-.2pt'>&nbsp;</span>±<span style='letter-spacing:
   -.2pt'>&nbsp;</span>2<span style='letter-spacing:-.2pt'>&nbsp;</span>d</span></p>
   </td>
  </tr>
 </thead>
 <tr style='height:13.15pt'>
  <td width=115 style='width:1.2in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All<span style='letter-spacing:-.45pt'> </span>treated</span></p>
  </td>
  <td width=121 style='width:90.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.2pt'>&nbsp;</span>=<span style='letter-spacing:-.2pt'>&nbsp;</span>2,6<span
  style='letter-spacing:-.05pt'>7</span>3</span></p>
  </td>
  <td width=113 style='width:85.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.2pt'>&nbsp;</span>=<span style='letter-spacing:-.2pt'>&nbsp;</span>2,6<span
  style='letter-spacing:-.05pt'>5</span>9</span></p>
  </td>
  <td width=113 style='width:85.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.2pt'>&nbsp;</span>=<span style='letter-spacing:-.2pt'>&nbsp;</span>1,5<span
  style='letter-spacing:-.05pt'>0</span>1</span></p>
  </td>
  <td width=142 style='width:106.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.2pt'>&nbsp;</span>=<span style='letter-spacing:-.2pt'>&nbsp;</span>1,5<span
  style='letter-spacing:-.05pt'>0</span>8</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=605 colspan=5 style='width:6.3in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><b><i><span
  lang=EN-GB style='font-size:11.0pt'>Treatment<span style='letter-spacing:
  -.5pt'> </span>P<span style='letter-spacing:.05pt'>e</span>riod<sup><span
  style='letter-spacing:-1.35pt'>1</span></sup></span></i></b></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=115 style='width:1.2in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major</span></p>
  </td>
  <td width=121 style='width:90.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>22<span style='letter-spacing:
  -.45pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>8<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=113 style='width:85.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>18<span style='letter-spacing:
  -.45pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>7<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=113 style='width:85.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>9<span style='letter-spacing:
  -.4pt'> </span>(0.6<span style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=142 style='width:106.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14<span style='letter-spacing:
  -.45pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>9<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=115 style='width:1.2in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Fatal</span></p>
  </td>
  <td width=121 style='width:90.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0</span></p>
  </td>
  <td width=113 style='width:85.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0</span></p>
  </td>
  <td width=113 style='width:85.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0</span></p>
  </td>
  <td width=142 style='width:106.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=115 style='width:1.2in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.35pt'>
  </span>+<span style='letter-spacing:-.35pt'> </span>CRNM</span></p>
  </td>
  <td width=121 style='width:90.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>129<span style='letter-spacing:
  -.5pt'> </span>(<span style='letter-spacing:-.05pt'>4</span>.8<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=113 style='width:85.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>134<span style='letter-spacing:
  -.5pt'> </span>(<span style='letter-spacing:-.05pt'>5</span>.0<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=113 style='width:85.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>53<span style='letter-spacing:
  -.45pt'> </span>(3<span style='letter-spacing:-.05pt'>.</span>5<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=142 style='width:106.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>72<span style='letter-spacing:
  -.45pt'> </span>(4<span style='letter-spacing:-.05pt'>.</span>8<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=115 style='width:1.2in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All</span></p>
  </td>
  <td width=121 style='width:90.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>313<span style='letter-spacing:
  -.55pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>1.7<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=113 style='width:85.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>334<span style='letter-spacing:
  -.55pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>2.6<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=113 style='width:85.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>104<span style='letter-spacing:
  -.5pt'> </span>(<span style='letter-spacing:-.05pt'>6</span>.9<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=142 style='width:106.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>126<span style='letter-spacing:
  -.5pt'> </span>(<span style='letter-spacing:-.05pt'>8</span>.4<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
 </tr>
 <tr style='height:13.2pt'>
  <td width=605 colspan=5 style='width:6.3in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:13.2pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><b><i><span
  lang=EN-GB style='font-size:11.0pt'>Post-surgery<span style='letter-spacing:
  -.4pt'> </span>treatment<span style='letter-spacing:-.45pt'> </span>period<sup>2</sup><span
  style='letter-spacing:-.5pt'> </span></span></i></b></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=115 style='width:1.2in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:4.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major</span></p>
  </td>
  <td width=121 style='width:90.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>9<span style='letter-spacing:
  -.4pt'> </span>(0.3%)</span></p>
  </td>
  <td width=113 style='width:85.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>11<span style='letter-spacing:
  -.45pt'> </span>(0.4%)</span></p>
  </td>
  <td width=113 style='width:85.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>4<span style='letter-spacing:
  -.4pt'> </span>(0.3%)</span></p>
  </td>
  <td width=142 style='width:106.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>9<span style='letter-spacing:
  -.4pt'> </span>(0.6%)</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=115 style='width:1.2in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:4.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Fatal</span></p>
  </td>
  <td width=121 style='width:90.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0</span></p>
  </td>
  <td width=113 style='width:85.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0</span></p>
  </td>
  <td width=113 style='width:85.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0</span></p>
  </td>
  <td width=142 style='width:106.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=115 style='width:1.2in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:4.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.35pt'>
  </span>+<span style='letter-spacing:-.35pt'> </span>CRNM</span></p>
  </td>
  <td width=121 style='width:90.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>96<span style='letter-spacing:
  -.45pt'> </span>(3<span style='letter-spacing:-.05pt'>.</span>6<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=113 style='width:85.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>115<span style='letter-spacing:
  -.5pt'> </span>(<span style='letter-spacing:-.05pt'>4</span>.3<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=113 style='width:85.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>41<span style='letter-spacing:
  -.45pt'> </span>(2<span style='letter-spacing:-.05pt'>.</span>7<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=142 style='width:106.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>56<span style='letter-spacing:
  -.45pt'> </span>(3<span style='letter-spacing:-.05pt'>.</span>7<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
 </tr>
 <tr style='height:13.2pt'>
  <td width=115 style='width:1.2in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.2pt'>
  <p class=TableParagraph style='margin-left:4.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All</span></p>
  </td>
  <td width=121 style='width:90.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>261<span style='letter-spacing:
  -.5pt'> </span>(<span style='letter-spacing:-.05pt'>9</span>.8<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=113 style='width:85.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>293<span style='letter-spacing:
  -.55pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>1.0<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=113 style='width:85.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>89<span style='letter-spacing:
  -.45pt'> </span>(5<span style='letter-spacing:-.05pt'>.</span>9<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
  <td width=142 style='width:106.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>103<span style='letter-spacing:
  -.5pt'> </span>(<span style='letter-spacing:-.05pt'>6</span>.8<span
  style='letter-spacing:-.05pt'>%</span>)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>*<span style='letter-spacing:-.25pt'> </span>All<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>bl<span
style='letter-spacing:-.05pt'>e</span>edi<span style='letter-spacing:-.1pt'>n</span>g<span
style='letter-spacing:-.2pt'> </span>cr<span style='letter-spacing:-.05pt'>i</span>ter<span
style='letter-spacing:-.05pt'>i</span>a<span style='letter-spacing:-.25pt'> </span>inclu<span
style='letter-spacing:-.1pt'>d</span><span style='letter-spacing:-.05pt'>e</span>d<span
style='letter-spacing:-.25pt'> </span>surgic<span style='letter-spacing:-.05pt'>a</span>l<span
style='letter-spacing:-.15pt'> </span>si<span style='letter-spacing:-.05pt'>t</span>e<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>b</span><span
style='letter-spacing:-.05pt'>l</span>eeding</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><sup><span lang=EN-GB
style='font-size:10.0pt'>1</span></sup><span lang=EN-GB style='font-size:10.0pt'>
Inclu<span style='letter-spacing:-.1pt'>d</span>es<span style='letter-spacing:
-.2pt'> </span>e<span style='letter-spacing:-.1pt'>v</span>ents<span
style='letter-spacing:-.3pt'> </span>occur<span style='letter-spacing:-.1pt'>r</span>ing<span
style='letter-spacing:-.2pt'> </span>af<span style='letter-spacing:-.05pt'>t</span>er<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>f</span>ir<span
style='letter-spacing:-.05pt'>s</span>t<span style='letter-spacing:-.2pt'> </span>do<span
style='letter-spacing:-.05pt'>s</span>e<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>eno<span style='letter-spacing:-.1pt'>x</span>aparin<span
style='letter-spacing:-.25pt'> </span>(pre-<span style='letter-spacing:-.05pt'>s</span>ur<span
style='letter-spacing:-.1pt'>g</span>e<span style='letter-spacing:-.1pt'>r</span><span
style='letter-spacing:.05pt'>y</span>)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><sup><span lang=EN-GB
style='font-size:10.0pt'>2</span></sup><span lang=EN-GB style='font-size:10.0pt'>
Inclu<span style='letter-spacing:-.1pt'>d</span>es<span style='letter-spacing:
-.2pt'> </span>e<span style='letter-spacing:-.1pt'>v</span>ents<span
style='letter-spacing:-.25pt'> </span>occur<span style='letter-spacing:-.1pt'>r</span>ing<span
style='letter-spacing:-.25pt'> </span>af<span style='letter-spacing:-.05pt'>t</span>er<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>f</span>ir<span
style='letter-spacing:-.05pt'>s</span>t<span style='letter-spacing:-.2pt'> </span>do<span
style='letter-spacing:-.05pt'>s</span>e<span style='letter-spacing:-.15pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.1pt'>p</span>i<span
style='letter-spacing:-.1pt'>x</span>aban<span style='letter-spacing:-.15pt'> </span>(po<span
style='letter-spacing:-.05pt'>s</span>t-<span style='letter-spacing:-.05pt'>s</span>ur<span
style='letter-spacing:-.1pt'>g</span><span style='letter-spacing:-.05pt'>e</span><span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:.1pt'>y</span>)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>overall<span
style='letter-spacing:-.35pt'> </span>incidences<span style='letter-spacing:
-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>adverse<span
style='letter-spacing:-.35pt'> </span>react<span style='letter-spacing:.05pt'>i</span>ons<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>b<span
style='letter-spacing:-.05pt'>l</span>eed<span style='letter-spacing:-.05pt'>i</span>ng,<span
style='letter-spacing:-.35pt'> </span>anae<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>a<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>abnor<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>lities<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>transaminases (e.g.,<span
style='letter-spacing:-.3pt'> </span>ALT<span style='letter-spacing:-.3pt'> </span>levels)<span
style='letter-spacing:-.25pt'> </span>were<span style='letter-spacing:-.3pt'> </span>n<span
style='letter-spacing:.05pt'>u</span>merically<span style='letter-spacing:-.15pt'>
</span>lo<span style='letter-spacing:-.1pt'>w</span><span style='letter-spacing:
-.05pt'>e</span>r<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>pati<span style='letter-spacing:-.1pt'>e</span>nts<span
style='letter-spacing:-.3pt'> </span>on<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>c</span>o<span
style='letter-spacing:-.1pt'>m</span>pared<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>enoxaparin<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>t</span>he
phase<span style='letter-spacing:-.25pt'> </span>II<span style='letter-spacing:
-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>phase<span
style='letter-spacing:-.25pt'> </span>III<span style='letter-spacing:-.25pt'> </span>studies<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>elective<span
style='letter-spacing:-.25pt'> </span>hip<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>knee<span style='letter-spacing:-.25pt'> </span>replacement<span
style='letter-spacing:-.25pt'> </span>surger<span style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>knee<span style='letter-spacing:-.3pt'> </span>replac<span
style='letter-spacing:.05pt'>e</span>ment<span style='letter-spacing:-.25pt'> </span>surgery<span
style='letter-spacing:-.2pt'> </span>study<span style='letter-spacing:-.3pt'> </span>during<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>i<span
style='letter-spacing:-.05pt'>n</span>tended<span style='letter-spacing:-.25pt'>
</span>treat<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>e</span>nt<span style='letter-spacing:-.3pt'> </span>period,<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>arm 4&nbsp;cases<span style='letter-spacing:
-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>PE<span
style='letter-spacing:-.15pt'> </span>were<span style='letter-spacing:-.25pt'> </span>diagnosed<span
style='letter-spacing:-.2pt'> </span>against<span style='letter-spacing:-.2pt'>
</span>no<span style='letter-spacing:-.3pt'> </span>cases<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>enoxaparin<span style='letter-spacing:
-.2pt'> </span>a<span style='letter-spacing:-.1pt'>rm</span>.<span
style='letter-spacing:-.2pt'> </span>No<span style='letter-spacing:-.2pt'> </span>explanation<span
style='letter-spacing:-.25pt'> </span>can<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.2pt'> </span>given<span style='letter-spacing:-.25pt'> </span>to
this<span style='letter-spacing:-.3pt'> </span>higher<span style='letter-spacing:
-.25pt'> </span><span style='letter-spacing:-.05pt'>nu</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>b</span><span
style='letter-spacing:-.05pt'>e</span>r<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>PE.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Prevention<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>stroke<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.4pt'> </span>systemic<span
style='letter-spacing:-.3pt'> </span>embolism<span style='letter-spacing:-.4pt'>
</span>in<span style='letter-spacing:-.35pt'> </span>patien<span
style='letter-spacing:-.1pt'>t</span>s<span style='letter-spacing:-.45pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>non-va<span style='letter-spacing:-.05pt'>lv</span>ular<span
style='letter-spacing:-.4pt'> </span>atrial<span style='letter-spacing:-.35pt'>
</span>f<span style='letter-spacing:-.05pt'>i</span>brillation<span
style='letter-spacing:-.35pt'> </span>(NVAF)</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>A<span style='letter-spacing:-.35pt'> </span>total<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>23<span
style='letter-spacing:-.05pt'>,</span>799<span style='letter-spacing:-.2pt'>&nbsp;</span>patients<span
style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:-.3pt'> </span>rand<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>sed<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span>cli<span
style='letter-spacing:-.05pt'>n</span>ical<span style='letter-spacing:-.3pt'> </span>program<span
style='letter-spacing:-.35pt'> </span>(ARISTOTLE:<span style='letter-spacing:
-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>ve</span>rsus warfarin,<span style='letter-spacing:
-.4pt'> </span>AVERROES:<span style='letter-spacing:-.4pt'> </span>a<span
style='letter-spacing:.05pt'>p</span>ixaban<span style='letter-spacing:-.4pt'> </span>versus<span
style='letter-spacing:-.35pt'> </span>ASA)<span style='letter-spacing:-.4pt'> </span>including<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.05pt'>1</span>1,9<span
style='letter-spacing:-.05pt'>2</span>7<span style='letter-spacing:-.35pt'> </span>r<span
style='letter-spacing:-.1pt'>a</span>ndo<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.4pt'> </span>to<span style='letter-spacing:-.4pt'> </span>apixaban.<span
style='letter-spacing:-.35pt'> </span>T<span style='letter-spacing:-.05pt'>h</span>e<span
style='letter-spacing:-.4pt'> </span>program was<span style='letter-spacing:
-.3pt'> </span>designed<span style='letter-spacing:-.15pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>de<span style='letter-spacing:-.1pt'>m</span>onstrate<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>effica<span
style='letter-spacing:.05pt'>c</span>y<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>safety<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>prevention<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>stroke<span
style='letter-spacing:-.25pt'> </span>and s<span style='letter-spacing:.05pt'>y</span>ste<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.4pt'> </span>e<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>b</span>olism<span style='letter-spacing:-.4pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:-.35pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>non<span
style='letter-spacing:-.1pt'>-</span>valvular<span style='letter-spacing:-.35pt'>
</span>atrial<span style='letter-spacing:-.3pt'> </span>fibrillation<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>(</span>NVAF)<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>one<span
style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ore<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:.05pt'>d</span>ditional risk<span style='letter-spacing:
-.3pt'> </span>factors,<span style='letter-spacing:-.25pt'> </span>such<span
style='letter-spacing:-.3pt'> </span>as:</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>prior<span style='letter-spacing:-.35pt'> </span>stroke<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>transient<span
style='letter-spacing:-.35pt'> </span>ischa<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.25pt'> </span>attack<span
style='letter-spacing:-.25pt'> </span>(TIA)</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>ag</span><span
lang=EN-GB>e<span style='letter-spacing:-.2pt'> </span>&#8805;<span
style='letter-spacing:-.2pt'>&nbsp;</span>75<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>h</span><span
lang=EN-GB style='letter-spacing:.05pt'>y</span><span lang=EN-GB
style='letter-spacing:-.05pt'>pertension</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>diabetes<span style='letter-spacing:-.7pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>ll<span
style='letter-spacing:.05pt'>i</span>tus</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptomatic<span style='letter-spacing:-.3pt'>
</span>heart<span style='letter-spacing:-.3pt'> </span>failure<span
style='letter-spacing:-.3pt'> </span>(NYHA<span style='letter-spacing:-.3pt'> </span>Class<span
style='letter-spacing:-.3pt'> </span>&#8805;<span style='letter-spacing:-.35pt'>
</span>II)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>ARISTOTLE<span style='letter-spacing:-.95pt'> </span>STUDY</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>ARISTOTLE<span style='letter-spacing:-.3pt'>
</span>study<span style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:
-.25pt'> </span>total<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>18<span style='letter-spacing:-.05pt'>,</span>201<span
style='letter-spacing:-.2pt'>&nbsp;</span>patients<span style='letter-spacing:
-.25pt'> </span>were<span style='letter-spacing:-.3pt'> </span>rand<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>double<span
style='letter-spacing:-.1pt'>-</span>blind<span style='letter-spacing:-.25pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>with
apixaban<span style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:
-.2pt'>&nbsp;</span>mg<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.2pt'> </span>daily<span style='letter-spacing:-.2pt'> </span>(or<span
style='letter-spacing:-.25pt'> </span>2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.2pt'> </span>daily<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.2pt'> </span>selected<span style='letter-spacing:-.2pt'>
</span>patients<span style='letter-spacing:-.25pt'> </span>[4.7%],<span
style='letter-spacing:-.2pt'> </span>see<span style='letter-spacing:-.2pt'> </span>section<span
style='letter-spacing:-.2pt'>&nbsp;</span>4.2)<span style='letter-spacing:-.2pt'>
</span>or warfarin<span style='letter-spacing:-.25pt'> </span>(tar<span
style='letter-spacing:.05pt'>g</span><span style='letter-spacing:-.05pt'>e</span>t<span
style='letter-spacing:-.25pt'> </span>INR<span style='letter-spacing:-.25pt'> </span>range<span
style='letter-spacing:-.2pt'> </span>2.0-3<span style='letter-spacing:-.05pt'>.</span>0),<span
style='letter-spacing:-.2pt'>&nbsp;</span>pat<span style='letter-spacing:-.05pt'>i</span>ents<span
style='letter-spacing:-.25pt'> </span>were<span style='letter-spacing:-.2pt'> </span>exposed<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.2pt'> </span>stu<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.3pt'> </span>drug<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>mean<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>20<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>on<span style='letter-spacing:-.05pt'>t</span>hs.<span
style='letter-spacing:-.2pt'> </span>The mean<span style='letter-spacing:-.25pt'>
</span>age<span style='letter-spacing:-.2pt'> </span>was<span style='letter-spacing:
-.25pt'> </span>69.1<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears,<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>mean<span style='letter-spacing:-.2pt'> </span>CHAD<span
style='letter-spacing:-.05pt'>S<sub>2</sub></span><span style='position:relative;
top:1.0pt;letter-spacing:.8pt'> </span>score<span style='letter-spacing:-.2pt'>
</span>was<span style='letter-spacing:-.2pt'> </span>2.1<span style='letter-spacing:
-.2pt'>&nbsp;</span>and<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.05pt'>1</span>8.9%<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>had<span style='letter-spacing:-.2pt'> </span>prior<span
style='letter-spacing:-.35pt'> </span>stroke<span style='letter-spacing:-.25pt'>
</span>or TIA.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>stu<span style='letter-spacing:-.05pt'>d</span>y,<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>achieved<span style='letter-spacing:-.35pt'> </span>statistically<span
style='letter-spacing:-.2pt'> </span>s<span style='letter-spacing:-.1pt'>i</span><span
style='letter-spacing:-.05pt'>g</span>nificant<span style='letter-spacing:-.3pt'>
</span>superiori<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>pri<span style='letter-spacing:-.1pt'>m</span>ary<span
style='letter-spacing:-.35pt'> </span>endp<span style='letter-spacing:-.05pt'>o</span>int<span
style='letter-spacing:-.3pt'> </span>of prevention<span style='letter-spacing:
-.4pt'> </span>of<span style='letter-spacing:-.3pt'> </span>stroke<span
style='letter-spacing:-.35pt'> </span>(ha<span style='letter-spacing:.05pt'>e</span>morrhagic<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.35pt'> </span>i<span
style='letter-spacing:-.1pt'>s</span>cha<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c)<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>s<span
style='letter-spacing:.05pt'>y</span>ste<span style='letter-spacing:-.1pt'>m</span>ic<span
style='letter-spacing:-.3pt'> </span>e<span style='letter-spacing:-.05pt'>m</span>bolism<span
style='letter-spacing:-.4pt'> </span>(see<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>a</span>ble<span
style='letter-spacing:-.3pt'> </span>6)<span style='letter-spacing:-.3pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>p</span>ared<span
style='letter-spacing:-.35pt'> </span>with warfarin.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>6:<span
style='letter-spacing:-.3pt'> </span>Efficacy<span style='letter-spacing:-.25pt'>
o</span>utco<span style='letter-spacing:-.1pt'>m</span>es<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> p</span>atients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> a</span>trial<span
style='letter-spacing:-.3pt'> f</span>ibrillation<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>ARISTO<span style='letter-spacing:.05pt'>T</span>LE<span
style='letter-spacing:-.3pt'> s</span>tudy</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:2.85pt'>
  <td width=189 style='width:142.05pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=76 style='width:56.7pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b><b><span
  lang=EN-GB style='font-size:11.0pt'> </span></b><b><span lang=EN-GB
  style='font-size:11.0pt'>N=9,120</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.4pt'> </span>(%/yr)</span></b></p>
  </td>
  <td width=76 style='width:56.7pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Warfarin N=9,081</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.4pt'> </span>(%/yr)</span></b></p>
  </td>
  <td width=112 style='width:84.15pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:
  .05pt'>a</span>zard<span style='letter-spacing:-.65pt'> r</span>atio (95%<span
  style='letter-spacing:-.45pt'>&nbsp;</span>CI)</span></b></p>
  </td>
  <td width=61 style='width:45.65pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>p-value</span></b></p>
  </td>
 </tr>
 <tr style='height:2.85pt'>
  <td width=189 style='width:142.05pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:2.85pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stroke<span style='letter-spacing:-.4pt'>
  </span>or<span style='letter-spacing:-.4pt'> </span><span style='letter-spacing:
  -.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>s<span
  style='letter-spacing:-.05pt'>t</span>e<span style='letter-spacing:-.1pt'>m</span>ic<span
  style='letter-spacing:-.4pt'> </span>embolism</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>212<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>.27)</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>265<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>.60)</span></p>
  </td>
  <td width=112 style='width:84.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.79<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.6<span
  style='letter-spacing:-.05pt'>6</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>95)</span></p>
  </td>
  <td width=61 style='width:45.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>1</span>14</span></p>
  </td>
 </tr>
 <tr style='height:2.85pt'>
  <td width=189 style='width:142.05pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:2.85pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stroke</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=112 style='width:84.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=61 style='width:45.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:2.85pt'>
  <td width=189 style='width:142.05pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:2.85pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Ischaemic<span style='letter-spacing:
  -.55pt'> </span>or<span style='letter-spacing:-.5pt'> </span>unspecified</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>162<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>0</span>.97)</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>175<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>.05)</span></p>
  </td>
  <td width=112 style='width:84.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.92<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.7<span
  style='letter-spacing:-.05pt'>4</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>13)</span></p>
  </td>
  <td width=61 style='width:45.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:2.85pt'>
  <td width=189 style='width:142.05pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:2.85pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.1pt'>m</span>orr<span
  style='letter-spacing:.05pt'>h</span>agic</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>40<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>24)</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>78<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>47)</span></p>
  </td>
  <td width=112 style='width:84.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.51<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.3<span
  style='letter-spacing:-.05pt'>5</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>75)</span></p>
  </td>
  <td width=61 style='width:45.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:2.85pt'>
  <td width=189 style='width:142.05pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:2.85pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>S<span style='letter-spacing:.05pt'>y</span>ste<span
  style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.85pt'> </span>embolism</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>15<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>09)</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>17<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>10)</span></p>
  </td>
  <td width=112 style='width:84.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.87<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.4<span
  style='letter-spacing:-.05pt'>4</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>75)</span></p>
  </td>
  <td width=61 style='width:45.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:2.85pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>warfarin,<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>median<span
style='letter-spacing:-.3pt'> </span>percentage<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>time<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>therapeutic<span
style='letter-spacing:-.3pt'> </span>range<span style='letter-spacing:-.3pt'> </span>(TTR)
(INR<span style='letter-spacing:-.3pt'> </span>2&#8209;3)<span
style='letter-spacing:-.25pt'> </span>was<span style='letter-spacing:-.3pt'> </span>66<span
style='letter-spacing:-.05pt'>%</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.3pt'> </span>showed<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.3pt'> </span>reduction<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>stroke<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.05pt'>t</span>e<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.35pt'> </span>e<span
style='letter-spacing:-.1pt'>m</span>boli<span style='letter-spacing:.05pt'>s</span>m<span
style='letter-spacing:-.3pt'> </span>c<span style='letter-spacing:.05pt'>o</span>mpared<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>warfarin<span
style='letter-spacing:-.3pt'> </span>across<span style='letter-spacing:-.3pt'> </span>the
different<span style='letter-spacing:-.3pt'> </span>levels<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>center<span
style='letter-spacing:-.25pt'> </span>TTR;<span style='letter-spacing:-.25pt'> </span>within<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>highest<span
style='letter-spacing:-.3pt'> </span>qu<span style='letter-spacing:-.1pt'>a</span>rtile<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>TTR<span
style='letter-spacing:-.25pt'> </span>according<span style='letter-spacing:
-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:-.05pt'>e</span>nter,<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>hazard<span
style='letter-spacing:-.25pt'> </span>ratio for<span style='letter-spacing:
-.25pt'> </span>apixaban<span style='letter-spacing:-.3pt'> </span>vs<span
style='letter-spacing:-.25pt'> </span>warfarin<span style='letter-spacing:-.25pt'>
</span>was<span style='letter-spacing:-.25pt'> </span>0.73<span
style='letter-spacing:-.25pt'> </span>(95%<span style='letter-spacing:-.35pt'>&nbsp;</span>CI,<span
style='letter-spacing:-.25pt'> </span>0.38,<span style='letter-spacing:-.3pt'> </span>1.<span
style='letter-spacing:-.05pt'>40</span>).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Key<span style='letter-spacing:-.2pt'> </span>secondary<span
style='letter-spacing:-.25pt'> </span>endp<span style='letter-spacing:-.05pt'>o</span>ints<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>o</span>f<span
style='letter-spacing:-.25pt'> </span>major<span style='letter-spacing:-.25pt'>
</span>bleeding<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>all<span style='letter-spacing:-.35pt'> </span>c<span
style='letter-spacing:-.1pt'>a</span>use<span style='letter-spacing:-.25pt'> </span>death<span
style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:-.25pt'> </span>tested<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>pre-specified hierarchical<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>t</span>esting<span
style='letter-spacing:-.25pt'> </span>strategy<span style='letter-spacing:-.3pt'>
</span>to<span style='letter-spacing:-.3pt'> </span>control<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.25pt'> </span>type<span style='letter-spacing:-.3pt'> </span>1<span
style='letter-spacing:-.25pt'> </span>error<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>trial.<span
style='letter-spacing:-.25pt'> </span>Statistically<span style='letter-spacing:
-.2pt'> </span>signifi<span style='letter-spacing:-.1pt'>c</span><span
style='letter-spacing:-.05pt'>a</span>nt superiori<span style='letter-spacing:
-.05pt'>t</span>y<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>w</span>as<span style='letter-spacing:-.3pt'> </span>also<span
style='letter-spacing:-.3pt'> </span>achie<span style='letter-spacing:.05pt'>v</span><span
style='letter-spacing:-.05pt'>e</span>d<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>k<span
style='letter-spacing:-.1pt'>e</span>y<span style='letter-spacing:-.3pt'> </span>secondary<span
style='letter-spacing:-.2pt'> </span>e<span style='letter-spacing:-.05pt'>n</span>dpoints<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>b<span
style='letter-spacing:-.05pt'>ot</span>h<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor<span
style='letter-spacing:-.3pt'> </span>blee<span style='letter-spacing:.05pt'>d</span>ing<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>all-cause
death<span style='letter-spacing:-.3pt'> </span>(see<span style='letter-spacing:
-.25pt'> </span>T<span style='letter-spacing:.05pt'>a</span>ble<span
style='letter-spacing:-.3pt'> </span>7).<span style='letter-spacing:-.25pt'> </span>With<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.1pt'>m</span>proving<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>o</span>nitoring<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>I<span style='letter-spacing:
-.05pt'>N</span>R<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>observed<span style='letter-spacing:-.3pt'>
</span>benefits<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>compared<span style='letter-spacing:-.3pt'> </span>to warfarin<span
style='letter-spacing:-.4pt'> </span>regarding<span style='letter-spacing:-.35pt'>
</span>all<span style='letter-spacing:-.35pt'> </span>cause<span
style='letter-spacing:-.35pt'> </span>death<span style='letter-spacing:-.35pt'>
</span>di<span style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:
.05pt'>n</span>ish.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.35pt'> </span>7:<span
style='letter-spacing:-.3pt'> </span>Seconda<span style='letter-spacing:-.1pt'>r</span>y<span
style='letter-spacing:-.2pt'> e</span>ndpo<span style='letter-spacing:-.05pt'>i</span>nts<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.35pt'> p</span>atien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>w</span>ith<span style='letter-spacing:-.3pt'> a</span>trial<span
style='letter-spacing:-.3pt'> f</span>ibrillation<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.3pt'> </span>ARISTOTLE<span
style='letter-spacing:-.35pt'> s</span>tudy</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:38.45pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:38.45pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=129 style='width:96.85pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b><b><span
  lang=EN-GB style='font-size:11.0pt'> <br>
  </span></b><b><span lang=EN-GB style='font-size:11.0pt'>N<span
  style='letter-spacing:-.2pt'>&nbsp;</span>=<span style='letter-spacing:-.2pt'>&nbsp;</span>9,088</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.5pt'> </span>(%/year)</span></b></p>
  </td>
  <td width=132 style='width:99.0pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Warfarin <br>
  N<span style='letter-spacing:-.2pt'>&nbsp;</span>=<span style='letter-spacing:
  -.2pt'>&nbsp;</span>9,052</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.5pt'> </span>(%/year)</span></b></p>
  </td>
  <td width=132 style='width:99.0pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:
  .05pt'>a</span>zard<span style='letter-spacing:-.65pt'> r</span>atio <br>
  (95%<span style='letter-spacing:-.45pt'>&nbsp;</span>CI)</span></b></p>
  </td>
  <td width=85 style='width:63.65pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>p-value</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width=608 colspan=5 style='width:456.05pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:.2in'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Bleeding<span style='letter-spacing:-.85pt'>
  o</span>utc<span style='letter-spacing:.05pt'>o</span><span style='letter-spacing:
  -.1pt'>m</span>es</span></p>
  </td>
 </tr>
 <tr style='height:14.45pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.45pt'>
  <p class=TableParagraph style='margin-left:12.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major*</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>327<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>2</span>.13)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>462<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>3</span>.09)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.69<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.6<span
  style='letter-spacing:-.05pt'>0</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>80)</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>&lt;<span style='letter-spacing:
  -.4pt'>&nbsp;</span>0.00<span style='letter-spacing:-.05pt'>0</span>1</span></p>
  </td>
 </tr>
 <tr style='height:14.05pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.05pt'>
  <p class=TableParagraph style='margin-left:24.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Fatal</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>10<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>06)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>37<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>24)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:24.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Intracranial</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>52<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>33)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>122<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>0</span>.80)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:.2in'>
  <p class=TableParagraph style='margin-left:12.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.35pt'>
  </span>+<span style='letter-spacing:-.35pt'> </span>CRNM</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>613<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>4</span>.07)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>877<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>6</span>.01)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.68<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.6<span
  style='letter-spacing:-.05pt'>1</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>75)</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>&lt;<span style='letter-spacing:
  -.4pt'>&nbsp;</span>0.00<span style='letter-spacing:-.05pt'>0</span>1</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:12.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2356<span style='letter-spacing:
  -.55pt'> </span>(18<span style='letter-spacing:-.05pt'>.</span>1)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>3060<span style='letter-spacing:
  -.55pt'> </span>(25<span style='letter-spacing:-.05pt'>.</span>8)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.71<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.6<span
  style='letter-spacing:-.05pt'>8</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>75)</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>&lt;<span style='letter-spacing:
  -.4pt'>&nbsp;</span>0.00<span style='letter-spacing:-.05pt'>0</span>1</span></p>
  </td>
 </tr>
 <tr style='height:19.15pt'>
  <td width=608 colspan=5 style='width:456.05pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:19.15pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Other<span style='letter-spacing:-.7pt'> e</span>ndpo<span
  style='letter-spacing:-.05pt'>i</span>nts</span></p>
  </td>
 </tr>
 <tr style='height:19.15pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:19.15pt'>
  <p class=TableParagraph style='margin-left:12.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All-cause<span style='letter-spacing:
  -.7pt'> </span>death</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:19.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>603<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>3</span>.52)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:19.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>669<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>3</span>.94)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:19.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.89<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.8<span
  style='letter-spacing:-.05pt'>0</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>00)</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:19.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>4</span>65</span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:25.8pt'>
  <p class=TableParagraph style='margin-left:12.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Myocardial</span><span lang=EN-GB
  style='font-size:11.0pt'> </span><span lang=EN-GB style='font-size:11.0pt'>infarction</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>90<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>53)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>102<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>0</span>.61)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='margin-left:21.0pt;text-align:
  center;text-indent:-21.0pt;punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>0.88<span style='font:7.0pt "Times New Roman"'> </span></span><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>(</span><span
  lang=EN-GB style='font-size:11.0pt'>0.6<span style='letter-spacing:-.05pt'>6</span>,<span
  style='letter-spacing:-.35pt'> </span>1<span style='letter-spacing:-.05pt'>.</span>17)</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>* Major<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>b</span>leedi<span style='letter-spacing:-.1pt'>n</span>g<span
style='letter-spacing:-.25pt'> </span>defi<span style='letter-spacing:-.1pt'>n</span>ed<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>p</span>er<span
style='letter-spacing:-.25pt'> </span>I<span style='letter-spacing:-.1pt'>n</span>ternational<span
style='letter-spacing:-.25pt'> </span>Socie<span style='letter-spacing:-.1pt'>t</span>y<span
style='letter-spacing:-.2pt'> </span>on<span style='letter-spacing:-.25pt'> </span>Thrombosis<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>H</span>ae<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>ostasi</span>s<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>(ISTH</span>)<span style='letter-spacing:
-.2pt'> </span><span style='letter-spacing:-.05pt'>criteria.</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>d</span>iscontinuati<span
style='letter-spacing:-.05pt'>o</span>n<span style='letter-spacing:-.25pt'> </span>rate<span
style='letter-spacing:-.3pt'> </span>due<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>adverse<span style='letter-spacing:-.3pt'>
</span>reactions<span style='letter-spacing:-.25pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>1.8%<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>2.6%<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.35pt'> </span>warfarin
in<span style='letter-spacing:-.4pt'> </span>the<span style='letter-spacing:
-.35pt'> </span>ARISTOTLE<span style='letter-spacing:-.35pt'> </span>stud<span
style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>efficacy<span
style='letter-spacing:-.25pt'> </span>results<span style='letter-spacing:-.35pt'>
</span>for<span style='letter-spacing:-.35pt'> </span>prespecified<span
style='letter-spacing:-.3pt'> </span>subgroups,<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.05pt'>i</span>ncluding<span
style='letter-spacing:-.35pt'> </span>CHAD<span style='letter-spacing:-.05pt'>S<sub>2</sub></span><span
style='position:relative;top:1.0pt;letter-spacing:.65pt'> </span>score,<span
style='letter-spacing:-.3pt'> </span>age,<span style='letter-spacing:-.35pt'> </span>body<span
style='letter-spacing:-.25pt'> </span>weight,<span style='letter-spacing:-.35pt'>
</span>gender, status<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>renal<span style='letter-spacing:-.25pt'>
</span>function,<span style='letter-spacing:-.3pt'> </span>pr<span
style='letter-spacing:-.05pt'>i</span>or<span style='letter-spacing:-.3pt'> </span>stroke<span
style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>T</span>IA<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>diabetes<span style='letter-spacing:-.3pt'>
</span>we<span style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:
-.3pt'> </span>cons<span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.05pt'>s</span>tent<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>pri<span
style='letter-spacing:-.1pt'>m</span>ary<span style='letter-spacing:-.2pt'> </span>effi<span
style='letter-spacing:.05pt'>c</span>acy results<span style='letter-spacing:
-.3pt'> </span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>overall<span style='letter-spacing:-.25pt'>
</span>popu<span style='letter-spacing:-.05pt'>l</span>ation<span
style='letter-spacing:-.25pt'> </span>studied<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:
-.25pt'> </span>trial.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>incidence<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>ISTH<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>ajor<span
style='letter-spacing:-.3pt'> </span>gastroint<span style='letter-spacing:-.1pt'>e</span>stinal<span
style='letter-spacing:-.25pt'> </span>b<span style='letter-spacing:-.05pt'>l</span>eeds<span
style='letter-spacing:-.3pt'> </span>(including<span style='letter-spacing:
-.3pt'> </span>upper<span style='letter-spacing:-.3pt'> </span>GI,<span
style='letter-spacing:-.3pt'> </span>lower<span style='letter-spacing:-.25pt'> </span>GI,<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>rectal
bleeding)<span style='letter-spacing:-.4pt'> </span>was<span style='letter-spacing:
-.35pt'> </span>0.76<span style='letter-spacing:-.05pt'>%/</span><span
style='letter-spacing:.05pt'>y</span>ear<span style='letter-spacing:-.4pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.4pt'> </span>0<span style='letter-spacing:
-.05pt'>.</span>86<span style='letter-spacing:-.05pt'>%/</span><span
style='letter-spacing:.05pt'>y</span>ear<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>warfarin.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>major<span
style='letter-spacing:-.35pt'> </span>bleeding<span style='letter-spacing:-.3pt'>
</span>results<span style='letter-spacing:-.35pt'> </span>for<span
style='letter-spacing:-.35pt'> </span>prespecified<span style='letter-spacing:
-.3pt'> </span>subgroups<span style='letter-spacing:-.35pt'> </span>including<span
style='letter-spacing:-.35pt'> </span>CHAD<span style='letter-spacing:-.05pt'>S</span><sub>2</sub><span
style='position:relative;top:1.0pt;letter-spacing:.7pt'> </span>score,<span
style='letter-spacing:-.35pt'> </span>age,<span style='letter-spacing:-.35pt'> </span>bo<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.3pt'> </span>weight,
gender,<span style='letter-spacing:-.25pt'> </span>status<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>renal<span
style='letter-spacing:-.25pt'> </span>fun<span style='letter-spacing:-.1pt'>c</span>tion,<span
style='letter-spacing:-.25pt'> </span>pr<span style='letter-spacing:-.05pt'>i</span>or<span
style='letter-spacing:-.25pt'> </span>st<span style='letter-spacing:-.1pt'>r</span>oke<span
style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.25pt'> </span>T<span
style='letter-spacing:-.1pt'>I</span>A<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>diabetes<span style='letter-spacing:-.25pt'>
</span>were<span style='letter-spacing:-.25pt'> </span>consistent<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>results<span style='letter-spacing:-.25pt'>
</span>for the<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.25pt'> </span>population<span style='letter-spacing:
-.3pt'> </span>stud<span style='letter-spacing:-.05pt'>ie</span>d<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>trial.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>AVERROES<span style='letter-spacing:-.95pt'> </span>STUDY</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>AVERROES<span style='letter-spacing:-.2pt'>
</span>study<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>total<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>5,598<span style='letter-spacing:-.2pt'>&nbsp;</span>patients<span
style='letter-spacing:-.25pt'> </span>considered<span style='letter-spacing:
-.25pt'> </span>to<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>unsuitable<span style='letter-spacing:
-.2pt'> </span>for<span style='letter-spacing:-.25pt'> </span>VKA<span
style='letter-spacing:-.25pt'> </span>by<span style='letter-spacing:-.1pt'> </span>the
investigators<span style='letter-spacing:-.25pt'> </span>were<span
style='letter-spacing:-.25pt'> </span>rand<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>sed<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>ment<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>api<span style='letter-spacing:-.15pt'>x</span>aban<span
style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.15pt'>
</span>(or<span style='letter-spacing:-.3pt'> </span>2.5<span style='letter-spacing:
-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:
-.05pt'>a</span>ily<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.05pt'>i</span>n selec<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.2pt'>
</span>[6.4%],<span style='letter-spacing:-.2pt'> </span>see<span
style='letter-spacing:-.2pt'> </span>section<span style='letter-spacing:-.2pt'>&nbsp;</span>4.2)<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.2pt'> </span>ASA.<span
style='letter-spacing:-.25pt'> </span>ASA<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>given<span style='letter-spacing:-.2pt'> </span>at<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.2pt'> </span>once<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.2pt'> </span>dose<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>8</span>1<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g (64<span style='letter-spacing:-.05pt'>%</span>),<span
style='letter-spacing:-.3pt'> </span>162<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>(</span><span style='letter-spacing:-.05pt'>2</span>6.9<span
style='letter-spacing:-.05pt'>%</span>),<span style='letter-spacing:-.25pt'> </span>243<span
style='letter-spacing:-.3pt'> </span>(<span style='letter-spacing:-.05pt'>2</span>.1<span
style='letter-spacing:-.05pt'>%</span>),<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>3<span style='letter-spacing:-.05pt'>2</span>4<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>(6.6<span style='letter-spacing:-.05pt'>%</span>)<span
style='letter-spacing:-.25pt'> </span>at<span style='letter-spacing:-.15pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>discretion<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>vestigator.<span
style='letter-spacing:-.25pt'> </span>Patients<span style='letter-spacing:-.25pt'>
</span>were exposed<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.2pt'> </span>s<span style='letter-spacing:-.05pt'>t</span>u<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.2pt'> </span>drug<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ean<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>14<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>onth<span style='letter-spacing:-.05pt'>s</span>.<span
style='letter-spacing:-.25pt'> </span>The<span style='letter-spacing:-.2pt'> </span>mean<span
style='letter-spacing:-.2pt'> </span>age<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>69.9<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears,<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>mean<span style='letter-spacing:-.2pt'> </span>CHAD<span
style='letter-spacing:-.05pt'>S</span><sub>2</sub><span style='position:relative;
top:1.0pt'> </span>score<span style='letter-spacing:-.25pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>2.0<span style='letter-spacing:-.2pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>13<span style='letter-spacing:-.05pt'>.</span>6%<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>o</span>f<span
style='letter-spacing:-.2pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>had<span style='letter-spacing:-.2pt'> </span>prior<span
style='letter-spacing:-.2pt'> </span>stroke<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>TIA.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>C<span style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:
-.1pt'>m</span>on<span style='letter-spacing:-.35pt'> </span>reasons<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.35pt'> </span>unsui<span
style='letter-spacing:-.05pt'>t</span>abili<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.2pt'> </span>for<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>V</span>KA<span style='letter-spacing:-.3pt'> </span>therapy<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>AVERROES<span
style='letter-spacing:-.35pt'> </span>study<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>i</span>ncluded unable/unlikely<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.35pt'> </span>obtain<span
style='letter-spacing:-.35pt'> </span>INRs<span style='letter-spacing:-.3pt'> </span>at<span
style='letter-spacing:-.35pt'> </span>requ<span style='letter-spacing:.05pt'>e</span>sted<span
style='letter-spacing:-.35pt'> </span>int<span style='letter-spacing:-.15pt'>e</span>rvals<span
style='letter-spacing:-.3pt'> </span>(42.6%),<span style='letter-spacing:-.35pt'>
</span>patient<span style='letter-spacing:-.35pt'> </span>refused<span
style='letter-spacing:-.3pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>VKA
(37.4%),<span style='letter-spacing:-.3pt'> </span>CHADS<sub>2</sub><span
style='letter-spacing:-.25pt'> </span>score<span style='letter-spacing:-.2pt'>&nbsp;</span>=<span
style='letter-spacing:-.3pt'>&nbsp;</span>1<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>ph<span style='letter-spacing:
.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>ician<span
style='letter-spacing:-.3pt'> </span>did<span style='letter-spacing:-.25pt'> </span>not<span
style='letter-spacing:-.4pt'> </span>rec<span style='letter-spacing:.05pt'>o</span>mmend<span
style='letter-spacing:-.25pt'> </span>VKA<span style='letter-spacing:-.25pt'> </span>(21.3%),<span
style='letter-spacing:-.3pt'> </span>patient<span style='letter-spacing:-.25pt'>
</span>could<span style='letter-spacing:-.3pt'> </span>not<span
style='letter-spacing:-.3pt'> </span>be relied<span style='letter-spacing:-.35pt'>
</span>on<span style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.1pt'>a</span>dhere<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>VKA<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>dicinal<span style='letter-spacing:-.3pt'>
</span>product<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nstruct<span style='letter-spacing:-.1pt'>i</span>on<span
style='letter-spacing:-.3pt'> </span>(15.0%),<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>difficul<span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>/expected<span
style='letter-spacing:-.35pt'> </span>d<span style='letter-spacing:-.05pt'>i</span>fficulty<span
style='letter-spacing:-.3pt'> </span>in contacting<span style='letter-spacing:
-.3pt'> </span>p<span style='letter-spacing:-.1pt'>a</span>tient<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>case<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>urgent<span
style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:-.3pt'> </span>change<span
style='letter-spacing:-.3pt'> </span>(11.7%).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>AVERROES<span style='letter-spacing:-.35pt'> </span>was<span
style='letter-spacing:-.35pt'> </span>stopped<span style='letter-spacing:-.3pt'>
</span>early<span style='letter-spacing:-.25pt'> </span>based<span
style='letter-spacing:-.35pt'> </span>on<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.35pt'> </span>rec<span style='letter-spacing:.05pt'>o</span>mmendation<span
style='letter-spacing:-.35pt'> </span>by<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>th</span>e<span style='letter-spacing:-.35pt'> </span>independent<span
style='letter-spacing:-.35pt'> </span>Data<span style='letter-spacing:-.35pt'> </span>Monitoring
C<span style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>ittee<span
style='letter-spacing:-.3pt'> </span>due<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>clear<span style='letter-spacing:-.3pt'> </span>evidence<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>reduction<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>s<span
style='letter-spacing:-.05pt'>t</span>roke<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>s</span><span
style='letter-spacing:.05pt'>y</span>stemic<span style='letter-spacing:-.3pt'> </span>e<span
style='letter-spacing:-.1pt'>m</span>bolism<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>an<span style='letter-spacing:-.25pt'> </span>acceptable
<span style='letter-spacing:-.05pt'>safet</span>y<span style='letter-spacing:
-.5pt'> </span><span style='letter-spacing:-.05pt'>profile.</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>d</span>iscontinuati<span
style='letter-spacing:-.05pt'>o</span>n<span style='letter-spacing:-.25pt'> </span>rate<span
style='letter-spacing:-.25pt'> </span>due<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>adverse<span style='letter-spacing:-.25pt'>
</span>reactions<span style='letter-spacing:-.25pt'> </span>was<span
style='letter-spacing:-.25pt'> </span>1.5%<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>1.3%<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>ASA<span
style='letter-spacing:-.25pt'> </span>in the<span style='letter-spacing:-.5pt'>
</span>AVER<span style='letter-spacing:.05pt'>R</span>OES<span
style='letter-spacing:-.5pt'> </span>stud<span style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>stu<span style='letter-spacing:-.05pt'>d</span>y,<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>achieved<span style='letter-spacing:-.35pt'> </span>statistically<span
style='letter-spacing:-.2pt'> </span>s<span style='letter-spacing:-.1pt'>i</span><span
style='letter-spacing:-.05pt'>g</span>nificant<span style='letter-spacing:-.3pt'>
</span>superiori<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>pri<span style='letter-spacing:-.1pt'>m</span>ary<span
style='letter-spacing:-.35pt'> </span>endp<span style='letter-spacing:-.05pt'>o</span>int<span
style='letter-spacing:-.3pt'> </span>of prevention<span style='letter-spacing:
-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>stroke<span
style='letter-spacing:-.35pt'> </span>(ha<span style='letter-spacing:.05pt'>e</span>morrhagic,<span
style='letter-spacing:-.3pt'> </span>ischa<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:-.4pt'> </span>unspecified)<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.35pt'> </span>s<span
style='letter-spacing:.05pt'>y</span>ste<span style='letter-spacing:-.1pt'>m</span>ic<span
style='letter-spacing:-.35pt'> </span>e<span style='letter-spacing:-.05pt'>m</span>boli<span
style='letter-spacing:.05pt'>s</span>m<span style='letter-spacing:-.4pt'> </span>(see<span
style='letter-spacing:-.4pt'> </span>Ta<span style='letter-spacing:.05pt'>b</span>le<span
style='letter-spacing:-.35pt'> </span>8) c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>pared<span style='letter-spacing:-.4pt'> </span>to<span
style='letter-spacing:-.4pt'> </span>ASA.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>8:<span
style='letter-spacing:-.3pt'> </span>Key<span style='letter-spacing:-.3pt'> e</span>fficacy<span
style='letter-spacing:-.2pt'> o</span>utcomes<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.3pt'> p</span>atients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.3pt'> a</span>trial<span
style='letter-spacing:-.3pt'> f</span>ibrillation<span style='letter-spacing:
-.35pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>AVERROES<span style='letter-spacing:-.3pt'>
s</span>tudy</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:46.45pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:46.45pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=101 style='width:1.05in;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:46.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N<span style='letter-spacing:
  -.2pt'>&nbsp;</span>=<span style='letter-spacing:-.2pt'>&nbsp;</span>2,807</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.5pt'> </span>(%/year)</span></b></p>
  </td>
  <td width=113 style='width:85.05pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:46.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>ASA</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N<span style='letter-spacing:
  -.2pt'>&nbsp;</span>=<span style='letter-spacing:-.2pt'>&nbsp;</span>2,791</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.5pt'> </span>(%/year)</span></b></p>
  </td>
  <td width=122 style='width:91.65pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:46.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:
  .05pt'>a</span>zard<span style='letter-spacing:-.65pt'> r</span>atio</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(95%<span
  style='letter-spacing:-.45pt'>&nbsp;</span>CI)</span></b></p>
  </td>
  <td width=67 style='width:50.05pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:46.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>p-value</span></b></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stroke<span style='letter-spacing:-.45pt'>
  </span>or<span style='letter-spacing:-.4pt'> </span><span style='letter-spacing:
  -.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>s<span
  style='letter-spacing:-.05pt'>t</span>e<span style='letter-spacing:-.1pt'>m</span>ic<span
  style='letter-spacing:-.45pt'> </span>embolis<span style='letter-spacing:
  -.1pt'>m</span>*</span></p>
  </td>
  <td width=101 style='width:1.05in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>51<span style='letter-spacing:
  -.4pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>62)</span></p>
  </td>
  <td width=113 style='width:85.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>113<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>3</span>.63)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.45<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.3<span
  style='letter-spacing:-.05pt'>2</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>62)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>&lt;<span style='letter-spacing:
  -.4pt'>&nbsp;</span>0.00<span style='letter-spacing:-.05pt'>0</span>1</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:15.05pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stroke</span></p>
  </td>
  <td width=101 style='width:1.05in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=113 style='width:85.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:29.75pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Ischaemic<span style='letter-spacing:
  -.55pt'> </span>or<span style='letter-spacing:-.5pt'> </span>unspecified</span></p>
  </td>
  <td width=101 style='width:1.05in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>43<span style='letter-spacing:
  -.4pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>37)</span></p>
  </td>
  <td width=113 style='width:85.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>97<span style='letter-spacing:
  -.4pt'> </span>(3<span style='letter-spacing:-.05pt'>.</span>11)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.44<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.3<span
  style='letter-spacing:-.05pt'>1</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>63)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.2pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.2pt'>
  <p class=TableParagraph style='margin-left:29.75pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.1pt'>m</span>orr<span
  style='letter-spacing:.05pt'>h</span>agic</span></p>
  </td>
  <td width=101 style='width:1.05in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>6<span style='letter-spacing:
  -.35pt'> </span>(0.<span style='letter-spacing:-.05pt'>1</span>9)</span></p>
  </td>
  <td width=113 style='width:85.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>9<span style='letter-spacing:
  -.35pt'> </span>(0.<span style='letter-spacing:-.05pt'>2</span>8)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.67<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.2<span
  style='letter-spacing:-.05pt'>4</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>88)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:15.05pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>S<span style='letter-spacing:.05pt'>y</span>ste<span
  style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.85pt'> </span>embolism</span></p>
  </td>
  <td width=101 style='width:1.05in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2<span style='letter-spacing:
  -.35pt'> </span>(0.<span style='letter-spacing:-.05pt'>0</span>6)</span></p>
  </td>
  <td width=113 style='width:85.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>13<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>41)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.15<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.0<span
  style='letter-spacing:-.05pt'>3</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>68)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:25.8pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stroke,<span style='letter-spacing:-.6pt'>
  </span><span style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:
  .05pt'>y</span>stemic<span style='letter-spacing:-.6pt'> </span>e<span
  style='letter-spacing:-.1pt'>m</span>bolis<span style='letter-spacing:-.1pt'>m</span>,
  MI,<span style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:
  -.3pt'> </span>vascular<span style='letter-spacing:-.3pt'> </span>death<b>*</b><sup>†</sup></span></p>
  </td>
  <td width=101 style='width:1.05in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>132<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>4</span>.21)</span></p>
  </td>
  <td width=113 style='width:85.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>197<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>6</span>.35)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.66<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.5<span
  style='letter-spacing:-.05pt'>3</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>83)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>0</span>3</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:17.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Myocardial<span style='letter-spacing:
  -.95pt'> </span>infarction</span></p>
  </td>
  <td width=101 style='width:1.05in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>24<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>76)</span></p>
  </td>
  <td width=113 style='width:85.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>28<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>89)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.86<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.5<span
  style='letter-spacing:-.05pt'>0</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>48)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:17.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Vascular<span style='letter-spacing:-.65pt'>
  d</span>eath</span></p>
  </td>
  <td width=101 style='width:1.05in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>84<span style='letter-spacing:
  -.4pt'> </span>(2.65)</span></p>
  </td>
  <td width=113 style='width:85.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>96<span style='letter-spacing:
  -.4pt'> </span>(<span style='letter-spacing:-.05pt'>3</span>.03)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.87<span style='letter-spacing:
  -.35pt'> </span>(0.65,<span style='letter-spacing:-.35pt'> </span>1.17)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All-cause<span style='letter-spacing:
  -.7pt'> </span>death<sup>†</sup></span></p>
  </td>
  <td width=101 style='width:1.05in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>111<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>3</span>.51)</span></p>
  </td>
  <td width=113 style='width:85.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>140<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>4</span>.42)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.79<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.6<span
  style='letter-spacing:-.05pt'>2</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>02)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>6</span>8</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>* Assessed<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.1pt'>b</span>y<span style='letter-spacing:-.1pt'> </span>s<span
style='letter-spacing:-.05pt'>e</span>quent<span style='letter-spacing:-.05pt'>i</span>al<span
style='letter-spacing:-.2pt'> </span>testing<span style='letter-spacing:-.2pt'>
</span><span style='letter-spacing:-.1pt'>s</span>tra<span style='letter-spacing:
-.05pt'>t</span>e<span style='letter-spacing:-.1pt'>g</span>y<span
style='letter-spacing:-.1pt'> </span>desig<span style='letter-spacing:-.1pt'>n</span>ed<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.15pt'> </span>control<span
style='letter-spacing:-.2pt'> </span>t<span style='letter-spacing:-.1pt'>h</span>e<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>o</span>vera<span
style='letter-spacing:-.05pt'>l</span>l<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>p</span>e<span style='letter-spacing:-.1pt'> </span>I<span
style='letter-spacing:-.2pt'> </span>err<span style='letter-spacing:-.1pt'>o</span>r<span
style='letter-spacing:-.15pt'> </span>in<span style='letter-spacing:-.15pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>tr<span style='letter-spacing:-.05pt'>i</span>a<span
style='letter-spacing:-.05pt'>l</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>†<span style='letter-spacing:-.35pt'> </span>Seconda<span
style='letter-spacing:-.1pt'>r</span>y<span style='letter-spacing:-.35pt'> </span>en<span
style='letter-spacing:-.1pt'>d</span>point.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.35pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>no<span style='letter-spacing:-.2pt'> </span>statistically<span
style='letter-spacing:-.25pt'> </span>significant<span style='letter-spacing:
-.3pt'> </span>difference<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.4pt'> </span>the<span style='letter-spacing:-.3pt'> </span>incidence<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>major<span
style='letter-spacing:-.35pt'> </span>bleeding<span style='letter-spacing:-.3pt'>
</span>between<span style='letter-spacing:-.3pt'> </span>apixaban and<span
style='letter-spacing:-.25pt'> </span>ASA<span style='letter-spacing:-.25pt'> </span>(see<span
style='letter-spacing:-.2pt'> </span>Table<span style='letter-spacing:-.25pt'> </span>9).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>9:<span
style='letter-spacing:-.3pt'> </span>Bleeding<span style='letter-spacing:-.3pt'>
e</span>vents<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.05pt'>i</span>n<span style='letter-spacing:-.25pt'> p</span>atients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> a</span>trial<span
style='letter-spacing:-.3pt'> f</span>ibri<span style='letter-spacing:-.05pt'>l</span>lation<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:-.3pt'> </span>AVERROES<span
style='letter-spacing:-.3pt'> s</span>tu<span style='letter-spacing:-.05pt'>d</span>y</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:38.45pt'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:38.45pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=132 style='width:99.0pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N<span style='letter-spacing:
  -.2pt'>&nbsp;</span>=<span style='letter-spacing:-.2pt'>&nbsp;</span>2,798</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n (%/year)</span></b></p>
  </td>
  <td width=114 style='width:85.5pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>ASA</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N<span style='letter-spacing:
  -.2pt'>&nbsp;</span>=<span style='letter-spacing:-.2pt'>&nbsp;</span>2,780</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.5pt'> </span>(%/year)</span></b></p>
  </td>
  <td width=138 style='width:103.5pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:
  .05pt'>a</span>zard<span style='letter-spacing:-.65pt'> r</span>atio</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(95%&nbsp;CI)</span></b></p>
  </td>
  <td width=66 style='width:49.5pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>p-value</span></b></p>
  </td>
 </tr>
 <tr style='height:14.45pt'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.45pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major*</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>45<span style='letter-spacing:
  -.4pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>41)</span></p>
  </td>
  <td width=114 style='width:85.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>29<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>92)</span></p>
  </td>
  <td width=138 style='width:103.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.54<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.9<span
  style='letter-spacing:-.05pt'>6</span>,<span style='letter-spacing:-.35pt'> </span>2<span
  style='letter-spacing:-.05pt'>.</span>45)</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>7</span>16</span></p>
  </td>
 </tr>
 <tr style='height:14.0pt'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.0pt'>
  <p class=TableParagraph style='margin-left:11.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Fatal,<span style='letter-spacing:-.35pt'>
  </span>n</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>5<span style='letter-spacing:
  -.35pt'> </span>(0.<span style='letter-spacing:-.05pt'>1</span>6)</span></p>
  </td>
  <td width=114 style='width:85.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>5<span style='letter-spacing:
  -.35pt'> </span>(0.<span style='letter-spacing:-.05pt'>1</span>6)</span></p>
  </td>
  <td width=138 style='width:103.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.2pt'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.2pt'>
  <p class=TableParagraph style='margin-left:11.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Intracranial,<span style='letter-spacing:
  -.6pt'> </span>n</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>11<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>34)</span></p>
  </td>
  <td width=114 style='width:85.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>11<span style='letter-spacing:
  -.4pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>35)</span></p>
  </td>
  <td width=138 style='width:103.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:.2in'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.4pt'> </span>+<span
  style='letter-spacing:-.35pt'> </span>CRNM<sup>†</sup></span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>140<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>4</span>.46)</span></p>
  </td>
  <td width=114 style='width:85.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>101<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>3</span>.24)</span></p>
  </td>
  <td width=138 style='width:103.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.38<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>1.0<span
  style='letter-spacing:-.05pt'>7</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>78)</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>1</span>44</span></p>
  </td>
 </tr>
 <tr style='height:17.5pt'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.5pt'>
  <p class=TableParagraph style='margin-left:2.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.5pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>325<span style='letter-spacing:
  -.5pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>0.<span
  style='letter-spacing:-.05pt'>8</span>5)</span></p>
  </td>
  <td width=114 style='width:85.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.5pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>250<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>8</span>.32)</span></p>
  </td>
  <td width=138 style='width:103.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.5pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.30<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>1.1<span
  style='letter-spacing:-.05pt'>0</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>53)</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.5pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>0</span>17</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>* Major<span style='letter-spacing:-.25pt'> </span>bleeding<span
style='letter-spacing:-.3pt'> </span>defi<span style='letter-spacing:-.1pt'>n</span>ed<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>p</span>er<span
style='letter-spacing:-.25pt'> </span>I<span style='letter-spacing:-.1pt'>n</span>ternatio<span
style='letter-spacing:-.1pt'>n</span>al<span style='letter-spacing:-.25pt'> </span>Socie<span
style='letter-spacing:-.15pt'>t</span>y<span style='letter-spacing:-.25pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>Thrombosis<span style='letter-spacing:
-.3pt'> </span>ad<span style='letter-spacing:-.25pt'> </span>Hae<span
style='letter-spacing:-.1pt'>m</span>ostasis<span style='letter-spacing:-.25pt'>
</span>(ISTH)<span style='letter-spacing:-.25pt'> </span>criteria.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>†<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>Clinicall</span>y<span style='letter-spacing:
-.15pt'> </span><span style='letter-spacing:-.1pt'>R</span>e<span
style='letter-spacing:-.05pt'>levan</span>t<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>Non-Major</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>NVAF patients with ACS and/or undergoing PCI</span></u></i></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>AUGUSTUS, an open-label, randomised, controlled, 2 by
2 factorial design trial, enrolled 4614 patients with NVAF who had ACS (43%)
and/or underwent PCI (56%). All patients received background therapy with a
P2Y12 inhibitor (clopidogrel: 90.3%) prescribed per local standard of care.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>Patients were randomised up to 14 days after the ACS
and/or PCI to either apixaban 5 mg twice daily (2.5 mg twice daily if two or
more of the dose-reduction criteria were met; 10% received lower dose) or VKA
and to either ASA (81 mg once daily) or placebo. The mean age was 69.9 years,
94% of patients randomised had a CHA2DS2-VASc score &gt; 2, and 47% had a
HAS-BLED score &gt; 3. For patients randomised to VKA, the proportion of time
in therapeutic range (TTR) (INR 2-3) was 56%, with 32% of time below TTR and
12% above TTR.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>The primary objective of AUGUSTUS was to assess
safety, with a primary endpoint of ISTH major or CRNM bleeding. In the apixaban
versus VKA comparison, the primary safety endpoint of ISTH major or CRNM
bleeding at month 6 occurred in 241 (10.5%), and 332 (14.7%) patients in the
apixaban arm and in the VKA arm respectively (HR=0.69, 95% CI: 0.58, 0.82;
2-sided p&lt;0.0001 for non-inferiority and p&lt;0.0001 for superiority). For
VKA, additional analyses using subgroups by TTR showed that the highest rate of
bleeding was associated with the lowest quartile of TTR. The rate of bleeding
was similar between apixaban and the highest quartile of TTR.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>In the ASA versus placebo comparison, the primary
safety endpoint of ISTH major or CRNM bleeding at month 6 occurred in 367
(16.1%), and 204 (9.0%) patients in the ASA arm and in the placebo arm
respectively (HR=1.88, 95% CI: 1.58, 2.23; two-sided p&lt;0.0001).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>Specifically, in apixaban-treated patients, major or
CRNM bleeding occurred in 157 (13.7%), and 84</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>(7.4%) patients in the ASA arm and in the placebo arm
respectively. In VKA-treated patients, major or CRNM bleeding occurred in 208
(18.5%), and 122 (10.8%) patients in the ASA arm and in the placebo arm
respectively.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>Other treatment effects were evaluated as a secondary
objective of the study, with composite endpoints.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>In the apixaban versus VKA comparison, the composite
endpoint of death or re-hospitalization occurred in 541 (23.5%) and 632 (27.4%)
patients in the apixaban and in the VKA arm, respectively. The composite endpoint
of death or ischemic event (stroke, myocardial infarction, stent thrombosis or urgent
revascularization) occured in 170 (7.4%), and 182 (7.9%) patients in the
apixaban and in the</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>VKA arm, respectively.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>In the ASA versus placebo comparison, the composite
endpoint of death or re-hospitalization occurred in 604 (26.2%) and 569 (24.7%)
patients in the ASA and in the placebo arm, respectively. The composite
endpoint of death or ischemic event (stroke, myocardial infarction, stent
thrombosis or urgent revascularization) occured in 163 (7.1%), and 189 (8.2%)
patients in the ASA and in the placebo arm, respectively.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Patients<span style='letter-spacing:-.8pt'> </span>und<span
style='letter-spacing:-.1pt'>e</span>rgoing<span style='letter-spacing:-.75pt'>
</span>card<span style='letter-spacing:-.05pt'>io</span>version</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>EMANATE,<span style='letter-spacing:-.3pt'> </span>an<span
style='letter-spacing:-.35pt'> </span>open-label,<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span>ulti-center<span
style='letter-spacing:-.35pt'> </span>stud<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.3pt'> </span>e<span style='letter-spacing:-.15pt'>n</span>rol<span
style='letter-spacing:-.05pt'>l</span>ed<span style='letter-spacing:-.35pt'> </span>1500<span
style='letter-spacing:-.35pt'>&nbsp;</span>patients<span style='letter-spacing:
-.35pt'> </span>who<span style='letter-spacing:-.3pt'> </span>were<span
style='letter-spacing:-.35pt'> </span>either<span style='letter-spacing:-.35pt'>
</span>oral anticoagulant<span style='letter-spacing:-.35pt'> </span>naïve<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>pre-treated<span
style='letter-spacing:-.3pt'> </span>less<span style='letter-spacing:-.35pt'> </span>than<span
style='letter-spacing:-.3pt'> </span>48<span style='letter-spacing:-.4pt'>&nbsp;</span>hours<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>scheduled<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>cardioversion<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>NVAF.
Patients<span style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:
-.25pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.25pt'> </span>1:1<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.05pt'>p</span>ixa<span
style='letter-spacing:-.05pt'>b</span>an<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>heparin<span
style='letter-spacing:-.25pt'> </span>and/or<span style='letter-spacing:-.25pt'>
</span>V<span style='letter-spacing:-.1pt'>K</span>A<span style='letter-spacing:
-.25pt'> </span>for<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>prevention<span style='letter-spacing:
-.3pt'> </span>of cardiovascular<span style='letter-spacing:-.4pt'> </span>events.<span
style='letter-spacing:-.35pt'> </span>Electrical<span style='letter-spacing:
-.4pt'> </span>and/or<span style='letter-spacing:-.35pt'> </span>pharmaco<span
style='letter-spacing:-.1pt'>l</span>ogic<span style='letter-spacing:-.35pt'> </span>cardiovers<span
style='letter-spacing:.05pt'>i</span>on<span style='letter-spacing:-.4pt'> </span>was<span
style='letter-spacing:-.35pt'> </span>conducted<span style='letter-spacing:
-.4pt'> </span>after<span style='letter-spacing:-.35pt'> </span>at<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:.05pt'>l</span>east<span
style='letter-spacing:-.4pt'> </span>5&nbsp;doses<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>5<span
style='letter-spacing:-.2pt'>&nbsp;</span>mg<span style='letter-spacing:-.2pt'>
</span>twice<span style='letter-spacing:-.2pt'> </span>daily<span
style='letter-spacing:-.2pt'> </span>apixaban<span style='letter-spacing:-.2pt'>
</span>(or<span style='letter-spacing:-.25pt'> </span>2.5<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.15pt'>
</span>daily<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.2pt'> </span>selected<span style='letter-spacing:-.2pt'>
</span>patients<span style='letter-spacing:-.2pt'> </span>(see<span
style='letter-spacing:-.2pt'> </span>section<span style='letter-spacing:-.2pt'>&nbsp;</span>4.2))<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.25pt'> </span>at
least<span style='letter-spacing:-.2pt'> </span>2<span style='letter-spacing:
-.2pt'>&nbsp;</span>hours<span style='letter-spacing:-.25pt'> </span>after<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.2pt'> </span>10<span
style='letter-spacing:-.15pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>loading<span style='letter-spacing:-.25pt'>
</span>dose<span style='letter-spacing:-.2pt'> </span>(or<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.2pt'> </span>5<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.15pt'> </span>loading<span style='letter-spacing:-.2pt'>
</span>dose<span style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:
-.25pt'> </span>selec<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.2pt'> </span>patients<span style='letter-spacing:-.2pt'>
</span>(see<span style='letter-spacing:-.2pt'> </span>sect<span
style='letter-spacing:.05pt'>i</span>on<span style='letter-spacing:-.2pt'>&nbsp;</span>4.2))
if<span style='letter-spacing:-.3pt'> </span>earlier<span style='letter-spacing:
-.25pt'> </span>cardioversion<span style='letter-spacing:-.3pt'> </span>was<span
style='letter-spacing:-.25pt'> </span>required.<span style='letter-spacing:
-.3pt'> </span>In<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:-.3pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban<span style='letter-spacing:-.25pt'> </span>group,<span
style='letter-spacing:-.3pt'> </span>342<span style='letter-spacing:-.35pt'>&nbsp;</span>pat<span
style='letter-spacing:-.05pt'>i</span>ents<span style='letter-spacing:-.25pt'> </span>received<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>loading<span
style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>(331&nbsp;patients<span
style='letter-spacing:-.25pt'> </span>rece<span style='letter-spacing:.05pt'>i</span>ved<span
style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:-.25pt'> </span>10<span
style='letter-spacing:-.2pt'>&nbsp;</span>mg<span style='letter-spacing:-.25pt'>
</span>dose<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>11<span style='letter-spacing:-.2pt'>&nbsp;</span>patients<span
style='letter-spacing:-.2pt'> </span>rece<span style='letter-spacing:.05pt'>i</span>ved<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>5<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>dose).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.25pt'> </span>were<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:.05pt'>n</span>o<span
style='letter-spacing:-.25pt'> </span>strokes<span style='letter-spacing:-.2pt'>
</span>(0<span style='letter-spacing:-.05pt'>%</span>)<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.2pt'> </span>g<span style='letter-spacing:-.05pt'>r</span>o<span
style='letter-spacing:-.05pt'>u</span>p<span style='letter-spacing:-.25pt'> </span>(<span
style='letter-spacing:-.05pt'>n</span>=<span style='letter-spacing:-.2pt'>&nbsp;</span>753)<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.3pt'> </span>6<span
style='letter-spacing:-.25pt'>&nbsp;</span>(0.80<span style='letter-spacing:
-.05pt'>%</span>)<span style='letter-spacing:-.25pt'> </span>stro<span
style='letter-spacing:-.05pt'>k</span>es<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>heparin
and/or<span style='letter-spacing:-.25pt'> </span>VKA<span style='letter-spacing:
-.2pt'> </span>group<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>(</span>n<span style='letter-spacing:-.2pt'>&nbsp;</span>=<span
style='letter-spacing:-.25pt'>&nbsp;</span>747;<span style='letter-spacing:
-.2pt'> </span>RR<span style='letter-spacing:-.25pt'> </span>0.00,<span
style='letter-spacing:-.2pt'> </span>95%<span style='letter-spacing:-.25pt'> </span>CI<span
style='letter-spacing:-.2pt'> </span>0.00,<span style='letter-spacing:-.3pt'> </span>0.64).<span
style='letter-spacing:-.2pt'> </span>All-cause<span style='letter-spacing:-.25pt'>
</span>death<span style='letter-spacing:-.2pt'> </span>occurred<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>2<span
style='letter-spacing:-.25pt'>&nbsp;</span>pati<span style='letter-spacing:
-.1pt'>e</span>nts (0.27%)<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>th</span>e<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>g<span style='letter-spacing:-.1pt'>r</span>oup<span style='letter-spacing:
-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>1<span
style='letter-spacing:-.25pt'>&nbsp;</span>pa<span style='letter-spacing:-.05pt'>t</span>ient<span
style='letter-spacing:-.25pt'> </span>(0.13<span style='letter-spacing:-.05pt'>%</span>)<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>heparin<span
style='letter-spacing:-.3pt'> </span>and/or<span style='letter-spacing:-.25pt'>
</span>VKA<span style='letter-spacing:-.25pt'> </span>group.<span
style='letter-spacing:-.25pt'> </span>No<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>s</span>yste<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>c e<span style='letter-spacing:-.1pt'>m</span>bolism<span
style='letter-spacing:-.55pt'> </span>events<span style='letter-spacing:-.45pt'>
</span>were<span style='letter-spacing:-.45pt'> </span>rep<span
style='letter-spacing:.05pt'>o</span>rted.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Major<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>CRNM<span
style='letter-spacing:-.3pt'> </span>bleeding<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.1pt'>e</span>vents<span style='letter-spacing:
-.25pt'> </span>occ<span style='letter-spacing:-.05pt'>u</span>rred<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>3<span
style='letter-spacing:-.3pt'> </span>(0.<span style='letter-spacing:-.05pt'>4</span>1<span
style='letter-spacing:-.05pt'>%</span>)<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>11<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>(</span>1.<span style='letter-spacing:-.05pt'>5</span>0<span
style='letter-spacing:-.05pt'>%</span>)<span style='letter-spacing:-.3pt'>&nbsp;</span>patients,
respectivel<span style='letter-spacing:.1pt'>y</span>,<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>group,<span style='letter-spacing:2.25pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>p</span>ared<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>6<span
style='letter-spacing:-.2pt'> </span>(0.83<span style='letter-spacing:-.05pt'>%</span>)<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>1</span>3<span style='letter-spacing:-.25pt'> </span>(1.<span
style='letter-spacing:-.05pt'>8</span>0<span style='letter-spacing:-.05pt'>%</span>)<span
style='letter-spacing:-.25pt'>&nbsp;</span>patients<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>h<span style='letter-spacing:-.1pt'>e</span>parin
and/or<span style='letter-spacing:-.45pt'> </span>VKA<span style='letter-spacing:
-.4pt'> </span>group.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>This<span style='letter-spacing:-.35pt'> </span>exploratory<span
style='letter-spacing:-.25pt'> </span>study<span style='letter-spacing:-.35pt'>
</span>showed<span style='letter-spacing:-.35pt'> </span>c<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>par<span
style='letter-spacing:.05pt'>a</span>ble<span style='letter-spacing:-.35pt'> </span>efficacy<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>safety<span
style='letter-spacing:-.35pt'> </span>between<span style='letter-spacing:-.35pt'>
</span>apixab<span style='letter-spacing:.05pt'>a</span>n<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>heparin<span
style='letter-spacing:-.3pt'> </span>and/or VKA<span style='letter-spacing:
-.35pt'> </span>trea<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>groups<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>setting<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>cardioversion.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Treatment<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>DVT,<span style='letter-spacing:-.3pt'> </span>treatment<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>PE<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.4pt'> </span>prevention<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>recurrent<span
style='letter-spacing:-.3pt'> </span>D<span style='letter-spacing:.05pt'>V</span>T<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.35pt'> </span>(VTEt)</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.55pt'> </span>clinical<span
style='letter-spacing:-.5pt'> </span>program<span style='letter-spacing:-.65pt'>
</span>(AMPLIFY:<span style='letter-spacing:-.5pt'> </span>apixaban<span
style='letter-spacing:-.55pt'> </span>versus<span style='letter-spacing:-.5pt'>
</span>enoxaparin/warfarin,<span style='letter-spacing:-.55pt'> </span>AMPLIFY-EXT:<span
style='letter-spacing:-.5pt'> </span>apixaban versus<span style='letter-spacing:
-.3pt'> </span>place<span style='letter-spacing:.05pt'>b</span>o)<span
style='letter-spacing:-.25pt'> </span>was<span style='letter-spacing:-.25pt'> </span>designed<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.25pt'> </span>de<span
style='letter-spacing:-.1pt'>m</span>onstrate<span style='letter-spacing:-.3pt'>
</span>the<span style='letter-spacing:-.25pt'> </span>efficacy<span
style='letter-spacing:-.15pt'> </span>and<span style='letter-spacing:-.3pt'> </span>safety<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>treatment<span style='letter-spacing:
-.3pt'> </span>of DVT<span style='letter-spacing:-.3pt'> </span>and/or<span
style='letter-spacing:-.3pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>(AMPLIFY),<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>extended<span
style='letter-spacing:-.25pt'> </span>thera<span style='letter-spacing:-.05pt'>p</span>y<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>preven<span
style='letter-spacing:-.05pt'>t</span>ion<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>recurrent<span style='letter-spacing:-.25pt'>
</span>DVT<span style='letter-spacing:-.3pt'> </span>and/<span
style='letter-spacing:-.05pt'>o</span>r<span style='letter-spacing:-.3pt'> </span>PE
following<span style='letter-spacing:-.35pt'> </span>6<span style='letter-spacing:
-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>t</span>o<span
style='letter-spacing:-.3pt'>&nbsp;</span>12<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.1pt'>m</span>onths<span style='letter-spacing:
-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>anticoagu<span
style='letter-spacing:-.05pt'>l</span>ant<span style='letter-spacing:-.3pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.15pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>DVT<span
style='letter-spacing:-.3pt'> </span>and/or<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.3pt'> </span>(AMPLIFY-EXT).<span style='letter-spacing:
-.25pt'> </span>Both studies<span style='letter-spacing:-.45pt'> </span>were<span
style='letter-spacing:-.4pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised,<span
style='letter-spacing:-.4pt'> </span>parallel-group,<span style='letter-spacing:
-.45pt'> </span>double-blind,<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ultinational<span style='letter-spacing:
-.4pt'> </span>trials<span style='letter-spacing:-.45pt'> </span>in<span
style='letter-spacing:-.4pt'> </span>pat<span style='letter-spacing:-.05pt'>i</span>ents<span
style='letter-spacing:-.4pt'> </span>with s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptomatic<span style='letter-spacing:-.3pt'>
</span>proxi<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>a</span>l<span style='letter-spacing:-.25pt'> </span>DVT<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptomatic<span style='letter-spacing:-.3pt'>
</span>PE.<span style='letter-spacing:-.3pt'> </span>A<span style='letter-spacing:
-.1pt'>l</span>l<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>k<span style='letter-spacing:-.1pt'>e</span>y<span
style='letter-spacing:-.2pt'> </span>safety<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>efficacy<span style='letter-spacing:-.3pt'>
</span>endp<span style='letter-spacing:-.05pt'>o</span>ints<span
style='letter-spacing:-.35pt'> </span>were adjudicated<span style='letter-spacing:
-.45pt'> </span>by<span style='letter-spacing:-.4pt'> </span>an<span
style='letter-spacing:-.45pt'> </span>independent<span style='letter-spacing:
-.4pt'> </span>blinded<span style='letter-spacing:-.45pt'> </span>c<span
style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>ittee.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>AMPLIFY<span style='letter-spacing:-.85pt'> </span>STUDY</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>AMPLIFY<span style='letter-spacing:-.25pt'>
</span>stu<span style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:
-.15pt'> </span>a<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>t</span>otal<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:-.05pt'>,</span>395<span
style='letter-spacing:-.3pt'>&nbsp;</span>patients<span style='letter-spacing:
-.25pt'> </span>were<span style='letter-spacing:-.25pt'> </span>rando<span
style='letter-spacing:-.1pt'>m</span>ised<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g twice<span style='letter-spacing:-.25pt'>
</span>daily<span style='letter-spacing:-.15pt'> </span>o<span
style='letter-spacing:-.1pt'>r</span>ally<span style='letter-spacing:-.1pt'> f</span>or<span
style='letter-spacing:-.25pt'> </span>7<span style='letter-spacing:-.25pt'>&nbsp;</span>days<span
style='letter-spacing:-.25pt'> </span>followed<span style='letter-spacing:-.2pt'>
</span><span style='letter-spacing:-.05pt'>b</span>y<span style='letter-spacing:
-.2pt'> </span>apixaban<span style='letter-spacing:-.3pt'> </span>5<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.2pt'> </span>daily<span
style='letter-spacing:-.25pt'> </span>oral<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.1pt'> </span>for<span style='letter-spacing:-.3pt'> </span>6<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>onths,<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.25pt'> </span>enoxaparin
1<span style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:
-.1pt'>m</span>g/kg<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.1pt'> </span>subcutaneously<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>at<span
style='letter-spacing:-.2pt'> </span>least<span style='letter-spacing:-.25pt'> </span>5<span
style='letter-spacing:-.25pt'>&nbsp;</span>days<span style='letter-spacing:
-.2pt'> </span>(until<span style='letter-spacing:-.25pt'> </span>IN<span
style='letter-spacing:-.1pt'>R</span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>2)<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span>warfarin<span
style='letter-spacing:-.25pt'> </span>(target<span style='letter-spacing:-.2pt'>
</span>INR<span style='letter-spacing:-.25pt'> </span>range 2.0-3<span
style='letter-spacing:-.05pt'>.</span>0)<span style='letter-spacing:-.3pt'> </span>oral<span
style='letter-spacing:-.05pt'>l</span>y<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>6<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>ont<span style='letter-spacing:-.05pt'>hs</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>mean<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:.05pt'>g</span>e<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.25pt'> </span>56.9<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:.05pt'>y</span>ears<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>89.<span
style='letter-spacing:-.05pt'>8</span>%<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>had<span style='letter-spacing:-.3pt'> </span>unpr<span
style='letter-spacing:-.05pt'>o</span>vok<span style='letter-spacing:-.1pt'>e</span>d<span
style='letter-spacing:-.25pt'> </span>VTE<span style='letter-spacing:-.3pt'> </span>events.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.25pt'> </span>warfarin,<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>mean<span
style='letter-spacing:-.3pt'> </span>perce<span style='letter-spacing:.05pt'>n</span>tage<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>time<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>therapeutic<span
style='letter-spacing:-.25pt'> </span>range<span style='letter-spacing:-.3pt'> </span>(INR<span
style='letter-spacing:-.3pt'> </span>2.0-3.0) was<span style='letter-spacing:
-.3pt'> </span>60.9.<span style='letter-spacing:-.3pt'> </span>Ap<span
style='letter-spacing:-.05pt'>i</span>xaban<span style='letter-spacing:-.3pt'> </span>showed<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.25pt'> </span>reduction<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>recurrent<span
style='letter-spacing:-.3pt'> </span>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>pto<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>t<span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.25pt'> </span>VTE<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>VTE-<span style='letter-spacing:-.3pt'> </span>related<span
style='letter-spacing:-.25pt'> </span>death<span style='letter-spacing:-.3pt'> </span>across
the<span style='letter-spacing:-.3pt'> </span>different<span style='letter-spacing:
-.25pt'> </span>levels<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>center<span style='letter-spacing:-.25pt'>
</span>TTR;<span style='letter-spacing:-.25pt'> </span>within<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>hig<span
style='letter-spacing:-.05pt'>h</span>est<span style='letter-spacing:-.25pt'> </span>quartile<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>TTR<span
style='letter-spacing:-.25pt'> </span>according<span style='letter-spacing:
-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>center,<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>relative
risk<span style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:
-.3pt'> </span>apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.3pt'> </span>vs<span style='letter-spacing:-.3pt'> </span>enox<span
style='letter-spacing:-.1pt'>a</span>parin/warfarin<span style='letter-spacing:
-.3pt'> </span>was<span style='letter-spacing:-.25pt'> </span>0.79<span
style='letter-spacing:-.3pt'> </span>(<span style='letter-spacing:-.05pt'>9</span>5%<span
style='letter-spacing:-.35pt'> </span>CI,<span style='letter-spacing:-.3pt'> </span>0.39,<span
style='letter-spacing:-.3pt'> </span>1.61).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>stu<span style='letter-spacing:-.05pt'>d</span>y,<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>was<span style='letter-spacing:-.25pt'> </span>shown<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.35pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>non-infer<span style='letter-spacing:-.05pt'>i</span>or<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>t</span>o<span
style='letter-spacing:-.3pt'> </span>enoxaparin<span style='letter-spacing:
-.05pt'>/</span>warfarin<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>c<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>bined<span
style='letter-spacing:-.25pt'> </span>pri<span style='letter-spacing:-.1pt'>m</span>ary
endpoint<span style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.1pt'>a</span>djudicated<span
style='letter-spacing:-.35pt'> </span>recurrent<span style='letter-spacing:
-.3pt'> </span>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptomatic<span style='letter-spacing:-.35pt'>
</span>VTE<span style='letter-spacing:-.4pt'> </span>(nonfatal<span
style='letter-spacing:-.35pt'> </span>DVT<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.35pt'> </span>n<span style='letter-spacing:-.05pt'>o</span>nfatal<span
style='letter-spacing:-.35pt'> </span>PE)<span style='letter-spacing:-.35pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>VTE-related death<span style='letter-spacing:
-.3pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>T<span
style='letter-spacing:.05pt'>a</span>ble<span style='letter-spacing:-.25pt'> </span>10).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>10:<span
style='letter-spacing:-.3pt'> </span>Efficacy<span style='letter-spacing:-.2pt'>
r</span>esults<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>AMPLIFY<span
style='letter-spacing:-.25pt'> s</span>tudy</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=631
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:17.0pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=119 style='width:89.55pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N=2,609</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></b></p>
  </td>
  <td width=154 style='width:115.25pt;border:solid black 1.0pt;border-left:
  none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Enoxaparin<span
  style='letter-spacing:-.05pt'>/ w</span>arfar</span></b><b><span lang=EN-GB
  style='font-size:11.0pt'>in</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N=2,635</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></b></p>
  </td>
  <td width=213 style='width:159.7pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Relative<span
  style='letter-spacing:-.6pt'> r</span>isk</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(95%&nbsp;CI)</span></b></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.45pt'> </span>or<span
  style='letter-spacing:-.45pt'> </span>VTE-related death</span></p>
  </td>
  <td width=119 style='width:89.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>59<span style='letter-spacing:
  -.35pt'> </span>(2<span style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=154 style='width:115.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>71<span style='letter-spacing:
  -.35pt'> </span>(2<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=213 style='width:159.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.84<span style='letter-spacing:
  -.4pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.6<span
  style='letter-spacing:-.05pt'>0</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>18)*</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:15.05pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>DVT</span></p>
  </td>
  <td width=119 style='width:89.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>20<span style='letter-spacing:
  -.35pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=154 style='width:115.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>33<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>2)</span></p>
  </td>
  <td width=213 style='width:159.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:15.05pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>PE</span></p>
  </td>
  <td width=119 style='width:89.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>27<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>0)</span></p>
  </td>
  <td width=154 style='width:115.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>23<span style='letter-spacing:
  -.35pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>9)</span></p>
  </td>
  <td width=213 style='width:159.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:15.05pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE-related</span><span lang=EN-GB
  style='font-size:11.0pt'> </span><span lang=EN-GB style='font-size:11.0pt'>death</span></p>
  </td>
  <td width=119 style='width:89.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>12<span style='letter-spacing:
  -.35pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>4)</span></p>
  </td>
  <td width=154 style='width:115.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>15<span style='letter-spacing:
  -.35pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>6)</span></p>
  </td>
  <td width=213 style='width:159.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.35pt'> </span>or<span
  style='letter-spacing:-.35pt'> </span>all-c<span style='letter-spacing:.05pt'>a</span>use
  death</span></p>
  </td>
  <td width=119 style='width:89.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>84<span style='letter-spacing:
  -.35pt'> </span>(3<span style='letter-spacing:-.05pt'>.</span>2)</span></p>
  </td>
  <td width=154 style='width:115.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>104<span style='letter-spacing:
  -.4pt'> </span>(<span style='letter-spacing:-.05pt'>4</span>.0)</span></p>
  </td>
  <td width=213 style='width:159.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.82<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.6<span
  style='letter-spacing:-.05pt'>1</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>08)</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.4pt'> </span>or<span
  style='letter-spacing:-.4pt'> </span>CV-<span style='letter-spacing:.05pt'>r</span>elated
  death</span></p>
  </td>
  <td width=119 style='width:89.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>61<span style='letter-spacing:
  -.35pt'> </span>(2<span style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=154 style='width:115.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>77<span style='letter-spacing:
  -.35pt'> </span>(2<span style='letter-spacing:-.05pt'>.</span>9)</span></p>
  </td>
  <td width=213 style='width:159.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.80<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.5<span
  style='letter-spacing:-.05pt'>7</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>11)</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE,<span style='letter-spacing:-.8pt'> </span>VTE-related
  death,<span style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
  style='letter-spacing:-.05pt'>a</span>jor bleeding</span></p>
  </td>
  <td width=119 style='width:89.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>73<span style='letter-spacing:
  -.35pt'> </span>(2<span style='letter-spacing:-.05pt'>.</span>8)</span></p>
  </td>
  <td width=154 style='width:115.25pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>118<span style='letter-spacing:
  -.4pt'> </span>(<span style='letter-spacing:-.05pt'>4</span>.5)</span></p>
  </td>
  <td width=213 style='width:159.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:21.0pt;text-align:
  center;text-indent:-21.0pt;punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>0.62<span style='font:7.0pt "Times New Roman"'> </span></span><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>(</span><span
  lang=EN-GB style='font-size:11.0pt'>0.4<span style='letter-spacing:-.05pt'>7</span>,<span
  style='letter-spacing:-.35pt'> </span>0<span style='letter-spacing:-.05pt'>.</span>83)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-align:justify;punctuation-wrap:simple'><span
lang=EN-GB style='font-size:10.0pt'>* Noninferior<span style='letter-spacing:
-.15pt'> </span>c<span style='letter-spacing:-.1pt'>o</span>mpared<span
style='letter-spacing:-.15pt'> </span>to<span style='letter-spacing:-.15pt'> </span>enoxaparin/war<span
style='letter-spacing:-.05pt'>f</span>arin<span style='letter-spacing:-.15pt'> </span>(<span
style='letter-spacing:-.1pt'>p</span>-value &lt;<span style='letter-spacing:
-.1pt'>0</span>.0001)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:.3pt'> </span>efficacy<span
style='letter-spacing:.3pt'> </span>in<span style='letter-spacing:.3pt'> </span>initial<span
style='letter-spacing:.3pt'> </span>trea<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:.3pt'> </span>of<span style='letter-spacing:.3pt'> </span>VTE<span
style='letter-spacing:.3pt'> </span>was<span style='letter-spacing:.25pt'> </span>consistent<span
style='letter-spacing:.3pt'> </span>between<span style='letter-spacing:.3pt'> </span>patients<span
style='letter-spacing:.3pt'> </span>who<span style='letter-spacing:.3pt'> </span>were<span
style='letter-spacing:.3pt'> </span>treated<span style='letter-spacing:.3pt'> </span>for<span
style='letter-spacing:.3pt'> </span>a PE<span style='letter-spacing:1.05pt'> </span>[<span
style='letter-spacing:.05pt'>R</span>elative<span style='letter-spacing:1.2pt'>
</span>Risk<span style='letter-spacing:1.1pt'> </span>0.9;<span
style='letter-spacing:1.05pt'> </span>95%<span style='letter-spacing:1.1pt'> </span>CI<span
style='letter-spacing:1.1pt'> </span>(0.5,<span style='letter-spacing:1.1pt'> </span>1.6<span
style='letter-spacing:.05pt'>)</span>]<span style='letter-spacing:1.0pt'> </span>or<span
style='letter-spacing:1.05pt'> </span>D<span style='letter-spacing:-.05pt'>V</span>T<span
style='letter-spacing:1.2pt'> </span>[Relative<span style='letter-spacing:1.1pt'>
</span>R<span style='letter-spacing:.05pt'>i</span>sk<span style='letter-spacing:
1.1pt'> </span>0.8;<span style='letter-spacing:1.05pt'> </span>95%<span
style='letter-spacing:1.1pt'> </span>CI<span style='letter-spacing:1.1pt'> </span>(0.5,<span
style='letter-spacing:1.1pt'> </span>1.3)<span style='letter-spacing:-.15pt'>]</span>.<span
style='letter-spacing:1.15pt'> </span>Efficacy across<span style='letter-spacing:
.4pt'> </span>subgroups,<span style='letter-spacing:.45pt'> </span>includi<span
style='letter-spacing:-.05pt'>n</span>g<span style='letter-spacing:.5pt'> </span>age,<span
style='letter-spacing:.5pt'> </span>gender,<span style='letter-spacing:.45pt'> </span>bo<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:.55pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ass<span style='letter-spacing:.45pt'> </span>ind<span
style='letter-spacing:-.1pt'>e</span>x<span style='letter-spacing:.4pt'> </span>(BMI),<span
style='letter-spacing:.45pt'> </span>renal<span style='letter-spacing:.45pt'> </span>function,<span
style='letter-spacing:.45pt'> </span>extent<span style='letter-spacing:.45pt'> </span>of<span
style='letter-spacing:.45pt'> </span>index<span style='letter-spacing:.45pt'> </span>PE,
location<span style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.1pt'>D</span><span
style='letter-spacing:-.05pt'>V</span>T<span style='letter-spacing:-.3pt'> </span>thro<span
style='letter-spacing:-.1pt'>m</span>bus,<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>pr<span style='letter-spacing:-.05pt'>i</span>or<span
style='letter-spacing:-.3pt'> </span>p<span style='letter-spacing:-.1pt'>a</span>rente<span
style='letter-spacing:-.05pt'>r</span>al<span style='letter-spacing:-.3pt'> </span>heparin<span
style='letter-spacing:-.35pt'> </span>use<span style='letter-spacing:-.3pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>generally<span style='letter-spacing:-.25pt'>
</span>consi<span style='letter-spacing:-.1pt'>s</span>tent.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:.7pt'> </span>pri<span
style='letter-spacing:-.1pt'>m</span>ary<span style='letter-spacing:.8pt'> </span>safety<span
style='letter-spacing:.85pt'> </span>endpo<span style='letter-spacing:-.05pt'>i</span>nt<span
style='letter-spacing:.7pt'> </span>was<span style='letter-spacing:.85pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor<span
style='letter-spacing:.75pt'> </span>bleeding.<span style='letter-spacing:.75pt'>
</span><span style='letter-spacing:-.1pt'>I</span>n<span style='letter-spacing:
.75pt'> </span>t<span style='letter-spacing:-.05pt'>h</span>e<span
style='letter-spacing:.75pt'> </span>stu<span style='letter-spacing:-.05pt'>d</span><span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:.75pt'> </span>ap<span
style='letter-spacing:-.05pt'>i</span>xaban<span style='letter-spacing:.7pt'> </span>was<span
style='letter-spacing:.75pt'> </span>statistically<span style='letter-spacing:
.85pt'> </span>superior<span style='letter-spacing:.75pt'> </span><span
style='letter-spacing:-.05pt'>t</span>o enoxaparin/warfarin<span
style='letter-spacing:2.2pt'> </span>in<span style='letter-spacing:2.15pt'> </span>the<span
style='letter-spacing:2.2pt'> </span>pri<span style='letter-spacing:-.1pt'>m</span>ary<span
style='letter-spacing:2.25pt'> </span>safety<span style='letter-spacing:2.25pt'>
</span>end<span style='letter-spacing:-.05pt'>p</span>oint<span
style='letter-spacing:2.05pt'> </span>[Relative<span style='letter-spacing:
2.2pt'> </span>Risk<span style='letter-spacing:2.15pt'> </span>0.31,<span
style='letter-spacing:2.2pt'> </span>9<span style='letter-spacing:-.05pt'>5</span>%<span
style='letter-spacing:2.15pt'> </span>confidence<span style='letter-spacing:
2.2pt'> </span>interval (0.17,<span style='letter-spacing:-.4pt'> </span>0.<span
style='letter-spacing:-.05pt'>5</span>5),<span style='letter-spacing:-.35pt'> </span>P-value<span
style='letter-spacing:-.3pt'> </span>&lt;0.<span style='letter-spacing:-.05pt'>0</span>001]<span
style='letter-spacing:-.45pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>Ta<span
style='letter-spacing:.05pt'>b</span>le<span style='letter-spacing:-.35pt'> </span>11).</span></p>

<p class=MsoBodyText style='margin-left:0in;text-align:justify;punctuation-wrap:
simple'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>11:<span
style='letter-spacing:-.3pt'> </span>Bleeding<span style='letter-spacing:-.3pt'>
r</span>esults<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>AMP<span
style='letter-spacing:-.05pt'>L</span>IFY<span style='letter-spacing:-.3pt'> s</span>tu<span
style='letter-spacing:-.05pt'>d</span>y</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:17.0pt'>
  <td width=146 style='width:109.35pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=146 style='width:109.5pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N=2,676</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></b></p>
  </td>
  <td width=164 style='width:123.2pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Enoxaparin/</span></b><b><span
  lang=EN-GB style='font-size:11.0pt'> w</span></b><b><span lang=EN-GB
  style='font-size:11.0pt'>arfarin</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N=2,689</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></b></p>
  </td>
  <td width=128 style='width:95.7pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Relative<span
  style='letter-spacing:-.6pt'> r</span>isk</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(95%<span
  style='letter-spacing:-.45pt'>&nbsp;</span>CI)</span></b></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=146 style='width:109.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major</span></p>
  </td>
  <td width=146 style='width:109.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>15<span style='letter-spacing:
  -.35pt'> </span>(0<span style='letter-spacing:-.05pt'>.</span>6)</span></p>
  </td>
  <td width=164 style='width:123.2pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>49<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>8)</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.31<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.1<span
  style='letter-spacing:-.05pt'>7</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>55)</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=146 style='width:109.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.35pt'>
  </span>+<span style='letter-spacing:-.35pt'> </span>CRNM</span></p>
  </td>
  <td width=146 style='width:109.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>115<span style='letter-spacing:
  -.4pt'> </span>(<span style='letter-spacing:-.05pt'>4</span>.3)</span></p>
  </td>
  <td width=164 style='width:123.2pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>261<span style='letter-spacing:
  -.4pt'> </span>(<span style='letter-spacing:-.05pt'>9</span>.7)</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.44<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.3<span
  style='letter-spacing:-.05pt'>6</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>55)</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=146 style='width:109.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Minor</span></p>
  </td>
  <td width=146 style='width:109.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>313<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>1.7)</span></p>
  </td>
  <td width=164 style='width:123.2pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>505<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>8.8)</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.62<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.5<span
  style='letter-spacing:-.05pt'>4</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>70)</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=146 style='width:109.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All</span></p>
  </td>
  <td width=146 style='width:109.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>402<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>5.0)</span></p>
  </td>
  <td width=164 style='width:123.2pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>676<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>2</span>5.1)</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.59<span style='letter-spacing:
  -.35pt'> </span><span style='letter-spacing:-.1pt'>(</span>0.5<span
  style='letter-spacing:-.05pt'>3</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>66)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>adjudicated<span
style='letter-spacing:-.3pt'> </span>major<span style='letter-spacing:-.3pt'> </span>ble<span
style='letter-spacing:.05pt'>e</span>ding<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>CRNM<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.3pt'> </span>at<span style='letter-spacing:-.35pt'> </span>any<span
style='letter-spacing:-.2pt'> </span>anatomical<span style='letter-spacing:
-.3pt'> </span>si<span style='letter-spacing:.05pt'>t</span>e<span
style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:-.3pt'> </span>generally<span
style='letter-spacing:-.2pt'> </span>lower<span style='letter-spacing:-.3pt'> </span>in
the<span style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:
-.4pt'> </span>group<span style='letter-spacing:-.35pt'> </span>as<span
style='letter-spacing:-.35pt'> </span>compared<span style='letter-spacing:-.3pt'>
</span>to<span style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:
-.35pt'> </span>enoxaparin/warfarin<span style='letter-spacing:-.35pt'> </span>grou<span
style='letter-spacing:-.05pt'>p</span>.<span style='letter-spacing:-.4pt'> </span>Adjudicated<span
style='letter-spacing:-.3pt'> </span>ISTH<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor
gastrointestinal<span style='letter-spacing:-.4pt'> </span>bleeding<span
style='letter-spacing:-.35pt'> </span>occurred<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.35pt'> </span>6<span style='letter-spacing:
-.35pt'> </span>(0.2%)<span style='letter-spacing:-.45pt'> </span>apixaban-treated<span
style='letter-spacing:-.35pt'> </span>pa<span style='letter-spacing:.05pt'>t</span>ients<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>17<span
style='letter-spacing:-.35pt'> </span>(0.6%) enoxaparin/warfarin-treated<span
style='letter-spacing:-1.6pt'> </span>patients.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>AMPLIFY-<span style='letter-spacing:.05pt'>E</span>XT<span
style='letter-spacing:-1.05pt'> </span>STUDY</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>AMPLIFY-EXT<span style='letter-spacing:
-.25pt'> </span>st<span style='letter-spacing:.05pt'>u</span><span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>total<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.05pt'>2</span>,482<span
style='letter-spacing:-.35pt'>&nbsp;</span>patien<span style='letter-spacing:
-.05pt'>t</span>s<span style='letter-spacing:-.25pt'> </span>were<span
style='letter-spacing:-.3pt'> </span>rand<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>sed<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>treatment<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban 2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.2pt'> </span>daily<span style='letter-spacing:-.25pt'> </span>orall<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>a</span>pixaban<span style='letter-spacing:-.25pt'>
</span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.2pt'> </span>d<span style='letter-spacing:-.1pt'>a</span>ily<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.05pt'>o</span>rall<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>placebo<span style='letter-spacing:-.2pt'>
</span>for<span style='letter-spacing:-.3pt'> </span>12<span style='letter-spacing:
-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>onths<span
style='letter-spacing:-.25pt'> </span>after<span style='letter-spacing:-.2pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span>pleting 6<span style='letter-spacing:-.3pt'>&nbsp;</span>to<span
style='letter-spacing:-.25pt'>&nbsp;</span>12<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>onths<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>initial<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.1pt'>a</span>nticoagulant<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>t</span>rea<span
style='letter-spacing:.05pt'>t</span>ment.<span style='letter-spacing:-.25pt'> </span>Of<span
style='letter-spacing:-.35pt'> </span>these,<span style='letter-spacing:-.25pt'>
</span>836<span style='letter-spacing:-.25pt'>&nbsp;</span>pat<span
style='letter-spacing:-.05pt'>i</span>ents<span style='letter-spacing:-.25pt'> </span>(33.7%)<span
style='letter-spacing:-.3pt'> </span>participated<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the AMPLIFY<span
style='letter-spacing:-.35pt'> </span>stu<span style='letter-spacing:-.05pt'>d</span>y<span
style='letter-spacing:-.35pt'> </span>prior<span style='letter-spacing:-.35pt'>
</span>to<span style='letter-spacing:-.4pt'> </span>enroll<span
style='letter-spacing:-.1pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.35pt'> </span>AMPLIFY-EXT<span
style='letter-spacing:-.35pt'> </span>study.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>mean<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:.05pt'>g</span>e<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.25pt'> </span>56.7<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:.05pt'>y</span>ears<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>91.<span
style='letter-spacing:-.05pt'>7</span>%<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>had<span style='letter-spacing:-.3pt'> </span>unpr<span
style='letter-spacing:-.05pt'>o</span>vok<span style='letter-spacing:-.1pt'>e</span>d<span
style='letter-spacing:-.25pt'> </span>VTE<span style='letter-spacing:-.3pt'> </span>events.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>study,<span style='letter-spacing:-.3pt'>
</span>both<span style='letter-spacing:-.3pt'> </span>doses<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>were<span style='letter-spacing:-.25pt'> </span>statistically<span
style='letter-spacing:-.25pt'> </span>superior<span style='letter-spacing:-.25pt'>
</span>to<span style='letter-spacing:-.3pt'> </span>p<span style='letter-spacing:
-.05pt'>l</span>acebo<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>pr<span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>ary<span
style='letter-spacing:-.15pt'> </span>endpoint<span style='letter-spacing:-.25pt'>
</span>of s<span style='letter-spacing:.05pt'>y</span><span style='letter-spacing:
-.1pt'>m</span>ptomatic,<span style='letter-spacing:-.3pt'> </span>recurrent<span
style='letter-spacing:-.3pt'> </span>VTE<span style='letter-spacing:-.3pt'> </span>(nonfatal<span
style='letter-spacing:-.3pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>nonfa<span style='letter-spacing:-.05pt'>t</span>al<span
style='letter-spacing:-.3pt'> </span>PE)<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>all-cause<span style='letter-spacing:-.25pt'>
</span>death<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.3pt'> </span>Table<span style='letter-spacing:-.3pt'> </span>12).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.35pt'> </span>12:<span
style='letter-spacing:-.35pt'> </span>Efficacy<span style='letter-spacing:-.2pt'>
r</span>esults<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span>AMPLIFY-EXT<span
style='letter-spacing:-.3pt'> s</span>tudy</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=621
 style='margin-left:5.5pt;border-collapse:collapse'>
 <thead>
  <tr style='height:14.15pt'>
   <td width=102 style='width:76.3pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:14.15pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=85 style='width:64.1pt;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:14.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
   </td>
   <td width=86 style='width:.9in;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:14.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
   </td>
   <td width=91 style='width:.95in;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:14.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Placebo</span></b></p>
   </td>
   <td width=257 colspan=2 style='width:192.45pt;border:solid black 1.0pt;
   border-left:none;padding:0in 0in 0in 0in;height:14.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Relative<span
   style='letter-spacing:-.35pt'> r</span>isk<span style='letter-spacing:-.35pt'>
   </span>(95%<span style='letter-spacing:-.35pt'>&nbsp;</span>CI)</span></b></p>
   </td>
  </tr>
  <tr style='height:14.15pt'>
   <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
   padding:0in 0in 0in 0in;height:14.15pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=85 style='width:64.1pt;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:14.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>2.5<span
   style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>m</span>g</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>(N=840)</span></b></p>
   </td>
   <td width=86 style='width:.9in;border-top:none;border-left:none;border-bottom:
   solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:14.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>5.0<span
   style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>m</span>g</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>(N=813)</span></b></p>
   </td>
   <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
   solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:14.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>(N=829)</span></b></p>
   </td>
   <td width=124 style='width:93.3pt;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:14.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix<span
   style='letter-spacing:-.3pt'> </span>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
   style='letter-spacing:-.05pt'>m</span>g vs.<span style='letter-spacing:-.5pt'>
   p</span>lacebo</span></b></p>
   </td>
   <td width=132 style='width:99.15pt;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:14.15pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix<span
   style='letter-spacing:-.3pt'> </span>5.0<span style='letter-spacing:-.25pt'>&nbsp;</span><span
   style='letter-spacing:-.05pt'>m</span>g vs.<span style='letter-spacing:-.5pt'>
   p</span>lacebo</span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=263 colspan=3 style='width:197.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Recurrent</span></p>
  </td>
  <td width=85 rowspan=2 style='width:64.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>19<span style='letter-spacing:
  -.35pt'> </span>(2<span style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=86 rowspan=2 style='width:.9in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>77<span style='letter-spacing:
  -.35pt'> </span>(9<span style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.24</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.19</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.25pt'> </span>or<span
  style='letter-spacing:-.25pt'> </span>all-<span style='letter-spacing:-.05pt'>caus</span>e<span
  style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>death</span></span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.15,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>4</span>0)<sup><span
  style='letter-spacing:-.05pt'>¥</span></sup></span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.11,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>3)<sup><span
  style='letter-spacing:-.05pt'>¥</span></sup></span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:12.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>DVT*</span></p>
  </td>
  <td width=85 style='width:64.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>6<span style='letter-spacing:
  -.3pt'> </span>(0.7)</span></p>
  </td>
  <td width=86 style='width:.9in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>7<span style='letter-spacing:
  -.3pt'> </span>(0.9)</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>53<span style='letter-spacing:
  -.35pt'> </span>(6<span style='letter-spacing:-.05pt'>.</span>4)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:12.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>PE*</span></p>
  </td>
  <td width=85 style='width:64.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>7<span style='letter-spacing:
  -.3pt'> </span>(0.8)</span></p>
  </td>
  <td width=86 style='width:.9in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>4<span style='letter-spacing:
  -.3pt'> </span>(0.5)</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>13<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>6)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:12.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>All-cause </span><span
  lang=EN-GB style='font-size:11.0pt'>death</span></p>
  </td>
  <td width=85 style='width:64.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>6<span style='letter-spacing:
  -.3pt'> </span>(0.7)</span></p>
  </td>
  <td width=86 style='width:.9in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>3<span style='letter-spacing:
  -.3pt'> </span>(0.4)</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>11<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Recurrent</span></p>
  </td>
  <td width=85 rowspan=2 style='width:64.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=86 rowspan=2 style='width:.9in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>73<span style='letter-spacing:
  -.35pt'> </span>(8<span style='letter-spacing:-.05pt'>.</span>8)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.19</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.20</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.3pt'> </span>or<span
  style='letter-spacing:-.3pt'> </span>VTE-related<span style='letter-spacing:
  -.55pt'> </span>death</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.11,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>3)</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.11,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>4)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Recurrent</span></p>
  </td>
  <td width=85 rowspan=2 style='width:64.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=86 rowspan=2 style='width:.9in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>76<span style='letter-spacing:
  -.35pt'> </span>(9<span style='letter-spacing:-.05pt'>.</span>2)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.18</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.19</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.25pt'> </span>or<span
  style='letter-spacing:-.25pt'> </span>CV-related<span style='letter-spacing:
  -.55pt'> </span>death</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.10,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>2)</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.11,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>3)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Nonfatal</span></p>
  </td>
  <td width=85 rowspan=2 style='width:64.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>6<span style='letter-spacing:
  -.3pt'> </span>(0.7)</span></p>
  </td>
  <td width=86 rowspan=2 style='width:.9in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>8<span style='letter-spacing:
  -.3pt'> </span>(1.0)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>53<span style='letter-spacing:
  -.35pt'> </span>(6<span style='letter-spacing:-.05pt'>.</span>4)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.11</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.15</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>DV</span><span
  lang=EN-GB style='font-size:11.0pt'>T<sup>†</sup></span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.05,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>2</span>6)</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.07,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>2)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Nonfatal<span style='letter-spacing:-.55pt'>
  </span>P<span style='letter-spacing:-.05pt'>E</span><sup>†</sup></span></p>
  </td>
  <td width=85 style='width:64.1pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>8<span style='letter-spacing:
  -.3pt'> </span>(1.0)</span></p>
  </td>
  <td width=86 style='width:.9in;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>4<span style='letter-spacing:
  -.3pt'> </span>(0.5)</span></p>
  </td>
  <td width=91 style='width:.95in;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>15<span style='letter-spacing:
  -.35pt'> </span>(1<span style='letter-spacing:-.05pt'>.</span>8)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.51</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.22,<span
  style='letter-spacing:-.55pt'> </span>1.<span style='letter-spacing:-.05pt'>2</span>1)</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.27</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.09,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>8</span>0)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE-related</span><span lang=EN-GB
  style='font-size:11.0pt'> </span><span lang=EN-GB style='font-size:11.0pt'>death</span></p>
  </td>
  <td width=85 style='width:64.1pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2<span style='letter-spacing:
  -.3pt'> </span>(0.2)</span></p>
  </td>
  <td width=86 style='width:.9in;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>3<span style='letter-spacing:
  -.3pt'> </span>(0.4)</span></p>
  </td>
  <td width=91 style='width:.95in;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>7<span style='letter-spacing:
  -.3pt'> </span>(0.8)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.28</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.06,<span
  style='letter-spacing:-.55pt'> </span>1.<span style='letter-spacing:-.05pt'>3</span>7)</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.45</span></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.12,<span
  style='letter-spacing:-.55pt'> </span>1.<span style='letter-spacing:-.05pt'>7</span>1)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><sup><span lang=EN-GB
style='font-size:10.0pt;letter-spacing:-.05pt'>¥</span></sup><span lang=EN-GB
style='font-size:10.0pt;position:relative;top:-3.0pt;letter-spacing:-.1pt'> </span><span
lang=EN-GB style='font-size:10.0pt;letter-spacing:-.05pt'>p-valu</span><span
lang=EN-GB style='font-size:10.0pt'>e<span style='letter-spacing:-.1pt'> </span>&lt;<span
style='letter-spacing:-.15pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>0.00</span><span
style='letter-spacing:-.1pt'>0</span>1</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>* For<span style='letter-spacing:.7pt'> </span>patients<span
style='letter-spacing:.7pt'> </span><span style='letter-spacing:-.1pt'>w</span>ith<span
style='letter-spacing:.7pt'> </span>more<span style='letter-spacing:.7pt'> </span>t<span
style='letter-spacing:-.1pt'>h</span>an<span style='letter-spacing:.7pt'> </span><span
style='letter-spacing:-.1pt'>o</span>ne<span style='letter-spacing:.7pt'> </span>e<span
style='letter-spacing:-.1pt'>v</span>ent<span style='letter-spacing:.65pt'> </span>contri<span
style='letter-spacing:-.1pt'>b</span>uting<span style='letter-spacing:.7pt'> </span>to<span
style='letter-spacing:.65pt'> </span>the<span style='letter-spacing:.65pt'> </span>composite<span
style='letter-spacing:.7pt'> </span>endp<span style='letter-spacing:-.1pt'>o</span>int,<span
style='letter-spacing:.7pt'> </span>only<span style='letter-spacing:.75pt'> </span>t<span
style='letter-spacing:-.1pt'>h</span>e<span style='letter-spacing:.7pt'> </span>fir<span
style='letter-spacing:-.1pt'>s</span>t<span style='letter-spacing:.7pt'> </span><span
style='letter-spacing:-.05pt'>even</span>t<span style='letter-spacing:.7pt'> </span><span
style='letter-spacing:-.05pt'>wa</span>s<span style='letter-spacing:.7pt'> </span><span
style='letter-spacing:-.1pt'>r</span>e<span style='letter-spacing:-.05pt'>porte</span>d<span
style='letter-spacing:.7pt'> </span><span style='letter-spacing:-.05pt'>(eg</span>,<span
style='letter-spacing:.7pt'> </span><span style='letter-spacing:-.05pt'>i</span>f<span
style='letter-spacing:.65pt'> </span>a <span style='letter-spacing:-.05pt'>s</span>ubject<span
style='letter-spacing:-.2pt'> </span>exp<span style='letter-spacing:-.05pt'>e</span>rie<span
style='letter-spacing:-.1pt'>n</span>ced<span style='letter-spacing:-.1pt'> </span>b<span
style='letter-spacing:-.1pt'>o</span>th<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.1pt'> </span>DVT<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.1pt'> </span>t<span style='letter-spacing:-.1pt'>h</span>en<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.1pt'> </span><span
style='letter-spacing:-.05pt'>PE</span>,<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.1pt'>o</span>n<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.05pt'> </span>t<span style='letter-spacing:-.1pt'>h</span>e<span
style='letter-spacing:-.15pt'> </span>DVT<span style='letter-spacing:-.1pt'> </span>w<span
style='letter-spacing:-.05pt'>a</span>s<span style='letter-spacing:-.15pt'> </span>reported)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><sup><span lang=EN-GB
style='font-size:10.0pt'>†</span></sup><span lang=EN-GB style='font-size:10.0pt;
letter-spacing:-.25pt'> </span><span lang=EN-GB style='font-size:10.0pt'>Individ<span
style='letter-spacing:-.1pt'>u</span>al<span style='letter-spacing:-.2pt'> </span>subjects<span
style='letter-spacing:-.3pt'> </span>could<span style='letter-spacing:-.25pt'> </span>expe<span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>i</span>ence<span
style='letter-spacing:-.2pt'> </span>more<span style='letter-spacing:-.25pt'> </span>t<span
style='letter-spacing:-.1pt'>h</span>an<span style='letter-spacing:-.25pt'> </span>one<span
style='letter-spacing:-.2pt'> </span>e<span style='letter-spacing:-.1pt'>v</span>ent<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>repre<span style='letter-spacing:-.1pt'>s</span>ented<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>b</span>oth<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>c</span>la<span style='letter-spacing:-.05pt'>ss</span>ifi<span
style='letter-spacing:-.05pt'>c</span>atio<span style='letter-spacing:-.1pt'>n</span>s</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:.2pt'> </span>efficacy<span
style='letter-spacing:.25pt'> </span>for<span style='letter-spacing:.25pt'> </span>prevention<span
style='letter-spacing:.2pt'> </span>of<span style='letter-spacing:.15pt'> </span>a<span
style='letter-spacing:.25pt'> </span>recur<span style='letter-spacing:.05pt'>r</span>e<span
style='letter-spacing:.05pt'>n</span>ce<span style='letter-spacing:.2pt'> </span>of<span
style='letter-spacing:.2pt'> </span>a<span style='letter-spacing:.25pt'> </span>VTE<span
style='letter-spacing:.25pt'> </span>was<span style='letter-spacing:.3pt'> </span>mainta<span
style='letter-spacing:.05pt'>i</span>ned<span style='letter-spacing:.2pt'> </span>across<span
style='letter-spacing:.3pt'> </span>subgroups, includi<span style='letter-spacing:
-.05pt'>n</span>g<span style='letter-spacing:-.35pt'> </span>age,<span
style='letter-spacing:-.3pt'> </span>gender,<span style='letter-spacing:-.35pt'>
</span>B<span style='letter-spacing:-.05pt'>M</span>I,<span style='letter-spacing:
-.3pt'> </span>and<span style='letter-spacing:-.35pt'> </span>renal<span
style='letter-spacing:-.3pt'> </span>function.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:2.6pt'> </span>primary<span
style='letter-spacing:2.65pt'> </span>safety<span style='letter-spacing:2.7pt'>
</span>end<span style='letter-spacing:-.05pt'>p</span>oint<span
style='letter-spacing:2.65pt'> </span>was<span style='letter-spacing:2.7pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ajor<span style='letter-spacing:2.65pt'> </span>bleeding<span
style='letter-spacing:2.55pt'> </span>during<span style='letter-spacing:2.65pt'>
</span><span style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:
2.65pt'> </span>treatment<span style='letter-spacing:2.65pt'> </span>period.<span
style='letter-spacing:2.6pt'> </span>In<span style='letter-spacing:2.65pt'> </span>the<span
style='letter-spacing:2.65pt'> </span>s<span style='letter-spacing:-.05pt'>t</span>u<span
style='letter-spacing:-.05pt'>d</span><span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:2.65pt'> </span>the incidence<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>major<span
style='letter-spacing:-.2pt'> </span>bleeding<span style='letter-spacing:-.25pt'>
</span>for<span style='letter-spacing:-.2pt'> </span>bo<span style='letter-spacing:
-.05pt'>t</span>h<span style='letter-spacing:-.2pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>doses<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>not<span style='letter-spacing:-.2pt'> </span>stat<span
style='letter-spacing:.05pt'>i</span>stically<span style='letter-spacing:-.15pt'>
</span>different<span style='letter-spacing:-.2pt'> </span>from<span
style='letter-spacing:-.3pt'> </span>pl<span style='letter-spacing:.05pt'>a</span><span
style='letter-spacing:-.05pt'>c</span>ebo.<span style='letter-spacing:-.25pt'> </span>There
was<span style='letter-spacing:.35pt'> </span>no<span style='letter-spacing:
.35pt'> </span>statistically<span style='letter-spacing:.45pt'> </span>signifi<span
style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:-.05pt'>a</span>nt<span
style='letter-spacing:.35pt'> </span>difference<span style='letter-spacing:
.35pt'> </span>in<span style='letter-spacing:.35pt'> </span>the<span
style='letter-spacing:.3pt'> </span>incid<span style='letter-spacing:-.1pt'>e</span>nce<span
style='letter-spacing:.35pt'> </span>of<span style='letter-spacing:.35pt'> </span>major<span
style='letter-spacing:.35pt'> </span>+<span style='letter-spacing:.35pt'> </span>CRNM,<span
style='letter-spacing:.4pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>nor,<span style='letter-spacing:.35pt'> </span>and<span
style='letter-spacing:.35pt'> </span>all<span style='letter-spacing:.3pt'> </span><span
style='letter-spacing:-.05pt'>b</span>leeding between<span style='letter-spacing:
-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>2.5<span style='letter-spacing:-.35pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>tw<span
style='letter-spacing:.05pt'>i</span>ce<span style='letter-spacing:-.25pt'> </span>dai<span
style='letter-spacing:.05pt'>l</span>y<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>placebo<span style='letter-spacing:-.25pt'>
</span>trea<span style='letter-spacing:.05pt'>t</span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>g<span style='letter-spacing:.05pt'>r</span>oups<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>Table<span
style='letter-spacing:-.3pt'> </span>13).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.35pt'> </span>13:<span
style='letter-spacing:-.35pt'> </span>Bleeding<span style='letter-spacing:-.3pt'>
r</span>esults<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.3pt'> </span>AMP<span
style='letter-spacing:-.05pt'>L</span>IFY-EXT<span style='letter-spacing:-.35pt'>
s</span>tu<span style='letter-spacing:-.05pt'>d</span>y</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:14.15pt'>
  <td width=91 style='width:.95in;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=91 style='width:.95in;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  </td>
  <td width=91 style='width:.95in;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  </td>
  <td width=91 style='width:.95in;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Placebo</span></b></p>
  </td>
  <td width=272 colspan=2 style='width:204.3pt;border:solid black 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Relative<span
  style='letter-spacing:-.35pt'> r</span>isk<span style='letter-spacing:-.35pt'>
  </span>(95%<span style='letter-spacing:-.35pt'>&nbsp;</span>CI)</span></b></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=91 style='width:.95in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>2.5<span
  style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>m</span>g</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(N=840)</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>5.0<span
  style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>m</span>g</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(N=811)</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(N=826)</span></p>
  </td>
  <td width=128 style='width:96.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix<span
  style='letter-spacing:-.3pt'> </span>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.05pt'>m</span>g</span></b><b><span lang=EN-GB
  style='font-size:11.0pt'> vs.<span style='letter-spacing:-.5pt'> p</span>lacebo</span></b></p>
  </td>
  <td width=144 style='width:1.5in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix<span
  style='letter-spacing:-.3pt'> </span>5.0<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.05pt'>m</span>g</span></b><b><span lang=EN-GB
  style='font-size:11.0pt'> vs.<span style='letter-spacing:-.5pt'> p</span>lacebo</span></b></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=91 style='width:.95in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=128 style='width:96.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=144 style='width:1.5in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=91 rowspan=2 style='width:.95in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2<span style='letter-spacing:
  -.3pt'> </span>(0.2)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1<span style='letter-spacing:
  -.3pt'> </span>(0.1)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>4<span style='letter-spacing:
  -.3pt'> </span>(0.5)</span></p>
  </td>
  <td width=128 style='width:96.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.49</span></p>
  </td>
  <td width=144 style='width:1.5in;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.25</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=128 style='width:96.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.09,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>6</span>4)</span></p>
  </td>
  <td width=144 style='width:1.5in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.03,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>2</span>4)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=91 style='width:.95in;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.35pt'>
  </span>+</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>27<span style='letter-spacing:
  -.35pt'> </span>(3<span style='letter-spacing:-.05pt'>.</span>2)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>35<span style='letter-spacing:
  -.35pt'> </span>(4<span style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>22<span style='letter-spacing:
  -.35pt'> </span>(2<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=128 style='width:96.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.20</span></p>
  </td>
  <td width=144 style='width:1.5in;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.62</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=91 style='width:.95in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>CRNM</span></p>
  </td>
  <td width=128 style='width:96.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.69,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>1</span>0)</span></p>
  </td>
  <td width=144 style='width:1.5in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.96,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>7</span>3)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=91 rowspan=2 style='width:.95in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Minor</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>75<span style='letter-spacing:
  -.35pt'> </span>(8<span style='letter-spacing:-.05pt'>.</span>9)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>98<span style='letter-spacing:
  -.4pt'> </span>(1<span style='letter-spacing:-.05pt'>2</span>.1)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>58<span style='letter-spacing:
  -.35pt'> </span>(7<span style='letter-spacing:-.05pt'>.</span>0)</span></p>
  </td>
  <td width=128 style='width:96.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.26</span></p>
  </td>
  <td width=144 style='width:1.5in;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.70</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=128 style='width:96.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.91,<span
  style='letter-spacing:-.55pt'> </span>1.<span style='letter-spacing:-.05pt'>7</span>5)</span></p>
  </td>
  <td width=144 style='width:1.5in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(1.25,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>3</span>1)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=91 rowspan=2 style='width:.95in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>94<span style='letter-spacing:
  -.4pt'> </span>(1<span style='letter-spacing:-.05pt'>1</span>.2)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>121<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>4.9)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>74<span style='letter-spacing:
  -.35pt'> </span>(9<span style='letter-spacing:-.05pt'>.</span>0)</span></p>
  </td>
  <td width=128 style='width:96.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.24</span></p>
  </td>
  <td width=144 style='width:1.5in;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.65</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=128 style='width:96.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.93,<span
  style='letter-spacing:-.55pt'> </span>1.<span style='letter-spacing:-.05pt'>6</span>5)</span></p>
  </td>
  <td width=144 style='width:1.5in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(1.26,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>1</span>6)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Adjudicated ISTH<span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor
gastrointestin<span style='letter-spacing:.05pt'>a</span>l bleeding<span
style='letter-spacing:-.05pt'> </span>occurred in 1 (0.1%) apixaban-treated
patient at the 5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.2pt'> </span>dose,<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>at<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>t<span
style='letter-spacing:-.05pt'>w</span>ice<span style='letter-spacing:-.2pt'> </span>dai<span
style='letter-spacing:-.05pt'>l</span>y<span style='letter-spacing:-.15pt'> </span>dose,<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>a</span>nd<span
style='letter-spacing:-.25pt'> </span>1<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>(</span>0.1<span style='letter-spacing:-.05pt'>%</span>)<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>p</span>lacebo-treated<span
style='letter-spacing:-.2pt'> </span>patient.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Paediatric<span style='letter-spacing:-.95pt'> </span>population</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>European<span
style='letter-spacing:-.3pt'> </span>Medicines<span style='letter-spacing:-.25pt'>
</span>Agency<span style='letter-spacing:-.2pt'> </span>has<span
style='letter-spacing:-.25pt'> </span>deferred<span style='letter-spacing:-.3pt'>
</span>the<span style='letter-spacing:-.25pt'> </span>obligation<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>sub<span
style='letter-spacing:-.1pt'>m</span>it<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>results<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>studies<span
style='letter-spacing:-.25pt'> </span>with Apixaban<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>one<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ore<span style='letter-spacing:-.25pt'> </span>subsets<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>paediatric<span style='letter-spacing:
-.25pt'> </span>popul<span style='letter-spacing:-.1pt'>a</span>tion<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>ven<span
style='letter-spacing:-.05pt'>ou</span>s<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>arterial<span style='letter-spacing:-.2pt'>
</span>e<span style='letter-spacing:-.1pt'>m</span>bolism<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:.05pt'>n</span>d
thro<span style='letter-spacing:-.1pt'>m</span>bosis<span style='letter-spacing:
-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.2<span style='letter-spacing:-.4pt'>
</span>for<span style='letter-spacing:-.3pt'> </span>infor<span
style='letter-spacing:-.1pt'>m</span>at<span style='letter-spacing:.05pt'>i</span>on<span
style='letter-spacing:-.3pt'> </span>on<span style='letter-spacing:-.35pt'> </span>paediatric<span
style='letter-spacing:-.3pt'> </span>use).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>5.2<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Phar<span style='letter-spacing:-.05pt'>m</span>acokinetic<span
style='letter-spacing:-1.3pt'> </span>properties</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Absorption</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>absolute<span
style='letter-spacing:-.25pt'> </span>bioavailability<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.25pt'> </span>approxi<span
style='letter-spacing:-.1pt'>m</span>ately<span style='letter-spacing:-.25pt'> </span>50%<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.35pt'> </span>doses<span
style='letter-spacing:-.25pt'> </span>up<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g.<span style='letter-spacing:-.3pt'> </span>Apixaban<span
style='letter-spacing:-.25pt'> </span>is rapidly<span style='letter-spacing:
-.2pt'> </span>absorbed<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span><span style='letter-spacing:.05pt'>xi</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>u</span>m<span
style='letter-spacing:-.4pt'> </span>conce<span style='letter-spacing:.05pt'>n</span>trations<span
style='letter-spacing:-.25pt'> </span>(C<sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub>)<span style='letter-spacing:-.3pt'> </span>appearing<span
style='letter-spacing:-.3pt'> </span>3<span style='letter-spacing:-.3pt'>&nbsp;</span>to<span
style='letter-spacing:-.3pt'>&nbsp;</span>4<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.05pt'>h</span>ours<span style='letter-spacing:-.3pt'> </span>af<span
style='letter-spacing:-.05pt'>te</span>r<span style='letter-spacing:-.3pt'> </span>tablet<span
style='letter-spacing:-.25pt'> </span>intake.<span style='letter-spacing:-.3pt'>
</span>Intake with<span style='letter-spacing:-.2pt'> </span>food<span
style='letter-spacing:-.25pt'> </span>do<span style='letter-spacing:-.1pt'>e</span>s<span
style='letter-spacing:-.2pt'> </span>not<span style='letter-spacing:-.2pt'> </span>affect<span
style='letter-spacing:-.2pt'> </span>apixaban<span style='letter-spacing:-.2pt'>
</span>AUC<span style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:
-.15pt'> </span>C<sub><span style='position:relative;top:1.0pt;letter-spacing:
-.15pt'>m</span><span style='position:relative;top:1.0pt'>ax</span></sub><span
style='position:relative;top:1.0pt;letter-spacing:.8pt'> </span>at<span
style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:-.2pt'> </span>10<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>dose.<span style='letter-spacing:-.2pt'> </span>Apixaban<span
style='letter-spacing:-.2pt'> </span>can<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.15pt'> </span>taken<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.2pt'> </span>or without<span style='letter-spacing:
-.6pt'> </span>f<span style='letter-spacing:-.05pt'>o</span>od.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.4pt'> </span>de<span
style='letter-spacing:-.1pt'>m</span>onst<span style='letter-spacing:.05pt'>r</span>ates<span
style='letter-spacing:-.4pt'> </span>l<span style='letter-spacing:.05pt'>i</span>near<span
style='letter-spacing:-.35pt'> </span>pha<span style='letter-spacing:.05pt'>r</span><span
style='letter-spacing:-.1pt'>m</span>acokinetics<span style='letter-spacing:
-.4pt'> </span>with<span style='letter-spacing:-.35pt'> </span>dose<span
style='letter-spacing:-.4pt'> </span>propo<span style='letter-spacing:-.1pt'>r</span>tional<span
style='letter-spacing:-.35pt'> </span>increases<span style='letter-spacing:
-.4pt'> </span>in<span style='letter-spacing:-.4pt'> </span>exposu<span
style='letter-spacing:-.1pt'>r</span>e<span style='letter-spacing:-.35pt'> </span>for<span
style='letter-spacing:-.4pt'> </span>oral doses<span style='letter-spacing:
-.3pt'> </span>up<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g.<span style='letter-spacing:-.25pt'> </span>At<span
style='letter-spacing:-.25pt'> </span>doses<span style='letter-spacing:-.25pt'>
</span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>25<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>displa<span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.3pt'> </span>dissolut<span style='letter-spacing:-.1pt'>i</span>on<span
style='letter-spacing:-.25pt'> </span>li<span style='letter-spacing:-.1pt'>m</span>ited<span
style='letter-spacing:-.25pt'> </span>absorption<span style='letter-spacing:
-.25pt'> </span>with<span style='letter-spacing:-.3pt'> </span>decreased bioavailabili<span
style='letter-spacing:-.05pt'>t</span>y.<span style='letter-spacing:-.4pt'> </span>Apixaban<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>e</span>xposure<span
style='letter-spacing:-.35pt'> </span>parameters<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.05pt'>e</span>xhibit<span
style='letter-spacing:-.35pt'> </span>low<span style='letter-spacing:-.35pt'> </span>to<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.35pt'> </span>variability<span style='letter-spacing:
-.35pt'> </span>reflected<span style='letter-spacing:-.35pt'> </span>by<span
style='letter-spacing:-.35pt'> </span>a within-subject<span style='letter-spacing:
-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>inter-subject<span
style='letter-spacing:-.35pt'> </span>variability<span style='letter-spacing:
-.45pt'> </span>of<span style='letter-spacing:-.35pt'> </span>~20%<span
style='letter-spacing:-.35pt'> </span>CV<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>~30%<span style='letter-spacing:-.35pt'> </span>CV,<span
style='letter-spacing:-.35pt'> </span>respecti<span style='letter-spacing:.05pt'>v</span>el<span
style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Following<span style='letter-spacing:-.3pt'> </span>o<span
style='letter-spacing:-.1pt'>r</span>al<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>10<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>a</span>s<span
style='letter-spacing:-.25pt'> </span>2 crushed<span style='letter-spacing:
-.25pt'> </span>5&nbsp;<span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>tablets<span style='letter-spacing:-.2pt'>
</span>suspended<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>3</span>0<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>L<span
style='letter-spacing:-.25pt'> </span>of water,<span style='letter-spacing:
-.3pt'> </span>exposure<span style='letter-spacing:-.25pt'> </span>was<span
style='letter-spacing:-.25pt'> </span>c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>parable<span style='letter-spacing:-.25pt'>
</span>to<span style='letter-spacing:-.3pt'> </span>exp<span style='letter-spacing:
-.05pt'>o</span>sure<span style='letter-spacing:-.25pt'> </span>aft<span
style='letter-spacing:-.05pt'>e</span>r<span style='letter-spacing:-.25pt'> </span>oral<span
style='letter-spacing:-.3pt'> </span>ad<span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>2<span
style='letter-spacing:-.3pt'> </span>w<span style='letter-spacing:-.05pt'>h</span>ole<span
style='letter-spacing:-.3pt'> </span>5&nbsp;<span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>tablets. Following<span style='letter-spacing:
-.3pt'> </span>o<span style='letter-spacing:-.1pt'>r</span>al<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>10&nbsp;<span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.15pt'>
</span><span style='letter-spacing:-.1pt'>a</span>s<span style='letter-spacing:
-.25pt'> </span>2<span style='letter-spacing:-.2pt'> </span>crushed<span
style='letter-spacing:-.2pt'> </span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>tablets<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.2pt'> </span>30<span
style='letter-spacing:-.25pt'>&nbsp;</span>g<span style='letter-spacing:-.2pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:
-.05pt'>pp</span>le puree,<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:.05pt'>C</span><sub><span
style='position:relative;top:1.0pt;letter-spacing:-.1pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub><span style='position:relative;
top:1.0pt;letter-spacing:.75pt'> </span>and<span style='letter-spacing:-.3pt'> </span>AUC<span
style='letter-spacing:-.25pt'> </span>were<span style='letter-spacing:-.25pt'> </span>21%<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:.05pt'>n</span>d<span
style='letter-spacing:-.25pt'> </span>16%<span style='letter-spacing:-.25pt'> </span>lower,<span
style='letter-spacing:-.25pt'> </span>respecti<span style='letter-spacing:-.05pt'>v</span>el<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.35pt'> </span>when<span
style='letter-spacing:-.25pt'> </span>c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>pa<span style='letter-spacing:.05pt'>r</span>ed<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.25pt'> </span>of 2<span style='letter-spacing:-.3pt'> </span>whole<span
style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>tablets.<span
style='letter-spacing:-.25pt'> </span>The<span style='letter-spacing:-.3pt'> </span>reduction<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>e</span>xposu<span style='letter-spacing:-.05pt'>r</span>e<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.25pt'> </span>n<span
style='letter-spacing:-.05pt'>o</span>t<span style='letter-spacing:-.3pt'> </span>considered<span
style='letter-spacing:-.25pt'> </span>clinically<span style='letter-spacing:
-.15pt'> </span>rele<span style='letter-spacing:-.05pt'>va</span>nt.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Following<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>d</span>ministration<span style='letter-spacing:
-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>crushed<span style='letter-spacing:-.25pt'>
</span>5&nbsp;mg<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>tablet<span style='letter-spacing:-.25pt'>
</span>suspended<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>60<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> G</span>5W<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>d delivered<span style='letter-spacing:
-.25pt'> </span>via<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>nasogastric<span style='letter-spacing:
-.2pt'> </span>tube,<span style='letter-spacing:-.25pt'> </span>exposu<span
style='letter-spacing:-.1pt'>r</span>e<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.25pt'> </span>similar<span style='letter-spacing:-.15pt'>
</span>to<span style='letter-spacing:-.25pt'> </span>exposure<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>s</span>een<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>other<span
style='letter-spacing:-.2pt'> </span>clinical<span style='letter-spacing:-.25pt'>
</span>trials involving<span style='letter-spacing:-.35pt'> </span>healthy<span
style='letter-spacing:-.2pt'> </span>subjects<span style='letter-spacing:-.3pt'>
</span>receiving<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>single<span style='letter-spacing:-.3pt'>
</span>oral<span style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:
-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>t<span style='letter-spacing:-.1pt'>a</span>blet<span style='letter-spacing:
-.3pt'> </span>dose.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Given<span style='letter-spacing:-.45pt'> </span>the<span
style='letter-spacing:-.45pt'> </span>predictable,<span style='letter-spacing:
-.45pt'> </span>dose-proport<span style='letter-spacing:-.05pt'>i</span>onal<span
style='letter-spacing:-.5pt'> </span>pharmacok<span style='letter-spacing:-.05pt'>i</span>netic<span
style='letter-spacing:-.45pt'> </span>profile<span style='letter-spacing:-.45pt'>
</span>of<span style='letter-spacing:-.45pt'> </span>apixaban,<span
style='letter-spacing:-.45pt'> </span>the<span style='letter-spacing:-.55pt'> </span>bioavailabili<span
style='letter-spacing:-.05pt'>t</span>y results<span style='letter-spacing:
-.3pt'> </span>fr<span style='letter-spacing:.05pt'>o</span>m<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:.05pt'>t</span>he<span
style='letter-spacing:-.3pt'> </span>conducted<span style='letter-spacing:-.35pt'>
</span>studies<span style='letter-spacing:-.3pt'> </span>are<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:.1pt'>p</span>plicable<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>lower<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>doses.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Distribution</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Plasma<span style='letter-spacing:-.3pt'> </span>protein<span
style='letter-spacing:-.3pt'> </span>bi<span style='letter-spacing:-.05pt'>n</span>ding<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>hu<span
style='letter-spacing:-.1pt'>m</span>ans<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>approxi<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>tely<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>8</span>7<span style='letter-spacing:-.05pt'>%</span>.<span
style='letter-spacing:-.3pt'> </span>The<span style='letter-spacing:-.25pt'> </span>vol<span
style='letter-spacing:-.05pt'>um</span>e<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>distribution<span style='letter-spacing:
-.3pt'> </span>(Vss)<span style='letter-spacing:-.25pt'> </span>is approxi<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.5pt'> </span>21<span style='letter-spacing:-.5pt'>&nbsp;</span>l<span
style='letter-spacing:-.05pt'>i</span>tres.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Biotransformation<span style='letter-spacing:-.8pt'> </span>and<span
style='letter-spacing:-.75pt'> </span>el<span style='letter-spacing:-.05pt'>im</span>ination</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.35pt'> </span>has<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>ultiple<span
style='letter-spacing:-.3pt'> </span>routes<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>el<span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.1pt'>m</span>ina<span style='letter-spacing:.05pt'>t</span>ion.<span
style='letter-spacing:-.35pt'> </span>Of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>administered<span style='letter-spacing:
-.3pt'> </span>a<span style='letter-spacing:.05pt'>p</span>ixaban<span
style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:-.35pt'> </span>hu<span
style='letter-spacing:-.1pt'>m</span>ans, approxi<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>te<span
style='letter-spacing:.05pt'>l</span>y<span style='letter-spacing:-.35pt'> </span>25%<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.35pt'> </span>recovered<span
style='letter-spacing:-.3pt'> </span>as<span style='letter-spacing:-.3pt'> </span>metabolites,<span
style='letter-spacing:-.35pt'> </span>w<span style='letter-spacing:.05pt'>i</span>th<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jori<span
style='letter-spacing:.05pt'>t</span>y<span style='letter-spacing:-.3pt'> </span>recovered<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>faeces.<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>R</span><span
style='letter-spacing:-.05pt'>e</span>nal excretion<span style='letter-spacing:
-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>accounts<span style='letter-spacing:-.4pt'>
</span>for<span style='letter-spacing:-.35pt'> </span>app<span
style='letter-spacing:-.1pt'>r</span>oxi<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>tely<span style='letter-spacing:-.3pt'> </span>27%<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>total<span
style='letter-spacing:-.35pt'> </span>clearance.<span style='letter-spacing:
-.4pt'> </span>Additional<span style='letter-spacing:-.35pt'> </span>contributions
from<span style='letter-spacing:-.4pt'> </span>biliary<span style='letter-spacing:
-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>direct<span
style='letter-spacing:-.3pt'> </span>int<span style='letter-spacing:-.1pt'>e</span>stinal<span
style='letter-spacing:-.35pt'> </span>excretion<span style='letter-spacing:
-.3pt'> </span>w<span style='letter-spacing:-.1pt'>e</span>re<span
style='letter-spacing:-.3pt'> </span>observed<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>clini<span
style='letter-spacing:-.1pt'>c</span>al<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>noncl<span style='letter-spacing:-.05pt'>i</span>nical<span
style='letter-spacing:-.3pt'> </span>studies, respectivel<span
style='letter-spacing:.1pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.25pt'> </span>has<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>total<span
style='letter-spacing:-.2pt'> </span>clearance<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>about<span
style='letter-spacing:-.25pt'> </span>3.3<span style='letter-spacing:-.25pt'>&nbsp;</span>L/h<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>half-life<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>approxi<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.1pt'> </span><span style='letter-spacing:-.05pt'>1</span>2<span
style='letter-spacing:-.25pt'>&nbsp;</span>h<span style='letter-spacing:-.05pt'>o</span>urs.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>O-de<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>th<span style='letter-spacing:.05pt'>y</span>lation<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>h</span><span style='letter-spacing:.05pt'>y</span>d<span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>ox</span><span
style='letter-spacing:.05pt'>y</span>lation<span style='letter-spacing:-.35pt'>
</span>at<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.05pt'>th</span>e<span style='letter-spacing:-.35pt'> </span>3-oxo<span
style='letter-spacing:-.05pt'>p</span>iperidi<span style='letter-spacing:-.05pt'>n</span><span
style='letter-spacing:.05pt'>y</span>l<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>oiety<span style='letter-spacing:-.35pt'> </span>are<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor<span
style='letter-spacing:-.3pt'> </span>sites<span style='letter-spacing:-.3pt'> </span>of
biotransformation.<span style='letter-spacing:-.4pt'> </span>Apixa<span
style='letter-spacing:-.05pt'>b</span>an<span style='letter-spacing:-.4pt'> </span>is<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>tabolised<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>i<span style='letter-spacing:-.1pt'>n</span>ly<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>v</span>ia<span
style='letter-spacing:-.4pt'> </span>CYP3A4/5<span style='letter-spacing:-.4pt'>
</span>with<span style='letter-spacing:-.4pt'> </span><span style='letter-spacing:
-.1pt'>m</span>inor<span style='letter-spacing:-.4pt'> </span>contribu<span
style='letter-spacing:-.05pt'>t</span>ions<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.1pt'>f</span>rom CYP1A2,<span style='letter-spacing:
-.35pt'> </span>2C8,<span style='letter-spacing:-.3pt'> </span>2C9,<span
style='letter-spacing:-.35pt'> </span>2C1<span style='letter-spacing:-.05pt'>9</span>,<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>2J2.<span
style='letter-spacing:-.3pt'> </span>U<span style='letter-spacing:-.05pt'>n</span>changed<span
style='letter-spacing:-.3pt'> </span>api<span style='letter-spacing:-.05pt'>x</span>aban<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>major<span style='letter-spacing:-.3pt'> </span>drug-related<span
style='letter-spacing:-.3pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>ponent<span
style='letter-spacing:-.3pt'> </span>in hu<span style='letter-spacing:-.1pt'>m</span>an<span
style='letter-spacing:-.35pt'> </span>plasma<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>no<span style='letter-spacing:
-.3pt'> </span>active<span style='letter-spacing:-.3pt'> </span>circulating<span
style='letter-spacing:-.3pt'> </span>metabolites<span style='letter-spacing:
-.3pt'> </span>present.<span style='letter-spacing:-.3pt'> </span>Apixaban<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>substrate<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>transport proteins,<span
style='letter-spacing:-.35pt'> </span>P-gp<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>breast<span style='letter-spacing:-.35pt'>
</span>cancer<span style='letter-spacing:-.35pt'> </span>res<span
style='letter-spacing:.05pt'>i</span>sta<span style='letter-spacing:.05pt'>n</span>ce<span
style='letter-spacing:-.35pt'> </span>protein<span style='letter-spacing:-.35pt'>
</span>(BCRP).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Renal<span style='letter-spacing:-.8pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pairment</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.3pt'> </span>was<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.15pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pact<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>impaired<span style='letter-spacing:-.3pt'>
</span>renal<span style='letter-spacing:-.25pt'> </span>function<span
style='letter-spacing:-.35pt'> </span>on<span style='letter-spacing:-.25pt'> </span>p<span
style='letter-spacing:-.1pt'>e</span>ak<span style='letter-spacing:-.25pt'> </span>concentration<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban.<span
style='letter-spacing:-.25pt'> </span>There<span style='letter-spacing:-.3pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>an increase<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:.05pt'>p</span>ixaban<span style='letter-spacing:-.3pt'> </span>expo<span
style='letter-spacing:-.1pt'>s</span>ure<span style='letter-spacing:-.3pt'> </span>correlated<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>d</span>ecrease<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:
-.3pt'> </span>renal<span style='letter-spacing:-.3pt'> </span>funct<span
style='letter-spacing:-.05pt'>i</span>on,<span style='letter-spacing:-.3pt'> </span>as<span
style='letter-spacing:-.3pt'> </span>assessed<span style='letter-spacing:-.3pt'>
</span>via<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.1pt'>m</span>easured creatinine<span style='letter-spacing:-.4pt'> </span>clearance.<span
style='letter-spacing:-.4pt'> </span>In<span style='letter-spacing:-.35pt'> </span>individuals<span
style='letter-spacing:-.4pt'> </span>with<span style='letter-spacing:-.45pt'> </span>mild<span
style='letter-spacing:-.3pt'> </span>(creatin<span style='letter-spacing:.05pt'>i</span>ne<span
style='letter-spacing:-.4pt'> </span>clearan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.35pt'> </span>51-80<span style='letter-spacing:-.35pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>n),<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate
(creatinine<span style='letter-spacing:-.4pt'> </span>c<span style='letter-spacing:
.05pt'>l</span>earan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.4pt'> </span>30-50<span style='letter-spacing:-.4pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.05pt'>m</span>in)<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.4pt'> </span>severe<span style='letter-spacing:-.35pt'>
</span>(cr<span style='letter-spacing:.05pt'>e</span>atinine<span
style='letter-spacing:-.4pt'> </span>clearance<span style='letter-spacing:-.35pt'>
</span>15-29<span style='letter-spacing:-.4pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.05pt'>m</span>in)<span style='letter-spacing:-.35pt'> </span>renal
<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>pai<span
style='letter-spacing:.05pt'>r</span>ment,<span style='letter-spacing:-.4pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>pla<span style='letter-spacing:-.1pt'>s</span>ma<span
style='letter-spacing:-.4pt'> </span>concentr<span style='letter-spacing:.05pt'>a</span>tions<span
style='letter-spacing:-.35pt'> </span>(AU<span style='letter-spacing:-.05pt'>C</span>)<span
style='letter-spacing:-.35pt'> </span>were<span style='letter-spacing:-.4pt'> </span>increased<span
style='letter-spacing:-.35pt'> </span>16,<span style='letter-spacing:-.4pt'> </span>29,<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.45pt'> </span>44%<span
style='letter-spacing:-.4pt'> </span>respectively, c<span style='letter-spacing:
.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>pared<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.3pt'> </span>individuals<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>nor<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>l<span
style='letter-spacing:-.3pt'> </span>cr<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.05pt'>a</span>tinine<span style='letter-spacing:-.3pt'>
</span>clearance.<span style='letter-spacing:-.35pt'> </span>Renal<span
style='letter-spacing:-.3pt'> </span>impair<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.3pt'> </span>had<span
style='letter-spacing:-.35pt'> </span>no<span style='letter-spacing:-.3pt'> </span>evident<span
style='letter-spacing:-.3pt'> </span>ef<span style='letter-spacing:-.1pt'>f</span>ect<span
style='letter-spacing:-.35pt'> </span>on the<span style='letter-spacing:-.45pt'>
</span>relationship<span style='letter-spacing:-.4pt'> </span>between<span
style='letter-spacing:-.4pt'> </span>apixaban<span style='letter-spacing:-.4pt'>
</span>plas<span style='letter-spacing:-.05pt'>m</span>a<span style='letter-spacing:
-.4pt'> </span>concentrat<span style='letter-spacing:.05pt'>i</span>on<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>anti-FXa<span
style='letter-spacing:-.4pt'> </span>activit<span style='letter-spacing:.1pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>subjects<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>end-stage<span
style='letter-spacing:-.25pt'> </span>renal<span style='letter-spacing:-.25pt'>
</span>disease<span style='letter-spacing:-.25pt'> </span>(ESRD),<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>AUC<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>was<span style='letter-spacing:-.3pt'> </span>inc<span
style='letter-spacing:.05pt'>r</span>eased<span style='letter-spacing:-.25pt'> </span>by<span
style='letter-spacing:-.15pt'> </span>36%<span style='letter-spacing:-.25pt'> </span>when<span
style='letter-spacing:-.25pt'> </span>a single<span style='letter-spacing:-.35pt'>
</span>dose<span style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:
-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'> </span>5<span
style='letter-spacing:-.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:.05pt'>d</span>m<span style='letter-spacing:.05pt'>i</span>nistered<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>i</span>mmediately<span
style='letter-spacing:-.25pt'> </span>after<span style='letter-spacing:-.3pt'> </span>ha<span
style='letter-spacing:.05pt'>e</span><span style='letter-spacing:-.1pt'>m</span>odial<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is,<span
style='letter-spacing:-.3pt'> </span>c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>pared<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:.05pt'>t</span>o<span style='letter-spacing:-.3pt'> </span>that
seen<span style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:
-.3pt'> </span>subjects<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>normal<span style='letter-spacing:-.3pt'> </span>renal<span
style='letter-spacing:-.3pt'> </span>function.<span style='letter-spacing:-.3pt'>
</span>Hae<span style='letter-spacing:-.1pt'>m</span>od<span style='letter-spacing:
-.1pt'>i</span>al<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>s</span>is,<span style='letter-spacing:-.3pt'> </span>started<span
style='letter-spacing:-.25pt'> </span>two<span style='letter-spacing:-.3pt'> </span>hours<span
style='letter-spacing:-.3pt'> </span>af<span style='letter-spacing:-.05pt'>te</span>r<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistra<span style='letter-spacing:.05pt'>t</span>ion<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>a
single<span style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g,<span style='letter-spacing:-.25pt'> </span>dec<span
style='letter-spacing:.05pt'>r</span>eased<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>A</span><span
style='letter-spacing:-.05pt'>U</span>C<span style='letter-spacing:-.25pt'> </span>by<span
style='letter-spacing:-.25pt'> </span>14%<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>these<span style='letter-spacing:-.25pt'>
</span>ESRD<span style='letter-spacing:-.25pt'> </span>subjects, correspondi<span
style='letter-spacing:-.05pt'>n</span>g<span style='letter-spacing:-.35pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>an<span style='letter-spacing:-.35pt'> </span>ap<span
style='letter-spacing:-.05pt'>i</span>xaban<span style='letter-spacing:-.3pt'> </span>dia<span
style='letter-spacing:-.05pt'>l</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>s</span>is<span style='letter-spacing:-.3pt'> </span>clearance<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:.05pt'>1</span>8<span style='letter-spacing:-.35pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L/min.<span style='letter-spacing:-.3pt'> </span>Therefore,<span
style='letter-spacing:-.3pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>odial<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is<span
style='letter-spacing:-.35pt'> </span>is<span style='letter-spacing:-.3pt'> </span>unlike<span
style='letter-spacing:-.05pt'>l</span>y<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>t</span>o be<span style='letter-spacing:-.35pt'> </span>an<span
style='letter-spacing:-.3pt'> </span>effective<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.1pt'>m</span>eans<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>managing<span
style='letter-spacing:-.35pt'> </span>apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.3pt'> </span>overdose.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Hepatic<span style='letter-spacing:-.9pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pair<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>study<span style='letter-spacing:-.15pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>p</span>aring<span
style='letter-spacing:-.2pt'> </span>8<span style='letter-spacing:-.25pt'>&nbsp;</span>subjects<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.2pt'> </span>mild<span
style='letter-spacing:-.2pt'> </span>hepatic<span style='letter-spacing:-.35pt'>
</span>impair<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>e</span>nt,<span style='letter-spacing:-.2pt'> </span>Child-Pugh<span
style='letter-spacing:-.3pt'> </span>A<span style='letter-spacing:-.2pt'> </span>score<span
style='letter-spacing:-.2pt'> </span>5<span style='letter-spacing:-.25pt'> </span>(n<span
style='letter-spacing:-.2pt'>&nbsp;</span>=<span style='letter-spacing:-.25pt'>&nbsp;</span>6)<span
style='letter-spacing:-.25pt'> </span>and score<span style='letter-spacing:
-.25pt'> </span>6<span style='letter-spacing:-.2pt'> </span>(n<span
style='letter-spacing:-.2pt'>&nbsp;</span>=&nbsp;2),<span style='letter-spacing:
-.2pt'> </span>and<span style='letter-spacing:-.2pt'> </span>8<span
style='letter-spacing:-.2pt'>&nbsp;</span>s<span style='letter-spacing:-.05pt'>u</span>bjects<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.1pt'>m</span>oderate<span style='letter-spacing:-.2pt'>
</span>hep<span style='letter-spacing:-.15pt'>a</span>tic<span
style='letter-spacing:-.15pt'> </span>i<span style='letter-spacing:-.1pt'>m</span>pairment,<span
style='letter-spacing:-.2pt'> </span>Child-Pu<span style='letter-spacing:-.05pt'>g</span>h<span
style='letter-spacing:-.2pt'> </span>B<span style='letter-spacing:-.2pt'> </span>score<span
style='letter-spacing:-.2pt'> </span>7<span style='letter-spacing:-.2pt'> </span>(n<span
style='letter-spacing:-.25pt'>&nbsp;</span>=&nbsp;6)<span style='letter-spacing:
-.2pt'> </span>and score<span style='letter-spacing:-.3pt'> </span>8<span
style='letter-spacing:-.25pt'> </span>(n&nbsp;=&nbsp;2),<span style='letter-spacing:
-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>1</span>6<span style='letter-spacing:-.25pt'>&nbsp;</span>healt<span
style='letter-spacing:-.05pt'>h</span>y<span style='letter-spacing:-.3pt'> </span>control<span
style='letter-spacing:-.25pt'> </span>s<span style='letter-spacing:-.05pt'>u</span>b<span
style='letter-spacing:-.05pt'>j</span>ects,<span style='letter-spacing:-.25pt'>
</span>the<span style='letter-spacing:-.25pt'> </span>single-dose<span
style='letter-spacing:-.25pt'> </span>pharmacokinetics<span style='letter-spacing:
-.25pt'> </span>and pharmacod<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>n</span>a<span style='letter-spacing:-.1pt'>m</span>ics<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>5<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>were<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.3pt'> </span>alter<span
style='letter-spacing:-.1pt'>e</span>d<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>subjects<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>hepatic<span
style='letter-spacing:-.3pt'> </span>impair<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt.<span style='letter-spacing:-.25pt'> </span>Changes<span
style='letter-spacing:-.3pt'> </span>in anti-Factor<span style='letter-spacing:
-.35pt'> </span>Xa<span style='letter-spacing:-.35pt'> </span>activity<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.3pt'> </span>INR<span
style='letter-spacing:-.3pt'> </span>we<span style='letter-spacing:.05pt'>r</span>e<span
style='letter-spacing:-.35pt'> </span>co<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>p</span>arable<span style='letter-spacing:-.35pt'>
</span>be<span style='letter-spacing:.05pt'>t</span><span style='letter-spacing:
-.05pt'>w</span>een<span style='letter-spacing:-.3pt'> </span>subjects<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ild<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.3pt'> </span>he<span style='letter-spacing:.05pt'>p</span><span
style='letter-spacing:-.05pt'>a</span>tic i<span style='letter-spacing:-.1pt'>m</span>pairment<span
style='letter-spacing:-.5pt'> </span>and<span style='letter-spacing:-.45pt'> </span>healt<span
style='letter-spacing:-.05pt'>h</span>y<span style='letter-spacing:-.35pt'> </span>s<span
style='letter-spacing:-.05pt'>u</span>bjects.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Elderly</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Elderly<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>(above<span style='letter-spacing:-.35pt'>
</span>65<span style='letter-spacing:-.45pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears)<span style='letter-spacing:-.35pt'> </span>exhibited<span
style='letter-spacing:-.35pt'> </span>higher<span style='letter-spacing:-.4pt'>
</span>pl<span style='letter-spacing:-.1pt'>a</span>s<span style='letter-spacing:
-.1pt'>m</span>a<span style='letter-spacing:-.3pt'> </span>concentrations<span
style='letter-spacing:-.35pt'> </span>than<span style='letter-spacing:-.4pt'> </span>younger<span
style='letter-spacing:-.35pt'> </span>patie<span style='letter-spacing:-.05pt'>n</span>ts,<span
style='letter-spacing:-.35pt'> </span>with mean<span style='letter-spacing:
-.3pt'> </span>AUC<span style='letter-spacing:-.25pt'> </span>values<span
style='letter-spacing:-.3pt'> </span>being<span style='letter-spacing:-.25pt'> </span>approxi<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.3pt'> </span>32%<span style='letter-spacing:-.3pt'> </span>higher<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>a</span>nd<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>n</span>o<span
style='letter-spacing:-.3pt'> </span>difference<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>C<sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Gender</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Exposure<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>a</span>pixaban<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.3pt'> </span>approxi<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.25pt'> </span>18%<span style='letter-spacing:-.3pt'> </span>hi<span
style='letter-spacing:-.05pt'>g</span>her<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>females<span style='letter-spacing:-.25pt'>
</span>t<span style='letter-spacing:.05pt'>h</span>an<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>les.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Ethnic<span style='letter-spacing:-.35pt'> </span>orig<span
style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>race</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>results<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:.05pt'>c</span>ross<span
style='letter-spacing:-.3pt'> </span>phase<span style='letter-spacing:-.35pt'> </span>I<span
style='letter-spacing:-.35pt'> </span>studies<span style='letter-spacing:-.3pt'>
</span>showed<span style='letter-spacing:-.35pt'> </span>no<span
style='letter-spacing:-.35pt'> </span>discernible<span style='letter-spacing:
-.35pt'> </span>difference<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.4pt'>
</span>pharmacokinetics between<span style='letter-spacing:-.45pt'> </span>White/Caucasian,<span
style='letter-spacing:-.4pt'> </span>Asian<span style='letter-spacing:-.4pt'> </span>and<span
style='letter-spacing:-.45pt'> </span>Black/African<span style='letter-spacing:
-.4pt'> </span>A<span style='letter-spacing:-.1pt'>m</span>erican<span
style='letter-spacing:-.4pt'> </span>subjects.<span style='letter-spacing:-.4pt'>
</span>Findin<span style='letter-spacing:-.05pt'>g</span>s<span
style='letter-spacing:-.45pt'> </span>fr<span style='letter-spacing:.05pt'>o</span>m<span
style='letter-spacing:-.5pt'> </span>a<span style='letter-spacing:-.4pt'> </span>pop<span
style='letter-spacing:-.05pt'>u</span>lation pharmacokinetic<span
style='letter-spacing:-.35pt'> </span>anal<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>s</span>is<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.35pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span>who<span style='letter-spacing:-.3pt'> </span>received<span
style='letter-spacing:-.35pt'> </span>api<span style='letter-spacing:-.1pt'>x</span>aban<span
style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:-.3pt'> </span>generally<span
style='letter-spacing:-.2pt'> </span>consistent<span style='letter-spacing:
-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>phase<span style='letter-spacing:-.35pt'> </span>I
results.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Bo<span style='letter-spacing:-.05pt'>d</span>y<span
style='letter-spacing:-.5pt'> </span>weight</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>C<span style='letter-spacing:.05pt'>o</span><span style='letter-spacing:
-.1pt'>m</span>pared<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.2pt'> </span>apixaban<span style='letter-spacing:-.2pt'>
</span>ex<span style='letter-spacing:-.05pt'>p</span>osure<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>subj<span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:-.05pt'>c</span>ts<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.25pt'> </span>bo<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.2pt'> </span>weight<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>6</span>5<span style='letter-spacing:-.25pt'>&nbsp;</span>to<span
style='letter-spacing:-.2pt'>&nbsp;</span>85<span style='letter-spacing:-.3pt'>
</span>kg,<span style='letter-spacing:-.25pt'> </span>bo<span style='letter-spacing:
-.05pt'>d</span>y<span style='letter-spacing:-.2pt'> </span>weight<span
style='letter-spacing:-.25pt'> </span>&gt;<span style='letter-spacing:-.2pt'> </span>1<span
style='letter-spacing:-.05pt'>2</span>0<span style='letter-spacing:-.2pt'>&nbsp;</span>kg
was<span style='letter-spacing:-.3pt'> </span>associa<span style='letter-spacing:
.05pt'>t</span>ed<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>approx<span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.15pt'> </span>30%<span style='letter-spacing:-.3pt'> </span>lower<span
style='letter-spacing:-.25pt'> </span>expo<span style='letter-spacing:-.05pt'>s</span>ure<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>body<span
style='letter-spacing:-.35pt'> </span>weight<span style='letter-spacing:-.25pt'>
</span>&lt;<span style='letter-spacing:-.25pt'>&nbsp;</span>50<span
style='letter-spacing:-.3pt'>&nbsp;</span>kg<span style='letter-spacing:-.25pt'>
</span>was<span style='letter-spacing:-.3pt'> </span>ass<span style='letter-spacing:
.05pt'>o</span>ciated<span style='letter-spacing:-.25pt'> </span>with approxi<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.55pt'> </span>30%<span style='letter-spacing:-.55pt'> </span>hi<span
style='letter-spacing:-.05pt'>g</span>her<span style='letter-spacing:-.5pt'> </span>exposure.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Phar<span style='letter-spacing:-.1pt'>m</span>acokinetic/pharmacodynamics
relationship</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.55pt'> </span>pharmacokinetic<span
style='letter-spacing:-.55pt'> </span>/pha<span style='letter-spacing:-.1pt'>r</span><span
style='letter-spacing:-.05pt'>m</span>acod<span style='letter-spacing:.05pt'>y</span>na<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.5pt'> </span>(PK/P<span style='letter-spacing:-.05pt'>D</span>)<span
style='letter-spacing:-.55pt'> </span>re<span style='letter-spacing:.05pt'>l</span><span
style='letter-spacing:-.05pt'>a</span>tionship<span style='letter-spacing:-.55pt'>
</span>between<span style='letter-spacing:-.5pt'> </span>apixab<span
style='letter-spacing:.05pt'>a</span>n<span style='letter-spacing:-.55pt'> </span>plasma
concentration<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>several<span style='letter-spacing:-.3pt'>
</span>PD<span style='letter-spacing:-.3pt'> </span>endpoints<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>(</span><span
style='letter-spacing:-.05pt'>a</span>nti-FXa<span style='letter-spacing:-.3pt'>
</span>ac<span style='letter-spacing:-.05pt'>t</span>ivi<span style='letter-spacing:
-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.3pt'> </span>INR,<span style='letter-spacing:-.3pt'> </span>P<span
style='letter-spacing:-.05pt'>T</span>,<span style='letter-spacing:-.3pt'> </span>aPTT)<span
style='letter-spacing:-.35pt'> </span>has<span style='letter-spacing:-.3pt'> </span>been<span
style='letter-spacing:-.3pt'> </span>evaluated<span style='letter-spacing:-.25pt'>
</span>after a<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>wide<span style='letter-spacing:-.25pt'> </span>range<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>doses<span
style='letter-spacing:-.25pt'> </span>(0.5<span style='letter-spacing:-.25pt'>&nbsp;</span>–<span
style='letter-spacing:-.25pt'>&nbsp;</span>50<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g).<span style='letter-spacing:-.25pt'> </span>The<span
style='letter-spacing:-.3pt'> </span>relationship<span style='letter-spacing:
-.25pt'> </span>between<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>pla<span style='letter-spacing:-.1pt'>s</span>ma
concentration<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>anti-Factor<span style='letter-spacing:
-.25pt'> </span>Xa<span style='letter-spacing:-.3pt'> </span>activity<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>b</span>est<span style='letter-spacing:-.3pt'> </span>described<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>b</span>y<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.3pt'> </span>l<span
style='letter-spacing:-.05pt'>i</span>near<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>odel.<span style='letter-spacing:-.25pt'> </span>The<span
style='letter-spacing:-.3pt'> </span>PK/PD relationship<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.05pt'>o</span>bserved<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>p<span
style='letter-spacing:-.1pt'>a</span>tients<span style='letter-spacing:-.35pt'>
</span>was<span style='letter-spacing:-.3pt'> </span>c<span style='letter-spacing:
.05pt'>o</span>nsistent<span style='letter-spacing:-.45pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>that<span style='letter-spacing:-.35pt'> </span>established<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.35pt'> </span>healthy<span
style='letter-spacing:-.3pt'> </span>subjects.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>5.3<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Preclinical<span style='letter-spacing:-.5pt'> </span>safety<span
style='letter-spacing:-.5pt'> </span>data</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Preclinical<span style='letter-spacing:-.3pt'> </span>data<span
style='letter-spacing:-.3pt'> </span>reveal<span style='letter-spacing:-.25pt'>
</span>no<span style='letter-spacing:-.3pt'> </span>special<span
style='letter-spacing:-.3pt'> </span>hazard<span style='letter-spacing:-.25pt'>
</span>f<span style='letter-spacing:-.15pt'>o</span>r<span style='letter-spacing:
-.25pt'> </span>hu<span style='letter-spacing:-.1pt'>m</span>ans<span
style='letter-spacing:-.3pt'> </span>based<span style='letter-spacing:-.3pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>conventional<span style='letter-spacing:
-.3pt'> </span>studies<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>safety pharmacology,<span
style='letter-spacing:-.5pt'> </span>repeated<span style='letter-spacing:-.45pt'>
</span>dose<span style='letter-spacing:-.5pt'> </span>toxici<span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.5pt'> </span>genotoxici<span style='letter-spacing:
-.05pt'>t</span>y,<span style='letter-spacing:-.5pt'> </span>carcinogenic<span
style='letter-spacing:-.5pt'> </span>potential,<span style='letter-spacing:
-.45pt'> </span>fertili<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.5pt'> </span>e<span
style='letter-spacing:-.1pt'>m</span>bryo-foetal develop<span style='letter-spacing:
-.1pt'>m</span>ent<span style='letter-spacing:-.45pt'> </span>and<span
style='letter-spacing:-.5pt'> </span>juvenile<span style='letter-spacing:-.45pt'>
</span><span style='letter-spacing:-.05pt'>t</span>oxici<span style='letter-spacing:
-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>major<span
style='letter-spacing:-.25pt'> </span>observed<span style='letter-spacing:-.25pt'>
</span>effec<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:
-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>repeated<span style='letter-spacing:-.25pt'>
</span>dose<span style='letter-spacing:-.25pt'> </span>toxicity<span
style='letter-spacing:-.25pt'> </span>studies<span style='letter-spacing:-.25pt'>
</span>were<span style='letter-spacing:-.25pt'> </span>those<span
style='letter-spacing:-.25pt'> </span>relat<span style='letter-spacing:.05pt'>e</span>d<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>the
pharmacod<span style='letter-spacing:.05pt'>y</span>na<span style='letter-spacing:
-.1pt'>m</span>ic<span style='letter-spacing:-.35pt'> </span>action<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.4pt'> </span>on<span style='letter-spacing:-.3pt'> </span>blood<span
style='letter-spacing:-.3pt'> </span>coagu<span style='letter-spacing:-.05pt'>l</span>ation<span
style='letter-spacing:-.35pt'> </span>parame<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>e</span>rs.<span style='letter-spacing:-.4pt'> </span>In<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>toxicity<span
style='letter-spacing:-.25pt'> </span>studies<span style='letter-spacing:-.3pt'>
</span>little<span style='letter-spacing:-.35pt'> </span>to no<span
style='letter-spacing:-.25pt'> </span>increase<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.2pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>tendency<span style='letter-spacing:-.15pt'>
</span>was<span style='letter-spacing:-.25pt'> </span>found.<span
style='letter-spacing:-.2pt'> </span>However,<span style='letter-spacing:-.3pt'>
</span>since<span style='letter-spacing:-.25pt'> </span>this<span
style='letter-spacing:-.2pt'> </span>may<span style='letter-spacing:-.15pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>due<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>t</span>o<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>lower<span style='letter-spacing:-.2pt'> </span>sensitivi<span
style='letter-spacing:-.05pt'>t</span>y<span style='letter-spacing:-.15pt'> </span>of
the<span style='letter-spacing:-.35pt'> </span>non-clini<span style='letter-spacing:
-.1pt'>c</span>al<span style='letter-spacing:-.3pt'> </span>species<span
style='letter-spacing:-.3pt'> </span>co<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>p</span>ared<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>h<span style='letter-spacing:-.05pt'>u</span>mans,<span
style='letter-spacing:-.3pt'> </span>this<span style='letter-spacing:-.35pt'> </span>result<span
style='letter-spacing:-.3pt'> </span>shou<span style='letter-spacing:-.05pt'>l</span>d<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.3pt'> </span>interpreted<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>caution<span
style='letter-spacing:-.35pt'> </span>w<span style='letter-spacing:-.05pt'>h</span>en
extrapolating<span style='letter-spacing:-.6pt'> </span>to<span
style='letter-spacing:-.5pt'> </span>hu<span style='letter-spacing:-.1pt'>m</span>ans.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>PHAR</span><span
lang=EN-GB>M<span style='letter-spacing:-.05pt'>A</span>C<span
style='letter-spacing:-.05pt'>EUT</span>I<span style='letter-spacing:-.05pt'>CA</span>L
P<span style='letter-spacing:-.05pt'>ART</span>I<span style='letter-spacing:
-.05pt'>CU</span>LA<span style='letter-spacing:-.05pt'>R</span>S</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><b><span lang=EN-GB style='font-size:11.0pt'>6.1<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='font-size:11.0pt'>List<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>excipients</span></b></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Tablet<span style='letter-spacing:-.55pt'> </span>core</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.05pt'>Lactose</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Cellulose, microcrystalline</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Crosca<span style='letter-spacing:.05pt'>r</span>mell<span
style='letter-spacing:.05pt'>o</span>se<span style='letter-spacing:-1.05pt'> </span>sodium</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Sodium laurilsulfate </span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Magnesi<span style='letter-spacing:.05pt'>u</span>m<span
style='letter-spacing:-.7pt'> </span>stearate<span style='letter-spacing:-.65pt'>
</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Film<span style='letter-spacing:-.5pt'> </span>coat</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.05pt'>Hypromellose</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.05pt'>Lactos</span><span lang=EN-GB>e<span
style='letter-spacing:-.9pt'> </span><span style='letter-spacing:-.1pt'>m</span>o<span
style='letter-spacing:.05pt'>n</span>o<span style='letter-spacing:-.05pt'>h</span><span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>drate </span></span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Titanium<span style='letter-spacing:-.65pt'> </span>dioxide<span
style='letter-spacing:-.5pt'> </span>(E1<span style='letter-spacing:-.05pt'>7</span>1)</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Triacetin</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Iron oxide yellow (E172)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.2<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Incompatibilities</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Not<span style='letter-spacing:-.65pt'> </span>applicable</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.3<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Shelf<span style='letter-spacing:-.4pt'> </span>life</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.35pt'>3&nbsp;</span><span lang=EN-GB
style='letter-spacing:.05pt'>y</span><span lang=EN-GB>ears</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.4<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Special<span style='letter-spacing:-.5pt'> </span>precautions<span
style='letter-spacing:-.45pt'> </span>for<span style='letter-spacing:-.45pt'> </span>storage</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>This<span style='letter-spacing:-.35pt'> </span>medicinal<span
style='letter-spacing:-.3pt'> </span>product<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.05pt'>do</span>es<span style='letter-spacing:
-.35pt'> </span>not<span style='letter-spacing:-.3pt'> </span>require<span
style='letter-spacing:-.3pt'> </span>any<span style='letter-spacing:-.35pt'> </span>special<span
style='letter-spacing:-.3pt'> </span>storage<span style='letter-spacing:-.3pt'>
</span>condit<span style='letter-spacing:-.05pt'>i</span>on.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.5<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Nature<span style='letter-spacing:-.4pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>contents<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>container</span></h1>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>PVC/PVdC-Aluminium blisters <span style='color:black'>are available
in </span>10, 14, 20, 28, 56, 60, 100, 112, 168, and 200&nbsp;film&#8209;coated
tablets.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>PVC/PVdC-Aluminium blisters <span style='color:black'>are available
in </span>perforated unit dose blisters of 10&nbsp;x&nbsp;1, 20&nbsp;x&nbsp;1,
28&nbsp;x&nbsp;1, 56&nbsp;x&nbsp;1, 60&nbsp;x&nbsp;1, 100&nbsp;x&nbsp;1 and 168&nbsp;x&nbsp;1&nbsp;film-coated
tablet.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>HDPE bottle with polypropylene child resistant/continues threaded closure
containing 60, 100, 168, 180, 200 and 1,000&nbsp;film-coated tablets.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Not all pack sizes may be marketed.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.6<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Special<span style='letter-spacing:-.5pt'> </span>pre<span
style='letter-spacing:.05pt'>c</span>autions<span style='letter-spacing:-.45pt'>
</span>for<span style='letter-spacing:-.5pt'> </span>disposal</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>No<span style='letter-spacing:-.55pt'> </span>special<span
style='letter-spacing:-.5pt'> </span>requirements.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Any<span style='letter-spacing:-.3pt'> </span>unused<span
style='letter-spacing:-.3pt'> </span>medicinal<span style='letter-spacing:-.3pt'>
</span>product<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>waste<span style='letter-spacing:-.25pt'> </span>mater<span
style='letter-spacing:.05pt'>i</span>al<span style='letter-spacing:-.3pt'> </span>should<span
style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:-.3pt'> </span>dispos<span
style='letter-spacing:-.1pt'>e</span>d<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>accordance<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>local
require<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>e</span>nts.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>MARKET</span><span
lang=EN-GB>I<span style='letter-spacing:-.05pt'>N</span>G<span
style='letter-spacing:-1.1pt'> </span>A<span style='letter-spacing:-.05pt'>UTHORISA</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>IO</span>N<span
style='letter-spacing:-1.0pt'> </span><span style='letter-spacing:-.05pt'>HO</span><span
style='letter-spacing:.05pt'>L</span><span style='letter-spacing:-.05pt'>D</span><span
style='letter-spacing:.05pt'>E</span>R</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Accord Healthcare S.L.U.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>World Trade Center, Moll de Barcelona s/n,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Edifici Est, 6<sup>a</sup> Planta,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Barcelona, 08039</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Spain</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>MARKETING<span style='letter-spacing:-1.15pt'> </span>A<span
style='letter-spacing:-.05pt'>U</span>THORISA<span style='letter-spacing:.05pt'>T</span>ION<span
style='letter-spacing:-1.1pt'> </span>NUMB<span style='letter-spacing:.05pt'>E</span>R(<span
style='letter-spacing:.05pt'>S</span>)</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-size:11.0pt'>EU/1/20/1458/001-020, 041-043</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>9.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>DAT</span><span
lang=EN-GB>E<span style='letter-spacing:-.6pt'> </span><span style='letter-spacing:
-.05pt'>O</span>F<span style='letter-spacing:-.6pt'> </span><span
style='letter-spacing:.05pt'>F</span><span style='letter-spacing:-.05pt'>IRS</span>T<span
style='letter-spacing:-.6pt'> </span>A<span style='letter-spacing:-.05pt'>UTHORI</span><span
style='letter-spacing:.05pt'>S</span><span style='letter-spacing:-.05pt'>AT</span>IO<span
style='letter-spacing:-.05pt'>N/RE</span>N<span style='letter-spacing:-.05pt'>EW</span>AL<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>O</span>F<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>TH</span>E<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>AU</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>HORI</span><span
style='letter-spacing:.05pt'>S</span><span style='letter-spacing:-.05pt'>AT</span>I<span
style='letter-spacing:-.05pt'>ON</span></span></h1>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Date<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>first<span style='letter-spacing:-.3pt'> </span>authorisation:</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.3pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.3pt'>&nbsp;</span></p>

<h1 style='margin-left:0in;text-indent:0in;punctuation-wrap:simple'><span
lang=EN-GB>10.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>DATE<span style='letter-spacing:-.3pt'> </span>OF<span
style='letter-spacing:-.35pt'> </span>REVISION<span style='letter-spacing:-.3pt'>
</span>OF<span style='letter-spacing:-.35pt'> </span>THE<span style='letter-spacing:
-.3pt'> </span>TE<span style='letter-spacing:.1pt'>X</span>T</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Detailed<span style='letter-spacing:-.3pt'> </span>information<span
style='letter-spacing:-.3pt'> </span>on<span style='letter-spacing:-.3pt'> </span>th<span
style='letter-spacing:-.05pt'>i</span>s<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>dicinal<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>p</span>roduct<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.15pt'>v</span>ailable<span style='letter-spacing:-.25pt'>
</span>on<span style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:
-.35pt'> </span>website<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>European<span
style='letter-spacing:-.35pt'> </span>Medicines Agency<span style='letter-spacing:
-1.45pt'> <span style='color:blue'><a href="http://www.ema.europa.eu/"><span
style='letter-spacing:0pt'>http://www.</span><span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.05pt'>m</span><span style='letter-spacing:0pt'>a.e</span><span
style='letter-spacing:.05pt'>u</span><span style='letter-spacing:0pt'>ropa.eu</span></a></span></span></span></p>

</div>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>NAME<span style='letter-spacing:-.45pt'> </span>OF<span
style='letter-spacing:-.5pt'> </span>THE<span style='letter-spacing:-.45pt'> </span>M<span
style='letter-spacing:.05pt'>E</span>DICINAL<span style='letter-spacing:-.5pt'>
</span>PRODUCT</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>5<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.35pt'> </span>fil<span style='letter-spacing:-.1pt'>m</span>-coated<span
style='letter-spacing:-.35pt'> </span>tablets</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.05pt'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>QU</span><span
lang=EN-GB>A<span style='letter-spacing:-.05pt'>LI</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>A</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>IV</span>E<span
style='letter-spacing:-.9pt'> </span>A<span style='letter-spacing:-.05pt'>N</span>D<span
style='letter-spacing:-.9pt'> </span><span style='letter-spacing:-.05pt'>QUAN</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>IT</span>A<span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>IV</span>E<span
style='letter-spacing:-.9pt'> </span>C<span style='letter-spacing:-.05pt'>OM</span><span
style='letter-spacing:.05pt'>P</span><span style='letter-spacing:-.05pt'>OSI</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>ION</span></span></h1>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Each<span style='letter-spacing:-.35pt'> </span>fi<span
style='letter-spacing:.05pt'>l</span><span style='letter-spacing:-.1pt'>m</span>-c<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.05pt'>a</span>ted<span
style='letter-spacing:-.35pt'> </span>tablet<span style='letter-spacing:-.3pt'>
</span>contains<span style='letter-spacing:-.35pt'> </span>5<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.35pt'> </span>apixaban. </span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Excipients<span style='letter-spacing:-.45pt'> </span>with<span
style='letter-spacing:-.45pt'> </span>k<span style='letter-spacing:-.05pt'>n</span>own<span
style='letter-spacing:-.4pt'> </span>effect</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Each<span style='letter-spacing:-.3pt'> </span>5<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>film-coated<span style='letter-spacing:
-.25pt'> </span>tablet<span style='letter-spacing:-.3pt'> </span>contains<span
style='letter-spacing:-.35pt'> </span>103.95<span style='letter-spacing:-.05pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>lactose<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.4). </span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>full<span style='letter-spacing:-.25pt'> </span>list<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.2pt'> </span>excipients,<span
style='letter-spacing:-.25pt'> </span>see<span style='letter-spacing:-.2pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>6.1.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>PHAR</span><span
lang=EN-GB style='letter-spacing:.05pt'>M</span><span lang=EN-GB
style='letter-spacing:-.05pt'>A</span><span lang=EN-GB>C<span style='letter-spacing:
-.05pt'>EUT</span>I<span style='letter-spacing:-.05pt'>CA</span>L<span
style='letter-spacing:-1.45pt'> </span><span style='letter-spacing:.05pt'>F</span><span
style='letter-spacing:-.05pt'>ORM</span></span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Fil<span style='letter-spacing:-.1pt'>m</span>-coated<span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>a</span>blet<span style='letter-spacing:-.55pt'> </span>(tablet)</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Pink, oval shaped, approximate 9.8 mm in length, 5.2 mm in width, biconvex,
film&#8209;coated tablet debossed with “IU2” on one side and plain on other
side.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>CLI</span><span
lang=EN-GB>N<span style='letter-spacing:-.05pt'>I</span>C<span
style='letter-spacing:-.05pt'>A</span>L<span style='letter-spacing:-1.3pt'> </span><span
style='letter-spacing:-.05pt'>PART</span>I<span style='letter-spacing:-.05pt'>CU</span><span
style='letter-spacing:.05pt'>L</span><span style='letter-spacing:-.05pt'>ARS</span></span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><b><span lang=EN-GB style='font-size:11.0pt'>4.1<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='font-size:11.0pt'>Therapeutic<span
style='letter-spacing:-1.05pt'> </span>indications</span></b></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Prevention<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>stroke<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.35pt'> </span><span style='letter-spacing:
-.1pt'>s</span>yste<span style='letter-spacing:-.1pt'>m</span>ic<span
style='letter-spacing:-.3pt'> </span>e<span style='letter-spacing:-.1pt'>m</span>bolism<span
style='letter-spacing:-.4pt'> </span>in<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>a</span>dult<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>non-valvular<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.05pt'>t</span>rial<span
style='letter-spacing:-.35pt'> </span>fibrillation (NVAF),<span
style='letter-spacing:-.3pt'> </span>wi<span style='letter-spacing:.05pt'>t</span>h<span
style='letter-spacing:-.25pt'> </span>one<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>ore<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>factors,<span
style='letter-spacing:-.25pt'> </span>such<span style='letter-spacing:-.25pt'> </span>as<span
style='letter-spacing:-.25pt'> </span>p<span style='letter-spacing:-.1pt'>r</span>ior<span
style='letter-spacing:-.25pt'> </span>stroke<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>transient<span
style='letter-spacing:-.25pt'> </span>ischa<span style='letter-spacing:.05pt'>e</span>mic<span
style='letter-spacing:-.25pt'> </span>attack<span style='letter-spacing:-.25pt'>
</span>(T<span style='letter-spacing:.05pt'>I</span><span style='letter-spacing:
-.05pt'>A</span>); ag<span style='letter-spacing:-.05pt'>e</span>&#8805;<span
style='letter-spacing:-.4pt'>&nbsp;</span>75<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears;<span style='letter-spacing:-.3pt'> </span>h<span
style='letter-spacing:.05pt'>y</span>pertension;<span style='letter-spacing:
-.35pt'> </span>diabetes<span style='letter-spacing:-.25pt'> </span>mellitus;<span
style='letter-spacing:-.35pt'> </span>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptomatic<span style='letter-spacing:-.35pt'>
</span>heart<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
.05pt'>f</span><span style='letter-spacing:-.05pt'>a</span>ilure<span
style='letter-spacing:-.3pt'> </span>(NYHA<span style='letter-spacing:-.35pt'> </span>Class<span
style='letter-spacing:-.3pt'> </span>&#8805;<span style='letter-spacing:-.35pt'>&nbsp;</span>II).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Treatment<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>deep<span style='letter-spacing:-.35pt'> </span>vein<span
style='letter-spacing:-.3pt'> </span>th<span style='letter-spacing:-.1pt'>r</span>o<span
style='letter-spacing:-.1pt'>m</span>bosis<span style='letter-spacing:-.3pt'> </span>(DVT)<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>pu<span
style='letter-spacing:-.05pt'>l</span><span style='letter-spacing:-.1pt'>m</span>onary<span
style='letter-spacing:-.25pt'> </span>e<span style='letter-spacing:-.1pt'>m</span>bolism<span
style='letter-spacing:-.4pt'> </span>(PE),<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>prevention<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>r</span>ecurrent DVT<span style='letter-spacing:
-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>adults<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.4<span style='letter-spacing:-.3pt'>
</span>f<span style='letter-spacing:-.15pt'>o</span>r<span style='letter-spacing:
-.3pt'> </span>ha<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>od<span style='letter-spacing:.05pt'>y</span>n<span
style='letter-spacing:-.1pt'>a</span>mically<span style='letter-spacing:-.15pt'>
</span>unstable<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.3pt'> </span>patients).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.2<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Posology<span style='letter-spacing:-.5pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.05pt'>me</span>thod<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.45pt'> </span>ad<span style='letter-spacing:-.05pt'>m</span>inistration</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Posology</span></u></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Prevention<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>stroke<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.4pt'> </span>systemic<span
style='letter-spacing:-.3pt'> </span>embolism<span style='letter-spacing:-.4pt'>
</span>in<span style='letter-spacing:-.35pt'> </span>patien<span
style='letter-spacing:-.1pt'>t</span>s<span style='letter-spacing:-.45pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>non-va<span style='letter-spacing:-.05pt'>lv</span>ular<span
style='letter-spacing:-.4pt'> </span>atrial<span style='letter-spacing:-.35pt'>
</span>f<span style='letter-spacing:-.05pt'>i</span>brillation<span
style='letter-spacing:-.35pt'> </span>(NVAF)</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:
-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>taken<span style='letter-spacing:-.25pt'>
</span>ora<span style='letter-spacing:.05pt'>l</span>ly<span style='letter-spacing:
-.25pt'> </span>twice<span style='letter-spacing:-.25pt'> </span>daily.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Dose<span style='letter-spacing:-.65pt'> </span>reduct<span
style='letter-spacing:.05pt'>i</span>on</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.2pt'> </span>2.5<span style='letter-spacing:
-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>taken<span style='letter-spacing:-.2pt'> </span>orally<span
style='letter-spacing:-.15pt'> </span>twice<span style='letter-spacing:-.25pt'>
</span>daily<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.2pt'> </span>NVAF<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.2pt'> </span>at
least<span style='letter-spacing:-.25pt'> </span>two<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>following<span style='letter-spacing:
-.25pt'> </span>charact<span style='letter-spacing:.05pt'>e</span>risti<span
style='letter-spacing:.05pt'>c</span>s:<span style='letter-spacing:-.25pt'> </span>age<span
style='letter-spacing:-.3pt'> </span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>80<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>e</span>ars,<span style='letter-spacing:-.2pt'> </span>bo<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.15pt'> </span>weight<span
style='letter-spacing:-.3pt'> </span>&#8804;<span style='letter-spacing:-.25pt'>&nbsp;</span>60<span
style='letter-spacing:-.3pt'>&nbsp;</span>kg,<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>ser<span style='letter-spacing:
.05pt'>u</span>m<span style='letter-spacing:-.3pt'> </span>c<span
style='letter-spacing:.05pt'>r</span>eat<span style='letter-spacing:.05pt'>i</span>nine
&#8805;<span style='letter-spacing:-.4pt'>&nbsp;</span>1.5<span
style='letter-spacing:-.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g/dL<span
style='letter-spacing:-.3pt'> </span>(133<span style='letter-spacing:-.35pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>icr<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>o</span>le/L).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Therapy<span style='letter-spacing:-.35pt'> </span>s<span
style='letter-spacing:-.05pt'>h</span>o<span style='letter-spacing:-.05pt'>u</span>ld<span
style='letter-spacing:-.4pt'> </span>be<span style='letter-spacing:-.4pt'> </span>conti<span
style='letter-spacing:-.05pt'>nue</span>d<span style='letter-spacing:-.45pt'> </span>long-ter<span
style='letter-spacing:-.1pt'>m</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Treatment<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>DVT,<span style='letter-spacing:-.3pt'> </span>treatment<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>PE<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.4pt'> </span>prevention<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>recurrent<span
style='letter-spacing:-.3pt'> </span>D<span style='letter-spacing:.05pt'>V</span>T<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.35pt'> </span>(VTEt)</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>for<span style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:
-.25pt'> </span>trea<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.15pt'> </span>of<span style='letter-spacing:-.2pt'> </span>acute<span
style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span><span style='letter-spacing:.05pt'>n</span>t<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>PE<span
style='letter-spacing:-.2pt'> </span>is<span style='letter-spacing:-.25pt'> </span>10<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g
taken<span style='letter-spacing:-.25pt'> </span>oral<span style='letter-spacing:
-.05pt'>l</span>y<span style='letter-spacing:-.1pt'> </span><span
style='letter-spacing:-.05pt'>tw</span>ice<span style='letter-spacing:-.2pt'> </span>daily<span
style='letter-spacing:-.15pt'> </span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>first<span style='letter-spacing:-.2pt'> </span>7<span
style='letter-spacing:-.2pt'>&nbsp;</span>d<span style='letter-spacing:-.1pt'>a</span><span
style='letter-spacing:.05pt'>y</span>s<span style='letter-spacing:-.25pt'> </span>f<span
style='letter-spacing:-.05pt'>o</span>llowed<span style='letter-spacing:-.3pt'>
</span>by<span style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:
-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>taken<span style='letter-spacing:-.2pt'> </span>orally<span
style='letter-spacing:-.2pt'> </span>twice<span style='letter-spacing:-.25pt'> </span>dail<span
style='letter-spacing:.05pt'>y</span>.<span style='letter-spacing:-.2pt'> </span>As<span
style='letter-spacing:-.2pt'> </span>per<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>a</span>vailable medical<span style='letter-spacing:
-.3pt'> </span>guidelines,<span style='letter-spacing:-.25pt'> </span>short<span
style='letter-spacing:-.25pt'> </span>duration<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>tr<span style='letter-spacing:
-.1pt'>e</span><span style='letter-spacing:-.05pt'>a</span><span
style='letter-spacing:.05pt'>t</span><span style='letter-spacing:-.1pt'>m</span>ent<span
style='letter-spacing:-.25pt'> </span>(at<span style='letter-spacing:-.35pt'> </span>least<span
style='letter-spacing:-.3pt'> </span>3<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>onths)<span style='letter-spacing:-.25pt'>
</span>should<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>based<span style='letter-spacing:-.25pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>transient<span style='letter-spacing:
-.3pt'> </span>risk factors<span style='letter-spacing:-.45pt'> </span>(e.g.,<span
style='letter-spacing:-.45pt'> </span>recent<span style='letter-spacing:-.45pt'>
</span>surgery,<span style='letter-spacing:-.45pt'> </span>trauma,<span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.05pt'>m</span><span style='letter-spacing:-.1pt'>m</span>obilisation<span
style='letter-spacing:.05pt'>)</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.2pt'>
</span>f<span style='letter-spacing:.05pt'>o</span>r<span style='letter-spacing:
-.25pt'> </span><span style='letter-spacing:-.05pt'>t</span>he<span
style='letter-spacing:-.25pt'> </span>prevention<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.2pt'> </span>recurrent<span
style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>is<span
style='letter-spacing:-.2pt'> </span>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>taken<span
style='letter-spacing:-.25pt'> </span>oral<span style='letter-spacing:-.05pt'>l</span>y
twice<span style='letter-spacing:-.25pt'> </span>dail<span style='letter-spacing:
.05pt'>y</span>.<span style='letter-spacing:-.3pt'> </span>When<span
style='letter-spacing:-.25pt'> </span>prevention<span style='letter-spacing:
-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>recurrent<span
style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>a</span>nd<span style='letter-spacing:-.2pt'> </span>PE<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.25pt'> </span>indicated,<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>2.5<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.25pt'>
</span>daily<span style='letter-spacing:-.1pt'> </span>dose should<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.25pt'> </span>ini<span
style='letter-spacing:-.05pt'>t</span>iated<span style='letter-spacing:-.25pt'>
</span>followi<span style='letter-spacing:-.05pt'>n</span>g<span
style='letter-spacing:-.25pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>pletion<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>6<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>onths<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>o</span>f<span
style='letter-spacing:-.25pt'> </span>treatment<span style='letter-spacing:
-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.25pt'>
</span>or with<span style='letter-spacing:-.3pt'> </span>another<span
style='letter-spacing:-.3pt'> </span>anticoagulant,<span style='letter-spacing:
-.25pt'> </span>as<span style='letter-spacing:-.25pt'> </span>indicated<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>Table<span
style='letter-spacing:-.25pt'> </span>1<span style='letter-spacing:-.25pt'> </span>below<span
style='letter-spacing:-.3pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>also<span
style='letter-spacing:-.25pt'> </span>section<span style='letter-spacing:-.25pt'>&nbsp;</span>5.1)</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.35pt'> </span>1:</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:17.0pt'>
  <td width=221 valign=top style='width:2.3in;border:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=240 valign=top style='width:2.5in;border:solid black 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Dosing<span style='letter-spacing:-.75pt'>
  </span>schedule</span></p>
  </td>
  <td width=158 valign=top style='width:118.7pt;border:solid black 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Maxi<span style='letter-spacing:-.1pt'>m</span><span
  style='letter-spacing:.05pt'>u</span>m<span style='letter-spacing:-.55pt'> </span>daily<span
  style='letter-spacing:-.45pt'> </span>dose</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=221 rowspan=2 valign=top style='width:2.3in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Treatment<span style='letter-spacing:
  -.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>DVT<span
  style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.25pt'> </span>PE</span></p>
  </td>
  <td width=240 valign=top style='width:2.5in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>10<span style='letter-spacing:-.2pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.15pt'> </span>twice<span
  style='letter-spacing:-.15pt'> </span>daily<span style='letter-spacing:-.2pt'>
  </span>for<span style='letter-spacing:-.15pt'> </span>the<span
  style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>f</span>irst<span
  style='letter-spacing:-.15pt'> </span>7<span style='letter-spacing:-.2pt'> </span>d<span
  style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:.05pt'>y</span>s</span></p>
  </td>
  <td width=158 valign=top style='width:118.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>20<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=240 valign=top style='width:2.5in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>followed<span style='letter-spacing:-.25pt'>
  </span><span style='letter-spacing:-.05pt'>b</span>y<span style='letter-spacing:
  -.25pt'> </span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
  style='letter-spacing:-.25pt'> </span>daily</span></p>
  </td>
  <td width=158 valign=top style='width:118.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=221 valign=top style='width:2.3in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Prevention<span style='letter-spacing:
  -.4pt'> </span>of<span style='letter-spacing:-.4pt'> </span>recurrent<span
  style='letter-spacing:-.4pt'> </span>DVT and/or<span style='letter-spacing:
  -.4pt'> </span>PE<span style='letter-spacing:-.35pt'> </span>fo<span
  style='letter-spacing:-.05pt'>l</span>lowing<span style='letter-spacing:-.35pt'>
  </span>co<span style='letter-spacing:-.1pt'>m</span>pletion<span
  style='letter-spacing:-.35pt'> </span>of 6<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>onths<span style='letter-spacing:-.2pt'>
  </span>of<span style='letter-spacing:-.25pt'> </span>treatment<span
  style='letter-spacing:-.2pt'> </span>for<span style='letter-spacing:-.25pt'> </span>DVT<span
  style='letter-spacing:-.2pt'> </span>or PE</span></p>
  </td>
  <td width=240 valign=top style='width:2.5in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
  style='letter-spacing:-.2pt'> </span>daily</span></p>
  </td>
  <td width=158 valign=top style='width:118.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>5<span style='letter-spacing:-.2pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>duration<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.3pt'> </span>th<span style='letter-spacing:-.1pt'>e</span>rapy<span
style='letter-spacing:-.25pt'> </span>should<span style='letter-spacing:-.3pt'>
</span>be<span style='letter-spacing:-.3pt'> </span>individualised<span
style='letter-spacing:-.3pt'> </span>after<span style='letter-spacing:-.3pt'> </span>ca<span
style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:.05pt'>f</span>ul<span
style='letter-spacing:-.3pt'> </span>assess<span style='letter-spacing:-.05pt'>m</span>ent<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>treatment benefit<span style='letter-spacing:
-.3pt'> </span>against<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>bleeding<span style='letter-spacing:-.25pt'>
</span>(see<span style='letter-spacing:-.25pt'> </span>section<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.4).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Missed<span style='letter-spacing:-.55pt'> </span>dose</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>If<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>is<span
style='letter-spacing:-.2pt'> </span>missed,<span style='letter-spacing:-.25pt'>
</span>the<span style='letter-spacing:-.25pt'> </span>patient<span
style='letter-spacing:-.2pt'> </span>should<span style='letter-spacing:-.3pt'> </span>take<span
style='letter-spacing:-.25pt'> </span>Apixaban Accord<span style='letter-spacing:
-.25pt'> </span>immediately<span style='letter-spacing:-.15pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>then<span style='letter-spacing:-.25pt'> </span>cont<span
style='letter-spacing:-.05pt'>in</span>ue<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.25pt'>
</span>dai<span style='letter-spacing:-.05pt'>l</span>y intake<span
style='letter-spacing:-.35pt'> </span>as<span style='letter-spacing:-.35pt'> </span>before.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Switching</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Switching<span style='letter-spacing:-.3pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.25pt'> </span>fr<span style='letter-spacing:.05pt'>o</span>m<span
style='letter-spacing:-.35pt'> </span>parenteral<span style='letter-spacing:
-.25pt'> </span>anticoagulants<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>Apixaban Accord<span style='letter-spacing:
-.25pt'> </span>(and<span style='letter-spacing:-.35pt'> </span>vice<span
style='letter-spacing:-.25pt'> </span>versa)<span style='letter-spacing:-.3pt'>
</span>can<span style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:
-.3pt'> </span>d<span style='letter-spacing:-.05pt'>o</span>ne<span
style='letter-spacing:-.25pt'> </span>at<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>next scheduled<span style='letter-spacing:
-.35pt'> </span>dose<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.35pt'> </span>section<span style='letter-spacing:-.3pt'>&nbsp;</span>4.5).<span
style='letter-spacing:-.3pt'> </span>These<span style='letter-spacing:-.35pt'> </span>med<span
style='letter-spacing:-.05pt'>i</span>cinal<span style='letter-spacing:-.3pt'> </span>products<span
style='letter-spacing:-.35pt'> </span>should<span style='letter-spacing:-.35pt'>
</span>not<span style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:
-.35pt'> </span>ad<span style='letter-spacing:-.1pt'>m</span>inistered si<span
style='letter-spacing:-.1pt'>m</span>ultaneously.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Switching<span style='letter-spacing:-.35pt'> </span>fr<span
style='letter-spacing:-.05pt'>o</span>m<span style='letter-spacing:-.35pt'> </span>vitamin<span
style='letter-spacing:-.3pt'> </span>K<span style='letter-spacing:-.35pt'> </span>anta<span
style='letter-spacing:-.05pt'>g</span>onist<span style='letter-spacing:-.3pt'> </span>(<span
style='letter-spacing:-.05pt'>V</span>KA)<span style='letter-spacing:-.3pt'> </span>therapy<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>When<span style='letter-spacing:-.35pt'> </span>conve<span
style='letter-spacing:-.1pt'>r</span>ting<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>f</span>rom<span
style='letter-spacing:-.35pt'> </span>vitamin<span style='letter-spacing:-.3pt'>
</span>K<span style='letter-spacing:-.35pt'> </span>antagonist<span
style='letter-spacing:-.3pt'> </span>(VKA)<span style='letter-spacing:-.3pt'> </span>thera<span
style='letter-spacing:.05pt'>p</span>y<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>Apixaban Accord,<span style='letter-spacing:
-.35pt'> </span>warfarin<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>other VKA<span style='letter-spacing:-.35pt'>
</span>therapy<span style='letter-spacing:-.25pt'> </span>should<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.3pt'> </span>di<span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:-.05pt'>c</span>ontinued<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>star<span style='letter-spacing:
-.05pt'>te</span>d<span style='letter-spacing:-.35pt'> </span>when<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span>international<span
style='letter-spacing:-.3pt'> </span>normalised<span style='letter-spacing:
-.35pt'> </span>rat<span style='letter-spacing:.05pt'>i</span>o<span
style='letter-spacing:-.3pt'> </span>(INR) is<span style='letter-spacing:-.15pt'>
</span>&lt;<span style='letter-spacing:-.1pt'>&nbsp;</span>2.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Switching<span style='letter-spacing:-.35pt'> </span>fr<span
style='letter-spacing:-.05pt'>o</span>m<span style='letter-spacing:-.35pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:
-.4pt'> </span>VKA<span style='letter-spacing:-.3pt'> </span>therapy</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>When<span style='letter-spacing:-.35pt'> </span>conve<span
style='letter-spacing:-.1pt'>r</span>ting<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>f</span>rom<span
style='letter-spacing:-.4pt'> </span>Apixaban Accord<span style='letter-spacing:
-.3pt'> </span>to<span style='letter-spacing:-.35pt'> </span>VKA<span
style='letter-spacing:-.3pt'> </span>thera<span style='letter-spacing:-.05pt'>p</span><span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban Accord<span
style='letter-spacing:-.35pt'> </span>should<span style='letter-spacing:-.3pt'>
</span>be<span style='letter-spacing:-.35pt'> </span><span style='letter-spacing:
-.1pt'>c</span>ontinued for<span style='letter-spacing:-.25pt'> </span>at<span
style='letter-spacing:-.25pt'> </span>least<span style='letter-spacing:-.25pt'>
</span>2<span style='letter-spacing:-.25pt'>&nbsp;</span>da<span
style='letter-spacing:.05pt'>y</span>s<span style='letter-spacing:-.25pt'> </span>after<span
style='letter-spacing:-.25pt'> </span>beginning<span style='letter-spacing:
-.25pt'> </span>VKA<span style='letter-spacing:-.25pt'> </span>therapy.<span
style='letter-spacing:-.25pt'> </span>A<span style='letter-spacing:-.05pt'>f</span>ter<span
style='letter-spacing:-.2pt'> </span>2<span style='letter-spacing:-.25pt'>&nbsp;</span>d<span
style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>coa<span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:
-.25pt'> </span>VKA therap<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.35pt'> </span>an<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>I</span><span style='letter-spacing:-.05pt'>N</span>R<span
style='letter-spacing:-.25pt'> </span>should<span style='letter-spacing:-.3pt'>
</span>be<span style='letter-spacing:-.35pt'> </span>obtained<span
style='letter-spacing:-.25pt'> </span>pr<span style='letter-spacing:-.05pt'>io</span>r<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>next<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:-.05pt'>c</span>heduled<span
style='letter-spacing:-.3pt'> </span>do<span style='letter-spacing:-.1pt'>s</span>e<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>Apixaban
Accord.<span style='letter-spacing:-.35pt'> </span>Coa<span style='letter-spacing:
.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.25pt'> </span>of Apixaban Accord<span style='letter-spacing:
-.25pt'> </span>and<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>V</span>KA<span style='letter-spacing:-.25pt'> </span>therapy<span
style='letter-spacing:-.1pt'> </span>should<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>con<span style='letter-spacing:-.05pt'>t</span>inued<span
style='letter-spacing:-.2pt'> </span>until<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>INR<span style='letter-spacing:-.2pt'> </span>is<span
style='letter-spacing:-.2pt'> </span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>2.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Renal<span style='letter-spacing:-.8pt'> </span>impai<span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>m</span>ent</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ild<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.35pt'> </span>renal<span style='letter-spacing:-.35pt'>
</span><span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:
-.15pt'>m</span><span style='letter-spacing:.05pt'>p</span><span
style='letter-spacing:-.05pt'>a</span>irment,<span style='letter-spacing:-.35pt'>
</span>the<span style='letter-spacing:-.3pt'> </span>following<span
style='letter-spacing:-.4pt'> </span>rec<span style='letter-spacing:.05pt'>o</span>mmendations<span
style='letter-spacing:-.35pt'> </span>app<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span>:</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>treatment<span style='letter-spacing:
-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>DVT,<span
style='letter-spacing:-.25pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.2pt'> </span>p<span style='letter-spacing:-.05pt'>r</span>ev<span
style='letter-spacing:-.1pt'>e</span>ntion<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>recurrent<span style='letter-spacing:
-.2pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.2pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>(VTEt),<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>n</span>o<span
style='letter-spacing:-.2pt'> </span>dose adjus<span style='letter-spacing:
.05pt'>t</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.35pt'> </span>is<span
style='letter-spacing:-.35pt'> </span>necessary<span style='letter-spacing:
-.25pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.35pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>for<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>prevention<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>stroke<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>stemic<span
style='letter-spacing:-.25pt'> </span>e<span style='letter-spacing:-.15pt'>m</span>boli<span
style='letter-spacing:.05pt'>s</span>m<span style='letter-spacing:-.4pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>NVAF<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>serum<span
style='letter-spacing:-.35pt'> </span>c<span style='letter-spacing:.05pt'>r</span>e<span
style='letter-spacing:-.05pt'>a</span>tinine<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.05pt'>&#8805;</span>1.5&nbsp;<span
style='letter-spacing:-.1pt'>m</span>g/dL<span style='letter-spacing:-.25pt'> </span>(133<span
style='letter-spacing:-.25pt'>&nbsp;</span>micr<span style='letter-spacing:
.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>ole/L)<span
style='letter-spacing:-.2pt'> </span>associa<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>age<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>&#8805;</span>80<span
style='letter-spacing:-.3pt'>&nbsp;</span>years<span style='letter-spacing:
-.25pt'> </span>or<span style='letter-spacing:-.25pt'> </span>bo<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.25pt'> </span>weight<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>&#8804;</span>60<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>k</span>g,<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>red<span style='letter-spacing:-.05pt'>u</span>ction<span
style='letter-spacing:-.25pt'> </span>is necessary<span style='letter-spacing:
-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span>described<span
style='letter-spacing:-.3pt'> </span>above.<span style='letter-spacing:-.25pt'>
</span>In<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.25pt'> </span>absence<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>other<span
style='letter-spacing:-.25pt'> </span>criteria<span style='letter-spacing:-.3pt'>
</span>for<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>reduction<span style='letter-spacing:
-.3pt'> </span>(age,<span style='letter-spacing:-.25pt'> </span>body<span
style='letter-spacing:-.25pt'> </span>weight), no<span style='letter-spacing:
-.3pt'> </span>dose<span style='letter-spacing:-.3pt'> </span>adjus<span
style='letter-spacing:.05pt'>t</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.25pt'> </span>is<span
style='letter-spacing:-.3pt'> </span>nec<span style='letter-spacing:.05pt'>e</span>ssary<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>severe<span
style='letter-spacing:-.35pt'> </span>renal<span style='letter-spacing:-.3pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pairment<span style='letter-spacing:-.3pt'>
</span>(creatinine<span style='letter-spacing:-.35pt'> </span>c<span
style='letter-spacing:.05pt'>l</span>earan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.4pt'> </span>15-29<span style='letter-spacing:-.35pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.05pt'>m</span>in)<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>following rec<span style='letter-spacing:
.05pt'>o</span>mmendations<span style='letter-spacing:-.35pt'> </span>app<span
style='letter-spacing:-.05pt'>l</span>y<span style='letter-spacing:-.25pt'> </span>(s<span
style='letter-spacing:-.1pt'>e</span>e<span style='letter-spacing:-.4pt'> </span>sections<span
style='letter-spacing:-.35pt'>&nbsp;</span>4.4<span style='letter-spacing:-.35pt'>&nbsp;</span>and<span
style='letter-spacing:-.35pt'>&nbsp;</span>5.2<span style='letter-spacing:-.1pt'>)</span>:</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>treatment<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>DVT,<span
style='letter-spacing:-.25pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>prev<span style='letter-spacing:-.1pt'>e</span>ntion<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.2pt'> </span>recurrent<span
style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>(VTEt)
apixaban<span style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:
-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.2pt'> </span>used<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>caution;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>for<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>prev<span style='letter-spacing:-.1pt'>e</span>ntion<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.25pt'> </span>stroke<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>s<span
style='letter-spacing:.05pt'>y</span>ste<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.3pt'> </span>e<span
style='letter-spacing:-.1pt'>m</span>bolism<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>NVAF,<span
style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>should<span style='letter-spacing:-.3pt'> </span>r<span
style='letter-spacing:-.1pt'>e</span>ceive the<span style='letter-spacing:-.25pt'>
</span>lower<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.2pt'> </span>dai<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoListParagraph><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>creatinine<span
style='letter-spacing:-.25pt'> </span>clearan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.3pt'> </span>&lt;<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>1</span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.05pt'>m</span>in,<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>u<span style='letter-spacing:-.05pt'>n</span>dergoing<span
style='letter-spacing:-.3pt'> </span>dia<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is,<span
style='letter-spacing:-.25pt'> </span>there<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.3pt'> </span>no clinical<span
style='letter-spacing:-.35pt'> </span>experience<span style='letter-spacing:
-.3pt'> </span>therefo<span style='letter-spacing:.05pt'>r</span>e<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>is<span style='letter-spacing:-.35pt'> </span>not<span style='letter-spacing:
-.3pt'> </span>recomm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>sections<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.4<span style='letter-spacing:-.3pt'>&nbsp;</span>and<span
style='letter-spacing:-.4pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Hepatic<span style='letter-spacing:-.9pt'> </span>impairment</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>is<span
style='letter-spacing:-.35pt'> </span>contraindicated<span style='letter-spacing:
-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>hepatic<span
style='letter-spacing:-.35pt'> </span>disease<span style='letter-spacing:-.3pt'>
</span>associa<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>coagulopathy<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.35pt'> </span>clinically
relevant<span style='letter-spacing:-.35pt'> </span>ble<span style='letter-spacing:
.05pt'>e</span>ding<span style='letter-spacing:-.3pt'> </span>risk<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.3).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>It<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>not<span style='letter-spacing:-.25pt'> </span>recommended<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>severe<span
style='letter-spacing:-.3pt'> </span>h<span style='letter-spacing:-.15pt'>e</span>pat<span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>pai<span
style='letter-spacing:.05pt'>r</span>ment<span style='letter-spacing:-.25pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>sections<span style='letter-spacing:-.3pt'>&nbsp;</span>4.4<span
style='letter-spacing:-.25pt'>&nbsp;</span>and<span style='letter-spacing:-.25pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>It<span style='letter-spacing:-.25pt'> </span>should<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>u</span>sed<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>caution<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ild<span style='letter-spacing:-.35pt'> </span>or<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.25pt'> </span>he<span style='letter-spacing:.05pt'>p</span><span
style='letter-spacing:-.05pt'>a</span>tic<span style='letter-spacing:-.25pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pairment<span style='letter-spacing:-.25pt'>
</span>(Child<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:
-.05pt'>P</span>u<span style='letter-spacing:-.05pt'>g</span>h<span
style='letter-spacing:-.25pt'> </span>A<span style='letter-spacing:-.25pt'> </span>or
B).<span style='letter-spacing:-.3pt'> </span>No<span style='letter-spacing:
-.25pt'> </span>dose<span style='letter-spacing:-.3pt'> </span>adjustment<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.3pt'> </span>required<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>pa<span
style='letter-spacing:-.05pt'>t</span>ients<span style='letter-spacing:-.35pt'>
</span>with<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.1pt'>m</span>i<span style='letter-spacing:.05pt'>l</span>d<span
style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>oderate<span style='letter-spacing:-.3pt'>
</span>hepatic<span style='letter-spacing:-.25pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>p</span>air<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt
(see<span style='letter-spacing:-.3pt'> </span>sections<span style='letter-spacing:
-.25pt'>&nbsp;</span>4.4<span style='letter-spacing:-.25pt'>&nbsp;</span>and<span
style='letter-spacing:-.3pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Patients<span style='letter-spacing:-.55pt'> </span>with<span
style='letter-spacing:-.5pt'> </span>elevated<span style='letter-spacing:-.5pt'>
</span>liver<span style='letter-spacing:-.5pt'> </span>enz<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.1pt'>m</span>es<span
style='letter-spacing:-.5pt'> </span>a<span style='letter-spacing:.05pt'>l</span>anine<span
style='letter-spacing:-.5pt'> </span>a<span style='letter-spacing:-.1pt'>m</span>inotransferase<span
style='letter-spacing:-.5pt'> </span>(A<span style='letter-spacing:.05pt'>L</span>T)/aspartate<span
style='letter-spacing:-.45pt'> </span>aminotransferase (AST)<span
style='letter-spacing:-.25pt'> </span>&gt;2<span style='letter-spacing:-.25pt'>&nbsp;</span>x<span
style='letter-spacing:-.2pt'>&nbsp;</span>ULN<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.2pt'> </span>total<span
style='letter-spacing:-.25pt'> </span>bilirub<span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.25pt'> </span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>1<span
style='letter-spacing:-.05pt'>.</span>5<span style='letter-spacing:-.2pt'>&nbsp;</span>x<span
style='letter-spacing:-.25pt'>&nbsp;</span>ULN<span style='letter-spacing:-.2pt'>
</span>were<span style='letter-spacing:-.25pt'> </span>excluded<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.3pt'> </span>clinical<span
style='letter-spacing:-.2pt'> </span>trials.<span style='letter-spacing:-.25pt'>
</span>Therefore<span style='letter-spacing:-.2pt'> </span>Apixaban Accord should<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.25pt'> </span>used<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>caution<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>this<span
style='letter-spacing:-.25pt'> </span>population<span style='letter-spacing:
-.25pt'> </span>(see<span style='letter-spacing:-.35pt'> </span>sections<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.4<span style='letter-spacing:-.25pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.2).<span style='letter-spacing:
-.25pt'> </span>Pr<span style='letter-spacing:-.05pt'>i</span>or<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>initiating<span
style='letter-spacing:-.25pt'> </span>Apixaban Accord, liver<span
style='letter-spacing:-.35pt'> </span>function<span style='letter-spacing:-.4pt'>
</span>testing<span style='letter-spacing:-.35pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.35pt'> </span>be<span
style='letter-spacing:-.35pt'> </span>performed.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Body<span style='letter-spacing:-.55pt'> </span>weight</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>VTEt<span style='letter-spacing:-.25pt'> </span>-<span
style='letter-spacing:-.25pt'> </span>No<span style='letter-spacing:-.25pt'> </span>d<span
style='letter-spacing:-.05pt'>o</span>se<span style='letter-spacing:-.25pt'> </span>adjust<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.25pt'> </span>required<span style='letter-spacing:-.25pt'>
</span>(see<span style='letter-spacing:-.25pt'> </span>sections<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.4<span style='letter-spacing:-.3pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>NVAF<span style='letter-spacing:-.3pt'> </span>-<span
style='letter-spacing:-.25pt'> </span>No<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>adjus<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span>ent<span style='letter-spacing:-.25pt'> </span>required,<span
style='letter-spacing:-.25pt'> </span>unless<span style='letter-spacing:-.25pt'>
</span>criteria<span style='letter-spacing:-.2pt'> </span>for<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>reduction<span
style='letter-spacing:-.3pt'> </span>are<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>t<span
style='letter-spacing:-.2pt'> </span>(see<span style='letter-spacing:-.25pt'> </span><i>Dose<span
style='letter-spacing:-.25pt'> </span>re<span style='letter-spacing:.05pt'>d</span>uction<span
style='letter-spacing:-.25pt'> </span></i><span style='letter-spacing:-.05pt'>at
</span>the<span style='letter-spacing:-.3pt'> </span>beginn<span
style='letter-spacing:-.05pt'>i</span>ng<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>section<span style='letter-spacing:-.3pt'>&nbsp;</span>4<span
style='letter-spacing:-.05pt'>.</span>2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Gender</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>No<span style='letter-spacing:-.35pt'> </span>dose<span
style='letter-spacing:-.3pt'> </span>adjus<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>required<span style='letter-spacing:-.3pt'>
</span>(see<span style='letter-spacing:-.35pt'> </span>section<span
style='letter-spacing:-.3pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Elderly</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>VTEt<span style='letter-spacing:-.25pt'> </span>-<span
style='letter-spacing:-.25pt'> </span>No<span style='letter-spacing:-.25pt'> </span>d<span
style='letter-spacing:-.05pt'>o</span>se<span style='letter-spacing:-.25pt'> </span>adjust<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.25pt'> </span>required<span style='letter-spacing:-.25pt'>
</span>(see<span style='letter-spacing:-.25pt'> </span>sections<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.4<span style='letter-spacing:-.3pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>NVAF<span style='letter-spacing:-.3pt'> </span>-<span
style='letter-spacing:-.25pt'> </span>No<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>adjus<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span>ent<span style='letter-spacing:-.25pt'> </span>required,<span
style='letter-spacing:-.25pt'> </span>unless<span style='letter-spacing:-.25pt'>
</span>criteria<span style='letter-spacing:-.2pt'> </span>for<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>reduction<span
style='letter-spacing:-.3pt'> </span>are<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>t<span
style='letter-spacing:-.2pt'> </span>(see<span style='letter-spacing:-.25pt'> </span><i>Dose<span
style='letter-spacing:-.25pt'> </span>re<span style='letter-spacing:.05pt'>d</span>uction<span
style='letter-spacing:-.25pt'> </span></i><span style='letter-spacing:-.05pt'>at
</span>the<span style='letter-spacing:-.3pt'> </span>beginn<span
style='letter-spacing:-.05pt'>i</span>ng<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>section<span style='letter-spacing:-.3pt'>&nbsp;</span>4<span
style='letter-spacing:-.05pt'>.</span>2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Patients undergoing catheter ablation (NVAF)</span></u></i></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>Patients can continue apixaban use while undergoing
catheter ablation (see sections 4.3, 4.4 and 4.5).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Patients<span style='letter-spacing:-.8pt'> </span>und<span
style='letter-spacing:-.1pt'>e</span>rgoing<span style='letter-spacing:-.75pt'>
</span>card<span style='letter-spacing:-.05pt'>io</span>version</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.35pt'> </span>can<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.3pt'> </span>initiated<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>continued<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.35pt'> </span>NVAF<span
style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span>who<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.25pt'> </span>require<span style='letter-spacing:-.3pt'>
</span>cardioversion.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>For patients not previously treated with
anticoagulants, exclusion of left atrial thrombus using an image guided
approach (e.g. transesophageal echocardiography (TEE) or computed tomographic
scan (CT)) prior to cardioversion should be considered, in accordance with
established medical guidelines.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>For patients initiating treatment with apixaban,
5&nbsp;mg should be given twice daily for at least 2.5&nbsp;days (5&nbsp;single
doses) before cardioversion to ensure adequate anticoagulation (see section
5.1). The dosing regimen should be reduced to 2.5&nbsp;mg apixaban given twice
daily for at least 2.5&nbsp;days (5&nbsp;single doses) if the patient meets the
criteria for dose reduction (see above sections <i>Dose reduction</i> and <i>Renal
impairment</i>).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>If<span style='letter-spacing:-.25pt'> </span>cardioversion<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.25pt'> </span>required<span
style='letter-spacing:-.3pt'> </span>before<span style='letter-spacing:-.25pt'>
</span>5<span style='letter-spacing:-.2pt'>&nbsp;</span>do<span
style='letter-spacing:-.1pt'>s</span>es<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>can<span style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:
-.25pt'> </span>ad<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>nistered,<span style='letter-spacing:-.2pt'>
</span>a<span style='letter-spacing:-.25pt'> </span>10<span style='letter-spacing:
-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>loading<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>d</span>ose should<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.2pt'> </span>gi<span
style='letter-spacing:-.05pt'>ve</span>n,<span style='letter-spacing:-.2pt'> </span>followed<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>b</span>y<span
style='letter-spacing:-.1pt'> </span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>twice<span
style='letter-spacing:-.2pt'> </span>dail<span style='letter-spacing:.05pt'>y</span>.<span
style='letter-spacing:-.3pt'> </span>The<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>d</span>osing<span style='letter-spacing:-.2pt'> </span>regi<span
style='letter-spacing:-.1pt'>m</span>en<span style='letter-spacing:-.25pt'> </span>shou<span
style='letter-spacing:-.1pt'>l</span>d<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>r</span><span
style='letter-spacing:-.05pt'>e</span>duced<span style='letter-spacing:-.2pt'> </span>to<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.2pt'> </span>5<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g
loading<span style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:
-.25pt'> </span>followed<span style='letter-spacing:-.2pt'> </span>by<span
style='letter-spacing:-.25pt'> </span>2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.05pt'>a</span>ily<span style='letter-spacing:-.15pt'> </span>if<span
style='letter-spacing:-.3pt'> </span>t<span style='letter-spacing:.05pt'>h</span>e<span
style='letter-spacing:-.2pt'> </span>patient<span style='letter-spacing:-.25pt'>
</span>meets<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>criteria<span style='letter-spacing:-.25pt'>
</span>for<span style='letter-spacing:-.2pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>reduction<span style='letter-spacing:
-.2pt'> </span>(see above<span style='letter-spacing:-.35pt'> </span>sections<span
style='letter-spacing:-.3pt'> </span><i>Dose<span style='letter-spacing:-.3pt'>
</span>reduc<span style='letter-spacing:.05pt'>t</span>ion<span
style='letter-spacing:-.35pt'> </span></i>and<span style='letter-spacing:-.3pt'>
</span><i><span style='letter-spacing:-.05pt'>Rena</span>l<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>impairment</span>)</i>.<span
style='letter-spacing:-.35pt'> </span>The<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>l</span>oading<span
style='letter-spacing:-.35pt'> </span>dose<span style='letter-spacing:-.35pt'> </span>should
be<span style='letter-spacing:-.25pt'> </span>given<span style='letter-spacing:
-.25pt'> </span>at<span style='letter-spacing:-.25pt'> </span>l<span
style='letter-spacing:-.1pt'>e</span>ast<span style='letter-spacing:-.25pt'> </span>2<span
style='letter-spacing:-.25pt'>&nbsp;</span>hours<span style='letter-spacing:
-.25pt'> </span>b<span style='letter-spacing:-.1pt'>e</span>fore<span
style='letter-spacing:-.25pt'> </span>cardioversion<span style='letter-spacing:
-.25pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For all patients undergoing cardioversion, confirmation<span
style='letter-spacing:-.3pt'> </span>should<span style='letter-spacing:-.35pt'>
</span>be<span style='letter-spacing:-.3pt'> </span>sought<span
style='letter-spacing:-.35pt'> </span>prior<span style='letter-spacing:-.25pt'>
</span>to<span style='letter-spacing:-.35pt'> </span>cardioversion<span
style='letter-spacing:-.3pt'> </span>that<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>patient<span style='letter-spacing:-.3pt'>
</span>has<span style='letter-spacing:-.25pt'> </span>taken<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>as<span style='letter-spacing:-.3pt'> </span>p<span style='letter-spacing:
-.1pt'>r</span>escribed. Decisions<span style='letter-spacing:-.4pt'> </span>on<span
style='letter-spacing:-.4pt'> </span>initiation<span style='letter-spacing:
-.35pt'> </span>and<span style='letter-spacing:-.45pt'> </span>duration<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.4pt'> </span>t<span
style='letter-spacing:-.1pt'>r</span>eatment<span style='letter-spacing:-.45pt'>
</span>shou<span style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:
-.35pt'> </span>take<span style='letter-spacing:-.4pt'> </span>established<span
style='letter-spacing:-.4pt'> </span>guideline<span style='letter-spacing:-.35pt'>
</span>rec<span style='letter-spacing:.05pt'>o</span>mmen<span
style='letter-spacing:.05pt'>d</span>ations for<span style='letter-spacing:
-.45pt'> </span>anticoagu<span style='letter-spacing:-.05pt'>l</span>ant<span
style='letter-spacing:-.4pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.4pt'> </span>patients<span style='letter-spacing:-.45pt'>
</span>u<span style='letter-spacing:-.05pt'>n</span>dergoing<span
style='letter-spacing:-.45pt'> </span>cardioversion<span style='letter-spacing:
-.4pt'> </span>in<span style='letter-spacing:-.05pt'>t</span>o<span
style='letter-spacing:-.45pt'> </span>account.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><i><u><span
lang=EN-GB>Patients with NVAF and acute coronary syndrome (ACS) and/or
percutaneous coronary intervention (PCI)</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There is limited experience of treatment with apixaban at the
recommended dose for NVAF patients when used in combination with antiplatelet
agents in patients with ACS and/or undergoing PCI after haemostasis is achieved
(see sections 4.4, 5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Paediatric<span style='letter-spacing:-1.0pt'> </span>p<span
style='letter-spacing:-.05pt'>o</span>pulat<span style='letter-spacing:-.05pt'>i</span>on</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>safety<span
style='letter-spacing:-.15pt'> </span>and<span style='letter-spacing:-.25pt'> </span>efficacy<span
style='letter-spacing:-.15pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:
-.25pt'> </span>children<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>adolescents<span style='letter-spacing:
-.25pt'> </span>bel<span style='letter-spacing:.05pt'>o</span>w<span
style='letter-spacing:-.25pt'> </span>age<span style='letter-spacing:-.3pt'> </span>18<span
style='letter-spacing:-.25pt'> </span>have<span style='letter-spacing:-.25pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>been<span style='letter-spacing:-.25pt'> </span>established.
No<span style='letter-spacing:-.3pt'> </span>data<span style='letter-spacing:
-.3pt'> </span>are<span style='letter-spacing:-.3pt'> </span>available.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Method<span style='letter-spacing:-.6pt'> </span>of<span
style='letter-spacing:-.55pt'> </span>a<span style='letter-spacing:-.05pt'>d</span>ministration</span></u></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Oral<span style='letter-spacing:-.35pt'> </span>use</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.3pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>swallowed<span style='letter-spacing:
-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>water,<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>wit<span style='letter-spacing:-.05pt'>h</span>out<span
style='letter-spacing:-.25pt'> </span>f<span style='letter-spacing:-.05pt'>o</span>od.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>who<span style='letter-spacing:-.25pt'> </span>are<span
style='letter-spacing:-.25pt'> </span>unable<span style='letter-spacing:-.25pt'>
</span>to<span style='letter-spacing:-.25pt'> </span>swallow<span
style='letter-spacing:-.25pt'> </span>whole<span style='letter-spacing:-.25pt'>
</span>tablets,<span style='letter-spacing:-.2pt'> </span>Apixaban Accord<span
style='letter-spacing:-.25pt'> </span>table<span style='letter-spacing:-.05pt'>t</span>s<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>y<span style='letter-spacing:-.15pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>crushed<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>sus<span
style='letter-spacing:-.05pt'>p</span>ended<span style='letter-spacing:-.25pt'>
</span>in water,<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>5%<span style='letter-spacing:-.25pt'> </span>glucose<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>water<span
style='letter-spacing:-.2pt'> </span>(G5W),<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>apple<span
style='letter-spacing:-.3pt'> </span>juice<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>ixed<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>apple<span
style='letter-spacing:-.25pt'> </span>puree<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.2pt'> </span>immediately a<span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistered<span
style='letter-spacing:-.3pt'> </span>orally<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.3pt'> </span>section<span style='letter-spacing:-.3pt'>&nbsp;</span>5.2).<span
style='letter-spacing:-.35pt'> </span>Alternativel<span style='letter-spacing:
.1pt'>y</span>,<span style='letter-spacing:-.3pt'> </span>Apixaban Accord<span
style='letter-spacing:-.3pt'> </span>tablets<span style='letter-spacing:-.3pt'>
</span>may<span style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:
-.3pt'> </span>crushed<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>suspended<span style='letter-spacing:-.35pt'>
</span>in 60<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>wa<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>e</span>r<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> G</span>5W<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>immediate<span style='letter-spacing:
.05pt'>l</span>y<span style='letter-spacing:-.25pt'> </span>delivered<span
style='letter-spacing:-.3pt'> </span>through<span style='letter-spacing:-.25pt'>
</span>a<span style='letter-spacing:-.3pt'> </span>nasogastric<span
style='letter-spacing:-.25pt'> </span>tube<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>section<span style='letter-spacing:-.25pt'>&nbsp;</span>5.2).
Crushed<span style='letter-spacing:-.25pt'> </span>Apixaban Accord<span
style='letter-spacing:-.2pt'> </span>tablets<span style='letter-spacing:-.25pt'>
</span>are<span style='letter-spacing:-.2pt'> </span>stable<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>water,<span
style='letter-spacing:-.2pt'> G</span>5W,<span style='letter-spacing:-.25pt'> </span>apple<span
style='letter-spacing:-.2pt'> </span>juice,<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.2pt'> </span>apple<span
style='letter-spacing:-.2pt'> </span>puree<span style='letter-spacing:-.25pt'> </span>f<span
style='letter-spacing:-.05pt'>o</span>r<span style='letter-spacing:-.2pt'> </span>up<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>4<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>h</span>ou<span
style='letter-spacing:-.1pt'>r</span>s.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.3<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Contraindications</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>H<span style='letter-spacing:.05pt'>y</span>persensitivity<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>active<span style='letter-spacing:-.25pt'>
</span>substance<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>any<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>excipients<span style='letter-spacing:
-.25pt'> </span>listed<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.2pt'> </span>section<span style='letter-spacing:-.25pt'>&nbsp;</span>6.1.</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Active<span style='letter-spacing:-.55pt'> </span>clinically<span
style='letter-spacing:-.55pt'> </span>significant<span style='letter-spacing:
-.55pt'> </span>bleeding.</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Hepatic<span style='letter-spacing:-.4pt'> </span>disease<span
style='letter-spacing:-.35pt'> </span>associated<span style='letter-spacing:
-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>coagulopathy<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.35pt'> </span>clinically<span
style='letter-spacing:-.25pt'> </span>relev<span style='letter-spacing:-.1pt'>a</span>nt<span
style='letter-spacing:-.35pt'> </span>bleeding<span style='letter-spacing:-.35pt'>
</span>risk<span style='letter-spacing:-.35pt'> </span>(see section<span
style='letter-spacing:-.55pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Lesion<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>condition<span style='letter-spacing:
-.3pt'> </span>if<span style='letter-spacing:-.25pt'> </span>considered<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.25pt'> </span>significant<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.35pt'> </span>factor<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor<span
style='letter-spacing:-.3pt'> </span>bleeding.<span style='letter-spacing:-.25pt'>
</span>This<span style='letter-spacing:-.35pt'> </span>may<span
style='letter-spacing:-.15pt'> </span>include current<span style='letter-spacing:
-.35pt'> </span>or<span style='letter-spacing:-.3pt'> </span>recent<span
style='letter-spacing:-.3pt'> </span>gastrointestinal<span style='letter-spacing:
-.3pt'> </span>ulcerat<span style='letter-spacing:.05pt'>i</span>on,<span
style='letter-spacing:-.35pt'> </span>presence<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>malignant<span
style='letter-spacing:-.3pt'> </span>neopla<span style='letter-spacing:.05pt'>s</span><span
style='letter-spacing:-.1pt'>m</span>s<span style='letter-spacing:-.35pt'> </span>at<span
style='letter-spacing:-.3pt'> </span>high<span style='letter-spacing:-.3pt'> </span>risk<span
style='letter-spacing:-.35pt'> </span>of bleeding,<span style='letter-spacing:
-.3pt'> </span>recent<span style='letter-spacing:-.3pt'> </span>brain<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>s</span>pinal<span style='letter-spacing:-.3pt'> </span>injury,<span
style='letter-spacing:-.3pt'> </span>recent<span style='letter-spacing:-.4pt'> </span>brain,<span
style='letter-spacing:-.3pt'> </span>spinal<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>ophtha<span style='letter-spacing:.05pt'>l</span><span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.25pt'> </span>surge<span
style='letter-spacing:.05pt'>r</span>y,<span style='letter-spacing:-.3pt'> </span>recent
intracranial<span style='letter-spacing:-.5pt'> </span>hae<span
style='letter-spacing:-.1pt'>m</span>orrhage,<span style='letter-spacing:-.45pt'>
</span>known<span style='letter-spacing:-.5pt'> </span>or<span
style='letter-spacing:-.5pt'> </span>suspec<span style='letter-spacing:-.15pt'>t</span>ed<span
style='letter-spacing:-.5pt'> </span>oesophageal<span style='letter-spacing:
-.5pt'> </span>varices,<span style='letter-spacing:-.5pt'> </span>arteriovenous
malfo<span style='letter-spacing:.05pt'>r</span>mations,<span style='letter-spacing:
-.45pt'> </span>vascular<span style='letter-spacing:-.4pt'> </span>a<span
style='letter-spacing:.05pt'>n</span>eur<span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.1pt'>m</span>s<span style='letter-spacing:-.4pt'> </span>or<span
style='letter-spacing:-.4pt'> </span>major<span style='letter-spacing:-.4pt'> </span>intraspinal<span
style='letter-spacing:-.45pt'> </span>or<span style='letter-spacing:-.4pt'> </span>intracer<span
style='letter-spacing:.05pt'>e</span>bral<span style='letter-spacing:-.4pt'> </span>vascular
abnor<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>a</span>lities.</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-.25in;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Conco<span style='letter-spacing:-.1pt'>m</span>itant<span
style='letter-spacing:-.35pt'> </span>treatment<span style='letter-spacing:
-.4pt'> </span>with<span style='letter-spacing:-.4pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>y<span style='letter-spacing:-.3pt'> </span>o<span
style='letter-spacing:-.05pt'>t</span>her<span style='letter-spacing:-.35pt'> </span>anticoagu<span
style='letter-spacing:-.15pt'>l</span>ant<span style='letter-spacing:-.45pt'> </span>agent<span
style='letter-spacing:-.4pt'> </span>e.g.,<span style='letter-spacing:-.35pt'> </span>u<span
style='letter-spacing:-.05pt'>n</span>fractionated<span style='letter-spacing:
-.4pt'> </span>heparin<span style='letter-spacing:-.4pt'> </span>(UFH), low<span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.1pt'>m</span>olecular<span
style='letter-spacing:-.4pt'> </span>weight<span style='letter-spacing:-.45pt'>
</span>heparins<span style='letter-spacing:-.4pt'> </span>(enoxaparin,<span
style='letter-spacing:-.45pt'> </span>dalteparin,<span style='letter-spacing:
-.4pt'> </span>etc.),<span style='letter-spacing:-.45pt'> </span>heparin<span
style='letter-spacing:-.4pt'> </span>derivatives (fondaparin<span
style='letter-spacing:-.05pt'>u</span>x,<span style='letter-spacing:-.45pt'> </span>etc.),<span
style='letter-spacing:-.45pt'> </span>oral<span style='letter-spacing:-.4pt'> </span>anticoagulants<span
style='letter-spacing:-.5pt'> </span>(warf<span style='letter-spacing:-.1pt'>a</span>rin,<span
style='letter-spacing:-.45pt'> </span>rivaroxaban,<span style='letter-spacing:
-.4pt'> </span>dabigatran,<span style='letter-spacing:-.45pt'> </span>etc.)<span
style='letter-spacing:-.45pt'> </span>except<span style='letter-spacing:-.4pt'>
</span>under specific<span style='letter-spacing:-.35pt'> </span>ci<span
style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.05pt'>c</span>umstan<span
style='letter-spacing:.05pt'>c</span>es<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>s<span style='letter-spacing:-.05pt'>w</span>itching<span
style='letter-spacing:-.3pt'> </span>anticoagulant<span style='letter-spacing:
-.3pt'> </span>th<span style='letter-spacing:-.1pt'>e</span>rapy<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>sec<span
style='letter-spacing:.05pt'>t</span>ion<span style='letter-spacing:-.3pt'>&nbsp;</span>4.2)<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>w</span>hen<span style='letter-spacing:-.3pt'> </span>UFH<span
style='letter-spacing:-.3pt'> </span>is given<span style='letter-spacing:-.3pt'>
</span>at<span style='letter-spacing:-.25pt'> </span>dos<span style='letter-spacing:
-.1pt'>e</span>s<span style='letter-spacing:-.3pt'> </span>necessary<span
style='letter-spacing:-.15pt'> </span>to<span style='letter-spacing:-.25pt'> </span>maintain<span
style='letter-spacing:-.25pt'> </span>an<span style='letter-spacing:-.25pt'> </span>op<span
style='letter-spacing:-.15pt'>e</span>n<span style='letter-spacing:-.25pt'> </span>central<span
style='letter-spacing:-.3pt'> </span>venous<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>ar<span style='letter-spacing:
-.05pt'>te</span>rial<span style='letter-spacing:-.25pt'> </span>catheter<span
style='letter-spacing:-.25pt'> or when UFH is given during catheter ablation
for atrial fibrillation </span>(see section<span style='letter-spacing:-.55pt'>&nbsp;4.4
and </span>4.5).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.4<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Special<span style='letter-spacing:-.4pt'> </span>warnings<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>precautions<span
style='letter-spacing:-.35pt'> </span>for<span style='letter-spacing:-.35pt'> </span>use</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Hae<span style='letter-spacing:-.1pt'>m</span>orr<span
style='letter-spacing:.05pt'>h</span>age<span style='letter-spacing:-.8pt'> </span>risk</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>As<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>other<span style='letter-spacing:-.3pt'> </span>anticoagula<span
style='letter-spacing:-.05pt'>n</span>ts,<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>taking<span style='letter-spacing:-.25pt'>
</span>Apixaban Accord<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:-.05pt'>r</span>e<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>careful<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>o</span>bserved<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.3pt'> </span>signs<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>b</span>leeding. It<span style='letter-spacing:
-.3pt'> </span>is<span style='letter-spacing:-.25pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.35pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>u<span style='letter-spacing:-.1pt'>s</span>ed<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.3pt'> </span>caution<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>con<span
style='letter-spacing:-.05pt'>d</span>itions<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>increased<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>ha<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>orrhage.<span style='letter-spacing:-.2pt'>
</span>Apixaban Accord a<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.35pt'> </span>shou<span style='letter-spacing:-.05pt'>l</span>d<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.35pt'> </span>discontinued<span
style='letter-spacing:-.3pt'> </span>if<span style='letter-spacing:-.35pt'> </span>severe<span
style='letter-spacing:-.35pt'> </span>h<span style='letter-spacing:-.15pt'>a</span>emorrhage<span
style='letter-spacing:-.3pt'> </span>occurs<span style='letter-spacing:-.35pt'>
</span>(see<span style='letter-spacing:-.3pt'> </span>sections<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.8<span style='letter-spacing:-.35pt'>&nbsp;</span>and<span
style='letter-spacing:-.35pt'>&nbsp;</span>4.9<span style='letter-spacing:-.1pt'>)</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Although<span style='letter-spacing:-.4pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>does<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>n</span>ot<span style='letter-spacing:-.3pt'> </span>require<span
style='letter-spacing:-.4pt'> </span>ro<span style='letter-spacing:-.05pt'>u</span>tine<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>onitoring<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>e<span
style='letter-spacing:-.05pt'>x</span>posu<span style='letter-spacing:-.1pt'>r</span>e,<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:-.3pt'> </span>calibrated
quantitative<span style='letter-spacing:-.35pt'> </span>anti-Factor<span
style='letter-spacing:-.3pt'> </span>Xa<span style='letter-spacing:-.3pt'> </span>assay<span
style='letter-spacing:-.25pt'> </span>may<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.45pt'> </span>useful<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>exceptional<span
style='letter-spacing:-.3pt'> </span>situations<span style='letter-spacing:
-.35pt'> </span>where<span style='letter-spacing:-.3pt'> </span>knowledge<span
style='letter-spacing:-.3pt'> </span>of apixaban<span style='letter-spacing:
-.35pt'> </span>exposure<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.2pt'> </span>h<span style='letter-spacing:-.1pt'>e</span>lp<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.35pt'> </span>inform<span
style='letter-spacing:-.4pt'> </span>clinical<span style='letter-spacing:-.3pt'>
</span>decisions,<span style='letter-spacing:-.3pt'> </span>e.g.,<span
style='letter-spacing:-.35pt'> </span>overdose<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>em<span style='letter-spacing:
.05pt'>e</span>rgency<span style='letter-spacing:-.2pt'> </span>surgery<span
style='letter-spacing:-.3pt'> </span>(see section<span style='letter-spacing:
-.55pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>An agent to reverse the anti-factor Xa activity of apixaban is
available.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Interaction<span style='letter-spacing:-.5pt'> </span>with<span
style='letter-spacing:-.45pt'> </span>other<span style='letter-spacing:-.45pt'>
</span><span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>e</span>dicin<span style='letter-spacing:-.1pt'>a</span>l<span
style='letter-spacing:-.5pt'> </span>produc<span style='letter-spacing:-.05pt'>t</span>s<span
style='letter-spacing:-.45pt'> </span>affecting<span style='letter-spacing:
-.45pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>ostasis</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Due<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>an<span style='letter-spacing:-.3pt'> </span>increased<span
style='letter-spacing:-.3pt'> </span>bleed<span style='letter-spacing:.05pt'>i</span>ng<span
style='letter-spacing:-.3pt'> </span>risk,<span style='letter-spacing:-.3pt'> </span>con<span
style='letter-spacing:-.1pt'>c</span>o<span style='letter-spacing:-.1pt'>m</span>itant<span
style='letter-spacing:-.3pt'> </span>tr<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.05pt'>a</span><span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>any<span style='letter-spacing:-.3pt'> </span>other<span
style='letter-spacing:-.3pt'> </span>anticoagulants<span style='letter-spacing:
-.3pt'> </span>is contraindicated<span style='letter-spacing:-.5pt'> </span>(see<span
style='letter-spacing:-.45pt'> </span>section<span style='letter-spacing:-.45pt'>&nbsp;</span>4.3).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>conco<span
style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:.05pt'>t</span>ant<span
style='letter-spacing:-.25pt'> </span>use<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>Apixaban Accord<span style='letter-spacing:
-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>antiplatelet<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.05pt'>g</span>ents<span
style='letter-spacing:-.25pt'> </span>increa<span style='letter-spacing:.05pt'>s</span>es<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>risk<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>sec<span
style='letter-spacing:.05pt'>t</span>ion<span style='letter-spacing:-.25pt'>&nbsp;</span>4.5).
</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Care<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>taken<span style='letter-spacing:-.3pt'> </span>if<span
style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>are<span style='letter-spacing:-.3pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>ed<span style='letter-spacing:-.3pt'> </span>con<span
style='letter-spacing:-.1pt'>c</span>o<span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:.05pt'>t</span>antly<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>select<span style='letter-spacing:.05pt'>i</span>ve<span
style='letter-spacing:-.3pt'> </span>serotonin<span style='letter-spacing:-.25pt'>
</span>reuptake<span style='letter-spacing:-.3pt'> </span>inhibitors (SSRIs)<span
style='letter-spacing:-.5pt'> </span>or<span style='letter-spacing:-.45pt'> </span>serotonin<span
style='letter-spacing:-.5pt'> </span>nore<span style='letter-spacing:-.05pt'>p</span>inephrine<span
style='letter-spacing:-.5pt'> </span>re<span style='letter-spacing:-.05pt'>u</span>ptake<span
style='letter-spacing:-.45pt'> </span>inhibi<span style='letter-spacing:-.05pt'>to</span>rs<span
style='letter-spacing:-.45pt'> </span>(SNRIs),<span style='letter-spacing:-.5pt'>
</span><span style='letter-spacing:.05pt'>o</span>r<span style='letter-spacing:
-.45pt'> </span>non-steroid<span style='letter-spacing:-.1pt'>a</span>l<span
style='letter-spacing:-.45pt'> </span>anti-inflammatory drugs<span
style='letter-spacing:-.5pt'> </span>(NSAIDs),<span style='letter-spacing:-.5pt'>
</span>including<span style='letter-spacing:-.5pt'> </span>acet<span
style='letter-spacing:.05pt'>y</span>lsalicylic<span style='letter-spacing:
-.5pt'> </span>acid.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Following<span style='letter-spacing:-.45pt'> </span>surger<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.4pt'> </span>other<span
style='letter-spacing:-.4pt'> </span>platelet<span style='letter-spacing:-.45pt'>
</span>aggregation<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.1pt'>i</span>nh<span style='letter-spacing:-.05pt'>i</span>bit<span
style='letter-spacing:-.05pt'>o</span>rs<span style='letter-spacing:-.4pt'> </span>are<span
style='letter-spacing:-.4pt'> </span>not<span style='letter-spacing:-.4pt'> </span>recommended<span
style='letter-spacing:-.4pt'> </span>conco<span style='letter-spacing:-.1pt'>m</span>itantly<span
style='letter-spacing:-.35pt'> </span>with Apixaban Accord<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.35pt'> </span>section<span
style='letter-spacing:-.35pt'>&nbsp;</span>4.5).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>atrial<span
style='letter-spacing:-.3pt'> </span>fibri<span style='letter-spacing:-.05pt'>l</span>lation<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>conditions<span
style='letter-spacing:-.35pt'> </span>that<span style='letter-spacing:-.35pt'> </span>warrant<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>ono<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.25pt'> </span>dual<span
style='letter-spacing:-.3pt'> </span>ant<span style='letter-spacing:-.05pt'>i</span>p<span
style='letter-spacing:-.05pt'>l</span>atelet<span style='letter-spacing:-.25pt'>
</span>therapy,<span style='letter-spacing:-.3pt'> </span>a careful<span
style='letter-spacing:-.3pt'> </span>assessment<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>p</span>otential<span
style='letter-spacing:-.3pt'> </span>benefits<span style='letter-spacing:-.3pt'>
</span>a<span style='letter-spacing:-.05pt'>g</span>ainst<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>potential<span
style='letter-spacing:-.3pt'> </span>ris<span style='letter-spacing:-.05pt'>k</span>s<span
style='letter-spacing:-.3pt'> </span>should<span style='letter-spacing:-.25pt'>
</span>be<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>de<span
style='letter-spacing:-.3pt'> </span>before c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>bining<span style='letter-spacing:-.4pt'> </span>this<span
style='letter-spacing:-.35pt'> </span>therapy<span style='letter-spacing:-.3pt'>
</span>wi<span style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:
-.35pt'> </span>Apixaban Accord.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>clinical<span style='letter-spacing:-.25pt'>
</span>trial<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>atrial<span
style='letter-spacing:-.25pt'> </span>fib<span style='letter-spacing:-.1pt'>r</span>illation,<span
style='letter-spacing:-.25pt'> </span>conco<span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:.05pt'>t</span>ant<span style='letter-spacing:-.25pt'> </span>use<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> acetylsalicylic
acid (</span>ASA)<span style='letter-spacing:-.25pt'> </span>increased<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>j<span
style='letter-spacing:.05pt'>o</span>r bleeding<span style='letter-spacing:
-.25pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.1pt'>f</span>rom<span style='letter-spacing:
-.3pt'> </span>1.8%<span style='letter-spacing:-.25pt'> </span>per<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>y</span>ear<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.25pt'> </span>3.4%<span
style='letter-spacing:-.3pt'> </span>per<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:.05pt'>y</span>ear<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>ncreased<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>on
warfarin<span style='letter-spacing:-.25pt'> </span>fr<span style='letter-spacing:
.05pt'>o</span>m<span style='letter-spacing:-.2pt'> </span>2.7%<span
style='letter-spacing:-.25pt'> </span>per<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:.05pt'>y</span>ear<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.2pt'> </span>4<span style='letter-spacing:-.05pt'>.</span>6%<span
style='letter-spacing:-.25pt'> </span>per<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:.05pt'>y</span>ear.<span style='letter-spacing:-.2pt'> </span>In<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>t</span>his<span
style='letter-spacing:-.3pt'> </span>clinical<span style='letter-spacing:-.25pt'>
</span>trial,<span style='letter-spacing:-.2pt'> </span>there<span
style='letter-spacing:-.2pt'> </span>was<span style='letter-spacing:-.2pt'> </span>l<span
style='letter-spacing:.05pt'>i</span>m<span style='letter-spacing:.05pt'>i</span>ted<span
style='letter-spacing:-.25pt'> </span>(2.1%)<span style='letter-spacing:-.2pt'>
</span>use<span style='letter-spacing:-.2pt'> </span>of conco<span
style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:.05pt'>t</span>ant<span
style='letter-spacing:-.55pt'> </span>dual<span style='letter-spacing:-.55pt'> </span>antiplatelet<span
style='letter-spacing:-.5pt'> </span>therap<span style='letter-spacing:.05pt'>y
(see section 5.1)</span>.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>A clinical trial enrolled patients with atrial fibrillation with ACS
and/or undergoing PCI and a planned treatment period with a P2Y12 inhibitor,
with or without ASA, and oral anticoagulant (either apixaban or VKA) for 6
months. Concomitant use of ASA increased the risk of ISTH (International
Society on Thrombosis and Hemostasis) major or CRNM (Clinically Relevant Non&#8209;Major)
bleeding in apixaban&#8209;treated subjects from 16.4% per year to 33.1% per
year (see section&nbsp;5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>clinical<span style='letter-spacing:-.3pt'>
</span>trial<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>high-ri<span style='letter-spacing:-.1pt'>s</span>k<span
style='letter-spacing:-.3pt'> </span>post<span style='letter-spacing:-.25pt'>&#8209;</span>acute<span
style='letter-spacing:-.3pt'> </span>corona<span style='letter-spacing:-.1pt'>r</span>y<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>s</span><span
style='letter-spacing:.05pt'>y</span>nd<span style='letter-spacing:-.1pt'>r</span>ome<span
style='letter-spacing:-.3pt'> </span>patients without atrial fibrillation,<span
style='letter-spacing:-.3pt'> </span>characterised<span style='letter-spacing:
-.25pt'> </span>by<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ultiple<span style='letter-spacing:-.3pt'>
</span>cardiac and<span style='letter-spacing:-.35pt'> </span>non-card<span
style='letter-spacing:-.05pt'>i</span>ac<span style='letter-spacing:-.3pt'> </span>c<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>orbidities,<span
style='letter-spacing:-.3pt'> </span>who<span style='letter-spacing:-.3pt'> </span>rece<span
style='letter-spacing:.05pt'>i</span>ved<span style='letter-spacing:-.3pt'> </span>ASA<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>binat<span
style='letter-spacing:.05pt'>i</span>on<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>ASA<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>clopidogrel,<span style='letter-spacing:
-.3pt'> </span>a significant<span style='letter-spacing:-.35pt'> </span>increa<span
style='letter-spacing:.05pt'>s</span>e<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>risk<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>ISTH<span style='letter-spacing:-.3pt'> </span>(Internation<span
style='letter-spacing:-.05pt'>a</span>l<span style='letter-spacing:-.35pt'> </span>Soc<span
style='letter-spacing:-.05pt'>i</span>ety<span style='letter-spacing:-.35pt'> </span>on<span
style='letter-spacing:-.3pt'> </span>Th<span style='letter-spacing:-.1pt'>r</span>ombosis<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>Hae<span
style='letter-spacing:-.1pt'>m</span>ostasis)<span style='letter-spacing:-.3pt'>
</span>major bleeding<span style='letter-spacing:-.3pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>reported<span style='letter-spacing:-.3pt'>
</span>for<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>(5.13%<span style='letter-spacing:-.3pt'> </span>per<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>y</span>ear)<span
style='letter-spacing:-.3pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>pa<span
style='letter-spacing:.05pt'>r</span>ed<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>placebo<span style='letter-spacing:-.25pt'>
</span>(2.04%<span style='letter-spacing:-.3pt'> </span>per<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:.05pt'>y</span>ear).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Use<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>thrombol<span style='letter-spacing:.05pt'>y</span>tic<span
style='letter-spacing:-.3pt'> </span>agents<span style='letter-spacing:-.4pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>treatment<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>acute<span
style='letter-spacing:-.25pt'> </span>isch<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.25pt'> </span>stroke</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.25pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>very<span style='letter-spacing:-.25pt'> </span>li<span
style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.25pt'> </span>experience<span style='letter-spacing:
-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>use<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>thro<span style='letter-spacing:-.1pt'>m</span>bo<span
style='letter-spacing:-.05pt'>l</span><span style='letter-spacing:.05pt'>y</span>tic<span
style='letter-spacing:-.25pt'> </span>agents<span style='letter-spacing:-.25pt'>
</span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>acute
isch<span style='letter-spacing:.05pt'>e</span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.5pt'> </span>stroke<span style='letter-spacing:-.4pt'> </span>in<span
style='letter-spacing:-.4pt'> </span>patients<span style='letter-spacing:-.5pt'>
</span>a<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:
-.1pt'>m</span>inistered<span style='letter-spacing:-.35pt'> </span>apixaban
(see section 4.5).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Patients<span style='letter-spacing:-.4pt'> </span>with<span
style='letter-spacing:-.4pt'> </span>prosthetic<span style='letter-spacing:
-.4pt'> </span>heart<span style='letter-spacing:-.4pt'> </span>valves</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Safety<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.2pt'> </span>efficacy<span style='letter-spacing:-.2pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>Apixaban Accord<span
style='letter-spacing:-.2pt'> </span>have<span style='letter-spacing:-.25pt'> </span>not<span
style='letter-spacing:-.3pt'> </span>been<span style='letter-spacing:-.25pt'> </span>studied<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>prosthetic<span
style='letter-spacing:-.25pt'> </span>heart<span style='letter-spacing:-.25pt'>
</span>valves,<span style='letter-spacing:-.2pt'> </span>w<span
style='letter-spacing:.05pt'>i</span>th<span style='letter-spacing:-.25pt'> </span>or
without<span style='letter-spacing:-.3pt'> </span>atrial<span style='letter-spacing:
-.3pt'> </span>fibrillation.<span style='letter-spacing:-.3pt'> </span>Therefore,<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>use<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:
-.25pt'> </span>not<span style='letter-spacing:-.3pt'> </span>recommended<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>this<span
style='letter-spacing:-.3pt'> </span>setting.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><u><span lang=EN-GB
style='font-size:11.0pt'>Patients with antiphospholipid syndrome</span></u></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>Direct acting oral anticoagulants (DOACs) including
apixaban are not recommended for patients with a history of thrombosis who are
diagnosed with antiphospholipid syndrome. In particular for patients that are
triple positive (for lupus anticoagulant, anticardiolipin antibodies, and
anti-beta 2&#8209;glycoprotein I antibodies), treatment with DOACs could be
associated with increased rates of recurrent thrombotic events compared with
vitamin K antagonist therapy.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Surge<span style='letter-spacing:-.1pt'>r</span>y<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nvasive<span style='letter-spacing:-.45pt'>
</span>procedures</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.3pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>discont<span style='letter-spacing:-.05pt'>i</span>nued<span
style='letter-spacing:-.25pt'> </span>at<span style='letter-spacing:-.25pt'> </span>least<span
style='letter-spacing:-.25pt'> </span>48<span style='letter-spacing:-.25pt'> </span>hours<span
style='letter-spacing:-.25pt'> </span>prior<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>elective<span style='letter-spacing:-.25pt'>
</span>surge<span style='letter-spacing:-.1pt'>r</span>y<span style='letter-spacing:
-.15pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nvasive<span style='letter-spacing:-.25pt'>
</span>procedures<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>a <span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>high<span
style='letter-spacing:-.3pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>bl<span style='letter-spacing:-.1pt'>e</span><span
style='letter-spacing:-.05pt'>e</span>ding.<span style='letter-spacing:-.3pt'> </span>This<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>in</span>cludes<span
style='letter-spacing:-.3pt'> </span>interventions<span style='letter-spacing:
-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>which<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>prob<span
style='letter-spacing:-.1pt'>a</span>bili<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.35pt'> </span>clin<span
style='letter-spacing:-.05pt'>i</span>cally significant<span style='letter-spacing:
-.3pt'> </span>b<span style='letter-spacing:-.05pt'>l</span>eeding<span
style='letter-spacing:-.3pt'> </span>cannot<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>excluded<span style='letter-spacing:-.3pt'>
</span>or<span style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:
-.25pt'> </span>which<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:-.25pt'> </span>risk<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>bl<span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:-.05pt'>e</span>ding<span
style='letter-spacing:-.3pt'> </span>wou<span style='letter-spacing:-.05pt'>l</span>d<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.3pt'> </span>unacceptable.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.3pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>discont<span style='letter-spacing:-.05pt'>i</span>nued<span
style='letter-spacing:-.25pt'> </span>at<span style='letter-spacing:-.25pt'> </span>least<span
style='letter-spacing:-.25pt'> </span>24<span style='letter-spacing:-.25pt'>&nbsp;</span>hours<span
style='letter-spacing:-.25pt'> </span>prior<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>elective<span style='letter-spacing:-.25pt'>
</span>surge<span style='letter-spacing:-.1pt'>r</span>y<span style='letter-spacing:
-.15pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nvasive<span style='letter-spacing:-.25pt'>
</span>procedures<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>a low<span style='letter-spacing:-.25pt'>
</span>risk<span style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:
-.25pt'> </span>bleeding.<span style='letter-spacing:-.25pt'> </span>This<span
style='letter-spacing:-.25pt'> </span>includes<span style='letter-spacing:-.25pt'>
</span>interventions<span style='letter-spacing:-.25pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>which<span style='letter-spacing:-.25pt'> </span>any<span
style='letter-spacing:-.25pt'> </span>b<span style='letter-spacing:-.05pt'>l</span>eeding<span
style='letter-spacing:-.25pt'> </span>that<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>o</span>ccurs<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.25pt'> </span>expected<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>be
min<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>l,<span style='letter-spacing:-.35pt'> </span>non-critical<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.35pt'> </span>its<span
style='letter-spacing:-.3pt'> </span>location<span style='letter-spacing:-.35pt'>
</span>or<span style='letter-spacing:-.3pt'> </span>easily<span
style='letter-spacing:-.25pt'> </span>controll<span style='letter-spacing:-.1pt'>e</span>d.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>If<span style='letter-spacing:-.3pt'> </span>surgery<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nvasive<span style='letter-spacing:-.3pt'>
</span>procedures<span style='letter-spacing:-.25pt'> </span>cannot<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.25pt'> </span>dela<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>e</span>d,<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>a</span>ppropriate<span
style='letter-spacing:-.25pt'> </span>caution<span style='letter-spacing:-.3pt'>
</span>s<span style='letter-spacing:-.05pt'>h</span>ould<span style='letter-spacing:
-.35pt'> </span>be<span style='letter-spacing:-.3pt'> </span>exercised,<span
style='letter-spacing:-.25pt'> </span>taking into<span style='letter-spacing:
-.25pt'> </span>consideration<span style='letter-spacing:-.25pt'> </span>an<span
style='letter-spacing:-.25pt'> </span>increased<span style='letter-spacing:
-.25pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>bleeding.<span style='letter-spacing:-.25pt'>
</span>T<span style='letter-spacing:-.1pt'>h</span>is<span style='letter-spacing:
-.3pt'> </span>risk<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>bleeding<span style='letter-spacing:-.2pt'>
</span>should<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>weighed<span style='letter-spacing:-.25pt'>
</span>against<span style='letter-spacing:-.2pt'> </span>the urgen<span
style='letter-spacing:-.1pt'>c</span>y<span style='letter-spacing:-.45pt'> </span>of<span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>in</span>tervention.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.3pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>restarted<span style='letter-spacing:
-.3pt'> </span>after<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>invasive<span style='letter-spacing:-.3pt'>
</span>procedure<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>surgical<span style='letter-spacing:-.3pt'>
</span>intervention<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>a</span>s<span style='letter-spacing:-.3pt'> </span>soon<span
style='letter-spacing:-.3pt'> </span>as<span style='letter-spacing:-.3pt'> </span>possible
provided<span style='letter-spacing:-.4pt'> </span>the<span style='letter-spacing:
-.4pt'> </span>clinical<span style='letter-spacing:-.35pt'> </span>situation<span
style='letter-spacing:-.35pt'> </span>allows<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.4pt'> </span>adequate<span
style='letter-spacing:-.4pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>ostasis<span
style='letter-spacing:-.35pt'> </span>has<span style='letter-spacing:-.35pt'> </span>been<span
style='letter-spacing:-.35pt'> </span>established<span style='letter-spacing:
-.4pt'> </span>(for<span style='letter-spacing:-.35pt'> </span>cardioversion see<span
style='letter-spacing:-.35pt'> </span>section<span style='letter-spacing:-.35pt'>&nbsp;</span>4.2).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For patients undergoing catheter ablation for atrial fibrillation,
Apixaban Accord treatment does not need to be interrupted (see sections 4.2,
4.3 and 4.5).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Te<span style='letter-spacing:-.1pt'>m</span>porary<span
style='letter-spacing:-1.15pt'> </span>d<span style='letter-spacing:-.05pt'>i</span>scontinuation</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Discontinui<span style='letter-spacing:-.05pt'>n</span>g<span
style='letter-spacing:-.45pt'> </span>anticoagul<span style='letter-spacing:
-.1pt'>a</span>nts,<span style='letter-spacing:-.4pt'> </span>includ<span
style='letter-spacing:-.05pt'>i</span>ng<span style='letter-spacing:-.4pt'> </span>Apixaban
Accord,<span style='letter-spacing:-.4pt'> </span>for<span style='letter-spacing:
-.4pt'> </span><span style='letter-spacing:-.1pt'>a</span><span
style='letter-spacing:-.05pt'>c</span>tive<span style='letter-spacing:-.4pt'> </span>bleeding,<span
style='letter-spacing:-.4pt'> </span>elective<span style='letter-spacing:-.45pt'>
</span>surger<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.4pt'> </span>or<span style='letter-spacing:-.4pt'> </span>i<span
style='letter-spacing:-.05pt'>n</span>vasive procedures<span style='letter-spacing:
-.3pt'> </span>places<span style='letter-spacing:-.25pt'> </span>pat<span
style='letter-spacing:.05pt'>i</span>ents<span style='letter-spacing:-.3pt'> </span>at<span
style='letter-spacing:-.25pt'> </span>an<span style='letter-spacing:-.3pt'> </span>increased<span
style='letter-spacing:-.25pt'> </span>risk<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>th</span>ro<span
style='letter-spacing:-.1pt'>m</span>bos<span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.05pt'>s</span>.<span style='letter-spacing:-.3pt'> </span>Lapses<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>therapy<span
style='letter-spacing:-.25pt'> </span>should<span style='letter-spacing:-.3pt'>
</span>be<span style='letter-spacing:-.3pt'> </span>avoided<span
style='letter-spacing:-.25pt'> </span>and if<span style='letter-spacing:-.35pt'>
</span>anticoagulation<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>Apixaban Accord<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>ust<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.3pt'> </span>te<span
style='letter-spacing:-.1pt'>m</span>pora<span style='letter-spacing:-.05pt'>r</span>ily<span
style='letter-spacing:-.2pt'> </span>discontinued<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.3pt'> </span>any<span style='letter-spacing:-.35pt'> </span>reason,<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>t</span>herapy<span
style='letter-spacing:-.2pt'> </span>s<span style='letter-spacing:-.05pt'>h</span>ou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.3pt'> </span>be
restarted<span style='letter-spacing:-.3pt'> </span>as<span style='letter-spacing:
-.3pt'> </span>soon<span style='letter-spacing:-.3pt'> </span>as<span
style='letter-spacing:-.3pt'> </span>possi<span style='letter-spacing:-.05pt'>b</span>le.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Hae<span style='letter-spacing:-.1pt'>m</span>od<span
style='letter-spacing:.05pt'>y</span>namically<span style='letter-spacing:-.35pt'>
</span>unstable<span style='letter-spacing:-.4pt'> </span>PE<span
style='letter-spacing:-.4pt'> </span>patients<span style='letter-spacing:-.4pt'>
</span>or<span style='letter-spacing:-.4pt'> </span>patien<span
style='letter-spacing:-.1pt'>t</span>s<span style='letter-spacing:-.4pt'> </span>who<span
style='letter-spacing:-.4pt'> </span>require<span style='letter-spacing:-.4pt'>
</span><span style='letter-spacing:-.05pt'>t</span>hro<span style='letter-spacing:
-.1pt'>m</span>bol<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>s</span>is<span style='letter-spacing:-.45pt'> </span>or<span
style='letter-spacing:-.45pt'> </span>pul<span style='letter-spacing:-.1pt'>m</span>onary</span></u><span
lang=EN-GB> </span><u><span lang=EN-GB style='letter-spacing:.05pt'>e</span><span
lang=EN-GB style='letter-spacing:-.1pt'>m</span><span lang=EN-GB>bol<span
style='letter-spacing:-.05pt'>ec</span>t<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>y</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>is<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.35pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mmend<span style='letter-spacing:.05pt'>e</span>d<span
style='letter-spacing:-.3pt'> </span>as<span style='letter-spacing:-.3pt'> </span>an<span
style='letter-spacing:-.3pt'> </span>alternative<span style='letter-spacing:
-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>u<span
style='letter-spacing:-.05pt'>n</span>fr<span style='letter-spacing:-.1pt'>a</span>ctionated<span
style='letter-spacing:-.3pt'> </span>he<span style='letter-spacing:-.05pt'>pa</span>rin<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>patien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>pul<span style='letter-spacing:-.1pt'>m</span>onary
e<span style='letter-spacing:-.1pt'>m</span>bolism<span style='letter-spacing:
-.5pt'> </span>w<span style='letter-spacing:.05pt'>h</span>o<span
style='letter-spacing:-.35pt'> </span>are<span style='letter-spacing:-.35pt'> </span>hae<span
style='letter-spacing:-.1pt'>m</span>odyna<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>cally<span style='letter-spacing:-.3pt'> </span>unstable<span
style='letter-spacing:-.4pt'> </span>or<span style='letter-spacing:-.35pt'> </span>may<span
style='letter-spacing:-.35pt'> </span>receive<span style='letter-spacing:-.4pt'>
</span>thro<span style='letter-spacing:-.1pt'>m</span>bol<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is<span
style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:-.4pt'> </span>pul<span
style='letter-spacing:-.1pt'>m</span>onary e<span style='letter-spacing:-.1pt'>m</span>bolect<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>y<span
style='letter-spacing:-.2pt'> </span>since<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>sa<span style='letter-spacing:.05pt'>f</span>ety<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.3pt'> </span>efficacy<span
style='letter-spacing:-.15pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apixab<span
style='letter-spacing:-.1pt'>a</span>n<span style='letter-spacing:-.25pt'> </span>have<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.25pt'> </span>been<span
style='letter-spacing:-.3pt'> </span>establish<span style='letter-spacing:.05pt'>e</span>d<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>these<span
style='letter-spacing:-.3pt'> </span>clinical situations.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Patients<span style='letter-spacing:-.4pt'> </span>with<span
style='letter-spacing:-.4pt'> </span>active<span style='letter-spacing:-.4pt'> </span>cancer</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Efficacy<span style='letter-spacing:.25pt'> </span>and<span
style='letter-spacing:.2pt'> </span>safety<span style='letter-spacing:.3pt'> </span>of<span
style='letter-spacing:.2pt'> </span>apixaban<span style='letter-spacing:.25pt'>
</span>in<span style='letter-spacing:.2pt'> </span>the<span style='letter-spacing:
.2pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:.25pt'> </span>of<span style='letter-spacing:.15pt'> </span>D<span
style='letter-spacing:-.05pt'>V</span>T,<span style='letter-spacing:.2pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>me<span style='letter-spacing:.05pt'>n</span>t<span
style='letter-spacing:.25pt'> </span>of<span style='letter-spacing:.2pt'> </span>PE<span
style='letter-spacing:.2pt'> </span>and<span style='letter-spacing:.2pt'> </span>prevention<span
style='letter-spacing:.25pt'> </span>of<span style='letter-spacing:.2pt'> </span>recurrent
DVT<span style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:
-.25pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>(VTEt)<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>ac<span
style='letter-spacing:.05pt'>t</span>ive<span style='letter-spacing:-.25pt'> </span>cancer<span
style='letter-spacing:-.3pt'> </span>have<span style='letter-spacing:-.25pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>been<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:-.05pt'>s</span>tablished.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Patients<span style='letter-spacing:-.5pt'> </span>with<span
style='letter-spacing:-.45pt'> </span>renal<span style='letter-spacing:-.45pt'>
</span><span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:
-.1pt'>m</span>pairment</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>L<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:
-.1pt'>m</span>ited<span style='letter-spacing:-.35pt'> </span>clinical<span
style='letter-spacing:-.3pt'> </span>data<span style='letter-spacing:-.35pt'> </span>indicate<span
style='letter-spacing:-.3pt'> </span>that<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>plasma<span style='letter-spacing:-.45pt'>
</span>concentrations<span style='letter-spacing:-.35pt'> </span>are<span
style='letter-spacing:-.3pt'> </span>incre<span style='letter-spacing:.05pt'>a</span>sed<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.3pt'> </span>severe
renal<span style='letter-spacing:-.35pt'> </span><span style='letter-spacing:
.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>pairment<span
style='letter-spacing:-.3pt'> </span>(creatinine<span style='letter-spacing:
-.3pt'> </span>clearan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.3pt'> </span>15-29<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>n)<span
style='letter-spacing:-.3pt'> </span>which<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.25pt'> </span>lead<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>an<span style='letter-spacing:-.35pt'> </span>increa<span
style='letter-spacing:.05pt'>s</span>ed<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.3pt'> </span>risk. For<span style='letter-spacing:-.3pt'>
</span>the<span style='letter-spacing:-.25pt'> </span>treatment<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>DVT,<span
style='letter-spacing:-.25pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>prev<span style='letter-spacing:-.1pt'>e</span>ntion<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>recurrent<span
style='letter-spacing:-.25pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>PE<span style='letter-spacing:-.3pt'> </span>(VTEt),<span
style='letter-spacing:-.25pt'> </span>apixaban is<span style='letter-spacing:
-.3pt'> </span>to<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>used<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>caution<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:
-.25pt'> </span>patients<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>severe<span style='letter-spacing:-.25pt'>
</span>renal<span style='letter-spacing:-.25pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pai<span style='letter-spacing:.05pt'>r</span>ment<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:.05pt'>(</span><span
style='letter-spacing:-.05pt'>c</span>reatinine<span style='letter-spacing:
-.25pt'> </span>cl<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.05pt'>a</span>rance 15-29<span style='letter-spacing:
-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>L<span
style='letter-spacing:.05pt'>/</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>n)<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>sections<span style='letter-spacing:-.3pt'>&nbsp;</span>4.2<span
style='letter-spacing:-.25pt'>&nbsp;</span>and<span style='letter-spacing:-.3pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>prev<span style='letter-spacing:-.1pt'>e</span>ntion<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.25pt'> </span>stroke<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>s<span
style='letter-spacing:.05pt'>y</span>ste<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.35pt'> </span>e<span
style='letter-spacing:-.1pt'>m</span>boli<span style='letter-spacing:.05pt'>s</span>m<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:.05pt'>i</span>n<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>NVAF,<span
style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>severe<span
style='letter-spacing:-.25pt'> </span>renal i<span style='letter-spacing:-.1pt'>m</span>pairment<span
style='letter-spacing:-.35pt'> </span>(creatinine<span style='letter-spacing:
-.35pt'> </span>clearance<span style='letter-spacing:-.3pt'> </span>15-29<span
style='letter-spacing:-.35pt'>&nbsp;</span>mL/<span style='letter-spacing:-.25pt'>m</span>in),<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>ser<span
style='letter-spacing:.05pt'>u</span>m<span style='letter-spacing:-.4pt'> </span>creatinine<span
style='letter-spacing:-.4pt'> </span>&#8805;<span style='letter-spacing:-.35pt'>&nbsp;</span>1.5<span
style='letter-spacing:-.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g/dL
(133<span style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:
-.1pt'>m</span>icr<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.05pt'>m</span>ole/L)<span style='letter-spacing:-.25pt'>
</span>associated<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>age<span style='letter-spacing:-.3pt'> </span>&#8805;<span
style='letter-spacing:-.25pt'>&nbsp;</span>80<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears<span style='letter-spacing:-.2pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>bo<span style='letter-spacing:-.05pt'>d</span>y<span
style='letter-spacing:-.2pt'> </span>weight<span style='letter-spacing:-.35pt'>
</span>&#8804;<span style='letter-spacing:-.25pt'>&nbsp;</span>60<span
style='letter-spacing:-.25pt'>&nbsp;</span>kg<span style='letter-spacing:-.25pt'>
</span>should<span style='letter-spacing:-.2pt'> </span>receive<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>lower
dose<span style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:
-.25pt'> </span>apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.25pt'> </span>2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.1pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>section<span style='letter-spacing:-.25pt'>&nbsp;</span>4.2);</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>creatinine<span
style='letter-spacing:-.25pt'> </span>clearan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.3pt'> </span>&lt;<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>1</span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.05pt'>m</span>in,<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>u<span style='letter-spacing:-.05pt'>n</span>dergoing<span
style='letter-spacing:-.3pt'> </span>dia<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is,<span
style='letter-spacing:-.25pt'> </span>there<span style='letter-spacing:-.25pt'>
</span>is<span style='letter-spacing:-.3pt'> </span>no clinical<span
style='letter-spacing:-.35pt'> </span>experience<span style='letter-spacing:
-.3pt'> </span>therefo<span style='letter-spacing:.05pt'>r</span>e<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>is<span style='letter-spacing:-.35pt'> </span>not<span style='letter-spacing:
-.3pt'> </span>recomm<span style='letter-spacing:.05pt'>e</span>nded<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>sections<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.2<span style='letter-spacing:-.3pt'>&nbsp;</span>and<span
style='letter-spacing:-.4pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Elderly<span style='letter-spacing:-.7pt'> </span>patients</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Increasing<span style='letter-spacing:-.35pt'> </span>age<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>y<span style='letter-spacing:-.2pt'> </span>increa<span
style='letter-spacing:.05pt'>s</span>e<span style='letter-spacing:-.35pt'> </span>ha<span
style='letter-spacing:.05pt'>e</span><span style='letter-spacing:-.1pt'>m</span>orrha<span
style='letter-spacing:.05pt'>g</span>ic<span style='letter-spacing:-.3pt'> </span>risk<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.35pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Also,<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>co-ad<span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:
-.3pt'> </span>ASA<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>el<span style='letter-spacing:-.05pt'>de</span>rly<span
style='letter-spacing:-.2pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.1pt'>s</span>hould<span style='letter-spacing:
-.35pt'> </span>be<span style='letter-spacing:-.3pt'> </span>used<span
style='letter-spacing:-.3pt'> </span>cautious<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.2pt'> </span>b<span style='letter-spacing:-.1pt'>e</span>cause
of<span style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.3pt'>
</span>potential<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.3pt'> </span>hi<span style='letter-spacing:-.05pt'>g</span>her<span
style='letter-spacing:-.3pt'> </span>bleeding<span style='letter-spacing:-.3pt'>
</span>risk.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Bo<span style='letter-spacing:-.05pt'>d</span>y<span
style='letter-spacing:-.5pt'> </span>weight</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Low<span style='letter-spacing:-.3pt'> </span>body<span
style='letter-spacing:-.25pt'> </span>weight<span style='letter-spacing:-.25pt'>
</span>(&lt;<span style='letter-spacing:-.25pt'>&nbsp;</span>60<span
style='letter-spacing:-.25pt'>&nbsp;</span>kg)<span style='letter-spacing:-.25pt'>
</span>may<span style='letter-spacing:-.2pt'> </span>increase<span
style='letter-spacing:-.25pt'> </span>ha<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>orrhagic<span style='letter-spacing:-.25pt'>
</span>risk<span style='letter-spacing:-.25pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>s<span style='letter-spacing:-.05pt'>e</span>ction<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Patients<span style='letter-spacing:-.5pt'> </span>with<span
style='letter-spacing:-.5pt'> </span>hepatic<span style='letter-spacing:-.5pt'>
</span>i<span style='letter-spacing:-.1pt'>m</span>pair<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>is<span
style='letter-spacing:-.35pt'> </span>contraindicated<span style='letter-spacing:
-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>hepatic<span
style='letter-spacing:-.35pt'> </span>disease<span style='letter-spacing:-.35pt'>
</span>associa<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>coagulopathy<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.35pt'> </span>clinically
relevant<span style='letter-spacing:-.35pt'> </span>ble<span style='letter-spacing:
.05pt'>e</span>ding<span style='letter-spacing:-.3pt'> </span>risk<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.3pt'>&nbsp;</span>4.3).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>It<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.25pt'> </span>recommended<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>se<span
style='letter-spacing:-.05pt'>v</span>ere<span style='letter-spacing:-.3pt'> </span>hepat<span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>pai<span
style='letter-spacing:.05pt'>r</span>ment<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>section<span style='letter-spacing:-.3pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>It<span style='letter-spacing:-.25pt'> </span>should<span
style='letter-spacing:-.3pt'> </span>be<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>u</span>sed<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>caution<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ild<span style='letter-spacing:-.35pt'> </span>or<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.25pt'> </span>he<span style='letter-spacing:.05pt'>p</span><span
style='letter-spacing:-.05pt'>a</span>tic<span style='letter-spacing:-.25pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pairment<span style='letter-spacing:-.25pt'>
</span>(Child<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:
-.05pt'>P</span>u<span style='letter-spacing:-.05pt'>g</span>h<span
style='letter-spacing:-.25pt'> </span>A<span style='letter-spacing:-.25pt'> </span>or
B)<span style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:
-.25pt'> </span>secti<span style='letter-spacing:.05pt'>o</span>ns<span
style='letter-spacing:-.2pt'>&nbsp;</span>4.2<span style='letter-spacing:-.25pt'>&nbsp;</span>and<span
style='letter-spacing:-.2pt'>&nbsp;</span>5.2).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Patients<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.2pt'> </span>elevated<span style='letter-spacing:-.25pt'>
</span>liver<span style='letter-spacing:-.2pt'> </span>enz<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.1pt'>m</span>es<span
style='letter-spacing:-.2pt'> </span>A<span style='letter-spacing:.05pt'>L</span>T/AST<span
style='letter-spacing:-.25pt'> </span>&gt;<span style='letter-spacing:-.2pt'>&nbsp;</span>2<span
style='letter-spacing:-.25pt'>&nbsp;</span>x<span style='letter-spacing:-.25pt'>&nbsp;</span>ULN<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.25pt'> </span>total<span
style='letter-spacing:-.2pt'> </span>bilirub<span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.3pt'> </span>&#8805;<span style='letter-spacing:-.25pt'>&nbsp;</span>1<span
style='letter-spacing:-.05pt'>.</span>5<span style='letter-spacing:-.25pt'>&nbsp;</span>x<span
style='letter-spacing:-.2pt'>&nbsp;</span>ULN<span style='letter-spacing:-.25pt'>
</span>were excluded<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>c</span>linical<span
style='letter-spacing:-.3pt'> </span>trials.<span style='letter-spacing:-.3pt'>
</span>Therefore<span style='letter-spacing:-.25pt'> </span>Apixaban Accord<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>s</span>hou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>used<span style='letter-spacing:-.25pt'> </span>cautiously<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>t</span>his<span style='letter-spacing:-.3pt'> </span>population<span
style='letter-spacing:-.25pt'> </span>(see section<span style='letter-spacing:
-.3pt'>&nbsp;</span>5.2).<span style='letter-spacing:-.35pt'> </span>Prior<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>initiating<span
style='letter-spacing:-.3pt'> </span>Apixaban Accord,<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:-.1pt'>i</span>ver<span style='letter-spacing:-.35pt'> </span>function<span
style='letter-spacing:-.3pt'> </span>testing<span style='letter-spacing:-.3pt'>
</span>shou<span style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:
-.3pt'> </span>be<span style='letter-spacing:-.3pt'> </span>performed.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Interaction<span style='letter-spacing:-.4pt'> </span>with<span
style='letter-spacing:-.4pt'> </span>inh<span style='letter-spacing:-.05pt'>i</span>bitors<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.4pt'> </span>bo<span
style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:.05pt'>y</span>to<span
style='letter-spacing:-.1pt'>c</span>hro<span style='letter-spacing:-.1pt'>m</span>e<span
style='letter-spacing:-.45pt'> </span>P450<span style='letter-spacing:-.4pt'>&nbsp;</span>3A4<span
style='letter-spacing:-.35pt'> </span>(CYP3A4)<span style='letter-spacing:-.4pt'>
</span>and<span style='letter-spacing:-.4pt'> </span>P-g<span style='letter-spacing:
-.05pt'>l</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>c</span>oprotein<span style='letter-spacing:-.35pt'>
</span>(P<span style='letter-spacing:-.1pt'>-</span><span style='letter-spacing:
-.05pt'>g</span>p)</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>use<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:
-.3pt'> </span>not<span style='letter-spacing:-.3pt'> </span>r<span
style='letter-spacing:-.1pt'>e</span>c<span style='letter-spacing:.05pt'>o</span>mmended<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>patien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.3pt'> </span>receiving<span
style='letter-spacing:-.3pt'> </span>concomitant<span style='letter-spacing:
-.3pt'> </span>s<span style='letter-spacing:.05pt'>y</span>stemic<span
style='letter-spacing:-.3pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:-.25pt'> </span>with strong<span style='letter-spacing:
-.35pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>hibi<span
style='letter-spacing:-.05pt'>t</span>ors<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>bo<span style='letter-spacing:-.05pt'>t</span>h<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>C</span><span
style='letter-spacing:-.05pt'>Y</span>P3A4<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.05pt'>P</span>-gp,<span
style='letter-spacing:-.35pt'> </span>such<span style='letter-spacing:-.35pt'> </span>as<span
style='letter-spacing:-.35pt'> </span>azole-anti<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>c</span>otics<span style='letter-spacing:-.3pt'> </span>(e.g.,<span
style='letter-spacing:-.35pt'> </span>ketoconazole, itraconazole,<span
style='letter-spacing:-.4pt'> </span>voriconazole<span style='letter-spacing:
-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>posaconazole)<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>H<span
style='letter-spacing:-.1pt'>I</span>V<span style='letter-spacing:-.4pt'> </span>protease<span
style='letter-spacing:-.4pt'> </span>inhibitors<span style='letter-spacing:
-.4pt'> </span>(e.g.,<span style='letter-spacing:-.45pt'> </span>ritonavir).<span
style='letter-spacing:-.4pt'> </span>These medicinal<span style='letter-spacing:
-.3pt'> </span>products<span style='letter-spacing:-.25pt'> </span>may<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.1pt'>c</span>rease<span
style='letter-spacing:-.2pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>exposure<span style='letter-spacing:-.25pt'> </span>by<span
style='letter-spacing:-.25pt'> </span>2-fold<span style='letter-spacing:-.25pt'>
</span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.5)<span style='letter-spacing:
-.3pt'> </span>or<span style='letter-spacing:-.25pt'> </span>greater<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>the
presence<span style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:
-.35pt'> </span>additional<span style='letter-spacing:-.35pt'> </span>factors<span
style='letter-spacing:-.35pt'> </span>that<span style='letter-spacing:-.35pt'> </span>increase<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>exposure<span style='letter-spacing:-.35pt'> </span>(e.g.,<span
style='letter-spacing:-.35pt'> </span>severe<span style='letter-spacing:-.35pt'>
</span>renal<span style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:
-.1pt'>m</span>pai<span style='letter-spacing:.05pt'>r</span>ment).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Interaction<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.05pt'>d</span>ucers<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>both<span
style='letter-spacing:-.3pt'> </span>CYP3<span style='letter-spacing:-.1pt'>A</span>4<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>P-<span
style='letter-spacing:-.05pt'>g</span>p</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>conco<span
style='letter-spacing:-.1pt'>m</span>itant<span style='letter-spacing:-.3pt'> </span>use<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:
-.3pt'> </span>str<span style='letter-spacing:-.05pt'>o</span>ng<span
style='letter-spacing:-.3pt'> </span>CYP3A4<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.35pt'> </span>P-gp<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.05pt'>d</span>ucers<span style='letter-spacing:-.3pt'> </span>(e.g.,<span
style='letter-spacing:-.3pt'> </span>rifa<span style='letter-spacing:-.1pt'>m</span>picin,<span
style='letter-spacing:-.35pt'> </span>phe<span style='letter-spacing:-.05pt'>n</span><span
style='letter-spacing:.05pt'>y</span>toi<span style='letter-spacing:-.05pt'>n</span>,
carbamazepine,<span style='letter-spacing:-.3pt'> </span>phenobarb<span
style='letter-spacing:-.05pt'>i</span>tal<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>St.<span style='letter-spacing:-.3pt'> </span>Jo<span
style='letter-spacing:-.05pt'>hn</span><span style='letter-spacing:.05pt'>’</span>s<span
style='letter-spacing:-.3pt'> </span>Wort)<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.3pt'> </span>lead<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.3pt'> </span>~5<span
style='letter-spacing:-.05pt'>0</span>%<span style='letter-spacing:-.35pt'> </span>reduction<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>e<span style='letter-spacing:-.05pt'>x</span>posure.
In<span style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.25pt'>
</span>clinical<span style='letter-spacing:-.25pt'> </span>study<span
style='letter-spacing:-.15pt'> </span>in<span style='letter-spacing:-.25pt'> </span>atrial<span
style='letter-spacing:-.25pt'> </span>fibrillation<span style='letter-spacing:
-.25pt'> </span>p<span style='letter-spacing:-.1pt'>a</span>tients,<span
style='letter-spacing:-.25pt'> </span>d<span style='letter-spacing:-.15pt'>i</span><span
style='letter-spacing:-.1pt'>m</span>in<span style='letter-spacing:.05pt'>i</span>shed<span
style='letter-spacing:-.25pt'> </span>efficacy<span style='letter-spacing:-.15pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:
-.25pt'> </span>higher<span style='letter-spacing:-.25pt'> </span>risk<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>were observed<span style='letter-spacing:
-.35pt'> </span>with<span style='letter-spacing:-.3pt'> </span>coad<span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apix<span
style='letter-spacing:-.1pt'>a</span>ban<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>str<span style='letter-spacing:-.05pt'>o</span>ng<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>ducers<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>both<span
style='letter-spacing:-.3pt'> </span>CYP<span style='letter-spacing:-.05pt'>3</span>A4<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>P-gp<span
style='letter-spacing:-.4pt'> </span>c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>pared with<span style='letter-spacing:
-.4pt'> </span>using<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>alone.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>receiving<span style='letter-spacing:-.3pt'>
</span>concomitant<span style='letter-spacing:-.35pt'> </span>s<span
style='letter-spacing:.05pt'>y</span>stemic<span style='letter-spacing:-.3pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>ment<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>strong<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.05pt'>i</span>nducers<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>both<span
style='letter-spacing:-.35pt'> </span>CYP3A4<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>P&#8209;gp the<span
style='letter-spacing:-.4pt'> </span>following<span style='letter-spacing:-.4pt'>
</span>rec<span style='letter-spacing:.05pt'>o</span>mmend<span
style='letter-spacing:.05pt'>a</span>tions<span style='letter-spacing:-.35pt'> </span>apply<span
style='letter-spacing:-.4pt'> </span>(see<span style='letter-spacing:-.4pt'> </span>section<span
style='letter-spacing:-.35pt'>&nbsp;</span>4.5):</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>- for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>prevention<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>stroke<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>stemic<span
style='letter-spacing:-.25pt'> </span>e<span style='letter-spacing:-.1pt'>m</span>boli<span
style='letter-spacing:-.05pt'>s</span>m<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.2pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>NVAF<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>for<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>prevention<span
style='letter-spacing:-.3pt'> </span>of recurrent<span style='letter-spacing:
-.3pt'> </span>DVT<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>PE,<span style='letter-spacing:-.3pt'> </span>ap<span
style='letter-spacing:-.05pt'>i</span>xaban<span style='letter-spacing:-.25pt'>
</span>shou<span style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:
-.35pt'> </span>be<span style='letter-spacing:-.25pt'> </span>used<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>caution;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>- for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>treatment<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.2pt'> </span>DVT<span style='letter-spacing:
-.25pt'> </span>and<span style='letter-spacing:-.2pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span><span
style='letter-spacing:.05pt'>n</span>t<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>PE,<span style='letter-spacing:-.25pt'> </span>apix<span
style='letter-spacing:-.1pt'>a</span>ban<span style='letter-spacing:-.2pt'> </span>shou<span
style='letter-spacing:-.05pt'>l</span>d<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>n</span>ot<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>used<span style='letter-spacing:-.2pt'> </span>si<span
style='letter-spacing:-.05pt'>n</span>ce<span style='letter-spacing:-.25pt'> </span>efficacy<span
style='letter-spacing:-.1pt'> </span>may<span style='letter-spacing:-.15pt'> </span>be
<span style='letter-spacing:-.05pt'>c</span><span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>p<span style='letter-spacing:-.05pt'>r</span><span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:-.05pt'>se</span><span style='letter-spacing:.05pt'>d</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Laborato<span style='letter-spacing:-.05pt'>r</span>y<span
style='letter-spacing:-.9pt'> </span><span style='letter-spacing:-.05pt'>pa</span>rameters</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Clotting<span style='letter-spacing:-.3pt'> </span>tests<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>[</span><span
style='letter-spacing:-.05pt'>e</span>.g.,<span style='letter-spacing:-.25pt'> </span>prothr<span
style='letter-spacing:-.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.3pt'> </span>time<span style='letter-spacing:-.3pt'> </span>(PT),<span
style='letter-spacing:-.25pt'> </span>INR,<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>a</span>nd<span style='letter-spacing:-.3pt'> </span>activated<span
style='letter-spacing:-.25pt'> </span>partial<span style='letter-spacing:-.3pt'>
</span>thro<span style='letter-spacing:-.15pt'>m</span>boplastin<span
style='letter-spacing:-.3pt'> </span>ti<span style='letter-spacing:-.1pt'>m</span>e<span
style='letter-spacing:-.3pt'> </span>(aPTT)]<span style='letter-spacing:-.45pt'>
</span>are affec<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.25pt'> </span>as<span style='letter-spacing:-.25pt'> </span>e<span
style='letter-spacing:.05pt'>x</span>pected<span style='letter-spacing:-.25pt'>
</span>by<span style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:
-.3pt'> </span>mechanism<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>action<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>apixaban.<span
style='letter-spacing:-.2pt'> </span>Changes<span style='letter-spacing:-.25pt'>
</span>observ<span style='letter-spacing:-.05pt'>e</span>d<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>these<span
style='letter-spacing:-.25pt'> </span>clotting<span style='letter-spacing:-.25pt'>
</span>tests at<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>expected<span style='letter-spacing:-.25pt'>
</span>therapeutic<span style='letter-spacing:-.2pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>are<span style='letter-spacing:-.25pt'> </span>sma<span
style='letter-spacing:.05pt'>l</span>l<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>sub<span style='letter-spacing:-.05pt'>j</span>ect<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>high<span style='letter-spacing:-.25pt'> </span>degree<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>variability<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>secti<span
style='letter-spacing:.05pt'>o</span>n<span style='letter-spacing:-.2pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Infor<span style='letter-spacing:-.1pt'>m</span>ation<span
style='letter-spacing:-.65pt'> </span>about<span style='letter-spacing:-.65pt'>
</span>excipie<span style='letter-spacing:-.05pt'>n</span>ts</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>contains<span
style='letter-spacing:-.35pt'> </span>lactose.<span style='letter-spacing:-.3pt'>
</span>Patients<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>rare<span style='letter-spacing:-.35pt'> </span>her<span
style='letter-spacing:-.1pt'>e</span>ditary<span style='letter-spacing:-.25pt'>
</span>problems<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>galactose<span style='letter-spacing:
-.35pt'> </span>intolerance,<span style='letter-spacing:-.3pt'> </span>total lactase<span
style='letter-spacing:-.4pt'> </span>deficiency<span style='letter-spacing:
-.3pt'> </span>or<span style='letter-spacing:-.45pt'> </span>gluc<span
style='letter-spacing:-.05pt'>o</span>se-galactose<span style='letter-spacing:
-.3pt'> </span>malab<span style='letter-spacing:-.1pt'>s</span>orption<span
style='letter-spacing:-.4pt'> </span>shou<span style='letter-spacing:-.05pt'>l</span>d<span
style='letter-spacing:-.4pt'> </span>not<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.05pt'>ta</span>ke<span style='letter-spacing:-.4pt'> </span>this<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>dicinal product.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>This medicinal product contains less than 1 mmol sodium (23 mg) per
tablet, that is to say essentially ‘sodium-free’</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.5<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Interaction<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>other<span style='letter-spacing:-.35pt'>
</span>medicinal<span style='letter-spacing:-.35pt'> </span>products<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>other<span
style='letter-spacing:-.35pt'> </span>forms<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>interaction</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Inhibitors<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.4pt'> </span>CYP3A4<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.35pt'> </span>P-gp</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>ap<span
style='letter-spacing:-.05pt'>i</span>xa<span style='letter-spacing:-.05pt'>b</span>an<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>ketoconazole<span
style='letter-spacing:-.25pt'> </span>(400<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>once<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.3pt'> </span>da<span
style='letter-spacing:.05pt'>y</span>),<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>strong<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>in</span>hibitor<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.25pt'> </span>b<span
style='letter-spacing:-.05pt'>ot</span>h CYP3A4<span style='letter-spacing:
-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>P-gp,<span
style='letter-spacing:-.2pt'> </span>led<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.35pt'> </span>2-fold<span
style='letter-spacing:-.2pt'> </span>increase<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:
-.1pt'>m</span>ean<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:.05pt'>p</span>ixaban<span style='letter-spacing:-.25pt'>
</span>AUC<span style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:
-.25pt'> </span>a<span style='letter-spacing:-.2pt'> </span>1<span
style='letter-spacing:-.05pt'>.6-fol</span>d<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>increas</span>e<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.05pt'>mean </span>apixaban<span
style='letter-spacing:-.5pt'> </span>C<sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>use<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>Apixaban
Accord<span style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:
-.3pt'> </span>not<span style='letter-spacing:-.3pt'> </span>r<span
style='letter-spacing:-.1pt'>e</span>c<span style='letter-spacing:.05pt'>o</span>mmended<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>patien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.3pt'> </span>receiving<span
style='letter-spacing:-.3pt'> </span>concomitant<span style='letter-spacing:
-.3pt'> </span>s<span style='letter-spacing:.05pt'>y</span>stemic<span
style='letter-spacing:-.3pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:-.25pt'> </span>with strong<span style='letter-spacing:
-.35pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>hibi<span
style='letter-spacing:-.05pt'>t</span>ors<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>bo<span style='letter-spacing:-.05pt'>t</span>h<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>C</span><span
style='letter-spacing:-.05pt'>Y</span>P3A4<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.05pt'>P</span>-gp,<span
style='letter-spacing:-.35pt'> </span>such<span style='letter-spacing:-.35pt'> </span>as<span
style='letter-spacing:-.35pt'> </span>azole-anti<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>c</span>otics<span style='letter-spacing:-.3pt'> </span>(e.g.,<span
style='letter-spacing:-.35pt'> </span>ketoconazole, itraconazole,<span
style='letter-spacing:-.4pt'> </span>voriconazole<span style='letter-spacing:
-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>posaconazole)<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.45pt'> </span>HIV<span
style='letter-spacing:-.4pt'> </span>protease<span style='letter-spacing:-.4pt'>
</span>inhibitors<span style='letter-spacing:-.4pt'> </span>(e.g.,<span
style='letter-spacing:-.4pt'> </span>ritonavir)<span style='letter-spacing:
-.4pt'> </span>(see section<span style='letter-spacing:-.55pt'>&nbsp;</span>4.4).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Active<span style='letter-spacing:-.3pt'> </span>substances<span
style='letter-spacing:-.3pt'> </span>which<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:-.3pt'> </span>not<span
style='letter-spacing:-.3pt'> </span>consid<span style='letter-spacing:-.1pt'>e</span>red<span
style='letter-spacing:-.3pt'> </span>s<span style='letter-spacing:.05pt'>t</span>rong<span
style='letter-spacing:-.3pt'> </span>inhibitors<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>bo<span
style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:-.3pt'> </span>CYP3A4<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>P-gp,
(e.g.,<span style='letter-spacing:-.45pt'> </span>a<span style='letter-spacing:
-.1pt'>m</span>iodaron<span style='letter-spacing:-.1pt'>e</span>, clarithr<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>y</span>cin, diltiaze<span style='letter-spacing:
-.1pt'>m</span>,<span style='letter-spacing:-.4pt'> fluconazole, </span>naproxen,<span
style='letter-spacing:-.45pt'> </span>quinidine, verapa<span style='letter-spacing:
-.1pt'>m</span>il)<span style='letter-spacing:-.4pt'> </span>are<span
style='letter-spacing:-.45pt'> </span>expected<span style='letter-spacing:-.4pt'>
</span>to<span style='letter-spacing:-.45pt'> </span>increase apixaban<span
style='letter-spacing:-.3pt'> </span>plasma<span style='letter-spacing:-.3pt'> </span>concentr<span
style='letter-spacing:.05pt'>a</span>tion<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.3pt'> </span>lesser<span
style='letter-spacing:-.3pt'> </span>extent.<span style='letter-spacing:-.3pt'>
</span>No<span style='letter-spacing:-.25pt'> </span>dose<span
style='letter-spacing:-.3pt'> </span>adjus<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>apixab<span style='letter-spacing:-.1pt'>a</span>n<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.3pt'> </span>required<span
style='letter-spacing:-.35pt'> </span>when coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistered<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>agents<span
style='letter-spacing:-.25pt'> </span>that<span style='letter-spacing:-.3pt'> </span>are<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.25pt'> </span>strong<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.1pt'>n</span>hibi<span
style='letter-spacing:-.05pt'>t</span>ors<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>bo<span style='letter-spacing:-.05pt'>t</span>h<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>C</span><span
style='letter-spacing:-.05pt'>Y</span>P3A4<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>P</span>-gp.<span
style='letter-spacing:-.25pt'> </span>For<span style='letter-spacing:-.3pt'> </span>ex<span
style='letter-spacing:-.1pt'>am</span>ple, diltiazem<span style='letter-spacing:
-.35pt'> </span>(360<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>once<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.15pt'> </span>da<span
style='letter-spacing:.05pt'>y</span>),<span style='letter-spacing:2.25pt'> </span>consid<span
style='letter-spacing:-.1pt'>e</span>red<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>m</span>oder<span
style='letter-spacing:-.05pt'>a</span>te<span style='letter-spacing:-.25pt'> </span>CYP3A4<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>weak<span style='letter-spacing:-.2pt'> </span>P-gp<span
style='letter-spacing:-.2pt'> </span>inh<span style='letter-spacing:-.05pt'>i</span>bitor,<span
style='letter-spacing:-.25pt'> </span>l<span style='letter-spacing:-.1pt'>e</span>d<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.2pt'> </span>a
1.4-fold<span style='letter-spacing:-.3pt'> </span>increase<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ean<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>AUC<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>1.3-fold<span
style='letter-spacing:-.3pt'> </span>increase<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.25pt'> </span>C<sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub>.<span style='letter-spacing:
-.25pt'> </span>Naproxen<span style='letter-spacing:-.25pt'> </span>(500<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g,<span
style='letter-spacing:-.25pt'> </span>single dose)<span style='letter-spacing:
-.25pt'> </span>an<span style='letter-spacing:-.2pt'> </span>inhibitor<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>P-gp<span
style='letter-spacing:-.25pt'> </span>but<span style='letter-spacing:-.2pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>an<span style='letter-spacing:-.2pt'> </span>inhibitor<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.3pt'> </span>CYP3A4,<span
style='letter-spacing:-.2pt'> </span>led<span style='letter-spacing:-.2pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>1.5-fold<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span>1.6-fold<span
style='letter-spacing:-.25pt'> </span>increase<span style='letter-spacing:-.2pt'>
</span>in mean<span style='letter-spacing:-.3pt'> </span>apixab<span
style='letter-spacing:.05pt'>a</span>n<span style='letter-spacing:-.25pt'> </span>AUC<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>C<sub><span style='position:relative;top:1.0pt'>m</span></sub></span><sub><span
style='position:relative;top:1.0pt'>ax</span></sub>,<span style='letter-spacing:
-.3pt'> </span>respectivel<span style='letter-spacing:.1pt'>y</span>.<span
style='letter-spacing:-.25pt'> </span>Clarithr<span style='letter-spacing:-.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>y</span>cin<span
style='letter-spacing:-.25pt'> </span>(500<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g,<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.05pt'>a</span><span
style='letter-spacing:.05pt'>y</span>),<span style='letter-spacing:-.25pt'> </span>an<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>nh<span
style='letter-spacing:-.05pt'>i</span>bi<span style='letter-spacing:-.05pt'>t</span>or<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>P-gp<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>strong<span style='letter-spacing:-.25pt'>
</span>inhibitor<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>CYP3A4,<span style='letter-spacing:-.25pt'>
</span>led<span style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:
-.2pt'> </span>a<span style='letter-spacing:-.25pt'> </span>1.<span
style='letter-spacing:-.05pt'>6</span>-fold<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>1.3-fold<span style='letter-spacing:-.25pt'>
</span>increase<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>mean<span style='letter-spacing:-.25pt'> </span>apixab<span
style='letter-spacing:.05pt'>a</span>n<span style='letter-spacing:-.2pt'> </span>AUC
and<span style='letter-spacing:-.4pt'> </span>C<sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub><span style='position:relative;top:1.0pt;letter-spacing:
.6pt'> </span>respectivel<span style='letter-spacing:.1pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Inducers<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>CYP3A4<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.05pt'>P</span>-gp</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistr<span style='letter-spacing:.05pt'>a</span>tion<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>rif<span
style='letter-spacing:.05pt'>a</span>mpicin,<span style='letter-spacing:-.25pt'>
</span>a<span style='letter-spacing:-.3pt'> </span>str<span style='letter-spacing:
-.05pt'>on</span>g<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.05pt'>d</span>ucer<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>b</span>oth<span
style='letter-spacing:-.25pt'> </span>CYP3A4<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>P-gp,<span
style='letter-spacing:-.3pt'> </span>led<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>an approxi<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>te<span
style='letter-spacing:-.3pt'> </span>54%<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>42%<span style='letter-spacing:-.3pt'> </span>decr<span
style='letter-spacing:.05pt'>e</span>ase<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.2pt'> </span>mean<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>AUC<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>C</span><sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub>,<span style='letter-spacing:
-.3pt'> </span>respect<span style='letter-spacing:.05pt'>i</span>vely.<span
style='letter-spacing:-.3pt'> </span>The<span style='letter-spacing:-.3pt'> </span>conc<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>itant
use<span style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:
-.3pt'> </span>apixa<span style='letter-spacing:-.05pt'>b</span>an<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.3pt'> </span>other<span
style='letter-spacing:-.4pt'> </span>strong<span style='letter-spacing:-.3pt'> </span>CYP<span
style='letter-spacing:-.05pt'>3</span>A4<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>P-gp<span style='letter-spacing:-.35pt'> </span>inducers<span
style='letter-spacing:-.35pt'> </span>(e.g.,<span style='letter-spacing:-.3pt'>
</span>phe<span style='letter-spacing:-.05pt'>n</span><span style='letter-spacing:
.05pt'>y</span><span style='letter-spacing:-.05pt'>t</span>oin,<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>c</span><span
style='letter-spacing:-.05pt'>a</span>rba<span style='letter-spacing:-.1pt'>m</span>azepine,
phenobarbital<span style='letter-spacing:-.35pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>St.<span style='letter-spacing:-.3pt'> </span>Jo<span
style='letter-spacing:-.05pt'>hn</span><span style='letter-spacing:.05pt'>’</span>s<span
style='letter-spacing:-.3pt'> </span>Wort)<span style='letter-spacing:-.3pt'> </span>may<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.05pt'>l</span>so<span
style='letter-spacing:-.3pt'> </span>lead<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>reduced<span style='letter-spacing:-.3pt'>
</span>apixaban<span style='letter-spacing:-.25pt'> </span>plasma<span
style='letter-spacing:-.3pt'> </span>concentrations.<span style='letter-spacing:
-.3pt'> </span>No<span style='letter-spacing:-.3pt'> </span>dose adjust<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.35pt'> </span>for<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>is<span style='letter-spacing:-.35pt'> </span>required<span
style='letter-spacing:-.35pt'> </span>dur<span style='letter-spacing:-.05pt'>i</span>ng<span
style='letter-spacing:-.35pt'> </span>con<span style='letter-spacing:-.1pt'>c</span>o<span
style='letter-spacing:-.1pt'>m</span>itant<span style='letter-spacing:-.35pt'> </span>thera<span
style='letter-spacing:-.05pt'>p</span>y<span style='letter-spacing:-.25pt'> </span>wi<span
style='letter-spacing:-.05pt'>t</span>h<span style='letter-spacing:-.35pt'> </span>such<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>dicinal<span style='letter-spacing:-.35pt'>
</span>pro<span style='letter-spacing:-.05pt'>d</span>ucts, however<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>pa</span>tients<span style='letter-spacing:-.35pt'>
</span>receiving<span style='letter-spacing:-.35pt'> </span>conco<span
style='letter-spacing:-.1pt'>m</span>itant<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>ste<span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.4pt'> </span>treatment<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>strong<span
style='letter-spacing:-.35pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>ducers<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>both<span
style='letter-spacing:-.3pt'> </span>C<span style='letter-spacing:-.1pt'>Y</span>P3A4
and<span style='letter-spacing:-.3pt'> </span>P-gp<span style='letter-spacing:
-.25pt'> </span>ap<span style='letter-spacing:-.05pt'>ix</span>aban<span
style='letter-spacing:-.25pt'> </span>should<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.05pt'>b</span>e<span style='letter-spacing:
-.3pt'> </span>used<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>caution<span style='letter-spacing:-.25pt'>
</span>for<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.25pt'> </span>prevention<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>o</span>f<span
style='letter-spacing:-.25pt'> </span>stroke<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>s<span style='letter-spacing:
.05pt'>y</span>ste<span style='letter-spacing:-.1pt'>m</span>ic<span
style='letter-spacing:-.25pt'> </span>embolism<span style='letter-spacing:-.35pt'>
</span>in patients<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>NVAF<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>prevention<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>recurrent<span
style='letter-spacing:-.3pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>PE.<span style='letter-spacing:-.3pt'> </span>Apixaban<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.3pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>recommended for<span style='letter-spacing:
-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>ment<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>DVT<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>PE<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>pat<span style='letter-spacing:-.05pt'>i</span>ents<span
style='letter-spacing:-.3pt'> </span>rece<span style='letter-spacing:-.05pt'>i</span>ving<span
style='letter-spacing:-.3pt'> </span>conco<span style='letter-spacing:-.1pt'>m</span>itant<span
style='letter-spacing:-.2pt'> </span>s<span style='letter-spacing:.05pt'>y</span>ste<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.35pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>strong
inducers<span style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>b</span>oth<span
style='letter-spacing:-.25pt'> </span>CYP3A4<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>P-gp<span
style='letter-spacing:-.25pt'> </span>sin<span style='letter-spacing:-.1pt'>c</span>e<span
style='letter-spacing:-.3pt'> </span>efficacy<span style='letter-spacing:-.2pt'>
</span><span style='letter-spacing:-.1pt'>m</span>ay<span style='letter-spacing:
-.25pt'> </span>be<span style='letter-spacing:-.3pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span>promised<span style='letter-spacing:-.25pt'>
</span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>4.4<span style='letter-spacing:-.1pt'>)</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Anticoagulants,<span style='letter-spacing:-.55pt'> </span>platelet<span
style='letter-spacing:-.55pt'> </span>aggregation<span style='letter-spacing:
-.6pt'> </span>inh<span style='letter-spacing:-.05pt'>i</span>bitors,<span
style='letter-spacing:-.55pt'> </span>SSRIs/SNRIs<span style='letter-spacing:
-.55pt'> </span>and<span style='letter-spacing:-.55pt'> </span>NSAIDs</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Due<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>an<span style='letter-spacing:-.3pt'> </span>increased<span
style='letter-spacing:-.3pt'> </span>bleed<span style='letter-spacing:.05pt'>i</span>ng<span
style='letter-spacing:-.3pt'> </span>risk,<span style='letter-spacing:-.3pt'> </span>con<span
style='letter-spacing:-.1pt'>c</span>o<span style='letter-spacing:-.1pt'>m</span>itant<span
style='letter-spacing:-.3pt'> </span>tr<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.05pt'>a</span><span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>any<span style='letter-spacing:-.3pt'> </span>other<span
style='letter-spacing:-.3pt'> </span>anticoagulants<span style='letter-spacing:
-.3pt'> </span>is contraindicated<span style='letter-spacing:-.5pt'> except
under specific circumstances of switching anticoagulant therapy, when UFH is given
at doses necessary to maintain an open central venous or arterial catheter or
when UFH is given during catheter ablation for atrial fibrillation </span>(see<span
style='letter-spacing:-.45pt'> </span>section<span style='letter-spacing:-.45pt'>&nbsp;</span>4.3).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>After<span style='letter-spacing:-.3pt'> </span>c<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>bi<span
style='letter-spacing:.05pt'>n</span>ed<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inist<span style='letter-spacing:.05pt'>r</span>ation<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>enox<span
style='letter-spacing:-.1pt'>a</span>parin<span style='letter-spacing:-.3pt'> </span>(40<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>single<span style='letter-spacing:-.25pt'>
</span>dose)<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>(5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>single<span
style='letter-spacing:-.3pt'> </span>dose), an<span style='letter-spacing:-.3pt'>
</span>additive<span style='letter-spacing:-.3pt'> </span>effect<span
style='letter-spacing:-.3pt'> </span>on<span style='letter-spacing:-.3pt'> </span>anti-Factor<span
style='letter-spacing:-.3pt'> </span>Xa<span style='letter-spacing:-.3pt'> </span>activi<span
style='letter-spacing:-.05pt'>t</span>y<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>observed.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Phar<span style='letter-spacing:-.1pt'>m</span>acokinetic<span
style='letter-spacing:-.45pt'> </span>or<span style='letter-spacing:-.4pt'> </span>pharmacodyna<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.4pt'> </span>interactions<span style='letter-spacing:
-.4pt'> </span>were<span style='letter-spacing:-.4pt'> </span>not<span
style='letter-spacing:-.4pt'> </span>evident<span style='letter-spacing:-.4pt'>
</span>when<span style='letter-spacing:-.4pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban<span style='letter-spacing:-.4pt'> </span>was
coa<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistered<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>ASA<span
style='letter-spacing:-.25pt'> </span>325<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>once<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>da<span
style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.3pt'> </span>coad<span
style='letter-spacing:-.1pt'>m</span>iniste<span style='letter-spacing:.05pt'>r</span>ed<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>clopidogrel<span
style='letter-spacing:-.3pt'> </span>(75<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>o<span
style='letter-spacing:-.05pt'>n</span>ce<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>da<span style='letter-spacing:.05pt'>y</span>)<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>combination<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.25pt'> </span>clopid<span
style='letter-spacing:-.05pt'>o</span>grel 75<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.2pt'> </span>ASA<span style='letter-spacing:-.2pt'> </span>162<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>once<span style='letter-spacing:-.2pt'> </span>dail<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.2pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.2pt'> </span>prasugrel<span
style='letter-spacing:-.2pt'> </span>(60<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>foll<span
style='letter-spacing:-.05pt'>o</span>wed<span style='letter-spacing:-.2pt'> </span>by<span
style='letter-spacing:-.2pt'> </span>10<span style='letter-spacing:-.15pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>once<span
style='letter-spacing:-.2pt'> </span>dai<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span>)<span style='letter-spacing:-.25pt'> </span>in
Phase<span style='letter-spacing:-.25pt'>&nbsp;</span>I<span style='letter-spacing:
-.25pt'> </span>studies<span style='letter-spacing:-.25pt'> </span>did<span
style='letter-spacing:-.25pt'> </span>not<span style='letter-spacing:-.25pt'> </span>show<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.25pt'> </span>relevant<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:.05pt'>i</span>ncrea<span
style='letter-spacing:.05pt'>s</span>e<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>t<span style='letter-spacing:-.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>p<span style='letter-spacing:.05pt'>l</span><span
style='letter-spacing:-.05pt'>a</span>te<span style='letter-spacing:-.2pt'> </span>bleed<span
style='letter-spacing:.05pt'>i</span>ng<span style='letter-spacing:-.25pt'> </span>ti<span
style='letter-spacing:-.1pt'>m</span>e,<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>further<span style='letter-spacing:-.25pt'>
</span>inhibition<span style='letter-spacing:-.25pt'> </span>of platelet<span
style='letter-spacing:-.4pt'> </span>aggregation,<span style='letter-spacing:
-.4pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>pared<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.4pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:.05pt'>n</span>istration<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.5pt'> </span>the<span
style='letter-spacing:-.4pt'> </span>antiplatelet<span style='letter-spacing:
-.35pt'> </span>agents<span style='letter-spacing:-.4pt'> </span>without<span
style='letter-spacing:-.4pt'> </span>apixaban.<span style='letter-spacing:-.35pt'>
</span>Increa<span style='letter-spacing:.05pt'>s</span>es in<span
style='letter-spacing:-.25pt'> </span>clotting<span style='letter-spacing:-.25pt'>
</span>tests<span style='letter-spacing:-.25pt'> </span>(PT,<span
style='letter-spacing:-.25pt'> </span>INR,<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>aPTT)<span style='letter-spacing:-.25pt'>
</span>were<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.1pt'>c</span>onsistent<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>effects<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>alone.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Naproxen<span style='letter-spacing:-.25pt'> </span>(500<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g),<span
style='letter-spacing:-.25pt'> </span>an<span style='letter-spacing:-.25pt'> </span>inhibitor<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>P-gp,<span
style='letter-spacing:-.2pt'> </span>led<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:-.25pt'> </span>1.5-fold<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>1.6-fold<span
style='letter-spacing:-.3pt'> </span>increase<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.1pt'>m</span>ean<span style='letter-spacing:-.25pt'> </span>apixaban AUC<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>C<sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt;letter-spacing:.05pt'>a</span><span
style='position:relative;top:1.0pt'>x</span></sub>,<span style='letter-spacing:
-.3pt'> </span>respectively.<span style='letter-spacing:-.3pt'> </span>Corresponding<span
style='letter-spacing:-.3pt'> </span>increases<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>cl<span style='letter-spacing:
-.05pt'>o</span>tting<span style='letter-spacing:-.35pt'> </span>tests<span
style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:-.3pt'> </span>observed<span
style='letter-spacing:-.35pt'> </span>for<span style='letter-spacing:-.3pt'> </span>apixaban.<span
style='letter-spacing:-.3pt'> </span>No changes<span style='letter-spacing:
-.3pt'> </span>were<span style='letter-spacing:-.3pt'> </span>observed<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:-.3pt'> </span>effect<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>naproxen<span
style='letter-spacing:-.3pt'> </span>on<span style='letter-spacing:-.35pt'> </span>arachidonic<span
style='letter-spacing:-.3pt'> </span>acid-induced<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>p</span>latelet<span
style='letter-spacing:-.25pt'> </span>aggregation<span style='letter-spacing:
-.3pt'> </span>and no<span style='letter-spacing:-.3pt'> </span>clinical<span
style='letter-spacing:-.05pt'>l</span>y<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>e</span>levant<span
style='letter-spacing:-.3pt'> </span>prol<span style='letter-spacing:-.05pt'>o</span>ngation<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>bl<span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:-.05pt'>e</span>ding<span
style='letter-spacing:-.3pt'> </span>ti<span style='letter-spacing:-.25pt'>m</span>e<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.25pt'> </span>observed<span
style='letter-spacing:-.3pt'> </span>after<span style='letter-spacing:-.3pt'> </span>conc<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>itant<span
style='letter-spacing:-.25pt'> </span>ad<span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.3pt'> </span>of apixaban<span style='letter-spacing:
-.5pt'> </span>and<span style='letter-spacing:-.55pt'> </span>naproxen.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Despite<span style='letter-spacing:-.35pt'> </span>these<span
style='letter-spacing:-.35pt'> </span>findi<span style='letter-spacing:-.05pt'>n</span>gs,<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.1pt'>r</span>e<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>y<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.35pt'> </span>ind<span style='letter-spacing:-.05pt'>i</span>viduals<span
style='letter-spacing:-.4pt'> </span>with<span style='letter-spacing:-.4pt'> </span>a<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>ore<span
style='letter-spacing:-.35pt'> </span>pron<span style='letter-spacing:-.05pt'>o</span>unced<span
style='letter-spacing:-.3pt'> </span>pharmacodyna<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.35pt'> </span>response when<span style='letter-spacing:
-.35pt'> </span>antiplatelet<span style='letter-spacing:-.3pt'> </span>agents<span
style='letter-spacing:-.35pt'> </span>are<span style='letter-spacing:-.35pt'> </span>coa<span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistered<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban.<span style='letter-spacing:-.35pt'>
</span>Apixaban Accord<span style='letter-spacing:-.35pt'> </span>should<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.35pt'> </span>used<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>cauti<span
style='letter-spacing:-.05pt'>o</span>n<span style='letter-spacing:-.35pt'> </span>when
coa<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>iniste<span
style='letter-spacing:.05pt'>r</span>ed<span style='letter-spacing:-.45pt'> </span>with<span
style='letter-spacing:-.4pt'> </span>SSRIs/SNRIs,<span style='letter-spacing:
-.4pt'> </span>NSAIDs, ASA and/or P2Y12 because<span style='letter-spacing:
-.45pt'> </span>th<span style='letter-spacing:.05pt'>e</span>se<span
style='letter-spacing:-.35pt'> </span>medicinal products<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>t</span>yp<span
style='letter-spacing:-.05pt'>i</span>cally<span style='letter-spacing:-.2pt'> </span>increase<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.35pt'> </span>risk<span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:.05pt'>(</span>see<span style='letter-spacing:-.35pt'> </span>section<span
style='letter-spacing:-.4pt'>&nbsp;</span>4.4).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>There is limited experience of co-administration with
other platelet aggregation inhibitors (such as GPIIb/IIIa receptor antagonists,
dipyridamole, dextran or sulfinpyrazone) or thrombolytic agents. As such agents
increase the bleeding risk, co-administration of these products with Apixaban
Accord is not recommended (see section 4.4). </span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Other<span style='letter-spacing:-.65pt'> </span>concomitant<span
style='letter-spacing:-.6pt'> </span>therapies</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>No<span style='letter-spacing:-.45pt'> </span>clinically<span
style='letter-spacing:-.4pt'> </span>significant<span style='letter-spacing:
-.45pt'> </span>p<span style='letter-spacing:-.05pt'>h</span>ar<span
style='letter-spacing:-.1pt'>m</span>acokinetic<span style='letter-spacing:
-.45pt'> </span>or<span style='letter-spacing:-.45pt'> </span>ph<span
style='letter-spacing:-.15pt'>a</span>r<span style='letter-spacing:-.1pt'>m</span>aco<span
style='letter-spacing:-.05pt'>d</span><span style='letter-spacing:.05pt'>y</span>na<span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.45pt'> </span>interactions<span
style='letter-spacing:-.45pt'> </span>were<span style='letter-spacing:-.45pt'> </span>observed<span
style='letter-spacing:-.45pt'> </span>when apixaban<span style='letter-spacing:
-.35pt'> </span>was<span style='letter-spacing:-.3pt'> </span>coad<span
style='letter-spacing:-.1pt'>m</span>inis<span style='letter-spacing:.05pt'>t</span>e<span
style='letter-spacing:.05pt'>r</span>ed<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>atenolol<span style='letter-spacing:-.35pt'>
</span>or<span style='letter-spacing:-.3pt'> </span>f<span style='letter-spacing:
-.05pt'>a</span><span style='letter-spacing:-.1pt'>m</span>otidine.<span
style='letter-spacing:-.35pt'> </span>Coad<span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:.05pt'>n</span>istration<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>10<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.35pt'> </span>with
atenolol<span style='letter-spacing:-.3pt'> </span>1<span style='letter-spacing:
-.05pt'>0</span>0<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>did<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.25pt'> </span>h<span
style='letter-spacing:-.1pt'>a</span>ve<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>clinically<span style='letter-spacing:
-.25pt'> </span>rel<span style='letter-spacing:-.1pt'>e</span>vant<span
style='letter-spacing:-.3pt'> </span>effect<span style='letter-spacing:-.25pt'>
</span>on<span style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:
-.3pt'> </span>ph<span style='letter-spacing:-.1pt'>a</span>r<span
style='letter-spacing:-.1pt'>m</span>acokinetics<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban. Following<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:-.05pt'>d</span>ministration<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>two<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>edicinal<span style='letter-spacing:-.3pt'>
</span>pro<span style='letter-spacing:-.05pt'>duc</span>ts<span
style='letter-spacing:-.3pt'> </span>together,<span style='letter-spacing:-.35pt'>
</span>mean<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>AUC<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.15pt'>C</span><sub><span
style='position:relative;top:1.0pt;letter-spacing:-.1pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub><span style='position:relative;
top:1.0pt;letter-spacing:.7pt'> </span><span style='letter-spacing:-.05pt'>were
</span>15%<span style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:
-.25pt'> </span>18%<span style='letter-spacing:-.3pt'> </span>lower<span
style='letter-spacing:-.25pt'> </span>than<span style='letter-spacing:-.3pt'> </span>when<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistered<span style='letter-spacing:-.3pt'>
</span>alon<span style='letter-spacing:-.05pt'>e</span>.<span style='letter-spacing:
-.25pt'> </span>The<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inist<span style='letter-spacing:.05pt'>r</span>ation<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>with
fa<span style='letter-spacing:-.1pt'>m</span>otidine<span style='letter-spacing:
-.25pt'> </span>40<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>had<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.2pt'> </span>effect<span
style='letter-spacing:-.25pt'> </span>on<span style='letter-spacing:-.2pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>AUC<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>C</span><sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Effect<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>on<span style='letter-spacing:-.35pt'> </span>o<span style='letter-spacing:
-.05pt'>t</span>her<span style='letter-spacing:-.35pt'> </span>medicinal<span
style='letter-spacing:-.35pt'> </span>products</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><i><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>vitro<span
style='letter-spacing:-.3pt'> </span></span></i><span lang=EN-GB>apixaban<span
style='letter-spacing:-.3pt'> </span>studies<span style='letter-spacing:-.3pt'>
</span>showed<span style='letter-spacing:-.3pt'> </span>no<span
style='letter-spacing:-.25pt'> </span>inhibitory<span style='letter-spacing:
-.2pt'> </span>effect<span style='letter-spacing:-.3pt'> </span>on<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>activity<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>CYP1A2,<span
style='letter-spacing:-.25pt'> </span>CYP2A6,<span style='letter-spacing:-.3pt'>
</span>CYP2B6, CYP2C8,<span style='letter-spacing:-.3pt'> </span>CYP2C9,<span
style='letter-spacing:-.25pt'> </span>CYP2D6<span style='letter-spacing:-.3pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>CYP3A4<span
style='letter-spacing:-.25pt'> </span>(IC50<span style='letter-spacing:-.3pt'>&nbsp;</span>&gt;<span
style='letter-spacing:-.25pt'>&nbsp;</span>45<span style='letter-spacing:-.25pt'>&nbsp;</span>µM)<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>weak<span
style='letter-spacing:-.3pt'> </span>inhibitory<span style='letter-spacing:
-.25pt'> </span>effect<span style='letter-spacing:-.25pt'> </span>on<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>activity
of<span style='letter-spacing:-.3pt'> </span>CYP2C19<span style='letter-spacing:
-.3pt'> </span>(IC50<span style='letter-spacing:-.3pt'>&nbsp;</span>&gt;<span
style='letter-spacing:-.25pt'>&nbsp;</span>20<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.05pt'>µ</span>M)<span style='letter-spacing:-.3pt'> </span>at<span
style='letter-spacing:-.25pt'> </span>concentrations<span style='letter-spacing:
-.25pt'> </span>that<span style='letter-spacing:-.35pt'> </span>are<span
style='letter-spacing:-.25pt'> </span>significantly<span style='letter-spacing:
-.25pt'> </span>greater<span style='letter-spacing:-.3pt'> </span>than<span
style='letter-spacing:-.25pt'> </span>peak<span style='letter-spacing:-.3pt'> </span>plas<span
style='letter-spacing:-.1pt'>m</span>a concentrations<span style='letter-spacing:
-.35pt'> </span>observed<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.35pt'> </span>patients.<span style='letter-spacing:
-.35pt'> </span>Apixaban<span style='letter-spacing:-.4pt'> </span>did<span
style='letter-spacing:-.4pt'> </span>not<span style='letter-spacing:-.4pt'> </span>induce<span
style='letter-spacing:-.3pt'> </span>CYP1A2,<span style='letter-spacing:-.35pt'>
</span>CYP2B6,<span style='letter-spacing:-.35pt'> </span>CYP3A4/5<span
style='letter-spacing:-.35pt'> </span>at<span style='letter-spacing:-.35pt'> </span>a
concentration<span style='letter-spacing:-.3pt'> </span>up<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>20<span
style='letter-spacing:-.25pt'>&nbsp;</span>µM.<span style='letter-spacing:-.3pt'>
</span>Therefore,<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.35pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>expected<span style='letter-spacing:-.3pt'>
</span>to<span style='letter-spacing:-.3pt'> </span>alter<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span><span
style='letter-spacing:.05pt'>t</span>abolic<span style='letter-spacing:-.3pt'> </span>clearan<span
style='letter-spacing:.05pt'>c</span>e<span style='letter-spacing:-.3pt'> </span>of
coa<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>iniste<span
style='letter-spacing:.05pt'>r</span>ed<span style='letter-spacing:-.3pt'> </span>drugs<span
style='letter-spacing:-.3pt'> </span>that<span style='letter-spacing:-.35pt'> </span>are<span
style='letter-spacing:-.25pt'> </span>metabolised<span style='letter-spacing:
-.3pt'> </span>by<span style='letter-spacing:-.2pt'> </span>these<span
style='letter-spacing:-.3pt'> </span>e<span style='letter-spacing:.05pt'>n</span>z<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.1pt'>m</span>es.<span
style='letter-spacing:-.3pt'> </span>Apixaban<span style='letter-spacing:-.3pt'>
</span>is<span style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:
-.25pt'> </span>a<span style='letter-spacing:-.35pt'> </span>significant<span
style='letter-spacing:-.3pt'> </span>inhibitor<span style='letter-spacing:-.35pt'>
</span>of P-gp.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>studies<span
style='letter-spacing:-.3pt'> </span>conducted<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.25pt'> </span>he<span style='letter-spacing:
-.1pt'>a</span>lthy<span style='letter-spacing:-.2pt'> </span>subjects,<span
style='letter-spacing:-.35pt'> </span>as<span style='letter-spacing:-.3pt'> </span>described<span
style='letter-spacing:-.2pt'> </span>below,<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>did<span style='letter-spacing:-.35pt'> </span>not<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>eaningfully<span
style='letter-spacing:-.2pt'> </span>alter<span style='letter-spacing:-.25pt'> </span>the
pharmacokinetics<span style='letter-spacing:-.45pt'> </span>of<span
style='letter-spacing:-.45pt'> </span>digo<span style='letter-spacing:-.05pt'>x</span>in,<span
style='letter-spacing:-.4pt'> </span>napr<span style='letter-spacing:-.05pt'>o</span>xen,<span
style='letter-spacing:-.5pt'> </span>or<span style='letter-spacing:-.4pt'> </span>atenolol.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Digoxin</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>ap<span
style='letter-spacing:-.05pt'>i</span>xa<span style='letter-spacing:-.05pt'>b</span>an<span
style='letter-spacing:-.25pt'> </span>(20<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>o<span
style='letter-spacing:-.05pt'>n</span>ce<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>da<span style='letter-spacing:.05pt'>y</span>)<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.3pt'> </span>digox<span
style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:-.25pt'> </span>(0<span
style='letter-spacing:-.05pt'>.</span>25<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>once<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>da<span
style='letter-spacing:.05pt'>y</span>),<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>P-gp<span style='letter-spacing:-.25pt'> </span>s<span
style='letter-spacing:-.05pt'>ubs</span>trate, did<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>n</span>ot<span
style='letter-spacing:-.25pt'> </span>affect<span style='letter-spacing:-.3pt'>
</span>digox<span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.25pt'> </span>AUC<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>C</span><sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub>.<span style='letter-spacing:
-.25pt'> </span>Therefore,<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>does<span style='letter-spacing:-.3pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>inhibit<span style='letter-spacing:-.25pt'>
</span>P-gp<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.1pt'>m</span>ediated<span style='letter-spacing:-.25pt'> </span>substrate transport.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Naproxen</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>single<span
style='letter-spacing:-.3pt'> </span>doses<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>(10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g)<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>naproxen<span style='letter-spacing:-.3pt'>
</span>(500<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g),<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>commonly<span style='letter-spacing:-.3pt'>
</span>used NSAID,<span style='letter-spacing:-.25pt'> </span>did<span
style='letter-spacing:-.2pt'> </span>not<span style='letter-spacing:-.2pt'> </span>have<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.05pt'>n</span>y<span
style='letter-spacing:-.25pt'> </span>effect<span style='letter-spacing:-.2pt'>
</span>on<span style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:
-.25pt'> </span>naproxen<span style='letter-spacing:-.2pt'> </span>AUC<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>C</span><sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><span lang=EN-GB
style='font-size:11.0pt'>Atenolol</span></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Coa<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>si<span style='letter-spacing:-.05pt'>n</span>g<span
style='letter-spacing:-.05pt'>l</span>e<span style='letter-spacing:-.3pt'> </span>dose<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban<span style='letter-spacing:-.3pt'> </span>(10<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g)<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>atenolol<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>(</span>100<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g),<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.25pt'> </span>common<span
style='letter-spacing:-.3pt'> </span>beta-blocker, did<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.05pt'>n</span>ot<span
style='letter-spacing:-.3pt'> </span>alter<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>pharmac<span style='letter-spacing:.05pt'>o</span>kinetics<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>atenolol.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Activated<span style='letter-spacing:-.85pt'> </span>ch<span
style='letter-spacing:.05pt'>a</span>rcoal</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>A<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:
-.1pt'>m</span>inistration<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>activated<span style='letter-spacing:
-.4pt'> </span>charcoal<span style='letter-spacing:-.35pt'> </span>r<span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:.05pt'>d</span>uces<span
style='letter-spacing:-.4pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>exposure<span style='letter-spacing:-.4pt'> </span>(see<span
style='letter-spacing:-.35pt'> </span>section<span style='letter-spacing:-.35pt'>&nbsp;</span>4.9).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.6<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Fertility,<span style='letter-spacing:-.55pt'> </span>pregnancy<span
style='letter-spacing:-.5pt'> </span>and<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>l</span>actation</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Pregnancy</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.25pt'> </span>are<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.25pt'> </span>data<span
style='letter-spacing:-.2pt'> </span>fr<span style='letter-spacing:.05pt'>o</span>m<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.2pt'> </span>use<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>pr<span
style='letter-spacing:-.05pt'>e</span>gna<span style='letter-spacing:-.05pt'>n</span>t<span
style='letter-spacing:-.25pt'> </span>women.<span style='letter-spacing:-.25pt'>
</span>Animal<span style='letter-spacing:-.2pt'> </span>studies<span
style='letter-spacing:-.25pt'> </span>do<span style='letter-spacing:-.25pt'> </span>not<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>i</span>ndicate<span
style='letter-spacing:-.25pt'> </span>direct or<span style='letter-spacing:
-.35pt'> </span>indirect<span style='letter-spacing:-.3pt'> </span>h<span
style='letter-spacing:-.1pt'>a</span>r<span style='letter-spacing:-.1pt'>m</span>ful<span
style='letter-spacing:-.35pt'> </span>effects<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>respect<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.3pt'> </span>rep<span
style='letter-spacing:-.1pt'>r</span>oducti<span style='letter-spacing:-.05pt'>v</span>e<span
style='letter-spacing:-.3pt'> </span>toxici<span style='letter-spacing:-.05pt'>t</span><span
style='letter-spacing:.05pt'>y</span>.<span style='letter-spacing:-.35pt'> </span>A<span
style='letter-spacing:-.05pt'>p</span>ixaban<span style='letter-spacing:-.3pt'>
</span>is<span style='letter-spacing:-.35pt'> </span>not<span style='letter-spacing:
-.35pt'> </span>rec<span style='letter-spacing:.05pt'>o</span>mmended<span
style='letter-spacing:-.3pt'> </span>dur<span style='letter-spacing:-.05pt'>i</span>ng
pregnan<span style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:
.05pt'>y</span>.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Breast-<span style='letter-spacing:.05pt'>f</span>eeding</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>It<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>unknown<span style='letter-spacing:-.25pt'>
</span>whether<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.25pt'> </span>its<span
style='letter-spacing:-.25pt'> </span>metabolites<span style='letter-spacing:
-.25pt'> </span>are<span style='letter-spacing:-.2pt'> </span>excreted<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>human<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>ilk.<span
style='letter-spacing:-.25pt'> </span>Available<span style='letter-spacing:
-.25pt'> </span>data<span style='letter-spacing:-.25pt'> </span>in an<span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>als<span
style='letter-spacing:-.25pt'> </span>have<span style='letter-spacing:-.2pt'> </span>shown<span
style='letter-spacing:-.2pt'> </span>excretion<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ilk.<span style='letter-spacing:-.2pt'> </span>In<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>r</span><span
style='letter-spacing:-.05pt'>a</span>t<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ilk,<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>high<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ilk<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>ma<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>e</span>rnal<span style='letter-spacing:-.2pt'> </span>plas<span
style='letter-spacing:-.1pt'>m</span>a<span style='letter-spacing:-.2pt'> </span>ratio
(<span style='letter-spacing:.05pt'>C</span><sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub><span style='position:relative;top:1.0pt;letter-spacing:
.75pt'> </span>about<span style='letter-spacing:-.2pt'> </span>8,<span
style='letter-spacing:-.25pt'> </span>AUC<span style='letter-spacing:-.2pt'> </span>about<span
style='letter-spacing:-.2pt'> </span>30)<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>fou<span style='letter-spacing:-.05pt'>n</span>d,<span
style='letter-spacing:-.2pt'> </span>possib<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>d</span>ue<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.2pt'> </span>active<span
style='letter-spacing:-.2pt'> </span>transport<span style='letter-spacing:-.2pt'>
</span>into<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ilk.<span style='letter-spacing:-.2pt'> </span>A<span
style='letter-spacing:-.2pt'> </span>risk<span style='letter-spacing:-.2pt'> </span>to
newborns<span style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:
-.4pt'> </span>infants<span style='letter-spacing:-.35pt'> </span>cannot<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.35pt'> </span>exclud<span
style='letter-spacing:-.1pt'>e</span>d.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>A<span style='letter-spacing:-.35pt'> </span>decision<span
style='letter-spacing:-.25pt'> </span>must<span style='letter-spacing:-.35pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>made<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>either<span style='letter-spacing:-.3pt'>
</span>discontinue<span style='letter-spacing:-.3pt'> </span>b<span
style='letter-spacing:-.1pt'>r</span>east-feeding<span style='letter-spacing:
-.35pt'> </span>or<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.35pt'> </span>discontinue/abstain<span
style='letter-spacing:-.35pt'> </span>from<span style='letter-spacing:-.4pt'> </span>apixaban
therap<span style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Fertility</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Studies<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>animals<span style='letter-spacing:-.25pt'>
</span>dosed<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:.05pt'>p</span>ixaban<span
style='letter-spacing:-.3pt'> </span>have<span style='letter-spacing:-.25pt'> </span>shown<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.25pt'> </span>effect<span
style='letter-spacing:-.3pt'> </span>on<span style='letter-spacing:-.25pt'> </span>fertility<span
style='letter-spacing:-.15pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>section<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.3).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.7<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Effects<span style='letter-spacing:-.3pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.05pt'>b</span>ility<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>drive<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>use<span
style='letter-spacing:-.25pt'> </span>machines</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban Accord<span style='letter-spacing:-.25pt'> </span>has<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>negl<span style='letter-spacing:-.05pt'>i</span>gib<span
style='letter-spacing:-.05pt'>l</span>e<span style='letter-spacing:-.25pt'> </span>influence<span
style='letter-spacing:-.25pt'> </span>on<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>abili<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>t</span>o<span
style='letter-spacing:-.25pt'> </span>drive<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>use<span style='letter-spacing:
-.15pt'> </span>machines.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.8<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Undesirabl</span><span
lang=EN-GB>e<span style='letter-spacing:-.85pt'> </span><span style='letter-spacing:
-.05pt'>effec</span><span style='letter-spacing:.05pt'>t</span>s</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Summary<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.3pt'> </span>safety<span
style='letter-spacing:-.25pt'> </span>profile</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>safety<span
style='letter-spacing:-.15pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>has<span style='letter-spacing:-.25pt'> </span>been<span
style='letter-spacing:-.2pt'> </span>investigated<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>4<span
style='letter-spacing:-.25pt'> </span>Pha<span style='letter-spacing:-.1pt'>s</span>e<span
style='letter-spacing:-.25pt'> </span>III<span style='letter-spacing:-.25pt'> </span>clinical<span
style='letter-spacing:-.25pt'> </span>studies<span style='letter-spacing:-.25pt'>
</span>including<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ore<span style='letter-spacing:-.25pt'> </span>than
15,000<span style='letter-spacing:-.3pt'>&nbsp;</span>patients:<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>ore<span
style='letter-spacing:-.25pt'> </span>than<span style='letter-spacing:-.25pt'> </span>11,000<span
style='letter-spacing:-.25pt'>&nbsp;</span>patients<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>NVAF<span
style='letter-spacing:-.35pt'> </span>studies<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>more<span
style='letter-spacing:-.25pt'> </span>than<span style='letter-spacing:-.25pt'> </span>4,000<span
style='letter-spacing:-.25pt'>&nbsp;</span>patients<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>VTE treatment<span style='letter-spacing:
-.3pt'> </span>(VTEt)<span style='letter-spacing:-.25pt'> </span>studies,<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.25pt'> </span>an<span
style='letter-spacing:-.25pt'> </span>average<span style='letter-spacing:-.3pt'>
</span>total<span style='letter-spacing:-.35pt'> </span>expos<span
style='letter-spacing:-.05pt'>u</span>re<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>1.7<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ea<span style='letter-spacing:-.1pt'>r</span>s<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>221<span
style='letter-spacing:-.3pt'>&nbsp;</span>d<span style='letter-spacing:-.1pt'>a</span>ys<span
style='letter-spacing:-.3pt'> </span>respectively (see<span style='letter-spacing:
-.35pt'> </span>section<span style='letter-spacing:-.35pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>C<span style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:
-.1pt'>m</span>on<span style='letter-spacing:-.35pt'> </span>adverse<span
style='letter-spacing:-.35pt'> </span>reactions<span style='letter-spacing:
-.35pt'> </span>were<span style='letter-spacing:-.35pt'> </span>haemorrhage,<span
style='letter-spacing:-.35pt'> </span>contu<span style='letter-spacing:-.1pt'>s</span>ion,<span
style='letter-spacing:-.35pt'> </span>epistaxis,<span style='letter-spacing:
-.3pt'> </span>and<span style='letter-spacing:-.35pt'> </span>haematoma<span
style='letter-spacing:-.35pt'> </span>(see<span style='letter-spacing:-.35pt'> </span>Tab<span
style='letter-spacing:.05pt'>l</span>e<span style='letter-spacing:-.35pt'> </span>2<span
style='letter-spacing:-.35pt'> </span>for adverse<span style='letter-spacing:
-.4pt'> </span>reaction<span style='letter-spacing:-.35pt'> </span>prof<span
style='letter-spacing:-.05pt'>i</span>le<span style='letter-spacing:-.4pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>frequencies<span style='letter-spacing:
-.4pt'> </span><span style='letter-spacing:-.05pt'>b</span>y<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>dicatio<span
style='letter-spacing:-.05pt'>n</span>).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>NVAF<span style='letter-spacing:-.3pt'> </span>studies,<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.25pt'> </span>incidence<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>adve<span
style='letter-spacing:-.05pt'>r</span>se<span style='letter-spacing:-.2pt'> </span>reactions<span
style='letter-spacing:-.3pt'> </span>rel<span style='letter-spacing:.05pt'>a</span>ted<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>was 24.3%<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>vs<span style='letter-spacing:-.3pt'> </span>warfarin<span
style='letter-spacing:-.25pt'> </span>study<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.2pt'> </span>9.6%<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>vs<span style='letter-spacing:-.25pt'> </span>acet<span
style='letter-spacing:.05pt'>y</span>lsalic<span style='letter-spacing:.05pt'>y</span>lic<span
style='letter-spacing:-.25pt'> </span>acid<span style='letter-spacing:-.2pt'> </span>study.<span
style='letter-spacing:-.25pt'> </span>In<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he apixaban<span style='letter-spacing:
-.35pt'> </span>vs<span style='letter-spacing:-.35pt'> </span>warfarin<span
style='letter-spacing:-.3pt'> </span>study<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>incide<span style='letter-spacing:-.05pt'>n</span>ce<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>ISTH<span
style='letter-spacing:-.25pt'> </span>m<span style='letter-spacing:-.15pt'>a</span>jor<span
style='letter-spacing:-.35pt'> </span>gastroin<span style='letter-spacing:-.05pt'>t</span>estinal<span
style='letter-spacing:-.3pt'> </span>bleeds<span style='letter-spacing:-.3pt'> </span>(includi<span
style='letter-spacing:-.05pt'>n</span>g<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>u</span>pper<span style='letter-spacing:-.35pt'> </span>GI,
lower<span style='letter-spacing:-.3pt'> </span>GI,<span style='letter-spacing:
-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>rectal<span
style='letter-spacing:-.25pt'> </span>bleed<span style='letter-spacing:.05pt'>i</span>ng)<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.3pt'> </span>0.76%/<span
style='letter-spacing:.05pt'>y</span>ear.<span style='letter-spacing:-.3pt'> </span>The<span
style='letter-spacing:-.35pt'> </span>incidence<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>ISTH<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>jor intraocular<span style='letter-spacing:
-.45pt'> </span>b<span style='letter-spacing:-.05pt'>l</span>eeding<span
style='letter-spacing:-.45pt'> </span>with<span style='letter-spacing:-.45pt'> </span>apixaban<span
style='letter-spacing:-.45pt'> </span>was<span style='letter-spacing:-.4pt'> </span>0.18%/<span
style='letter-spacing:.05pt'>y</span>ear.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>VTEt<span style='letter-spacing:-.3pt'> </span>studies,<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>overall<span
style='letter-spacing:-.3pt'> </span>incidence<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>adve<span
style='letter-spacing:-.05pt'>r</span>se<span style='letter-spacing:-.3pt'> </span>reactions<span
style='letter-spacing:-.25pt'> </span>rela<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>e</span>d<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>bleeding<span style='letter-spacing:-.25pt'>
</span>with<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>was 15.6%<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>vs<span style='letter-spacing:-.25pt'> </span>enoxaparin/warfarin<span
style='letter-spacing:-.3pt'> </span>s<span style='letter-spacing:-.05pt'>t</span>udy<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>a</span>nd<span
style='letter-spacing:-.3pt'> </span>13.3%<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>t</span>he<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>vs<span style='letter-spacing:-.25pt'> </span>placebo<span
style='letter-spacing:-.3pt'> </span>study (see<span style='letter-spacing:
-.35pt'> </span>section<span style='letter-spacing:-.35pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Tabulated<span style='letter-spacing:-.4pt'> </span>list<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>adverse<span
style='letter-spacing:-.4pt'> </span>reactions</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>2<span
style='letter-spacing:-.25pt'> </span>shows<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>adverse<span style='letter-spacing:-.25pt'>
</span>reactions<span style='letter-spacing:-.25pt'> </span>ra<span
style='letter-spacing:.05pt'>n</span>ked<span style='letter-spacing:-.3pt'> </span>under<span
style='letter-spacing:-.3pt'> </span>headings<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.05pt'>t</span>em<span style='letter-spacing:-.35pt'> </span>organ<span
style='letter-spacing:-.3pt'> </span>class<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>frequency<span style='letter-spacing:-.15pt'>
</span>us<span style='letter-spacing:-.05pt'>i</span>ng the<span
style='letter-spacing:-.3pt'> </span>following<span style='letter-spacing:-.3pt'>
</span>conventi<span style='letter-spacing:-.05pt'>o</span>n:<span
style='letter-spacing:-.35pt'> </span>very<span style='letter-spacing:-.15pt'> </span>com<span
style='letter-spacing:-.1pt'>m</span>on<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>(</span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>1/10)<span
style='letter-spacing:-.25pt'> </span>com<span style='letter-spacing:-.1pt'>m</span>on<span
style='letter-spacing:-.3pt'> </span>(&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>1/100<span
style='letter-spacing:-.3pt'>&nbsp;</span>to<span style='letter-spacing:-.25pt'>&nbsp;</span>&lt;<span
style='letter-spacing:-.25pt'>&nbsp;</span>1/<span style='letter-spacing:-.05pt'>1</span>0);<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>u</span>ncommon<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>(</span>&#8805;<span
style='letter-spacing:-.3pt'>&nbsp;</span>1/1,<span style='letter-spacing:-.05pt'>0</span>00&nbsp;to<span
style='letter-spacing:-.25pt'>&nbsp;</span>&lt;<span style='letter-spacing:
-.25pt'>&nbsp;</span>1/1<span style='letter-spacing:-.05pt'>0</span>0);<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>r</span><span
style='letter-spacing:-.05pt'>a</span>re<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>(</span>&#8805;<span style='letter-spacing:-.25pt'>&nbsp;</span>1/10,000<span
style='letter-spacing:-.25pt'>&nbsp;</span>to<span style='letter-spacing:-.2pt'>&nbsp;</span>&lt;<span
style='letter-spacing:-.3pt'>&nbsp;</span>1/1,<span style='letter-spacing:-.05pt'>0</span>00);<span
style='letter-spacing:-.2pt'> </span>ve<span style='letter-spacing:-.1pt'>r</span>y<span
style='letter-spacing:-.15pt'> </span>rare<span style='letter-spacing:-.25pt'> </span>(&lt;<span
style='letter-spacing:-.2pt'>&nbsp;</span>1/10,<span style='letter-spacing:
-.05pt'>0</span>00);<span style='letter-spacing:-.3pt'> </span>not<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>k</span>nown<span
style='letter-spacing:-.25pt'> </span>(<span style='letter-spacing:-.1pt'>c</span>annot<span
style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:-.2pt'> </span>estimated
from<span style='letter-spacing:-.4pt'> </span>the<span style='letter-spacing:
-.3pt'> </span>ava<span style='letter-spacing:.05pt'>i</span>lable<span
style='letter-spacing:-.3pt'> </span>data)<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>NVAF<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>VTEt<span style='letter-spacing:-.3pt'> </span>respect<span
style='letter-spacing:.05pt'>i</span>vely.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.35pt'> </span>2</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=623
 style='margin-left:5.5pt;border-collapse:collapse'>
 <thead>
  <tr style='height:17.0pt'>
   <td width=242 valign=top style='width:181.35pt;border:solid black 1.0pt;
   padding:0in 0in 0in 0in;height:17.0pt'>
   <p class=TableParagraph style='punctuation-wrap:simple'><b><span lang=EN-GB
   style='font-size:11.0pt'>System<span style='letter-spacing:-.4pt'> o</span>rgan<span
   style='letter-spacing:-.45pt'> c</span>lass</span></b></p>
   </td>
   <td width=205 valign=top style='width:153.6pt;border:solid black 1.0pt;
   border-left:none;padding:0in 0in 0in 0in;height:17.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Prevention<span
   style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>stroke<span
   style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.35pt'>
   </span>system<span style='letter-spacing:.05pt'>i</span>c embolism<span
   style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.35pt'>
   </span>adult<span style='letter-spacing:-.35pt'> </span>patien<span
   style='letter-spacing:-.1pt'>t</span>s<span style='letter-spacing:-.4pt'> </span>with
   NVAF,<span style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:
   -.2pt'> </span>one<span style='letter-spacing:-.25pt'> </span>or<span
   style='letter-spacing:-.25pt'> </span>more<span style='letter-spacing:-.2pt'>
   </span>risk factors<span style='letter-spacing:-.75pt'> </span>(NV<span
   style='letter-spacing:-.05pt'>A</span>F)</span></b></p>
   </td>
   <td width=176 valign=top style='width:132.35pt;border:solid black 1.0pt;
   border-left:none;padding:0in 0in 0in 0in;height:17.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Treatment<span
   style='letter-spacing:-.45pt'> </span>of<span style='letter-spacing:-.4pt'> </span>DVT
   and<span style='letter-spacing:-.3pt'> </span>PE,<span style='letter-spacing:
   -.25pt'> </span>and prevention<span style='letter-spacing:-.6pt'> </span>of recu<span
   style='letter-spacing:.05pt'>r</span>rent<span style='letter-spacing:-.45pt'>
   </span>D<span style='letter-spacing:-.05pt'>V</span>T<span style='letter-spacing:
   -.45pt'> </span>and PE<span style='letter-spacing:-.5pt'> </span>(VTEt)</span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Blood<span style='letter-spacing:-.45pt'>
  </span>and<span style='letter-spacing:-.45pt'> </span>lymphatic<span
  style='letter-spacing:-.4pt'> </span>system<span style='letter-spacing:-.4pt'>
  </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>Ana</span><span
  lang=EN-GB style='font-size:11.0pt'>e<span style='letter-spacing:-.1pt'>m</span><span
  style='letter-spacing:.05pt'>i</span>a</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Thro<span style='letter-spacing:-.1pt'>m</span>boc<span
  style='letter-spacing:.05pt'>y</span>t<span style='letter-spacing:-.05pt'>o</span>penia</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Immune<span style='letter-spacing:-.55pt'>
  </span>sys<span style='letter-spacing:.05pt'>t</span>em<span
  style='letter-spacing:-.6pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:.05pt'>y</span>persensitivity,<span
  style='letter-spacing:-.55pt'> </span>allergic<span style='letter-spacing:
  -.5pt'> </span>oede<span style='letter-spacing:-.1pt'>m</span>a<span
  style='letter-spacing:-.5pt'> </span>and a<span style='letter-spacing:-.05pt'>naph</span><span
  style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>laxis</span></span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Pruritus</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on*</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Nervous<span style='letter-spacing:-.55pt'>
  </span>syst<span style='letter-spacing:.05pt'>e</span>m<span
  style='letter-spacing:-.6pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Brain<span style='letter-spacing:-.85pt'>
  </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhag<span
  style='letter-spacing:-.1pt'>e</span><sup>†</sup></span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Eye<span style='letter-spacing:-.6pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>E<span style='letter-spacing:.05pt'>y</span>e<span
  style='letter-spacing:-.6pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage<span
  style='letter-spacing:-.6pt'> </span>(includ<span style='letter-spacing:-.05pt'>i</span>ng
  conjunctival<span style='letter-spacing:-1.25pt'> </span>hae<span
  style='letter-spacing:-.1pt'>m</span>orrhage)</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Vascular<span style='letter-spacing:-.85pt'>
  </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.1pt'>m</span>orr<span
  style='letter-spacing:.05pt'>h</span>age,<span style='letter-spacing:-1.15pt'>
  </span>hae<span style='letter-spacing:-.1pt'>m</span>at<span
  style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.05pt'>m</span>a</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:.05pt'>y</span><span
  style='letter-spacing:-.05pt'>p</span>otension<span style='letter-spacing:
  -.8pt'> </span>(including<span style='letter-spacing:-.8pt'> </span>p<span
  style='letter-spacing:-.1pt'>r</span>ocedural <span style='letter-spacing:
  -.05pt'>h</span><span style='letter-spacing:.05pt'>y</span><span
  style='letter-spacing:-.05pt'>potension)</span></span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Intra-abdo<span style='letter-spacing:
  -.1pt'>m</span>inal<span style='letter-spacing:-1.3pt'> </span>hae<span
  style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span
  style='letter-spacing:-.5pt'> </span>known</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Respiratory,<span style='letter-spacing:
  -.55pt'> </span>thoracic<span style='letter-spacing:-.5pt'> </span>and<span
  style='letter-spacing:-.55pt'> </span>mediastinal<span style='letter-spacing:
  -.5pt'> </span><span style='letter-spacing:-.05pt'>d</span>isorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Epistaxis</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.1pt'>m</span>opt<span
  style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Respiratory<span style='letter-spacing:
  -.6pt'> </span>tract<span style='letter-spacing:-.6pt'> </span>ha<span
  style='letter-spacing:.05pt'>e</span><span style='letter-spacing:-.1pt'>m</span>orr<span
  style='letter-spacing:.05pt'>h</span>age</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Gastrointestinal<span style='letter-spacing:
  -1.15pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Nausea</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Gastrointest<span style='letter-spacing:
  .05pt'>i</span>nal<span style='letter-spacing:-1.3pt'> </span>ha<span
  style='letter-spacing:.05pt'>e</span><span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.1pt'>m</span>orrhoidal<span
  style='letter-spacing:-1.25pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Mouth<span style='letter-spacing:-.95pt'>
  </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.05pt'>m</span>atoche<span
  style='letter-spacing:.05pt'>z</span>ia</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Rectal<span style='letter-spacing:-.55pt'>
  </span>haem<span style='letter-spacing:.05pt'>o</span>rrhage,<span
  style='letter-spacing:-.55pt'> </span>ging<span style='letter-spacing:-.05pt'>i</span>val<span
  style='letter-spacing:-.55pt'> </span>bleeding</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Retroperitoneal<span style='letter-spacing:
  -1.3pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Not<span
  style='letter-spacing:-.5pt'> </span>known</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Hepatobilia<span style='letter-spacing:
  -.1pt'>r</span>y<span style='letter-spacing:-1.1pt'> </span>disorders</span></i></p>
  </td>
  <td width=381 colspan=2 style='width:285.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=MsoNormal align=center style='margin-left:4.55pt;text-align:center'><span
  lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Liver<span style='letter-spacing:-.4pt'> </span>functi<span
  style='letter-spacing:-.05pt'>o</span>n<span style='letter-spacing:-.4pt'> </span>test<span
  style='letter-spacing:-.4pt'> </span>abnormal,<span style='letter-spacing:
  -.4pt'> </span>aspartate a<span style='letter-spacing:-.1pt'>m</span>inotransfe<span
  style='letter-spacing:.05pt'>r</span>ase<span style='letter-spacing:-.75pt'> </span>incr<span
  style='letter-spacing:.05pt'>e</span>ased,<span style='letter-spacing:-.65pt'>
  </span>blood alkaline<span style='letter-spacing:-.55pt'> </span>pho<span
  style='letter-spacing:-.1pt'>s</span>phatase<span style='letter-spacing:-.55pt'>
  </span>increased,<span style='letter-spacing:-.5pt'> </span>blood bilirubin<span
  style='letter-spacing:-.8pt'> </span>increased</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Gamma-glut<span style='letter-spacing:
  .05pt'>a</span><span style='letter-spacing:-.1pt'>m</span><span
  style='letter-spacing:.05pt'>y</span>ltransfer<span style='letter-spacing:
  .05pt'>a</span>se<span style='letter-spacing:-1.7pt'> </span>increa<span
  style='letter-spacing:.05pt'>s</span>ed</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Alanine<span style='letter-spacing:-.8pt'>
  </span>a<span style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:
  .05pt'>n</span>otransfera<span style='letter-spacing:.05pt'>s</span>e<span
  style='letter-spacing:-.8pt'> </span>increa<span style='letter-spacing:.05pt'>s</span>ed</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Skin<span style='letter-spacing:-.45pt'> </span>a<span
  style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:-.4pt'> </span>sub<span
  style='letter-spacing:-.1pt'>c</span>utaneous<span style='letter-spacing:
  -.4pt'> </span>tis<span style='letter-spacing:-.1pt'>s</span>ue<span
  style='letter-spacing:-.4pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Skin<span style='letter-spacing:-.4pt'> </span>rash</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Alopecia</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Uncommon</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Uncommon</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Musculoske<span style='letter-spacing:
  .05pt'>l</span>etal<span style='letter-spacing:-.55pt'> </span>and<span
  style='letter-spacing:-.5pt'> </span>conn<span style='letter-spacing:-.1pt'>e</span>ctive<span
  style='letter-spacing:-.5pt'> </span>tissue<span style='letter-spacing:-.5pt'>
  </span>d<span style='letter-spacing:.05pt'>i</span>sorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Muscle<span style='letter-spacing:-.9pt'>
  </span>ha<span style='letter-spacing:.05pt'>e</span>morrhage</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Rare</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Renal<span style='letter-spacing:-.4pt'> </span>and<span
  style='letter-spacing:-.4pt'> </span>urinary<span style='letter-spacing:-.4pt'>
  </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Haematuria</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Reproductive<span style='letter-spacing:
  -.45pt'> </span>system<span style='letter-spacing:-.45pt'> </span>and<span
  style='letter-spacing:-.45pt'> </span>b<span style='letter-spacing:-.1pt'>r</span>east<span
  style='letter-spacing:-.4pt'> </span>disorders</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Abnor<span style='letter-spacing:-.1pt'>m</span><span
  style='letter-spacing:-.05pt'>a</span>l<span style='letter-spacing:-.7pt'> </span>vaginal<span
  style='letter-spacing:-.7pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage,
  urogenital<span style='letter-spacing:-1.05pt'> </span>h<span
  style='letter-spacing:-.1pt'>a</span>e<span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>General<span style='letter-spacing:-.45pt'>
  </span>disorders<span style='letter-spacing:-.45pt'> </span>and<span
  style='letter-spacing:-.45pt'> </span>administration<span style='letter-spacing:
  -.45pt'> </span>site<span style='letter-spacing:-.4pt'> </span>conditions</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Application<span style='letter-spacing:
  -.55pt'> </span>site<span style='letter-spacing:-.55pt'> </span>bleeding</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Investigations</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Occult<span style='letter-spacing:-.45pt'>
  </span>blood<span style='letter-spacing:-.5pt'> </span>positive</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=623 colspan=3 style='width:467.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Injury,<span style='letter-spacing:-.55pt'>
  </span>pois<span style='letter-spacing:-.05pt'>o</span>ning<span
  style='letter-spacing:-.5pt'> </span>and<span style='letter-spacing:-.55pt'> </span>pr<span
  style='letter-spacing:-.05pt'>o</span>cedural<span style='letter-spacing:
  -.55pt'> </span>complications</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Contusion</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>C<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Post<span style='letter-spacing:-.65pt'> </span>procedu<span
  style='letter-spacing:-.1pt'>r</span>al<span style='letter-spacing:-.6pt'> </span>hae<span
  style='letter-spacing:-.1pt'>m</span>orrhage (including<span
  style='letter-spacing:-.6pt'> </span>p<span style='letter-spacing:-.05pt'>o</span>st<span
  style='letter-spacing:-.6pt'> </span>procedural hae<span style='letter-spacing:
  -.1pt'>m</span>at<span style='letter-spacing:.05pt'>o</span><span
  style='letter-spacing:-.05pt'>m</span>a,<span style='letter-spacing:-.7pt'> </span>wound<span
  style='letter-spacing:-.7pt'> </span>haemorrhage, vessel<span
  style='letter-spacing:-.4pt'> </span>puncture<span style='letter-spacing:
  -.35pt'> </span>site<span style='letter-spacing:-.4pt'> </span>haema<span
  style='letter-spacing:.05pt'>t</span>oma<span style='letter-spacing:-.35pt'> </span>and
  catheter<span style='letter-spacing:-.5pt'> </span>site<span
  style='letter-spacing:-.5pt'> </span><span style='letter-spacing:.05pt'>h</span><span
  style='letter-spacing:-.05pt'>a</span>e<span style='letter-spacing:-.1pt'>m</span>orrhage),<span
  style='letter-spacing:-.4pt'> </span>wound secretion,<span style='letter-spacing:
  -.5pt'> </span>incision<span style='letter-spacing:-.5pt'> </span>site<span
  style='letter-spacing:-.5pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage
  (including<span style='letter-spacing:-.6pt'> </span>in<span
  style='letter-spacing:-.1pt'>c</span>ision<span style='letter-spacing:-.5pt'>
  </span>site<span style='letter-spacing:-.5pt'> </span>haemat<span
  style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.05pt'>m</span>a),
  operative<span style='letter-spacing:-1.0pt'> </span>hae<span
  style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=242 style='width:181.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Tra<span style='letter-spacing:.05pt'>u</span><span
  style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tic<span
  style='letter-spacing:-1.05pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>orrhage</span></p>
  </td>
  <td width=205 style='width:153.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
  <td width=176 style='width:132.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:4.55pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>Unc<span
  style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>on</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>*<span style='letter-spacing:-.2pt'> </span>The<span
style='letter-spacing:-.1pt'>r</span>e<span style='letter-spacing:-.15pt'> </span>we<span
style='letter-spacing:-.1pt'>r</span>e<span style='letter-spacing:-.1pt'> </span>no<span
style='letter-spacing:-.25pt'> </span>occurre<span style='letter-spacing:-.1pt'>n</span>ces<span
style='letter-spacing:-.15pt'> </span>of<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>g</span>eneralised<span style='letter-spacing:
-.15pt'> </span>p<span style='letter-spacing:-.1pt'>r</span>u<span
style='letter-spacing:-.1pt'>r</span>itus<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.15pt'> </span>CV185057<span style='letter-spacing:-.2pt'>
</span>(long<span style='letter-spacing:-.15pt'> </span>term<span
style='letter-spacing:-.15pt'> </span>prevention<span style='letter-spacing:
-.15pt'> </span>of<span style='letter-spacing:-.2pt'> </span>VTE)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><sup><span lang=EN-GB
style='font-size:10.0pt'>†</span></sup><span lang=EN-GB style='font-size:10.0pt;
position:relative;top:-5.0pt;letter-spacing:-.25pt'> </span><span lang=EN-GB
style='font-size:10.0pt'>The<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>t</span>erm<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>“B</span>ra<span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.2pt'> </span>hae<span style='letter-spacing:-.05pt'>m</span>orrha<span
style='letter-spacing:-.1pt'>g</span>e”<span style='letter-spacing:-.35pt'> </span>enco<span
style='letter-spacing:-.05pt'>m</span>pa<span style='letter-spacing:-.05pt'>ss</span>es<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.05pt'>l</span>l<span
style='letter-spacing:-.25pt'> </span>intr<span style='letter-spacing:-.05pt'>a</span>cran<span
style='letter-spacing:-.05pt'>i</span>al<span style='letter-spacing:-.4pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>i<span style='letter-spacing:-.1pt'>n</span>traspinal<span
style='letter-spacing:-.25pt'> </span>haemorrhages<span style='letter-spacing:
-.2pt'> </span>(<span style='letter-spacing:-.1pt'>i</span>e.,<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>h</span>aemorrhagic<span
style='letter-spacing:-.25pt'> </span>stro<span style='letter-spacing:-.1pt'>k</span>e<span
style='letter-spacing:-.3pt'> </span>or putamen,<span style='letter-spacing:
-.4pt'> </span>ce<span style='letter-spacing:-.1pt'>r</span>ebella<span
style='letter-spacing:-.05pt'>r</span>,<span style='letter-spacing:-.4pt'> </span>i<span
style='letter-spacing:-.1pt'>n</span>tra<span style='letter-spacing:-.1pt'>v</span>entricular,<span
style='letter-spacing:-.4pt'> </span>or<span style='letter-spacing:-.4pt'> </span>subdural<span
style='letter-spacing:-.4pt'> </span>haemorrha<span style='letter-spacing:-.1pt'>g</span>es).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.25pt'> </span>use<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.2pt'> </span>Apixaban
Accord<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.1pt'> </span>be<span style='letter-spacing:-.2pt'> </span>associa<span
style='letter-spacing:.05pt'>t</span>ed<span style='letter-spacing:-.25pt'> </span>w<span
style='letter-spacing:.05pt'>i</span>th<span style='letter-spacing:-.2pt'> </span>an<span
style='letter-spacing:-.2pt'> </span>increas<span style='letter-spacing:.05pt'>e</span>d<span
style='letter-spacing:-.2pt'> </span>risk<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>occult<span style='letter-spacing:-.2pt'> </span>or<span
style='letter-spacing:-.2pt'> </span>overt<span style='letter-spacing:-.25pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>from<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>y<span style='letter-spacing:-.1pt'> </span>tissue
or<span style='letter-spacing:-.3pt'> </span>organ,<span style='letter-spacing:
-.25pt'> </span>wh<span style='letter-spacing:-.05pt'>ic</span>h<span
style='letter-spacing:-.25pt'> </span>may<span style='letter-spacing:-.15pt'> </span>result<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>posthaemorrhagic<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.05pt'>n</span>aemia.<span
style='letter-spacing:-.25pt'> </span>The<span style='letter-spacing:-.25pt'> </span>signs,<span
style='letter-spacing:-.25pt'> </span>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptoms,<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>severity<span
style='letter-spacing:-.25pt'> </span>will<span style='letter-spacing:-.3pt'> </span>vary
according<span style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:
-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>location<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>degree<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.3pt'> </span>extent<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>bleeding<span style='letter-spacing:-.25pt'>
</span>(see<span style='letter-spacing:-.25pt'> </span>sections<span
style='letter-spacing:-.2pt'>&nbsp;</span>4.4<span style='letter-spacing:-.25pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>5.1).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Reporting<span style='letter-spacing:-.5pt'> </span>of<span
style='letter-spacing:-.45pt'> </span>suspected<span style='letter-spacing:
-.45pt'> </span>adverse<span style='letter-spacing:-.5pt'> </span>reactions</span></u></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Reporting<span style='letter-spacing:-.35pt'> </span>su<span
style='letter-spacing:-.1pt'>s</span>pected<span style='letter-spacing:-.35pt'>
</span>adverse<span style='letter-spacing:-.3pt'> </span>reactions<span
style='letter-spacing:-.35pt'> </span>after<span style='letter-spacing:-.35pt'>
</span>author<span style='letter-spacing:-.05pt'>i</span>sation<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span><span
style='letter-spacing:.05pt'>d</span>icinal<span style='letter-spacing:-.35pt'>
</span>product<span style='letter-spacing:-.4pt'> </span>is<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.1pt'>m</span>portant.<span
style='letter-spacing:-.35pt'> </span>It allows<span style='letter-spacing:
-.35pt'> </span>continued<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>m</span>onitoring<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.35pt'> </span><span style='letter-spacing:
-.05pt'>t</span>he<span style='letter-spacing:-.35pt'> </span>benefit/ri<span
style='letter-spacing:-.1pt'>s</span>k<span style='letter-spacing:-.35pt'> </span>balance<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span><span style='letter-spacing:.05pt'>d</span>icinal<span
style='letter-spacing:-.35pt'> </span>produc<span style='letter-spacing:-.05pt'>t</span>.<span
style='letter-spacing:-.35pt'> </span>Healthcare professionals<span
style='letter-spacing:-.35pt'> </span>are<span style='letter-spacing:-.3pt'> </span>asked<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>report<span
style='letter-spacing:-.3pt'> </span>any<span style='letter-spacing:-.2pt'> </span>su<span
style='letter-spacing:-.1pt'>s</span>pected<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>a</span>dverse<span style='letter-spacing:-.3pt'>
</span>reactions<span style='letter-spacing:-.35pt'> </span>via<span
style='letter-spacing:-.3pt'> </span><span style='background:silver'>the<span
style='letter-spacing:-.3pt'> </span>national<span style='letter-spacing:-.35pt'>
</span>reporting<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>s</span>tem listed<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span><span
style='color:blue'>Ap<span style='letter-spacing:-.05pt'>pe</span>ndix<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>V</span></span><span
style='color:black'>.</span></span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>4.9<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Overdose</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Overdo<span style='letter-spacing:-.1pt'>s</span>e<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>may<span style='letter-spacing:-.15pt'> </span>result<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>higher<span style='letter-spacing:-.25pt'>
</span>risk<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>bleeding.<span style='letter-spacing:-.3pt'>
</span>In<span style='letter-spacing:-.2pt'> </span>the event<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>hae<span
style='letter-spacing:-.1pt'>m</span>orrhagic<span style='letter-spacing:-.25pt'>
</span>co<span style='letter-spacing:-.1pt'>m</span>pli<span style='letter-spacing:
.05pt'>c</span>ations,<span style='letter-spacing:-.35pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>ment<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ust<span style='letter-spacing:-.35pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>disconti<span style='letter-spacing:-.05pt'>n</span>ued<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>s</span>ource<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>bleeding
investigated.<span style='letter-spacing:-.35pt'> </span>The<span
style='letter-spacing:-.35pt'> </span>initiation<span style='letter-spacing:
-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>appropriate<span
style='letter-spacing:-.35pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment,<span
style='letter-spacing:-.35pt'> </span>e.g.,<span style='letter-spacing:-.35pt'>
</span>surgical<span style='letter-spacing:-.3pt'> </span>hae<span
style='letter-spacing:-.1pt'>m</span>os<span style='letter-spacing:.05pt'>t</span>asis<span
style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>transfusion<span style='letter-spacing:
-.35pt'> </span>of fresh<span style='letter-spacing:-.35pt'> </span>frozen<span
style='letter-spacing:-.35pt'> </span>plasma<span style='letter-spacing:-.35pt'>
or the administration of a reversal agent for factor Xa inhibitors </span>should<span
style='letter-spacing:-.4pt'> </span>be<span style='letter-spacing:-.35pt'> </span>considered.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>controlled<span
style='letter-spacing:-.3pt'> </span>clinical<span style='letter-spacing:-.3pt'>
</span>trials,<span style='letter-spacing:-.2pt'> </span>orall<span
style='letter-spacing:.05pt'>y</span>-ad<span style='letter-spacing:-.1pt'>m</span>i<span
style='letter-spacing:.05pt'>n</span>istered<span style='letter-spacing:-.3pt'>
</span>a<span style='letter-spacing:-.1pt'>p</span>ixaban<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>healthy<span
style='letter-spacing:-.25pt'> </span>subjects<span style='letter-spacing:-.3pt'>
</span>at<span style='letter-spacing:-.25pt'> </span>doses<span
style='letter-spacing:-.3pt'> </span>up<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>50<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>daily
for<span style='letter-spacing:-.2pt'> </span>3<span style='letter-spacing:
-.15pt'>&nbsp;</span>to<span style='letter-spacing:-.2pt'>&nbsp;</span>7<span
style='letter-spacing:-.15pt'>&nbsp;</span>d<span style='letter-spacing:-.1pt'>a</span>ys<span
style='letter-spacing:-.15pt'> </span>(25<span style='letter-spacing:-.15pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.15pt'> </span>twice<span
style='letter-spacing:-.15pt'> </span>daily<span style='letter-spacing:-.05pt'>
</span><span style='letter-spacing:-.1pt'>(</span>bid)<span style='letter-spacing:
-.15pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.15pt'> </span>7<span style='letter-spacing:-.15pt'>&nbsp;</span>d<span
style='letter-spacing:-.1pt'>a</span><span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>5</span>0<span style='letter-spacing:-.15pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.15pt'> </span>once<span
style='letter-spacing:-.15pt'> </span>daily<span style='letter-spacing:-.2pt'> </span>(od)<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.15pt'> </span>3<span style='letter-spacing:-.2pt'>&nbsp;</span>da<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>)<span
style='letter-spacing:-.15pt'> </span>had<span style='letter-spacing:-.2pt'> </span>no
clinically<span style='letter-spacing:-.4pt'> </span>relevant<span
style='letter-spacing:-.5pt'> </span>adverse<span style='letter-spacing:-.45pt'>
</span>events.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>healthy<span
style='letter-spacing:-.1pt'> </span>subjects,<span style='letter-spacing:-.25pt'>
</span>a<span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:
-.1pt'>m</span>i<span style='letter-spacing:.05pt'>n</span>istration<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.2pt'> </span>activated<span
style='letter-spacing:-.25pt'> </span>cha<span style='letter-spacing:-.1pt'>r</span>coal<span
style='letter-spacing:-.2pt'> </span>2<span style='letter-spacing:-.2pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>6<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.05pt'>h</span>ours<span style='letter-spacing:-.2pt'> </span>after<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.05pt'>g</span>estion<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>20<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>dose
of<span style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:
-.2pt'> </span>reduced<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ean<span style='letter-spacing:-.2pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban<span style='letter-spacing:-.2pt'> </span>AUC<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>b</span>y<span
style='letter-spacing:-.1pt'> </span>50%<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:-.25pt'> </span>27<span
style='letter-spacing:-.05pt'>%</span>,<span style='letter-spacing:-.2pt'> </span>respectivel<span
style='letter-spacing:.1pt'>y</span>,<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>d<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>ha</span>d<span style='letter-spacing:-.25pt'> </span>no<span
style='letter-spacing:-.2pt'> </span>i<span style='letter-spacing:-.1pt'>m</span>pact<span
style='letter-spacing:-.15pt'> </span>on<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.15pt'>C<sub><span style='position:relative;top:1.0pt'>m</span></sub></span><sub><span
style='position:relative;top:1.0pt'>ax</span></sub>. Mean<span
style='letter-spacing:-.3pt'> </span>half-life<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>decreased<span style='letter-spacing:
-.3pt'> </span>from<span style='letter-spacing:-.4pt'> </span>13.4<span
style='letter-spacing:-.35pt'>&nbsp;</span>hou<span style='letter-spacing:-.1pt'>r</span>s<span
style='letter-spacing:-.3pt'> </span>when<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>nistered<span style='letter-spacing:-.3pt'>
</span>alone<span style='letter-spacing:-.3pt'> </span>to 5.3<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>h</span>ours<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>4.9<span
style='letter-spacing:-.25pt'>&nbsp;</span>hours,<span style='letter-spacing:
-.25pt'> </span>r<span style='letter-spacing:-.1pt'>e</span>spectivel<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>w</span>hen<span style='letter-spacing:-.25pt'> </span>activated<span
style='letter-spacing:-.25pt'> </span>charcoal<span style='letter-spacing:-.2pt'>
</span>was<span style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:
.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistered<span
style='letter-spacing:-.2pt'> </span>2<span style='letter-spacing:-.25pt'>&nbsp;</span>and<span
style='letter-spacing:-.25pt'>&nbsp;</span>6<span style='letter-spacing:-.25pt'>&nbsp;</span>hours<span
style='letter-spacing:-.35pt'> </span>after apixaban.<span style='letter-spacing:
-.3pt'> </span>Thus,<span style='letter-spacing:-.25pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inist<span style='letter-spacing:.05pt'>r</span><span
style='letter-spacing:-.05pt'>a</span>tion<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>activated<span style='letter-spacing:
-.25pt'> </span>charcoal<span style='letter-spacing:-.3pt'> </span>may<span
style='letter-spacing:-.2pt'> </span>be<span style='letter-spacing:-.25pt'> </span>usef<span
style='letter-spacing:-.05pt'>u</span>l<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>nage<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban
overdose<span style='letter-spacing:-.5pt'> </span>or<span style='letter-spacing:
-.45pt'> </span>accidental<span style='letter-spacing:-.45pt'> </span>ingestion.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>For situations when reversal of anticoagulation is
needed due to life-threatening or uncontrolled bleeding, a reversal agent for
factor Xa inhibitors is available (see section 4.4).<span style='letter-spacing:
-.35pt'> A</span><span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>p<span
style='letter-spacing:-.1pt'>r</span>o<span style='letter-spacing:-.05pt'>t</span>hro<span
style='letter-spacing:-.1pt'>m</span>bin c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>plex<span style='letter-spacing:-.35pt'> </span>concentrates<span
style='letter-spacing:-.35pt'> </span>(PC<span style='letter-spacing:.05pt'>C</span>s)<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.35pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>binant<span
style='letter-spacing:-.3pt'> </span>factor<span style='letter-spacing:-.35pt'>
</span>VIIa<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:-.35pt'> </span>considered.<span
style='letter-spacing:-.3pt'> </span>Reversal<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>Apixaban Accord pharmacod<span
style='letter-spacing:.05pt'>y</span>na<span style='letter-spacing:-.1pt'>m</span>ic<span
style='letter-spacing:-.35pt'> </span>effec<span style='letter-spacing:.05pt'>t</span>s,<span
style='letter-spacing:-.35pt'> </span>as<span style='letter-spacing:-.35pt'> </span>de<span
style='letter-spacing:-.1pt'>m</span>onstra<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.35pt'> </span>by<span style='letter-spacing:-.25pt'> </span>ch<span
style='letter-spacing:-.05pt'>a</span>ng<span style='letter-spacing:-.1pt'>e</span>s<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>thro<span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.3pt'> </span>generation<span style='letter-spacing:
-.35pt'> </span>assa<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.35pt'> </span>was<span style='letter-spacing:-.35pt'> </span>evident
at<span style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:
-.2pt'> </span>end<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>i</span>nfusion<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>r</span>eached<span style='letter-spacing:-.2pt'> </span>basel<span
style='letter-spacing:.05pt'>i</span>ne<span style='letter-spacing:-.2pt'> </span>values<span
style='letter-spacing:-.25pt'> </span>within<span style='letter-spacing:-.2pt'>
</span>4<span style='letter-spacing:-.25pt'>&nbsp;</span>hours<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.1pt'>f</span>ter<span
style='letter-spacing:-.2pt'> </span>the<span style='letter-spacing:-.2pt'> </span>start<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>4-factor<span style='letter-spacing:-.2pt'>
</span>PCC 30<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>inute<span style='letter-spacing:-.25pt'> </span>infusion<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>healt<span
style='letter-spacing:-.05pt'>h</span>y<span style='letter-spacing:-.2pt'> </span>subjects.<span
style='letter-spacing:-.3pt'> </span>However,<span style='letter-spacing:-.25pt'>
</span>t<span style='letter-spacing:-.05pt'>h</span>ere<span style='letter-spacing:
-.25pt'> </span>is<span style='letter-spacing:-.25pt'> </span>no<span
style='letter-spacing:-.25pt'> </span>clinical<span style='letter-spacing:-.25pt'>
</span>experience<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>use<span
style='letter-spacing:-.25pt'> </span>of 4-factor<span style='letter-spacing:
-.3pt'> </span>PCC medicinal<span style='letter-spacing:-.25pt'> </span>products<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>r<span
style='letter-spacing:-.1pt'>e</span>verse<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>indiv<span
style='letter-spacing:-.05pt'>i</span>du<span style='letter-spacing:-.15pt'>a</span>ls<span
style='letter-spacing:-.25pt'> </span>who<span style='letter-spacing:-.3pt'> </span>have<span
style='letter-spacing:-.25pt'> </span>received<span style='letter-spacing:-.25pt'>
</span>Apixaban Accord.<span style='letter-spacing:-.3pt'> </span>Currently<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>t</span>here<span
style='letter-spacing:-.25pt'> </span>is no<span style='letter-spacing:-.3pt'> </span>experience<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>use<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>rec<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>binant<span style='letter-spacing:-.25pt'>
</span>factor<span style='letter-spacing:-.3pt'> </span>VIIa<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>individuals<span
style='letter-spacing:-.3pt'> </span>receiving<span style='letter-spacing:-.25pt'>
</span>apixaban.<span style='letter-spacing:-.25pt'> </span>Re-dosing<span
style='letter-spacing:-.3pt'> </span>of rec<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>binant<span style='letter-spacing:-.35pt'>
</span>factor<span style='letter-spacing:-.35pt'> </span>VIIa<span
style='letter-spacing:-.3pt'> </span>c<span style='letter-spacing:.05pt'>o</span>uld<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.3pt'> </span>considered<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>a</span>nd<span
style='letter-spacing:-.35pt'> </span>titrated<span style='letter-spacing:-.3pt'>
</span>depending<span style='letter-spacing:-.35pt'> </span>on<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.15pt'>m</span>provement<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>bleeding.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Depending<span style='letter-spacing:-.3pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>local<span style='letter-spacing:-.3pt'> </span>availabili<span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.3pt'> </span>con<span
style='letter-spacing:-.1pt'>s</span>ultation<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:
-.35pt'> </span>coagulation<span style='letter-spacing:-.25pt'> </span>expert<span
style='letter-spacing:-.3pt'> </span>should<span style='letter-spacing:-.3pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>considered<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>case<span
style='letter-spacing:-.25pt'> </span>of major<span style='letter-spacing:-.75pt'>
</span>bleedings.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Hae<span style='letter-spacing:-.1pt'>m</span>odial<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is<span
style='letter-spacing:-.35pt'> </span>decre<span style='letter-spacing:.05pt'>a</span>sed<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>AUC<span style='letter-spacing:-.35pt'> </span>by<span style='letter-spacing:
-.25pt'> </span>14%<span style='letter-spacing:-.4pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>subjects<span style='letter-spacing:-.35pt'>
</span>with<span style='letter-spacing:-.35pt'> </span>end-stage<span
style='letter-spacing:-.3pt'> </span>renal<span style='letter-spacing:-.35pt'> </span>disease<span
style='letter-spacing:-.35pt'> </span>(ES<span style='letter-spacing:.05pt'>R</span>D),
when<span style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:
-.25pt'> </span>single<span style='letter-spacing:-.3pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apix<span
style='letter-spacing:-.1pt'>a</span>ban<span style='letter-spacing:-.3pt'> </span>5<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.2pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inis<span style='letter-spacing:.05pt'>t</span>ered<span
style='letter-spacing:-.25pt'> </span>oral<span style='letter-spacing:-.05pt'>l</span><span
style='letter-spacing:.05pt'>y</span>.<span style='letter-spacing:-.25pt'> </span>Therefore,<span
style='letter-spacing:-.25pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>odial<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.25pt'> </span>unl<span
style='letter-spacing:-.05pt'>ik</span>ely<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>t</span>o be<span style='letter-spacing:-.35pt'> </span>an<span
style='letter-spacing:-.3pt'> </span>effective<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.1pt'>m</span>eans<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>managing<span
style='letter-spacing:-.35pt'> </span>apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.3pt'> </span>overdose.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>PHAR</span><span
lang=EN-GB>M<span style='letter-spacing:-.05pt'>A</span>C<span
style='letter-spacing:-.05pt'>OLOG</span>I<span style='letter-spacing:-.05pt'>CA</span>L
<span style='letter-spacing:-.05pt'>PROPE</span>R<span style='letter-spacing:
-.05pt'>T</span>I<span style='letter-spacing:-.05pt'>ES</span></span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><b><span lang=EN-GB style='font-size:11.0pt'>5.1<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='font-size:11.0pt'>Phar<span
style='letter-spacing:-.05pt'>m</span>acodyna<span style='letter-spacing:-.05pt'>m</span>ic<span
style='letter-spacing:-1.4pt'> </span>properties</span></b></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Phar<span style='letter-spacing:-.1pt'>m</span>acotherapeutic<span
style='letter-spacing:-.45pt'> </span>group:<span style='letter-spacing:-.4pt'>
</span>Antithro<span style='letter-spacing:-.1pt'>m</span>botic<span
style='letter-spacing:-.45pt'> </span>agents,<span style='letter-spacing:-.4pt'>
</span>d<span style='letter-spacing:-.05pt'>i</span>rect<span style='letter-spacing:
-.4pt'> </span>factor<span style='letter-spacing:-.45pt'> </span>Xa<span
style='letter-spacing:-.4pt'> </span>inhibi<span style='letter-spacing:-.05pt'>t</span>ors,<span
style='letter-spacing:-.4pt'> </span>ATC<span style='letter-spacing:-.45pt'> </span>code:<span
style='letter-spacing:-.4pt'> </span>B01AF02 </span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Mechani<span style='letter-spacing:.05pt'>s</span>m<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:.05pt'>o</span>f<span
style='letter-spacing:-.45pt'> </span>action</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.25pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>potent,<span
style='letter-spacing:-.3pt'> </span>oral,<span style='letter-spacing:-.3pt'> </span>reversible,<span
style='letter-spacing:-.25pt'> </span>direct<span style='letter-spacing:-.25pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>h<span style='letter-spacing:
-.05pt'>i</span>ghly<span style='letter-spacing:-.25pt'> </span>selective<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:.05pt'>c</span>tive<span
style='letter-spacing:-.25pt'> </span>site<span style='letter-spacing:-.25pt'> </span>inhibitor<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>factor<span
style='letter-spacing:-.3pt'> </span>Xa.<span style='letter-spacing:-.25pt'> </span>It
does<span style='letter-spacing:-.35pt'> </span>not<span style='letter-spacing:
-.35pt'> </span>require<span style='letter-spacing:-.35pt'> </span>antithrombin<span
style='letter-spacing:-.3pt'> </span>III<span style='letter-spacing:-.35pt'> </span>for<span
style='letter-spacing:-.35pt'> </span>an<span style='letter-spacing:-.05pt'>t</span>ithro<span
style='letter-spacing:-.1pt'>m</span>botic<span style='letter-spacing:-.3pt'> </span>activi<span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>.<span
style='letter-spacing:-.35pt'> </span>Apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.35pt'> </span>inh<span style='letter-spacing:-.05pt'>i</span>bits<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>f</span>ree<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.35pt'> </span>clot-bound
factor<span style='letter-spacing:-.35pt'> </span>Xa,<span style='letter-spacing:
-.3pt'> </span>a<span style='letter-spacing:.05pt'>n</span>d<span
style='letter-spacing:-.3pt'> </span>prothro<span style='letter-spacing:-.1pt'>m</span>binase<span
style='letter-spacing:-.3pt'> </span>activit<span style='letter-spacing:.1pt'>y</span>.<span
style='letter-spacing:-.35pt'> </span>Apixaban<span style='letter-spacing:-.3pt'>
</span>has<span style='letter-spacing:-.3pt'> </span>no<span style='letter-spacing:
-.3pt'> </span>direct<span style='letter-spacing:-.3pt'> </span>effects<span
style='letter-spacing:-.35pt'> </span>on<span style='letter-spacing:-.3pt'> </span>platelet<span
style='letter-spacing:-.3pt'> </span>aggregation,<span style='letter-spacing:
-.35pt'> </span>but indirectly<span style='letter-spacing:-.35pt'> </span>inhibits<span
style='letter-spacing:-.35pt'> </span>platelet<span style='letter-spacing:-.35pt'>
</span>aggregation<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>i</span>nduced<span style='letter-spacing:-.45pt'>
</span>by<span style='letter-spacing:-.35pt'> </span>th<span style='letter-spacing:
-.1pt'>r</span>o<span style='letter-spacing:-.1pt'>m</span>bin.<span
style='letter-spacing:-.35pt'> </span>By<span style='letter-spacing:-.25pt'> </span>inhibiting<span
style='letter-spacing:-.35pt'> </span>factor<span style='letter-spacing:-.35pt'>
</span>Xa,<span style='letter-spacing:-.35pt'> </span>apixaban prevents<span
style='letter-spacing:-.4pt'> </span>thr<span style='letter-spacing:-.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>bin<span style='letter-spacing:-.35pt'> </span>generation<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>thrombus<span
style='letter-spacing:-.35pt'> </span>develop<span style='letter-spacing:-.1pt'>m</span>ent.<span
style='letter-spacing:-.4pt'> </span>Preclinical<span style='letter-spacing:
-.35pt'> </span>studies<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.4pt'> </span>an<span style='letter-spacing:
.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>al <span
style='letter-spacing:-.1pt'>m</span>ode<span style='letter-spacing:.05pt'>l</span>s<span
style='letter-spacing:-.4pt'> </span>have<span style='letter-spacing:-.35pt'> </span>de<span
style='letter-spacing:-.1pt'>m</span>onstrated<span style='letter-spacing:-.25pt'>
</span>antithro<span style='letter-spacing:-.1pt'>m</span>botic<span
style='letter-spacing:-.35pt'> </span>efficacy<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:
-.35pt'> </span>prevention<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>arterial<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.35pt'> </span>venous<span
style='letter-spacing:-.35pt'> </span>th<span style='letter-spacing:-.1pt'>r</span>o<span
style='letter-spacing:-.1pt'>m</span>bosis at<span style='letter-spacing:-.4pt'>
</span>doses<span style='letter-spacing:-.35pt'> </span>that<span
style='letter-spacing:-.4pt'> </span>preserved<span style='letter-spacing:-.35pt'>
</span>ha<span style='letter-spacing:.05pt'>e</span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.05pt'>s</span>tas<span style='letter-spacing:.05pt'>i</span>s.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB style='letter-spacing:-.05pt'>Pha</span><span lang=EN-GB
style='letter-spacing:.05pt'>r</span><span lang=EN-GB style='letter-spacing:
-.1pt'>m</span><span lang=EN-GB style='letter-spacing:-.05pt'>acod</span><span
lang=EN-GB style='letter-spacing:.05pt'>y</span><span lang=EN-GB
style='letter-spacing:-.05pt'>n</span><span lang=EN-GB>a<span style='letter-spacing:
-.1pt'>m</span>ic<span style='letter-spacing:-1.15pt'> </span>e<span
style='letter-spacing:-.05pt'>ffec</span><span style='letter-spacing:.05pt'>t</span>s</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>pharma<span
style='letter-spacing:.05pt'>c</span>od<span style='letter-spacing:.05pt'>y</span>na<span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.3pt'> </span>ef<span
style='letter-spacing:.05pt'>f</span>ects<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>are<span style='letter-spacing:-.35pt'> </span>refl<span
style='letter-spacing:.05pt'>e</span><span style='letter-spacing:-.05pt'>c</span>tive<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span>echanism<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.3pt'> </span>action<span
style='letter-spacing:-.35pt'> </span>(FXa<span style='letter-spacing:-.3pt'> </span>inh<span
style='letter-spacing:-.05pt'>i</span>bition). As<span style='letter-spacing:
-.3pt'> </span>a<span style='letter-spacing:-.25pt'> </span>result<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>FXa<span
style='letter-spacing:-.25pt'> </span>inhibit<span style='letter-spacing:-.05pt'>i</span>on,<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>prolo<span style='letter-spacing:-.05pt'>n</span>gs<span
style='letter-spacing:-.25pt'> </span>clot<span style='letter-spacing:-.05pt'>t</span>ing<span
style='letter-spacing:-.25pt'> </span>tests<span style='letter-spacing:-.25pt'>
</span>such<span style='letter-spacing:-.3pt'> </span>as<span style='letter-spacing:
-.25pt'> </span>prothro<span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.25pt'> </span>ti<span style='letter-spacing:-.1pt'>m</span>e<span
style='letter-spacing:-.25pt'> </span>(PT),<span style='letter-spacing:-.2pt'> </span>INR<span
style='letter-spacing:-.25pt'> </span>and activated<span style='letter-spacing:
-.35pt'> </span>partial<span style='letter-spacing:-.3pt'> </span>thro<span
style='letter-spacing:-.1pt'>m</span>boplastin<span style='letter-spacing:-.3pt'>
</span>t<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:
-.1pt'>m</span>e<span style='letter-spacing:-.4pt'> </span>(a<span
style='letter-spacing:.05pt'>P</span>TT).<span style='letter-spacing:-.3pt'> </span>Chan<span
style='letter-spacing:-.1pt'>g</span>es<span style='letter-spacing:-.3pt'> </span>observed<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>t</span>hese<span style='letter-spacing:-.3pt'> </span>clotting<span
style='letter-spacing:-.35pt'> </span>tests<span style='letter-spacing:-.3pt'> </span>at<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span>e<span
style='letter-spacing:.05pt'>x</span>pected therapeutic<span style='letter-spacing:
-.25pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>are<span
style='letter-spacing:-.25pt'> </span>small<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>subject<span style='letter-spacing:-.25pt'>
</span>to<span style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:
-.25pt'> </span>high<span style='letter-spacing:-.3pt'> </span>d<span
style='letter-spacing:-.1pt'>e</span>gree<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>variability.<span style='letter-spacing:
-.2pt'> </span>Th<span style='letter-spacing:-.1pt'>e</span>y<span
style='letter-spacing:-.2pt'> </span>are<span style='letter-spacing:-.2pt'> </span>not<span
style='letter-spacing:-.25pt'> </span>recomme<span style='letter-spacing:.05pt'>n</span>ded<span
style='letter-spacing:-.25pt'> </span>to assess<span style='letter-spacing:
-.35pt'> </span>the<span style='letter-spacing:-.35pt'> </span>pha<span
style='letter-spacing:.05pt'>r</span><span style='letter-spacing:-.1pt'>m</span>acodynamic<span
style='letter-spacing:-.35pt'> </span>ef<span style='letter-spacing:.05pt'>f</span>ects<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apixaban.<span
style='letter-spacing:-.35pt'> </span>In<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.35pt'> </span>thro<span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.3pt'> </span>generation<span style='letter-spacing:
-.35pt'> </span>assa<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>reduced endogenous<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>t</span>hro<span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.35pt'> </span>potential,<span style='letter-spacing:
-.35pt'> </span>a<span style='letter-spacing:-.35pt'> </span>meas<span
style='letter-spacing:.05pt'>u</span>re<span style='letter-spacing:-.35pt'> </span>of<span
style='letter-spacing:-.4pt'> </span>thro<span style='letter-spacing:-.1pt'>m</span>bin<span
style='letter-spacing:-.35pt'> </span>generation<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.35pt'> </span>hu<span style='letter-spacing:-.1pt'>m</span>an<span
style='letter-spacing:-.35pt'> </span>plasma.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:.05pt'> </span>also<span
style='letter-spacing:.1pt'> </span>de<span style='letter-spacing:-.1pt'>m</span>onstra<span
style='letter-spacing:.05pt'>t</span>es<span style='letter-spacing:.1pt'> </span>anti-FXa<span
style='letter-spacing:.1pt'> </span>activi<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:.2pt'> </span>as<span style='letter-spacing:.05pt'> </span>evident<span
style='letter-spacing:.1pt'> </span>by<span style='letter-spacing:.2pt'> </span>redu<span
style='letter-spacing:-.1pt'>c</span>tion<span style='letter-spacing:.05pt'> </span>in<span
style='letter-spacing:.1pt'> </span>Factor<span style='letter-spacing:.05pt'> </span>Xa<span
style='letter-spacing:.1pt'> </span>enz<span style='letter-spacing:.05pt'>y</span>me<span
style='letter-spacing:.05pt'> </span>activi<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:.2pt'> </span>in <span style='letter-spacing:-.1pt'>m</span>ultiple<span
style='letter-spacing:-.1pt'> </span>c<span style='letter-spacing:.05pt'>o</span>mmerc<span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.05pt'>a</span>l<span
style='letter-spacing:-.15pt'> </span>anti-FXa<span style='letter-spacing:-.15pt'>
</span>kits,<span style='letter-spacing:-.2pt'> </span>ho<span
style='letter-spacing:-.05pt'>w</span>ever<span style='letter-spacing:-.15pt'> </span>results<span
style='letter-spacing:-.1pt'> </span>differ<span style='letter-spacing:-.2pt'> </span>across<span
style='letter-spacing:-.1pt'> </span>kits.<span style='letter-spacing:-.15pt'> </span>Data<span
style='letter-spacing:-.15pt'> </span>fr<span style='letter-spacing:.05pt'>o</span>m<span
style='letter-spacing:-.2pt'> </span>clinical<span style='letter-spacing:-.05pt'>
</span>trials<span style='letter-spacing:-.15pt'> </span>are<span
style='letter-spacing:-.2pt'> </span>only available<span style='letter-spacing:
1.15pt'> </span>for<span style='letter-spacing:1.25pt'> </span>the<span
style='letter-spacing:1.2pt'> </span>Rotachro<span style='letter-spacing:-.1pt'>m</span><span
style='position:relative;top:-4.5pt;letter-spacing:.5pt'> </span>Heparin<span
style='letter-spacing:1.25pt'> </span>chro<span style='letter-spacing:-.1pt'>m</span>ogenic<span
style='letter-spacing:1.25pt'> </span>assa<span style='letter-spacing:.05pt'>y</span>.<span
style='letter-spacing:1.2pt'> </span>Anti-FXa<span style='letter-spacing:1.25pt'>
</span>activity<span style='letter-spacing:1.2pt'> </span>exhibits<span
style='letter-spacing:1.2pt'> </span>a<span style='letter-spacing:1.2pt'> </span>c<span
style='letter-spacing:.05pt'>l</span>ose<span style='letter-spacing:1.2pt'> </span>dire<span
style='letter-spacing:.05pt'>c</span>t linear<span style='letter-spacing:2.1pt'>
</span>relati<span style='letter-spacing:.05pt'>o</span>nship<span
style='letter-spacing:2.15pt'> </span>with<span style='letter-spacing:2.15pt'> </span>apixaban<span
style='letter-spacing:2.15pt'> </span>plasma<span style='letter-spacing:2.2pt'>
</span>concent<span style='letter-spacing:-.05pt'>r</span>ation,<span
style='letter-spacing:2.15pt'> </span>reaching<span style='letter-spacing:2.15pt'>
</span>max<span style='letter-spacing:.05pt'>i</span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:.05pt'>u</span>m<span
style='letter-spacing:2.15pt'> </span>values<span style='letter-spacing:2.15pt'>
</span>at<span style='letter-spacing:2.15pt'> </span>the<span style='letter-spacing:
2.15pt'> </span>t<span style='letter-spacing:.05pt'>i</span>me<span
style='letter-spacing:2.15pt'> </span><span style='letter-spacing:.05pt'>o</span>f
apixaban<span style='letter-spacing:1.1pt'> </span>peak<span style='letter-spacing:
1.15pt'> </span>plas<span style='letter-spacing:-.1pt'>m</span>a<span
style='letter-spacing:1.15pt'> </span>concentrations.<span style='letter-spacing:
1.15pt'> </span>The<span style='letter-spacing:1.1pt'> </span>relat<span
style='letter-spacing:-.05pt'>i</span>onship<span style='letter-spacing:1.15pt'>
</span>between<span style='letter-spacing:1.15pt'> </span>apixaban<span
style='letter-spacing:1.15pt'> </span>plas<span style='letter-spacing:-.1pt'>m</span>a<span
style='letter-spacing:1.2pt'> </span>concent<span style='letter-spacing:.05pt'>r</span>ation<span
style='letter-spacing:1.1pt'> </span>and anti-FXa<span style='letter-spacing:
-.3pt'> </span>act<span style='letter-spacing:.05pt'>i</span>vity<span
style='letter-spacing:-.2pt'> </span>is<span style='letter-spacing:-.25pt'> </span>approx<span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>tely<span style='letter-spacing:-.2pt'> </span>linear<span
style='letter-spacing:-.3pt'> </span>over<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>wide<span style='letter-spacing:-.3pt'> </span>dose<span
style='letter-spacing:-.25pt'> </span>range<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>apixaban.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:.35pt'> </span>3<span
style='letter-spacing:.4pt'> </span>below<span style='letter-spacing:.4pt'> </span>shows<span
style='letter-spacing:.4pt'> </span>the<span style='letter-spacing:.4pt'> </span>predicted<span
style='letter-spacing:.4pt'> </span>steady<span style='letter-spacing:.5pt'> </span>state<span
style='letter-spacing:.35pt'> </span>expo<span style='letter-spacing:-.1pt'>s</span>ure<span
style='letter-spacing:.4pt'> </span>and<span style='letter-spacing:.4pt'> </span>anti-Factor<span
style='letter-spacing:.4pt'> </span>Xa<span style='letter-spacing:.35pt'> </span>activi<span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>.<span
style='letter-spacing:.4pt'> </span>In<span style='letter-spacing:.4pt'> </span>n<span
style='letter-spacing:-.05pt'>o</span>n&#8209;valvular atrial<span
style='letter-spacing:1.5pt'> </span>fibrillation<span style='letter-spacing:
1.5pt'> </span>patients<span style='letter-spacing:1.55pt'> </span><span
style='letter-spacing:-.05pt'>ta</span>king<span style='letter-spacing:1.5pt'> </span>apixaban<span
style='letter-spacing:1.5pt'> </span>for<span style='letter-spacing:1.55pt'> </span>the<span
style='letter-spacing:1.45pt'> </span>p<span style='letter-spacing:-.1pt'>r</span>evention<span
style='letter-spacing:1.55pt'> </span>of<span style='letter-spacing:1.5pt'> </span><span
style='letter-spacing:-.1pt'>s</span>troke<span style='letter-spacing:1.5pt'> </span>and<span
style='letter-spacing:1.55pt'> </span><span style='letter-spacing:-.1pt'>s</span>yste<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:1.45pt'> </span>e<span style='letter-spacing:-.1pt'>m</span>bo<span
style='letter-spacing:.05pt'>l</span>is<span style='letter-spacing:-.1pt'>m</span>,<span
style='letter-spacing:1.55pt'> </span>the results<span style='letter-spacing:
.45pt'> </span>de<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>o</span>nstrate<span style='letter-spacing:.45pt'>
</span>a<span style='letter-spacing:.45pt'> </span>less<span style='letter-spacing:
.4pt'> </span>than<span style='letter-spacing:.45pt'> </span>1.7&#8209;<span
style='letter-spacing:-.1pt'>f</span>old<span style='letter-spacing:.45pt'> </span>fluctuat<span
style='letter-spacing:-.05pt'>i</span>on<span style='letter-spacing:.45pt'> </span>in<span
style='letter-spacing:.35pt'> </span>peak-to-trou<span style='letter-spacing:
-.05pt'>g</span>h<span style='letter-spacing:.45pt'> </span>le<span
style='letter-spacing:-.05pt'>ve</span>ls.<span style='letter-spacing:.45pt'> </span>In<span
style='letter-spacing:.45pt'> </span>patients<span style='letter-spacing:.45pt'>
</span>taking apixaban<span style='letter-spacing:2.25pt'> </span>for<span
style='letter-spacing:2.3pt'> </span>the<span style='letter-spacing:2.25pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span><span style='letter-spacing:-.1pt'>m</span>ent<span
style='letter-spacing:2.3pt'> </span>of<span style='letter-spacing:2.3pt'> </span>DVT<span
style='letter-spacing:2.25pt'> </span>and<span style='letter-spacing:2.3pt'> </span>PE<span
style='letter-spacing:2.2pt'> </span>or<span style='letter-spacing:2.3pt'> </span>p<span
style='letter-spacing:-.05pt'>r</span>evention<span style='letter-spacing:2.3pt'>
</span>of<span style='letter-spacing:2.25pt'> </span>recurrent<span
style='letter-spacing:2.3pt'> </span>DVT<span style='letter-spacing:2.25pt'> </span>and<span
style='letter-spacing:2.3pt'> </span>PE,<span style='letter-spacing:2.3pt'> </span>the<span
style='letter-spacing:2.25pt'> </span>results de<span style='letter-spacing:
-.1pt'>m</span>onstrate<span style='letter-spacing:-.35pt'> </span>a<span
style='letter-spacing:-.4pt'> </span>less<span style='letter-spacing:-.35pt'> </span>than<span
style='letter-spacing:-.35pt'> </span>2.2<span style='letter-spacing:-.1pt'>&#8209;</span>fold<span
style='letter-spacing:-.35pt'> </span>fluctuat<span style='letter-spacing:-.05pt'>i</span>on<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.35pt'> </span>peak-to-trough<span
style='letter-spacing:-.4pt'> </span>levels.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:17.0pt'>
  <td width=638 colspan=5 style='width:6.65in;border:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><b><span
  lang=EN-GB style='font-size:11.0pt'>Table<span style='letter-spacing:-.45pt'>
  </span>3:<span style='letter-spacing:-.4pt'> </span>Predicted<span
  style='letter-spacing:-.4pt'> a</span>pixaban<span style='letter-spacing:
  -.4pt'> s</span>teady-<span style='letter-spacing:-.1pt'>s</span>tate<span
  style='letter-spacing:-.4pt'> e</span>xposure<span style='letter-spacing:
  -.4pt'> </span>and<span style='letter-spacing:-.4pt'> a</span>nti-Xa<span
  style='letter-spacing:-.4pt'> a</span>ctivity</span></b></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix. <span
  style='letter-spacing:.05pt'>C</span><sub><span style='position:relative;
  top:1.0pt;letter-spacing:-.1pt'>m</span><span style='position:relative;
  top:1.0pt'>ax</span></sub></span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(ng/mL)</span></b></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix. <span
  style='letter-spacing:.05pt'>C</span><span style='position:relative;
  top:1.0pt;letter-spacing:-.1pt'>m</span><span style='position:relative;
  top:1.0pt'>in</span></span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(ng/mL)</span></b></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix.<span
  style='letter-spacing:-.65pt'> a</span>nti-Xa activity<span style='letter-spacing:
  -.6pt'> m</span>ax (IU/mL)</span></b></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix.<span
  style='letter-spacing:-.65pt'> a</span>nti-Xa activity<span style='letter-spacing:
  -.6pt'> m</span>in (IU/mL)</span></b></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=511 colspan=4 style='width:383.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Median<span
  style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.1pt'>[</span>5th,<span
  style='letter-spacing:-.4pt'> </span>95th<span style='letter-spacing:-.4pt'> </span>Percenti<span
  style='letter-spacing:-.05pt'>l</span>e]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=638 colspan=5 style='width:6.65in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Prevention<span style='letter-spacing:
  -.35pt'> </span>of<span style='letter-spacing:-.35pt'> </span>stroke<span
  style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.4pt'> </span>systemic<span
  style='letter-spacing:-.3pt'> </span>embolism:<span style='letter-spacing:
  -.35pt'> </span>NVAF</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>2.5<span style='letter-spacing:-.3pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice
  daily*</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>123<span
  style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>[</span>69,<span
  style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>2</span>21]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>79<span
  style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>[</span>34,<span
  style='letter-spacing:-.25pt'> </span>1<span style='letter-spacing:-.05pt'>6</span>2]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>1.8&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>1.0,<span style='letter-spacing:-.25pt'>
  </span><span style='letter-spacing:-.05pt'>3</span>.3]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>1.2&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>0.51,<span style='letter-spacing:-.35pt'>
  </span>2.<span style='letter-spacing:-.05pt'>4</span>]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>twice<span
  style='letter-spacing:-.25pt'> </span>daily</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>171<span
  style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>[</span>91,<span
  style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>3</span>21]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>103&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>41,<span style='letter-spacing:-.25pt'> </span><span
  style='letter-spacing:-.05pt'>2</span>30]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>2.6&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>1.4,<span style='letter-spacing:-.25pt'>
  </span><span style='letter-spacing:-.05pt'>4</span>.8]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>1.5&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>0.61,<span style='letter-spacing:-.35pt'>
  </span>3.<span style='letter-spacing:-.05pt'>4</span>]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=638 colspan=5 style='width:6.65in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><i><span
  lang=EN-GB style='font-size:11.0pt'>Treatment<span style='letter-spacing:
  -.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>DVT,<span
  style='letter-spacing:-.25pt'> </span>treatment<span style='letter-spacing:
  -.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>PE<span
  style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.4pt'> </span>prevention<span
  style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>recurrent<span
  style='letter-spacing:-.25pt'> </span>D<span style='letter-spacing:.05pt'>V</span>T<span
  style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>PE<span
  style='letter-spacing:-.3pt'> </span>(VTEt)</span></i></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
  style='letter-spacing:-.2pt'> </span>daily</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>67&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>30,<span style='letter-spacing:-.25pt'> </span>1<span
  style='letter-spacing:-.05pt'>5</span>3]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>32&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>11,<span style='letter-spacing:-.2pt'> </span>90]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>1.0&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>0.46,<span style='letter-spacing:-.35pt'>
  </span>2.<span style='letter-spacing:-.05pt'>5</span>]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>0.49&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>0.1<span style='letter-spacing:-.05pt'>7</span>,<span
  style='letter-spacing:-.3pt'> </span>1<span style='letter-spacing:-.05pt'>.</span><span
  style='letter-spacing:.05pt'>4</span>]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>twice<span
  style='letter-spacing:-.25pt'> </span>daily</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>132&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>59,<span style='letter-spacing:-.25pt'> </span><span
  style='letter-spacing:-.05pt'>3</span>02]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>63&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>22,<span style='letter-spacing:-.25pt'> </span>1<span
  style='letter-spacing:-.05pt'>7</span>7]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>2.1&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>0.91,<span style='letter-spacing:-.35pt'>
  </span>5.<span style='letter-spacing:-.05pt'>2</span>]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>1.0<span
  style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>[</span>0.33,<span
  style='letter-spacing:-.35pt'> </span>2.<span style='letter-spacing:-.05pt'>9</span>]</span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=128 style='width:95.75pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.0pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
  style='letter-spacing:-.2pt'> </span>daily</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>251&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>111,<span style='letter-spacing:-.35pt'>
  </span>5<span style='letter-spacing:-.05pt'>7</span><span style='letter-spacing:
  .05pt'>2</span>]</span></p>
  </td>
  <td width=128 style='width:95.75pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>120&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>41,<span style='letter-spacing:-.25pt'> </span><span
  style='letter-spacing:-.05pt'>3</span>35]</span></p>
  </td>
  <td width=128 style='width:95.7pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt'>4.2&nbsp;<span
  style='letter-spacing:-.1pt'>[</span>1.8,<span style='letter-spacing:-.3pt'> </span><span
  style='letter-spacing:-.05pt'>1</span>0.<span style='letter-spacing:-.05pt'>8</span>]</span></p>
  </td>
  <td width=128 style='width:95.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.0pt'>
  <p class=TableParagraph align=center style='margin-left:3.15pt;text-align:
  center;punctuation-wrap:simple'><span lang=EN-GB style='font-size:11.0pt;
  letter-spacing:-.1pt'>1.9&nbsp;[</span><span lang=EN-GB style='font-size:
  11.0pt'>0.64,<span style='letter-spacing:-.35pt'> </span>5.<span
  style='letter-spacing:-.05pt'>8</span>]</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:10.0pt'>* Dose<span style='letter-spacing:-.2pt'> </span>adjusted<span
style='letter-spacing:-.2pt'> </span>population<span style='letter-spacing:
-.2pt'> </span>based<span style='letter-spacing:-.2pt'> </span>on<span
style='letter-spacing:-.2pt'> </span>2<span style='letter-spacing:-.2pt'>&nbsp;</span>of<span
style='letter-spacing:-.15pt'>&nbsp;</span>3<span style='letter-spacing:-.2pt'>&nbsp;</span>dose<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>r</span>eduction<span
style='letter-spacing:-.15pt'> </span>c<span style='letter-spacing:-.1pt'>r</span>iteria<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.15pt'> </span>t<span
style='letter-spacing:-.1pt'>h</span>e<span style='letter-spacing:-.2pt'> </span>ARISTOTLE<span
style='letter-spacing:-.15pt'> </span>stu<span style='letter-spacing:-.1pt'>d</span><span
style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Although<span style='letter-spacing:-.4pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>does<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>n</span>ot<span style='letter-spacing:-.3pt'> </span>require<span
style='letter-spacing:-.4pt'> </span>ro<span style='letter-spacing:-.05pt'>u</span>tine<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>onitoring<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>e<span
style='letter-spacing:-.05pt'>x</span>posu<span style='letter-spacing:-.1pt'>r</span>e,<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:-.3pt'> </span>calibrated
quantitative<span style='letter-spacing:-.35pt'> </span>anti-Factor<span
style='letter-spacing:-.3pt'> </span>Xa<span style='letter-spacing:-.3pt'> </span>assay<span
style='letter-spacing:-.25pt'> </span>may<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.45pt'> </span>useful<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>exceptional<span
style='letter-spacing:-.3pt'> </span>situations<span style='letter-spacing:
-.35pt'> </span>where<span style='letter-spacing:-.3pt'> </span>knowledge<span
style='letter-spacing:-.3pt'> </span>of apixaban<span style='letter-spacing:
-.35pt'> </span>exposure<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>y<span
style='letter-spacing:-.2pt'> </span>h<span style='letter-spacing:-.1pt'>e</span>lp<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.35pt'> </span>inform<span
style='letter-spacing:-.4pt'> </span>clinical<span style='letter-spacing:-.35pt'>
</span>decisions,<span style='letter-spacing:-.3pt'> </span>e.g.,<span
style='letter-spacing:-.4pt'> </span>overdose<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.35pt'> </span>em<span style='letter-spacing:
.05pt'>e</span>rgency<span style='letter-spacing:-.25pt'> </span>surgery.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Clinical<span style='letter-spacing:-.4pt'> </span>effi<span
style='letter-spacing:.05pt'>c</span>acy<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.4pt'> </span>safety</span></u></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Prevention<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>stroke<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.4pt'> </span>systemic<span
style='letter-spacing:-.3pt'> </span>embolism<span style='letter-spacing:-.4pt'>
</span>in<span style='letter-spacing:-.35pt'> </span>patien<span
style='letter-spacing:-.1pt'>t</span>s<span style='letter-spacing:-.45pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>non-va<span style='letter-spacing:-.05pt'>lv</span>ular<span
style='letter-spacing:-.4pt'> </span>atrial<span style='letter-spacing:-.35pt'>
</span>f<span style='letter-spacing:-.05pt'>i</span>brillation<span
style='letter-spacing:-.35pt'> </span>(NVAF)</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>A<span style='letter-spacing:-.35pt'> </span>total<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>23<span
style='letter-spacing:-.05pt'>,</span>799<span style='letter-spacing:-.35pt'>&nbsp;</span>patients<span
style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:-.3pt'> </span>rand<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>sed<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span>cli<span
style='letter-spacing:-.05pt'>n</span>ical<span style='letter-spacing:-.3pt'> </span>program<span
style='letter-spacing:-.35pt'> </span>(ARISTOTLE:<span style='letter-spacing:
-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>ve</span>rsus warfarin,<span style='letter-spacing:
-.4pt'> </span>AVERROES:<span style='letter-spacing:-.4pt'> </span>a<span
style='letter-spacing:.05pt'>p</span>ixaban<span style='letter-spacing:-.4pt'> </span>versus<span
style='letter-spacing:-.35pt'> </span>ASA)<span style='letter-spacing:-.4pt'> </span>including<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.05pt'>1</span>1,9<span
style='letter-spacing:-.05pt'>2</span>7<span style='letter-spacing:-.35pt'>&nbsp;</span>r<span
style='letter-spacing:-.1pt'>a</span>ndo<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.4pt'> </span>to<span style='letter-spacing:-.4pt'> </span>apixaban.<span
style='letter-spacing:-.35pt'> </span>T<span style='letter-spacing:-.05pt'>h</span>e<span
style='letter-spacing:-.4pt'> </span>program was<span style='letter-spacing:
-.3pt'> </span>designed<span style='letter-spacing:-.15pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>de<span style='letter-spacing:-.1pt'>m</span>onstrate<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>effica<span
style='letter-spacing:.05pt'>c</span>y<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>safety<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>prevention<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>stroke<span
style='letter-spacing:-.25pt'> </span>and s<span style='letter-spacing:.05pt'>y</span>ste<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.4pt'> </span>e<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>b</span>olism<span style='letter-spacing:-.4pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:-.35pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>non<span
style='letter-spacing:-.1pt'>-</span>valvular<span style='letter-spacing:-.35pt'>
</span>atrial<span style='letter-spacing:-.3pt'> </span>fibrillation<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>(</span>NVAF)<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>one<span
style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ore<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:.05pt'>d</span>ditional risk<span style='letter-spacing:
-.3pt'> </span>factors,<span style='letter-spacing:-.25pt'> </span>such<span
style='letter-spacing:-.3pt'> </span>as:</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>prior<span style='letter-spacing:-.35pt'> </span>stroke<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>transient<span
style='letter-spacing:-.35pt'> </span>ischa<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.25pt'> </span>attack<span
style='letter-spacing:-.25pt'> </span>(TIA)</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>ag</span><span
lang=EN-GB>e<span style='letter-spacing:-.2pt'> </span>&#8805;<span
style='letter-spacing:-.25pt'> </span>75<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>h</span><span
lang=EN-GB style='letter-spacing:.05pt'>y</span><span lang=EN-GB
style='letter-spacing:-.05pt'>pertension</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>diabetes<span style='letter-spacing:-.7pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>ll<span
style='letter-spacing:.05pt'>i</span>tus</span></p>

<p class=MsoBodyText style='margin-left:28.35pt;text-indent:-28.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptomatic<span style='letter-spacing:-.3pt'>
</span>heart<span style='letter-spacing:-.3pt'> </span>failure<span
style='letter-spacing:-.3pt'> </span>(NYHA<span style='letter-spacing:-.3pt'> </span>Class<span
style='letter-spacing:-.3pt'> </span>&#8805;<span style='letter-spacing:-.35pt'>&nbsp;</span>II)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>ARISTOTLE<span style='letter-spacing:-.95pt'> </span>STUDY</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>ARISTOTLE<span style='letter-spacing:-.3pt'>
</span>study<span style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:
-.25pt'> </span>total<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>18<span style='letter-spacing:-.05pt'>,</span>201<span
style='letter-spacing:-.3pt'>&nbsp;</span>patients<span style='letter-spacing:
-.25pt'> </span>were<span style='letter-spacing:-.3pt'> </span>rand<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>double<span
style='letter-spacing:-.1pt'>-</span>blind<span style='letter-spacing:-.25pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>with
apixaban<span style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:
-.2pt'>&nbsp;</span>mg<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.2pt'> </span>daily<span style='letter-spacing:-.2pt'> </span>(or<span
style='letter-spacing:-.25pt'> </span>2.5<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.2pt'> </span>daily<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.2pt'> </span>selected<span style='letter-spacing:-.2pt'>
</span>patients<span style='letter-spacing:-.25pt'> </span>[4.7%],<span
style='letter-spacing:-.2pt'> </span>see<span style='letter-spacing:-.2pt'> </span>section&nbsp;4.2)<span
style='letter-spacing:-.2pt'> </span>or warfarin<span style='letter-spacing:
-.25pt'> </span>(tar<span style='letter-spacing:.05pt'>g</span><span
style='letter-spacing:-.05pt'>e</span>t<span style='letter-spacing:-.25pt'> </span>INR<span
style='letter-spacing:-.25pt'> </span>range<span style='letter-spacing:-.2pt'> </span>2.0-3<span
style='letter-spacing:-.05pt'>.</span>0),<span style='letter-spacing:-.3pt'> </span>pat<span
style='letter-spacing:-.05pt'>i</span>ents<span style='letter-spacing:-.25pt'> </span>were<span
style='letter-spacing:-.2pt'> </span>exposed<span style='letter-spacing:-.25pt'>
</span>to<span style='letter-spacing:-.2pt'> </span>stu<span style='letter-spacing:
-.05pt'>d</span>y<span style='letter-spacing:-.3pt'> </span>drug<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>mean<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>20<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>on<span style='letter-spacing:-.05pt'>t</span>hs.<span
style='letter-spacing:-.2pt'> </span>The mean<span style='letter-spacing:-.25pt'>
</span>age<span style='letter-spacing:-.2pt'> </span>was<span style='letter-spacing:
-.2pt'> </span>69.1&nbsp;years,<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>mean<span style='letter-spacing:-.2pt'> </span>CHAD<span
style='letter-spacing:-.05pt'>S</span><span style='position:relative;
top:1.0pt'>2<span style='letter-spacing:.8pt'> </span></span>score<span
style='letter-spacing:-.15pt'> </span>was<span style='letter-spacing:-.25pt'> </span>2.1,<span
style='letter-spacing:-.2pt'> </span>18.9<span style='letter-spacing:-.3pt'> </span>%<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>patients<span
style='letter-spacing:-.2pt'> </span>had<span style='letter-spacing:-.25pt'> </span>prior<span
style='letter-spacing:-.2pt'> </span>str<span style='letter-spacing:-.05pt'>o</span>ke<span
style='letter-spacing:-.2pt'> </span>or TIA.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>stu<span style='letter-spacing:-.05pt'>d</span>y,<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>achieved<span style='letter-spacing:-.35pt'> </span>statistically<span
style='letter-spacing:-.2pt'> </span>s<span style='letter-spacing:-.1pt'>i</span><span
style='letter-spacing:-.05pt'>g</span>nificant<span style='letter-spacing:-.3pt'>
</span>superiori<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>pri<span style='letter-spacing:-.1pt'>m</span>ary<span
style='letter-spacing:-.35pt'> </span>endp<span style='letter-spacing:-.05pt'>o</span>int<span
style='letter-spacing:-.3pt'> </span>of prevention<span style='letter-spacing:
-.4pt'> </span>of<span style='letter-spacing:-.3pt'> </span>stroke<span
style='letter-spacing:-.35pt'> </span>(ha<span style='letter-spacing:.05pt'>e</span>morrhagic<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.35pt'> </span>i<span
style='letter-spacing:-.1pt'>s</span>cha<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c)<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>s<span
style='letter-spacing:.05pt'>y</span>ste<span style='letter-spacing:-.1pt'>m</span>ic<span
style='letter-spacing:-.3pt'> </span>e<span style='letter-spacing:-.05pt'>m</span>bolism<span
style='letter-spacing:-.4pt'> </span>(see<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>a</span>ble<span
style='letter-spacing:-.3pt'> </span>4)<span style='letter-spacing:-.3pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>p</span>ared<span
style='letter-spacing:-.35pt'> </span>with warfarin.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>4:<span
style='letter-spacing:-.3pt'> </span>Efficacy<span style='letter-spacing:-.25pt'>
o</span>utco<span style='letter-spacing:-.1pt'>m</span>es<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> p</span>atients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> a</span>trial<span
style='letter-spacing:-.3pt'> f</span>ibrillation<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>ARISTO<span style='letter-spacing:.05pt'>T</span>LE<span
style='letter-spacing:-.3pt'> s</span>tudy</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:38.45pt'>
  <td width=185 style='width:138.8pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:38.45pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=76 style='width:56.7pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N=9,120</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.4pt'> </span>(%/yr)</span></b></p>
  </td>
  <td width=76 style='width:56.65pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Warfarin</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N=9,081</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.4pt'> </span>(%/yr)</span></b></p>
  </td>
  <td width=125 style='width:93.55pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:
  .05pt'>a</span>zard<span style='letter-spacing:-.65pt'> r</span>atio</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(95%<span
  style='letter-spacing:-.45pt'> </span>CI)</span></b></p>
  </td>
  <td width=66 style='width:49.6pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>p-value</span></b></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=185 style='width:138.8pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stroke<span style='letter-spacing:-.4pt'>
  </span>or<span style='letter-spacing:-.4pt'> </span><span style='letter-spacing:
  -.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>s<span
  style='letter-spacing:-.05pt'>t</span>e<span style='letter-spacing:-.1pt'>m</span>ic<span
  style='letter-spacing:-.4pt'> </span>embolism</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>212&nbsp;(<span
  style='letter-spacing:-.05pt'>1</span>.27)</span></p>
  </td>
  <td width=76 style='width:56.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>265&nbsp;(<span
  style='letter-spacing:-.05pt'>1</span>.60)</span></p>
  </td>
  <td width=125 style='width:93.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.79<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.6<span
  style='letter-spacing:-.05pt'>6</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>95)</span></p>
  </td>
  <td width=66 style='width:49.6pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>1</span>14</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=185 style='width:138.8pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:10.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stroke</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=76 style='width:56.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=125 style='width:93.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=66 style='width:49.6pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=185 style='width:138.8pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:17.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Ischaemic<span style='letter-spacing:
  -.55pt'> </span>or<span style='letter-spacing:-.5pt'> </span>unspecified</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>162&nbsp;(<span
  style='letter-spacing:-.05pt'>0</span>.97)</span></p>
  </td>
  <td width=76 style='width:56.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>175&nbsp;(<span
  style='letter-spacing:-.05pt'>1</span>.05)</span></p>
  </td>
  <td width=125 style='width:93.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.92&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.7<span style='letter-spacing:-.05pt'>4</span>,<span
  style='letter-spacing:-.35pt'> </span>1<span style='letter-spacing:-.05pt'>.</span>13)</span></p>
  </td>
  <td width=66 style='width:49.6pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=185 style='width:138.8pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:17.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.1pt'>m</span>orr<span
  style='letter-spacing:.05pt'>h</span>agic</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>40&nbsp;(0<span
  style='letter-spacing:-.05pt'>.</span>24)</span></p>
  </td>
  <td width=76 style='width:56.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>78<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>47)</span></p>
  </td>
  <td width=125 style='width:93.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.51<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.3<span
  style='letter-spacing:-.05pt'>5</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>75)</span></p>
  </td>
  <td width=66 style='width:49.6pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.2pt'>
  <td width=185 style='width:138.8pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.2pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>S<span style='letter-spacing:.05pt'>y</span>ste<span
  style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.85pt'> </span>embolism</span></p>
  </td>
  <td width=76 style='width:56.7pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>15&nbsp;(0<span
  style='letter-spacing:-.05pt'>.</span>09)</span></p>
  </td>
  <td width=76 style='width:56.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>17<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>10)</span></p>
  </td>
  <td width=125 style='width:93.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.87<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.4<span
  style='letter-spacing:-.05pt'>4</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>75)</span></p>
  </td>
  <td width=66 style='width:49.6pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>For<span style='letter-spacing:-.3pt'> </span>patients<span
style='letter-spacing:-.3pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>warfarin,<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>median<span
style='letter-spacing:-.3pt'> </span>percentage<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>time<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>therapeutic<span
style='letter-spacing:-.3pt'> </span>range<span style='letter-spacing:-.3pt'> </span>(TTR)
(INR<span style='letter-spacing:-.3pt'> </span>2&#8209;3)<span
style='letter-spacing:-.25pt'> </span>was<span style='letter-spacing:-.3pt'> </span>66<span
style='letter-spacing:-.05pt'>%</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.3pt'> </span>showed<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.3pt'> </span>reduction<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>stroke<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.05pt'>t</span>e<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.35pt'> </span>e<span
style='letter-spacing:-.1pt'>m</span>boli<span style='letter-spacing:.05pt'>s</span>m<span
style='letter-spacing:-.3pt'> </span>c<span style='letter-spacing:.05pt'>o</span>mpared<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>warfarin<span
style='letter-spacing:-.3pt'> </span>across<span style='letter-spacing:-.3pt'> </span>the
different<span style='letter-spacing:-.3pt'> </span>levels<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>center<span
style='letter-spacing:-.25pt'> </span>TTR;<span style='letter-spacing:-.25pt'> </span>within<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>highest<span
style='letter-spacing:-.3pt'> </span>qu<span style='letter-spacing:-.1pt'>a</span>rtile<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>TTR<span
style='letter-spacing:-.25pt'> </span>according<span style='letter-spacing:
-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:-.05pt'>e</span>nter,<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>hazard<span
style='letter-spacing:-.25pt'> </span>ratio for<span style='letter-spacing:
-.25pt'> </span>apixaban<span style='letter-spacing:-.3pt'> </span>vs<span
style='letter-spacing:-.25pt'> </span>warfarin<span style='letter-spacing:-.25pt'>
</span>was<span style='letter-spacing:-.25pt'> </span>0.73<span
style='letter-spacing:-.25pt'>&nbsp;</span>(95%<span style='letter-spacing:
-.35pt'> </span>CI,<span style='letter-spacing:-.25pt'> </span>0.38,<span
style='letter-spacing:-.3pt'> </span>1.<span style='letter-spacing:-.05pt'>40</span>).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Key<span style='letter-spacing:-.2pt'> </span>secondary<span
style='letter-spacing:-.25pt'> </span>endp<span style='letter-spacing:-.05pt'>o</span>ints<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>o</span>f<span
style='letter-spacing:-.25pt'> </span>major<span style='letter-spacing:-.25pt'>
</span>bleeding<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>all<span style='letter-spacing:-.35pt'> </span>c<span
style='letter-spacing:-.1pt'>a</span>use<span style='letter-spacing:-.25pt'> </span>death<span
style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:-.25pt'> </span>tested<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>pre-specified hierarchical<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>t</span>esting<span
style='letter-spacing:-.25pt'> </span>strategy<span style='letter-spacing:-.3pt'>
</span>to<span style='letter-spacing:-.3pt'> </span>control<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.25pt'> </span>type<span style='letter-spacing:-.3pt'> </span>1<span
style='letter-spacing:-.25pt'> </span>error<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.3pt'> </span>trial.<span
style='letter-spacing:-.25pt'> </span>Statistically<span style='letter-spacing:
-.2pt'> </span>signifi<span style='letter-spacing:-.1pt'>c</span><span
style='letter-spacing:-.05pt'>a</span>nt superiori<span style='letter-spacing:
-.05pt'>t</span>y<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>w</span>as<span style='letter-spacing:-.3pt'> </span>also<span
style='letter-spacing:-.3pt'> </span>achie<span style='letter-spacing:.05pt'>v</span><span
style='letter-spacing:-.05pt'>e</span>d<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>k<span
style='letter-spacing:-.1pt'>e</span>y<span style='letter-spacing:-.3pt'> </span>secondary<span
style='letter-spacing:-.2pt'> </span>e<span style='letter-spacing:-.05pt'>n</span>dpoints<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>b<span
style='letter-spacing:-.05pt'>ot</span>h<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor<span
style='letter-spacing:-.3pt'> </span>blee<span style='letter-spacing:.05pt'>d</span>ing<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>all-cause
death<span style='letter-spacing:-.3pt'> </span>(see<span style='letter-spacing:
-.25pt'> </span>T<span style='letter-spacing:.05pt'>a</span>ble<span
style='letter-spacing:-.3pt'> </span>5).<span style='letter-spacing:-.25pt'> </span>With<span
style='letter-spacing:-.3pt'> </span>i<span style='letter-spacing:-.1pt'>m</span>proving<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>o</span>nitoring<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>I<span style='letter-spacing:
-.05pt'>N</span>R<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>observed<span style='letter-spacing:-.3pt'>
</span>benefits<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>compared<span style='letter-spacing:-.3pt'> </span>to warfarin<span
style='letter-spacing:-.4pt'> </span>regarding<span style='letter-spacing:-.35pt'>
</span>all<span style='letter-spacing:-.35pt'> </span>cause<span
style='letter-spacing:-.35pt'> </span>death<span style='letter-spacing:-.35pt'>
</span>di<span style='letter-spacing:-.1pt'>m</span>i<span style='letter-spacing:
.05pt'>n</span>ish.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.35pt'> </span>5:<span
style='letter-spacing:-.3pt'> </span>Seconda<span style='letter-spacing:-.1pt'>r</span>y<span
style='letter-spacing:-.2pt'> e</span>ndpo<span style='letter-spacing:-.05pt'>i</span>nts<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.35pt'> p</span>atien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>w</span>ith<span style='letter-spacing:-.3pt'> a</span>trial<span
style='letter-spacing:-.3pt'> f</span>ibrillation<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.3pt'> </span>ARISTOTLE<span
style='letter-spacing:-.35pt'> s</span>tudy</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:38.45pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:38.45pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=129 style='width:96.85pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N<span style='letter-spacing:
  -.2pt'> </span>=<span style='letter-spacing:-.2pt'> </span>9,088</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.5pt'> </span>(%/year)</span></b></p>
  </td>
  <td width=132 style='width:99.0pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Warfarin</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N<span style='letter-spacing:
  -.2pt'> </span>=<span style='letter-spacing:-.2pt'> </span>9,052</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.5pt'> </span>(%/year)</span></b></p>
  </td>
  <td width=132 style='width:99.0pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:
  .05pt'>a</span>zard<span style='letter-spacing:-.65pt'> r</span>atio</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(95%<span
  style='letter-spacing:-.45pt'> </span>CI)</span></b></p>
  </td>
  <td width=85 style='width:63.65pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:38.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>p-value</span></b></p>
  </td>
 </tr>
 <tr style='height:14.45pt'>
  <td width=608 colspan=5 style='width:456.05pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:14.45pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Bleeding<span style='letter-spacing:-.85pt'>
  o</span>utc<span style='letter-spacing:.05pt'>o</span><span style='letter-spacing:
  -.1pt'>m</span>es</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:.2in'>
  <p class=TableParagraph style='margin-left:11.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major*</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>327&nbsp;(<span
  style='letter-spacing:-.05pt'>2</span>.13)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>462&nbsp;(<span
  style='letter-spacing:-.05pt'>3</span>.09)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.69&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.6<span style='letter-spacing:-.05pt'>0</span>,<span
  style='letter-spacing:-.35pt'> </span>0<span style='letter-spacing:-.05pt'>.</span>80)</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>&lt;&nbsp;0.00<span
  style='letter-spacing:-.05pt'>0</span>1</span></p>
  </td>
 </tr>
 <tr style='height:14.05pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.05pt'>
  <p class=TableParagraph style='margin-left:18.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Fatal</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>10<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>06)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>37<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>24)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:18.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Intracranial</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>52<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>33)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>122&nbsp;(<span
  style='letter-spacing:-.05pt'>0</span>.80)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:.2in'>
  <p class=TableParagraph style='margin-left:11.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.35pt'>
  </span>+<span style='letter-spacing:-.35pt'> </span>CRNM<sup>†</sup></span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>613&nbsp;(<span
  style='letter-spacing:-.05pt'>4</span>.07)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>877&nbsp;(<span
  style='letter-spacing:-.05pt'>6</span>.01)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.68&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.6<span style='letter-spacing:-.05pt'>1</span>,<span
  style='letter-spacing:-.35pt'> </span>0<span style='letter-spacing:-.05pt'>.</span>75)</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>&lt;<span style='letter-spacing:
  -.4pt'>&nbsp;</span>0.00<span style='letter-spacing:-.05pt'>0</span>1</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:11.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2356&nbsp;(18<span
  style='letter-spacing:-.05pt'>.</span>1)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>3060&nbsp;(25<span
  style='letter-spacing:-.05pt'>.</span>8)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.71&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.6<span style='letter-spacing:-.05pt'>8</span>,<span
  style='letter-spacing:-.35pt'> </span>0<span style='letter-spacing:-.05pt'>.</span>75)</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>&lt;<span style='letter-spacing:
  -.4pt'>&nbsp;</span>0.00<span style='letter-spacing:-.05pt'>0</span>1</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=608 colspan=5 style='width:456.05pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Other<span style='letter-spacing:-.7pt'> e</span>ndpo<span
  style='letter-spacing:-.05pt'>i</span>nts</span></p>
  </td>
 </tr>
 <tr style='height:19.15pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:19.15pt'>
  <p class=TableParagraph style='margin-left:12.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All-cause<span style='letter-spacing:
  -.7pt'> </span>death</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:19.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>603&nbsp;(<span
  style='letter-spacing:-.05pt'>3</span>.52)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:19.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>669&nbsp;(<span
  style='letter-spacing:-.05pt'>3</span>.94)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:19.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.89&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.8<span style='letter-spacing:-.05pt'>0</span>,<span
  style='letter-spacing:-.35pt'> </span>1<span style='letter-spacing:-.05pt'>.</span>00)</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:19.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>4</span>65</span></p>
  </td>
 </tr>
 <tr style='height:25.85pt'>
  <td width=130 style='width:97.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:25.85pt'>
  <p class=TableParagraph style='margin-left:12.95pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Myocardial</span><span lang=EN-GB
  style='font-size:11.0pt'> </span><span lang=EN-GB style='font-size:11.0pt'>infarction</span></p>
  </td>
  <td width=129 style='width:96.85pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>90&nbsp;(0<span
  style='letter-spacing:-.05pt'>.</span>53)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>102&nbsp;(<span
  style='letter-spacing:-.05pt'>0</span>.61)</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.85pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>0.88&nbsp;(</span><span
  lang=EN-GB style='font-size:11.0pt'>0.6<span style='letter-spacing:-.05pt'>6</span>,<span
  style='letter-spacing:-.35pt'> </span>1<span style='letter-spacing:-.05pt'>.</span>17)</span></p>
  </td>
  <td width=85 style='width:63.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.85pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>* Major<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>b</span>leedi<span style='letter-spacing:-.1pt'>n</span>g<span
style='letter-spacing:-.25pt'> </span>defi<span style='letter-spacing:-.1pt'>n</span>ed<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>p</span>er<span
style='letter-spacing:-.25pt'> </span>I<span style='letter-spacing:-.1pt'>n</span>ternational<span
style='letter-spacing:-.25pt'> </span>Socie<span style='letter-spacing:-.1pt'>t</span>y<span
style='letter-spacing:-.2pt'> </span>on<span style='letter-spacing:-.25pt'> </span>Thrombosis<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>H</span>ae<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>ostasi</span>s<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.05pt'>(ISTH</span>)<span style='letter-spacing:
-.2pt'> </span><span style='letter-spacing:-.05pt'>criteria.</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><sup><span lang=EN-GB
style='font-size:11.0pt'>†</span></sup><span lang=EN-GB style='font-size:11.0pt;
letter-spacing:-.25pt'> </span><span lang=EN-GB style='font-size:11.0pt;
letter-spacing:-.05pt'>Clinicall</span><span lang=EN-GB style='font-size:11.0pt'>y<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>R</span>e<span
style='letter-spacing:-.05pt'>levan</span>t<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>Non-Major</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>d</span>iscontinuati<span
style='letter-spacing:-.05pt'>o</span>n<span style='letter-spacing:-.25pt'> </span>rate<span
style='letter-spacing:-.3pt'> </span>due<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>adverse<span style='letter-spacing:-.3pt'>
</span>reactions<span style='letter-spacing:-.25pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>1.8%<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.3pt'> </span>2.6%<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.35pt'> </span>warfarin
in<span style='letter-spacing:-.4pt'> </span>the<span style='letter-spacing:
-.35pt'> </span>ARISTOTLE<span style='letter-spacing:-.35pt'> </span>stud<span
style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>efficacy<span
style='letter-spacing:-.25pt'> </span>results<span style='letter-spacing:-.35pt'>
</span>for<span style='letter-spacing:-.35pt'> </span>prespecified<span
style='letter-spacing:-.3pt'> </span>subgroups,<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.05pt'>i</span>ncluding<span
style='letter-spacing:-.35pt'> </span>CHAD<span style='letter-spacing:-.05pt'>S</span><sub><span
style='position:relative;top:1.0pt'>2</span></sub><span style='position:relative;
top:1.0pt;letter-spacing:.65pt'> </span>score,<span style='letter-spacing:-.3pt'>
</span>age,<span style='letter-spacing:-.35pt'> </span>body<span
style='letter-spacing:-.25pt'> </span>weight,<span style='letter-spacing:-.35pt'>
</span>gender, status<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>renal<span style='letter-spacing:-.25pt'>
</span>function,<span style='letter-spacing:-.3pt'> </span>pr<span
style='letter-spacing:-.05pt'>i</span>or<span style='letter-spacing:-.3pt'> </span>stroke<span
style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>T</span>IA<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>diabetes<span style='letter-spacing:-.3pt'>
</span>we<span style='letter-spacing:.05pt'>r</span>e<span style='letter-spacing:
-.3pt'> </span>cons<span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.05pt'>s</span>tent<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>pri<span
style='letter-spacing:-.1pt'>m</span>ary<span style='letter-spacing:-.2pt'> </span>effi<span
style='letter-spacing:.05pt'>c</span>acy results<span style='letter-spacing:
-.3pt'> </span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>overall<span style='letter-spacing:-.25pt'>
</span>popu<span style='letter-spacing:-.05pt'>l</span>ation<span
style='letter-spacing:-.25pt'> </span>studied<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:
-.25pt'> </span>trial.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>incidence<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>ISTH<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>m</span>ajor<span
style='letter-spacing:-.3pt'> </span>gastroint<span style='letter-spacing:-.1pt'>e</span>stinal<span
style='letter-spacing:-.25pt'> </span>b<span style='letter-spacing:-.05pt'>l</span>eeds<span
style='letter-spacing:-.3pt'> </span>(including<span style='letter-spacing:
-.3pt'> </span>upper<span style='letter-spacing:-.3pt'> </span>GI,<span
style='letter-spacing:-.3pt'> </span>lower<span style='letter-spacing:-.25pt'> </span>GI,<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>rectal
bleeding)<span style='letter-spacing:-.4pt'> </span>was<span style='letter-spacing:
-.35pt'> </span>0.76<span style='letter-spacing:-.05pt'>%/</span><span
style='letter-spacing:.05pt'>y</span>ear<span style='letter-spacing:-.4pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>and<span style='letter-spacing:-.4pt'> </span>0<span style='letter-spacing:
-.05pt'>.</span>86<span style='letter-spacing:-.05pt'>%/</span><span
style='letter-spacing:.05pt'>y</span>ear<span style='letter-spacing:-.35pt'> </span>with<span
style='letter-spacing:-.35pt'> </span>warfarin.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>major<span
style='letter-spacing:-.35pt'> </span>bleeding<span style='letter-spacing:-.3pt'>
</span>results<span style='letter-spacing:-.35pt'> </span>for<span
style='letter-spacing:-.35pt'> </span>prespecified<span style='letter-spacing:
-.3pt'> </span>subgroups<span style='letter-spacing:-.35pt'> </span>including<span
style='letter-spacing:-.35pt'> </span>CHAD<span style='letter-spacing:-.05pt'>S</span><span
style='position:relative;top:1.0pt'>2<span style='letter-spacing:.7pt'> </span></span>score,<span
style='letter-spacing:-.35pt'> </span>age,<span style='letter-spacing:-.35pt'> </span>bo<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.3pt'> </span>weight,
gender,<span style='letter-spacing:-.25pt'> </span>status<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>renal<span
style='letter-spacing:-.25pt'> </span>fun<span style='letter-spacing:-.1pt'>c</span>tion,<span
style='letter-spacing:-.25pt'> </span>pr<span style='letter-spacing:-.05pt'>i</span>or<span
style='letter-spacing:-.25pt'> </span>st<span style='letter-spacing:-.1pt'>r</span>oke<span
style='letter-spacing:-.25pt'> </span>or<span style='letter-spacing:-.25pt'> </span>T<span
style='letter-spacing:-.1pt'>I</span>A<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>diabetes<span style='letter-spacing:-.25pt'>
</span>were<span style='letter-spacing:-.25pt'> </span>consistent<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>results<span style='letter-spacing:-.25pt'>
</span>for the<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.25pt'> </span>population<span style='letter-spacing:
-.3pt'> </span>stud<span style='letter-spacing:-.05pt'>ie</span>d<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>trial.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></i></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>AVERROES<span style='letter-spacing:-.95pt'> </span>STUDY</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>AVERROES<span style='letter-spacing:-.2pt'>
</span>study<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>total<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>5,598<span style='letter-spacing:-.2pt'>&nbsp;</span>patients<span
style='letter-spacing:-.25pt'> </span>considered<span style='letter-spacing:
-.25pt'> </span>to<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>unsuitable<span style='letter-spacing:
-.2pt'> </span>for<span style='letter-spacing:-.25pt'> </span>VKA<span
style='letter-spacing:-.25pt'> </span>by<span style='letter-spacing:-.1pt'> </span>the
investigators<span style='letter-spacing:-.25pt'> </span>were<span
style='letter-spacing:-.25pt'> </span>rand<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>sed<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>trea<span
style='letter-spacing:.05pt'>t</span>ment<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>api<span style='letter-spacing:-.15pt'>x</span>aban<span
style='letter-spacing:-.25pt'> </span>5&nbsp;<span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.25pt'>
</span>daily<span style='letter-spacing:-.15pt'> </span>(or<span
style='letter-spacing:-.3pt'> </span>2.5&nbsp;<span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:.05pt'>d</span><span style='letter-spacing:
-.05pt'>a</span>ily<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.05pt'>i</span>n selec<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.2pt'>
</span>[6.4%],<span style='letter-spacing:-.2pt'> </span>see<span
style='letter-spacing:-.2pt'> </span>section<span style='letter-spacing:-.2pt'>
</span>4.2)<span style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:
-.2pt'> </span>ASA.<span style='letter-spacing:-.25pt'> </span>ASA<span
style='letter-spacing:-.2pt'> </span>was<span style='letter-spacing:-.2pt'> </span>given<span
style='letter-spacing:-.2pt'> </span>at<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>once<span style='letter-spacing:-.25pt'> </span>daily<span
style='letter-spacing:-.2pt'> </span>dose<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.05pt'>8</span>1&nbsp;<span
style='letter-spacing:-.1pt'>m</span>g (64<span style='letter-spacing:-.05pt'>%</span>),<span
style='letter-spacing:-.3pt'> </span>162<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>(</span><span style='letter-spacing:-.05pt'>2</span>6.9<span
style='letter-spacing:-.05pt'>%</span>),<span style='letter-spacing:-.25pt'> </span>243<span
style='letter-spacing:-.3pt'>&nbsp;</span>(<span style='letter-spacing:-.05pt'>2</span>.1<span
style='letter-spacing:-.05pt'>%</span>),<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>3<span style='letter-spacing:-.05pt'>2</span>4&nbsp;<span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>(6.6<span
style='letter-spacing:-.05pt'>%</span>)<span style='letter-spacing:-.25pt'> </span>at<span
style='letter-spacing:-.15pt'> </span>the<span style='letter-spacing:-.25pt'> </span>discretion<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>i<span style='letter-spacing:-.05pt'>n</span>vestigator.<span
style='letter-spacing:-.25pt'> </span>Patients<span style='letter-spacing:-.25pt'>
</span>were exposed<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.2pt'> </span>s<span style='letter-spacing:-.05pt'>t</span>u<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.2pt'> </span>drug<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ean<span style='letter-spacing:-.2pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>14<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>onth<span style='letter-spacing:-.05pt'>s</span>.<span
style='letter-spacing:-.25pt'> </span>The<span style='letter-spacing:-.2pt'> </span>mean<span
style='letter-spacing:-.2pt'> </span>age<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>69.9&nbsp;<span style='letter-spacing:
.05pt'>y</span>ears,<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>mean<span style='letter-spacing:-.2pt'> </span>CHAD<span
style='letter-spacing:-.05pt'>S</span><sub><span style='position:relative;
top:1.0pt'>2</span></sub><span style='position:relative;top:1.0pt'> </span>score<span
style='letter-spacing:-.25pt'> </span>was<span style='letter-spacing:-.2pt'> </span>2.0<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span>13<span
style='letter-spacing:-.05pt'>.</span>6%<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>o</span>f<span style='letter-spacing:-.2pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>had<span style='letter-spacing:-.2pt'> </span>prior<span
style='letter-spacing:-.2pt'> </span>stroke<span style='letter-spacing:-.25pt'>
</span>or<span style='letter-spacing:-.25pt'> </span>TIA.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>C<span style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:
-.1pt'>m</span>on<span style='letter-spacing:-.35pt'> </span>reasons<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.35pt'> </span>unsui<span
style='letter-spacing:-.05pt'>t</span>abili<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.2pt'> </span>for<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>V</span>KA<span style='letter-spacing:-.3pt'> </span>therapy<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>AVERROES<span
style='letter-spacing:-.35pt'> </span>study<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>i</span>ncluded unable/unlikely<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.35pt'> </span>obtain<span
style='letter-spacing:-.35pt'> </span>INRs<span style='letter-spacing:-.3pt'> </span>at<span
style='letter-spacing:-.35pt'> </span>requ<span style='letter-spacing:.05pt'>e</span>sted<span
style='letter-spacing:-.35pt'> </span>int<span style='letter-spacing:-.15pt'>e</span>rvals<span
style='letter-spacing:-.3pt'> </span>(42.6%),<span style='letter-spacing:-.35pt'>
</span>patient<span style='letter-spacing:-.35pt'> </span>refused<span
style='letter-spacing:-.3pt'> </span>trea<span style='letter-spacing:.05pt'>t</span>ment<span
style='letter-spacing:-.35pt'> </span>with<span style='letter-spacing:-.35pt'> </span>VKA
(37.4%),<span style='letter-spacing:-.3pt'> </span>CHADS2<span
style='letter-spacing:-.25pt'> </span>score<span style='letter-spacing:-.2pt'> </span>=<span
style='letter-spacing:-.3pt'> </span>1<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>ph<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>s</span>ician<span style='letter-spacing:-.3pt'> </span>did<span
style='letter-spacing:-.25pt'> </span>not<span style='letter-spacing:-.4pt'> </span>rec<span
style='letter-spacing:.05pt'>o</span>mmend<span style='letter-spacing:-.25pt'> </span>VKA<span
style='letter-spacing:-.25pt'> </span>(21.3%),<span style='letter-spacing:-.3pt'>
</span>patient<span style='letter-spacing:-.25pt'> </span>could<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.3pt'> </span>be
relied<span style='letter-spacing:-.35pt'> </span>on<span style='letter-spacing:
-.3pt'> </span>to<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>a</span>dhere<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>VKA<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>dicinal<span
style='letter-spacing:-.3pt'> </span>product<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.05pt'>i</span>nstruct<span
style='letter-spacing:-.1pt'>i</span>on<span style='letter-spacing:-.3pt'> </span>(15.0%),<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>difficul<span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>/expected<span
style='letter-spacing:-.35pt'> </span>d<span style='letter-spacing:-.05pt'>i</span>fficulty<span
style='letter-spacing:-.3pt'> </span>in contacting<span style='letter-spacing:
-.3pt'> </span>p<span style='letter-spacing:-.1pt'>a</span>tient<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>case<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>urgent<span
style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:-.3pt'> </span>change<span
style='letter-spacing:-.3pt'> </span>(11.7%).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>AVERROES<span style='letter-spacing:-.35pt'> </span>was<span
style='letter-spacing:-.35pt'> </span>stopped<span style='letter-spacing:-.3pt'>
</span>early<span style='letter-spacing:-.25pt'> </span>based<span
style='letter-spacing:-.35pt'> </span>on<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.35pt'> </span>rec<span style='letter-spacing:.05pt'>o</span>mmendation<span
style='letter-spacing:-.35pt'> </span>by<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>th</span>e<span style='letter-spacing:-.35pt'> </span>independent<span
style='letter-spacing:-.35pt'> </span>Data<span style='letter-spacing:-.35pt'> </span>Monitoring
C<span style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>ittee<span
style='letter-spacing:-.3pt'> </span>due<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>clear<span style='letter-spacing:-.3pt'> </span>evidence<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>reduction<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>s<span
style='letter-spacing:-.05pt'>t</span>roke<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>s</span><span
style='letter-spacing:.05pt'>y</span>stemic<span style='letter-spacing:-.3pt'> </span>e<span
style='letter-spacing:-.1pt'>m</span>bolism<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>an<span style='letter-spacing:-.25pt'> </span>acceptable
<span style='letter-spacing:-.05pt'>safet</span>y<span style='letter-spacing:
-.5pt'> </span><span style='letter-spacing:-.05pt'>profile.</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>overall<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>d</span>iscontinuati<span
style='letter-spacing:-.05pt'>o</span>n<span style='letter-spacing:-.25pt'> </span>rate<span
style='letter-spacing:-.25pt'> </span>due<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>adverse<span style='letter-spacing:-.25pt'>
</span>reactions<span style='letter-spacing:-.25pt'> </span>was<span
style='letter-spacing:-.25pt'> </span>1.5%<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>and<span style='letter-spacing:-.25pt'> </span>1.3%<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>ASA<span
style='letter-spacing:-.25pt'> </span>in the<span style='letter-spacing:-.5pt'>
</span>AVER<span style='letter-spacing:.05pt'>R</span>OES<span
style='letter-spacing:-.5pt'> </span>stud<span style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>stu<span style='letter-spacing:-.05pt'>d</span>y,<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>achieved<span style='letter-spacing:-.35pt'> </span>statistically<span
style='letter-spacing:-.2pt'> </span>s<span style='letter-spacing:-.1pt'>i</span><span
style='letter-spacing:-.05pt'>g</span>nificant<span style='letter-spacing:-.3pt'>
</span>superiori<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>pri<span style='letter-spacing:-.1pt'>m</span>ary<span
style='letter-spacing:-.35pt'> </span>endp<span style='letter-spacing:-.05pt'>o</span>int<span
style='letter-spacing:-.3pt'> </span>of prevention<span style='letter-spacing:
-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>stroke<span
style='letter-spacing:-.35pt'> </span>(ha<span style='letter-spacing:.05pt'>e</span>morrhagic,<span
style='letter-spacing:-.3pt'> </span>ischa<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:-.4pt'> </span>unspecified)<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.35pt'> </span>s<span
style='letter-spacing:.05pt'>y</span>ste<span style='letter-spacing:-.1pt'>m</span>ic<span
style='letter-spacing:-.35pt'> </span>e<span style='letter-spacing:-.05pt'>m</span>boli<span
style='letter-spacing:.05pt'>s</span>m<span style='letter-spacing:-.4pt'> </span>(see<span
style='letter-spacing:-.4pt'> </span>Ta<span style='letter-spacing:.05pt'>b</span>le<span
style='letter-spacing:-.35pt'> </span>6) c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>pared<span style='letter-spacing:-.4pt'> </span>to<span
style='letter-spacing:-.4pt'> </span>ASA.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>6:<span
style='letter-spacing:-.3pt'> </span>Key<span style='letter-spacing:-.3pt'> e</span>fficacy<span
style='letter-spacing:-.2pt'> o</span>utcomes<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.3pt'> p</span>atients<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.3pt'> a</span>trial<span
style='letter-spacing:-.3pt'> f</span>ibrillation<span style='letter-spacing:
-.35pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>AVERROES<span style='letter-spacing:-.3pt'>
s</span>tudy</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:46.45pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:46.45pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=112 style='width:84.3pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:46.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N<span style='letter-spacing:
  -.2pt'> </span>=<span style='letter-spacing:-.2pt'> </span>2,807</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.5pt'> </span>(%/year)</span></b></p>
  </td>
  <td width=102 style='width:76.35pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:46.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>ASA</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N<span style='letter-spacing:
  -.2pt'> </span>=<span style='letter-spacing:-.2pt'> </span>2,791</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.5pt'> </span>(%/year)</span></b></p>
  </td>
  <td width=122 style='width:91.65pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:46.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>H<span style='letter-spacing:
  .05pt'>a</span>zard<span style='letter-spacing:-.65pt'> r</span>atio</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(95%<span
  style='letter-spacing:-.45pt'> </span>CI)</span></b></p>
  </td>
  <td width=67 style='width:50.05pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:46.45pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>p-value</span></b></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stroke<span style='letter-spacing:-.45pt'>
  </span>or<span style='letter-spacing:-.4pt'> </span><span style='letter-spacing:
  -.1pt'>s</span><span style='letter-spacing:.05pt'>y</span>s<span
  style='letter-spacing:-.05pt'>t</span>e<span style='letter-spacing:-.1pt'>m</span>ic<span
  style='letter-spacing:-.45pt'> </span>embolis<span style='letter-spacing:
  -.1pt'>m</span>*</span></p>
  </td>
  <td width=112 style='width:84.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>51&nbsp;(1<span
  style='letter-spacing:-.05pt'>.</span>62)</span></p>
  </td>
  <td width=102 style='width:76.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>113<span style='letter-spacing:
  -.45pt'>&nbsp;</span>(<span style='letter-spacing:-.05pt'>3</span>.63)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.45&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.3<span style='letter-spacing:-.05pt'>2</span>,<span
  style='letter-spacing:-.35pt'> </span>0<span style='letter-spacing:-.05pt'>.</span>62)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>&lt;&nbsp;0.00<span
  style='letter-spacing:-.05pt'>0</span>1</span></p>
  </td>
 </tr>
 <tr style='height:13.2pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.2pt'>
  <p class=TableParagraph style='margin-left:14.35pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stroke</span></p>
  </td>
  <td width=112 style='width:84.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=102 style='width:76.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:23.1pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Ischaemic<span style='letter-spacing:
  -.55pt'> </span>or<span style='letter-spacing:-.5pt'> </span>unspecified</span></p>
  </td>
  <td width=112 style='width:84.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>43&nbsp;(1<span
  style='letter-spacing:-.05pt'>.</span>37)</span></p>
  </td>
  <td width=102 style='width:76.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>97&nbsp;(3<span
  style='letter-spacing:-.05pt'>.</span>11)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.44<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.3<span
  style='letter-spacing:-.05pt'>1</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>63)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:23.1pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Hae<span style='letter-spacing:-.1pt'>m</span>orr<span
  style='letter-spacing:.05pt'>h</span>agic</span></p>
  </td>
  <td width=112 style='width:84.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>6<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0.<span style='letter-spacing:-.05pt'>1</span>9)</span></p>
  </td>
  <td width=102 style='width:76.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>9<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0.<span style='letter-spacing:-.05pt'>2</span>8)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.67<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.2<span
  style='letter-spacing:-.05pt'>4</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>88)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:14.35pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>S<span style='letter-spacing:.05pt'>y</span>ste<span
  style='letter-spacing:-.1pt'>m</span>ic<span style='letter-spacing:-.85pt'> </span>embolism</span></p>
  </td>
  <td width=112 style='width:84.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0.<span style='letter-spacing:-.05pt'>0</span>6)</span></p>
  </td>
  <td width=102 style='width:76.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>13<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>41)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.15<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.0<span
  style='letter-spacing:-.05pt'>3</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>68)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:25.8pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Stroke,<span style='letter-spacing:-.6pt'>
  </span><span style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:
  .05pt'>y</span>stemic<span style='letter-spacing:-.6pt'> </span>e<span
  style='letter-spacing:-.1pt'>m</span>bolis<span style='letter-spacing:-.1pt'>m</span>,
  MI,<span style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:
  -.3pt'> </span>vascular<span style='letter-spacing:-.3pt'> </span>death<b>*</b><sup>†</sup></span></p>
  </td>
  <td width=112 style='width:84.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>132<span style='letter-spacing:
  -.45pt'>&nbsp;</span>(<span style='letter-spacing:-.05pt'>4</span>.21)</span></p>
  </td>
  <td width=102 style='width:76.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>197&nbsp;(<span
  style='letter-spacing:-.05pt'>6</span>.35)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.66<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.5<span
  style='letter-spacing:-.05pt'>3</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>83)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:25.8pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>0</span>3</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:14.35pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Myocardial<span style='letter-spacing:
  -.95pt'> </span>infarction</span></p>
  </td>
  <td width=112 style='width:84.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>24<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>76)</span></p>
  </td>
  <td width=102 style='width:76.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>28<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>89)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.86<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.5<span
  style='letter-spacing:-.05pt'>0</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>48)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:14.35pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Vascular<span style='letter-spacing:-.65pt'>
  d</span>eath</span></p>
  </td>
  <td width=112 style='width:84.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>84<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(2.65)</span></p>
  </td>
  <td width=102 style='width:76.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>96<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(<span style='letter-spacing:-.05pt'>3</span>.03)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.87<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0.65,<span style='letter-spacing:-.35pt'> </span>1.17)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.2pt'>
  <td width=199 style='width:149.55pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.2pt'>
  <p class=TableParagraph style='margin-left:3.15pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All-cause<span style='letter-spacing:
  -.7pt'> </span>death<sup>†</sup></span></p>
  </td>
  <td width=112 style='width:84.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>111<span style='letter-spacing:
  -.45pt'>&nbsp;</span>(<span style='letter-spacing:-.05pt'>3</span>.51)</span></p>
  </td>
  <td width=102 style='width:76.35pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>140<span style='letter-spacing:
  -.45pt'>&nbsp;</span>(<span style='letter-spacing:-.05pt'>4</span>.42)</span></p>
  </td>
  <td width=122 style='width:91.65pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.79<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.6<span
  style='letter-spacing:-.05pt'>2</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>02)</span></p>
  </td>
  <td width=67 style='width:50.05pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.2pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>6</span>8</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>* Assessed<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.1pt'>b</span>y<span style='letter-spacing:-.1pt'> </span>s<span
style='letter-spacing:-.05pt'>e</span>quent<span style='letter-spacing:-.05pt'>i</span>al<span
style='letter-spacing:-.2pt'> </span>testing<span style='letter-spacing:-.2pt'>
</span><span style='letter-spacing:-.1pt'>s</span>tra<span style='letter-spacing:
-.05pt'>t</span>e<span style='letter-spacing:-.1pt'>g</span>y<span
style='letter-spacing:-.1pt'> </span>desig<span style='letter-spacing:-.1pt'>n</span>ed<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.15pt'> </span>control<span
style='letter-spacing:-.2pt'> </span>t<span style='letter-spacing:-.1pt'>h</span>e<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>o</span>vera<span
style='letter-spacing:-.05pt'>l</span>l<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>p</span>e<span style='letter-spacing:-.1pt'> </span>I<span
style='letter-spacing:-.2pt'> </span>err<span style='letter-spacing:-.1pt'>o</span>r<span
style='letter-spacing:-.15pt'> </span>in<span style='letter-spacing:-.15pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>tr<span style='letter-spacing:-.05pt'>i</span>al</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><sup><span lang=EN-GB
style='font-size:11.0pt'>†</span></sup><span lang=EN-GB style='font-size:11.0pt;
letter-spacing:-.35pt'> </span><span lang=EN-GB style='font-size:11.0pt'>Seconda<span
style='letter-spacing:-.1pt'>r</span>y<span style='letter-spacing:-.35pt'> </span>en<span
style='letter-spacing:-.1pt'>d</span>point.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.35pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>no<span style='letter-spacing:-.2pt'> </span>statistically<span
style='letter-spacing:-.25pt'> </span>significant<span style='letter-spacing:
-.3pt'> </span>difference<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.4pt'> </span>the<span style='letter-spacing:-.3pt'> </span>incidence<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>major<span
style='letter-spacing:-.35pt'> </span>bleeding<span style='letter-spacing:-.3pt'>
</span>between<span style='letter-spacing:-.3pt'> </span>apixaban and<span
style='letter-spacing:-.25pt'> </span>ASA<span style='letter-spacing:-.25pt'> </span>(see<span
style='letter-spacing:-.2pt'> </span>Table<span style='letter-spacing:-.25pt'> </span>7).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>7:<span
style='letter-spacing:-.3pt'> </span>Bleeding<span style='letter-spacing:-.3pt'>
e</span>vents<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.05pt'>i</span>n<span style='letter-spacing:-.25pt'> p</span>atients<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> a</span>trial<span
style='letter-spacing:-.3pt'> f</span>ibri<span style='letter-spacing:-.05pt'>l</span>lation<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:-.3pt'> </span>AVERROES<span
style='letter-spacing:-.3pt'> s</span>tu<span style='letter-spacing:-.05pt'>d</span>y</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <thead>
  <tr style='height:38.45pt'>
   <td width=133 style='width:99.9pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:38.45pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=132 style='width:99.0pt;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:38.45pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>N<span
   style='letter-spacing:-.2pt'> </span>=<span style='letter-spacing:-.2pt'> </span>2,798</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>n(%/year)</span></b></p>
   </td>
   <td width=114 style='width:85.5pt;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:38.45pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>ASA</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>N<span
   style='letter-spacing:-.2pt'> </span>=<span style='letter-spacing:-.2pt'> </span>2,780</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span
   style='letter-spacing:-.5pt'> </span>(%/year)</span></b></p>
   </td>
   <td width=138 style='width:103.5pt;border:solid black 1.0pt;border-left:
   none;padding:0in 0in 0in 0in;height:38.45pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>H<span
   style='letter-spacing:.05pt'>a</span>zard<span style='letter-spacing:-.65pt'>
   r</span>atio</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>(95%CI)</span></b></p>
   </td>
   <td width=66 style='width:49.5pt;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:38.45pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>p-value</span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='height:.2in'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:.2in'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major*</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>45<span style='letter-spacing:
  -.4pt'>&nbsp;</span>(1<span style='letter-spacing:-.05pt'>.</span>41)</span></p>
  </td>
  <td width=114 style='width:85.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>29&nbsp;(0<span
  style='letter-spacing:-.05pt'>.</span>92)</span></p>
  </td>
  <td width=138 style='width:103.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.54&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.9<span style='letter-spacing:-.05pt'>6</span>,<span
  style='letter-spacing:-.35pt'> </span>2<span style='letter-spacing:-.05pt'>.</span>45)</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>7</span>16</span></p>
  </td>
 </tr>
 <tr style='height:14.05pt'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.05pt'>
  <p class=TableParagraph style='margin-left:13.65pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Fatal,<span style='letter-spacing:-.35pt'>
  </span>n</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>5<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0.<span style='letter-spacing:-.05pt'>1</span>6)</span></p>
  </td>
  <td width=114 style='width:85.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>5<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0.<span style='letter-spacing:-.05pt'>1</span>6)</span></p>
  </td>
  <td width=138 style='width:103.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.05pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:13.15pt'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:13.15pt'>
  <p class=TableParagraph style='margin-left:13.65pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Intracranial,<span style='letter-spacing:
  -.6pt'> </span>n</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>11&nbsp;(0<span
  style='letter-spacing:-.05pt'>.</span>34)</span></p>
  </td>
  <td width=114 style='width:85.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>11&nbsp;(0<span
  style='letter-spacing:-.05pt'>.</span>35)</span></p>
  </td>
  <td width=138 style='width:103.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:13.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:.2in'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.4pt'> </span>+<span
  style='letter-spacing:-.35pt'> </span>CRNM<sup>†</sup></span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>140&nbsp;(<span
  style='letter-spacing:-.05pt'>4</span>.46)</span></p>
  </td>
  <td width=114 style='width:85.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>101&nbsp;(<span
  style='letter-spacing:-.05pt'>3</span>.24)</span></p>
  </td>
  <td width=138 style='width:103.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.38<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>1.0<span
  style='letter-spacing:-.05pt'>7</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>78)</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:.2in'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>1</span>44</span></p>
  </td>
 </tr>
 <tr style='height:17.6pt'>
  <td width=133 style='width:99.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:17.6pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All</span></p>
  </td>
  <td width=132 style='width:99.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.6pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>325<span style='letter-spacing:
  -.5pt'>&nbsp;</span>(<span style='letter-spacing:-.05pt'>1</span>0.<span
  style='letter-spacing:-.05pt'>8</span>5)</span></p>
  </td>
  <td width=114 style='width:85.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.6pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>250<span style='letter-spacing:
  -.45pt'>&nbsp;</span>(<span style='letter-spacing:-.05pt'>8</span>.32)</span></p>
  </td>
  <td width=138 style='width:103.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.6pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.30<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>1.1<span
  style='letter-spacing:-.05pt'>0</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>53)</span></p>
  </td>
  <td width=66 style='width:49.5pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:17.6pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.0<span style='letter-spacing:
  -.05pt'>0</span>17</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>* Major<span style='letter-spacing:-.25pt'> </span>bleeding<span
style='letter-spacing:-.3pt'> </span>defi<span style='letter-spacing:-.1pt'>n</span>ed<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>p</span>er<span
style='letter-spacing:-.25pt'> </span>I<span style='letter-spacing:-.1pt'>n</span>ternatio<span
style='letter-spacing:-.1pt'>n</span>al<span style='letter-spacing:-.25pt'> </span>Socie<span
style='letter-spacing:-.15pt'>t</span>y<span style='letter-spacing:-.25pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>Thrombosis<span style='letter-spacing:
-.3pt'> </span>ad<span style='letter-spacing:-.25pt'> </span>Hae<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>ostasi</span>s<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>(ISTH</span>)<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>criteria.</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>†<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>Clinicall</span>y<span style='letter-spacing:
-.15pt'> </span><span style='letter-spacing:-.1pt'>R</span>e<span
style='letter-spacing:-.05pt'>levan</span>t<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>Non-Major</span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>NVAF patients with ACS and/or undergoing PCI</span></u></i></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>AUGUSTUS, an open-label, randomised, controlled, 2 by
2 factorial design trial, enrolled 4614 patients with NVAF who had ACS (43%)
and/or underwent PCI (56%). All patients received background therapy with a
P2Y12 inhibitor (clopidogrel: 90.3%) prescribed per local standard of care.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>Patients were randomised up to 14 days after the ACS
and/or PCI to either apixaban 5 mg twice daily (2.5 mg twice daily if two or
more of the dose-reduction criteria were met; 10% received lower dose) or VKA
and to either ASA (81 mg once daily) or placebo. The mean age was 69.9 years,
94% of patients randomised had a CHA2DS2-VASc score &gt; 2, and 47% had a
HAS-BLED score &gt; 3. For patients randomised to VKA, the proportion of time
in therapeutic range (TTR) (INR 2-3) was 56%, with 32% of time below TTR and
12% above TTR.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>The primary objective of AUGUSTUS was to assess
safety, with a primary endpoint of ISTH major or CRNM bleeding. In the apixaban
versus VKA comparison, the primary safety endpoint of ISTH major or CRNM bleeding
at month 6 occurred in 241 (10.5%), and 332 (14.7%) patients in the apixaban
arm and in the VKA arm respectively (HR=0.69, 95% CI: 0.58, 0.82; 2-sided
p&lt;0.0001 for non inferiority and p&lt;0.0001 for superiority). For VKA,
additional analyses using subgroups by TTR showed that the highest rate of
bleeding was associated with the lowest quartile of TTR. The rate of bleeding
was similar between apixaban and the highest quartile of TTR.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>In the ASA versus placebo comparison, the primary
safety endpoint of ISTH major or CRNM bleeding at month 6 occurred in 367
(16.1%), and 204 (9.0%) patients in the ASA arm and in the placebo arm
respectively (HR=1.88, 95% CI: 1.58, 2.23; two-sided p&lt;0.0001).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>Specifically, in apixaban-treated patients, major or
CRNM bleeding occurred in 157 (13.7%), and 84 (7.4%) patients in the ASA arm
and in the placebo arm respectively. In VKA-treated patients, major or CRNM
bleeding occurred in 208 (18.5%), and 122 (10.8%) patients in the ASA arm and
in the placebo arm respectively.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>Other treatment effects were evaluated as a secondary
objective of the study, with composite endpoints.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>In the apixaban versus VKA comparison, the composite
endpoint of death or re-hospitalization occurred in 541 (23.5%) and 632 (27.4%)
patients in the apixaban and in the VKA arm, respectively.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>The composite endpoint of death or ischemic event
(stroke, myocardial infarction, stent thrombosis or urgent revascularization)
occurred in 170 (7.4%), and 182 (7.9%) patients in the apixaban and in the VKA
arm, respectively.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>In the ASA versus placebo comparison, the composite
endpoint of death or re-hospitalization occurred in 604 (26.2%) and 569 (24.7%)
patients in the ASA and in the placebo arm, respectively. The composite
endpoint of death or ischemic event (stroke, myocardial infarction, stent
thrombosis or urgent revascularization) occurred in 163 (7.1%), and 189 (8.2%)
patients in the ASA and in the placebo arm, respectively.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Patients<span style='letter-spacing:-.8pt'> </span>und<span
style='letter-spacing:-.1pt'>e</span>rgoing<span style='letter-spacing:-.75pt'>
</span>card<span style='letter-spacing:-.05pt'>io</span>version</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>EMANATE,<span style='letter-spacing:-.3pt'> </span>an<span
style='letter-spacing:-.35pt'> </span>open-label,<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span>ulti-center<span
style='letter-spacing:-.35pt'> </span>stud<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.3pt'> </span>e<span style='letter-spacing:-.15pt'>n</span>rol<span
style='letter-spacing:-.05pt'>l</span>ed<span style='letter-spacing:-.35pt'> </span>1500<span
style='letter-spacing:-.35pt'>&nbsp;</span>patients<span style='letter-spacing:
-.35pt'> </span>who<span style='letter-spacing:-.3pt'> </span>were<span
style='letter-spacing:-.35pt'> </span>either<span style='letter-spacing:-.35pt'>
</span>oral anticoagulant<span style='letter-spacing:-.35pt'> </span>naïve<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span>pre-treated<span
style='letter-spacing:-.3pt'> </span>less<span style='letter-spacing:-.35pt'> </span>than<span
style='letter-spacing:-.3pt'> </span>48&nbsp;hours<span style='letter-spacing:
-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>scheduled<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>cardioversion<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>NVAF.
Patients<span style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:
-.25pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.25pt'> </span>1:1<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.05pt'>p</span>ixa<span
style='letter-spacing:-.05pt'>b</span>an<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>heparin<span
style='letter-spacing:-.25pt'> </span>and/or<span style='letter-spacing:-.25pt'>
</span>V<span style='letter-spacing:-.1pt'>K</span>A<span style='letter-spacing:
-.25pt'> </span>for<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>prevention<span style='letter-spacing:
-.3pt'> </span>of cardiovascular<span style='letter-spacing:-.4pt'> </span>events.<span
style='letter-spacing:-.35pt'> </span>Electrical<span style='letter-spacing:
-.4pt'> </span>and/or<span style='letter-spacing:-.35pt'> </span>pharmaco<span
style='letter-spacing:-.1pt'>l</span>ogic<span style='letter-spacing:-.35pt'> </span>cardiovers<span
style='letter-spacing:.05pt'>i</span>on<span style='letter-spacing:-.4pt'> </span>was<span
style='letter-spacing:-.35pt'> </span>conducted<span style='letter-spacing:
-.4pt'> </span>after<span style='letter-spacing:-.35pt'> </span>at<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:.05pt'>l</span>east<span
style='letter-spacing:-.4pt'> </span>5&nbsp;doses<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.2pt'> </span>5<span
style='letter-spacing:-.2pt'>&nbsp;</span>mg<span style='letter-spacing:-.2pt'>
</span>twice<span style='letter-spacing:-.2pt'> </span>daily<span
style='letter-spacing:-.2pt'> </span>apixaban<span style='letter-spacing:-.2pt'>
</span>(or<span style='letter-spacing:-.25pt'> </span>2.5&nbsp;<span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.15pt'> </span>daily<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.2pt'> </span>selected<span style='letter-spacing:-.2pt'>
</span>patients<span style='letter-spacing:-.2pt'> </span>(see<span
style='letter-spacing:-.2pt'> </span>section<span style='letter-spacing:-.2pt'>
</span>4.2))<span style='letter-spacing:-.2pt'> </span>or<span
style='letter-spacing:-.25pt'> </span>at least<span style='letter-spacing:-.2pt'>
</span>2<span style='letter-spacing:-.2pt'>&nbsp;</span>hours<span
style='letter-spacing:-.25pt'> </span>after<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>10<span style='letter-spacing:-.15pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>loading<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.2pt'> </span>(or<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.2pt'> </span>5<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.15pt'> </span>loading<span style='letter-spacing:-.2pt'>
</span>dose<span style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:
-.25pt'> </span>selec<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.2pt'> </span>patients<span style='letter-spacing:-.2pt'>
</span>(see<span style='letter-spacing:-.2pt'> </span>sect<span
style='letter-spacing:.05pt'>i</span>on<span style='letter-spacing:-.2pt'>&nbsp;</span>4.2))
if<span style='letter-spacing:-.3pt'> </span>earlier<span style='letter-spacing:
-.25pt'> </span>cardioversion<span style='letter-spacing:-.3pt'> </span>was<span
style='letter-spacing:-.25pt'> </span>required.<span style='letter-spacing:
-.3pt'> </span>In<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:-.3pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban<span style='letter-spacing:-.25pt'> </span>group,<span
style='letter-spacing:-.3pt'> </span>342<span style='letter-spacing:-.35pt'>&nbsp;</span>pat<span
style='letter-spacing:-.05pt'>i</span>ents<span style='letter-spacing:-.25pt'> </span>received<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>loading<span
style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:-.25pt'> </span>(331
patients<span style='letter-spacing:-.25pt'> </span>rece<span style='letter-spacing:
.05pt'>i</span>ved<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>10<span style='letter-spacing:-.2pt'>&nbsp;</span>mg<span
style='letter-spacing:-.25pt'> </span>dose<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>11<span style='letter-spacing:-.2pt'>&nbsp;</span>patients<span
style='letter-spacing:-.2pt'> </span>rece<span style='letter-spacing:.05pt'>i</span>ved<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.2pt'> </span>5<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>dose).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.25pt'> </span>were<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:.05pt'>n</span>o<span
style='letter-spacing:-.25pt'> </span>strokes<span style='letter-spacing:-.2pt'>
</span>(0<span style='letter-spacing:-.05pt'>%</span>)<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.2pt'> </span>g<span style='letter-spacing:-.05pt'>r</span>o<span
style='letter-spacing:-.05pt'>u</span>p<span style='letter-spacing:-.25pt'> </span>(<span
style='letter-spacing:-.05pt'>n</span>=<span style='letter-spacing:-.2pt'> </span>753)<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.3pt'> </span>6<span
style='letter-spacing:-.25pt'> </span>(0.80<span style='letter-spacing:-.05pt'>%</span>)<span
style='letter-spacing:-.25pt'> </span>stro<span style='letter-spacing:-.05pt'>k</span>es<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>heparin and/or<span style='letter-spacing:
-.25pt'> </span>VKA<span style='letter-spacing:-.2pt'> </span>group<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>(</span>n<span
style='letter-spacing:-.2pt'> </span>=<span style='letter-spacing:-.25pt'> </span>747;<span
style='letter-spacing:-.2pt'> </span>RR<span style='letter-spacing:-.25pt'> </span>0.00,<span
style='letter-spacing:-.2pt'> </span>95%<span style='letter-spacing:-.25pt'> </span>CI<span
style='letter-spacing:-.2pt'> </span>0.00,<span style='letter-spacing:-.3pt'> </span>0.64).<span
style='letter-spacing:-.2pt'> </span>All-cause<span style='letter-spacing:-.25pt'>
</span>death<span style='letter-spacing:-.2pt'> </span>occurred<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>2<span
style='letter-spacing:-.25pt'>&nbsp;</span>pati<span style='letter-spacing:
-.1pt'>e</span>nts (0.27%)<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>th</span>e<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>g<span style='letter-spacing:-.1pt'>r</span>oup<span style='letter-spacing:
-.25pt'> </span>and<span style='letter-spacing:-.25pt'> </span>1<span
style='letter-spacing:-.25pt'>&nbsp;</span>pa<span style='letter-spacing:-.05pt'>t</span>ient<span
style='letter-spacing:-.25pt'> </span>(0.13<span style='letter-spacing:-.05pt'>%</span>)<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>i</span>n<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>heparin<span
style='letter-spacing:-.3pt'> </span>and/or<span style='letter-spacing:-.25pt'>
</span>VKA<span style='letter-spacing:-.25pt'> </span>group.<span
style='letter-spacing:-.25pt'> </span>No<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>s</span>yste<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>c e<span style='letter-spacing:-.1pt'>m</span>bolism<span
style='letter-spacing:-.55pt'> </span>events<span style='letter-spacing:-.45pt'>
</span>were<span style='letter-spacing:-.45pt'> </span>rep<span
style='letter-spacing:.05pt'>o</span>rted.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Major<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>CRNM<span
style='letter-spacing:-.3pt'> </span>bleeding<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.1pt'>e</span>vents<span style='letter-spacing:
-.25pt'> </span>occ<span style='letter-spacing:-.05pt'>u</span>rred<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>3<span
style='letter-spacing:-.3pt'>&nbsp;</span>(0.<span style='letter-spacing:-.05pt'>4</span>1<span
style='letter-spacing:-.05pt'>%</span>)<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>11<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>(</span>1.<span style='letter-spacing:-.05pt'>5</span>0<span
style='letter-spacing:-.05pt'>%</span>)<span style='letter-spacing:-.3pt'> </span>patients,
respectivel<span style='letter-spacing:.1pt'>y</span>,<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>group,<span style='letter-spacing:2.25pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>p</span>ared<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>6<span
style='letter-spacing:-.2pt'>&nbsp;</span>(0.83<span style='letter-spacing:
-.05pt'>%</span>)<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>1</span>3<span
style='letter-spacing:-.25pt'>&nbsp;</span>(1.<span style='letter-spacing:-.05pt'>8</span>0<span
style='letter-spacing:-.05pt'>%</span>)<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>h<span style='letter-spacing:-.1pt'>e</span>parin
and/or<span style='letter-spacing:-.45pt'> </span>VKA<span style='letter-spacing:
-.4pt'> </span>group.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>This<span style='letter-spacing:-.35pt'> </span>exploratory<span
style='letter-spacing:-.25pt'> </span>study<span style='letter-spacing:-.35pt'>
</span>showed<span style='letter-spacing:-.35pt'> </span>c<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>par<span
style='letter-spacing:.05pt'>a</span>ble<span style='letter-spacing:-.35pt'> </span>efficacy<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>safety<span
style='letter-spacing:-.35pt'> </span>between<span style='letter-spacing:-.35pt'>
</span>apixab<span style='letter-spacing:.05pt'>a</span>n<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>heparin<span
style='letter-spacing:-.3pt'> </span>and/or VKA<span style='letter-spacing:
-.35pt'> </span>trea<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>m</span>ent<span style='letter-spacing:-.3pt'> </span>groups<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>setting<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>cardioversion.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>Treatment<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>DVT,<span style='letter-spacing:-.3pt'> </span>treatment<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>PE<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.4pt'> </span>prevention<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.35pt'> </span>recurrent<span
style='letter-spacing:-.3pt'> </span>D<span style='letter-spacing:.05pt'>V</span>T<span
style='letter-spacing:-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.35pt'> </span>(VTEt)</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.55pt'> </span>clinical<span
style='letter-spacing:-.5pt'> </span>program<span style='letter-spacing:-.65pt'>
</span>(AMPLIFY:<span style='letter-spacing:-.5pt'> </span>apixaban<span
style='letter-spacing:-.55pt'> </span>versus<span style='letter-spacing:-.5pt'>
</span>enoxaparin/warfarin,<span style='letter-spacing:-.55pt'> </span>AMPLIFY-EXT:<span
style='letter-spacing:-.5pt'> </span>apixaban versus<span style='letter-spacing:
-.3pt'> </span>place<span style='letter-spacing:.05pt'>b</span>o)<span
style='letter-spacing:-.25pt'> </span>was<span style='letter-spacing:-.25pt'> </span>designed<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.25pt'> </span>de<span
style='letter-spacing:-.1pt'>m</span>onstrate<span style='letter-spacing:-.3pt'>
</span>the<span style='letter-spacing:-.25pt'> </span>efficacy<span
style='letter-spacing:-.15pt'> </span>and<span style='letter-spacing:-.3pt'> </span>safety<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>treatment<span style='letter-spacing:
-.3pt'> </span>of DVT<span style='letter-spacing:-.3pt'> </span>and/or<span
style='letter-spacing:-.3pt'> </span>PE<span style='letter-spacing:-.25pt'> </span>(AMPLIFY),<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>extended<span
style='letter-spacing:-.25pt'> </span>thera<span style='letter-spacing:-.05pt'>p</span>y<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>f</span>or<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>preven<span
style='letter-spacing:-.05pt'>t</span>ion<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>recurrent<span style='letter-spacing:-.25pt'>
</span>DVT<span style='letter-spacing:-.3pt'> </span>and/<span
style='letter-spacing:-.05pt'>o</span>r<span style='letter-spacing:-.3pt'> </span>PE
following<span style='letter-spacing:-.35pt'> </span>6&nbsp;<span
style='letter-spacing:-.05pt'>t</span>o<span style='letter-spacing:-.3pt'> </span>12<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>onths<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span>anticoagu<span
style='letter-spacing:-.05pt'>l</span>ant<span style='letter-spacing:-.3pt'> </span>treat<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.15pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>DVT<span
style='letter-spacing:-.3pt'> </span>and/or<span style='letter-spacing:-.3pt'> </span>PE<span
style='letter-spacing:-.3pt'> </span>(AMPLIFY-EXT).<span style='letter-spacing:
-.25pt'> </span>Both studies<span style='letter-spacing:-.45pt'> </span>were<span
style='letter-spacing:-.4pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised,<span
style='letter-spacing:-.4pt'> </span>parallel-group,<span style='letter-spacing:
-.45pt'> </span>double-blind,<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ultinational<span style='letter-spacing:
-.4pt'> </span>trials<span style='letter-spacing:-.45pt'> </span>in<span
style='letter-spacing:-.4pt'> </span>pat<span style='letter-spacing:-.05pt'>i</span>ents<span
style='letter-spacing:-.4pt'> </span>with s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptomatic<span style='letter-spacing:-.3pt'>
</span>proxi<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>a</span>l<span style='letter-spacing:-.25pt'> </span>DVT<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>s</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptomatic<span style='letter-spacing:-.3pt'>
</span>PE.<span style='letter-spacing:-.3pt'> </span>A<span style='letter-spacing:
-.1pt'>l</span>l<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>k<span style='letter-spacing:-.1pt'>e</span>y<span
style='letter-spacing:-.2pt'> </span>safety<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>efficacy<span style='letter-spacing:-.3pt'>
</span>endp<span style='letter-spacing:-.05pt'>o</span>ints<span
style='letter-spacing:-.35pt'> </span>were adjudicated<span style='letter-spacing:
-.45pt'> </span>by<span style='letter-spacing:-.4pt'> </span>an<span
style='letter-spacing:-.45pt'> </span>independent<span style='letter-spacing:
-.4pt'> </span>blinded<span style='letter-spacing:-.45pt'> </span>c<span
style='letter-spacing:.05pt'>o</span>m<span style='letter-spacing:-.1pt'>m</span>ittee.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>AMPLIFY<span style='letter-spacing:-.85pt'> </span>STUDY</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>AMPLIFY<span style='letter-spacing:-.25pt'>
</span>stu<span style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:
-.15pt'> </span>a<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>t</span>otal<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:-.05pt'>,</span>395<span
style='letter-spacing:-.3pt'>&nbsp;</span>patients<span style='letter-spacing:
-.25pt'> </span>were<span style='letter-spacing:-.25pt'> </span>rando<span
style='letter-spacing:-.1pt'>m</span>ised<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.25pt'> </span>treat<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.25pt'> </span>with<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g twice<span style='letter-spacing:-.25pt'>
</span>daily<span style='letter-spacing:-.15pt'> </span>o<span
style='letter-spacing:-.1pt'>r</span>ally<span style='letter-spacing:-.1pt'> f</span>or<span
style='letter-spacing:-.25pt'> </span>7<span style='letter-spacing:-.25pt'>&nbsp;</span>days<span
style='letter-spacing:-.25pt'> </span>followed<span style='letter-spacing:-.2pt'>
</span><span style='letter-spacing:-.05pt'>b</span>y<span style='letter-spacing:
-.2pt'> </span>apixaban<span style='letter-spacing:-.3pt'> </span>5<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.2pt'> </span>daily<span
style='letter-spacing:-.25pt'> </span>oral<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.1pt'> </span>for<span style='letter-spacing:-.3pt'> </span>6<span
style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>onths,<span
style='letter-spacing:-.2pt'> </span>or<span style='letter-spacing:-.25pt'> </span>enoxaparin
1<span style='letter-spacing:-.25pt'>&nbsp;</span><span style='letter-spacing:
-.1pt'>m</span>g/kg<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.1pt'> </span>subcutaneously<span
style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:-.3pt'> </span>at<span
style='letter-spacing:-.2pt'> </span>least<span style='letter-spacing:-.25pt'> </span>5<span
style='letter-spacing:-.25pt'>&nbsp;</span>days<span style='letter-spacing:
-.2pt'> </span>(until<span style='letter-spacing:-.25pt'> </span>IN<span
style='letter-spacing:-.1pt'>R</span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>2)<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.25pt'> </span>warfarin<span
style='letter-spacing:-.25pt'> </span>(target<span style='letter-spacing:-.2pt'>
</span>INR<span style='letter-spacing:-.25pt'> </span>range 2.0&#8209;3<span
style='letter-spacing:-.05pt'>.</span>0)<span style='letter-spacing:-.3pt'> </span>oral<span
style='letter-spacing:-.05pt'>l</span>y<span style='letter-spacing:-.3pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>6<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>ont<span style='letter-spacing:-.05pt'>hs</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>mean<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:.05pt'>g</span>e<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.25pt'> </span>56.9<span
style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:.05pt'>y</span>ears<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>89.<span
style='letter-spacing:-.05pt'>8</span>%<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.25pt'> </span>patients<span style='letter-spacing:-.25pt'>
</span>had<span style='letter-spacing:-.3pt'> </span>unpr<span
style='letter-spacing:-.05pt'>o</span>vok<span style='letter-spacing:-.1pt'>e</span>d<span
style='letter-spacing:-.25pt'> </span>VTE<span style='letter-spacing:-.3pt'> </span>events.
For<span style='letter-spacing:-.3pt'> </span>patients<span style='letter-spacing:
-.3pt'> </span>rando<span style='letter-spacing:-.1pt'>m</span>ised<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.25pt'> </span>warfarin,<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>mean<span
style='letter-spacing:-.3pt'> </span>perce<span style='letter-spacing:.05pt'>n</span>tage<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>time<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>therapeutic<span
style='letter-spacing:-.25pt'> </span>range<span style='letter-spacing:-.3pt'> </span>(INR<span
style='letter-spacing:-.3pt'> </span>2.0&#8209;3.0) was<span style='letter-spacing:
-.3pt'> </span>60.9.<span style='letter-spacing:-.3pt'> </span>Ap<span
style='letter-spacing:-.05pt'>i</span>xaban<span style='letter-spacing:-.3pt'> </span>showed<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:-.25pt'> </span>reduction<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>recurrent<span
style='letter-spacing:-.3pt'> </span>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>pto<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>t<span style='letter-spacing:.05pt'>i</span>c<span
style='letter-spacing:-.25pt'> </span>VTE<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>VTE-<span style='letter-spacing:-.3pt'> </span>related<span
style='letter-spacing:-.25pt'> </span>death<span style='letter-spacing:-.3pt'> </span>across
the<span style='letter-spacing:-.3pt'> </span>different<span style='letter-spacing:
-.25pt'> </span>levels<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>center<span style='letter-spacing:-.25pt'>
</span>TTR;<span style='letter-spacing:-.25pt'> </span>within<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>hig<span
style='letter-spacing:-.05pt'>h</span>est<span style='letter-spacing:-.25pt'> </span>quartile<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>TTR<span
style='letter-spacing:-.25pt'> </span>according<span style='letter-spacing:
-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>center,<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>relative
risk<span style='letter-spacing:-.3pt'> </span>for<span style='letter-spacing:
-.3pt'> </span>apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.3pt'> </span>vs<span style='letter-spacing:-.3pt'> </span>enox<span
style='letter-spacing:-.1pt'>a</span>parin/warfarin<span style='letter-spacing:
-.3pt'> </span>was<span style='letter-spacing:-.25pt'> </span>0.79<span
style='letter-spacing:-.3pt'> </span>(<span style='letter-spacing:-.05pt'>9</span>5%<span
style='letter-spacing:-.35pt'> </span>CI,<span style='letter-spacing:-.3pt'> </span>0.39,<span
style='letter-spacing:-.3pt'> </span>1.61).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>stu<span style='letter-spacing:-.05pt'>d</span>y,<span
style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>was<span style='letter-spacing:-.25pt'> </span>shown<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.35pt'> </span>be<span
style='letter-spacing:-.3pt'> </span>non-infer<span style='letter-spacing:-.05pt'>i</span>or<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>t</span>o<span
style='letter-spacing:-.3pt'> </span>enoxaparin<span style='letter-spacing:
-.05pt'>/</span>warfarin<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>c<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>bined<span
style='letter-spacing:-.25pt'> </span>pri<span style='letter-spacing:-.1pt'>m</span>ary
endpoint<span style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.1pt'>a</span>djudicated<span
style='letter-spacing:-.35pt'> </span>recurrent<span style='letter-spacing:
-.3pt'> </span>s<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.1pt'>m</span>ptomatic<span style='letter-spacing:-.35pt'>
</span>VTE<span style='letter-spacing:-.4pt'> </span>(nonfatal<span
style='letter-spacing:-.35pt'> </span>DVT<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.35pt'> </span>n<span style='letter-spacing:-.05pt'>o</span>nfatal<span
style='letter-spacing:-.35pt'> </span>PE)<span style='letter-spacing:-.35pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>VTE-related death<span style='letter-spacing:
-.3pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>T<span
style='letter-spacing:.05pt'>a</span>ble<span style='letter-spacing:-.25pt'> 8</span>).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>8:<span
style='letter-spacing:-.3pt'> </span>Efficacy<span style='letter-spacing:-.2pt'>
r</span>esults<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>AMPLIFY<span
style='letter-spacing:-.25pt'> s</span>tudy</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=631
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:14.15pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=110 style='width:82.6pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N=2,609</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></b></p>
  </td>
  <td width=168 style='width:125.9pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Enoxaparin/ w</span></b><b><span
  lang=EN-GB style='font-size:11.0pt'>arfarin</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N=2,635</span></b><b><span
  lang=EN-GB style='font-size:11.0pt'> </span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></b></p>
  </td>
  <td width=208 style='width:156.0pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Relative<span
  style='letter-spacing:-.6pt'> r</span>isk</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(95%<span
  style='letter-spacing:-.45pt'> </span>CI)</span></b></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.45pt'> </span>or<span
  style='letter-spacing:-.45pt'> </span>VTE-related death</span></p>
  </td>
  <td width=110 style='width:82.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>59<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(2<span style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=168 style='width:125.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>71<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(2<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=208 style='width:156.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.84&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.6<span style='letter-spacing:-.05pt'>0</span>,<span
  style='letter-spacing:-.35pt'> </span>1<span style='letter-spacing:-.05pt'>.</span>18)*</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:16.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>DVT</span></p>
  </td>
  <td width=110 style='width:82.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>20<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=168 style='width:125.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>33<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(1<span style='letter-spacing:-.05pt'>.</span>2)</span></p>
  </td>
  <td width=208 style='width:156.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:16.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>PE</span></p>
  </td>
  <td width=110 style='width:82.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>27<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(1<span style='letter-spacing:-.05pt'>.</span>0)</span></p>
  </td>
  <td width=168 style='width:125.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>23<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>9)</span></p>
  </td>
  <td width=208 style='width:156.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:16.45pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE-related</span><span lang=EN-GB
  style='font-size:11.0pt'> </span><span lang=EN-GB style='font-size:11.0pt'>death</span></p>
  </td>
  <td width=110 style='width:82.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>12<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>4)</span></p>
  </td>
  <td width=168 style='width:125.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>15<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>6)</span></p>
  </td>
  <td width=208 style='width:156.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.35pt'> </span>or<span
  style='letter-spacing:-.35pt'> </span>all-c<span style='letter-spacing:.05pt'>a</span>use
  death</span></p>
  </td>
  <td width=110 style='width:82.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>84<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(3<span style='letter-spacing:-.05pt'>.</span>2)</span></p>
  </td>
  <td width=168 style='width:125.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>104&nbsp;(<span
  style='letter-spacing:-.05pt'>4</span>.0)</span></p>
  </td>
  <td width=208 style='width:156.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.82&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.6<span style='letter-spacing:-.05pt'>1</span>,<span
  style='letter-spacing:-.35pt'> </span>1<span style='letter-spacing:-.05pt'>.</span>08)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.4pt'> </span>or<span
  style='letter-spacing:-.4pt'> </span>CV-<span style='letter-spacing:.05pt'>r</span>elated
  death</span></p>
  </td>
  <td width=110 style='width:82.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>61<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(2<span style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=168 style='width:125.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>77<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(2<span style='letter-spacing:-.05pt'>.</span>9)</span></p>
  </td>
  <td width=208 style='width:156.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.80<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.5<span
  style='letter-spacing:-.05pt'>7</span>,<span style='letter-spacing:-.35pt'> </span>1<span
  style='letter-spacing:-.05pt'>.</span>11)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=145 style='width:108.9pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE,<span style='letter-spacing:-.8pt'> </span>VTE-related
  death,<span style='letter-spacing:-.35pt'> </span>or<span style='letter-spacing:
  -.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
  style='letter-spacing:-.05pt'>a</span>jor bleeding</span></p>
  </td>
  <td width=110 style='width:82.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>73<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(2<span style='letter-spacing:-.05pt'>.</span>8)</span></p>
  </td>
  <td width=168 style='width:125.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>118&nbsp;(<span
  style='letter-spacing:-.05pt'>4</span>.5)</span></p>
  </td>
  <td width=208 style='width:156.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='margin-left:21.0pt;text-align:
  center;text-indent:-21.0pt;punctuation-wrap:simple'><span lang=EN-GB
  style='font-size:11.0pt'>0.62<span style='font:7.0pt "Times New Roman"'> </span></span><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>(</span><span
  lang=EN-GB style='font-size:11.0pt'>0.4<span style='letter-spacing:-.05pt'>7</span>,<span
  style='letter-spacing:-.35pt'> </span>0<span style='letter-spacing:-.05pt'>.</span>83)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>* Noninferior<span style='letter-spacing:-.2pt'> </span>c<span
style='letter-spacing:-.1pt'>o</span>mpared<span style='letter-spacing:-.1pt'> </span>to<span
style='letter-spacing:-.15pt'> </span>enoxaparin/war<span style='letter-spacing:
-.05pt'>f</span>arin<span style='letter-spacing:-.15pt'> </span>(<span
style='letter-spacing:-.1pt'>p</span>-value<span style='letter-spacing:-.15pt'>
</span>&lt;&nbsp;0.0001)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:.3pt'> </span>efficacy<span
style='letter-spacing:.3pt'> </span>in<span style='letter-spacing:.3pt'> </span>initial<span
style='letter-spacing:.3pt'> </span>trea<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:.3pt'> </span>of<span style='letter-spacing:.3pt'> </span>VTE<span
style='letter-spacing:.3pt'> </span>was<span style='letter-spacing:.25pt'> </span>consistent<span
style='letter-spacing:.3pt'> </span>between<span style='letter-spacing:.3pt'> </span>patients<span
style='letter-spacing:.3pt'> </span>who<span style='letter-spacing:.3pt'> </span>were<span
style='letter-spacing:.3pt'> </span>treated<span style='letter-spacing:.3pt'> </span>for<span
style='letter-spacing:.3pt'> </span>a PE<span style='letter-spacing:1.05pt'> </span>[<span
style='letter-spacing:.05pt'>R</span>elative<span style='letter-spacing:1.2pt'>
</span>Risk<span style='letter-spacing:1.1pt'> </span>0.9;<span
style='letter-spacing:1.05pt'> </span>95%<span style='letter-spacing:1.1pt'> </span>CI<span
style='letter-spacing:1.1pt'> </span>(0.5,<span style='letter-spacing:1.1pt'> </span>1.6<span
style='letter-spacing:.05pt'>)</span>]<span style='letter-spacing:1.0pt'> </span>or<span
style='letter-spacing:1.05pt'> </span>D<span style='letter-spacing:-.05pt'>V</span>T<span
style='letter-spacing:1.2pt'> </span>[Relative<span style='letter-spacing:1.1pt'>
</span>R<span style='letter-spacing:.05pt'>i</span>sk<span style='letter-spacing:
1.1pt'> </span>0.8;<span style='letter-spacing:1.05pt'> </span>95%<span
style='letter-spacing:1.1pt'> </span>CI<span style='letter-spacing:1.1pt'> </span>(0.5,<span
style='letter-spacing:1.1pt'> </span>1.3)<span style='letter-spacing:-.15pt'>]</span>.<span
style='letter-spacing:1.15pt'> </span>Efficacy across<span style='letter-spacing:
.4pt'> </span>subgroups,<span style='letter-spacing:.45pt'> </span>includi<span
style='letter-spacing:-.05pt'>n</span>g<span style='letter-spacing:.5pt'> </span>age,<span
style='letter-spacing:.5pt'> </span>gender,<span style='letter-spacing:.45pt'> </span>bo<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:.55pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ass<span style='letter-spacing:.45pt'> </span>ind<span
style='letter-spacing:-.1pt'>e</span>x<span style='letter-spacing:.4pt'> </span>(BMI),<span
style='letter-spacing:.45pt'> </span>renal<span style='letter-spacing:.45pt'> </span>function,<span
style='letter-spacing:.45pt'> </span>extent<span style='letter-spacing:.45pt'> </span>of<span
style='letter-spacing:.45pt'> </span>index<span style='letter-spacing:.45pt'> </span>PE,
location<span style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.1pt'>D</span><span
style='letter-spacing:-.05pt'>V</span>T<span style='letter-spacing:-.3pt'> </span>thro<span
style='letter-spacing:-.1pt'>m</span>bus,<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>pr<span style='letter-spacing:-.05pt'>i</span>or<span
style='letter-spacing:-.3pt'> </span>p<span style='letter-spacing:-.1pt'>a</span>rente<span
style='letter-spacing:-.05pt'>r</span>al<span style='letter-spacing:-.3pt'> </span>heparin<span
style='letter-spacing:-.35pt'> </span>use<span style='letter-spacing:-.3pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>generally<span style='letter-spacing:-.25pt'>
</span>consi<span style='letter-spacing:-.1pt'>s</span>tent.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:.7pt'> </span>pri<span
style='letter-spacing:-.1pt'>m</span>ary<span style='letter-spacing:.8pt'> </span>safety<span
style='letter-spacing:.85pt'> </span>endpo<span style='letter-spacing:-.05pt'>i</span>nt<span
style='letter-spacing:.7pt'> </span>was<span style='letter-spacing:.85pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor<span
style='letter-spacing:.75pt'> </span>bleeding.<span style='letter-spacing:.75pt'>
</span><span style='letter-spacing:-.1pt'>I</span>n<span style='letter-spacing:
.75pt'> </span>t<span style='letter-spacing:-.05pt'>h</span>e<span
style='letter-spacing:.75pt'> </span>stu<span style='letter-spacing:-.05pt'>d</span><span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:.75pt'> </span>ap<span
style='letter-spacing:-.05pt'>i</span>xaban<span style='letter-spacing:.7pt'> </span>was<span
style='letter-spacing:.75pt'> </span>statistically<span style='letter-spacing:
.85pt'> </span>superior<span style='letter-spacing:.75pt'> </span><span
style='letter-spacing:-.05pt'>t</span>o enoxaparin/warfarin<span
style='letter-spacing:2.2pt'> </span>in<span style='letter-spacing:2.15pt'> </span>the<span
style='letter-spacing:2.2pt'> </span>pri<span style='letter-spacing:-.1pt'>m</span>ary<span
style='letter-spacing:2.25pt'> </span>safety<span style='letter-spacing:2.25pt'>
</span>end<span style='letter-spacing:-.05pt'>p</span>oint<span
style='letter-spacing:2.05pt'> </span>[Relative<span style='letter-spacing:
2.2pt'> </span>Risk<span style='letter-spacing:2.15pt'> </span>0.31,<span
style='letter-spacing:2.2pt'> </span>9<span style='letter-spacing:-.05pt'>5</span>%<span
style='letter-spacing:2.15pt'> </span>confidence<span style='letter-spacing:
2.2pt'> </span>interval (0.17,<span style='letter-spacing:-.35pt'> </span>0.<span
style='letter-spacing:-.05pt'>5</span>5),<span style='letter-spacing:-.3pt'> </span>P-value<span
style='letter-spacing:-.25pt'> </span>&lt;<span style='letter-spacing:-.25pt'>&nbsp;</span>0.<span
style='letter-spacing:-.05pt'>0</span>001]<span style='letter-spacing:-.4pt'> </span>(see<span
style='letter-spacing:-.25pt'> </span>Ta<span style='letter-spacing:.05pt'>b</span>le<span
style='letter-spacing:-.25pt'> </span>9).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.3pt'> </span>9:<span
style='letter-spacing:-.3pt'> </span>Bleeding<span style='letter-spacing:-.3pt'>
r</span>esults<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>AMPLIFY<span style='letter-spacing:-.3pt'>
s</span>tu<span style='letter-spacing:-.05pt'>d</span>y</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=584
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:14.15pt'>
  <td width=146 style='width:109.35pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=146 style='width:109.5pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N=2,676</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></b></p>
  </td>
  <td width=152 style='width:113.95pt;border:solid black 1.0pt;border-left:
  none;padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Enoxaparin/ w</span></b><b><span
  lang=EN-GB style='font-size:11.0pt'>arfarin</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>N=2,689</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></b></p>
  </td>
  <td width=140 style='width:104.95pt;border:solid black 1.0pt;border-left:
  none;padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Relative<span
  style='letter-spacing:-.6pt'> r</span>isk</span></b></p>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(95%<span
  style='letter-spacing:-.45pt'> </span>CI)</span></b></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=146 style='width:109.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major</span></p>
  </td>
  <td width=146 style='width:109.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>15<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(0<span style='letter-spacing:-.05pt'>.</span>6)</span></p>
  </td>
  <td width=152 style='width:113.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>49&nbsp;(1<span
  style='letter-spacing:-.05pt'>.</span>8)</span></p>
  </td>
  <td width=140 style='width:104.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.31<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.1<span
  style='letter-spacing:-.05pt'>7</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>55)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=146 style='width:109.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.35pt'>
  </span>+<span style='letter-spacing:-.35pt'> </span>CRNM</span></p>
  </td>
  <td width=146 style='width:109.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>115&nbsp;(<span
  style='letter-spacing:-.05pt'>4</span>.3)</span></p>
  </td>
  <td width=152 style='width:113.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>261&nbsp;(<span
  style='letter-spacing:-.05pt'>9</span>.7)</span></p>
  </td>
  <td width=140 style='width:104.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.44<span style='letter-spacing:
  -.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>(</span>0.3<span
  style='letter-spacing:-.05pt'>6</span>,<span style='letter-spacing:-.35pt'> </span>0<span
  style='letter-spacing:-.05pt'>.</span>55)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=146 style='width:109.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Minor</span></p>
  </td>
  <td width=146 style='width:109.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>313&nbsp;(<span
  style='letter-spacing:-.05pt'>1</span>1.7)</span></p>
  </td>
  <td width=152 style='width:113.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>505&nbsp;(<span
  style='letter-spacing:-.05pt'>1</span>8.8)</span></p>
  </td>
  <td width=140 style='width:104.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.62&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.5<span style='letter-spacing:-.05pt'>4</span>,<span
  style='letter-spacing:-.35pt'> </span>0<span style='letter-spacing:-.05pt'>.</span>70)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=146 style='width:109.35pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All</span></p>
  </td>
  <td width=146 style='width:109.5pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>402&nbsp;(<span
  style='letter-spacing:-.05pt'>1</span>5.0)</span></p>
  </td>
  <td width=152 style='width:113.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>676&nbsp;(<span
  style='letter-spacing:-.05pt'>2</span>5.1)</span></p>
  </td>
  <td width=140 style='width:104.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.59&nbsp;<span
  style='letter-spacing:-.1pt'>(</span>0.5<span style='letter-spacing:-.05pt'>3</span>,<span
  style='letter-spacing:-.35pt'> </span>0<span style='letter-spacing:-.05pt'>.</span>66)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>adjudicated<span
style='letter-spacing:-.3pt'> </span>major<span style='letter-spacing:-.3pt'> </span>ble<span
style='letter-spacing:.05pt'>e</span>ding<span style='letter-spacing:-.25pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>CRNM<span style='letter-spacing:-.3pt'> </span>bleeding<span
style='letter-spacing:-.3pt'> </span>at<span style='letter-spacing:-.35pt'> </span>any<span
style='letter-spacing:-.2pt'> </span>anatomical<span style='letter-spacing:
-.3pt'> </span>si<span style='letter-spacing:.05pt'>t</span>e<span
style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:-.3pt'> </span>generally<span
style='letter-spacing:-.2pt'> </span>lower<span style='letter-spacing:-.3pt'> </span>in
the<span style='letter-spacing:-.35pt'> </span>apixaban<span style='letter-spacing:
-.4pt'> </span>group<span style='letter-spacing:-.35pt'> </span>as<span
style='letter-spacing:-.35pt'> </span>compared<span style='letter-spacing:-.3pt'>
</span>to<span style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:
-.35pt'> </span>enoxaparin/warfarin<span style='letter-spacing:-.35pt'> </span>grou<span
style='letter-spacing:-.05pt'>p</span>.<span style='letter-spacing:-.4pt'> </span>Adjudicated<span
style='letter-spacing:-.3pt'> </span>ISTH<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor
gastrointestinal<span style='letter-spacing:-.4pt'> </span>bleeding<span
style='letter-spacing:-.35pt'> </span>occurred<span style='letter-spacing:-.35pt'>
</span>in<span style='letter-spacing:-.35pt'> </span>6<span style='letter-spacing:
-.35pt'>&nbsp;</span>(0.2%)<span style='letter-spacing:-.45pt'> </span>apixaban-treated<span
style='letter-spacing:-.35pt'> </span>pa<span style='letter-spacing:.05pt'>t</span>ients<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>17&nbsp;(0.6%)
enoxaparin/warfarin-treated<span style='letter-spacing:-1.6pt'> </span>patients.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><i><u><span lang=EN-GB
style='font-size:11.0pt'>AMPLIFY-<span style='letter-spacing:.05pt'>E</span>XT<span
style='letter-spacing:-1.05pt'> </span>STUDY</span></u></i></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>AMPLIFY-EXT<span style='letter-spacing:
-.25pt'> </span>st<span style='letter-spacing:.05pt'>u</span><span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>total<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.05pt'>2</span>,482&nbsp;patien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.25pt'> </span>were<span
style='letter-spacing:-.3pt'> </span>rand<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>sed<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>treatment<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>api<span
style='letter-spacing:-.05pt'>x</span>aban</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>twice<span
style='letter-spacing:-.2pt'> </span>daily<span style='letter-spacing:-.25pt'> </span>orall<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.1pt'>a</span>pixaban<span style='letter-spacing:-.25pt'>
</span>5&nbsp;<span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>twice<span style='letter-spacing:-.2pt'> </span>d<span
style='letter-spacing:-.1pt'>a</span>ily<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.05pt'>o</span>rall<span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.25pt'> </span>placebo<span
style='letter-spacing:-.2pt'> </span>for<span style='letter-spacing:-.3pt'> </span>12&nbsp;<span
style='letter-spacing:-.1pt'>m</span>onths<span style='letter-spacing:-.25pt'> </span>after<span
style='letter-spacing:-.2pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>pleting
6&nbsp;to<span style='letter-spacing:-.25pt'> </span>12&nbsp;<span
style='letter-spacing:-.1pt'>m</span>onths<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>initial<span style='letter-spacing:-.25pt'>
</span><span style='letter-spacing:-.1pt'>a</span>nticoagulant<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>t</span>rea<span
style='letter-spacing:.05pt'>t</span>ment.<span style='letter-spacing:-.25pt'> </span>Of<span
style='letter-spacing:-.35pt'> </span>these,<span style='letter-spacing:-.25pt'>
</span>836&nbsp;pat<span style='letter-spacing:-.05pt'>i</span>ents<span
style='letter-spacing:-.25pt'> </span>(33.7%)<span style='letter-spacing:-.3pt'>
</span>participated<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>the AMPLIFY<span style='letter-spacing:
-.3pt'> </span>stu<span style='letter-spacing:-.05pt'>d</span>y<span
style='letter-spacing:-.25pt'> </span>prior<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>enroll<span style='letter-spacing:-.1pt'>m</span>ent<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>AMPL<span style='letter-spacing:-.05pt'>I</span>FY-EXT<span
style='letter-spacing:-.3pt'> </span>study.<span style='letter-spacing:-.25pt'>
</span>The<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.1pt'>m</span>ean<span style='letter-spacing:-.3pt'> </span>age<span
style='letter-spacing:-.25pt'> </span>was<span style='letter-spacing:-.25pt'> </span>56.7<span
style='letter-spacing:-.35pt'>&nbsp;</span>years<span style='letter-spacing:
-.25pt'> </span>and 91.7%<span style='letter-spacing:-.4pt'> </span>of<span
style='letter-spacing:-.35pt'> </span>ra<span style='letter-spacing:-.05pt'>n</span>do<span
style='letter-spacing:-.1pt'>m</span>ised<span style='letter-spacing:-.35pt'> </span>patien<span
style='letter-spacing:-.05pt'>t</span>s<span style='letter-spacing:-.35pt'> </span>had<span
style='letter-spacing:-.35pt'> </span>u<span style='letter-spacing:-.05pt'>n</span>pr<span
style='letter-spacing:-.05pt'>o</span>voked<span style='letter-spacing:-.35pt'>
</span>VTE<span style='letter-spacing:-.35pt'> </span><span style='letter-spacing:
-.1pt'>e</span>vents.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>study,<span style='letter-spacing:-.3pt'>
</span>both<span style='letter-spacing:-.3pt'> </span>doses<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>were<span style='letter-spacing:-.25pt'> </span>statistically<span
style='letter-spacing:-.25pt'> </span>superior<span style='letter-spacing:-.25pt'>
</span>to<span style='letter-spacing:-.3pt'> </span>p<span style='letter-spacing:
-.05pt'>l</span>acebo<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>pr<span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span>ary<span
style='letter-spacing:-.15pt'> </span>endpoint<span style='letter-spacing:-.25pt'>
</span>of s<span style='letter-spacing:.05pt'>y</span><span style='letter-spacing:
-.1pt'>m</span>ptomatic,<span style='letter-spacing:-.3pt'> </span>recurrent<span
style='letter-spacing:-.3pt'> </span>VTE<span style='letter-spacing:-.3pt'> </span>(nonfatal<span
style='letter-spacing:-.3pt'> </span>DVT<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>nonfa<span style='letter-spacing:-.05pt'>t</span>al<span
style='letter-spacing:-.3pt'> </span>PE)<span style='letter-spacing:-.3pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>all-cause<span style='letter-spacing:-.25pt'>
</span>death<span style='letter-spacing:-.3pt'> </span>(see<span
style='letter-spacing:-.3pt'> </span>Table<span style='letter-spacing:-.3pt'> </span>10).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.35pt'> </span>10:<span
style='letter-spacing:-.35pt'> </span>Efficacy<span style='letter-spacing:-.2pt'>
r</span>esults<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span>AMPLIFY-EXT<span
style='letter-spacing:-.3pt'> s</span>tudy</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=85 style='width:64.1pt;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  </td>
  <td width=86 style='width:.9in;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
  </td>
  <td width=91 style='width:.95in;border:solid black 1.0pt;border-left:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Placebo</span></b></p>
  </td>
  <td width=257 colspan=2 style='width:192.45pt;border:solid black 1.0pt;
  border-left:none;padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Relative<span
  style='letter-spacing:-.35pt'> r</span>isk<span style='letter-spacing:-.35pt'>
  </span>(95%<span style='letter-spacing:-.35pt'> </span>CI)</span></b></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=85 style='width:64.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>2.5<span
  style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>m</span>g
  (N=840)</span></b></p>
  </td>
  <td width=86 style='width:.9in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>5.0<span
  style='letter-spacing:-.3pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>m</span>g
  (N=813)</span></b></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>(N=829)</span></b></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix<span
  style='letter-spacing:-.3pt'> </span>2.5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.05pt'>m</span>g vs.<span style='letter-spacing:-.5pt'>
  p</span>lacebo</span></b></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix<span
  style='letter-spacing:-.3pt'> </span>5.0<span style='letter-spacing:-.25pt'>&nbsp;</span><span
  style='letter-spacing:-.05pt'>m</span>g vs.<span style='letter-spacing:-.5pt'>
  p</span>lacebo</span></b></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=263 colspan=3 style='width:197.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
  -.25pt'> </span>(%)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>Recurrent</span></p>
  </td>
  <td width=85 rowspan=2 style='width:64.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>19&nbsp;(2<span
  style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=86 rowspan=2 style='width:.9in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14&nbsp;(1<span
  style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>77&nbsp;(9<span
  style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.24</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.19</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.25pt'> </span>or<span
  style='letter-spacing:-.25pt'> </span>all-<span style='letter-spacing:-.05pt'>caus</span>e<span
  style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>death</span></span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.15,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>4</span>0)<sup><span
  style='position:relative;top:-4.5pt'>¥</span></sup></span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.11,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>3)<sup><span
  style='position:relative;top:-4.5pt'>¥</span></sup></span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:13.65pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>DVT*</span></p>
  </td>
  <td width=85 style='width:64.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>6<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.7)</span></p>
  </td>
  <td width=86 style='width:.9in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>7<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.9)</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>53<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(6<span style='letter-spacing:-.05pt'>.</span>4)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:13.65pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>PE*</span></p>
  </td>
  <td width=85 style='width:64.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>7<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.8)</span></p>
  </td>
  <td width=86 style='width:.9in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>4<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.5)</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>13<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(1<span style='letter-spacing:-.05pt'>.</span>6)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:13.65pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>All-cause </span><span
  lang=EN-GB style='font-size:11.0pt'>death</span></p>
  </td>
  <td width=85 style='width:64.1pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>6<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.7)</span></p>
  </td>
  <td width=86 style='width:.9in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>3<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.4)</span></p>
  </td>
  <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>11<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(1<span style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
  style='font-size:11.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Recurrent</span></p>
  </td>
  <td width=85 rowspan=2 style='width:64.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14&nbsp;(1<span
  style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=86 rowspan=2 style='width:.9in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14&nbsp;(1<span
  style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>73<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(8<span style='letter-spacing:-.05pt'>.</span>8)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.19</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.20</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.3pt'> </span>or<span
  style='letter-spacing:-.3pt'> </span>VTE-related<span style='letter-spacing:
  -.55pt'> </span>death</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.11,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>3)</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.11,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>4)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Recurrent</span></p>
  </td>
  <td width=85 rowspan=2 style='width:64.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(1<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=86 rowspan=2 style='width:.9in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>14<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(1<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>76<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(9<span style='letter-spacing:-.05pt'>.</span>2)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.18</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.19</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE<span style='letter-spacing:-.25pt'> </span>or<span
  style='letter-spacing:-.25pt'> </span>CV-related<span style='letter-spacing:
  -.55pt'> </span>death</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.10,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>2)</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.11,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>3)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Nonfatal</span></p>
  </td>
  <td width=85 rowspan=2 style='width:64.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>6<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.7)</span></p>
  </td>
  <td width=86 rowspan=2 style='width:.9in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>8<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(1.0)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>53<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(6<span style='letter-spacing:-.05pt'>.</span>4)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.11</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.15</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>DV</span><span
  lang=EN-GB style='font-size:11.0pt'>T<span style='letter-spacing:-.05pt'>†</span></span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.05,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>2</span>6)</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.07,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>3</span>2)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 rowspan=2 style='width:76.3pt;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Nonfatal<span style='letter-spacing:-.55pt'>
  </span>P<span style='letter-spacing:-.05pt'>E†</span></span></p>
  </td>
  <td width=85 rowspan=2 style='width:64.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>8<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(1.0)</span></p>
  </td>
  <td width=86 rowspan=2 style='width:.9in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>4<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.5)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>15<span style='letter-spacing:
  -.35pt'>&nbsp;</span>(1<span style='letter-spacing:-.05pt'>.</span>8)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.51</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.27</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.22,<span
  style='letter-spacing:-.55pt'> </span>1.<span style='letter-spacing:-.05pt'>2</span>1)</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.09,<span
  style='letter-spacing:-.55pt'> </span>0.<span style='letter-spacing:-.05pt'>8</span>0)</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>VTE-related</span></p>
  </td>
  <td width=85 rowspan=2 style='width:64.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.2)</span></p>
  </td>
  <td width=86 rowspan=2 style='width:.9in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>3<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.4)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>7<span style='letter-spacing:
  -.3pt'>&nbsp;</span>(0.8)</span></p>
  </td>
  <td width=124 style='width:93.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.28</span></p>
  </td>
  <td width=132 style='width:99.15pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.45</span></p>
  </td>
 </tr>
 <tr style='height:14.15pt'>
  <td width=102 style='width:76.3pt;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:14.15pt'>
  <p class=TableParagraph style='margin-left:3.85pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>death</span></p>
  </td>
  <td width=124 style='width:93.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.06,<span
  style='letter-spacing:-.55pt'> </span>1.<span style='letter-spacing:-.05pt'>3</span>7)</span></p>
  </td>
  <td width=132 style='width:99.15pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:14.15pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.12,<span
  style='letter-spacing:-.55pt'> </span>1.<span style='letter-spacing:-.05pt'>7</span>1)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><sup><span lang=EN-GB
style='font-size:11.0pt;position:relative;top:-3.0pt'>¥</span></sup><span
lang=EN-GB style='font-size:11.0pt;position:relative;top:-3.0pt;letter-spacing:
-.1pt'> </span><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>p-valu</span><span
lang=EN-GB style='font-size:11.0pt'>e<span style='letter-spacing:-.1pt'> </span>&lt;<span
style='letter-spacing:-.15pt'>&nbsp;</span><span style='letter-spacing:-.05pt'>0.00</span><span
style='letter-spacing:-.1pt'>0</span>1</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>* For<span style='letter-spacing:.4pt'> </span>patients<span
style='letter-spacing:.45pt'> </span>with<span style='letter-spacing:.45pt'> </span>more<span
style='letter-spacing:.45pt'> </span>than<span style='letter-spacing:.45pt'> </span>o<span
style='letter-spacing:-.1pt'>n</span>e<span style='letter-spacing:.45pt'> </span>event<span
style='letter-spacing:.35pt'> </span>contrib<span style='letter-spacing:-.1pt'>u</span>ting<span
style='letter-spacing:.45pt'> </span>to<span style='letter-spacing:.45pt'> </span>the<span
style='letter-spacing:.4pt'> </span>c<span style='letter-spacing:-.05pt'>o</span>mposite<span
style='letter-spacing:.45pt'> </span>endpoi<span style='letter-spacing:-.1pt'>n</span>t,<span
style='letter-spacing:.45pt'> </span><span style='letter-spacing:-.1pt'>o</span>nly<span
style='letter-spacing:.5pt'> </span>the<span style='letter-spacing:.4pt'> </span>first<span
style='letter-spacing:.45pt'> </span>e<span style='letter-spacing:-.1pt'>v</span>ent<span
style='letter-spacing:.45pt'> </span>was<span style='letter-spacing:.45pt'> </span>reported<span
style='letter-spacing:.4pt'> </span>(e.g.,<span style='letter-spacing:.45pt'> </span>if<span
style='letter-spacing:.4pt'> </span>a <span style='letter-spacing:-.05pt'>s</span>ubject<span
style='letter-spacing:-.2pt'> </span>exp<span style='letter-spacing:-.05pt'>e</span>rie<span
style='letter-spacing:-.1pt'>n</span>ced<span style='letter-spacing:-.1pt'> </span>b<span
style='letter-spacing:-.1pt'>o</span>th<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.1pt'> </span>DVT<span style='letter-spacing:-.2pt'> </span>and<span
style='letter-spacing:-.1pt'> </span>t<span style='letter-spacing:-.1pt'>h</span>en<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.1pt'> </span><span
style='letter-spacing:-.05pt'>PE</span>,<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.1pt'>o</span>n<span style='letter-spacing:-.05pt'>l</span>y<span
style='letter-spacing:-.05pt'> </span>t<span style='letter-spacing:-.1pt'>h</span>e<span
style='letter-spacing:-.15pt'> </span>DVT<span style='letter-spacing:-.1pt'> </span>w<span
style='letter-spacing:-.05pt'>a</span>s<span style='letter-spacing:-.15pt'> </span>reported)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt;letter-spacing:-.05pt'>†</span><span lang=EN-GB
style='font-size:11.0pt;letter-spacing:-.25pt'> </span><span lang=EN-GB
style='font-size:11.0pt'>Individ<span style='letter-spacing:-.1pt'>u</span>al<span
style='letter-spacing:-.2pt'> </span>subjects<span style='letter-spacing:-.3pt'>
</span>could<span style='letter-spacing:-.25pt'> </span>expe<span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>i</span>ence<span
style='letter-spacing:-.2pt'> </span>more<span style='letter-spacing:-.25pt'> </span>t<span
style='letter-spacing:-.1pt'>h</span>an<span style='letter-spacing:-.25pt'> </span>one<span
style='letter-spacing:-.2pt'> </span>e<span style='letter-spacing:-.1pt'>v</span>ent<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.25pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>repre<span style='letter-spacing:-.1pt'>s</span>ented<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>b</span>oth<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>c</span>la<span style='letter-spacing:-.05pt'>ss</span>ifi<span
style='letter-spacing:-.05pt'>c</span>atio<span style='letter-spacing:-.1pt'>n</span>s</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:.2pt'> </span>efficacy<span
style='letter-spacing:.25pt'> </span>for<span style='letter-spacing:.25pt'> </span>prevention<span
style='letter-spacing:.2pt'> </span>of<span style='letter-spacing:.15pt'> </span>a<span
style='letter-spacing:.25pt'> </span>recur<span style='letter-spacing:.05pt'>r</span>e<span
style='letter-spacing:.05pt'>n</span>ce<span style='letter-spacing:.2pt'> </span>of<span
style='letter-spacing:.2pt'> </span>a<span style='letter-spacing:.25pt'> </span>VTE<span
style='letter-spacing:.25pt'> </span>was<span style='letter-spacing:.3pt'> </span>mainta<span
style='letter-spacing:.05pt'>i</span>ned<span style='letter-spacing:.2pt'> </span>across<span
style='letter-spacing:.3pt'> </span>subgroups, includi<span style='letter-spacing:
-.05pt'>n</span>g<span style='letter-spacing:-.35pt'> </span>age,<span
style='letter-spacing:-.3pt'> </span>gender,<span style='letter-spacing:-.35pt'>
</span>B<span style='letter-spacing:-.05pt'>M</span>I,<span style='letter-spacing:
-.3pt'> </span>and<span style='letter-spacing:-.35pt'> </span>renal<span
style='letter-spacing:-.3pt'> </span>function.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:2.6pt'> </span>primary<span
style='letter-spacing:2.65pt'> </span>safety<span style='letter-spacing:2.7pt'>
</span>end<span style='letter-spacing:-.05pt'>p</span>oint<span
style='letter-spacing:2.65pt'> </span>was<span style='letter-spacing:2.7pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ajor<span style='letter-spacing:2.65pt'> </span>bleeding<span
style='letter-spacing:2.55pt'> </span>during<span style='letter-spacing:2.65pt'>
</span><span style='letter-spacing:-.05pt'>t</span>he<span style='letter-spacing:
2.65pt'> </span>treatment<span style='letter-spacing:2.65pt'> </span>period.<span
style='letter-spacing:2.6pt'> </span>In<span style='letter-spacing:2.65pt'> </span>the<span
style='letter-spacing:2.65pt'> </span>s<span style='letter-spacing:-.05pt'>t</span>u<span
style='letter-spacing:-.05pt'>d</span><span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:2.65pt'> </span>the incidence<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>major<span
style='letter-spacing:-.2pt'> </span>bleeding<span style='letter-spacing:-.25pt'>
</span>for<span style='letter-spacing:-.2pt'> </span>bo<span style='letter-spacing:
-.05pt'>t</span>h<span style='letter-spacing:-.2pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>doses<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>not<span style='letter-spacing:-.2pt'> </span>stat<span
style='letter-spacing:.05pt'>i</span>stically<span style='letter-spacing:-.15pt'>
</span>different<span style='letter-spacing:-.2pt'> </span>from<span
style='letter-spacing:-.3pt'> </span>pl<span style='letter-spacing:.05pt'>a</span><span
style='letter-spacing:-.05pt'>c</span>ebo.<span style='letter-spacing:-.25pt'> </span>There
was<span style='letter-spacing:.35pt'> </span>no<span style='letter-spacing:
.35pt'> </span>statistically<span style='letter-spacing:.45pt'> </span>signifi<span
style='letter-spacing:-.1pt'>c</span><span style='letter-spacing:-.05pt'>a</span>nt<span
style='letter-spacing:.35pt'> </span>difference<span style='letter-spacing:
.35pt'> </span>in<span style='letter-spacing:.35pt'> </span>the<span
style='letter-spacing:.3pt'> </span>incid<span style='letter-spacing:-.1pt'>e</span>nce<span
style='letter-spacing:.35pt'> </span>of<span style='letter-spacing:.35pt'> </span>major<span
style='letter-spacing:.35pt'> </span>+<span style='letter-spacing:.35pt'> </span>CRNM,<span
style='letter-spacing:.4pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>nor,<span style='letter-spacing:.35pt'> </span>and<span
style='letter-spacing:.35pt'> </span>all<span style='letter-spacing:.3pt'> </span><span
style='letter-spacing:-.05pt'>b</span>leeding between<span style='letter-spacing:
-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>2.5<span style='letter-spacing:-.35pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>tw<span
style='letter-spacing:.05pt'>i</span>ce<span style='letter-spacing:-.25pt'> </span>dai<span
style='letter-spacing:.05pt'>l</span>y<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>placebo<span style='letter-spacing:-.25pt'>
</span>trea<span style='letter-spacing:.05pt'>t</span><span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>nt<span
style='letter-spacing:-.3pt'> </span>g<span style='letter-spacing:.05pt'>r</span>oups<span
style='letter-spacing:-.25pt'> </span>(see<span style='letter-spacing:-.25pt'> </span>Table<span
style='letter-spacing:-.3pt'> </span>11).</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Table<span style='letter-spacing:-.35pt'> </span>11:<span
style='letter-spacing:-.35pt'> </span>Bleeding<span style='letter-spacing:-.3pt'>
r</span>esults<span style='letter-spacing:-.35pt'> </span>in<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.3pt'> </span>AMP<span
style='letter-spacing:-.05pt'>L</span>IFY-EXT<span style='letter-spacing:-.35pt'>
s</span>tu<span style='letter-spacing:-.05pt'>d</span>y</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='margin-left:5.5pt;border-collapse:collapse'>
 <thead>
  <tr style='height:1.0pt'>
   <td width=91 style='width:.95in;border:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=91 style='width:.95in;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:1.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
   </td>
   <td width=91 style='width:.95in;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:1.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban</span></b></p>
   </td>
   <td width=91 style='width:.95in;border:solid black 1.0pt;border-left:none;
   padding:0in 0in 0in 0in;height:1.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Placebo</span></b></p>
   </td>
   <td width=272 colspan=2 style='width:204.3pt;border:solid black 1.0pt;
   border-left:none;padding:0in 0in 0in 0in;height:1.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Relative<span
   style='letter-spacing:-.35pt'> r</span>isk<span style='letter-spacing:-.35pt'>
   </span>(95%<span style='letter-spacing:-.35pt'> </span>CI)</span></b></p>
   </td>
  </tr>
  <tr style='height:1.0pt'>
   <td width=91 style='width:.95in;border:solid black 1.0pt;border-top:none;
   padding:0in 0in 0in 0in;height:1.0pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
   solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>2.5&nbsp;<span
   style='letter-spacing:-.05pt'>m</span>g</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><span lang=EN-GB style='font-size:11.0pt'>(N=840)</span></p>
   </td>
   <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
   solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>5.0&nbsp;<span
   style='letter-spacing:-.05pt'>m</span>g</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><span lang=EN-GB style='font-size:11.0pt'>(N=811)</span></p>
   </td>
   <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
   solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><span lang=EN-GB style='font-size:11.0pt'>(N=826)</span></p>
   </td>
   <td width=128 style='width:96.3pt;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix<span
   style='letter-spacing:-.3pt'> </span>2.5&nbsp;<span style='letter-spacing:
   -.05pt'>m</span>g</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><span lang=EN-GB style='font-size:11.0pt'>vs.<span style='letter-spacing:
   -.5pt'> p</span>lacebo</span></p>
   </td>
   <td width=144 style='width:1.5in;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><b><span lang=EN-GB style='font-size:11.0pt'>Apix<span
   style='letter-spacing:-.3pt'> </span>5.0&nbsp;<span style='letter-spacing:
   -.05pt'>m</span>g</span></b></p>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><span lang=EN-GB style='font-size:11.0pt'>vs.<span style='letter-spacing:
   -.5pt'> p</span>lacebo</span></p>
   </td>
  </tr>
  <tr style='height:1.0pt'>
   <td width=91 style='width:.95in;border:solid black 1.0pt;border-top:none;
   padding:0in 0in 0in 0in;height:1.0pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
   solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
   solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
   simple'><span lang=EN-GB style='font-size:11.0pt'>n<span style='letter-spacing:
   -.25pt'> </span>(%)</span></p>
   </td>
   <td width=91 style='width:.95in;border-top:none;border-left:none;border-bottom:
   solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=128 style='width:96.3pt;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
   <td width=144 style='width:1.5in;border-top:none;border-left:none;
   border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
   height:1.0pt'>
   <p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
   style='font-size:11.0pt'>&nbsp;</span></p>
   </td>
  </tr>
 </thead>
 <tr style='height:1.0pt'>
  <td width=91 rowspan=2 style='width:.95in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>2<span style='letter-spacing:
  -.3pt'> </span>(0.2)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1<span style='letter-spacing:
  -.3pt'> </span>(0.1)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>4<span style='letter-spacing:
  -.3pt'> </span>(0.5)</span></p>
  </td>
  <td width=128 style='width:96.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.49</span></p>
  </td>
  <td width=144 style='width:1.5in;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>0.25</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=128 style='width:96.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.09,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>6</span>4)</span></p>
  </td>
  <td width=144 style='width:1.5in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.03,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>2</span>4)</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=91 style='width:.95in;border-top:none;border-left:solid black 1.0pt;
  border-bottom:none;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Major<span style='letter-spacing:-.35pt'>
  </span>+</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>27<span style='letter-spacing:
  -.35pt'> </span>(3<span style='letter-spacing:-.05pt'>.</span>2)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>35<span style='letter-spacing:
  -.35pt'> </span>(4<span style='letter-spacing:-.05pt'>.</span>3)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>22<span style='letter-spacing:
  -.35pt'> </span>(2<span style='letter-spacing:-.05pt'>.</span>7)</span></p>
  </td>
  <td width=128 style='width:96.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.20</span></p>
  </td>
  <td width=144 style='width:1.5in;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.62</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=91 style='width:.95in;border:solid black 1.0pt;border-top:none;
  padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt;letter-spacing:-.05pt'>CRNM</span></p>
  </td>
  <td width=128 style='width:96.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.69,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>1</span>0)</span></p>
  </td>
  <td width=144 style='width:1.5in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.96,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>7</span>3)</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=91 rowspan=2 style='width:.95in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>Minor</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>75<span style='letter-spacing:
  -.35pt'> </span>(8<span style='letter-spacing:-.05pt'>.</span>9)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>98<span style='letter-spacing:
  -.4pt'> </span>(1<span style='letter-spacing:-.05pt'>2</span>.1)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>58<span style='letter-spacing:
  -.35pt'> </span>(7<span style='letter-spacing:-.05pt'>.</span>0)</span></p>
  </td>
  <td width=128 style='width:96.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.26</span></p>
  </td>
  <td width=144 style='width:1.5in;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.70</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=128 style='width:96.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.91,<span
  style='letter-spacing:-.55pt'> </span>1.<span style='letter-spacing:-.05pt'>7</span>5)</span></p>
  </td>
  <td width=144 style='width:1.5in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(1.25,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>3</span>1)</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=91 rowspan=2 style='width:.95in;border:solid black 1.0pt;
  border-top:none;padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph style='margin-left:4.55pt;punctuation-wrap:simple'><span
  lang=EN-GB style='font-size:11.0pt'>All</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>94<span style='letter-spacing:
  -.4pt'> </span>(1<span style='letter-spacing:-.05pt'>1</span>.2)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>121<span style='letter-spacing:
  -.45pt'> </span>(<span style='letter-spacing:-.05pt'>1</span>4.9)</span></p>
  </td>
  <td width=91 rowspan=2 style='width:.95in;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>74<span style='letter-spacing:
  -.35pt'> </span>(9<span style='letter-spacing:-.05pt'>.</span>0)</span></p>
  </td>
  <td width=128 style='width:96.3pt;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.24</span></p>
  </td>
  <td width=144 style='width:1.5in;border:none;border-right:solid black 1.0pt;
  padding:0in 0in 0in 0in;height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>1.65</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=128 style='width:96.3pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(0.93,<span
  style='letter-spacing:-.55pt'> </span>1.<span style='letter-spacing:-.05pt'>6</span>5)</span></p>
  </td>
  <td width=144 style='width:1.5in;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0in 0in 0in 0in;
  height:1.0pt'>
  <p class=TableParagraph align=center style='text-align:center;punctuation-wrap:
  simple'><span lang=EN-GB style='font-size:11.0pt'>(1.26,<span
  style='letter-spacing:-.55pt'> </span>2.<span style='letter-spacing:-.05pt'>1</span>6)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Adjudicated ISTH<span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor
gastrointestin<span style='letter-spacing:.05pt'>a</span>l bleeding<span
style='letter-spacing:-.05pt'> </span>occurred in 1&nbsp;(0.1%)
apixaban-treated patient at the 5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.2pt'> </span>twice<span
style='letter-spacing:-.25pt'> </span>daily<span style='letter-spacing:-.2pt'> </span>dose,<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.25pt'> </span>patients<span
style='letter-spacing:-.25pt'> </span>at<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>2.5&nbsp;<span style='letter-spacing:
-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>t<span
style='letter-spacing:-.05pt'>w</span>ice<span style='letter-spacing:-.2pt'> </span>dai<span
style='letter-spacing:-.05pt'>l</span>y<span style='letter-spacing:-.15pt'> </span>dose,<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>a</span>nd<span
style='letter-spacing:-.25pt'> </span>1&nbsp;<span style='letter-spacing:-.1pt'>(</span>0.1<span
style='letter-spacing:-.05pt'>%</span>)<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>p</span>lacebo-treated<span style='letter-spacing:
-.2pt'> </span>patient.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Paediatric<span style='letter-spacing:-.95pt'> </span>population</span></u></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>European<span
style='letter-spacing:-.3pt'> </span>Medicines<span style='letter-spacing:-.25pt'>
</span>Agency<span style='letter-spacing:-.2pt'> </span>has<span
style='letter-spacing:-.25pt'> </span>deferred<span style='letter-spacing:-.3pt'>
</span>the<span style='letter-spacing:-.25pt'> </span>obligation<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>sub<span
style='letter-spacing:-.1pt'>m</span>it<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>results<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>studies<span
style='letter-spacing:-.25pt'> </span>with Apixaban<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>one<span
style='letter-spacing:-.3pt'> </span>or<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ore<span style='letter-spacing:-.25pt'> </span>subsets<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>paediatric<span style='letter-spacing:
-.25pt'> </span>popul<span style='letter-spacing:-.1pt'>a</span>tion<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>ven<span
style='letter-spacing:-.05pt'>ou</span>s<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>arterial<span style='letter-spacing:-.2pt'>
</span>e<span style='letter-spacing:-.1pt'>m</span>bolism<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:.05pt'>n</span>d
thro<span style='letter-spacing:-.1pt'>m</span>bosis<span style='letter-spacing:
-.35pt'> </span>(see<span style='letter-spacing:-.3pt'> </span>section<span
style='letter-spacing:-.3pt'> </span>4.2<span style='letter-spacing:-.4pt'> </span>for<span
style='letter-spacing:-.3pt'> </span>infor<span style='letter-spacing:-.1pt'>m</span>at<span
style='letter-spacing:.05pt'>i</span>on<span style='letter-spacing:-.3pt'> </span>on<span
style='letter-spacing:-.35pt'> </span>paediatric<span style='letter-spacing:
-.3pt'> </span>use).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>5.2<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Phar<span style='letter-spacing:-.05pt'>m</span>acokinetic<span
style='letter-spacing:-1.3pt'> </span>properties</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Absorption</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>absolute<span
style='letter-spacing:-.25pt'> </span>bioavailability<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.25pt'> </span>approxi<span
style='letter-spacing:-.1pt'>m</span>ately<span style='letter-spacing:-.25pt'> </span>50%<span
style='letter-spacing:-.25pt'> </span>for<span style='letter-spacing:-.35pt'> </span>doses<span
style='letter-spacing:-.25pt'> </span>up<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g.<span style='letter-spacing:-.3pt'> </span>Apixaban<span
style='letter-spacing:-.25pt'> </span>is rapidly<span style='letter-spacing:
-.2pt'> </span>absorbed<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span><span style='letter-spacing:.05pt'>xi</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>u</span>m<span
style='letter-spacing:-.4pt'> </span>conce<span style='letter-spacing:.05pt'>n</span>trations<span
style='letter-spacing:-.25pt'> </span>(C<sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub>)<span style='letter-spacing:-.3pt'> </span>appearing<span
style='letter-spacing:-.3pt'> </span>3&nbsp;to<span style='letter-spacing:-.3pt'>
</span>4&nbsp;<span style='letter-spacing:-.05pt'>h</span>ours<span
style='letter-spacing:-.3pt'> </span>af<span style='letter-spacing:-.05pt'>te</span>r<span
style='letter-spacing:-.3pt'> </span>tablet<span style='letter-spacing:-.25pt'>
</span>intake.<span style='letter-spacing:-.3pt'> </span>Intake with<span
style='letter-spacing:-.2pt'> </span>food<span style='letter-spacing:-.25pt'> </span>do<span
style='letter-spacing:-.1pt'>e</span>s<span style='letter-spacing:-.2pt'> </span>not<span
style='letter-spacing:-.2pt'> </span>affect<span style='letter-spacing:-.2pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>AUC<span style='letter-spacing:-.2pt'> </span>or<span
style='letter-spacing:-.15pt'> </span>C<sub><span style='position:relative;
top:1.0pt;letter-spacing:-.15pt'>m</span><span style='position:relative;
top:1.0pt'>ax</span></sub><span style='position:relative;top:1.0pt;letter-spacing:
.8pt'> </span>at<span style='letter-spacing:-.2pt'> </span>the<span
style='letter-spacing:-.2pt'> </span>10&nbsp;<span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>dose.<span style='letter-spacing:-.2pt'> </span>Apixaban<span
style='letter-spacing:-.2pt'> </span>can<span style='letter-spacing:-.2pt'> </span>be<span
style='letter-spacing:-.15pt'> </span>taken<span style='letter-spacing:-.2pt'> </span>with<span
style='letter-spacing:-.2pt'> </span>or without<span style='letter-spacing:
-.6pt'> </span>f<span style='letter-spacing:-.05pt'>o</span>od.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.4pt'> </span>de<span
style='letter-spacing:-.1pt'>m</span>onst<span style='letter-spacing:.05pt'>r</span>ates<span
style='letter-spacing:-.4pt'> </span>l<span style='letter-spacing:.05pt'>i</span>near<span
style='letter-spacing:-.35pt'> </span>pha<span style='letter-spacing:.05pt'>r</span><span
style='letter-spacing:-.1pt'>m</span>acokinetics<span style='letter-spacing:
-.4pt'> </span>with<span style='letter-spacing:-.35pt'> </span>dose<span
style='letter-spacing:-.4pt'> </span>propo<span style='letter-spacing:-.1pt'>r</span>tional<span
style='letter-spacing:-.35pt'> </span>increases<span style='letter-spacing:
-.4pt'> </span>in<span style='letter-spacing:-.4pt'> </span>exposu<span
style='letter-spacing:-.1pt'>r</span>e<span style='letter-spacing:-.35pt'> </span>for<span
style='letter-spacing:-.4pt'> </span>oral doses<span style='letter-spacing:
-.3pt'> </span>up<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>10<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g.<span style='letter-spacing:-.25pt'> </span>At<span
style='letter-spacing:-.25pt'> </span>doses<span style='letter-spacing:-.25pt'>
</span>&#8805;<span style='letter-spacing:-.3pt'>&nbsp;</span>25<span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.25pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>displa<span style='letter-spacing:.05pt'>y</span>s<span
style='letter-spacing:-.3pt'> </span>dissolut<span style='letter-spacing:-.1pt'>i</span>on<span
style='letter-spacing:-.25pt'> </span>li<span style='letter-spacing:-.1pt'>m</span>ited<span
style='letter-spacing:-.25pt'> </span>absorption<span style='letter-spacing:
-.25pt'> </span>with<span style='letter-spacing:-.3pt'> </span>decreased bioavailabili<span
style='letter-spacing:-.05pt'>t</span>y.<span style='letter-spacing:-.4pt'> </span>Apixaban<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>e</span>xposure<span
style='letter-spacing:-.35pt'> </span>parameters<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.05pt'>e</span>xhibit<span
style='letter-spacing:-.35pt'> </span>low<span style='letter-spacing:-.35pt'> </span>to<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.35pt'> </span>variability<span style='letter-spacing:
-.35pt'> </span>reflected<span style='letter-spacing:-.35pt'> </span>by<span
style='letter-spacing:-.35pt'> </span>a within-subject<span style='letter-spacing:
-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span>inter-subject<span
style='letter-spacing:-.35pt'> </span>variability<span style='letter-spacing:
-.45pt'> </span>of<span style='letter-spacing:-.35pt'> </span>~20%<span
style='letter-spacing:-.35pt'> </span>CV<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>~30%<span style='letter-spacing:-.35pt'> </span>CV,<span
style='letter-spacing:-.35pt'> </span>respecti<span style='letter-spacing:.05pt'>v</span>el<span
style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Following<span style='letter-spacing:-.3pt'> </span>o<span
style='letter-spacing:-.1pt'>r</span>al<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:.05pt'>d</span><span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>10&nbsp;<span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.1pt'>a</span>s<span style='letter-spacing:
-.25pt'> </span>2<span style='letter-spacing:-.2pt'>&nbsp;</span>crushed<span
style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>tablets<span
style='letter-spacing:-.2pt'> </span>suspended<span style='letter-spacing:-.2pt'>
</span>in<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.05pt'>3</span>0<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:-.25pt'> </span>of
water,<span style='letter-spacing:-.3pt'> </span>exposure<span
style='letter-spacing:-.25pt'> </span>was<span style='letter-spacing:-.25pt'> </span>c<span
style='letter-spacing:.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>parable<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>exp<span
style='letter-spacing:-.05pt'>o</span>sure<span style='letter-spacing:-.25pt'> </span>aft<span
style='letter-spacing:-.05pt'>e</span>r<span style='letter-spacing:-.25pt'> </span>oral<span
style='letter-spacing:-.3pt'> </span>ad<span style='letter-spacing:-.1pt'>m</span>inistration<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>2<span
style='letter-spacing:-.3pt'>&nbsp;</span>w<span style='letter-spacing:-.05pt'>h</span>ole<span
style='letter-spacing:-.3pt'> </span>5&nbsp;<span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>tablets. Following<span style='letter-spacing:
-.3pt'> </span>o<span style='letter-spacing:-.1pt'>r</span>al<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>10<span
style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>a</span>s<span
style='letter-spacing:-.25pt'> </span>2<span style='letter-spacing:-.2pt'>&nbsp;</span>crushed<span
style='letter-spacing:-.2pt'> </span>5<span style='letter-spacing:-.25pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>tablets<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.2pt'> </span>30<span
style='letter-spacing:-.25pt'>&nbsp;</span>g<span style='letter-spacing:-.2pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:
-.05pt'>pp</span>le puree,<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:.05pt'>C</span><sub><span
style='position:relative;top:1.0pt;letter-spacing:-.1pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub><span style='position:relative;
top:1.0pt;letter-spacing:.75pt'> </span>and<span style='letter-spacing:-.3pt'> </span>AUC<span
style='letter-spacing:-.25pt'> </span>were<span style='letter-spacing:-.25pt'> </span>21%<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:.05pt'>n</span>d<span
style='letter-spacing:-.25pt'> </span>16%<span style='letter-spacing:-.25pt'> </span>lower,<span
style='letter-spacing:-.25pt'> </span>respecti<span style='letter-spacing:-.05pt'>v</span>el<span
style='letter-spacing:.05pt'>y</span>,<span style='letter-spacing:-.35pt'> </span>when<span
style='letter-spacing:-.25pt'> </span>c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>pa<span style='letter-spacing:.05pt'>r</span>ed<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.3pt'> </span>ad<span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.25pt'> </span>of 2<span style='letter-spacing:-.3pt'>&nbsp;</span>whole<span
style='letter-spacing:-.25pt'> </span>5&nbsp;mg<span style='letter-spacing:
-.25pt'> </span>tablets.<span style='letter-spacing:-.25pt'> </span>The<span
style='letter-spacing:-.3pt'> </span>reduction<span style='letter-spacing:-.25pt'>
</span>in<span style='letter-spacing:-.25pt'> </span><span style='letter-spacing:
-.1pt'>e</span>xposu<span style='letter-spacing:-.05pt'>r</span>e<span
style='letter-spacing:-.25pt'> </span>is<span style='letter-spacing:-.25pt'> </span>n<span
style='letter-spacing:-.05pt'>o</span>t<span style='letter-spacing:-.3pt'> </span>considered<span
style='letter-spacing:-.25pt'> </span>clinically<span style='letter-spacing:
-.15pt'> </span>rele<span style='letter-spacing:-.05pt'>va</span>nt.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Following<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>d</span>ministration<span style='letter-spacing:
-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>crushed<span style='letter-spacing:-.25pt'>
</span>5<span style='letter-spacing:-.2pt'>&nbsp;</span><span style='letter-spacing:
-.1pt'>m</span>g<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.2pt'> </span>tablet<span style='letter-spacing:-.25pt'>
</span>suspended<span style='letter-spacing:-.2pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>60<span style='letter-spacing:-.2pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.2pt'> G</span>5W<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.05pt'>n</span>d delivered<span style='letter-spacing:
-.25pt'> </span>via<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>nasogastric<span style='letter-spacing:
-.2pt'> </span>tube,<span style='letter-spacing:-.25pt'> </span>exposu<span
style='letter-spacing:-.1pt'>r</span>e<span style='letter-spacing:-.2pt'> </span>was<span
style='letter-spacing:-.25pt'> </span>similar<span style='letter-spacing:-.15pt'>
</span>to<span style='letter-spacing:-.25pt'> </span>exposure<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>s</span>een<span
style='letter-spacing:-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>other<span
style='letter-spacing:-.2pt'> </span>clinical<span style='letter-spacing:-.25pt'>
</span>trials involving<span style='letter-spacing:-.35pt'> </span>healthy<span
style='letter-spacing:-.2pt'> </span>subjects<span style='letter-spacing:-.3pt'>
</span>receiving<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>single<span style='letter-spacing:-.3pt'>
</span>oral<span style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:
-.3pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.25pt'>
</span>t<span style='letter-spacing:-.1pt'>a</span>blet<span style='letter-spacing:
-.3pt'> </span>dose.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Given<span style='letter-spacing:-.45pt'> </span>the<span
style='letter-spacing:-.45pt'> </span>predictable,<span style='letter-spacing:
-.45pt'> </span>dose-proport<span style='letter-spacing:-.05pt'>i</span>onal<span
style='letter-spacing:-.5pt'> </span>pharmacok<span style='letter-spacing:-.05pt'>i</span>netic<span
style='letter-spacing:-.45pt'> </span>profile<span style='letter-spacing:-.45pt'>
</span>of<span style='letter-spacing:-.45pt'> </span>apixaban,<span
style='letter-spacing:-.45pt'> </span>the<span style='letter-spacing:-.55pt'> </span>bioavailabili<span
style='letter-spacing:-.05pt'>t</span>y results<span style='letter-spacing:
-.3pt'> </span>fr<span style='letter-spacing:.05pt'>o</span>m<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:.05pt'>t</span>he<span
style='letter-spacing:-.3pt'> </span>conducted<span style='letter-spacing:-.35pt'>
</span>studies<span style='letter-spacing:-.3pt'> </span>are<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:.1pt'>p</span>plicable<span
style='letter-spacing:-.3pt'> </span>to<span style='letter-spacing:-.3pt'> </span>lower<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'>
</span>doses.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Distribution</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Plasma<span style='letter-spacing:-.3pt'> </span>protein<span
style='letter-spacing:-.3pt'> </span>bi<span style='letter-spacing:-.05pt'>n</span>ding<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>hu<span
style='letter-spacing:-.1pt'>m</span>ans<span style='letter-spacing:-.3pt'> </span>is<span
style='letter-spacing:-.25pt'> </span>approxi<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>tely<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>8</span>7<span style='letter-spacing:-.05pt'>%</span>.<span
style='letter-spacing:-.3pt'> </span>The<span style='letter-spacing:-.25pt'> </span>vol<span
style='letter-spacing:-.05pt'>um</span>e<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>distribution<span style='letter-spacing:
-.3pt'> </span>(Vss)<span style='letter-spacing:-.25pt'> </span>is approxi<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.5pt'> </span>21<span style='letter-spacing:-.5pt'>&nbsp;</span>l<span
style='letter-spacing:-.05pt'>i</span>tres.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Biotransformation<span style='letter-spacing:-.8pt'> </span>and<span
style='letter-spacing:-.75pt'> </span>el<span style='letter-spacing:-.05pt'>im</span>ination</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.35pt'> </span>has<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>ultiple<span
style='letter-spacing:-.3pt'> </span>routes<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>el<span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.1pt'>m</span>ina<span style='letter-spacing:.05pt'>t</span>ion.<span
style='letter-spacing:-.35pt'> </span>Of<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>administered<span style='letter-spacing:
-.3pt'> </span>a<span style='letter-spacing:.05pt'>p</span>ixaban<span
style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:-.35pt'> </span>hu<span
style='letter-spacing:-.1pt'>m</span>ans, approxi<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>te<span
style='letter-spacing:.05pt'>l</span>y<span style='letter-spacing:-.35pt'> </span>25%<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.35pt'> </span>recovered<span
style='letter-spacing:-.3pt'> </span>as<span style='letter-spacing:-.3pt'> </span>metabolites,<span
style='letter-spacing:-.35pt'> </span>w<span style='letter-spacing:.05pt'>i</span>th<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jori<span
style='letter-spacing:.05pt'>t</span>y<span style='letter-spacing:-.3pt'> </span>recovered<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>faeces.<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>R</span><span
style='letter-spacing:-.05pt'>e</span>nal excretion<span style='letter-spacing:
-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>apixaban<span
style='letter-spacing:-.35pt'> </span>accounts<span style='letter-spacing:-.4pt'>
</span>for<span style='letter-spacing:-.35pt'> </span>app<span
style='letter-spacing:-.1pt'>r</span>oxi<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>tely<span style='letter-spacing:-.3pt'> </span>27%<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>total<span
style='letter-spacing:-.35pt'> </span>clearance.<span style='letter-spacing:
-.4pt'> </span>Additional<span style='letter-spacing:-.35pt'> </span>contributions
from<span style='letter-spacing:-.4pt'> </span>biliary<span style='letter-spacing:
-.25pt'> </span>and<span style='letter-spacing:-.3pt'> </span>direct<span
style='letter-spacing:-.3pt'> </span>int<span style='letter-spacing:-.1pt'>e</span>stinal<span
style='letter-spacing:-.35pt'> </span>excretion<span style='letter-spacing:
-.3pt'> </span>w<span style='letter-spacing:-.1pt'>e</span>re<span
style='letter-spacing:-.3pt'> </span>observed<span style='letter-spacing:-.3pt'>
</span>in<span style='letter-spacing:-.3pt'> </span>clini<span
style='letter-spacing:-.1pt'>c</span>al<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.3pt'> </span>noncl<span style='letter-spacing:-.05pt'>i</span>nical<span
style='letter-spacing:-.3pt'> </span>studies, respectivel<span
style='letter-spacing:.1pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Apixaban<span style='letter-spacing:-.25pt'> </span>has<span
style='letter-spacing:-.25pt'> </span>a<span style='letter-spacing:-.25pt'> </span>total<span
style='letter-spacing:-.2pt'> </span>clearance<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>about<span
style='letter-spacing:-.25pt'> </span>3.3&nbsp;L/h<span style='letter-spacing:
-.3pt'> </span>and<span style='letter-spacing:-.2pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>half-life<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.25pt'> </span>approxi<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.1pt'> </span><span style='letter-spacing:-.05pt'>1</span>2<span
style='letter-spacing:-.25pt'>&nbsp;</span>h<span style='letter-spacing:-.05pt'>o</span>urs.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>O&#8209;de<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>th<span style='letter-spacing:.05pt'>y</span>lation<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>h</span><span style='letter-spacing:.05pt'>y</span>d<span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>ox</span><span
style='letter-spacing:.05pt'>y</span>lation<span style='letter-spacing:-.35pt'>
</span>at<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.05pt'>th</span>e<span style='letter-spacing:-.35pt'> </span>3&#8209;oxo<span
style='letter-spacing:-.05pt'>p</span>iperidi<span style='letter-spacing:-.05pt'>n</span><span
style='letter-spacing:.05pt'>y</span>l<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>oiety<span style='letter-spacing:-.35pt'> </span>are<span
style='letter-spacing:-.35pt'> </span>the<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>jor<span
style='letter-spacing:-.3pt'> </span>sites<span style='letter-spacing:-.3pt'> </span>of
biotransformation.<span style='letter-spacing:-.4pt'> </span>Apixa<span
style='letter-spacing:-.05pt'>b</span>an<span style='letter-spacing:-.4pt'> </span>is<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>tabolised<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>i<span style='letter-spacing:-.1pt'>n</span>ly<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>v</span>ia<span
style='letter-spacing:-.4pt'> </span>CYP3A4/5<span style='letter-spacing:-.4pt'>
</span>with<span style='letter-spacing:-.4pt'> </span><span style='letter-spacing:
-.1pt'>m</span>inor<span style='letter-spacing:-.4pt'> </span>contribu<span
style='letter-spacing:-.05pt'>t</span>ions<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.1pt'>f</span>rom CYP1A2,<span style='letter-spacing:
-.35pt'> </span>2C8,<span style='letter-spacing:-.3pt'> </span>2C9,<span
style='letter-spacing:-.35pt'> </span>2C1<span style='letter-spacing:-.05pt'>9</span>,<span
style='letter-spacing:-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>2J2.<span
style='letter-spacing:-.3pt'> </span>U<span style='letter-spacing:-.05pt'>n</span>changed<span
style='letter-spacing:-.3pt'> </span>api<span style='letter-spacing:-.05pt'>x</span>aban<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.3pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>major<span style='letter-spacing:-.3pt'> </span>drug-related<span
style='letter-spacing:-.3pt'> </span>co<span style='letter-spacing:-.1pt'>m</span>ponent<span
style='letter-spacing:-.3pt'> </span>in hu<span style='letter-spacing:-.1pt'>m</span>an<span
style='letter-spacing:-.35pt'> </span>plasma<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>no<span style='letter-spacing:
-.3pt'> </span>active<span style='letter-spacing:-.3pt'> </span>circulating<span
style='letter-spacing:-.3pt'> </span>metabolites<span style='letter-spacing:
-.3pt'> </span>present.<span style='letter-spacing:-.3pt'> </span>Apixaban<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.3pt'> </span>substrate<span style='letter-spacing:-.3pt'>
</span>of<span style='letter-spacing:-.3pt'> </span>transport proteins,<span
style='letter-spacing:-.35pt'> </span>P-gp<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>breast<span style='letter-spacing:-.35pt'>
</span>cancer<span style='letter-spacing:-.35pt'> </span>res<span
style='letter-spacing:.05pt'>i</span>sta<span style='letter-spacing:.05pt'>n</span>ce<span
style='letter-spacing:-.35pt'> </span>protein<span style='letter-spacing:-.35pt'>
</span>(BCRP).</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Renal<span style='letter-spacing:-.8pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pairment</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>There<span style='letter-spacing:-.3pt'> </span>was<span
style='letter-spacing:-.25pt'> </span>no<span style='letter-spacing:-.15pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pact<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>impaired<span style='letter-spacing:-.3pt'>
</span>renal<span style='letter-spacing:-.25pt'> </span>function<span
style='letter-spacing:-.35pt'> </span>on<span style='letter-spacing:-.25pt'> </span>p<span
style='letter-spacing:-.1pt'>e</span>ak<span style='letter-spacing:-.25pt'> </span>concentration<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban.<span
style='letter-spacing:-.25pt'> </span>There<span style='letter-spacing:-.3pt'> </span>was<span
style='letter-spacing:-.2pt'> </span>an increase<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:.05pt'>p</span>ixaban<span style='letter-spacing:-.3pt'> </span>expo<span
style='letter-spacing:-.1pt'>s</span>ure<span style='letter-spacing:-.3pt'> </span>correlated<span
style='letter-spacing:-.2pt'> </span>to<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>d</span>ecrease<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:.05pt'>i</span>n<span style='letter-spacing:
-.3pt'> </span>renal<span style='letter-spacing:-.3pt'> </span>funct<span
style='letter-spacing:-.05pt'>i</span>on,<span style='letter-spacing:-.3pt'> </span>as<span
style='letter-spacing:-.3pt'> </span>assessed<span style='letter-spacing:-.3pt'>
</span>via<span style='letter-spacing:-.3pt'> </span><span style='letter-spacing:
-.1pt'>m</span>easured creatinine<span style='letter-spacing:-.4pt'> </span>clearance.<span
style='letter-spacing:-.4pt'> </span>In<span style='letter-spacing:-.35pt'> </span>individuals<span
style='letter-spacing:-.4pt'> </span>with<span style='letter-spacing:-.45pt'> </span>mild<span
style='letter-spacing:-.3pt'> </span>(creatin<span style='letter-spacing:.05pt'>i</span>ne<span
style='letter-spacing:-.4pt'> </span>clearan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.35pt'> </span>51&#8209;80&nbsp;<span style='letter-spacing:
-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>i</span>n),<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate
(creatinine<span style='letter-spacing:-.4pt'> </span>c<span style='letter-spacing:
.05pt'>l</span>earan<span style='letter-spacing:.05pt'>c</span>e<span
style='letter-spacing:-.4pt'> </span>30&#8209;50&nbsp;<span style='letter-spacing:
-.1pt'>m</span>L<span style='letter-spacing:.05pt'>/</span><span
style='letter-spacing:-.05pt'>m</span>in)<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.4pt'> </span>severe<span style='letter-spacing:-.35pt'>
</span>(cr<span style='letter-spacing:.05pt'>e</span>atinine<span
style='letter-spacing:-.4pt'> </span>clearance<span style='letter-spacing:-.35pt'>
</span>15&#8209;29&nbsp;<span style='letter-spacing:-.1pt'>m</span>L<span
style='letter-spacing:.05pt'>/</span><span style='letter-spacing:-.05pt'>m</span>in)<span
style='letter-spacing:-.35pt'> </span>renal <span style='letter-spacing:.05pt'>i</span><span
style='letter-spacing:-.1pt'>m</span>pai<span style='letter-spacing:.05pt'>r</span>ment,<span
style='letter-spacing:-.4pt'> </span>apixaban<span style='letter-spacing:-.35pt'>
</span>pla<span style='letter-spacing:-.1pt'>s</span>ma<span style='letter-spacing:
-.4pt'> </span>concentr<span style='letter-spacing:.05pt'>a</span>tions<span
style='letter-spacing:-.35pt'> </span>(AU<span style='letter-spacing:-.05pt'>C</span>)<span
style='letter-spacing:-.35pt'> </span>were<span style='letter-spacing:-.4pt'> </span>increased<span
style='letter-spacing:-.35pt'> </span>16,<span style='letter-spacing:-.4pt'> </span>29,<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.45pt'> </span>44%<span
style='letter-spacing:-.4pt'> </span>respectively, c<span style='letter-spacing:
.05pt'>o</span><span style='letter-spacing:-.1pt'>m</span>pared<span
style='letter-spacing:-.35pt'> </span>to<span style='letter-spacing:-.3pt'> </span>individuals<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>nor<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>l<span
style='letter-spacing:-.3pt'> </span>cr<span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.05pt'>a</span>tinine<span style='letter-spacing:-.3pt'>
</span>clearance.<span style='letter-spacing:-.35pt'> </span>Renal<span
style='letter-spacing:-.3pt'> </span>impair<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt<span style='letter-spacing:-.3pt'> </span>had<span
style='letter-spacing:-.35pt'> </span>no<span style='letter-spacing:-.3pt'> </span>evident<span
style='letter-spacing:-.3pt'> </span>ef<span style='letter-spacing:-.1pt'>f</span>ect<span
style='letter-spacing:-.35pt'> </span>on the<span style='letter-spacing:-.45pt'>
</span>relationship<span style='letter-spacing:-.4pt'> </span>between<span
style='letter-spacing:-.4pt'> </span>apixaban<span style='letter-spacing:-.4pt'>
</span>plas<span style='letter-spacing:-.05pt'>m</span>a<span style='letter-spacing:
-.4pt'> </span>concentrat<span style='letter-spacing:.05pt'>i</span>on<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.4pt'> </span>anti-FXa<span
style='letter-spacing:-.4pt'> </span>activit<span style='letter-spacing:.1pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.3pt'> </span>subjects<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.25pt'> </span>end-stage<span
style='letter-spacing:-.25pt'> </span>renal<span style='letter-spacing:-.25pt'>
</span>disease<span style='letter-spacing:-.25pt'> </span>(ESRD),<span
style='letter-spacing:-.25pt'> </span>the<span style='letter-spacing:-.25pt'> </span>AUC<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>was<span style='letter-spacing:-.3pt'> </span>inc<span
style='letter-spacing:.05pt'>r</span>eased<span style='letter-spacing:-.25pt'> </span>by<span
style='letter-spacing:-.15pt'> </span>36%<span style='letter-spacing:-.25pt'> </span>when<span
style='letter-spacing:-.25pt'> </span>a single<span style='letter-spacing:-.35pt'>
</span>dose<span style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:
-.3pt'> </span>apixaban<span style='letter-spacing:-.3pt'> </span>5<span
style='letter-spacing:-.35pt'>&nbsp;</span><span style='letter-spacing:-.1pt'>m</span>g<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:.05pt'>d</span>m<span style='letter-spacing:.05pt'>i</span>nistered<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>i</span>mmediately<span
style='letter-spacing:-.25pt'> </span>after<span style='letter-spacing:-.3pt'> </span>ha<span
style='letter-spacing:.05pt'>e</span><span style='letter-spacing:-.1pt'>m</span>odial<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is,<span
style='letter-spacing:-.3pt'> </span>c<span style='letter-spacing:.05pt'>o</span><span
style='letter-spacing:-.1pt'>m</span>pared<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:.05pt'>t</span>o<span style='letter-spacing:-.3pt'> </span>that
seen<span style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:
-.3pt'> </span>subjects<span style='letter-spacing:-.3pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>normal<span style='letter-spacing:-.3pt'> </span>renal<span
style='letter-spacing:-.3pt'> </span>function.<span style='letter-spacing:-.3pt'>
</span>Hae<span style='letter-spacing:-.1pt'>m</span>od<span style='letter-spacing:
-.1pt'>i</span>al<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>s</span>is,<span style='letter-spacing:-.3pt'> </span>started<span
style='letter-spacing:-.25pt'> </span>two<span style='letter-spacing:-.3pt'> </span>hours<span
style='letter-spacing:-.3pt'> </span>af<span style='letter-spacing:-.05pt'>te</span>r<span
style='letter-spacing:-.3pt'> </span>a<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistra<span style='letter-spacing:.05pt'>t</span>ion<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>a
single<span style='letter-spacing:-.3pt'> </span>dose<span style='letter-spacing:
-.25pt'> </span>of<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span>5<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g,<span style='letter-spacing:-.25pt'> </span>dec<span
style='letter-spacing:.05pt'>r</span>eased<span style='letter-spacing:-.25pt'> </span>apixaban<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.1pt'>A</span><span
style='letter-spacing:-.05pt'>U</span>C<span style='letter-spacing:-.25pt'> </span>by<span
style='letter-spacing:-.25pt'> </span>14%<span style='letter-spacing:-.25pt'> </span>in<span
style='letter-spacing:-.25pt'> </span>these<span style='letter-spacing:-.25pt'>
</span>ESRD<span style='letter-spacing:-.25pt'> </span>subjects, correspondi<span
style='letter-spacing:-.05pt'>n</span>g<span style='letter-spacing:-.35pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>an<span style='letter-spacing:-.35pt'> </span>ap<span
style='letter-spacing:-.05pt'>i</span>xaban<span style='letter-spacing:-.3pt'> </span>dia<span
style='letter-spacing:-.05pt'>l</span><span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>s</span>is<span style='letter-spacing:-.3pt'> </span>clearance<span
style='letter-spacing:-.35pt'> </span>of<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:.05pt'>1</span>8<span style='letter-spacing:-.35pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>L/min.<span style='letter-spacing:-.3pt'> </span>Therefore,<span
style='letter-spacing:-.3pt'> </span>hae<span style='letter-spacing:-.1pt'>m</span>odial<span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>s</span>is<span
style='letter-spacing:-.35pt'> </span>is<span style='letter-spacing:-.3pt'> </span>unlike<span
style='letter-spacing:-.05pt'>l</span>y<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>t</span>o be<span style='letter-spacing:-.35pt'> </span>an<span
style='letter-spacing:-.3pt'> </span>effective<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.1pt'>m</span>eans<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>managing<span
style='letter-spacing:-.35pt'> </span>apix<span style='letter-spacing:-.1pt'>a</span>ban<span
style='letter-spacing:-.3pt'> </span>overdose.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Hepatic<span style='letter-spacing:-.9pt'> </span>i<span
style='letter-spacing:-.1pt'>m</span>pair<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>In<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.2pt'> </span>study<span style='letter-spacing:-.15pt'> </span>co<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:.05pt'>p</span>aring<span
style='letter-spacing:-.2pt'> </span>8<span style='letter-spacing:-.25pt'>&nbsp;</span>subjects<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.2pt'> </span>mild<span
style='letter-spacing:-.2pt'> </span>hepatic<span style='letter-spacing:-.35pt'>
</span>impair<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>e</span>nt,<span style='letter-spacing:-.2pt'> </span>Child-Pugh<span
style='letter-spacing:-.3pt'> </span>A<span style='letter-spacing:-.2pt'> </span>score<span
style='letter-spacing:-.2pt'> </span>5&nbsp;(n<span style='letter-spacing:-.2pt'>
</span>=<span style='letter-spacing:-.25pt'> </span>6)<span style='letter-spacing:
-.25pt'> </span>and score<span style='letter-spacing:-.25pt'> </span>6<span
style='letter-spacing:-.2pt'>&nbsp;</span>(n<span style='letter-spacing:-.2pt'>
</span>=<span style='letter-spacing:-.2pt'> </span>2),<span style='letter-spacing:
-.2pt'> </span>and<span style='letter-spacing:-.2pt'> </span>8<span
style='letter-spacing:-.2pt'>&nbsp;</span>s<span style='letter-spacing:-.05pt'>u</span>bjects<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.15pt'> </span><span
style='letter-spacing:-.1pt'>m</span>oderate<span style='letter-spacing:-.2pt'>
</span>hep<span style='letter-spacing:-.15pt'>a</span>tic<span
style='letter-spacing:-.15pt'> </span>i<span style='letter-spacing:-.1pt'>m</span>pairment,<span
style='letter-spacing:-.2pt'> </span>Child-Pu<span style='letter-spacing:-.05pt'>g</span>h<span
style='letter-spacing:-.2pt'> </span>B<span style='letter-spacing:-.2pt'> </span>score<span
style='letter-spacing:-.2pt'> </span>7&nbsp;(n<span style='letter-spacing:-.25pt'>
</span>=<span style='letter-spacing:-.2pt'> </span>6)<span style='letter-spacing:
-.2pt'> </span>and score<span style='letter-spacing:-.3pt'> </span>8&nbsp;(n<span
style='letter-spacing:-.25pt'> </span>=<span style='letter-spacing:-.25pt'> </span>2),<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>1</span>6<span style='letter-spacing:-.25pt'>&nbsp;</span>healt<span
style='letter-spacing:-.05pt'>h</span>y<span style='letter-spacing:-.3pt'> </span>control<span
style='letter-spacing:-.25pt'> </span>s<span style='letter-spacing:-.05pt'>u</span>b<span
style='letter-spacing:-.05pt'>j</span>ects,<span style='letter-spacing:-.25pt'>
</span>the<span style='letter-spacing:-.25pt'> </span>single-dose<span
style='letter-spacing:-.25pt'> </span>pharmacokinetics<span style='letter-spacing:
-.25pt'> </span>and pharmacod<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>n</span>a<span style='letter-spacing:-.1pt'>m</span>ics<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.3pt'> </span>5<span style='letter-spacing:-.3pt'>&nbsp;</span><span
style='letter-spacing:-.1pt'>m</span>g<span style='letter-spacing:-.3pt'> </span>were<span
style='letter-spacing:-.3pt'> </span>not<span style='letter-spacing:-.3pt'> </span>alter<span
style='letter-spacing:-.1pt'>e</span>d<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>subjects<span style='letter-spacing:-.3pt'>
</span>with<span style='letter-spacing:-.3pt'> </span>hepatic<span
style='letter-spacing:-.3pt'> </span>impair<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>e</span>nt.<span style='letter-spacing:-.25pt'> </span>Changes<span
style='letter-spacing:-.3pt'> </span>in anti-Factor<span style='letter-spacing:
-.35pt'> </span>Xa<span style='letter-spacing:-.35pt'> </span>activity<span
style='letter-spacing:-.2pt'> </span>and<span style='letter-spacing:-.3pt'> </span>INR<span
style='letter-spacing:-.3pt'> </span>we<span style='letter-spacing:.05pt'>r</span>e<span
style='letter-spacing:-.35pt'> </span>co<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>p</span>arable<span style='letter-spacing:-.35pt'>
</span>be<span style='letter-spacing:.05pt'>t</span><span style='letter-spacing:
-.05pt'>w</span>een<span style='letter-spacing:-.3pt'> </span>subjects<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span>ild<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>m</span>oderate<span
style='letter-spacing:-.3pt'> </span>he<span style='letter-spacing:.05pt'>p</span><span
style='letter-spacing:-.05pt'>a</span>tic i<span style='letter-spacing:-.1pt'>m</span>pairment<span
style='letter-spacing:-.5pt'> </span>and<span style='letter-spacing:-.45pt'> </span>healt<span
style='letter-spacing:-.05pt'>h</span>y<span style='letter-spacing:-.35pt'> </span>s<span
style='letter-spacing:-.05pt'>u</span>bjects.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Elderly</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Elderly<span style='letter-spacing:-.35pt'> </span>patients<span
style='letter-spacing:-.35pt'> </span>(above<span style='letter-spacing:-.35pt'>
</span>65<span style='letter-spacing:-.45pt'>&nbsp;</span><span
style='letter-spacing:.05pt'>y</span>ears)<span style='letter-spacing:-.35pt'> </span>exhibited<span
style='letter-spacing:-.35pt'> </span>higher<span style='letter-spacing:-.4pt'>
</span>pl<span style='letter-spacing:-.1pt'>a</span>s<span style='letter-spacing:
-.1pt'>m</span>a<span style='letter-spacing:-.3pt'> </span>concentrations<span
style='letter-spacing:-.35pt'> </span>than<span style='letter-spacing:-.4pt'> </span>younger<span
style='letter-spacing:-.35pt'> </span>patie<span style='letter-spacing:-.05pt'>n</span>ts,<span
style='letter-spacing:-.35pt'> </span>with mean<span style='letter-spacing:
-.3pt'> </span>AUC<span style='letter-spacing:-.25pt'> </span>values<span
style='letter-spacing:-.3pt'> </span>being<span style='letter-spacing:-.25pt'> </span>approxi<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.3pt'> </span>32%<span style='letter-spacing:-.3pt'> </span>higher<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>a</span>nd<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>n</span>o<span
style='letter-spacing:-.3pt'> </span>difference<span style='letter-spacing:
-.25pt'> </span>in<span style='letter-spacing:-.3pt'> </span>C<sub><span
style='position:relative;top:1.0pt;letter-spacing:-.15pt'>m</span><span
style='position:relative;top:1.0pt'>ax</span></sub>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Gender</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Exposure<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.1pt'>a</span>pixaban<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.3pt'> </span>approxi<span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.25pt'> </span>18%<span style='letter-spacing:-.3pt'> </span>hi<span
style='letter-spacing:-.05pt'>g</span>her<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>females<span style='letter-spacing:-.25pt'>
</span>t<span style='letter-spacing:.05pt'>h</span>an<span style='letter-spacing:
-.3pt'> </span>in<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>les.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Ethnic<span style='letter-spacing:-.35pt'> </span>orig<span
style='letter-spacing:-.05pt'>i</span>n<span style='letter-spacing:-.35pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>race</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.35pt'> </span>results<span
style='letter-spacing:-.35pt'> </span>a<span style='letter-spacing:.05pt'>c</span>ross<span
style='letter-spacing:-.3pt'> </span>phase<span style='letter-spacing:-.35pt'> </span>I<span
style='letter-spacing:-.35pt'> </span>studies<span style='letter-spacing:-.3pt'>
</span>showed<span style='letter-spacing:-.35pt'> </span>no<span
style='letter-spacing:-.35pt'> </span>discernible<span style='letter-spacing:
-.35pt'> </span>difference<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.3pt'> </span>apixaban<span style='letter-spacing:-.4pt'>
</span>pharmacokinetics between<span style='letter-spacing:-.45pt'> </span>White/Caucasian,<span
style='letter-spacing:-.4pt'> </span>Asian<span style='letter-spacing:-.4pt'> </span>and<span
style='letter-spacing:-.45pt'> </span>Black/African<span style='letter-spacing:
-.4pt'> </span>A<span style='letter-spacing:-.1pt'>m</span>erican<span
style='letter-spacing:-.4pt'> </span>subjects.<span style='letter-spacing:-.4pt'>
</span>Findin<span style='letter-spacing:-.05pt'>g</span>s<span
style='letter-spacing:-.45pt'> </span>fr<span style='letter-spacing:.05pt'>o</span>m<span
style='letter-spacing:-.5pt'> </span>a<span style='letter-spacing:-.4pt'> </span>pop<span
style='letter-spacing:-.05pt'>u</span>lation pharmacokinetic<span
style='letter-spacing:-.35pt'> </span>anal<span style='letter-spacing:.05pt'>y</span><span
style='letter-spacing:-.05pt'>s</span>is<span style='letter-spacing:-.3pt'> </span>in<span
style='letter-spacing:-.35pt'> </span>patients<span style='letter-spacing:-.3pt'>
</span>who<span style='letter-spacing:-.3pt'> </span>received<span
style='letter-spacing:-.35pt'> </span>api<span style='letter-spacing:-.1pt'>x</span>aban<span
style='letter-spacing:-.3pt'> </span>were<span style='letter-spacing:-.3pt'> </span>generally<span
style='letter-spacing:-.2pt'> </span>consistent<span style='letter-spacing:
-.3pt'> </span>with<span style='letter-spacing:-.35pt'> </span>the<span
style='letter-spacing:-.3pt'> </span>phase<span style='letter-spacing:-.35pt'> </span>I
results.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Bo<span style='letter-spacing:-.05pt'>d</span>y<span
style='letter-spacing:-.5pt'> </span>weight</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>C<span style='letter-spacing:.05pt'>o</span><span style='letter-spacing:
-.1pt'>m</span>pared<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.2pt'> </span>apixaban<span style='letter-spacing:-.2pt'>
</span>ex<span style='letter-spacing:-.05pt'>p</span>osure<span
style='letter-spacing:-.25pt'> </span>in<span style='letter-spacing:-.2pt'> </span>subj<span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:-.05pt'>c</span>ts<span
style='letter-spacing:-.2pt'> </span>with<span style='letter-spacing:-.25pt'> </span>bo<span
style='letter-spacing:-.05pt'>d</span>y<span style='letter-spacing:-.2pt'> </span>weight<span
style='letter-spacing:-.2pt'> </span>of<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>6</span>5<span style='letter-spacing:-.25pt'> </span>to<span
style='letter-spacing:-.2pt'> </span>85&nbsp;kg,<span style='letter-spacing:
-.25pt'> </span>bo<span style='letter-spacing:-.05pt'>d</span>y<span
style='letter-spacing:-.2pt'> </span>weight<span style='letter-spacing:-.25pt'>
</span>&gt;<span style='letter-spacing:-.2pt'>&nbsp;</span>1<span
style='letter-spacing:-.05pt'>2</span>0&nbsp;kg was<span style='letter-spacing:
-.3pt'> </span>associa<span style='letter-spacing:.05pt'>t</span>ed<span
style='letter-spacing:-.25pt'> </span>with<span style='letter-spacing:-.3pt'> </span>approx<span
style='letter-spacing:.05pt'>i</span><span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:-.05pt'>a</span>tely<span style='letter-spacing:-.15pt'> </span>30%<span
style='letter-spacing:-.3pt'> </span>lower<span style='letter-spacing:-.25pt'> </span>expo<span
style='letter-spacing:-.05pt'>s</span>ure<span style='letter-spacing:-.3pt'> </span>and<span
style='letter-spacing:-.25pt'> </span>body<span style='letter-spacing:-.35pt'> </span>weight<span
style='letter-spacing:-.25pt'> </span>&lt;&nbsp;50<span style='letter-spacing:
-.3pt'> </span>kg<span style='letter-spacing:-.25pt'> </span>was<span
style='letter-spacing:-.3pt'> </span>ass<span style='letter-spacing:.05pt'>o</span>ciated<span
style='letter-spacing:-.25pt'> </span>with approxi<span style='letter-spacing:
-.1pt'>m</span><span style='letter-spacing:-.05pt'>a</span>tely<span
style='letter-spacing:-.55pt'> </span>30%<span style='letter-spacing:-.55pt'> </span>hi<span
style='letter-spacing:-.05pt'>g</span>her<span style='letter-spacing:-.5pt'> </span>exposure.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Phar<span style='letter-spacing:-.1pt'>m</span>acokinetic/phar<span
style='letter-spacing:-.1pt'>m</span>ac<span style='letter-spacing:-.1pt'>o</span><span
style='letter-spacing:-.05pt'>d</span>yna<span style='letter-spacing:-.1pt'>m</span>ic
relationship</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.55pt'> </span>pharmacokinetic/pha<span
style='letter-spacing:-.1pt'>r</span><span style='letter-spacing:-.05pt'>m</span>acod<span
style='letter-spacing:.05pt'>y</span>na<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>i</span>c<span style='letter-spacing:-.5pt'> </span>(PK/P<span
style='letter-spacing:-.05pt'>D</span>)<span style='letter-spacing:-.55pt'> </span>re<span
style='letter-spacing:.05pt'>l</span><span style='letter-spacing:-.05pt'>a</span>tionship<span
style='letter-spacing:-.55pt'> </span>between<span style='letter-spacing:-.5pt'>
</span>apixab<span style='letter-spacing:.05pt'>a</span>n<span
style='letter-spacing:-.55pt'> </span>plasma concentration<span
style='letter-spacing:-.35pt'> </span>and<span style='letter-spacing:-.3pt'> </span>several<span
style='letter-spacing:-.3pt'> </span>PD<span style='letter-spacing:-.3pt'> </span>endpoints<span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.1pt'>(</span><span
style='letter-spacing:-.05pt'>a</span>nti-FXa<span style='letter-spacing:-.3pt'>
</span>ac<span style='letter-spacing:-.05pt'>t</span>ivi<span style='letter-spacing:
-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.3pt'> </span>INR,<span style='letter-spacing:-.3pt'> </span>P<span
style='letter-spacing:-.05pt'>T</span>,<span style='letter-spacing:-.3pt'> </span>aPTT)<span
style='letter-spacing:-.35pt'> </span>has<span style='letter-spacing:-.3pt'> </span>been<span
style='letter-spacing:-.3pt'> </span>evaluated<span style='letter-spacing:-.25pt'>
</span>after a<span style='letter-spacing:.05pt'>d</span><span
style='letter-spacing:-.1pt'>m</span>inistration<span style='letter-spacing:
-.3pt'> </span>of<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>wide<span style='letter-spacing:-.25pt'> </span>range<span
style='letter-spacing:-.25pt'> </span>of<span style='letter-spacing:-.3pt'> </span>doses<span
style='letter-spacing:-.25pt'> </span>(0.5&nbsp;–<span style='letter-spacing:
-.25pt'>&nbsp;</span>50&nbsp;<span style='letter-spacing:-.1pt'>m</span>g).<span
style='letter-spacing:-.25pt'> </span>The<span style='letter-spacing:-.3pt'> </span>relationship<span
style='letter-spacing:-.25pt'> </span>between<span style='letter-spacing:-.25pt'>
</span>apixaban<span style='letter-spacing:-.25pt'> </span>pla<span
style='letter-spacing:-.1pt'>s</span>ma concentration<span style='letter-spacing:
-.3pt'> </span>and<span style='letter-spacing:-.3pt'> </span>anti-Factor<span
style='letter-spacing:-.25pt'> </span>Xa<span style='letter-spacing:-.3pt'> </span>activity<span
style='letter-spacing:-.3pt'> </span>was<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>b</span>est<span style='letter-spacing:-.3pt'> </span>described<span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>b</span>y<span
style='letter-spacing:-.2pt'> </span>a<span style='letter-spacing:-.3pt'> </span>l<span
style='letter-spacing:-.05pt'>i</span>near<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span>odel.<span style='letter-spacing:-.25pt'> </span>The<span
style='letter-spacing:-.3pt'> </span>PK/PD relationship<span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.05pt'>o</span>bserved<span
style='letter-spacing:-.35pt'> </span>in<span style='letter-spacing:-.3pt'> </span>p<span
style='letter-spacing:-.1pt'>a</span>tients<span style='letter-spacing:-.35pt'>
</span>was<span style='letter-spacing:-.3pt'> </span>c<span style='letter-spacing:
.05pt'>o</span>nsistent<span style='letter-spacing:-.45pt'> </span>with<span
style='letter-spacing:-.3pt'> </span>that<span style='letter-spacing:-.35pt'> </span>established<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.35pt'> </span>healthy<span
style='letter-spacing:-.3pt'> </span>subjects.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>5.3<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Preclinical<span style='letter-spacing:-.5pt'> </span>safety<span
style='letter-spacing:-.5pt'> </span>data</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Preclinical<span style='letter-spacing:-.3pt'> </span>data<span
style='letter-spacing:-.3pt'> </span>reveal<span style='letter-spacing:-.25pt'>
</span>no<span style='letter-spacing:-.3pt'> </span>special<span
style='letter-spacing:-.3pt'> </span>hazard<span style='letter-spacing:-.25pt'>
</span>f<span style='letter-spacing:-.15pt'>o</span>r<span style='letter-spacing:
-.25pt'> </span>hu<span style='letter-spacing:-.1pt'>m</span>ans<span
style='letter-spacing:-.3pt'> </span>based<span style='letter-spacing:-.3pt'> </span>on<span
style='letter-spacing:-.25pt'> </span>conventional<span style='letter-spacing:
-.3pt'> </span>studies<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>safety pharmacology,<span
style='letter-spacing:-.5pt'> </span>repeated<span style='letter-spacing:-.45pt'>
</span>dose<span style='letter-spacing:-.5pt'> </span>toxici<span
style='letter-spacing:-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>,<span
style='letter-spacing:-.5pt'> </span>genotoxici<span style='letter-spacing:
-.05pt'>t</span>y,<span style='letter-spacing:-.5pt'> </span>carcinogenic<span
style='letter-spacing:-.5pt'> </span>potential,<span style='letter-spacing:
-.45pt'> </span>fertili<span style='letter-spacing:-.05pt'>t</span>y<span
style='letter-spacing:-.4pt'> </span>and<span style='letter-spacing:-.5pt'> </span>e<span
style='letter-spacing:-.1pt'>m</span>bryo-foetal develop<span style='letter-spacing:
-.1pt'>m</span>ent<span style='letter-spacing:-.45pt'> </span>and<span
style='letter-spacing:-.5pt'> </span>juvenile<span style='letter-spacing:-.45pt'>
</span><span style='letter-spacing:-.05pt'>t</span>oxici<span style='letter-spacing:
-.05pt'>t</span><span style='letter-spacing:.05pt'>y</span>.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>The<span style='letter-spacing:-.3pt'> </span>major<span
style='letter-spacing:-.25pt'> </span>observed<span style='letter-spacing:-.25pt'>
</span>effec<span style='letter-spacing:.05pt'>t</span>s<span style='letter-spacing:
-.2pt'> </span>in<span style='letter-spacing:-.25pt'> </span>the<span
style='letter-spacing:-.25pt'> </span>repeated<span style='letter-spacing:-.25pt'>
</span>dose<span style='letter-spacing:-.25pt'> </span>toxicity<span
style='letter-spacing:-.25pt'> </span>studies<span style='letter-spacing:-.25pt'>
</span>were<span style='letter-spacing:-.25pt'> </span>those<span
style='letter-spacing:-.25pt'> </span>relat<span style='letter-spacing:.05pt'>e</span>d<span
style='letter-spacing:-.25pt'> </span>to<span style='letter-spacing:-.25pt'> </span>the
pharmacod<span style='letter-spacing:.05pt'>y</span>na<span style='letter-spacing:
-.1pt'>m</span>ic<span style='letter-spacing:-.35pt'> </span>action<span
style='letter-spacing:-.3pt'> </span>of<span style='letter-spacing:-.3pt'> </span>apixaban<span
style='letter-spacing:-.4pt'> </span>on<span style='letter-spacing:-.3pt'> </span>blood<span
style='letter-spacing:-.3pt'> </span>coagu<span style='letter-spacing:-.05pt'>l</span>ation<span
style='letter-spacing:-.35pt'> </span>parame<span style='letter-spacing:.05pt'>t</span><span
style='letter-spacing:-.05pt'>e</span>rs.<span style='letter-spacing:-.4pt'> </span>In<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.3pt'> </span>toxicity<span
style='letter-spacing:-.25pt'> </span>studies<span style='letter-spacing:-.3pt'>
</span>little<span style='letter-spacing:-.35pt'> </span>to no<span
style='letter-spacing:-.25pt'> </span>increase<span style='letter-spacing:-.25pt'>
</span>of<span style='letter-spacing:-.2pt'> </span>bleeding<span
style='letter-spacing:-.25pt'> </span>tendency<span style='letter-spacing:-.15pt'>
</span>was<span style='letter-spacing:-.25pt'> </span>found.<span
style='letter-spacing:-.2pt'> </span>However,<span style='letter-spacing:-.3pt'>
</span>since<span style='letter-spacing:-.25pt'> </span>this<span
style='letter-spacing:-.2pt'> </span>may<span style='letter-spacing:-.15pt'> </span>be<span
style='letter-spacing:-.25pt'> </span>due<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>t</span>o<span style='letter-spacing:-.25pt'> </span>a<span
style='letter-spacing:-.25pt'> </span>lower<span style='letter-spacing:-.2pt'> </span>sensitivi<span
style='letter-spacing:-.05pt'>t</span>y<span style='letter-spacing:-.15pt'> </span>of
the<span style='letter-spacing:-.35pt'> </span>non-clini<span style='letter-spacing:
-.1pt'>c</span>al<span style='letter-spacing:-.3pt'> </span>species<span
style='letter-spacing:-.3pt'> </span>co<span style='letter-spacing:-.1pt'>m</span><span
style='letter-spacing:.05pt'>p</span>ared<span style='letter-spacing:-.3pt'> </span>to<span
style='letter-spacing:-.3pt'> </span>h<span style='letter-spacing:-.05pt'>u</span>mans,<span
style='letter-spacing:-.3pt'> </span>this<span style='letter-spacing:-.35pt'> </span>result<span
style='letter-spacing:-.3pt'> </span>shou<span style='letter-spacing:-.05pt'>l</span>d<span
style='letter-spacing:-.35pt'> </span>be<span style='letter-spacing:-.3pt'> </span>interpreted<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.3pt'> </span>caution<span
style='letter-spacing:-.35pt'> </span>w<span style='letter-spacing:-.05pt'>h</span>en
extrapolating<span style='letter-spacing:-.6pt'> </span>to<span
style='letter-spacing:-.5pt'> </span>hu<span style='letter-spacing:-.1pt'>m</span>ans.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>PHAR</span><span
lang=EN-GB>M<span style='letter-spacing:-.05pt'>A</span>C<span
style='letter-spacing:-.05pt'>EUT</span>I<span style='letter-spacing:-.05pt'>CA</span>L
P<span style='letter-spacing:-.05pt'>ART</span>I<span style='letter-spacing:
-.05pt'>CU</span>LA<span style='letter-spacing:-.05pt'>R</span>S</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><b><span lang=EN-GB style='font-size:11.0pt'>6.1<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='font-size:11.0pt'>List<span
style='letter-spacing:-.4pt'> </span>of<span style='letter-spacing:-.35pt'> </span>excipients</span></b></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Tablet<span style='letter-spacing:-.55pt'> </span>core</span></u><span
lang=EN-GB> </span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.05pt'>Lactose</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Cellulose, microcrystalline</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Crosca<span style='letter-spacing:.05pt'>r</span>mell<span
style='letter-spacing:.05pt'>o</span>se<span style='letter-spacing:-1.05pt'> </span>sodium</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Sodium laurilsulfate </span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Magnesi<span style='letter-spacing:.05pt'>u</span>m<span
style='letter-spacing:-.7pt'> </span>stearate</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB>Film<span style='letter-spacing:-.5pt'> </span>coat</span></u></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.05pt'>Hypromellose</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.05pt'>Lactos</span><span lang=EN-GB>e<span
style='letter-spacing:-.9pt'> </span><span style='letter-spacing:-.1pt'>m</span>o<span
style='letter-spacing:.05pt'>n</span>o<span style='letter-spacing:-.05pt'>h</span><span
style='letter-spacing:.05pt'>y</span><span style='letter-spacing:-.05pt'>drate </span></span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Titanium<span style='letter-spacing:-.65pt'> </span>dioxide<span
style='letter-spacing:-.5pt'> </span>(E1<span style='letter-spacing:-.05pt'>7</span>1)</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Triacetin</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>Iron oxide red (E172)</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.2<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Incompatibilities</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Not<span style='letter-spacing:-.65pt'> </span>applicable</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.3<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Shelf<span style='letter-spacing:-.4pt'> </span>life</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.35pt'>3&nbsp;</span><span lang=EN-GB
style='letter-spacing:.05pt'>y</span><span lang=EN-GB>ears</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.4<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Special<span style='letter-spacing:-.5pt'> </span>precautions<span
style='letter-spacing:-.45pt'> </span>for<span style='letter-spacing:-.45pt'> </span>storage</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>This<span style='letter-spacing:-.35pt'> </span>medicinal<span
style='letter-spacing:-.3pt'> </span>product<span style='letter-spacing:-.3pt'>
</span><span style='letter-spacing:-.05pt'>do</span>es<span style='letter-spacing:
-.35pt'> </span>not<span style='letter-spacing:-.3pt'> </span>require<span
style='letter-spacing:-.3pt'> </span>any<span style='letter-spacing:-.35pt'> </span>special<span
style='letter-spacing:-.3pt'> </span>storage<span style='letter-spacing:-.3pt'>
</span>condit<span style='letter-spacing:-.05pt'>i</span>on.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.5<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Nature<span style='letter-spacing:-.4pt'> </span>and<span
style='letter-spacing:-.35pt'> </span>contents<span style='letter-spacing:-.35pt'>
</span>of<span style='letter-spacing:-.35pt'> </span>container</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>PVC/PVdC-Aluminium blisters <span style='color:black'>are available
in </span>10, 14, 20, 28, 56, 60, 100, 112, 168, and 200&nbsp;film&#8209;coated
tablets.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>PVC/PVdC-Aluminium blisters <span style='color:black'>are available
in </span>perforated unit dose blisters of 10 x 1, 20 x 1, 28 x 1, 56 x 1, 60 x
1, 100 x 1 and 168 x 1&nbsp;film-coated tablet.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>HDPE bottle with polypropylene child resistant/continues threaded closure
containing 60, 100, 168, 180, 200 and 1,000&nbsp;film-coated tablets.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='background:yellow'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Not all pack sizes may be marketed.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>6.6<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>Special<span style='letter-spacing:-.5pt'> </span>pre<span
style='letter-spacing:.05pt'>c</span>autions<span style='letter-spacing:-.45pt'>
</span>for<span style='letter-spacing:-.5pt'> </span>disposal</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>No<span style='letter-spacing:-.55pt'> </span>special<span
style='letter-spacing:-.5pt'> </span>requirements.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Any<span style='letter-spacing:-.3pt'> </span>unused<span
style='letter-spacing:-.3pt'> </span>medicinal<span style='letter-spacing:-.3pt'>
</span>product<span style='letter-spacing:-.25pt'> </span>or<span
style='letter-spacing:-.3pt'> </span>waste<span style='letter-spacing:-.25pt'> </span>mater<span
style='letter-spacing:.05pt'>i</span>al<span style='letter-spacing:-.3pt'> </span>should<span
style='letter-spacing:-.25pt'> </span>be<span style='letter-spacing:-.3pt'> </span>dispos<span
style='letter-spacing:-.1pt'>e</span>d<span style='letter-spacing:-.25pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>in<span style='letter-spacing:-.25pt'> </span>accordance<span
style='letter-spacing:-.3pt'> </span>with<span style='letter-spacing:-.25pt'> </span>local
require<span style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:
-.05pt'>e</span>nts.</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>MARKET</span><span
lang=EN-GB>I<span style='letter-spacing:-.05pt'>N</span>G<span
style='letter-spacing:-1.1pt'> </span>A<span style='letter-spacing:-.05pt'>UTHORISA</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>IO</span>N<span
style='letter-spacing:-1.0pt'> </span><span style='letter-spacing:-.05pt'>HO</span><span
style='letter-spacing:.05pt'>L</span><span style='letter-spacing:-.05pt'>D</span><span
style='letter-spacing:.05pt'>E</span>R</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Accord Healthcare S.L.U.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>World Trade Center, Moll de Barcelona s/n,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Edifici Est, 6<sup>a</sup> Planta,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Barcelona, 08039</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Spain</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>MARKETING<span style='letter-spacing:-1.15pt'> </span>A<span
style='letter-spacing:-.05pt'>U</span>THORISA<span style='letter-spacing:.05pt'>T</span>ION<span
style='letter-spacing:-1.1pt'> </span>NUMB<span style='letter-spacing:.05pt'>E</span>R(<span
style='letter-spacing:.05pt'>S</span>)</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-size:11.0pt'>EU/1/20/1458/021-040, 044-046</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>9.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>DAT</span><span
lang=EN-GB>E<span style='letter-spacing:-.6pt'> </span><span style='letter-spacing:
-.05pt'>O</span>F<span style='letter-spacing:-.6pt'> </span><span
style='letter-spacing:.05pt'>F</span><span style='letter-spacing:-.05pt'>IRS</span>T<span
style='letter-spacing:-.6pt'> </span>A<span style='letter-spacing:-.05pt'>UTHORI</span><span
style='letter-spacing:.05pt'>S</span><span style='letter-spacing:-.05pt'>AT</span>IO<span
style='letter-spacing:-.05pt'>N/RE</span>N<span style='letter-spacing:-.05pt'>EW</span>AL<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>O</span>F<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>TH</span>E<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>AU</span><span
style='letter-spacing:.05pt'>T</span><span style='letter-spacing:-.05pt'>HORI</span><span
style='letter-spacing:.05pt'>S</span><span style='letter-spacing:-.05pt'>AT</span>I<span
style='letter-spacing:-.05pt'>ON</span></span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Date<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.25pt'> </span>first<span style='letter-spacing:-.3pt'> </span>authorisation:<span
style='letter-spacing:-.3pt'> </span></span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<h1 style='margin-left:28.35pt;text-indent:-28.35pt;punctuation-wrap:simple'><span
lang=EN-GB>10.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>DATE<span style='letter-spacing:-.3pt'> </span>OF<span
style='letter-spacing:-.35pt'> </span>REVISION<span style='letter-spacing:-.3pt'>
</span>OF<span style='letter-spacing:-.35pt'> </span>THE<span style='letter-spacing:
-.3pt'> </span>TE<span style='letter-spacing:.1pt'>X</span>T</span></h1>

<p class=MsoNormal style='punctuation-wrap:simple'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Detailed<span style='letter-spacing:-.3pt'> </span>information<span
style='letter-spacing:-.3pt'> </span>on<span style='letter-spacing:-.3pt'> </span>th<span
style='letter-spacing:-.05pt'>i</span>s<span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.1pt'>m</span><span style='letter-spacing:-.05pt'>e</span>dicinal<span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:.05pt'>p</span>roduct<span
style='letter-spacing:-.3pt'> </span>is<span style='letter-spacing:-.3pt'> </span>a<span
style='letter-spacing:-.15pt'>v</span>ailable<span style='letter-spacing:-.25pt'>
</span>on<span style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:
-.35pt'> </span>website<span style='letter-spacing:-.3pt'> </span>of<span
style='letter-spacing:-.3pt'> </span>the<span style='letter-spacing:-.25pt'> </span>European<span
style='letter-spacing:-.35pt'> </span>Medicines Agency<span style='letter-spacing:
-1.45pt'> <span style='color:blue'><a href="http://www.ema.europa.eu/"><span
style='letter-spacing:0pt'>http://www.</span><span style='letter-spacing:.05pt'>e</span><span
style='letter-spacing:-.05pt'>m</span><span style='letter-spacing:0pt'>a.e</span><span
style='letter-spacing:.05pt'>u</span><span style='letter-spacing:0pt'>ropa.eu</span></a></span></span></span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:blue;letter-spacing:-1.45pt'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:blue;
letter-spacing:-1.45pt'>&nbsp;</span></p>

<p class=MsoBodyText align=center style='margin-top:0in;margin-right:.3pt;
margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:center;
punctuation-wrap:simple'><b><span lang=EN-GB style='letter-spacing:-.1pt'>ANN</span><span
lang=EN-GB style='letter-spacing:-.05pt'>E</span><span lang=EN-GB
style='letter-spacing:-.1pt'>X</span><span lang=EN-GB style='letter-spacing:
-1.25pt'> </span><span lang=EN-GB>II</span></b></p>

<p class=MsoBodyText style='margin-top:.3pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><b><span
lang=EN-GB style='font-size:10.5pt'>&nbsp;</span></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:1.25pt;margin-bottom:
0in;margin-left:86.55pt;margin-bottom:.0001pt;text-indent:-33.25pt;line-height:
102%;punctuation-wrap:simple'><b><span lang=EN-GB>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='letter-spacing:-.05pt'>M</span><span
lang=EN-GB style='letter-spacing:-.1pt'>ANU</span><span lang=EN-GB
style='letter-spacing:-.05pt'>F</span><span lang=EN-GB style='letter-spacing:
-.1pt'>A</span><span lang=EN-GB style='letter-spacing:-.05pt'>CT</span><span
lang=EN-GB style='letter-spacing:-.1pt'>U</span><span lang=EN-GB
style='letter-spacing:-.05pt'>RER</span><span lang=EN-GB style='letter-spacing:
-.1pt'>(S)</span><span lang=EN-GB style='letter-spacing:-1.25pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>RE</span><span lang=EN-GB
style='letter-spacing:-.1pt'>S</span><span lang=EN-GB style='letter-spacing:
-.05pt'>PO</span><span lang=EN-GB style='letter-spacing:-.1pt'>NS</span><span
lang=EN-GB style='letter-spacing:-.05pt'>I</span><span lang=EN-GB
style='letter-spacing:-.1pt'>B</span><span lang=EN-GB style='letter-spacing:
-.05pt'>LE</span><span lang=EN-GB style='letter-spacing:-1.3pt'> </span><span
lang=EN-GB>FOR<span style='letter-spacing:-1.3pt'> </span>BATCH</span><span
lang=EN-GB style='letter-spacing:1.35pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>RELE</span><span lang=EN-GB style='letter-spacing:
-.1pt'>AS</span><span lang=EN-GB style='letter-spacing:-.05pt'>E</span></b></p>

<p class=MsoBodyText style='margin-top:.5pt;margin-right:1.25pt;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:1.25pt;margin-bottom:
0in;margin-left:86.55pt;margin-bottom:.0001pt;text-indent:-33.25pt;line-height:
102%;punctuation-wrap:simple'><b><span lang=EN-GB>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='letter-spacing:-.05pt'>CO</span><span
lang=EN-GB style='letter-spacing:-.1pt'>ND</span><span lang=EN-GB
style='letter-spacing:-.05pt'>ITIO</span><span lang=EN-GB style='letter-spacing:
-.1pt'>NS</span><span lang=EN-GB style='letter-spacing:-.6pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>OR</span><span lang=EN-GB
style='letter-spacing:-.55pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>RE</span><span lang=EN-GB style='letter-spacing:-.1pt'>S</span><span
lang=EN-GB style='letter-spacing:-.05pt'>TRICTIO</span><span lang=EN-GB
style='letter-spacing:-.1pt'>NS</span><span lang=EN-GB style='letter-spacing:
-.4pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>REG</span><span
lang=EN-GB style='letter-spacing:-.1pt'>A</span><span lang=EN-GB
style='letter-spacing:-.05pt'>R</span><span lang=EN-GB style='letter-spacing:
-.1pt'>D</span><span lang=EN-GB style='letter-spacing:-.05pt'>I</span><span
lang=EN-GB style='letter-spacing:-.1pt'>N</span><span lang=EN-GB
style='letter-spacing:-.05pt'>G</span><span lang=EN-GB style='letter-spacing:
-.6pt'> </span><span lang=EN-GB style='letter-spacing:-.1pt'>SU</span><span
lang=EN-GB style='letter-spacing:-.05pt'>PPL</span><span lang=EN-GB
style='letter-spacing:-.1pt'>Y</span><span lang=EN-GB style='letter-spacing:
1.65pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>AND</span><span
lang=EN-GB style='letter-spacing:-.35pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>USE</span></b></p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:1.25pt;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><b><span
lang=EN-GB style='font-size:10.5pt'>&nbsp;</span></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:1.25pt;margin-bottom:
0in;margin-left:86.55pt;margin-bottom:.0001pt;text-indent:-33.25pt;line-height:
102%;punctuation-wrap:simple'><b><span lang=EN-GB>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='letter-spacing:-.1pt'>OTHER</span><span
lang=EN-GB style='letter-spacing:-.45pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>CO</span><span lang=EN-GB style='letter-spacing:
-.1pt'>ND</span><span lang=EN-GB style='letter-spacing:-.05pt'>ITIO</span><span
lang=EN-GB style='letter-spacing:-.1pt'>NS</span><span lang=EN-GB
style='letter-spacing:-.25pt'> </span><span lang=EN-GB style='letter-spacing:
-.1pt'>AND</span><span lang=EN-GB style='letter-spacing:-.45pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>REQ</span><span lang=EN-GB
style='letter-spacing:-.1pt'>U</span><span lang=EN-GB style='letter-spacing:
-.05pt'>IREME</span><span lang=EN-GB style='letter-spacing:-.1pt'>N</span><span
lang=EN-GB style='letter-spacing:-.05pt'>T</span><span lang=EN-GB
style='letter-spacing:-.1pt'>S</span><span lang=EN-GB style='letter-spacing:
-.3pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>OF</span><span
lang=EN-GB style='letter-spacing:-.45pt'> </span><span lang=EN-GB
style='letter-spacing:-.1pt'>THE</span><span lang=EN-GB style='letter-spacing:
1.35pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>M</span><span
lang=EN-GB style='letter-spacing:-.1pt'>A</span><span lang=EN-GB
style='letter-spacing:-.05pt'>RKETI</span><span lang=EN-GB style='letter-spacing:
-.1pt'>N</span><span lang=EN-GB style='letter-spacing:-.05pt'>G</span><span
lang=EN-GB style='letter-spacing:-1.1pt'> </span><span lang=EN-GB
style='letter-spacing:-.1pt'>AU</span><span lang=EN-GB style='letter-spacing:
-.05pt'>THORI</span><span lang=EN-GB style='letter-spacing:-.1pt'>SA</span><span
lang=EN-GB style='letter-spacing:-.05pt'>TIO</span><span lang=EN-GB
style='letter-spacing:-.1pt'>N</span></b></p>

<p class=MsoBodyText style='margin-top:.4pt;margin-right:1.25pt;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><b><span
lang=EN-GB>&nbsp;</span></b></p>

<p class=MsoBodyText style='margin-top:0in;margin-right:1.25pt;margin-bottom:
0in;margin-left:86.55pt;margin-bottom:.0001pt;text-indent:-33.25pt;line-height:
102%;punctuation-wrap:simple'><b><span lang=EN-GB>D.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='letter-spacing:-.05pt'>CO</span><span
lang=EN-GB style='letter-spacing:-.1pt'>ND</span><span lang=EN-GB
style='letter-spacing:-.05pt'>ITIO</span><span lang=EN-GB style='letter-spacing:
-.1pt'>NS</span><span lang=EN-GB style='letter-spacing:-.3pt'> </span><span
lang=EN-GB>OR<span style='letter-spacing:-.2pt'> </span><span style='letter-spacing:
-.05pt'>RE</span><span style='letter-spacing:-.1pt'>S</span><span
style='letter-spacing:-.05pt'>TRICTIO</span><span style='letter-spacing:-.1pt'>NS</span><span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>WITH</span><span
style='letter-spacing:-.05pt'> REG</span><span style='letter-spacing:-.1pt'>A</span><span
style='letter-spacing:-.05pt'>R</span><span style='letter-spacing:-.1pt'>D</span><span
style='letter-spacing:-.25pt'> </span>TO</span><span lang=EN-GB
style='letter-spacing:1.25pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>THE</span><span lang=EN-GB style='letter-spacing:-.5pt'> </span><span
lang=EN-GB>SAFE<span style='letter-spacing:-.45pt'> </span>AND<span
style='letter-spacing:-.6pt'> </span>EFFECTIVE<span style='letter-spacing:-.5pt'>
</span><span style='letter-spacing:-.1pt'>US</span><span style='letter-spacing:
-.05pt'>E</span><span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>OF</span><span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.05pt'>THE</span><span style='letter-spacing:-.25pt'> </span><span
style='letter-spacing:-.05pt'>ME</span><span style='letter-spacing:-.1pt'>D</span><span
style='letter-spacing:-.05pt'>ICI</span><span style='letter-spacing:-.1pt'>NA</span><span
style='letter-spacing:-.05pt'>L</span></span><span lang=EN-GB style='letter-spacing:
1.25pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>PRO</span><span
lang=EN-GB style='letter-spacing:-.1pt'>DU</span><span lang=EN-GB
style='letter-spacing:-.05pt'>CT</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:blue;letter-spacing:-1.45pt'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoBodyText style='margin-top:2.55pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-top:2.55pt;margin-right:0in;margin-bottom:
0in;margin-left:28.1pt;margin-bottom:.0001pt;text-indent:-28.1pt;punctuation-wrap:
simple'><b><span lang=EN-GB>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='letter-spacing:-.05pt'>M</span><span
lang=EN-GB style='letter-spacing:-.1pt'>ANU</span><span lang=EN-GB
style='letter-spacing:-.05pt'>F</span><span lang=EN-GB style='letter-spacing:
-.1pt'>A</span><span lang=EN-GB style='letter-spacing:-.05pt'>CT</span><span
lang=EN-GB style='letter-spacing:-.1pt'>U</span><span lang=EN-GB
style='letter-spacing:-.05pt'>RER</span><span lang=EN-GB style='letter-spacing:
-.1pt'>(S)</span><span lang=EN-GB style='letter-spacing:-.9pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>RE</span><span lang=EN-GB
style='letter-spacing:-.1pt'>S</span><span lang=EN-GB style='letter-spacing:
-.05pt'>PO</span><span lang=EN-GB style='letter-spacing:-.1pt'>NS</span><span
lang=EN-GB style='letter-spacing:-.05pt'>I</span><span lang=EN-GB
style='letter-spacing:-.1pt'>B</span><span lang=EN-GB style='letter-spacing:
-.05pt'>LE</span><span lang=EN-GB style='letter-spacing:-.9pt'> </span><span
lang=EN-GB style='letter-spacing:-.1pt'>FOR</span><span lang=EN-GB
style='letter-spacing:-.95pt'> </span><span lang=EN-GB style='letter-spacing:
-.1pt'>BA</span><span lang=EN-GB style='letter-spacing:-.05pt'>TCH</span><span
lang=EN-GB style='letter-spacing:-.85pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>RELE</span><span lang=EN-GB style='letter-spacing:
-.1pt'>AS</span><span lang=EN-GB style='letter-spacing:-.05pt'>E</span></b></p>

<p class=MsoBodyText style='margin-top:.5pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><u><span
lang=EN-GB style='letter-spacing:-.05pt'>Name</span><span lang=EN-GB
style='letter-spacing:-.7pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>and</span><span lang=EN-GB style='letter-spacing:-.45pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>address</span><span lang=EN-GB
style='letter-spacing:-.65pt'> </span><span lang=EN-GB style='letter-spacing:
-.15pt'>of</span><span lang=EN-GB style='letter-spacing:-.55pt'> </span><span
lang=EN-GB>the<span style='letter-spacing:-.65pt'> </span><span
style='letter-spacing:-.05pt'>manufacturer(s)</span><span style='letter-spacing:
-.65pt'> </span><span style='letter-spacing:-.05pt'>responsible</span><span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:-.05pt'>for</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>batch</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>release</span></span></u></p>

<p class=MsoBodyText style='margin-top:.2pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB style='font-size:7.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>LABORATORI
FUNDACIÓ DAU</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>C/ C, 12-14 Pol.
Ind. Zona Franca, Barcelona,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>08040 Barcelona,
Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Accord Healthcare
Polska Sp. z.o.o.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>ul.Lutomierska 50,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>95-200, Pabianice,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Poland</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Pharmadox
Healthcare Limited</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>KW20A Kordin
Industrial Park,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Paola PLA 3000,
Malta</span></p>

<p class=MsoBodyText style='margin-left:0in;line-height:102%;punctuation-wrap:
simple'><span lang=EN-GB style='letter-spacing:-.05pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;line-height:102%;punctuation-wrap:
simple'><span lang=EN-GB style='letter-spacing:-.05pt'>The</span><span
lang=EN-GB style='letter-spacing:-.5pt'> </span><span lang=EN-GB>printed<span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.15pt'>package</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>leaflet</span><span
style='letter-spacing:-.45pt'> </span>of<span style='letter-spacing:-.4pt'> </span>the<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>medicinal</span><span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.05pt'>product</span><span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.05pt'>must</span><span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>state</span><span
style='letter-spacing:-.6pt'> </span>the<span style='letter-spacing:-.65pt'> </span>name<span
style='letter-spacing:-.5pt'> </span>and<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>address</span><span style='letter-spacing:-.55pt'>
</span>of<span style='letter-spacing:-.45pt'> </span>the</span><span
lang=EN-GB style='letter-spacing:3.45pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>manufacturer</span><span lang=EN-GB
style='letter-spacing:-.55pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>responsible</span><span lang=EN-GB style='letter-spacing:-.7pt'> </span><span
lang=EN-GB>for<span style='letter-spacing:-.6pt'> </span>the<span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:-.05pt'>release</span><span
style='letter-spacing:-.75pt'> </span>of<span style='letter-spacing:-.65pt'> </span>the<span
style='letter-spacing:-.7pt'> </span><span style='letter-spacing:-.05pt'>concerned</span><span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:-.05pt'>batch.</span></span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-top:.3pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB style='font-size:10.5pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-top:2.55pt;margin-right:0in;margin-bottom:
0in;margin-left:28.1pt;margin-bottom:.0001pt;text-indent:-28.1pt;punctuation-wrap:
simple'><b><span lang=EN-GB>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='letter-spacing:-.05pt'> CO</span><span
lang=EN-GB style='letter-spacing:-.1pt'>ND</span><span lang=EN-GB
style='letter-spacing:-.05pt'>ITIO</span><span lang=EN-GB style='letter-spacing:
-.1pt'>NS</span><span lang=EN-GB style='letter-spacing:-.75pt'> </span><span
lang=EN-GB style='letter-spacing:-.1pt'>OR</span><span lang=EN-GB
style='letter-spacing:-.8pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>RE</span><span lang=EN-GB style='letter-spacing:-.1pt'>S</span><span
lang=EN-GB style='letter-spacing:-.05pt'>TRICTIO</span><span lang=EN-GB
style='letter-spacing:-.1pt'>NS</span><span lang=EN-GB style='letter-spacing:
-.75pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>REG</span><span
lang=EN-GB style='letter-spacing:-.1pt'>A</span><span lang=EN-GB
style='letter-spacing:-.05pt'>R</span><span lang=EN-GB style='letter-spacing:
-.1pt'>D</span><span lang=EN-GB style='letter-spacing:-.05pt'>I</span><span
lang=EN-GB style='letter-spacing:-.1pt'>N</span><span lang=EN-GB
style='letter-spacing:-.05pt'>G</span><span lang=EN-GB style='letter-spacing:
-.9pt'> </span><span lang=EN-GB style='letter-spacing:-.1pt'>SU</span><span
lang=EN-GB style='letter-spacing:-.05pt'>PPL</span><span lang=EN-GB
style='letter-spacing:-.1pt'>Y</span><span lang=EN-GB style='letter-spacing:
-.8pt'> </span><span lang=EN-GB style='letter-spacing:-.1pt'>AND</span><span
lang=EN-GB style='letter-spacing:-.85pt'> </span><span lang=EN-GB>USE</span></b></p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB style='font-size:10.5pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.05pt'>Medicinal</span><span lang=EN-GB
style='letter-spacing:-.8pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>product</span><span lang=EN-GB style='letter-spacing:-.8pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>subject</span><span lang=EN-GB
style='letter-spacing:-.75pt'> </span><span lang=EN-GB>to<span
style='letter-spacing:-.8pt'> </span><span style='letter-spacing:-.05pt'>medical</span><span
style='letter-spacing:-.8pt'> </span>prescription.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-top:.25pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-top:2.55pt;margin-right:0in;margin-bottom:
0in;margin-left:28.1pt;margin-bottom:.0001pt;text-indent:-28.1pt;punctuation-wrap:
simple'><b><span lang=EN-GB>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='letter-spacing:-.1pt'>OTHER</span><span
lang=EN-GB style='letter-spacing:-.45pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>CO</span><span lang=EN-GB style='letter-spacing:
-.1pt'>ND</span><span lang=EN-GB style='letter-spacing:-.05pt'>ITIO</span><span
lang=EN-GB style='letter-spacing:-.1pt'>NS</span><span lang=EN-GB
style='letter-spacing:-.35pt'> </span><span lang=EN-GB style='letter-spacing:
-.1pt'>AND</span><span lang=EN-GB style='letter-spacing:-.4pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>REQ</span><span lang=EN-GB
style='letter-spacing:-.1pt'>U</span><span lang=EN-GB style='letter-spacing:
-.05pt'>IREME</span><span lang=EN-GB style='letter-spacing:-.1pt'>N</span><span
lang=EN-GB style='letter-spacing:-.05pt'>T</span><span lang=EN-GB
style='letter-spacing:-.1pt'>S</span><span lang=EN-GB style='letter-spacing:
-.4pt'> </span><span lang=EN-GB>OF<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.1pt'>THE</span><span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>M</span><span style='letter-spacing:-.1pt'>A</span><span
style='letter-spacing:-.05pt'>RKETI</span><span style='letter-spacing:-.1pt'>N</span><span
style='letter-spacing:-.05pt'>G</span></span><span lang=EN-GB style='letter-spacing:
2.15pt'> </span><span lang=EN-GB style='letter-spacing:-.1pt'>AU</span><span
lang=EN-GB style='letter-spacing:-.05pt'>THORI</span><span lang=EN-GB
style='letter-spacing:-.1pt'>SA</span><span lang=EN-GB style='letter-spacing:
-.05pt'>TIO</span><span lang=EN-GB style='letter-spacing:-.1pt'>N</span></b></p>

<p class=MsoBodyText style='margin-top:.55pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:27.0pt;text-indent:-27.0pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='letter-spacing:-.05pt'>P</span><span
lang=EN-GB style='letter-spacing:-.1pt'>e</span><span lang=EN-GB
style='letter-spacing:-.05pt'>r</span><span lang=EN-GB style='letter-spacing:
-.1pt'>io</span><span lang=EN-GB style='letter-spacing:-.05pt'>d</span><span
lang=EN-GB style='letter-spacing:-.1pt'>ic</span><span lang=EN-GB
style='letter-spacing:.05pt'> </span><span lang=EN-GB>safety<span
style='letter-spacing:.15pt'> </span><span style='letter-spacing:-.05pt'>updat</span><span
style='letter-spacing:-.1pt'>e</span><span style='letter-spacing:.05pt'> </span><span
style='letter-spacing:-.05pt'>r</span><span style='letter-spacing:-.1pt'>e</span><span
style='letter-spacing:-.05pt'>p</span><span style='letter-spacing:-.1pt'>o</span><span
style='letter-spacing:-.05pt'>rt</span><span style='letter-spacing:-.1pt'>s</span><span
style='letter-spacing:.05pt'> </span><span style='letter-spacing:-.1pt'>(</span><span
style='letter-spacing:-.05pt'>P</span><span style='letter-spacing:-.1pt'>SU</span><span
style='letter-spacing:-.05pt'>R</span><span style='letter-spacing:-.1pt'>s)</span></span></b></p>

<p class=MsoBodyText style='margin-top:.05pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB style='font-size:10.5pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;line-height:102%;punctuation-wrap:
simple'><span lang=EN-GB style='letter-spacing:-.05pt'>The</span><span
lang=EN-GB style='letter-spacing:-.5pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>requirements</span><span lang=EN-GB
style='letter-spacing:-.6pt'> </span><span lang=EN-GB>for<span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>submission</span><span
style='letter-spacing:-.5pt'> </span>of<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.05pt'>PSURs</span><span style='letter-spacing:-.65pt'> </span><span
style='letter-spacing:.05pt'>for</span><span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>this</span><span style='letter-spacing:-.7pt'> </span><span
style='letter-spacing:-.05pt'>medicinal</span><span style='letter-spacing:-.45pt'>
</span><span style='letter-spacing:-.05pt'>product</span><span
style='letter-spacing:-.55pt'> </span>are<span style='letter-spacing:-.55pt'> </span><span
style='letter-spacing:-.05pt'>set</span><span style='letter-spacing:-.45pt'> </span>out<span
style='letter-spacing:-.55pt'> </span>in<span style='letter-spacing:-.6pt'> </span>the<span
style='letter-spacing:-.55pt'> </span>list<span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.15pt'>of</span><span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.05pt'>Union</span></span><span lang=EN-GB
style='letter-spacing:4.05pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>reference</span><span lang=EN-GB style='letter-spacing:-.65pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>dates</span><span lang=EN-GB
style='letter-spacing:-.7pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>(EURD</span><span lang=EN-GB style='letter-spacing:-.6pt'> </span><span
lang=EN-GB>list)<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>provided</span><span style='letter-spacing:-.65pt'>
</span>for<span style='letter-spacing:-.7pt'> </span><span style='letter-spacing:
-.05pt'>under</span><span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>Article</span><span style='letter-spacing:-.6pt'>
</span><span style='letter-spacing:-.05pt'>107c(7)</span><span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:-.15pt'>of</span><span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:-.05pt'>Directive</span><span
style='letter-spacing:-.7pt'> </span>2001/83/EC<span style='letter-spacing:
-.65pt'> </span><span style='letter-spacing:-.05pt'>and</span><span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:-.05pt'>any</span></span><span
lang=EN-GB style='letter-spacing:3.05pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>subsequent</span><span lang=EN-GB
style='letter-spacing:-.8pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>updates</span><span lang=EN-GB style='letter-spacing:-.8pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>published</span><span lang=EN-GB
style='letter-spacing:-.85pt'> </span><span lang=EN-GB>on<span
style='letter-spacing:-.8pt'> </span>the<span style='letter-spacing:-.9pt'> </span><span
style='letter-spacing:-.05pt'>European</span><span style='letter-spacing:-.95pt'>
</span><span style='letter-spacing:-.05pt'>medicines</span><span
style='letter-spacing:-.8pt'> </span><span style='letter-spacing:-.05pt'>web-portal.</span></span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-top:.45pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB style='font-size:10.5pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-top:2.55pt;margin-right:0in;margin-bottom:
0in;margin-left:28.1pt;margin-bottom:.0001pt;text-indent:-28.1pt;punctuation-wrap:
simple'><b><span lang=EN-GB>D.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></b><b><span lang=EN-GB style='letter-spacing:-.05pt'>CO</span><span
lang=EN-GB style='letter-spacing:-.1pt'>ND</span><span lang=EN-GB
style='letter-spacing:-.05pt'>ITIO</span><span lang=EN-GB style='letter-spacing:
-.1pt'>NS</span><span lang=EN-GB style='letter-spacing:-.55pt'> </span><span
lang=EN-GB>OR<span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.05pt'>RE</span><span style='letter-spacing:-.1pt'>S</span><span
style='letter-spacing:-.05pt'>TRICTIO</span><span style='letter-spacing:-.1pt'>NS</span><span
style='letter-spacing:-.2pt'> </span><span style='letter-spacing:-.1pt'>WITH</span><span
style='letter-spacing:-.3pt'> </span><span style='letter-spacing:-.05pt'>REG</span><span
style='letter-spacing:-.1pt'>A</span><span style='letter-spacing:-.05pt'>R</span><span
style='letter-spacing:-.1pt'>D</span><span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.05pt'>TO</span><span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.1pt'>THE</span><span style='letter-spacing:-.35pt'> </span>SAFE<span
style='letter-spacing:-.45pt'> </span>AND</span><span lang=EN-GB
style='letter-spacing:2.05pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>EFFECTI</span><span lang=EN-GB style='letter-spacing:-.1pt'>V</span><span
lang=EN-GB style='letter-spacing:-.05pt'>E</span><span lang=EN-GB
style='letter-spacing:-.2pt'> </span><span lang=EN-GB style='letter-spacing:
-.1pt'>US</span><span lang=EN-GB style='letter-spacing:-.05pt'>E</span><span
lang=EN-GB style='letter-spacing:-.15pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>OF</span><span lang=EN-GB style='letter-spacing:
-.2pt'> </span><span lang=EN-GB>THE<span style='letter-spacing:-.2pt'> </span><span
style='letter-spacing:-.05pt'>ME</span><span style='letter-spacing:-.1pt'>D</span><span
style='letter-spacing:-.05pt'>ICI</span><span style='letter-spacing:-.1pt'>NA</span><span
style='letter-spacing:-.05pt'>L</span><span style='letter-spacing:-.15pt'> </span>PRODUCT</span></b></p>

<p class=MsoBodyText style='margin-top:.1pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:27.0pt;text-indent:-27.0pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='letter-spacing:-.05pt'>R</span><span
lang=EN-GB style='letter-spacing:-.1pt'>is</span><span lang=EN-GB
style='letter-spacing:-.05pt'>k</span><span lang=EN-GB style='letter-spacing:
.3pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>mana</span><span
lang=EN-GB style='letter-spacing:-.1pt'>ge</span><span lang=EN-GB
style='letter-spacing:-.05pt'>m</span><span lang=EN-GB style='letter-spacing:
-.1pt'>e</span><span lang=EN-GB style='letter-spacing:-.05pt'>nt</span><span
lang=EN-GB style='letter-spacing:.1pt'> </span><span lang=EN-GB>plan<span
style='letter-spacing:.2pt'> </span><span style='letter-spacing:-.15pt'>(</span><span
style='letter-spacing:-.1pt'>RMP</span><span style='letter-spacing:-.15pt'>)</span></span></b></p>

<p class=MsoBodyText style='margin-top:.5pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;line-height:102%;punctuation-wrap:
simple'><span lang=EN-GB style='letter-spacing:-.05pt'>The</span><span
lang=EN-GB style='letter-spacing:-.85pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>marketing</span><span lang=EN-GB
style='letter-spacing:-.8pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>authorisation</span><span lang=EN-GB style='letter-spacing:-.85pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>holder</span><span lang=EN-GB
style='letter-spacing:-.95pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>(MAH)</span><span lang=EN-GB style='letter-spacing:-.75pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>shall</span><span lang=EN-GB
style='letter-spacing:-.7pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>perform</span><span lang=EN-GB style='letter-spacing:-.8pt'> </span><span
lang=EN-GB>the<span style='letter-spacing:-.85pt'> </span><span
style='letter-spacing:-.05pt'>required</span><span style='letter-spacing:-.8pt'>
</span><span style='letter-spacing:-.05pt'>pharmacovigilance</span><span
style='letter-spacing:-.85pt'> </span><span style='letter-spacing:-.05pt'>activities
and</span><span style='letter-spacing:-.6pt'> </span><span style='letter-spacing:
-.05pt'>interventions</span><span style='letter-spacing:-.7pt'> </span><span
style='letter-spacing:-.05pt'>detailed</span><span style='letter-spacing:-.65pt'>
</span>in<span style='letter-spacing:-.6pt'> </span>the<span style='letter-spacing:
-.6pt'> </span><span style='letter-spacing:-.15pt'>agreed</span><span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>RMP</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>presented</span><span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:.05pt'>in</span><span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:-.05pt'>Module</span><span
style='letter-spacing:-.7pt'> </span>1.8.2<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.15pt'>of</span><span style='letter-spacing:-.6pt'> </span>the<span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:-.05pt'>marketing</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>authorisation</span></span><span
lang=EN-GB style='letter-spacing:4.95pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>and</span><span lang=EN-GB style='letter-spacing:
-.55pt'> </span><span lang=EN-GB>any<span style='letter-spacing:-.65pt'> </span><span
style='letter-spacing:-.05pt'>agreed</span><span style='letter-spacing:-.55pt'>
</span><span style='letter-spacing:-.05pt'>subsequent</span><span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>updates</span><span
style='letter-spacing:-.5pt'> </span>of<span style='letter-spacing:-.55pt'> </span>the<span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:-.15pt'>RMP.</span></span></p>

<p class=MsoBodyText style='margin-top:.4pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;line-height:102%;punctuation-wrap:
simple'><span lang=EN-GB style='letter-spacing:-.05pt'>An</span><span
lang=EN-GB style='letter-spacing:-.7pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>updated</span><span lang=EN-GB style='letter-spacing:
-.65pt'> </span><span lang=EN-GB style='letter-spacing:-.15pt'>RMP</span><span
lang=EN-GB style='letter-spacing:-.55pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>should</span><span lang=EN-GB style='letter-spacing:
-.6pt'> </span><span lang=EN-GB>be<span style='letter-spacing:-.6pt'> </span><span
style='letter-spacing:-.05pt'>submitted:</span></span></p>

<p class=MsoBodyText style='margin-top:.2pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB style='font-size:10.5pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:27.0pt;text-indent:-27.0pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;letter-spacing:-.1pt'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.1pt'>At the request of
the European Medicines Agency;</span></p>

<p class=MsoBodyText style='margin-left:27.0pt;text-indent:-27.0pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.1pt'>Whenever</span><span
lang=EN-GB style='letter-spacing:-.55pt'> </span><span lang=EN-GB>the<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>risk</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>management</span><span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>system</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:.05pt'>is</span><span
style='letter-spacing:-.8pt'> </span><span style='letter-spacing:-.05pt'>modified,</span><span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>especially</span><span
style='letter-spacing:-.5pt'> </span>as<span style='letter-spacing:-.8pt'> </span><span
style='letter-spacing:-.05pt'>the</span><span style='letter-spacing:-.65pt'> </span>result<span
style='letter-spacing:-.5pt'> </span>of<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>new</span><span style='letter-spacing:-.6pt'> </span><span
style='letter-spacing:-.05pt'>information</span><span style='letter-spacing:
-.6pt'> </span><span style='letter-spacing:-.05pt'>being</span></span><span
lang=EN-GB style='letter-spacing:3.35pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>received</span><span lang=EN-GB style='letter-spacing:
-.45pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>that</span><span
lang=EN-GB style='letter-spacing:-.4pt'> </span><span lang=EN-GB>may<span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.15pt'>lead</span><span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:.05pt'>to</span><span
style='letter-spacing:-.55pt'> </span>a<span style='letter-spacing:-.3pt'> </span><span
style='letter-spacing:-.05pt'>significant</span><span style='letter-spacing:
-.3pt'> </span><span style='letter-spacing:-.05pt'>change</span><span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:.05pt'>to</span><span
style='letter-spacing:-.5pt'> </span>the<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>benefit/risk</span><span style='letter-spacing:
-.45pt'> </span>profile<span style='letter-spacing:-.55pt'> </span>or<span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.15pt'>as</span><span
style='letter-spacing:-.55pt'> </span>the<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.05pt'>result</span><span style='letter-spacing:-.35pt'>
</span><span style='letter-spacing:-.15pt'>of</span><span style='letter-spacing:
-.35pt'> </span>an</span><span lang=EN-GB style='letter-spacing:3.35pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>important</span><span lang=EN-GB
style='letter-spacing:-.9pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>(pharmacovigilance</span><span lang=EN-GB style='letter-spacing:-1.0pt'>
</span><span lang=EN-GB style='letter-spacing:.05pt'>or</span><span lang=EN-GB
style='letter-spacing:-1.0pt'> </span><span lang=EN-GB>risk<span
style='letter-spacing:-.95pt'> </span><span style='letter-spacing:-.05pt'>minimisation)</span><span
style='letter-spacing:-1.0pt'> </span><span style='letter-spacing:-.05pt'>milestone</span><span
style='letter-spacing:-.9pt'> </span><span style='letter-spacing:-.05pt'>being</span><span
style='letter-spacing:-1.0pt'> </span><span style='letter-spacing:-.05pt'>reached.</span></span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:27.0pt;text-indent:-27.0pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='letter-spacing:-.1pt'>A</span><span
lang=EN-GB style='letter-spacing:-.05pt'>dd</span><span lang=EN-GB
style='letter-spacing:-.1pt'>i</span><span lang=EN-GB style='letter-spacing:
-.05pt'>t</span><span lang=EN-GB style='letter-spacing:-.1pt'>io</span><span
lang=EN-GB style='letter-spacing:-.05pt'>na</span><span lang=EN-GB
style='letter-spacing:-.1pt'>l</span><span lang=EN-GB style='letter-spacing:
.25pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>r</span><span
lang=EN-GB style='letter-spacing:-.1pt'>is</span><span lang=EN-GB
style='letter-spacing:-.05pt'>k</span><span lang=EN-GB style='letter-spacing:
.25pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>m</span><span
lang=EN-GB style='letter-spacing:-.1pt'>i</span><span lang=EN-GB
style='letter-spacing:-.05pt'>n</span><span lang=EN-GB style='letter-spacing:
-.1pt'>i</span><span lang=EN-GB style='letter-spacing:-.05pt'>m</span><span
lang=EN-GB style='letter-spacing:-.1pt'>is</span><span lang=EN-GB
style='letter-spacing:-.05pt'>at</span><span lang=EN-GB style='letter-spacing:
-.1pt'>io</span><span lang=EN-GB style='letter-spacing:-.05pt'>n</span><span
lang=EN-GB style='letter-spacing:.55pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>m</span><span lang=EN-GB style='letter-spacing:
-.1pt'>e</span><span lang=EN-GB style='letter-spacing:-.05pt'>a</span><span
lang=EN-GB style='letter-spacing:-.1pt'>s</span><span lang=EN-GB
style='letter-spacing:-.05pt'>ur</span><span lang=EN-GB style='letter-spacing:
-.1pt'>es</span></b></p>

<p class=MsoBodyText style='margin-top:.5pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;line-height:102%;punctuation-wrap:
simple'><span lang=EN-GB style='letter-spacing:-.05pt'>The</span><span
lang=EN-GB style='letter-spacing:-.65pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>Marketing</span><span lang=EN-GB
style='letter-spacing:-.7pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>Authorisation</span><span lang=EN-GB style='letter-spacing:-.65pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>Holder</span><span lang=EN-GB
style='letter-spacing:-.5pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>shall</span><span lang=EN-GB style='letter-spacing:-.55pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>ensure</span><span lang=EN-GB
style='letter-spacing:-.6pt'> </span><span lang=EN-GB>that<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>all</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>physicians</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>who</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>are</span><span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:-.05pt'>expected</span><span
style='letter-spacing:-.6pt'> </span>to<span style='letter-spacing:-.65pt'> </span><span
style='letter-spacing:-.05pt'>prescribe</span></span><span lang=EN-GB
style='letter-spacing:3.95pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>apixaban</span><span lang=EN-GB style='letter-spacing:-.95pt'> </span><span
lang=EN-GB style='letter-spacing:.05pt'>are</span><span lang=EN-GB
style='letter-spacing:-.85pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>provided</span><span lang=EN-GB style='letter-spacing:-.85pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>with</span><span lang=EN-GB
style='letter-spacing:-.8pt'> </span><span lang=EN-GB>the<span
style='letter-spacing:-.85pt'> </span>following<span style='letter-spacing:
-.85pt'> </span><span style='letter-spacing:-.05pt'>educational</span><span
style='letter-spacing:-.75pt'> </span><span style='letter-spacing:-.05pt'>material:</span></span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Summary</span><span
lang=EN-GB style='letter-spacing:-1.1pt'> </span><span lang=EN-GB
style='letter-spacing:.05pt'>of</span><span lang=EN-GB style='letter-spacing:
-1.0pt'> </span><span lang=EN-GB>Product<span style='letter-spacing:-1.05pt'> </span><span
style='letter-spacing:-.05pt'>Characteristics</span></span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Prescriber</span><span
lang=EN-GB style='letter-spacing:-1.5pt'> </span><span lang=EN-GB>Guide</span></p>

<p class=MsoBodyText style='margin-top:.5pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Patient</span><span
lang=EN-GB style='letter-spacing:-.75pt'> </span><span lang=EN-GB>Alert<span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:-.05pt'>Cards</span></span></p>

<p class=MsoBodyText style='margin-top:.2pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB style='font-size:10.5pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:6.6pt;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.05pt'>Key</span><span lang=EN-GB
style='letter-spacing:-.7pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>Elements</span><span lang=EN-GB style='letter-spacing:-.7pt'> </span><span
lang=EN-GB>of<span style='letter-spacing:-.6pt'> </span><span style='letter-spacing:
-.05pt'>the</span><span style='letter-spacing:-.7pt'> </span><span
style='letter-spacing:-.05pt'>Prescriber</span><span style='letter-spacing:
-.75pt'> </span>Guide:</span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Details</span><span
lang=EN-GB style='letter-spacing:-.7pt'> </span><span lang=EN-GB
style='letter-spacing:-.15pt'>of</span><span lang=EN-GB style='letter-spacing:
-.55pt'> </span><span lang=EN-GB>populations<span style='letter-spacing:-.75pt'>
</span><span style='letter-spacing:-.05pt'>potentially</span><span
style='letter-spacing:-.7pt'> </span>at<span style='letter-spacing:-.6pt'> </span><span
style='letter-spacing:-.05pt'>higher</span><span style='letter-spacing:-.6pt'> </span><span
style='letter-spacing:-.05pt'>risk</span><span style='letter-spacing:-.65pt'> </span>of<span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>bleeding</span></span></p>

<p class=MsoBodyText style='margin-top:.25pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Recommended</span><span
lang=EN-GB style='letter-spacing:-.75pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>doses</span><span lang=EN-GB style='letter-spacing:
-.7pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>and</span><span
lang=EN-GB style='letter-spacing:-.65pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>guidance</span><span lang=EN-GB style='letter-spacing:
-.8pt'> </span><span lang=EN-GB style='letter-spacing:.05pt'>on</span><span
lang=EN-GB style='letter-spacing:-.7pt'> </span><span lang=EN-GB>the<span
style='letter-spacing:-.8pt'> </span><span style='letter-spacing:-.05pt'>posology</span><span
style='letter-spacing:-.8pt'> </span><span style='letter-spacing:.05pt'>for</span><span
style='letter-spacing:-.75pt'> </span><span style='letter-spacing:-.05pt'>different</span><span
style='letter-spacing:-.7pt'> </span><span style='letter-spacing:-.05pt'>indications</span></span></p>

<p class=MsoBodyText style='margin-top:.5pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;line-height:
102%;punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol;
position:relative;top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Recommendations</span><span
lang=EN-GB style='letter-spacing:-.75pt'> </span><span lang=EN-GB>for<span
style='letter-spacing:-.7pt'> </span><span style='letter-spacing:-.05pt'>dose</span><span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:-.05pt'>adjustment</span><span
style='letter-spacing:-.55pt'> </span>in<span style='letter-spacing:-.65pt'> </span>at<span
style='letter-spacing:-.7pt'> </span>risk<span style='letter-spacing:-.7pt'> </span><span
style='letter-spacing:-.05pt'>populations,</span><span style='letter-spacing:
-.75pt'> </span><span style='letter-spacing:-.05pt'>including</span><span
style='letter-spacing:-.75pt'> </span><span style='letter-spacing:-.05pt'>renal</span><span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:.05pt'>or</span><span
style='letter-spacing:-.75pt'> </span><span style='letter-spacing:-.05pt'>hepatic</span></span><span
lang=EN-GB style='letter-spacing:3.25pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>impairment</span><span lang=EN-GB
style='letter-spacing:-1.6pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>patients</span></p>

<p class=MsoBodyText style='margin-left:31.95pt;text-indent:-25.35pt;
punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol;position:
relative;top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Guidance</span><span
lang=EN-GB style='letter-spacing:-.75pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>regarding</span><span lang=EN-GB
style='letter-spacing:-.8pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>switching</span><span lang=EN-GB style='letter-spacing:-.85pt'> </span><span
lang=EN-GB>from<span style='letter-spacing:-.8pt'> </span><span
style='letter-spacing:.05pt'>or</span><span style='letter-spacing:-.8pt'> </span><span
style='letter-spacing:.05pt'>to</span><span style='letter-spacing:-.7pt'> </span><span
style='letter-spacing:-.05pt'>Apixaban Accord treatment</span></span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Guidance</span><span
lang=EN-GB style='letter-spacing:-.9pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>regarding</span><span lang=EN-GB
style='letter-spacing:-.9pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>surgery</span><span lang=EN-GB style='letter-spacing:-.85pt'> </span><span
lang=EN-GB style='letter-spacing:.05pt'>or</span><span lang=EN-GB
style='letter-spacing:-.85pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>invasive</span><span lang=EN-GB style='letter-spacing:-.85pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>procedure,</span><span lang=EN-GB
style='letter-spacing:-.85pt'> </span><span lang=EN-GB>and<span
style='letter-spacing:-.85pt'> </span><span style='letter-spacing:-.05pt'>temporary</span><span
style='letter-spacing:-.95pt'> </span><span style='letter-spacing:-.05pt'>discontinuation</span></span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Management</span><span
lang=EN-GB style='letter-spacing:-.9pt'> </span><span lang=EN-GB>of<span
style='letter-spacing:-.85pt'> </span><span style='letter-spacing:-.05pt'>overdose</span><span
style='letter-spacing:-.95pt'> </span>situations<span style='letter-spacing:
-1.0pt'> </span><span style='letter-spacing:-.05pt'>and</span><span
style='letter-spacing:-.85pt'> </span><span style='letter-spacing:-.05pt'>haemorrhage</span></span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The<span style='letter-spacing:-.75pt'> </span>use<span
style='letter-spacing:-.7pt'> </span><span style='letter-spacing:.05pt'>of</span><span
style='letter-spacing:-.7pt'> </span><span style='letter-spacing:-.05pt'>coagulation</span><span
style='letter-spacing:-.7pt'> </span><span style='letter-spacing:-.05pt'>tests</span><span
style='letter-spacing:-.7pt'> </span><span style='letter-spacing:-.05pt'>and</span><span
style='letter-spacing:-.6pt'> </span>their<span style='letter-spacing:-.55pt'> </span><span
style='letter-spacing:-.05pt'>interpretation</span></span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>That<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>all</span><span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.05pt'>patients</span><span style='letter-spacing:-.55pt'>
</span><span style='letter-spacing:-.05pt'>should</span><span style='letter-spacing:
-.45pt'> </span><span style='letter-spacing:-.15pt'>be</span><span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:-.05pt'>provided</span><span
style='letter-spacing:-.5pt'> </span>with<span style='letter-spacing:-.5pt'> </span>a<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>Patient</span><span
style='letter-spacing:-.35pt'> </span><span style='letter-spacing:-.05pt'>alert</span><span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.05pt'>card</span><span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>and</span><span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.15pt'>be</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>counselled</span><span
style='letter-spacing:-.6pt'> </span>about:</span></p>

<p class=MsoBodyText style='margin-top:.5pt;margin-right:0in;margin-bottom:
0in;margin-left:40.45pt;margin-bottom:.0001pt;text-indent:0in;punctuation-wrap:
simple'><span lang=EN-GB>•<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span
lang=EN-GB style='letter-spacing:-.05pt'>Signs</span><span lang=EN-GB
style='letter-spacing:-.6pt'> </span><span lang=EN-GB>or<span style='letter-spacing:
-.45pt'> </span><span style='letter-spacing:-.05pt'>symptoms</span><span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.15pt'>of</span><span
style='letter-spacing:-.45pt'> </span>bleeding<span style='letter-spacing:-.6pt'>
</span><span style='letter-spacing:-.05pt'>and</span><span style='letter-spacing:
-.5pt'> </span>when<span style='letter-spacing:-.55pt'> </span>to<span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>seek</span><span
style='letter-spacing:-.5pt'> </span>attention<span style='letter-spacing:-.6pt'>
</span><span style='letter-spacing:-.05pt'>from</span><span style='letter-spacing:
-.6pt'> </span>a<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>health</span><span style='letter-spacing:-.55pt'>
</span>care<span style='letter-spacing:-.55pt'> </span><span style='letter-spacing:
-.05pt'>provider</span></span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:46.35pt;margin-bottom:.0001pt;text-indent:-5.9pt;punctuation-wrap:
simple'><span lang=EN-GB>•<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span
lang=EN-GB style='letter-spacing:-.05pt'>Importance</span><span lang=EN-GB
style='letter-spacing:-.95pt'> </span><span lang=EN-GB style='letter-spacing:
-.15pt'>of</span><span lang=EN-GB style='letter-spacing:-.85pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>treatment</span><span lang=EN-GB
style='letter-spacing:-.85pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>compliance</span></p>

<p class=MsoBodyText style='margin-top:.25pt;margin-right:0in;margin-bottom:
0in;margin-left:46.35pt;margin-bottom:.0001pt;text-indent:-5.9pt;punctuation-wrap:
simple'><span lang=EN-GB>•<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span
lang=EN-GB style='letter-spacing:-.05pt'>Necessity</span><span lang=EN-GB
style='letter-spacing:-.5pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>to</span><span lang=EN-GB style='letter-spacing:-.4pt'> </span><span
lang=EN-GB style='letter-spacing:-.05pt'>carry</span><span lang=EN-GB
style='letter-spacing:-.55pt'> </span><span lang=EN-GB>the<span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:-.05pt'>Patient</span><span
style='letter-spacing:-.25pt'> </span><span style='letter-spacing:-.05pt'>alert</span><span
style='letter-spacing:-.45pt'> </span>card<span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.05pt'>with</span><span style='letter-spacing:-.45pt'> </span>them<span
style='letter-spacing:-.55pt'> </span>at<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>all</span><span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>times</span></span></p>

<p class=MsoBodyText style='margin-top:.5pt;margin-right:0in;margin-bottom:
0in;margin-left:40.45pt;margin-bottom:.0001pt;text-indent:0in;line-height:102%;
punctuation-wrap:simple'><span lang=EN-GB>•<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span><span lang=EN-GB>The<span style='letter-spacing:-.5pt'> </span><span
style='letter-spacing:-.05pt'>need</span><span style='letter-spacing:-.5pt'> </span>to<span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>inform</span><span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.05pt'>Health</span><span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.05pt'>Care</span><span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>Professionals</span><span
style='letter-spacing:-.65pt'> </span>that<span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.05pt'>they</span><span style='letter-spacing:-.55pt'> </span><span
style='letter-spacing:-.05pt'>are</span><span style='letter-spacing:-.5pt'> </span>taking<span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:-.05pt'>Apixaban
Accord</span><span style='letter-spacing:-.5pt'> </span>if<span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>they</span><span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.15pt'>need</span><span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:.05pt'>to</span></span><span
lang=EN-GB style='letter-spacing:3.9pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>have</span><span lang=EN-GB style='letter-spacing:
-.65pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>any</span><span
lang=EN-GB style='letter-spacing:-.65pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>surgery</span><span lang=EN-GB style='letter-spacing:
-.75pt'> </span><span lang=EN-GB style='letter-spacing:-.15pt'>or</span><span
lang=EN-GB style='letter-spacing:-.55pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>invasive</span><span lang=EN-GB style='letter-spacing:
-.65pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>procedure.</span></p>

<p class=MsoBodyText style='margin-top:.4pt;margin-right:0in;margin-bottom:
0in;margin-left:0in;margin-bottom:.0001pt;punctuation-wrap:simple'><span
lang=EN-GB>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:6.6pt;punctuation-wrap:simple'><span
lang=EN-GB style='letter-spacing:-.05pt'>Key</span><span lang=EN-GB
style='letter-spacing:-.6pt'> </span><span lang=EN-GB style='letter-spacing:
-.05pt'>Elements</span><span lang=EN-GB style='letter-spacing:-.6pt'> </span><span
lang=EN-GB>of<span style='letter-spacing:-.5pt'> </span><span style='letter-spacing:
-.05pt'>the</span><span style='letter-spacing:-.55pt'> </span><span
style='letter-spacing:-.05pt'>Patient</span><span style='letter-spacing:-.55pt'>
</span>Alert<span style='letter-spacing:-.55pt'> </span><span style='letter-spacing:
-.05pt'>Card:</span></span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Signs</span><span
lang=EN-GB style='letter-spacing:-.55pt'> </span><span lang=EN-GB>or<span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.05pt'>symptoms</span><span
style='letter-spacing:-.5pt'> </span>of<span style='letter-spacing:-.5pt'> </span>bleeding<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>and</span><span
style='letter-spacing:-.55pt'> </span>when<span style='letter-spacing:-.6pt'> </span>to<span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>seek</span><span
style='letter-spacing:-.55pt'> </span>attention<span style='letter-spacing:
-.5pt'> </span>from<span style='letter-spacing:-.6pt'> </span>a<span
style='letter-spacing:-.6pt'> </span><span style='letter-spacing:-.05pt'>health</span><span
style='letter-spacing:-.5pt'> </span>care<span style='letter-spacing:-.6pt'> </span>provider.</span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Importance</span><span
lang=EN-GB style='letter-spacing:-1.1pt'> </span><span lang=EN-GB>of<span
style='letter-spacing:-.9pt'> </span><span style='letter-spacing:-.05pt'>treatment</span><span
style='letter-spacing:-.95pt'> </span><span style='letter-spacing:-.05pt'>compliance</span></span></p>

<p class=MsoBodyText style='margin-top:.35pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;punctuation-wrap:
simple'><span lang=EN-GB style='font-family:Symbol;position:relative;
top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='letter-spacing:-.05pt'>Necessity</span><span
lang=EN-GB style='letter-spacing:-.55pt'> </span><span lang=EN-GB
style='letter-spacing:.05pt'>to</span><span lang=EN-GB style='letter-spacing:
-.5pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>carry</span><span
lang=EN-GB style='letter-spacing:-.55pt'> </span><span lang=EN-GB>the<span
style='letter-spacing:-.55pt'> </span>Patient<span style='letter-spacing:-.4pt'>
</span><span style='letter-spacing:-.05pt'>alert</span><span style='letter-spacing:
-.35pt'> </span><span style='letter-spacing:-.05pt'>card</span><span
style='letter-spacing:-.45pt'> </span>with<span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.05pt'>them</span><span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.15pt'>at</span><span style='letter-spacing:-.45pt'> </span><span
style='letter-spacing:-.05pt'>all</span><span style='letter-spacing:-.35pt'> </span><span
style='letter-spacing:-.05pt'>times</span></span></p>

<p class=MsoBodyText style='margin-top:.5pt;margin-right:0in;margin-bottom:
0in;margin-left:31.95pt;margin-bottom:.0001pt;text-indent:-25.35pt;line-height:
102%;punctuation-wrap:simple'><span lang=EN-GB style='font-family:Symbol;
position:relative;top:-3.0pt'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The<span style='letter-spacing:-.6pt'> </span>need<span
style='letter-spacing:-.65pt'> </span><span style='letter-spacing:.05pt'>to</span><span
style='letter-spacing:-.4pt'> </span><span style='letter-spacing:-.05pt'>inform</span><span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:-.05pt'>Health</span><span
style='letter-spacing:-.55pt'> </span><span style='letter-spacing:-.05pt'>Care</span><span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>Professionals</span><span
style='letter-spacing:-.5pt'> </span><span style='letter-spacing:-.05pt'>that</span><span
style='letter-spacing:-.45pt'> </span>they<span style='letter-spacing:-.55pt'> </span><span
style='letter-spacing:-.05pt'>are</span><span style='letter-spacing:-.6pt'> </span>taking<span
style='letter-spacing:-.55pt'> </span>Apixaban Accord<span style='letter-spacing:
-.55pt'> </span>if<span style='letter-spacing:-.4pt'> </span><span
style='letter-spacing:-.05pt'>they</span><span style='letter-spacing:-.6pt'> </span><span
style='letter-spacing:-.15pt'>need</span><span style='letter-spacing:-.5pt'> </span>to<span
style='letter-spacing:-.45pt'> </span><span style='letter-spacing:-.05pt'>have</span></span><span
lang=EN-GB style='letter-spacing:3.25pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>any</span><span lang=EN-GB style='letter-spacing:
-.65pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>surgery</span><span
lang=EN-GB style='letter-spacing:-.75pt'> </span><span lang=EN-GB
style='letter-spacing:-.15pt'>or</span><span lang=EN-GB style='letter-spacing:
-.65pt'> </span><span lang=EN-GB style='letter-spacing:-.05pt'>invasive</span><span
lang=EN-GB style='letter-spacing:-.75pt'> </span><span lang=EN-GB
style='letter-spacing:-.05pt'>procedure.</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:blue;letter-spacing:-1.45pt'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB
style='font-size:11.0pt'>ANNEX III</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB
style='font-size:11.0pt'>LABELLING AND PACKAGE LEAFLET</span></b><span
lang=EN-GB style='font-size:11.0pt;color:blue;letter-spacing:-1.45pt'><br
clear=all style='page-break-before:always'>
</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB
style='font-size:11.0pt'>A. LABELLING</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='border:none;padding:0in'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>CARTON OF UNIT PACK </span></b><b><span
lang=EN-GB style='font-size:11.0pt'>2.5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>1.       NAME OF THE
MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord 2.5&nbsp;mg
film-coated tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>apixaban</span><b><span
lang=EN-GB style='font-size:11.0pt'> </span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>2.       STATEMENT OF
ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Each film-coated
tablet contains 2.5&nbsp;mg apixaban.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>3.       LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Contain lactose.
See leaflet for further information.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>4.       PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>Film-coated
tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>10&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>14&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>20&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>28&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>56&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>60&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>100&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>112&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>168&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>200&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>5.       METHOD AND
ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Read the package
leaflet before use.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Oral use</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>6.       SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Keep out of the
sight and reach of children.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>7.       OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>8.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>9.       SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>10.     SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>11.       NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Accord Healthcare S.L.U.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>World Trade Center, Moll de Barcelona s/n,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Edifici Est, 6<sup>a</sup> Planta,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Barcelona, 08039</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>12.       MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EU/1/20/1458/001</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/003</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/004</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/006</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/008</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/010</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/012</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/014</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/041</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/043</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>13.       BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>14.       GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>15.       INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>16.       INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
2.5&nbsp;mg</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>17.       UNIQUE IDENTIFIER – 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>2D
barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>18.       UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>PC</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>SN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>NN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>MINIMUM PARTICULARS
TO APPEAR ON BLISTERS OR STRIPS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>BLISTER </span></b><b><span
lang=EN-GB style='font-size:11.0pt'>FOR UNIT PACK</span></b><b><span
lang=EN-GB style='font-size:11.0pt'> 2.5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>1.         NAME OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
2.5&nbsp;mg tablets </span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>apixaban</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>2.         NAME OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>Accord</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:yellow'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>3.         EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>4.         BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot       </span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>5.         OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='border:none;padding:0in'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>CARTON </span></b><b><span lang=EN-GB
style='font-size:11.0pt'>FOR UNIT PACK</span></b><b><span lang=EN-GB
style='font-size:11.0pt'> 5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>1.       NAME OF THE
MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
5&nbsp;mg film-coated tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>apixaban</span><b><span
lang=EN-GB style='font-size:11.0pt'> </span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>2.       STATEMENT OF
ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Each film-coated
tablet contains 5&nbsp;mg apixaban.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>3.       LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Contain lactose.
See leaflet for further information.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>4.       PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>Film-coated
tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>10&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>14&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>20&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>28&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>56&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>60&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>100&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>112&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>168&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>200&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>5.       METHOD AND
ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Read the package
leaflet before use.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Oral use</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>6.       SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Keep out of the
sight and reach of children.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>7.       OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>8.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>9.       SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>10.     SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>11.       NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Accord Healthcare S.L.U.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>World Trade Center, Moll de Barcelona s/n,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Edifici Est, 6<sup>a</sup> Planta,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Barcelona, 08039</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>12.       MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EU/1/20/1458/021</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/023</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/024</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/026</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/028</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/030</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/032</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/034</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/044</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/046</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>13.       BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>14.       GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>15.       INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>16.       INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord 5&nbsp;mg</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>17.       UNIQUE IDENTIFIER – 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>2D
barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>18.       UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>PC</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>SN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>NN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>MINIMUM PARTICULARS
TO APPEAR ON BLISTERS OR STRIPS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>BLISTER </span></b><b><span
lang=EN-GB style='font-size:11.0pt'>FOR UNIT PACK</span></b><b><span
lang=EN-GB style='font-size:11.0pt'> 5 mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>1.         NAME OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord 5&nbsp;mg
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>apixaban</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>2.         NAME OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>Accord</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:yellow'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>3.         EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>4.         BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>5.         OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='border:none;padding:0in'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>CARTON
</span></b><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>OF
UNIT PACK CONTAINING SINGLE-UNIT-DOSE BLISTERS </span></b><b><span lang=EN-GB
style='font-size:11.0pt;letter-spacing:-.1pt'>2.5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>1.       NAME OF THE
MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
2.5&nbsp;mg film-coated tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>apixaban</span><b><span
lang=EN-GB style='font-size:11.0pt'> </span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>2.       STATEMENT OF
ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Each film-coated
tablet contains 2.5&nbsp;mg apixaban.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>3.       LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Contain lactose.
See leaflet for further information.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>4.       PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>Film-coated
tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>10 x 1&nbsp;film-coated
tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>20
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>28
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>56
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>60
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>100
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>168
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>5.       METHOD AND
ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Read the package
leaflet before use.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Oral use</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>6.       SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Keep out of the
sight and reach of children.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>7.       OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>8.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>9.       SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>10.     SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>11.       NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Accord Healthcare S.L.U.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>World Trade Center, Moll de Barcelona s/n,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Edifici Est, 6<sup>a</sup> Planta,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Barcelona, 08039</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>12.       MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EU/1/20/1458/002</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/005</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/007</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/009</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/011</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/013</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/042</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>13.       BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>14.       GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>15.       INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>16.       INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
2.5&nbsp;mg</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>17.       UNIQUE IDENTIFIER – 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>2D
barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>18.       UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>PC</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>SN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>NN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>MINIMUM PARTICULARS
TO APPEAR ON BLISTERS OR STRIPS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>SINGLE-UNIT-DOSE
BLISTERS </span></b><b><span lang=EN-GB style='font-size:11.0pt'>2.5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>1.         NAME OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
2.5&nbsp;mg tablets </span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>apixaban</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>2.         NAME OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>Accord</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:yellow'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>3.         EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>4.         BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>5.         OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='border:none;padding:0in'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;letter-spacing:-.1pt'>CARTON </span></b><b><span
lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>OF UNIT PACK
CONTAINING SINGLE-UNIT-DOSE BLISTERS</span></b><b><span lang=EN-GB
style='font-size:11.0pt'> 5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>1.       NAME OF THE
MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
5&nbsp;mg film-coated tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>apixaban</span><b><span
lang=EN-GB style='font-size:11.0pt'> </span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>2.       STATEMENT OF
ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Each film-coated
tablet contains 5&nbsp;mg apixaban.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>3.       LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Contain lactose.
See leaflet for further information.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>4.       PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>Film-coated
tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>10 x 1&nbsp;film-coated
tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>20
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>28
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>56
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>60
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>100
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>168
x 1&nbsp;film-coated tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>5.       METHOD AND
ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Read the package
leaflet before use.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Oral use</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>6.       SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Keep out of the
sight and reach of children.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>7.       OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>8.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>9.       SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>10.     SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>11.       NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Accord Healthcare S.L.U.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>World Trade Center, Moll de Barcelona s/n,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Edifici Est, 6<sup>a</sup> Planta,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Barcelona, 08039</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>12.       MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EU/1/20/1458/022</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/025</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/027</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/029</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/031</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/033</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/045</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>13.       BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>14.       GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>15.       INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>16.       INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
5&nbsp;mg</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>17.       UNIQUE IDENTIFIER – 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>2D
barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>18.       UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>PC</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>SN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>NN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>MINIMUM PARTICULARS
TO APPEAR ON BLISTERS OR STRIPS</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>SINGLE-UNIT-DOSE BLISTERS</span></b><b><span
lang=EN-GB style='font-size:11.0pt'> 5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>1.         NAME OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
5&nbsp;mg tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>apixaban</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>2.         NAME OF THE MARKETING AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>Accord</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:yellow'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>3.         EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP            </span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>4.         BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>5.         OTHER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='border:none;padding:0in'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>CARTON
</span></b><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>OF
BOTTLE PACK </span></b><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:
-.1pt'>2.5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>1.       NAME OF THE
MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
2.5&nbsp;mg film-coated tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>apixaban</span><b><span
lang=EN-GB style='font-size:11.0pt'> </span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>2.       STATEMENT OF
ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Each film-coated
tablet contains 2.5&nbsp;mg apixaban.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>3.       LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Contain lactose.
See leaflet for further information.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>4.       PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>Film-coated
tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>60&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>100&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>168&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>180&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>200&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>1000&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>5.       METHOD AND
ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Read the package
leaflet before use.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Oral use</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>6.       SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Keep out of the
sight and reach of children.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>7.       OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>8.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>9.       SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>10.     SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>11.       NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Accord Healthcare S.L.U.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>World Trade Center, Moll de Barcelona s/n,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Edifici Est, 6<sup>a</sup> Planta,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Barcelona, 08039</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>12.       MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EU/1/20/1458/015</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/016</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/017</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/018</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/019</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/020</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>13.       BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>14.       GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>15.       INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>16.       INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
2.5&nbsp;mg</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>17.       UNIQUE IDENTIFIER – 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>2D
barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>18.       UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>PC</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>SN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>NN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal style='background:white'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='border:none;padding:0in'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>LABEL
FOR</span></b><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>
BOTTLE PACK </span></b><b><span lang=EN-GB style='font-size:11.0pt;letter-spacing:
-.1pt'>2.5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>1.       NAME OF THE
MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
2.5&nbsp;mg tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>apixaban</span><b><span
lang=EN-GB style='font-size:11.0pt'> </span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>2.       STATEMENT OF
ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Each film-coated
tablet contains 2.5&nbsp;mg apixaban.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>3.       LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Contain lactose. <span
style='background:silver'>See leaflet for further information.</span></span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>4.       PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>Film-coated
tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>60&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>100&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>168&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>180&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>200&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>1000&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>5.       METHOD AND
ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Read the package
leaflet before use.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Oral use</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>6.       SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Keep out of the sight
and reach of children.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>7.       OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>8.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>9.       SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>10.     SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>11.       NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Accord <span style='background:silver'>Healthcare S.L.U.</span></span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='background:silver'>World Trade Center, Moll de Barcelona s/n,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='background:silver'>Edifici Est, 6<sup>a</sup> Planta,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='background:silver'>Barcelona, 08039</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='background:silver'>Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>12.       MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EU/1/20/1458/015</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/016</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/017</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/018</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/019</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/020</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>13.       BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>14.       GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>15.       INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>16.       INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>17.       UNIQUE IDENTIFIER – 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>18.       UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='border:none;padding:0in'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;letter-spacing:-.1pt'>CARTON </span></b><b><span
lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'>OF BOTTLE PACK </span></b><b><span
lang=EN-GB style='font-size:11.0pt'>5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>1.       NAME OF THE
MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
5&nbsp;mg film-coated tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>apixaban</span><b><span
lang=EN-GB style='font-size:11.0pt'> </span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>2.       STATEMENT OF
ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Each film-coated
tablet contains 5&nbsp;mg apixaban.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>3.       LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Contain lactose.
See leaflet for further information.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>4.       PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>Film-coated
tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>60&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>100&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>168&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>180&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>200&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>1000&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>5.       METHOD AND
ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Read the package
leaflet before use.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Oral use</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>6.       SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Keep out of the
sight and reach of children.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>7.       OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>8.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>9.       SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>10.     SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>11.       NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Accord Healthcare S.L.U.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>World Trade Center, Moll de Barcelona s/n,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Edifici Est, 6<sup>a</sup> Planta,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Barcelona, 08039</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>12.       MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EU/1/20/1458/035</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/036</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/037</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/038</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/039</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/040</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>13.       BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>14.       GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>15.       INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>16.       INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord 5&nbsp;mg</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>17.       UNIQUE IDENTIFIER – 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>2D
barcode carrying the unique identifier included.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>18.       UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>PC</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>SN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>NN</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;background:#CCCCCC'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>

<p class=MsoNormal style='border:none;padding:0in'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt;letter-spacing:-.1pt'>LABEL FOR</span></b><b><span
lang=EN-GB style='font-size:11.0pt;letter-spacing:-.1pt'> BOTTLE PACK </span></b><b><span
lang=EN-GB style='font-size:11.0pt'>5&nbsp;mg</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>1.       NAME OF THE
MEDICINAL PRODUCT</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
5&nbsp;mg tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>apixaban</span><b><span
lang=EN-GB style='font-size:11.0pt'> </span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>2.       STATEMENT OF
ACTIVE SUBSTANCE(S)</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Each film-coated
tablet contains 5&nbsp;mg apixaban.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>3.       LIST OF
EXCIPIENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Contain lactose. <span
style='background:silver'>See leaflet for further information.</span></span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>4.       PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>Film-coated
tablet</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>60&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>100&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>168&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>180&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>200&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>1000&nbsp;film-coated
tablets</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>5.       METHOD AND
ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Read the package
leaflet before use.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Oral use</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>6.       SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF
CHILDREN</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Keep out of the
sight and reach of children.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>7.       OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>8.       EXPIRY DATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EXP</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;border:none;padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>9.       SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;border:none;
padding:0in'><b><span lang=EN-GB style='font-size:11.0pt'>10.     SPECIAL
PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS
DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>11.       NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>Accord <span style='background:silver'>Healthcare S.L.U.</span></span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='background:silver'>World Trade Center, Moll de Barcelona s/n,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='background:silver'>Edifici Est, 6<sup>a</sup> Planta,</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='background:silver'>Barcelona, 08039</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB style='background:silver'>Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>12.       MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>EU/1/20/1458/035</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/036</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/037</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/038</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/039</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:silver'>EU/1/20/1458/040</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>13.       BATCH NUMBER</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Lot</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>14.       GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>15.       INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>16.       INFORMATION IN BRAILLE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:#CCCCCC'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>17.       UNIQUE IDENTIFIER – 2D BARCODE</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;display:none'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>18.       UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>

</div>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;padding:0in'><b><span lang=EN-GB
style='font-size:11.0pt'>PATIENT ALERT CARD</span></b></p>

</div>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
(apixaban)</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Patient Alert
Card</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Carry this card
with you at all times</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Show this card
to your pharmacist, dentist and any other healthcare professionals that treat
you.</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>I am under
anticoagulation treatment with Apixaban Accord (apixaban) to prevent blood
clots</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Please complete
this section or ask your doctor to do it</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Name:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Birth Date:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Indication:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Dose:   mg twice
daily</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Doctor's Name:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Doctor's
telephone:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Information for
patients</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Take Apixaban Accord
regularly as instructed. If you miss a dose, take it as soon as you remember
and continue to follow your dosing schedule.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Do not stop taking
Apixaban Accord without talking to your doctor, as you are at risk of suffering
from a stroke or other complications.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord helps
to thin your blood. However, this may increase your risk of bleeding.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Signs and symptoms of
bleeding include bruising or bleeding under the skin, tar-coloured stools,blood
in urine, nose-bleed, dizziness, tiredness, paleness or weakness, sudden severe
headache, coughing up blood or vomiting blood.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If the bleeding does
not stop on its own, <b>seek medical attention immediately</b>.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you need surgery,
inform your doctor that you are taking Apixaban Accord.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Information for
healthcare professionals</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord
(apixaban) is an oral anticoagulant acting by direct selective inhibition of
factor Xa.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Apixaban Accord may
increase the risk of bleeding. In case of major bleeding events, it should be
stopped immediately.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Treatment with Apixaban
Accord does not require routine monitoring of exposure. A calibrated
quantitative anti-Factor Xa assay may be useful in exceptional situations,
e.g., overdose and emergency surgery (prothrombin time (PT), international
normalised ratio (INR) and activated partial thromboplastin time (aPTT)
clotting tests are not recommended) – see SmPC.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>An agent to reverse the
anti-factor Xa activity of apixaban is available.</span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB
style='font-size:11.0pt'>B. PACKAGE LEAFLET</span></b></p>

<span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB
style='font-size:11.0pt'>Package leaflet: Information for the user</span></b></p>

<p class=MsoNormal align=center style='text-align:center;background:white'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord 2.5&nbsp;mg film-coated tablets </span></b></p>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
style='font-size:11.0pt'>apixaban</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Read all of
this leaflet carefully before you start taking this medicine because it
contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Keep this leaflet. You
may need to read it again.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you have any further
questions, ask your doctor, pharmacist or nurse.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-        This
medicine has been prescribed for you only. Do not pass it on to others. It may
harm them, even if their signs of illness are the same as yours.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you get any side
effects, talk to your doctor, pharmacist or nurse.</span><span lang=EN-GB
style='font-size:11.0pt;color:red'> </span><span lang=EN-GB style='font-size:
11.0pt'>This includes any possible side effects not listed in this leaflet. See
section 4.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.1pt;margin-bottom:.0001pt;text-indent:-28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>What is in this leaflet</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>1.       What Apixaban Accord is and what
it is used for</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>2.       What you need to know before you
take Apixaban Accord</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>3.       How to take Apixaban Accord</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>4.       Possible side effects</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>5.       How to store Apixaban Accord</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>6.       Contents of the pack and other
information</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB style='font-size:11.0pt'>1.       What Apixaban Accord is and what
it is used for</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord contains the active substance apixaban
and belongs to a group of medicines called anticoagulants. This medicine helps
to prevent blood clots from forming by blocking Factor Xa, which is an
important component of blood clotting.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord is used in adults:</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>to prevent blood clots
(deep vein thrombosis [DVT]) from forming after hip or knee replacement
operations. After an operation to the hip or knee you may be at a higher risk
of developing blood clots in your leg veins. This can cause the legs to swell,
with or without pain. If a blood clot travels from your leg to your lungs, it
can block blood flow causing breathlessness, with or without chest pain. This
condition (pulmonary embolism) can be life-threatening and requires immediate
medical attention.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>to prevent a blood clot
from forming in the heart in patients with an irregular heart beat (atrial
fibrillation) and at least one additional risk factor. Blood clots may break
off and travel to the brain and lead to a stroke or travel to other organs and
prevent normal blood flow to that organ (also known as a systemic embolism). A
stroke can be life-threatening and requires immediate medical attention.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>to treat blood clots in
the veins of your legs (deep vein thrombosis) and in the blood vessels of your
lungs (pulmonary embolism), and to prevent blood clots from re-occurring in the
blood vessels of your legs and/or lungs.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><b><span lang=EN-GB style='font-size:11.0pt'>2.       What
you need to know before you take Apixaban Accord</span></b><span lang=EN-GB
style='font-size:11.0pt'> </span></p>

<p class=MsoNormal><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Do not take
Apixaban Accord if:</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>you are allergic</span></b><span
lang=EN-GB style='font-size:11.0pt'> to apixaban or any of the other
ingredients of this medicine (listed in section 6)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you are <b>bleeding</b>
excessively</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you have <b>a disease
in an organ</b> of the body that increases the risk of serious bleeding (such <b>as
an active or a recent ulcer</b> of your stomach or bowel, <b>recent bleeding in
your brain</b>)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-align:justify;text-indent:
-28.1pt;text-autospace:ideograph-numeric ideograph-other'><span lang=EN-GB
style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you have a <b>liver
disease</b> which leads to increased risk of bleeding (hepatic coagulopathy)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-align:justify;text-indent:
-28.1pt;text-autospace:ideograph-numeric ideograph-other'><span lang=EN-GB
style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you are <b>taking
medicines to prevent blood clotting</b> (e.g., warfarin, rivaroxaban,
dabigatran or heparin), except when changing anticoagulant treatment, while
having a venous or arterial line and you get heparin through this line to keep
it open, or if a tube is inserted into your blood vessel (catheter ablation) to
treat an irregular heartbeat (arrhythmia).</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Warnings and
precautions </span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Talk to your doctor, pharmacist or nurse before you
take this medicine if you have any of the following:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an <b>increased risk of
bleeding</b>, such as:</span></p>

<p class=MsoNormal style='margin-left:56.4pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>bleeding disorders</span></b><span
lang=EN-GB style='font-size:11.0pt'>, including conditions resulting in reduced
platelet activity</span></p>

<p class=MsoNormal style='margin-left:56.4pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>very high blood
pressure</span></b><span lang=EN-GB style='font-size:11.0pt'>, not controlled
by medical treatment</span></p>

<p class=MsoNormal style='margin-left:56.4pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you are older than
75&nbsp;years</span></p>

<p class=MsoNormal style='margin-left:56.4pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you weigh 60&nbsp;kg or
less</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>a severe kidney
disease or if you are on dialysis</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>a liver problem or a
history of liver problems</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord will be used with caution in patients
with signs of altered liver function.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>had a tube
(catheter) or an injection into your spinal column</span></b><span lang=EN-GB
style='font-size:11.0pt'> (for anaesthesia or pain<b> </b>reduction), your
doctor will tell you to take Apixaban Accord 5&nbsp;hours or more after
catheter removal</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you have a <b>prosthetic
heart valve</b></span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if your doctor
determines that your blood pressure is unstable </span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if another treatment or
surgical procedure to remove a blood clot from your lungs is planned</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Take special care with Apixaban Accord</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you know that you
have a disease called antiphospholipid syndrome (a disorder of the immune
system that causes an increased risk of blood clots). In that case tell your
doctor who will decide if the treatment may need to be changed.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>If you need to have surgery or a procedure which may
cause bleeding, your doctor might ask you to temporarily stop taking this
medicine for a short while. If you are not sure whether a procedure may cause
bleeding ask your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Children and
adolescents</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord is not recommended in children and
adolescents under 18&nbsp;years of age.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Other medicines and Apixaban Accord</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Tell your doctor,
pharmacist or nurse if you are taking, have recently taken or might take any
other medicines.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Some medicines may
increase the effects of Apixaban Accord and some may decrease its effects. Your
doctor will decide, if you should be treated with Apixaban Accord when taking
these medicines and how closely you should be monitored.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The following
medicines may increase the effects of Apixaban Accord and increase the chance
for unwanted bleeding:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>some <b>medicines for
fungal infections</b> (e.g. ketoconazole)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>some <b>antiviral
medicines for HIV / AIDS</b> (e.g. ritonavir)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>other <b>medicines that
are used to reduce blood clotting</b> (e.g. enoxaparin)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>anti-inflammatory or
pain medicines</span></b><span lang=EN-GB style='font-size:11.0pt'> (e.g.
acetylsalicylic acid or naproxen). Especially, if you are older than 75&nbsp;years
and are taking acetylsalicylic acid, you may have an increased chance of
bleeding.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>medicines for high
blood pressure or heart problems</span></b><span lang=EN-GB style='font-size:
11.0pt'> (e.g. diltiazem)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>antidepressant
medicines</span></b><span lang=EN-GB style='font-size:11.0pt'> called <b>selective
serotonin re-uptake inhibitors</b> or <b>serotonin norepinephrine re-uptake
inhibitors</b></span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The following
medicines may reduce the ability of Apixaban Accord to help prevent blood clots
from forming:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>medicines to prevent
epilepsy or seizures</span></b><span lang=EN-GB style='font-size:11.0pt'> (e.g.
phenytoin)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>St John’s Wort</span></b><span
lang=EN-GB style='font-size:11.0pt'> (a herbal supplement used for depression)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>medicines to treat
tuberculosis or other infections</span></b><span lang=EN-GB style='font-size:
11.0pt'> (e.g. rifampicin)</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Pregnancy and
breast-feeding</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>If you are
pregnant or breast-feeding, think you may be pregnant or are planning to have a
baby, ask your doctor, pharmacist or nurse for advice before taking this
medicine.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The effects of
Apixaban Accord on pregnancy and the unborn child are not known. You should not
take Apixaban Accord if you are pregnant. <b>Contact your doctor immediately</b>
if you become pregnant while taking Apixaban Accord.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>It is not known if
Apixaban Accord passes into human breast milk. Ask your doctor, pharmacist or
nurse for advice before taking this medicine while breast-feeding. They will
advise you to either stop breastfeeding or to stop/not start taking Apixaban
Accord.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord has not been shown to impair your
ability to drive or use machine.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord contains lactose (a type of sugar) and
sodium.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>If you have been told by your doctor that you have an
intolerance to some sugars, contact your doctor before taking this medicinal
product.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>This medicine contains less than 1&nbsp;mmol sodium
(23&nbsp;mg) per tablet, that is to say essentially &quot;sodium free&quot;.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><b><span lang=EN-GB style='font-size:11.0pt'>3.       How
to take Apixaban Accord </span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Always take this medicine exactly as your doctor or
pharmacist has told you. Check with your doctor, pharmacist or nurse if you are
not sure.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Dose</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Swallow the tablet with a drink of water. Apixaban
Accord can be taken with or without food.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Try to take the tablets at the same times every day to
have the best treatment effect.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>If you have difficulty swallowing the tablet whole,
talk to your doctor about other ways to take Apixaban Accord. The tablet may be
crushed and mixed with water, or 5% dextrose in water, or apple juice or apple
puree, immediately before you take it.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Instructions for crushing:</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Crush the tablets with
a pestle and mortar or with the convex side of a spoon on a plate.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Transfer all the powder
carefully into a suitable container then mix the powder with a little e.g., 30&nbsp;mL
(2&nbsp;tablespoons), water or one of the other liquids mentioned above to make
a mixture.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Swallow the mixture.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:.1in;margin-bottom:0in;
margin-left:28.1pt;margin-bottom:.0001pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Rinse the pestle and
mortar (or the spoon and plate) you used for crushing the tablet and the
container, with a little water or one of the other liquids (e.g., 30&nbsp;mL),
and swallow the rinse.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>If necessary, your doctor may also give you the
crushed Apixaban Accord tablet mixed in 60&nbsp;mL of water or 5% dextrose in
water, through a nasogastric tube.</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Take Apixaban
Accord as recommended for the following:</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'>To prevent
blood clots from forming after hip or knee replacement operations.</span></u></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended
dose is one tablet of Apixaban Accord 2.5&nbsp;mg twice a day.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>For example, one
in the morning and one in the evening.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>You should take
the first tablet 12 to 24&nbsp;hours after your operation.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>If you have had a
major <b>hip</b> operation you will usually take the tablets for 32 to 38&nbsp;days</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>If you have had a
major <b>knee</b> operation you will usually take the tablets for 10 to 14&nbsp;days</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'>To prevent a
blood clot from forming in the heart in patients with an irregular heartbeat
and at least one additional risk factor.</span></u></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended
dose is one tablet of Apixaban Accord <b>5&nbsp;mg</b> twice a day.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended
dose is one tablet of Apixaban Accord <b>2.5&nbsp;mg</b> twice a day if:</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you have <b>severely
reduced kidney function</b></span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>two or more of the
following apply to you</span></b><span lang=EN-GB style='font-size:11.0pt'>:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>your blood test results
suggest poor kidney function (value of serum creatinine is 1.5&nbsp;mg/dL (133&nbsp;micromole/L)
or greater)</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you are 80&nbsp;years
old or older </span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>your weight is 60&nbsp;kg
or lower.</span></p>

<p class=MsoNormal style='margin-left:1.0in'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended
dose is one tablet twice a day, for example, one in the morning and one in the
evening. Your doctor will decide how long you must continue treatment for.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'>To treat blood
clots in the veins of your legs and blood clots in the blood vessels of your
lungs</span></u></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended
dose is <b>two tablets</b> of Apixaban Accord <b>5&nbsp;mg</b> twice a day for
the first 7&nbsp;days, for example, two in the morning and two in the evening.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>After 7&nbsp;days
the recommended dose is <b>one tablet</b> of Apixaban Accord <b>5&nbsp;mg</b>
twice a day, for example, one in the morning and one in the evening.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'>For preventing
blood clots from re-occurring following completion of 6&nbsp;months of
treatment</span></u></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended
dose is one tablet of Apixaban Accord <b>2.5&nbsp;mg</b> twice a day for
example, one in the morning and one in the evening.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Your doctor will
decide how long you must continue treatment for.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><u><span lang=EN-GB style='font-size:11.0pt'>Your doctor
might change your anticoagulant treatment as follows:</span></u></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span lang=EN-GB style='font-size:11.0pt'>Changing from
Apixaban Accord to anticoagulant medicines</span></i></p>

<p class=MsoNormal style='margin-left:28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Stop taking Apixaban Accord. Start treatment with the
anticoagulant medicines (for example heparin) at the time you would have taken
the next tablet.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span lang=EN-GB style='font-size:11.0pt'>Changing from
anticoagulant medicines to Apixaban Accord</span></i></p>

<p class=MsoNormal style='margin-left:28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Stop taking the anticoagulant medicines. Start
treatment with Apixaban Accord at the time you would have had the next dose of
anticoagulant medicine, then continue as normal.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span lang=EN-GB style='font-size:11.0pt'>Changing from
treatment with anticoagulant containing vitamin K antagonist (e.g., warfarin)
to Apixaban Accord</span></i></p>

<p class=MsoNormal style='margin-left:28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Stop taking the medicine containing a vitamin K
antagonist. Your doctor needs to do blood-measurements and instruct you when to
start taking Apixaban Accord.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span lang=EN-GB style='font-size:11.0pt'>Changing from
Apixaban Accord to anticoagulant treatment containing vitamin K antagonist
(e.g., warfarin).</span></i></p>

<p class=MsoNormal style='margin-left:28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>If your doctor tells you that you have to start taking
the medicine containing a vitamin K antagonist, continue to take Apixaban
Accord for at least 2&nbsp;days after your first dose of the medicine
containing a vitamin K antagonist. Your doctor needs to do blood-measurements
and instruct you when to stop taking Apixaban Accord.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Patients
undergoing cardioversion</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>If your abnormal
heartbeat needs to be restored to normal by a procedure called cardioversion,
take Apixaban Accord at the times your doctor tells you, to prevent blood clots
in blood vessels in your brain and other blood vessels in your body.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>If you take
more Apixaban Accord than you should</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Tell your
doctor immediately</span></b><span lang=EN-GB style='font-size:11.0pt'> if you
have taken more than the prescribed dose of Apixaban Accord. Take the medicine
pack with you, even if there are no tablets left.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>If you take more
Apixaban Accord than recommended, you may have an increased risk of bleeding.
If bleeding occurs, surgery or blood transfusions may be required.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>If you forget
to take Apixaban Accord</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Take the dose as soon
as you remember and:</span></p>

<p class=MsoNormal style='margin-left:59.55pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Courier New"'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB style='font-size:11.0pt'>take the next dose of Apixaban Accord at
the usual time</span></p>

<p class=MsoNormal style='margin-left:59.55pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Courier New"'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB style='font-size:11.0pt'>then continue as normal.</span></p>

<p class=MsoNormal style='text-indent:-28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>If you are not
sure what to do or have missed more than one dose</span></b><span lang=EN-GB
style='font-size:11.0pt'>, ask your doctor, pharmacist or nurse.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>If you stop
taking Apixaban Accord</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Do not stop taking
Apixaban Accord without talking to your doctor first, because the risk of
developing a blood clot could be higher if you stop treatment too early.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>If you have any
further questions on the use of this medicine, ask your doctor, pharmacist or
nurse.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB style='font-size:11.0pt'>4.       Possible side effects</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt'><span lang=EN-GB
style='font-size:11.0pt'>Like all medicines, this medicine can cause side
effects, although not everybody gets them.</span><span lang=EN-GB
style='font-size:11.0pt'> Apixaban Accord can be given for three different
medical conditions. The known side effects and how frequently they occur for
each of these medical conditions may differ and are listed separately below.For
these conditions, the most common general side effect of Apixaban Accord is
bleeding which may be potentially life threatening and require immediate
medical attention.</span></p>

<p class=MsoNormal style='margin-right:-1.45pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'>The following
side effects are known if you take Apixaban Accord to prevent blood clots from
forming after hip or knee replacement operations</span></u><span lang=EN-GB
style='font-size:11.0pt'>.</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Common side effects
(may affect up to 1 in 10&nbsp;people)</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Anaemia which may cause
tiredness or paleness</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding including bruising
and swelling</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Nausea (feeling sick)</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Uncommon side
effects (may affect up to 1 in 100&nbsp;people)</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Reduced number of
platelets in your blood (which can affect clotting)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>occurring after your
operation including bruising and swelling, blood or liquid leaking from the
surgical wound/incision (wound secretion) or injection site</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your stomach, bowel
or bright/red blood in the stools </span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>blood in the urine</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your nose</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from the vagina</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Low blood pressure
which may make you feel faint or have a quickened heartbeat</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Blood tests may show:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>abnormal liver function</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in some
liver enzymes </span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in
bilirubin, a breakdown product of red blood cells, which can cause yellowing of
the skin and eyes.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Itching</span></p>

<p class=MsoNormal style='margin-left:9.0pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Rare side
effects (may affect up to 1 in 1,000&nbsp;people)</span></b></p>

<p class=MsoNormal style='margin-left:9.0pt'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions
(hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue
and/or throat and difficulty breathing. <b>Contact your doctor immediately</b>
if you experience any of these symptoms.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into a muscle</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your eyes</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your gums and
blood in your spit when coughing</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your rectum</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Hair</span><span
lang=EN-GB style='font-size:11.0pt'> loss</span></p>

<p class=MsoNormal style='margin-left:9.0pt'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Not known (frequency
cannot be estimated from the available data)</span></b></p>

<p class=MsoNormal style='margin-left:9.0pt'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your brain or in
your spinal column,</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your lungs or your
throat</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your mouth</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into your abdomen or
space behind your abdominal cavity</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from a haemorrhoid</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>tests showing blood in
the stools or in the urin</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Skin rash</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><u><span lang=EN-GB
style='font-size:11.0pt'>The following side effects are known if you take
Apixaban Accord to prevent a blood clot from forming in the heart in patients
with an irregular heart beat and at least one additional risk factor.</span></u></p>

<p class=MsoNormal style='margin-right:-.1pt'><u><span lang=EN-GB
style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Common side effects (may affect up to 1 in 10 people)</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding including:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your eyes</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your stomach or
bowel</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your rectum</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>blood in the urine</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your nose</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your gums</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bruising and swelling</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Anaemia which may cause
tiredness or paleness</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Low blood pressure
which may make you feel faint or have a quickened heartbeat</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Nausea (feeling sick)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Blood tests may show:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in
gamma-glutamyltransferase (GGT)</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Uncommon side effects (may affect up to 1 in 100&nbsp;people)</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your brain or in
your spinal column</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your mouth or blood
in your spit when coughing</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into your abdomen, or
from the vagina</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bright/red blood in the
stools</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bleeding occurring
after your operation including bruising and swelling, blood or liquid leaking
from the surgical wound/incision (wound secretion) or injection site</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from a haemorrhoid</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>tests showing blood in
the stools or in the urine</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Reduced number of
platelets in your blood (which can affect clotting)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Blood tests may show:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>abnormal liver function</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in some
liver enzymes</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in
bilirubin, a breakdown product of red blood cells, which can cause yellowing of
the skin and eyes</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Skin rash</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Itching</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Hair loss</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions
(hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue
and/or throat and difficulty breathing. <b>Contact your doctor immediately</b>
if you experience any of these symptoms.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Rare side effects (may affect up to 1 in 1,000&nbsp;people)</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your lungs or your
throat</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into the space behind
your abdominal cavity</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into a muscle</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><u><span lang=EN-GB
style='font-size:11.0pt'>The following side effects are known if you take
Apixaban Accord to treat or prevent re-occurrence of blood clots in the veins
of your legs and blood clots in the blood vessels of your lungs</span></u><span
lang=EN-GB style='font-size:11.0pt'>.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Common side effects (may affect up to 1 in 10&nbsp;people)</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding including:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your nose</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your gums</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>blood in the urine</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bruising and swelling</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your stomach, your
bowel, from your rectum</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your mouth</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from the vagina</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Anaemia which may cause
tiredness or paleness</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Reduced number of
platelets in your blood (which can affect clotting)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Nausea (feeling sick)</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Skin rash</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Blood tests may show:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in
gamma-glutamyltransferase (GGT) or alanine aminotransferase (ALT)</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Uncommon side effects (may affect up to 1 in 100&nbsp;people)</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Low blood pressure
which may make you feel faint or have a quickened heartbeat</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your eyes</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your mouth or blood
in your spit when coughing</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bright/red blood in the
stools</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>tests showing blood in
the stools or in the urine</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bleeding occurring
after your operation including bruising and swelling, blood or liquid leaking
from the surgical wound/incision (wound secretion) or injection site</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from a haemorrhoid</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into a muscle</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Itching</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Hair loss</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions
(hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue
and/or throat and difficulty breathing. <b>Contact your doctor immediately</b>
if you experience any of these symptoms.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Blood tests may show:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>abnormal liver function</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in some
liver enzymes</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in
bilirubin, a breakdown product of red blood cells, which can cause yellowing of
the skin and eyes.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Rare side effects
(may affect up to 1 in 1,000&nbsp;people)</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your brain or in
your spinal column</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your lungs</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Not known
(frequency cannot be estimated from the available data)</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into your abdomen or
the space behind your abdominal cavity</span></p>

<p class=MsoNormal style='text-indent:-28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Reporting of
side effects</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=BodytextAgency style='margin-bottom:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you
get any side effects, talk to your doctor, pharmacist, or nurse.</span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:red'> </span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>This
includes any possible side effects not listed in this leaflet. You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>. By reporting side effects you can help provide more information
on the safety of this medicine.</span></p>

<p class=BodytextAgency style='margin-bottom:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB style='font-size:11.0pt'>5.       How to store Apixaban Accord</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Keep this medicine out of the sight and reach of
children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Do not use this medicine after the expiry date which
is stated on the carton and on blister after EXP. The expiry date refers to the
last day of that month.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>This medicine does not require any special storage
conditions.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Do not throw away any medicines via wastewater or
household waste. Ask your pharmacist how to throw away medicines you no longer
use. These measures will help protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB style='font-size:11.0pt'>6.       Contents of the pack and other information</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>What Apixaban Accord contains</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;page-break-after:
avoid;text-autospace:ideograph-numeric ideograph-other'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The active substance is
apixaban. Each tablet contains 2.5&nbsp;mg of apixaban.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;page-break-after:
avoid;text-autospace:ideograph-numeric ideograph-other'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The other ingredients
are:</span></p>

<p class=MsoNormal style='margin-left:65.2pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Tablet core<b>: Lactose
(see section 2)</b>, cellulose microcrystalline, croscarmellose sodium, sodium
laurilsulfate, magnesium stearate </span></p>

<p class=MsoNormal style='margin-left:65.2pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Film coat: <b>Lactose
monohydrate (see section 2)</b>, hypromellose, titanium dioxide (E171),
triacetin, iron oxide yellow (E172)</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>What Apixaban Accord looks like and contents of the
pack</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The film-coated
tablets are yellow, round shaped, biconvex, film coated tablet debossed with
“IU1” on one side and plain on the other side.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:yellow'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>PVC/PVdC-Aluminium blisters <span style='color:black'>are available
in </span>10, 14, 20, 28, 56, 60, 100, 112, 168, and 200&nbsp;film&#8209;coated
tablets.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>PVC/PVdC-Aluminium blisters <span style='color:black'>are available
in </span>perforated unit dose blisters of 10 x 1, 20 x 1, 28 x 1, 56 x 1, 60 x
1, 100 x 1 and 168 x 1&nbsp;film-coated tablet.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>HDPE bottle with polypropylene child resistant/continues threaded closure
containing 60, 100, 168, 180, 200 and 1000&nbsp;film-coated tablets.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;background:yellow'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Not all pack sizes
may be marketed.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Patient Alert
Card: handling information</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Inside the
Apixaban Accord pack together with the package leaflet you will find a Patient
Alert Card or your doctor might give you a similar card.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>This Patient Alert
Card includes information that will be helpful to you and alert other doctors
that you are taking Apixaban Accord. <b>You should keep this card with you at
all times.</b></span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>1. Take the card</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>2. Separate your
language as needed (this is facilitated by the perforated edges)</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>3. Complete the following
sections or ask your doctor to do it:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Name:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Birth Date:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Indication:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Dose: ……mg twice
daily</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Doctor's Name:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Doctor's
telephone:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>4. Fold the card
and keep it with you at all times</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Accord Healthcare
S.L.U.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>World Trade
Center, Moll de Barcelona, s/n,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Edifici Est, 6<sup>a</sup>
Planta,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>08039 Barcelona,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Spain</span></p>

<p class=Default><b><span style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=Default><b><span style='font-size:11.0pt'>Manufacturer</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>LABORATORI
FUNDACIÓ DAU</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>C/ C, 12-14 Pol.
Ind. Zona Franca, Barcelona,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>08040 Barcelona,
Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Accord Healthcare
Polska Sp. z.o.o.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>ul.Lutomierska 50,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>95-200, Pabianice,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Poland</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Pharmadox
Healthcare Limited</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>KW20A Kordin
Industrial Park,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Paola PLA 3000,
Malta</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=Default><b><span style='font-size:11.0pt'>This leaflet was last
revised in</span></b></p>

<p class=Default><span style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Other sources
of information</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Detailed
information on this medicine is available on the European Medicines Agency
website: <span style='color:blue'><a href="http://www.ema.europa.eu/">http://www.ema.europa.eu</a>.</span></span></p>

<b><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB
style='font-size:11.0pt'>Package leaflet: Information for the user</span></b></p>

<p class=MsoNormal align=center style='text-align:center;background:white'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord 5&nbsp;mg film-coated tablets </span></b></p>

<p class=MsoNormal align=center style='text-align:center'><span lang=EN-GB
style='font-size:11.0pt'>apixaban</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Read all of
this leaflet carefully before you start taking this medicine because it
contains important information for you.</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Keep this leaflet. You
may need to read it again. </span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you have any further
questions, ask your doctor, pharmacist or nurse.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-        This medicine has been prescribed
for you only. Do not pass it on to others. It may harm them, even if their
signs of illness are the same as yours.<span style='color:green'> </span></span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>If you get any side
effects, talk to your doctor, pharmacist or nurse.</span><span lang=EN-GB
style='font-size:11.0pt;color:red'> </span><span lang=EN-GB style='font-size:
11.0pt'>This includes any possible side effects not listed in this leaflet. See
section 4.</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.1pt;margin-bottom:.0001pt;text-indent:-28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>What is in this leaflet</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>1.       What Apixaban Accord is and what
it is used for</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>2.       What you need to know before you
take Apixaban Accord</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>3.       How to take Apixaban Accord</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>4.       Possible side effects</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>5.       How to store Apixaban Accord</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>6.       Contents of the pack and other
information</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB style='font-size:11.0pt'>1.       What Apixaban Accord is and what
it is used for</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord contains the active substance apixaban
and belongs to a group of medicines called anticoagulants. This medicine helps
to prevent blood clots from forming by blocking Factor Xa, which is an
important component of blood clotting.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.1pt;margin-bottom:.0001pt;text-indent:-28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord is used in adults:</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>to prevent a blood clot
from forming in the heart in patients with an irregular heart beat (atrial
fibrillation) and at least one additional risk factor. Blood clots may break
off and travel to the brain and lead to a stroke or travel other organs and
prevent normal blood flow to that organ (also known as a systemic embolism). A
stroke can be life-threatening and requires immediate medical attention.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>to treat blood clots in
the veins of your legs (deep vein thrombosis) and in the blood vessels of your
lungs (pulmonary embolism), and to prevent blood clots from re-occurring in the
blood vessels of your legs and/or lungs.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB style='font-size:11.0pt'>2.       What you need to know before you
take Apixaban Accord</span></b><span lang=EN-GB style='font-size:11.0pt'> </span></p>

<p class=MsoNormal><i><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></i></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><b><span
lang=EN-GB style='font-size:11.0pt'>Do not take Apixaban Accord if:</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>you are allergic</span></b><span
lang=EN-GB style='font-size:11.0pt'> to apixaban or any of the other
ingredients of this medicine (listed in section 6)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you are <b>bleeding</b>
excessively</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you have <b>a disease
in an organ</b> of the body that increases the risk of serious bleeding (such <b>as
an active or a recent ulcer</b> of your stomach or bowel, <b>recent bleeding in
your brain</b>)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you have a <b>liver
disease</b> which leads to increased risk of bleeding (hepatic coagulopathy) </span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you are <b>taking
medicines to prevent blood clotting</b> (e.g., warfarin, rivaroxaban,
dabigatran or heparin), except when changing anticoagulant treatment or while
having a venous or arterial line and you get heparin through this line to keep
it open, or if a tube is inserted into your blood vessel (catheter ablation) to
treat an irregular heartbeat (arrhythmia).</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Warnings and
precautions </span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Talk to your doctor, pharmacist or nurse before you
take this medicine if you have any of the following:</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an <b>increased risk of
bleeding</b>, such as:</span></p>

<p class=MsoNormal style='margin-left:64.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>bleeding disorders</span></b><span
lang=EN-GB style='font-size:11.0pt'>, including conditions resulting in reduced
platelet activity</span></p>

<p class=MsoNormal style='margin-left:64.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>very high blood
pressure</span></b><span lang=EN-GB style='font-size:11.0pt'>, not controlled
by medical treatment</span></p>

<p class=MsoNormal style='margin-left:64.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you are older than
75&nbsp;years</span></p>

<p class=MsoNormal style='margin-left:64.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you weigh 60&nbsp;kg or
less</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>a severe kidney
disease or if you are on dialysis</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>a liver problem or a
history of liver problems</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord will be used with caution in patients
with signs of altered liver function.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you have a <b>prosthetic
heart valve</b></span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if your doctor
determines that your blood pressure is unstable</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if another treatment or
surgical procedure to remove a blood clot from your lungs is planned</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>If you need to have surgery or a procedure which may
cause bleeding, your doctor might ask you to temporarily stop taking this
medicine for a short while. If you are not sure whether a procedure may cause
bleeding ask your doctor.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.1pt;margin-bottom:.0001pt;text-indent:-28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Take special care with Apixaban Accord</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>if you know that you
have a disease called antiphospholipid syndrome (a disorder of the immune system
that causes an increased risk of blood clots). In that case tell your doctor
who will decide if the treatment may need to be changed.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Children and
adolescents</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord is not recommended in children and
adolescents under 18&nbsp;years of age.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Other medicines and Apixaban Accord</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Tell your doctor,
pharmacist or nurse if you are taking, have recently taken or might take any
other medicines.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Some medicines may
increase the effects of Apixaban Accord and some may decrease its effects. Your
doctor will decide, if you should be treated with Apixaban Accord when taking
these medicines and how closely you should be monitored.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The following
medicines may increase the effects of Apixaban Accord and increase the chance
for unwanted bleeding:</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>some <b>medicines for
fungal infections</b> (e.g. ketoconazole)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>some <b>antiviral
medicines for HIV / AIDS</b> (e.g. ritonavir)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>other <b>medicines that
are used to reduce blood clotting</b> (e.g. enoxaparin)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>anti-inflammatory or
pain medicines</span></b><span lang=EN-GB style='font-size:11.0pt'> (e.g.
acetylsalicylic acid or naproxen). Especially, if you are older than 75 years
and are taking acetylsalicylic acid, you may have an increased chance of
bleeding.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>medicines for high
blood pressure or heart problems</span></b><span lang=EN-GB style='font-size:
11.0pt'> (e.g. diltiazem)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>antidepressant
medicines</span></b><span lang=EN-GB style='font-size:11.0pt'> called <b>selective
serotonin re-uptake inhibitors</b> or <b>serotonin norepinephrine re-uptake
inhibitors</b></span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The following
medicines may reduce the ability of Apixaban Accord to help prevent blood clots
from forming:</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>medicines to prevent
epilepsy or seizures</span></b><span lang=EN-GB style='font-size:11.0pt'> (e.g.
phenytoin.)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>St John’s Wort</span></b><span
lang=EN-GB style='font-size:11.0pt'> (a herbal supplement used for depression)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>medicines to treat
tuberculosis or other infections</span></b><span lang=EN-GB style='font-size:
11.0pt'> (e.g. rifampicin)</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Pregnancy and
breast-feeding</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>If you are
pregnant or breast-feeding, think you may be pregnant or are planning to have a
baby, ask your doctor, pharmacist or nurse for advice before taking this
medicine.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The effects of
Apixaban Accord on pregnancy and the unborn child are not known. You should not
take Apixaban Accord if you are pregnant. <b>Contact your doctor immediately</b>
if you become pregnant while taking Apixaban Accord.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>It is not known if
Apixaban Accord passes into human breast milk. Ask your doctor, pharmacist or
nurse for advice before taking this medicine while breast-feeding. They will
advise you to either stop breastfeeding or to stop/not start taking Apixaban
Accord.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Driving and using machines</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord has not been shown to impair your
ability to drive or use machine </span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Apixaban Accord contains lactose (a type of sugar) and
sodium.</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>If you have been told by your doctor that you have an
intolerance to some sugars, contact your doctor before taking this medicinal
product.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>This medicine contains less than 1&nbsp;mmol sodium
(23&nbsp;mg) per tablet, that is to say essentially &quot;sodium free&quot;.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB style='font-size:11.0pt'>3.       How to take Apixaban Accord </span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Always take this medicine exactly as your doctor or
pharmacist has told you. Check with your doctor, pharmacist or nurse if you are
not sure. </span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Dose</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Swallow the tablet with a drink of water. Apixaban
Accord can be taken with or without food.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Try to take the tablets at the same times every day to
have the best treatment effect.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>If you have difficulty swallowing the tablet whole,
talk to your doctor about other ways to take Apixaban Accord. The tablet may be
crushed and mixed with water, or 5% dextrose in water, or apple juice or apple
puree, immediately before you take it.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Instructions for crushing:</span></b></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Crush the tablets with
a pestle and mortar or with the convex side of a spoon on a plate..</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Transfer all the powder
carefully into a suitable container then mix the powder with a little e.g.,
30&nbsp;mL (2 tablespoons), water or one of the other liquids mentioned above
to make a mixture.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Swallow the mixture.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Rinse the pestle and
mortar (or the spoon and plate) you used for crushing the tablet and the
container, with a little water or one of the other liquids (e.g., 30&nbsp;mL),
and swallow the rinse.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>If necessary, your doctor may also give you the
crushed Apixaban Accord tablet mixed in 60 mL of water or 5% dextrose in water,
through a nasogastric tube.</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Take Apixaban
Accord as recommended for the following:</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'>To prevent a
blood clot from forming in the heart in patients with an irregular heartbeat
and at least one additional risk factor.</span></u></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended dose
is one tablet of Apixaban Accord <b>5&nbsp;mg</b> twice a day.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended
dose is one tablet of Apixaban Accord <b>2.5&nbsp;mg</b> twice a day if:</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you have <b>severely
reduced kidney function</b></span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-GB style='font-size:11.0pt'>two or more of the
following apply to you</span></b><span lang=EN-GB style='font-size:11.0pt'>:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>your blood test results
suggest poor kidney function (value of serum creatinine is 1.5&nbsp;mg/dL
(133&nbsp;micromole/L) or greater)</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>you are 80&nbsp;years
old or older </span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>your weight is 60&nbsp;kg
or lower.</span></p>

<p class=MsoNormal style='margin-left:1.0in'><span lang=EN-GB style='font-size:
11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended
dose is one tablet twice a day, for example, one in the morning and one in the
evening. </span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Your doctor will
decide how long you must continue treatment for.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'>To treat blood
clots in the veins of your legs and blood clots in the blood vessels of your
lungs</span></u></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'><span
 style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended
dose is <b>two tablets</b> of Apixaban Accord <b>5&nbsp;mg</b> twice a day for
the first 7&nbsp;days, for example, two in the morning and two in the evening.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>After 7&nbsp;days
the recommended dose is <b>one tablet</b> of Apixaban Accord <b>5&nbsp;mg</b>
twice a day, for example, one in the morning and one in the evening.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><u><span lang=EN-GB style='font-size:11.0pt'>For preventing
blood clots from re-occurring following completion of 6&nbsp;months of
treatment</span></u></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The recommended
dose is one tablet of Apixaban Accord <b>2.5&nbsp;mg</b> twice a day for
example, one in the morning and one in the evening.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Your doctor will
decide how long you must continue treatment for.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><u><span lang=EN-GB style='font-size:11.0pt'>Your doctor
might change your anticoagulant treatment as follows:</span></u></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span lang=EN-GB style='font-size:11.0pt'>Changing from
Apixaban Accord to anticoagulant medicines</span></i></p>

<p class=MsoNormal style='margin-left:28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Stop taking Apixaban Accord. Start treatment with the
anticoagulant medicines (for example heparin) at the time you would have taken
the next tablet.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span lang=EN-GB style='font-size:11.0pt'>Changing from
anticoagulant medicines to Apixaban Accord</span></i></p>

<p class=MsoNormal style='margin-left:28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Stop taking the anticoagulant medicines. Start
treatment with Apixaban Accord at the time you would have had the next dose of
anticoagulant medicine, then continue as normal.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span lang=EN-GB style='font-size:11.0pt'>Changing from
treatment with anticoagulant containing vitamin K antagonist (e.g., warfarin)
to Apixaban Accord</span></i></p>

<p class=MsoNormal style='margin-left:28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Stop taking the medicine containing a vitamin K
antagonist. Your doctor needs to do blood-measurements and instruct you when to
start taking Apixaban Accord.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><i><span lang=EN-GB style='font-size:11.0pt'>Changing from Apixaban
Accord to anticoagulant treatment containing vitamin K antagonist (e.g.,
warfarin).</span></i></p>

<p class=MsoNormal style='margin-left:28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>If your doctor tells you that you have to start taking
the medicine containing a vitamin K antagonist, continue to take Apixaban
Accord for at least 2&nbsp;days after your first dose of the medicine
containing a vitamin K antagonist. Your doctor needs to do blood-measurements
and instruct you when to stop taking Apixaban Accord.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Patients
undergoing cardioversion</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>If your abnormal
heartbeat needs to be restored to normal by a procedure called cardioversion,
take Apixaban Accord at the times your doctor tells you, to prevent blood clots
in blood vessels in your brain and other blood vessels in your body.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>If you take
more Apixaban Accord than you should</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Tell your
doctor immediately</span></b><span lang=EN-GB style='font-size:11.0pt'> if you
have taken more than the prescribed dose of Apixaban Accord. Take the medicine
pack with you, even if there are no tablets left.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>If you take more
Apixaban Accord than recommended, you may have an increased risk of bleeding.
If bleeding occurs, surgery or blood transfusions, or other treatments that may
reverse anti-factor Xa activity may be required.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>If you forget
to take Apixaban Accord</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Take the dose as soon
as you remember and:</span></p>

<p class=MsoNormal style='margin-left:59.8pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Courier New"'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB style='font-size:11.0pt'>take the next dose of Apixaban Accord at
the usual time</span></p>

<p class=MsoNormal style='margin-left:59.8pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Courier New"'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-GB style='font-size:11.0pt'>then continue as normal.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>If you are not
sure what to do or have missed more than one dose</span></b><span lang=EN-GB
style='font-size:11.0pt'>, ask your doctor, pharmacist or nurse.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>If you stop
taking Apixaban Accord</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Do not stop taking
Apixaban Accord without talking to your doctor first, because the risk of
developing a blood clot could be higher if you stop treatment too early.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>If you have any
further questions on the use of this medicine, ask your doctor, pharmacist or
nurse.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB style='font-size:11.0pt'>4.       Possible side effects</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-1.45pt'><span lang=EN-GB
style='font-size:11.0pt'>Like all medicines, this medicine can cause side effects,
although not everybody gets them.</span><span lang=EN-GB style='font-size:11.0pt'>
The most common general side effect of Apixaban Accord is bleeding which may be
potentially life threatening and require immediate medical attention.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><u><span lang=EN-GB
style='font-size:11.0pt'>The following side effects are known if you take
Apixaban Accord to prevent a blood clot from forming in the heart in patients
with an irregular heart beat and at least one additional risk factor.</span></u></p>

<p class=MsoNormal style='margin-right:-.1pt'><u><span lang=EN-GB
style='font-size:11.0pt'><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Common side effects (may affect up to 1 in 10&nbsp;people)</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding including:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your eyes</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your stomach or
bowel</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your rectum</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>blood in the urine</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your nose</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your gums</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bruising and swelling</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Anaemia which may cause
tiredness or paleness</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Low blood pressure
which may make you feel faint or have a quickened heartbeat</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Nausea (feeling sick)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Blood tests may show:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in
gamma-glutamyltransferase (GGT)</span></p>

<p class=MsoNormal style='margin-right:-.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Uncommon side effects (may affect up to 1 in 100
people)</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your brain or in
your spinal column</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your mouth or blood
in your spit when coughing</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into your abdomen, or
from the vagina</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bright/red blood in the
stools</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bleeding occurring
after your operation including bruising and swelling, blood or liquid leaking
from the surgical wound/incision (wound secretion) or injection site</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from a haemorrhoid</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>tests showing blood in
the stools or in the urine</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Reduced number of
platelets in your blood (which can affect clotting)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Blood tests may show:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>abnormal liver function</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in some
liver enzymes</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in
bilirubin, a breakdown product of red blood cells, which can cause yellowing of
the skin and eyes</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Skin rash</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Itching</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Hair loss</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions
(hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue
and/or throat and difficulty breathing. <b>Contact your doctor immediately</b>
if you experience any of these symptoms.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Rare side effects (may affect up to 1 in 1,000&nbsp;people)</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your lungs or your
throat</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into the space behind
your abdominal cavity</span></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into a muscle</span></p>

<p class=MsoNormal style='margin-right:-.1pt;text-indent:-28.1pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><u><span lang=EN-GB
style='font-size:11.0pt'>The following side effects are known if you take
Apixaban Accord to treat or prevent re-occurrence of blood clots in the veins
of your legs and blood clots in the blood vessels of your lungs</span></u><span
lang=EN-GB style='font-size:11.0pt'>.</span></p>

<p class=MsoNormal align=center style='margin-right:-.1pt;text-align:center'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Common side effects (may affect up to 1 in 10&nbsp;people)</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding including:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your nose</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from your gums</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>blood in the urine</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bruising and swelling</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your stomach, your
bowel, from your rectum</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your mouth</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from the vagina</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Anaemia which may cause
tiredness or paleness</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Reduced number of
platelets in your blood (which can affect clotting)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Nausea (feeling sick)</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Skin rash</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Blood tests may show:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in
gamma-glutamyltransferase (GGT) or alanine aminotransferase (ALT)</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Uncommon side effects (may affect up to 1 in 100&nbsp;people)</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Low blood pressure
which may make you feel faint or have a quickened heartbeat</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your eyes</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your mouth or blood
in your spit when coughing</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bright/red blood in the
stools</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>tests showing blood in
the stools or in the urine</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>bleeding occurring
after your operation including bruising and swelling, blood or liquid leaking
from the surgical wound/incision (wound secretion) or injection site</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>from a haemorrhoid</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into a muscle</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Itching</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Hair loss</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Allergic reactions
(hypersensitivity) which may cause: swelling of the face, lips, mouth, tongue
and/or throat and difficulty breathing. <b>Contact your doctor immediately</b>
if you experience any of these symptoms.</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Blood tests may show:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>abnormal liver function</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in some
liver enzymes</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>an increase in
bilirubin, a breakdown product of red blood cells, which can cause yellowing of
the skin and eyes.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Rare side
effects (may affect up to 1 in 1,000&nbsp;people)</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your brain or in
your spinal column</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>in your lungs</span></p>

<p class=MsoNormal style='text-indent:-28.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Not known
(frequency cannot be estimated from the available data)</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.1pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Bleeding:</span></p>

<p class=MsoNormal style='margin-left:70.6pt;text-indent:-28.1pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>into your abdomen or
the space behind your abdominal cavity</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Reporting of
side effects</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=BodytextAgency style='margin-bottom:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>If you
get any side effects, talk to your doctor, pharmacist, or nurse.</span><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif;
color:red'> </span><span lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>This
includes any possible side effects not listed in this leaflet. You can also
report side effects directly via <span style='background:silver'>the national
reporting system listed in <a
href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc">Appendix
V</a></span>. By reporting side effects you can help provide more information
on the safety of this medicine.</span></p>

<p class=BodytextAgency style='margin-bottom:0in;line-height:normal'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB style='font-size:11.0pt'>5.       How to store Apixaban Accord</span></b></p>

<p class=MsoNormal style='margin-top:0in;margin-right:-.1pt;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Keep this medicine out of the sight and reach of
children.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Do not use this medicine after the expiry date which
is stated on the carton and on blister after EXP. The expiry date refers to the
last day of that month.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>This medicine does not require any special storage
conditions.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>Do not throw away any medicines via wastewater or
household waste. Ask your pharmacist how to throw away medicines you no longer
use. These measures will help protect the environment.</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt'><b><span
lang=EN-GB style='font-size:11.0pt'>6.       Contents of the pack and other
information</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>What Apixaban Accord contains</span></b></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;text-autospace:ideograph-numeric ideograph-other'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The active substance is
apixaban. Each tablet contains 5&nbsp;mg of apixaban.</span></p>

<p class=MsoNormal style='margin-left:28.35pt;text-indent:-28.35pt;page-break-after:
avoid;text-autospace:ideograph-numeric ideograph-other'><span lang=EN-GB
style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>The other ingredients
are:</span></p>

<p class=MsoNormal style='margin-left:65.2pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Tablet core<b>: Lactose
(see section 2)</b>, cellulose microcrystalline, croscarmellose sodium, sodium
laurilsulfate, magnesium stearate </span></p>

<p class=MsoNormal style='margin-left:65.2pt;text-indent:-28.35pt;text-autospace:
ideograph-numeric ideograph-other'><span lang=EN-GB style='font-size:11.0pt'>-<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB style='font-size:11.0pt'>Film coat: <b>Lactose
monohydrate (see section 2)</b>, hypromellose, titanium dioxide (E171),
triacetin, iron oxide red (E172)</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>What Apixaban Accord looks like and contents of the
pack</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>The film-coated
tablets are pink, oval shaped, biconvex, film coated tablet debossed with “IU2”
on one side and plain on other side.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt;color:black'>&nbsp;</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>PVC/PVdC-Aluminium blisters <span style='color:black'>are available
in </span>10, 14, 20, 28, 56, 60, 100, 112, 168, and 200&nbsp;film&#8209;coated
tablets.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>PVC/PVdC-Aluminium blisters <span style='color:black'>are available
in </span>perforated unit dose blisters of 10 x 1, 20 x 1, 28 x 1, 56 x 1, 60 x
1, 100 x 1 and 168 x 1&nbsp;film-coated tablet.</span></p>

<p class=MsoBodyText style='margin-left:0in;punctuation-wrap:simple'><span
lang=EN-GB>HDPE bottle with polypropylene child resistant/continues threaded closure
containing 60, 100, 168, 180, 200 and 1000&nbsp;film-coated tablets.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Not all pack sizes
may be marketed.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Patient Alert
Card: handling information</span></b></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Inside the
Apixaban Accord pack together with the package leaflet you will find a Patient
Alert Card or your doctor might give you a similar card.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>This Patient Alert
Card includes information that will be helpful to you and alert other doctors
that you are taking Apixaban Accord. </span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>You should keep
this card with you at all times.</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>1. Take the card</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>2. Separate your
language as needed (this is facilitated by the perforated edges)</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>3. Complete the
following sections or ask your doctor to do it:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Name:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Birth Date:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Indication:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Dose: ........mg
twice daily</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Doctor's Name:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>- Doctor's
telephone:</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>4. Fold the card
and keep it with you at all times</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><b><span lang=EN-GB
style='font-size:11.0pt'>Marketing Authorisation Holder and Manufacturer</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Accord Healthcare
S.L.U.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>World Trade
Center, Moll de Barcelona, s/n,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Edifici Est, 6<sup>a</sup>
Planta,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>08039 Barcelona,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Spain</span></p>

<p class=Default><b><span style='font-size:11.0pt'>&nbsp;</span></b></p>

<p class=Default><b><span style='font-size:11.0pt'>Manufacturer</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>LABORATORI
FUNDACIÓ DAU</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>C/ C, 12-14 Pol.
Ind. Zona Franca, Barcelona,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>08040 Barcelona,
Spain</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Accord Healthcare
Polska Sp. z.o.o.</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>ul.Lutomierska 50,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>95-200, Pabianice,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Poland</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Pharmadox
Healthcare Limited</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>KW20A Kordin
Industrial Park,</span></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Paola PLA 3000,
Malta</span></p>

<p class=MsoNormal style='margin-right:-.1pt'><span lang=EN-GB
style='font-size:11.0pt'>&nbsp;</span></p>

<p class=Default><b><span style='font-size:11.0pt'>This leaflet was last
revised in</span></b></p>

<p class=Default><span style='font-size:11.0pt'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=EN-GB style='font-size:11.0pt'>Other sources
of information</span></b></p>

<p class=MsoNormal><span lang=EN-GB style='font-size:11.0pt'>Detailed
information on this medicine is available on the European Medicines Agency
website: <span style='color:blue'><a href="http://www.ema.europa.eu/">http://www.ema.europa.eu</a>.</span></span></p>

</div>

</body>

</html>
